WO2023276813A1 - Pyridazinone compound, agricultural and horticultural germicide, nematicide, and medical and animal antifungal agent - Google Patents
Pyridazinone compound, agricultural and horticultural germicide, nematicide, and medical and animal antifungal agent Download PDFInfo
- Publication number
- WO2023276813A1 WO2023276813A1 PCT/JP2022/024872 JP2022024872W WO2023276813A1 WO 2023276813 A1 WO2023276813 A1 WO 2023276813A1 JP 2022024872 W JP2022024872 W JP 2022024872W WO 2023276813 A1 WO2023276813 A1 WO 2023276813A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- substituted
- unsubstituted
- represented
- group represented
- Prior art date
Links
- 229940121375 antifungal agent Drugs 0.000 title claims description 27
- 239000003429 antifungal agent Substances 0.000 title claims description 27
- 239000005645 nematicide Substances 0.000 title claims description 19
- -1 Pyridazinone compound Chemical class 0.000 title abstract description 514
- 230000002070 germicidal effect Effects 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 title description 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract description 271
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 180
- 125000005843 halogen group Chemical group 0.000 claims abstract description 153
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims abstract description 147
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 91
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims abstract description 78
- 150000001875 compounds Chemical class 0.000 claims abstract description 72
- 150000003839 salts Chemical class 0.000 claims abstract description 46
- 239000004480 active ingredient Substances 0.000 claims abstract description 25
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 19
- 125000004434 sulfur atom Chemical group 0.000 claims abstract description 19
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 18
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims abstract description 10
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 173
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 86
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 76
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 34
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 31
- 239000000417 fungicide Substances 0.000 claims description 30
- 125000000962 organic group Chemical group 0.000 claims description 30
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 28
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 230000000855 fungicidal effect Effects 0.000 claims description 22
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims description 20
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 20
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims description 18
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 claims description 17
- 125000003320 C2-C6 alkenyloxy group Chemical group 0.000 claims description 17
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 17
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 17
- 125000004104 aryloxy group Chemical group 0.000 claims description 16
- 125000003277 amino group Chemical group 0.000 claims description 14
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims description 14
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 14
- 125000005110 aryl thio group Chemical group 0.000 claims description 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 13
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 12
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 10
- 125000006590 (C2-C6) alkenylene group Chemical group 0.000 claims description 9
- 125000006591 (C2-C6) alkynylene group Chemical group 0.000 claims description 7
- 125000002993 cycloalkylene group Chemical group 0.000 claims description 7
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 7
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 6
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 5
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 12
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 description 172
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 description 102
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 90
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 60
- 239000003112 inhibitor Substances 0.000 description 45
- SVMGVZLUIWGYPH-UHFFFAOYSA-N nitroscanate Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=CC=C(N=C=S)C=C1 SVMGVZLUIWGYPH-UHFFFAOYSA-N 0.000 description 42
- 125000002947 alkylene group Chemical group 0.000 description 40
- 239000000203 mixture Substances 0.000 description 40
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 36
- 239000000243 solution Substances 0.000 description 34
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 description 33
- 125000001072 heteroaryl group Chemical group 0.000 description 33
- 125000001246 bromo group Chemical group Br* 0.000 description 29
- 125000001153 fluoro group Chemical group F* 0.000 description 29
- 125000006164 6-membered heteroaryl group Chemical group 0.000 description 27
- 125000005529 alkyleneoxy group Chemical group 0.000 description 27
- 125000001309 chloro group Chemical group Cl* 0.000 description 27
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 26
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 26
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 26
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 26
- 241000123650 Botrytis cinerea Species 0.000 description 25
- 230000015572 biosynthetic process Effects 0.000 description 24
- 125000002346 iodo group Chemical group I* 0.000 description 24
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 24
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 24
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 23
- 125000001624 naphthyl group Chemical group 0.000 description 23
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 22
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 22
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 22
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 21
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 20
- 125000006606 n-butoxy group Chemical group 0.000 description 20
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 20
- 239000003795 chemical substances by application Substances 0.000 description 19
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 19
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 19
- 125000002541 furyl group Chemical group 0.000 description 19
- 125000002883 imidazolyl group Chemical group 0.000 description 19
- 125000001786 isothiazolyl group Chemical group 0.000 description 19
- 125000000842 isoxazolyl group Chemical group 0.000 description 19
- 125000001715 oxadiazolyl group Chemical group 0.000 description 19
- 125000002971 oxazolyl group Chemical group 0.000 description 19
- 125000003226 pyrazolyl group Chemical group 0.000 description 19
- 125000000168 pyrrolyl group Chemical group 0.000 description 19
- 125000003831 tetrazolyl group Chemical group 0.000 description 19
- 125000001113 thiadiazolyl group Chemical group 0.000 description 19
- 125000000335 thiazolyl group Chemical group 0.000 description 19
- 125000001544 thienyl group Chemical group 0.000 description 19
- 125000004306 triazinyl group Chemical group 0.000 description 19
- 125000001425 triazolyl group Chemical group 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 241000221785 Erysiphales Species 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 18
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 18
- 125000003373 pyrazinyl group Chemical group 0.000 description 18
- 125000002098 pyridazinyl group Chemical group 0.000 description 18
- 125000004076 pyridyl group Chemical group 0.000 description 18
- 125000000714 pyrimidinyl group Chemical group 0.000 description 18
- 125000006163 5-membered heteroaryl group Chemical group 0.000 description 17
- 125000001188 haloalkyl group Chemical group 0.000 description 17
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 17
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 17
- 238000005160 1H NMR spectroscopy Methods 0.000 description 16
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 16
- 238000009472 formulation Methods 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 125000006557 (C2-C5) alkylene group Chemical group 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- 125000002603 chloroethyl group Chemical group [H]C([*])([H])C([H])([H])Cl 0.000 description 15
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 125000005842 heteroatom Chemical group 0.000 description 15
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 15
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 15
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 15
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 15
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 14
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 14
- 241000223218 Fusarium Species 0.000 description 14
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 14
- 241000209140 Triticum Species 0.000 description 14
- 235000021307 Triticum Nutrition 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 13
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 13
- 125000004863 4-trifluoromethoxyphenyl group Chemical group [H]C1=C([H])C(OC(F)(F)F)=C([H])C([H])=C1* 0.000 description 13
- 241000813090 Rhizoctonia solani Species 0.000 description 13
- 239000003643 water by type Substances 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 125000004438 haloalkoxy group Chemical group 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 11
- 125000000532 dioxanyl group Chemical group 0.000 description 11
- 125000005879 dioxolanyl group Chemical group 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 239000000706 filtrate Substances 0.000 description 11
- 125000002636 imidazolinyl group Chemical group 0.000 description 11
- 125000003971 isoxazolinyl group Chemical group 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 125000002757 morpholinyl group Chemical group 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- 125000005968 oxazolinyl group Chemical group 0.000 description 11
- 125000004193 piperazinyl group Chemical group 0.000 description 11
- 125000005936 piperidyl group Chemical group 0.000 description 11
- 125000002755 pyrazolinyl group Chemical group 0.000 description 11
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 11
- 125000001422 pyrrolinyl group Chemical group 0.000 description 11
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 11
- 125000001984 thiazolidinyl group Chemical group 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 10
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 10
- 229920006395 saturated elastomer Polymers 0.000 description 10
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 10
- 125000006017 1-propenyl group Chemical group 0.000 description 9
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 9
- 241000233639 Pythium Species 0.000 description 9
- 241001361634 Rhizoctonia Species 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 125000003545 alkoxy group Chemical group 0.000 description 9
- 125000003118 aryl group Chemical group 0.000 description 9
- 125000002393 azetidinyl group Chemical group 0.000 description 9
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 9
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 9
- 125000003566 oxetanyl group Chemical group 0.000 description 9
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 8
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 8
- 229920000858 Cyclodextrin Polymers 0.000 description 8
- 241000233866 Fungi Species 0.000 description 8
- 239000000654 additive Substances 0.000 description 8
- 125000004429 atom Chemical group 0.000 description 8
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 8
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 8
- 125000004043 oxo group Chemical group O=* 0.000 description 8
- 230000000704 physical effect Effects 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 description 7
- 241001529387 Colletotrichum gloeosporioides Species 0.000 description 7
- 240000008067 Cucumis sativus Species 0.000 description 7
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 7
- 102000015782 Electron Transport Complex III Human genes 0.000 description 7
- 108010024882 Electron Transport Complex III Proteins 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 241000223221 Fusarium oxysporum Species 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 241000918585 Pythium aphanidermatum Species 0.000 description 7
- 125000004069 aziridinyl group Chemical group 0.000 description 7
- 229940097362 cyclodextrins Drugs 0.000 description 7
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 7
- 125000000262 haloalkenyl group Chemical group 0.000 description 7
- 125000000232 haloalkynyl group Chemical group 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 239000000543 intermediate Substances 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 7
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 6
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 6
- 125000006039 1-hexenyl group Chemical group 0.000 description 6
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 6
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 6
- 125000006040 2-hexenyl group Chemical group 0.000 description 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 6
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 6
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 6
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 6
- 125000006041 3-hexenyl group Chemical group 0.000 description 6
- 125000006043 5-hexenyl group Chemical group 0.000 description 6
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 241000244206 Nematoda Species 0.000 description 6
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 6
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 6
- 241000233679 Peronosporaceae Species 0.000 description 6
- 206010039509 Scab Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 6
- 125000006023 1-pentenyl group Chemical group 0.000 description 5
- 125000006024 2-pentenyl group Chemical group 0.000 description 5
- 125000006042 4-hexenyl group Chemical group 0.000 description 5
- 108091006146 Channels Proteins 0.000 description 5
- 241000220225 Malus Species 0.000 description 5
- 241000588702 Pectobacterium carotovorum subsp. carotovorum Species 0.000 description 5
- 229930182558 Sterol Natural products 0.000 description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 5
- 239000004927 clay Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 235000019688 fish Nutrition 0.000 description 5
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 5
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 5
- 125000003935 n-pentoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 235000015424 sodium Nutrition 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 150000003432 sterols Chemical class 0.000 description 5
- 235000003702 sterols Nutrition 0.000 description 5
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 5
- 201000004647 tinea pedis Diseases 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- ZCVAOQKBXKSDMS-PVAVHDDUSA-N (+)-trans-(S)-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-PVAVHDDUSA-N 0.000 description 4
- 125000004749 (C1-C6) haloalkylsulfinyl group Chemical group 0.000 description 4
- 125000004741 (C1-C6) haloalkylsulfonyl group Chemical group 0.000 description 4
- 125000006028 1-methyl-2-butenyl group Chemical group 0.000 description 4
- 125000006021 1-methyl-2-propenyl group Chemical group 0.000 description 4
- 125000006029 2-methyl-2-butenyl group Chemical group 0.000 description 4
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- 102000012440 Acetylcholinesterase Human genes 0.000 description 4
- 108010022752 Acetylcholinesterase Proteins 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- 241000223602 Alternaria alternata Species 0.000 description 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 4
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 4
- 241001123536 Colletotrichum acutatum Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 4
- 206010017533 Fungal infection Diseases 0.000 description 4
- 241000223195 Fusarium graminearum Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010027146 Melanoderma Diseases 0.000 description 4
- 241000896238 Oidium Species 0.000 description 4
- 241000589615 Pseudomonas syringae Species 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 241001123668 Verticillium dahliae Species 0.000 description 4
- 239000000642 acaricide Substances 0.000 description 4
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 4
- 229940022698 acetylcholinesterase Drugs 0.000 description 4
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 4
- 238000007605 air drying Methods 0.000 description 4
- 125000005336 allyloxy group Chemical group 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 125000000392 cycloalkenyl group Chemical group 0.000 description 4
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000005712 elicitor Substances 0.000 description 4
- 125000005290 ethynyloxy group Chemical group C(#C)O* 0.000 description 4
- 125000004995 haloalkylthio group Chemical group 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000002917 insecticide Substances 0.000 description 4
- 229940047889 isobutyramide Drugs 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 125000006626 methoxycarbonylamino group Chemical group 0.000 description 4
- 230000005787 mitochondrial ATP synthesis coupled electron transport Effects 0.000 description 4
- 125000001298 n-hexoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 238000001243 protein synthesis Methods 0.000 description 4
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 239000004071 soot Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 description 4
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 4
- 125000004607 1,2,3,4-tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- 241000272517 Anseriformes Species 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 3
- 241001530056 Athelia rolfsii Species 0.000 description 3
- 108010017443 B 43 Proteins 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 241000555706 Botryosphaeria dothidea Species 0.000 description 3
- 241000994678 Botryotinia squamosa Species 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 3
- 241000222199 Colletotrichum Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000896246 Golovinomyces cichoracearum Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000005802 Mancozeb Substances 0.000 description 3
- 239000002169 Metam Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001518729 Monilinia Species 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- 241000286209 Phasianidae Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000918584 Pythium ultimum Species 0.000 description 3
- 241000221662 Sclerotinia Species 0.000 description 3
- 241000187747 Streptomyces Species 0.000 description 3
- 241000894120 Trichoderma atroviride Species 0.000 description 3
- 241001669640 Venturia carpophila Species 0.000 description 3
- 230000000895 acaricidal effect Effects 0.000 description 3
- 230000003281 allosteric effect Effects 0.000 description 3
- 230000000507 anthelmentic effect Effects 0.000 description 3
- 125000004604 benzisothiazolyl group Chemical group S1N=C(C2=C1C=CC=C2)* 0.000 description 3
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 description 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 3
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 3
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 3
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 3
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 3
- 125000001352 cyclobutyloxy group Chemical group C1(CCC1)O* 0.000 description 3
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 description 3
- 125000001887 cyclopentyloxy group Chemical group C1(CCCC1)O* 0.000 description 3
- 125000000131 cyclopropyloxy group Chemical group C1(CC1)O* 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 125000003700 epoxy group Chemical group 0.000 description 3
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Aalpha Natural products C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 description 3
- RONFGUROBZGJKP-UHFFFAOYSA-N iminoctadine Chemical compound NC(N)=NCCCCCCCCNCCCCCCCCN=C(N)N RONFGUROBZGJKP-UHFFFAOYSA-N 0.000 description 3
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 3
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 3
- 125000001041 indolyl group Chemical group 0.000 description 3
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 3
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 3
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- 125000005146 naphthylsulfonyl group Chemical group C1(=CC=CC2=CC=CC=C12)S(=O)(=O)* 0.000 description 3
- 125000005029 naphthylthio group Chemical group C1(=CC=CC2=CC=CC=C12)S* 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- 230000010627 oxidative phosphorylation Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 3
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 3
- 125000003367 polycyclic group Chemical group 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 3
- 125000005554 pyridyloxy group Chemical group 0.000 description 3
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 3
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 3
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 3
- 235000007586 terpenes Nutrition 0.000 description 3
- 239000004563 wettable powder Substances 0.000 description 3
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- KAATUXNTWXVJKI-NSHGMRRFSA-N (1R)-cis-(alphaS)-cypermethrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-NSHGMRRFSA-N 0.000 description 2
- SBNFWQZLDJGRLK-RTWAWAEBSA-N (1R)-trans-phenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-RTWAWAEBSA-N 0.000 description 2
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 description 2
- SAPGTCDSBGMXCD-UHFFFAOYSA-N (2-chlorophenyl)-(4-fluorophenyl)-pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(F)C=C1 SAPGTCDSBGMXCD-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- RLLPVAHGXHCWKJ-MJGOQNOKSA-N (3-phenoxyphenyl)methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-MJGOQNOKSA-N 0.000 description 2
- ZFHGXWPMULPQSE-UKSCLKOJSA-N (Z)-(1R)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-UKSCLKOJSA-N 0.000 description 2
- GWEHVDNNLFDJLR-UHFFFAOYSA-N 1,3-diphenylurea Chemical compound C=1C=CC=CC=1NC(=O)NC1=CC=CC=C1 GWEHVDNNLFDJLR-UHFFFAOYSA-N 0.000 description 2
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- YNTJKQDWYXUTLZ-UHFFFAOYSA-N 2-(3-chlorophenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=CC(Cl)=C1 YNTJKQDWYXUTLZ-UHFFFAOYSA-N 0.000 description 2
- ZRDUSMYWDRPZRM-UHFFFAOYSA-N 2-sec-butyl-4,6-dinitrophenyl 3-methylbut-2-enoate Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)C=C(C)C ZRDUSMYWDRPZRM-UHFFFAOYSA-N 0.000 description 2
- SWBHWUYHHJCADA-UHFFFAOYSA-N 3-(2-chlorophenyl)-6-(2,6-difluorophenyl)-1,2,4,5-tetrazine Chemical compound FC1=CC=CC(F)=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 SWBHWUYHHJCADA-UHFFFAOYSA-N 0.000 description 2
- OQEBBZSWEGYTPG-UHFFFAOYSA-N 3-aminobutanoic acid Chemical compound CC(N)CC(O)=O OQEBBZSWEGYTPG-UHFFFAOYSA-N 0.000 description 2
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 2
- KZOZKFJGERLOJN-UHFFFAOYSA-N 4-({6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-sulfanyl-1H-1,2,4-triazol-1-yl)propyl]pyridin-3-yl}oxy)benzonitrile Chemical compound FC1=C(C=CC(=C1)F)C(C(F)(F)C1=CC=C(C=N1)OC1=CC=C(C#N)C=C1)(CN1N=CNC1=S)O KZOZKFJGERLOJN-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 241000213004 Alternaria solani Species 0.000 description 2
- 235000013479 Amaranthus retroflexus Nutrition 0.000 description 2
- 241000294569 Aphelenchoides Species 0.000 description 2
- 241001225321 Aspergillus fumigatus Species 0.000 description 2
- 241000193388 Bacillus thuringiensis Species 0.000 description 2
- 241001480061 Blumeria graminis Species 0.000 description 2
- 241000895502 Blumeria graminis f. sp. tritici Species 0.000 description 2
- 241000130841 Blumeriella jaapii Species 0.000 description 2
- XCYXPAMHCYDJFS-FYJGNVAPSA-N CC(C)O/N=C(\C)/C1=CC(CCC(C=CC=C2)=C2OC)=NNC1=O Chemical compound CC(C)O/N=C(\C)/C1=CC(CCC(C=CC=C2)=C2OC)=NNC1=O XCYXPAMHCYDJFS-FYJGNVAPSA-N 0.000 description 2
- NSGFJIMIPPYVLZ-UHFFFAOYSA-N COC(C(C=C(C#CC(C=CC=C1)=C1OC)N=N1)=C1OC)=O Chemical compound COC(C(C=C(C#CC(C=CC=C1)=C1OC)N=N1)=C1OC)=O NSGFJIMIPPYVLZ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 240000005674 Ceanothus americanus Species 0.000 description 2
- 235000014224 Ceanothus americanus Nutrition 0.000 description 2
- 235000001904 Ceanothus herbaceus Nutrition 0.000 description 2
- 206010008803 Chromoblastomycosis Diseases 0.000 description 2
- 208000015116 Chromomycosis Diseases 0.000 description 2
- 241000222290 Cladosporium Species 0.000 description 2
- 241000222239 Colletotrichum truncatum Species 0.000 description 2
- 201000007336 Cryptococcosis Diseases 0.000 description 2
- 241001527609 Cryptococcus Species 0.000 description 2
- 241000221204 Cryptococcus neoformans Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 239000005644 Dazomet Substances 0.000 description 2
- 239000005947 Dimethoate Substances 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 102000008013 Electron Transport Complex I Human genes 0.000 description 2
- 108010089760 Electron Transport Complex I Proteins 0.000 description 2
- 241001506775 Epicoccum nigrum Species 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- 241000272184 Falconiformes Species 0.000 description 2
- 239000005656 Fenazaquin Substances 0.000 description 2
- 239000005783 Fluopyram Substances 0.000 description 2
- 239000005787 Flutriafol Substances 0.000 description 2
- 239000005959 Fosthiazate Substances 0.000 description 2
- 241000427940 Fusarium solani Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000531392 Helicobasidium mompa Species 0.000 description 2
- 108010072039 Histidine kinase Proteins 0.000 description 2
- 241000549404 Hyaloperonospora parasitica Species 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 241000692870 Inachis io Species 0.000 description 2
- 241000190144 Lasiodiplodia theobromae Species 0.000 description 2
- 241000270322 Lepidosauria Species 0.000 description 2
- 241000228457 Leptosphaeria maculans Species 0.000 description 2
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 2
- 241001220360 Longidorus Species 0.000 description 2
- 108091054455 MAP kinase family Proteins 0.000 description 2
- 241001330975 Magnaporthe oryzae Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001143352 Meloidogyne Species 0.000 description 2
- 239000005914 Metaflumizone Substances 0.000 description 2
- MIFOMMKAVSCNKQ-HWIUFGAZSA-N Metaflumizone Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)N\N=C(C=1C=C(C=CC=1)C(F)(F)F)\CC1=CC=C(C#N)C=C1 MIFOMMKAVSCNKQ-HWIUFGAZSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241001518731 Monilinia fructicola Species 0.000 description 2
- 241001459558 Monographella nivalis Species 0.000 description 2
- 241000131448 Mycosphaerella Species 0.000 description 2
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 241000736122 Parastagonospora nodorum Species 0.000 description 2
- 241000287127 Passeridae Species 0.000 description 2
- 241001670201 Peronospora destructor Species 0.000 description 2
- 241001557902 Phomopsis sp. Species 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 241000233622 Phytophthora infestans Species 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000005923 Pirimicarb Substances 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 2
- 241000233870 Pneumocystis Species 0.000 description 2
- 241001294742 Podosphaera macularis Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 241000193943 Pratylenchus Species 0.000 description 2
- 241000394642 Pseudomonas marginalis pv. marginalis Species 0.000 description 2
- 241001246058 Puccinia allii Species 0.000 description 2
- 241001123569 Puccinia recondita Species 0.000 description 2
- MWMQNVGAHVXSPE-UHFFFAOYSA-N Pyriprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SC(F)F)=C1NCC1=CC=CC=N1 MWMQNVGAHVXSPE-UHFFFAOYSA-N 0.000 description 2
- 241000599030 Pythium debaryanum Species 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 241001300361 Sclerotinia borealis Species 0.000 description 2
- 241001518615 Sclerotium cepivorum Species 0.000 description 2
- 241001432632 Setophoma terrestris Species 0.000 description 2
- 108010052164 Sodium Channels Proteins 0.000 description 2
- 102000018674 Sodium Channels Human genes 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 241000228341 Talaromyces Species 0.000 description 2
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 239000005855 Trichoderma harzianum strains T-22 and ITEM 908 Substances 0.000 description 2
- 241001540434 Trichodoridae Species 0.000 description 2
- 241001220308 Trichodorus Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000221566 Ustilago Species 0.000 description 2
- 241000007070 Ustilago nuda Species 0.000 description 2
- 241000228452 Venturia inaequalis Species 0.000 description 2
- 241001123669 Verticillium albo-atrum Species 0.000 description 2
- 241000589636 Xanthomonas campestris Species 0.000 description 2
- 241000201423 Xiphinema Species 0.000 description 2
- 241001423921 Xiphinema diversicaudatum Species 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 206010061418 Zygomycosis Diseases 0.000 description 2
- 241001360088 Zymoseptoria tritici Species 0.000 description 2
- BZMIHNKNQJJVRO-LVZFUZTISA-N [(e)-c-(3-chloro-2,6-dimethoxyphenyl)-n-ethoxycarbonimidoyl] benzoate Chemical compound COC=1C=CC(Cl)=C(OC)C=1C(=N/OCC)\OC(=O)C1=CC=CC=C1 BZMIHNKNQJJVRO-LVZFUZTISA-N 0.000 description 2
- JNVCSEDACVAATK-UHFFFAOYSA-L [Ca+2].[S-]SSS[S-] Chemical compound [Ca+2].[S-]SSS[S-] JNVCSEDACVAATK-UHFFFAOYSA-L 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- IMIDOCRTMDIQIJ-UHFFFAOYSA-N aminocarb Chemical compound CNC(=O)OC1=CC=C(N(C)C)C(C)=C1 IMIDOCRTMDIQIJ-UHFFFAOYSA-N 0.000 description 2
- 229940124339 anthelmintic agent Drugs 0.000 description 2
- 239000000921 anthelmintic agent Substances 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- YBQWEUNEYYXYOI-UHFFFAOYSA-N arsenamide Chemical compound NC(=O)C1=CC=C([As](SCC(O)=O)SCC(O)=O)C=C1 YBQWEUNEYYXYOI-UHFFFAOYSA-N 0.000 description 2
- 229940091771 aspergillus fumigatus Drugs 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 2
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 201000003984 candidiasis Diseases 0.000 description 2
- TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 2
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- QAYICIQNSGETAS-UHFFFAOYSA-N dazomet Chemical compound CN1CSC(=S)N(C)C1 QAYICIQNSGETAS-UHFFFAOYSA-N 0.000 description 2
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 2
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 2
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- GCKZANITAMOIAR-XWVCPFKXSA-N dsstox_cid_14566 Chemical compound [O-]C(=O)C1=CC=CC=C1.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H]([NH2+]C)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 GCKZANITAMOIAR-XWVCPFKXSA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- DMYHGDXADUDKCQ-UHFFFAOYSA-N fenazaquin Chemical compound C1=CC(C(C)(C)C)=CC=C1CCOC1=NC=NC2=CC=CC=C12 DMYHGDXADUDKCQ-UHFFFAOYSA-N 0.000 description 2
- XDNBJTQLKCIJBV-UHFFFAOYSA-N fensulfothion Chemical compound CCOP(=S)(OCC)OC1=CC=C(S(C)=O)C=C1 XDNBJTQLKCIJBV-UHFFFAOYSA-N 0.000 description 2
- GOWLARCWZRESHU-AQTBWJFISA-N ferimzone Chemical compound C=1C=CC=C(C)C=1C(/C)=N\NC1=NC(C)=CC(C)=N1 GOWLARCWZRESHU-AQTBWJFISA-N 0.000 description 2
- GBIHOLCMZGAKNG-CGAIIQECSA-N flucythrinate Chemical compound O=C([C@@H](C(C)C)C=1C=CC(OC(F)F)=CC=1)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 GBIHOLCMZGAKNG-CGAIIQECSA-N 0.000 description 2
- KVDJTXBXMWJJEF-UHFFFAOYSA-N fluopyram Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CCNC(=O)C1=CC=CC=C1C(F)(F)F KVDJTXBXMWJJEF-UHFFFAOYSA-N 0.000 description 2
- DUFVKSUJRWYZQP-UHFFFAOYSA-N fosthiazate Chemical compound CCC(C)SP(=O)(OCC)N1CCSC1=O DUFVKSUJRWYZQP-UHFFFAOYSA-N 0.000 description 2
- 230000003371 gabaergic effect Effects 0.000 description 2
- 235000003869 genetically modified organism Nutrition 0.000 description 2
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 2
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 2
- SEEGHKWOBVVBTQ-NFMPGMCNSA-N gibberellin A7 Chemical compound C([C@@H]1C[C@]2(CC1=C)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 SEEGHKWOBVVBTQ-NFMPGMCNSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- YFVOXLJXJBQDEF-UHFFFAOYSA-N isocarbophos Chemical compound COP(N)(=S)OC1=CC=CC=C1C(=O)OC(C)C YFVOXLJXJBQDEF-UHFFFAOYSA-N 0.000 description 2
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000005910 lambda-Cyhalothrin Substances 0.000 description 2
- 231100001231 less toxic Toxicity 0.000 description 2
- 229960001614 levamisole Drugs 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- AFCCDDWKHLHPDF-UHFFFAOYSA-M metam-sodium Chemical compound [Na+].CNC([S-])=S AFCCDDWKHLHPDF-UHFFFAOYSA-M 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 201000007524 mucormycosis Diseases 0.000 description 2
- 125000004708 n-butylthio group Chemical group C(CCC)S* 0.000 description 2
- 125000004718 n-hexylthio group Chemical group C(CCCCC)S* 0.000 description 2
- 125000004712 n-pentylthio group Chemical group C(CCCC)S* 0.000 description 2
- 125000004706 n-propylthio group Chemical group C(CC)S* 0.000 description 2
- FOFBPRRSRZLRBW-UHFFFAOYSA-N o-propan-2-ylhydroxylamine;hydrochloride Chemical compound Cl.CC(C)ON FOFBPRRSRZLRBW-UHFFFAOYSA-N 0.000 description 2
- 230000009106 osmotic signaling Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Chemical group 0.000 description 2
- 125000005704 oxymethylene group Chemical group [H]C([H])([*:2])O[*:1] 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 description 2
- 239000005648 plant growth regulator Substances 0.000 description 2
- 201000000317 pneumocystosis Diseases 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- DQRQIQZHRCRSDB-UHFFFAOYSA-M potassium;n-methylcarbamodithioate Chemical class [K+].CNC([S-])=S DQRQIQZHRCRSDB-UHFFFAOYSA-M 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000000018 receptor agonist Substances 0.000 description 2
- 229940044601 receptor agonist Drugs 0.000 description 2
- 229940108410 resmethrin Drugs 0.000 description 2
- VEMKTZHHVJILDY-FIWHBWSRSA-N resmethrin Chemical compound CC1(C)[C@H](C=C(C)C)C1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-FIWHBWSRSA-N 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 125000003808 silyl group Chemical class [H][Si]([H])([H])[*] 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- XIUROWKZWPIAIB-UHFFFAOYSA-N sulfotep Chemical compound CCOP(=S)(OCC)OP(=S)(OCC)OCC XIUROWKZWPIAIB-UHFFFAOYSA-N 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- XLNZEKHULJKQBA-UHFFFAOYSA-N terbufos Chemical compound CCOP(=S)(OCC)SCSC(C)(C)C XLNZEKHULJKQBA-UHFFFAOYSA-N 0.000 description 2
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- KNDVJPKNBVIKML-UHFFFAOYSA-N tetraniliprole Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1NC(=O)C1=CC(CN2N=C(N=N2)C(F)(F)F)=NN1C1=NC=CC=C1Cl KNDVJPKNBVIKML-UHFFFAOYSA-N 0.000 description 2
- 239000004308 thiabendazole Substances 0.000 description 2
- 229960004546 thiabendazole Drugs 0.000 description 2
- 235000010296 thiabendazole Nutrition 0.000 description 2
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- YFNCATAIYKQPOO-UHFFFAOYSA-N thiophanate Chemical compound CCOC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OCC YFNCATAIYKQPOO-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- WPALTCMYPARVNV-UHFFFAOYSA-N tolfenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(OC=3C=CC(C)=CC=3)=CC=2)=C1Cl WPALTCMYPARVNV-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 2
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- CDBBMEYPRMUMTR-UHFFFAOYSA-N (+)-(3aR,4S,8bS,2'R)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-4-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroindeno[1,2-b]furan-2-one Natural products O1C(=O)C(C)=CC1OC=C1C(=O)OC2C(C(C)(C)CCC3)=C3C(O)C21 CDBBMEYPRMUMTR-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- VOFXXOPWCBSPAA-UPXBXCCMSA-N (+)-Strigol Natural products O(/C=C/1\C(=O)O[C@H]2[C@@H]\1CC=1[C@H](O)CCC(C)(C)C2=1)[C@@H]1OC(=O)C(C)=C1 VOFXXOPWCBSPAA-UPXBXCCMSA-N 0.000 description 1
- ZCVAOQKBXKSDMS-AQYZNVCMSA-N (+)-trans-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-AQYZNVCMSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 1
- CXBMCYHAMVGWJQ-CABCVRRESA-N (1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCN1C(=O)C(CCCC2)=C2C1=O CXBMCYHAMVGWJQ-CABCVRRESA-N 0.000 description 1
- CXBMCYHAMVGWJQ-LOACHALJSA-N (1R)-tetramethrin Chemical compound CC1(C)C(C=C(C)C)[C@H]1C(=O)OCN1C(=O)C(CCCC2)=C2C1=O CXBMCYHAMVGWJQ-LOACHALJSA-N 0.000 description 1
- KAATUXNTWXVJKI-GGPKGHCWSA-N (1R)-trans-(alphaS)-cypermethrin Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-GGPKGHCWSA-N 0.000 description 1
- FJDPATXIBIBRIM-QFMSAKRMSA-N (1R)-trans-cyphenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 FJDPATXIBIBRIM-QFMSAKRMSA-N 0.000 description 1
- XERJKGMBORTKEO-VZUCSPMQSA-N (1e)-2-(ethylcarbamoylamino)-n-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 description 1
- YATDSXRLIUJOQN-SVRRBLITSA-N (2,3,4,5,6-pentafluorophenyl)methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=C(F)C(F)=C1F YATDSXRLIUJOQN-SVRRBLITSA-N 0.000 description 1
- AGMMRUPNXPWLGF-AATRIKPKSA-N (2,3,5,6-tetrafluoro-4-methylphenyl)methyl 2,2-dimethyl-3-[(e)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound CC1(C)C(/C=C/C)C1C(=O)OCC1=C(F)C(F)=C(C)C(F)=C1F AGMMRUPNXPWLGF-AATRIKPKSA-N 0.000 description 1
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 description 1
- NHOWDZOIZKMVAI-UHFFFAOYSA-N (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 description 1
- WYLYBQSHRJMURN-UHFFFAOYSA-N (2-methoxyphenyl)methanol Chemical compound COC1=CC=CC=C1CO WYLYBQSHRJMURN-UHFFFAOYSA-N 0.000 description 1
- MIZYPRIEDMSCAC-UHFFFAOYSA-N (2-methyl-4-oxo-3-prop-2-enylcyclopent-2-en-1-yl) 2,2,3,3-tetramethylcyclopropane-1-carboxylate Chemical compound CC1=C(CC=C)C(=O)CC1OC(=O)C1C(C)(C)C1(C)C MIZYPRIEDMSCAC-UHFFFAOYSA-N 0.000 description 1
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 description 1
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 description 1
- LZTIMERBDGGAJD-SNAWJCMRSA-N (2e)-2-(nitromethylidene)-1,3-thiazinane Chemical compound [O-][N+](=O)\C=C1/NCCCS1 LZTIMERBDGGAJD-SNAWJCMRSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- CDBBMEYPRMUMTR-KIKJJFSISA-N (3E,3aR,4R,8bR)-4-hydroxy-8,8-dimethyl-3-[[(2R)-4-methyl-5-oxo-2H-furan-2-yl]oxymethylidene]-3a,4,5,6,7,8b-hexahydroindeno[1,2-b]furan-2-one Chemical compound O1C(=O)C(C)=C[C@@H]1O\C=C/1C(=O)O[C@H]2C(C(C)(C)CCC3)=C3[C@H](O)[C@H]2\1 CDBBMEYPRMUMTR-KIKJJFSISA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- SODPIMGUZLOIPE-UHFFFAOYSA-N (4-chlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1 SODPIMGUZLOIPE-UHFFFAOYSA-N 0.000 description 1
- XUNYDVLIZWUPAW-UHFFFAOYSA-N (4-chlorophenyl) n-(4-methylphenyl)sulfonylcarbamate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)OC1=CC=C(Cl)C=C1 XUNYDVLIZWUPAW-UHFFFAOYSA-N 0.000 description 1
- PWWPULQZEAPTTB-UHFFFAOYSA-N (4-phenoxyphenyl)methyl 2-amino-6-methylpyridine-3-carboxylate Chemical compound NC1=NC(C)=CC=C1C(=O)OCC(C=C1)=CC=C1OC1=CC=CC=C1 PWWPULQZEAPTTB-UHFFFAOYSA-N 0.000 description 1
- MGRRXBWTLBJEMS-YADHBBJMSA-N (5-benzylfuran-3-yl)methyl (1r,3r)-3-(cyclopentylidenemethyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C([C@H]1C([C@@H]1C(=O)OCC=1C=C(CC=2C=CC=CC=2)OC=1)(C)C)=C1CCCC1 MGRRXBWTLBJEMS-YADHBBJMSA-N 0.000 description 1
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 description 1
- 125000006624 (C1-C6) alkoxycarbonylamino group Chemical group 0.000 description 1
- 125000006719 (C6-C10) aryl (C1-C6) alkyl group Chemical group 0.000 description 1
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 1
- PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 description 1
- BKBSMMUEEAWFRX-NBVRZTHBSA-N (E)-flumorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(F)=CC=1)=C\C(=O)N1CCOCC1 BKBSMMUEEAWFRX-NBVRZTHBSA-N 0.000 description 1
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 1
- FZRBKIRIBLNOAM-UHFFFAOYSA-N (E,E)-2-propynyl 3,7,11-trimethyl-2,4-dodecadienoate Chemical compound CC(C)CCCC(C)CC=CC(C)=CC(=O)OCC#C FZRBKIRIBLNOAM-UHFFFAOYSA-N 0.000 description 1
- IQVNEKKDSLOHHK-FNCQTZNRSA-N (E,E)-hydramethylnon Chemical compound N1CC(C)(C)CNC1=NN=C(/C=C/C=1C=CC(=CC=1)C(F)(F)F)\C=C\C1=CC=C(C(F)(F)F)C=C1 IQVNEKKDSLOHHK-FNCQTZNRSA-N 0.000 description 1
- WUOACPNHFRMFPN-VIFPVBQESA-N (R)-(+)-alpha-terpineol Chemical compound CC1=CC[C@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-VIFPVBQESA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- GBFKIHJZPMECCF-BXUZGUMPSA-N (R,R)-cyclobutrifluram Chemical compound FC(F)(F)C1=NC=CC=C1C(=O)N[C@H]1[C@@H](C=2C(=CC(Cl)=CC=2)Cl)CC1 GBFKIHJZPMECCF-BXUZGUMPSA-N 0.000 description 1
- XGWIJUOSCAQSSV-XHDPSFHLSA-N (S,S)-hexythiazox Chemical compound S([C@H]([C@@H]1C)C=2C=CC(Cl)=CC=2)C(=O)N1C(=O)NC1CCCCC1 XGWIJUOSCAQSSV-XHDPSFHLSA-N 0.000 description 1
- DARPYRSDRJYGIF-PTNGSMBKSA-N (Z)-3-ethoxy-2-naphthalen-2-ylsulfonylprop-2-enenitrile Chemical compound C1=CC=CC2=CC(S(=O)(=O)C(\C#N)=C/OCC)=CC=C21 DARPYRSDRJYGIF-PTNGSMBKSA-N 0.000 description 1
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 description 1
- PCKNFPQPGUWFHO-SXBRIOAWSA-N (Z)-flucycloxuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1)=CC=C1CO\N=C(C=1C=CC(Cl)=CC=1)\C1CC1 PCKNFPQPGUWFHO-SXBRIOAWSA-N 0.000 description 1
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 1
- NQRKYASMKDDGHT-UHFFFAOYSA-M (aminooxy)acetate Chemical compound NOCC([O-])=O NQRKYASMKDDGHT-UHFFFAOYSA-M 0.000 description 1
- CKPCAYZTYMHQEX-NBVRZTHBSA-N (e)-1-(2,4-dichlorophenyl)-n-methoxy-2-pyridin-3-ylethanimine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=N/OC)/CC1=CC=CN=C1 CKPCAYZTYMHQEX-NBVRZTHBSA-N 0.000 description 1
- USGUVNUTPWXWBA-JRIXXDKMSA-N (e,2s)-2-amino-4-(2-aminoethoxy)but-3-enoic acid Chemical compound NCCO\C=C\[C@H](N)C(O)=O USGUVNUTPWXWBA-JRIXXDKMSA-N 0.000 description 1
- IAKOZHOLGAGEJT-UHFFFAOYSA-N 1,1,1-trichloro-2,2-bis(p-methoxyphenyl)-Ethane Chemical compound C1=CC(OC)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(OC)C=C1 IAKOZHOLGAGEJT-UHFFFAOYSA-N 0.000 description 1
- FXVNBZGTAWLLNE-UHFFFAOYSA-N 1,3-thiazole;zinc Chemical compound [Zn].C1=CSC=N1 FXVNBZGTAWLLNE-UHFFFAOYSA-N 0.000 description 1
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 1
- IHGSAQHSAGRWNI-UHFFFAOYSA-N 1-(4-bromophenyl)-2,2,2-trifluoroethanone Chemical compound FC(F)(F)C(=O)C1=CC=C(Br)C=C1 IHGSAQHSAGRWNI-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- RURQAJURNPMSSK-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3-{[2-(4-ethoxyphenyl)-3,3,3-trifluoropropoxy]methyl}benzene Chemical compound C1=CC(OCC)=CC=C1C(C(F)(F)F)COCC1=CC=CC(OC=2C=CC(Cl)=CC=2)=C1 RURQAJURNPMSSK-UHFFFAOYSA-N 0.000 description 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 1
- IAQLCKZJGNTRDO-UHFFFAOYSA-N 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone Chemical compound CC1=CC(C(F)(F)F)=NN1CC(=O)N1CCC(C=2SC=C(N=2)C=2CC(ON=2)C=2C(=CC=CC=2F)F)CC1 IAQLCKZJGNTRDO-UHFFFAOYSA-N 0.000 description 1
- VXLCINMWUKLJOC-UHFFFAOYSA-N 1-(6-chloro-3-methoxypyridazin-4-yl)ethanone Chemical compound COC1=NN=C(Cl)C=C1C(C)=O VXLCINMWUKLJOC-UHFFFAOYSA-N 0.000 description 1
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- 239000005970 1-Naphthylacetamide Substances 0.000 description 1
- HVQHXBNMBZJPLK-UHFFFAOYSA-N 1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[(2-methylprop-2-en-1-yl)amino]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound CC(=C)CNC1=C([S+]([O-])C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl HVQHXBNMBZJPLK-UHFFFAOYSA-N 0.000 description 1
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 description 1
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 description 1
- FLEFKKUZMDEUIP-QFIPXVFZSA-N 1-[6-[(5s)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3C[C@](ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 FLEFKKUZMDEUIP-QFIPXVFZSA-N 0.000 description 1
- ULCWZQJLFZEXCS-UHFFFAOYSA-N 1-[[2-(2,4-dichlorophenyl)-5-(2,2,2-trifluoroethoxy)oxolan-2-yl]methyl]-1,2,4-triazole Chemical compound O1C(OCC(F)(F)F)CCC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 ULCWZQJLFZEXCS-UHFFFAOYSA-N 0.000 description 1
- HILAYQUKKYWPJW-UHFFFAOYSA-N 1-dodecylguanidine Chemical compound CCCCCCCCCCCCN=C(N)N HILAYQUKKYWPJW-UHFFFAOYSA-N 0.000 description 1
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 description 1
- UFOVULIWACVAAC-UHFFFAOYSA-N 1-ethynyl-2-methoxybenzene Chemical compound COC1=CC=CC=C1C#C UFOVULIWACVAAC-UHFFFAOYSA-N 0.000 description 1
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
- NVEPPWDVLBMNMB-SNAWJCMRSA-N 1-methyl-2-[(e)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound CN1CCCN=C1\C=C\C1=C(C)C=CS1 NVEPPWDVLBMNMB-SNAWJCMRSA-N 0.000 description 1
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 1
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
- XFNJVKMNNVCYEK-UHFFFAOYSA-N 1-naphthaleneacetamide Chemical compound C1=CC=C2C(CC(=O)N)=CC=CC2=C1 XFNJVKMNNVCYEK-UHFFFAOYSA-N 0.000 description 1
- FMTFEIJHMMQUJI-NJAFHUGGSA-N 102130-98-3 Natural products CC=CCC1=C(C)[C@H](CC1=O)OC(=O)[C@@H]1[C@@H](C=C(C)C)C1(C)C FMTFEIJHMMQUJI-NJAFHUGGSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- YNEKMCSWRMRXIR-UHFFFAOYSA-N 2,3,5,5-tetrachloro-4,7-bis(chloromethyl)-7-(dichloromethyl)bicyclo[2.2.1]heptane Chemical compound C1C(Cl)(Cl)C2(CCl)C(Cl)C(Cl)C1C2(C(Cl)Cl)CCl YNEKMCSWRMRXIR-UHFFFAOYSA-N 0.000 description 1
- ZMZGFLUUZLELNE-UHFFFAOYSA-N 2,3,5-triiodobenzoic acid Chemical compound OC(=O)C1=CC(I)=CC(I)=C1I ZMZGFLUUZLELNE-UHFFFAOYSA-N 0.000 description 1
- NFTOEHBFQROATQ-UHFFFAOYSA-N 2,3-dihydrofuran-5-carboxylic acid Chemical compound OC(=O)C1=CCCO1 NFTOEHBFQROATQ-UHFFFAOYSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- NIOPZPCMRQGZCE-WEVVVXLNSA-N 2,4-dinitro-6-(octan-2-yl)phenyl (E)-but-2-enoate Chemical compound CCCCCCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)\C=C\C NIOPZPCMRQGZCE-WEVVVXLNSA-N 0.000 description 1
- SQSYNRCXIZHKAI-UHFFFAOYSA-N 2,6-dichloroisonicotinic acid Chemical compound OC(=O)C1=CC(Cl)=NC(Cl)=C1 SQSYNRCXIZHKAI-UHFFFAOYSA-N 0.000 description 1
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 description 1
- MZHCENGPTKEIGP-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=C(Cl)C=C1Cl MZHCENGPTKEIGP-UHFFFAOYSA-N 0.000 description 1
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 description 1
- OILIYWFQRJOPAI-UHFFFAOYSA-N 2-(2-chlorophenyl)-1h-benzimidazole Chemical compound ClC1=CC=CC=C1C1=NC2=CC=CC=C2N1 OILIYWFQRJOPAI-UHFFFAOYSA-N 0.000 description 1
- DNBMPXLFKQCOBV-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OCCOCCOCC)=NC2=C1 DNBMPXLFKQCOBV-UHFFFAOYSA-N 0.000 description 1
- PTQBEFQWTBZMED-UHFFFAOYSA-N 2-(3-ethylsulfonylpyridin-2-yl)-5-(trifluoromethylsulfonyl)-1,3-benzoxazole Chemical group CCS(=O)(=O)C1=CC=CN=C1C1=NC2=CC(S(=O)(=O)C(F)(F)F)=CC=C2O1 PTQBEFQWTBZMED-UHFFFAOYSA-N 0.000 description 1
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 1
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 1
- KWLVWJPJKJMCSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide Chemical compound C1=C(OCC#C)C(OC)=CC(CCNC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)=C1 KWLVWJPJKJMCSH-UHFFFAOYSA-N 0.000 description 1
- YABFPHSQTSFWQB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(O)(C[Si](C)(C)C)CN1C=NC=N1 YABFPHSQTSFWQB-UHFFFAOYSA-N 0.000 description 1
- NGLCOYIAJMJYQI-UHFFFAOYSA-N 2-(4-methoxyiminocyclohexyl)-2-(3,3,3-trifluoropropylsulfonyl)acetonitrile Chemical compound CON=C1CCC(C(C#N)S(=O)(=O)CCC(F)(F)F)CC1 NGLCOYIAJMJYQI-UHFFFAOYSA-N 0.000 description 1
- FXJRDUKXWHFPND-NSHDSACASA-N 2-[(1s)-1-(2,3-dimethylphenyl)ethyl]-1h-imidazole Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=NC=CN1 FXJRDUKXWHFPND-NSHDSACASA-N 0.000 description 1
- ZEXXEODAXHSRDJ-UHFFFAOYSA-N 2-[(ethanesulfonyl)amino]-5-fluoro-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzene-1-carbothioamide Chemical compound CS(=O)(=O)OC1=CC=CC(Cl)=C1C1ON=C(C=2N=C(SC=2)C2CCN(CC2)C(=O)CN2C(=CC(=N2)C(F)F)C(F)F)C1 ZEXXEODAXHSRDJ-UHFFFAOYSA-N 0.000 description 1
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 description 1
- BOTNFCTYKJBUMU-UHFFFAOYSA-N 2-[4-(2-methylpropyl)piperazin-4-ium-1-yl]-2-oxoacetate Chemical compound CC(C)C[NH+]1CCN(C(=O)C([O-])=O)CC1 BOTNFCTYKJBUMU-UHFFFAOYSA-N 0.000 description 1
- JERZEQUMJNCPRJ-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol Chemical compound C=1C=C(OC=2C=CC(Cl)=CC=2)C=C(C(F)(F)F)C=1C(O)(C)CN1C=NC=N1 JERZEQUMJNCPRJ-UHFFFAOYSA-N 0.000 description 1
- SIIJJFOXEOHODQ-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C=1C=C(OC=2C=CC(Cl)=CC=2)C=C(C(F)(F)F)C=1C(O)(C(C)C)CN1C=NC=N1 SIIJJFOXEOHODQ-UHFFFAOYSA-N 0.000 description 1
- ZJRUTGDCLVIVRD-UHFFFAOYSA-N 2-[4-chloro-2-(hydroxymethyl)phenoxy]acetic acid Chemical compound OCC1=CC(Cl)=CC=C1OCC(O)=O ZJRUTGDCLVIVRD-UHFFFAOYSA-N 0.000 description 1
- WCBVUETZRWGIJQ-UHFFFAOYSA-N 2-[[(methoxycarbonylamino)-(2-nitro-5-propylsulfanylanilino)methylidene]amino]ethanesulfonic acid Chemical compound CCCSC1=CC=C([N+]([O-])=O)C(NC(NC(=O)OC)=NCCS(O)(=O)=O)=C1 WCBVUETZRWGIJQ-UHFFFAOYSA-N 0.000 description 1
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 description 1
- ZDRBJJNXJOSCLR-YZKQBBCCSA-N 2-amino-2-[(2r,3s,5s,6r)-5-amino-2-methyl-6-[(2r,3s,5s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxyoxan-3-yl]iminoacetic acid;hydron;chloride Chemical compound Cl.N[C@H]1C[C@H](N=C(N)C(O)=O)[C@@H](C)O[C@@H]1OC1[C@H](O)[C@@H](O)C(O)[C@H](O)[C@@H]1O ZDRBJJNXJOSCLR-YZKQBBCCSA-N 0.000 description 1
- KTDMTNHBSFUQAD-UHFFFAOYSA-N 2-bromo-n-propan-2-ylpropanamide Chemical compound CC(C)NC(=O)C(C)Br KTDMTNHBSFUQAD-UHFFFAOYSA-N 0.000 description 1
- OWDLFBLNMPCXSD-UHFFFAOYSA-N 2-chloro-N-(2,6-dimethylphenyl)-N-(2-oxotetrahydrofuran-3-yl)acetamide Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)C1C(=O)OCC1 OWDLFBLNMPCXSD-UHFFFAOYSA-N 0.000 description 1
- YHDXOFFTMOZZPE-UHFFFAOYSA-N 2-ethyl-3-[3-ethyl-5-(4-ethylphenoxy)pentyl]-2-methyloxirane Chemical compound O1C(CC)(C)C1CCC(CC)CCOC1=CC=C(CC)C=C1 YHDXOFFTMOZZPE-UHFFFAOYSA-N 0.000 description 1
- ZDOOQPFIGYHZFV-UHFFFAOYSA-N 2-ethyl-4-[(4-phenoxyphenoxy)methyl]-1,3-dioxolane Chemical compound O1C(CC)OCC1COC(C=C1)=CC=C1OC1=CC=CC=C1 ZDOOQPFIGYHZFV-UHFFFAOYSA-N 0.000 description 1
- DMBTYPPQYTYHFZ-UHFFFAOYSA-N 2-hydroxybenzoic acid methyl 2-hydroxybenzoate Chemical compound OC(=O)C1=CC=CC=C1O.COC(=O)C1=CC=CC=C1O DMBTYPPQYTYHFZ-UHFFFAOYSA-N 0.000 description 1
- AWSZRJQNBMEZOI-UHFFFAOYSA-N 2-methoxyethyl 2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-[2-(trifluoromethyl)phenyl]propanoate Chemical compound C=1C=C(C(C)(C)C)C=CC=1C(C#N)(C(=O)OCCOC)C(=O)C1=CC=CC=C1C(F)(F)F AWSZRJQNBMEZOI-UHFFFAOYSA-N 0.000 description 1
- LLWADFLAOKUBDR-UHFFFAOYSA-N 2-methyl-4-chlorophenoxybutyric acid Chemical compound CC1=CC(Cl)=CC=C1OCCCC(O)=O LLWADFLAOKUBDR-UHFFFAOYSA-N 0.000 description 1
- NPCLRBQYESMUPD-UHFFFAOYSA-N 2-methylpropanethioamide Chemical group CC(C)C(N)=S NPCLRBQYESMUPD-UHFFFAOYSA-N 0.000 description 1
- DGMOBVGABMBZSB-UHFFFAOYSA-N 2-methylpropanoyl chloride Chemical compound CC(C)C(Cl)=O DGMOBVGABMBZSB-UHFFFAOYSA-N 0.000 description 1
- 229940044120 2-n-octyl-4-isothiazolin-3-one Drugs 0.000 description 1
- AVGVFDSUDIUXEU-UHFFFAOYSA-N 2-octyl-1,2-thiazolidin-3-one Chemical compound CCCCCCCCN1SCCC1=O AVGVFDSUDIUXEU-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- PDPWCKVFIFAQIQ-UHFFFAOYSA-N 2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide Chemical compound CNC(=O)C(OC)C1=CC=CC=C1COC1=CC(C)=CC=C1C PDPWCKVFIFAQIQ-UHFFFAOYSA-N 0.000 description 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
- UMZCLZPXPCNKML-UHFFFAOYSA-N 2h-imidazo[4,5-d][1,3]thiazole Chemical class C1=NC2=NCSC2=N1 UMZCLZPXPCNKML-UHFFFAOYSA-N 0.000 description 1
- AUQAUAIUNJIIEP-UHFFFAOYSA-N 3,4,5-trimethylphenyl methylcarbamate Chemical compound CNC(=O)OC1=CC(C)=C(C)C(C)=C1 AUQAUAIUNJIIEP-UHFFFAOYSA-N 0.000 description 1
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 description 1
- NRAYWXLNSHEHQO-UHFFFAOYSA-N 3-(1-benzothiophen-2-yl)-5,6-dihydro-1,4,2-oxathiazine 4-oxide Chemical compound O=S1CCON=C1C1=CC2=CC=CC=C2S1 NRAYWXLNSHEHQO-UHFFFAOYSA-N 0.000 description 1
- BZGLBXYQOMFXAU-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)propyl 3,4-dichlorobenzoate Chemical compound CC1CCCCN1CCCOC(=O)C1=CC=C(Cl)C(Cl)=C1 BZGLBXYQOMFXAU-UHFFFAOYSA-N 0.000 description 1
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 1
- XCGBHLLWJZOLEM-UHFFFAOYSA-N 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide Chemical compound CC1CC(C)(C)C(C(=CC=2)F)=C1C=2NC(=O)C1=CN(C)N=C1C(F)F XCGBHLLWJZOLEM-UHFFFAOYSA-N 0.000 description 1
- XTDZGXBTXBEZDN-UHFFFAOYSA-N 3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1C2CCC1C1=C2C=CC=C1NC(=O)C1=CN(C)N=C1C(F)F XTDZGXBTXBEZDN-UHFFFAOYSA-N 0.000 description 1
- DGOAXBPOVUPPEB-UHFFFAOYSA-N 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide Chemical compound C=1N(C)N=C(C(F)F)C=1C(=O)N(OC)C(C)CC1=C(Cl)C=C(Cl)C=C1Cl DGOAXBPOVUPPEB-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- CUTZZBQQGUIEGT-UHFFFAOYSA-N 3-[(3,4-dichloro-1,2-thiazol-5-yl)methoxy]-1,2-benzothiazole 1,1-dioxide Chemical compound ClC1=NSC(COC=2C3=CC=CC=C3S(=O)(=O)N=2)=C1Cl CUTZZBQQGUIEGT-UHFFFAOYSA-N 0.000 description 1
- RAMUASXTSSXCMB-UHFFFAOYSA-N 3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide Chemical compound C1CC1C(C)NC(=O)C1=CC(Cl)=CC(Br)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl RAMUASXTSSXCMB-UHFFFAOYSA-N 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- HDKWFBCPLKNOCK-SFHVURJKSA-N 3-methyl-n-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-5-[(5s)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)NCC(=O)NCC(F)(F)F)=C(C)C=C1C1=NO[C@](C(F)(F)F)(C=2C=C(Cl)C(Cl)=C(Cl)C=2)C1 HDKWFBCPLKNOCK-SFHVURJKSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- SWTPIYGGSMJRTB-UHFFFAOYSA-N 4,4-difluoro-3,3-dimethyl-1-quinolin-3-ylisoquinoline Chemical compound C12=CC=CC=C2C(F)(F)C(C)(C)N=C1C1=CN=C(C=CC=C2)C2=C1 SWTPIYGGSMJRTB-UHFFFAOYSA-N 0.000 description 1
- NMWKWBPNKPGATC-UHFFFAOYSA-N 4,5,6,7-tetrachloro-2-benzofuran-1(3H)-one Chemical compound ClC1=C(Cl)C(Cl)=C2COC(=O)C2=C1Cl NMWKWBPNKPGATC-UHFFFAOYSA-N 0.000 description 1
- PKTIFYGCWCQRSX-UHFFFAOYSA-N 4,6-diamino-2-(cyclopropylamino)pyrimidine-5-carbonitrile Chemical compound NC1=C(C#N)C(N)=NC(NC2CC2)=N1 PKTIFYGCWCQRSX-UHFFFAOYSA-N 0.000 description 1
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 description 1
- QDFVXXBCJYNKKC-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)-4-cyclopropylbutyl]-1-fluoro-2-phenoxybenzene Chemical compound C1=C(OC=2C=CC=CC=2)C(F)=CC=C1CCCC(C=1C=CC(Cl)=CC=1)C1CC1 QDFVXXBCJYNKKC-UHFFFAOYSA-N 0.000 description 1
- BPFUIWLQXNPZHI-UHFFFAOYSA-N 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(methoxyamino)methylidene]-2-methylbenzamide Chemical compound C1=C(C)C(C(=O)N\C=N/OC)=CC=C1C1=NOC(C(F)(F)F)(C=2C=C(Cl)C=C(Cl)C=2)C1 BPFUIWLQXNPZHI-UHFFFAOYSA-N 0.000 description 1
- OXDDDHGGRFRLEE-UHFFFAOYSA-N 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]-n-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide Chemical compound C12=CC=CC=C2C(C(=O)NCC(=O)NCC(F)(F)F)=CC=C1C(C1)=NOC1(C(F)(F)F)C1=CC(Cl)=CC(C(F)(F)F)=C1 OXDDDHGGRFRLEE-UHFFFAOYSA-N 0.000 description 1
- QOVTVIYTBRHADL-UHFFFAOYSA-N 4-amino-6-(1,2,2-trichloroethenyl)benzene-1,3-disulfonamide Chemical compound NC1=CC(C(Cl)=C(Cl)Cl)=C(S(N)(=O)=O)C=C1S(N)(=O)=O QOVTVIYTBRHADL-UHFFFAOYSA-N 0.000 description 1
- NNPRCLUGHFXSOU-UHFFFAOYSA-N 4-chloro-n-[cyano(ethoxy)methyl]benzamide Chemical compound CCOC(C#N)NC(=O)C1=CC=C(Cl)C=C1 NNPRCLUGHFXSOU-UHFFFAOYSA-N 0.000 description 1
- PGYDGBCATBINCB-UHFFFAOYSA-N 4-diethoxyphosphoryl-n,n-dimethylaniline Chemical compound CCOP(=O)(OCC)C1=CC=C(N(C)C)C=C1 PGYDGBCATBINCB-UHFFFAOYSA-N 0.000 description 1
- SBUKOHLFHYSZNG-UHFFFAOYSA-N 4-dodecyl-2,6-dimethylmorpholine Chemical compound CCCCCCCCCCCCN1CC(C)OC(C)C1 SBUKOHLFHYSZNG-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- LHZOTJOOBRODLL-UHFFFAOYSA-N 4-oxo-1-(pyrimidin-5-ylmethyl)-3-[3-(trifluoromethyl)phenyl]pyrido[1,2-a]pyrimidin-5-ium-2-olate Chemical compound O=C1[N+]2=CC=CC=C2N(CC=2C=NC=NC=2)C([O-])=C1C1=CC=CC(C(F)(F)F)=C1 LHZOTJOOBRODLL-UHFFFAOYSA-N 0.000 description 1
- ZMYKITJYWFYRFJ-UHFFFAOYSA-N 4-oxo-4-(2-phenylethylamino)butanoic acid Chemical compound OC(=O)CCC(=O)NCCC1=CC=CC=C1 ZMYKITJYWFYRFJ-UHFFFAOYSA-N 0.000 description 1
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 1
- ONILAONOGQYBHW-UHFFFAOYSA-N 5-bromo-n-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-2-(3,5-dichloropyridin-2-yl)pyrazole-3-carboxamide Chemical compound CNC(=O)C1=CC(Cl)=CC(Cl)=C1NC(=O)C1=CC(Br)=NN1C1=NC=C(Cl)C=C1Cl ONILAONOGQYBHW-UHFFFAOYSA-N 0.000 description 1
- XJFIKRXIJXAJGH-UHFFFAOYSA-N 5-chloro-1,3-dihydroimidazo[4,5-b]pyridin-2-one Chemical group ClC1=CC=C2NC(=O)NC2=N1 XJFIKRXIJXAJGH-UHFFFAOYSA-N 0.000 description 1
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 description 1
- NEKULYKCZPJMMJ-UHFFFAOYSA-N 5-chloro-N-{1-[4-(difluoromethoxy)phenyl]propyl}-6-methylpyrimidin-4-amine Chemical compound C=1C=C(OC(F)F)C=CC=1C(CC)NC1=NC=NC(C)=C1Cl NEKULYKCZPJMMJ-UHFFFAOYSA-N 0.000 description 1
- GOFJDXZZHFNFLV-UHFFFAOYSA-N 5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]pyrazole-4-carboxamide Chemical compound CC(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C GOFJDXZZHFNFLV-UHFFFAOYSA-N 0.000 description 1
- KVUHRPLZWABERU-UHFFFAOYSA-N 5-fluoro-4-imino-3-methyl-1-(4-methylphenyl)sulfonylpyrimidin-2-one Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C(=O)N(C)C(=N)C(F)=C1 KVUHRPLZWABERU-UHFFFAOYSA-N 0.000 description 1
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 description 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
- NQPDXQQQCQDHHW-UHFFFAOYSA-N 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole Chemical compound ClC=1C=C2NC(SC)=NC2=CC=1OC1=CC=CC(Cl)=C1Cl NQPDXQQQCQDHHW-UHFFFAOYSA-N 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 229940126565 ATP-synthase inhibitor Drugs 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 241000235389 Absidia Species 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 239000005651 Acequinocyl Substances 0.000 description 1
- 239000005875 Acetamiprid Substances 0.000 description 1
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 1
- 241001600124 Acidovorax avenae Species 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 239000005652 Acrinathrin Substances 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000777029 Aenigma Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 241000589176 Agrobacterium vitis Species 0.000 description 1
- 241000743339 Agrostis Species 0.000 description 1
- 241000919511 Albugo Species 0.000 description 1
- 241001163841 Albugo ipomoeae-panduratae Species 0.000 description 1
- YRRKLBAKDXSTNC-UHFFFAOYSA-N Aldicarb sulfonyl Natural products CNC(=O)ON=CC(C)(C)S(C)(=O)=O YRRKLBAKDXSTNC-UHFFFAOYSA-N 0.000 description 1
- YRRKLBAKDXSTNC-WEVVVXLNSA-N Aldoxycarb Chemical compound CNC(=O)O\N=C\C(C)(C)S(C)(=O)=O YRRKLBAKDXSTNC-WEVVVXLNSA-N 0.000 description 1
- FBEHFRAORPEGFH-UHFFFAOYSA-N Allyxycarb Chemical compound CNC(=O)OC1=CC(C)=C(N(CC=C)CC=C)C(C)=C1 FBEHFRAORPEGFH-UHFFFAOYSA-N 0.000 description 1
- 239000005877 Alpha-Cypermethrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000223600 Alternaria Species 0.000 description 1
- 241001149961 Alternaria brassicae Species 0.000 description 1
- 241001157812 Alternaria brassicicola Species 0.000 description 1
- 241000352690 Alternaria kikuchiana Species 0.000 description 1
- 241000412366 Alternaria mali Species 0.000 description 1
- 241000123432 Alternaria padwickii Species 0.000 description 1
- 241001558165 Alternaria sp. Species 0.000 description 1
- 239000005726 Ametoctradin Substances 0.000 description 1
- 239000005727 Amisulbrom Substances 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 241000380490 Anguina Species 0.000 description 1
- 241000380499 Anguina funesta Species 0.000 description 1
- 241000399940 Anguina tritici Species 0.000 description 1
- 241000196509 Anguinidae Species 0.000 description 1
- 244000303258 Annona diversifolia Species 0.000 description 1
- 235000002198 Annona diversifolia Nutrition 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 241000172143 Aphanomyces cochlioides Species 0.000 description 1
- 241000134843 Aphelenchoides besseyi Species 0.000 description 1
- 241000294568 Aphelenchoides fragariae Species 0.000 description 1
- 241000680417 Aphelenchoides ritzemabosi Species 0.000 description 1
- 241001467594 Aphelenchoididae Species 0.000 description 1
- 101100532518 Arabidopsis thaliana SAHH1 gene Proteins 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000726096 Aratinga Species 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 241000245589 Argyrolobium zanonii Species 0.000 description 1
- 241001373565 Ascochyta sp. Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 201000002909 Aspergillosis Diseases 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 208000036641 Aspergillus infections Diseases 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000228230 Aspergillus parasiticus Species 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 239000005878 Azadirachtin Substances 0.000 description 1
- 239000005730 Azoxystrobin Substances 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000194106 Bacillus mycoides Species 0.000 description 1
- 241000193400 Bacillus simplex Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000580315 Belonolaimidae Species 0.000 description 1
- 241000580217 Belonolaimus Species 0.000 description 1
- 241000580218 Belonolaimus longicaudatus Species 0.000 description 1
- 239000005734 Benalaxyl Substances 0.000 description 1
- 239000005735 Benalaxyl-M Substances 0.000 description 1
- 239000005736 Benthiavalicarb Substances 0.000 description 1
- 239000005737 Benzovindiflupyr Substances 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 239000005884 Beta-Cyfluthrin Substances 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 239000005653 Bifenazate Substances 0.000 description 1
- 239000005874 Bifenthrin Substances 0.000 description 1
- 241000228438 Bipolaris maydis Species 0.000 description 1
- 241001450781 Bipolaris oryzae Species 0.000 description 1
- 241001148506 Bitylenchus dubius Species 0.000 description 1
- 239000005738 Bixafen Substances 0.000 description 1
- 206010005098 Blastomycosis Diseases 0.000 description 1
- 241001480060 Blumeria Species 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 239000005739 Bordeaux mixture Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 239000005740 Boscalid Substances 0.000 description 1
- 241000113236 Botryotinia allii Species 0.000 description 1
- 241001465180 Botrytis Species 0.000 description 1
- 241000499339 Botrytis allii Species 0.000 description 1
- 241000493670 Botrytis elliptica Species 0.000 description 1
- 241000004822 Botrytis tulipae Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000233685 Bremia lactucae Species 0.000 description 1
- KWGUFOITWDSNQY-UHFFFAOYSA-N Bromophos-ethyl Chemical group CCOP(=S)(OCC)OC1=CC(Cl)=C(Br)C=C1Cl KWGUFOITWDSNQY-UHFFFAOYSA-N 0.000 description 1
- 239000005741 Bromuconazole Substances 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 206010006473 Bronchopulmonary aspergillosis Diseases 0.000 description 1
- MYTVVMGUDBRCDJ-UHFFFAOYSA-N Bufencarb Chemical compound CCCC(C)C1=CC=CC(OC(=O)NC)=C1.CCC(CC)C1=CC=CC(OC(=O)NC)=C1 MYTVVMGUDBRCDJ-UHFFFAOYSA-N 0.000 description 1
- 239000005742 Bupirimate Substances 0.000 description 1
- 239000005885 Buprofezin Substances 0.000 description 1
- 241001453380 Burkholderia Species 0.000 description 1
- 241000589638 Burkholderia glumae Species 0.000 description 1
- 241000134107 Burkholderia plantarii Species 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 241000243770 Bursaphelenchus Species 0.000 description 1
- 241000243771 Bursaphelenchus xylophilus Species 0.000 description 1
- ZZVVDIVWGXTDRQ-BSYVCWPDSA-N Buthiobate Chemical compound C=1C=CN=CC=1\N=C(/SCCCC)SCC1=CC=C(C(C)(C)C)C=C1 ZZVVDIVWGXTDRQ-BSYVCWPDSA-N 0.000 description 1
- QGULYFKGPBHCCY-SPTLEAKQSA-N CC(C)[C@@H](CN(C(C(/C(\C)=N/OC(C)C)=C1)=O)N=C1OCC(C=CC=C1)=C1OC)NC(C(C)C)=O Chemical compound CC(C)[C@@H](CN(C(C(/C(\C)=N/OC(C)C)=C1)=O)N=C1OCC(C=CC=C1)=C1OC)NC(C(C)C)=O QGULYFKGPBHCCY-SPTLEAKQSA-N 0.000 description 1
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 description 1
- 101150065528 CYP51 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000006009 Calcium phosphide Substances 0.000 description 1
- 241001072697 Calonectria ilicicola Species 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 241000222173 Candida parapsilosis Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- 239000005746 Carboxin Substances 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000530549 Cercospora beticola Species 0.000 description 1
- 241001658057 Cercospora kikuchii Species 0.000 description 1
- 241000437818 Cercospora vignicola Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000122205 Chamaeleonidae Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 102000005469 Chitin Synthase Human genes 0.000 description 1
- 108700040089 Chitin synthases Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 239000005714 Chitosan hydrochloride Substances 0.000 description 1
- 239000005886 Chlorantraniliprole Substances 0.000 description 1
- STUSTWKEFDQFFZ-UHFFFAOYSA-N Chlordimeform Chemical compound CN(C)C=NC1=CC=C(Cl)C=C1C STUSTWKEFDQFFZ-UHFFFAOYSA-N 0.000 description 1
- 239000005974 Chlormequat Substances 0.000 description 1
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 description 1
- 239000005747 Chlorothalonil Substances 0.000 description 1
- 239000005944 Chlorpyrifos Substances 0.000 description 1
- 239000005945 Chlorpyrifos-methyl Substances 0.000 description 1
- 241000593874 Chondrostereum purpureum Species 0.000 description 1
- 239000005887 Chromafenozide Substances 0.000 description 1
- 208000008818 Chronic Mucocutaneous Candidiasis Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241001149955 Cladosporium cladosporioides Species 0.000 description 1
- 241000395107 Cladosporium cucumerinum Species 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- PITWUHDDNUVBPT-UHFFFAOYSA-N Cloethocarb Chemical compound CNC(=O)OC1=CC=CC=C1OC(CCl)OC PITWUHDDNUVBPT-UHFFFAOYSA-N 0.000 description 1
- 239000005654 Clofentezine Substances 0.000 description 1
- 241000142531 Clonostachys Species 0.000 description 1
- 241001149472 Clonostachys rosea Species 0.000 description 1
- 239000005888 Clothianidin Substances 0.000 description 1
- 241001345409 Colletotrichum aenigma Species 0.000 description 1
- 241000071774 Colletotrichum fioriniae Species 0.000 description 1
- 241001123532 Colletotrichum fragariae Species 0.000 description 1
- 241001639769 Colletotrichum fructicola Species 0.000 description 1
- 241001466031 Colletotrichum gossypii Species 0.000 description 1
- 241001429695 Colletotrichum graminicola Species 0.000 description 1
- 241000152100 Colletotrichum horii Species 0.000 description 1
- 241001566509 Colletotrichum jiangxiense Species 0.000 description 1
- 241001120669 Colletotrichum lindemuthianum Species 0.000 description 1
- 241000222235 Colletotrichum orbiculare Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241001087348 Coniella castaneicola Species 0.000 description 1
- 241001312183 Coniothyrium Species 0.000 description 1
- 239000005748 Coniothyrium minitans Strain CON/M/91-08 (DSM 9660) Substances 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- 239000005750 Copper hydroxide Substances 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000609458 Corynespora Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241001268463 Criconema mutabile Species 0.000 description 1
- 241001540484 Criconematidae Species 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- 241000223208 Curvularia Species 0.000 description 1
- 241000371648 Curvularia intermedia Species 0.000 description 1
- 241000223211 Curvularia lunata Species 0.000 description 1
- LRNJHZNPJSPMGK-UHFFFAOYSA-N Cyanofenphos Chemical compound C=1C=CC=CC=1P(=S)(OCC)OC1=CC=C(C#N)C=C1 LRNJHZNPJSPMGK-UHFFFAOYSA-N 0.000 description 1
- 239000005889 Cyantraniliprole Substances 0.000 description 1
- 239000005754 Cyazofamid Substances 0.000 description 1
- 239000005755 Cyflufenamid Substances 0.000 description 1
- 239000005655 Cyflumetofen Substances 0.000 description 1
- 239000005756 Cymoxanil Substances 0.000 description 1
- 239000005946 Cypermethrin Substances 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 239000005757 Cyproconazole Substances 0.000 description 1
- 239000005758 Cyprodinil Substances 0.000 description 1
- KRZUZYJEQBXUIN-UHFFFAOYSA-N Cyprofuram Chemical compound ClC1=CC=CC(N(C2C(OCC2)=O)C(=O)C2CC2)=C1 KRZUZYJEQBXUIN-UHFFFAOYSA-N 0.000 description 1
- 239000005891 Cyromazine Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000003915 DNA Topoisomerases Human genes 0.000 description 1
- 108090000323 DNA Topoisomerases Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 240000004585 Dactylis glomerata Species 0.000 description 1
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 description 1
- 239000005975 Daminozide Substances 0.000 description 1
- 239000005892 Deltamethrin Substances 0.000 description 1
- PZIRJMYRYORVIT-UHFFFAOYSA-N Demeton-S-methylsulphon Chemical compound CCS(=O)(=O)CCSP(=O)(OC)OC PZIRJMYRYORVIT-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- MUMQYXACQUZOFP-UHFFFAOYSA-N Dialifor Chemical compound C1=CC=C2C(=O)N(C(CCl)SP(=S)(OCC)OCC)C(=O)C2=C1 MUMQYXACQUZOFP-UHFFFAOYSA-N 0.000 description 1
- 241001645342 Diaporthe citri Species 0.000 description 1
- 241000632534 Diaporthe pseudophoenicicola Species 0.000 description 1
- 241000382787 Diaporthe sojae Species 0.000 description 1
- 241001373666 Diaporthe sp. Species 0.000 description 1
- 241000723298 Dicentrarchus labrax Species 0.000 description 1
- WGOWCPGHOCIHBW-UHFFFAOYSA-N Dichlofenthion Chemical compound CCOP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl WGOWCPGHOCIHBW-UHFFFAOYSA-N 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- LWLJUMBEZJHXHV-UHFFFAOYSA-N Dienochlor Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C1(Cl)C1(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LWLJUMBEZJHXHV-UHFFFAOYSA-N 0.000 description 1
- 239000005759 Diethofencarb Substances 0.000 description 1
- 239000005760 Difenoconazole Substances 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- XXFACTAYGKKOQB-SSDOTTSWSA-N Dihydrozeatin Natural products OC[C@H](C)CCNC1=NC=NC2=C1NC=N2 XXFACTAYGKKOQB-SSDOTTSWSA-N 0.000 description 1
- 239000005761 Dimethomorph Substances 0.000 description 1
- 239000005762 Dimoxystrobin Substances 0.000 description 1
- HDWLUGYOLUHEMN-UHFFFAOYSA-N Dinobuton Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)OC(C)C HDWLUGYOLUHEMN-UHFFFAOYSA-N 0.000 description 1
- 241000663351 Diplocarpon rosae Species 0.000 description 1
- 241001523339 Discula theae-sinensis Species 0.000 description 1
- 239000005763 Disodium phosphonate Substances 0.000 description 1
- 239000005764 Dithianon Substances 0.000 description 1
- 241000399934 Ditylenchus Species 0.000 description 1
- 241000399948 Ditylenchus destructor Species 0.000 description 1
- 241000399949 Ditylenchus dipsaci Species 0.000 description 1
- 241000739471 Ditylenchus myceliophagus Species 0.000 description 1
- 239000005765 Dodemorph Substances 0.000 description 1
- 239000005766 Dodine Substances 0.000 description 1
- 241000201427 Dorylaimida Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- AIGRXSNSLVJMEA-UHFFFAOYSA-N EPN Chemical compound C=1C=CC=CC=1P(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 AIGRXSNSLVJMEA-UHFFFAOYSA-N 0.000 description 1
- 101150101942 ERG24 gene Proteins 0.000 description 1
- 101150036202 ERG27 gene Proteins 0.000 description 1
- UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
- 241001464668 Ecphyadophora tenuissima Species 0.000 description 1
- 241000855614 Ecphyadophoridae Species 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000901048 Elsinoe ampelina Species 0.000 description 1
- 241000125118 Elsinoe fawcettii Species 0.000 description 1
- 241001568757 Elsinoe glycines Species 0.000 description 1
- 239000005894 Emamectin Substances 0.000 description 1
- 241000243234 Encephalitozoon Species 0.000 description 1
- 241000243212 Encephalitozoon cuniculi Species 0.000 description 1
- 241001492222 Epicoccum Species 0.000 description 1
- 241001648116 Epinephelus bruneus Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 239000005767 Epoxiconazole Substances 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241001331845 Equus asinus x caballus Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000588694 Erwinia amylovora Species 0.000 description 1
- 241000984019 Erysiphe cruciferarum Species 0.000 description 1
- 241000510928 Erysiphe necator Species 0.000 description 1
- 241001489205 Erysiphe pisi Species 0.000 description 1
- 241001337809 Erysiphe simulans Species 0.000 description 1
- 239000005895 Esfenvalerate Substances 0.000 description 1
- 239000005976 Ethephon Substances 0.000 description 1
- FNELVJVBIYMIMC-UHFFFAOYSA-N Ethiprole Chemical compound N1=C(C#N)C(S(=O)CC)=C(N)N1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl FNELVJVBIYMIMC-UHFFFAOYSA-N 0.000 description 1
- 239000005961 Ethoprophos Substances 0.000 description 1
- GLPZEHFBLBYFHN-UHFFFAOYSA-N Ethychlozate Chemical compound C1=CC(Cl)=CC2=C(CC(=O)OCC)NN=C21 GLPZEHFBLBYFHN-UHFFFAOYSA-N 0.000 description 1
- 239000005896 Etofenprox Substances 0.000 description 1
- 239000005897 Etoxazole Substances 0.000 description 1
- 239000005769 Etridiazole Substances 0.000 description 1
- FGIWFCGDPUIBEZ-UHFFFAOYSA-N Etrimfos Chemical compound CCOC1=CC(OP(=S)(OC)OC)=NC(CC)=N1 FGIWFCGDPUIBEZ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241001411323 Exobasidium reticulatum Species 0.000 description 1
- 241001661371 Exobasidium vexans Species 0.000 description 1
- 239000005772 Famoxadone Substances 0.000 description 1
- HMCCXLBXIJMERM-UHFFFAOYSA-N Febantel Chemical compound C1=C(NC(NC(=O)OC)=NC(=O)OC)C(NC(=O)COC)=CC(SC=2C=CC=CC=2)=C1 HMCCXLBXIJMERM-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000005774 Fenamidone Substances 0.000 description 1
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 description 1
- 239000005775 Fenbuconazole Substances 0.000 description 1
- 239000005776 Fenhexamid Substances 0.000 description 1
- HMIBKHHNXANVHR-UHFFFAOYSA-N Fenothiocarb Chemical compound CN(C)C(=O)SCCCCOC1=CC=CC=C1 HMIBKHHNXANVHR-UHFFFAOYSA-N 0.000 description 1
- 239000005898 Fenoxycarb Substances 0.000 description 1
- 239000005777 Fenpropidin Substances 0.000 description 1
- 239000005778 Fenpropimorph Substances 0.000 description 1
- 239000005779 Fenpyrazamine Substances 0.000 description 1
- 239000005657 Fenpyroximate Substances 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- 239000005899 Fipronil Substances 0.000 description 1
- 239000005900 Flonicamid Substances 0.000 description 1
- 239000005780 Fluazinam Substances 0.000 description 1
- 239000005901 Flubendiamide Substances 0.000 description 1
- KVKHBPGBGOVMBN-PWLVHAGJSA-N Flubenzimine Chemical compound C=1C=CC=CC=1N/1C(=N/C(F)(F)F)/S\C(=N/C(F)(F)F)\C\1=N/C1=CC=CC=C1 KVKHBPGBGOVMBN-PWLVHAGJSA-N 0.000 description 1
- 239000005781 Fludioxonil Substances 0.000 description 1
- 239000005782 Fluopicolide Substances 0.000 description 1
- 239000005784 Fluoxastrobin Substances 0.000 description 1
- 239000005902 Flupyradifurone Substances 0.000 description 1
- 239000005785 Fluquinconazole Substances 0.000 description 1
- 239000005786 Flutolanil Substances 0.000 description 1
- 239000005788 Fluxapyroxad Substances 0.000 description 1
- 239000005789 Folpet Substances 0.000 description 1
- 241000122862 Fonsecaea Species 0.000 description 1
- 241001365745 Fonsecaea monophora Species 0.000 description 1
- 239000005979 Forchlorfenuron Substances 0.000 description 1
- 239000005948 Formetanate Substances 0.000 description 1
- AIKKULXCBHRFOS-UHFFFAOYSA-N Formothion Chemical compound COP(=S)(OC)SCC(=O)N(C)C=O AIKKULXCBHRFOS-UHFFFAOYSA-N 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 239000005791 Fuberidazole Substances 0.000 description 1
- 241000276423 Fundulus heteroclitus Species 0.000 description 1
- 208000014260 Fungal keratitis Diseases 0.000 description 1
- QTDRLOKFLJJHTG-UHFFFAOYSA-N Furmecyclox Chemical compound C1=C(C)OC(C)=C1C(=O)N(OC)C1CCCCC1 QTDRLOKFLJJHTG-UHFFFAOYSA-N 0.000 description 1
- 241000122692 Fusarium avenaceum Species 0.000 description 1
- 241000567163 Fusarium cerealis Species 0.000 description 1
- 241000223194 Fusarium culmorum Species 0.000 description 1
- 241000221778 Fusarium fujikuroi Species 0.000 description 1
- 108700042658 GAP-43 Proteins 0.000 description 1
- 241001149475 Gaeumannomyces graminis Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000005903 Gamma-cyhalothrin Substances 0.000 description 1
- 241000270290 Gekkota Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000735332 Gerbera Species 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- RSQSQJNRHICNNH-UHFFFAOYSA-N Gibberellin A4 Natural products OC(=O)C1C2(CC3=C)CC3CCC2C2(OC3=O)C1C3(C)C(O)CC2 RSQSQJNRHICNNH-UHFFFAOYSA-N 0.000 description 1
- HHDWSDSMWJQURA-UHFFFAOYSA-N Gibberellin A51 Natural products C12CCC(C3)C(=C)CC23C(C(O)=O)C2C3(C)C(=O)OC21CC(O)C3 HHDWSDSMWJQURA-UHFFFAOYSA-N 0.000 description 1
- 241001400955 Gibellulopsis nigrescens Species 0.000 description 1
- 241000896533 Gliocladium Species 0.000 description 1
- 239000005793 Gliocladium catenulatum strain J1446 Substances 0.000 description 1
- 241001442498 Globodera Species 0.000 description 1
- 241001489135 Globodera pallida Species 0.000 description 1
- 241001442497 Globodera rostochiensis Species 0.000 description 1
- 241000923667 Globodera tabacum Species 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000896218 Golovinomyces orontii Species 0.000 description 1
- 241000221557 Gymnosporangium Species 0.000 description 1
- 241001194823 Gymnosporangium asiaticum Species 0.000 description 1
- 101150096276 HOG1 gene Proteins 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 241001148481 Helicotylenchus Species 0.000 description 1
- 241000710418 Helicotylenchus dihystera Species 0.000 description 1
- 241001445511 Helicotylenchus multicinctus Species 0.000 description 1
- 241001268520 Hemicycliophora thienemanni Species 0.000 description 1
- 241001148480 Hemicycliophoridae Species 0.000 description 1
- 241001181532 Hemileia vastatrix Species 0.000 description 1
- 241001480224 Heterodera Species 0.000 description 1
- 241001481225 Heterodera avenae Species 0.000 description 1
- 241000040390 Heterodera cruciferae Species 0.000 description 1
- 241000498254 Heterodera glycines Species 0.000 description 1
- 241000379510 Heterodera schachtii Species 0.000 description 1
- 241000040487 Heterodera trifolii Species 0.000 description 1
- 241000243783 Heteroderidae Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 239000005661 Hexythiazox Substances 0.000 description 1
- 241000228402 Histoplasma Species 0.000 description 1
- 241000228404 Histoplasma capsulatum Species 0.000 description 1
- 201000002563 Histoplasmosis Diseases 0.000 description 1
- 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 description 1
- 101001047090 Homo sapiens Potassium voltage-gated channel subfamily H member 2 Proteins 0.000 description 1
- 101001077418 Homo sapiens Potassium voltage-gated channel subfamily H member 6 Proteins 0.000 description 1
- 241001254664 Hoplolaimus columbus Species 0.000 description 1
- 241001540500 Hoplolaimus galeatus Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 241000270347 Iguania Species 0.000 description 1
- 239000005795 Imazalil Substances 0.000 description 1
- PPCUNNLZTNMXFO-ACCUITESSA-N Imicyafos Chemical compound CCCSP(=O)(OCC)N1CCN(CC)\C1=N/C#N PPCUNNLZTNMXFO-ACCUITESSA-N 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- FKWDSATZSMJRLC-UHFFFAOYSA-N Iminoctadine acetate Chemical compound CC([O-])=O.CC([O-])=O.CC([O-])=O.NC([NH3+])=NCCCCCCCC[NH2+]CCCCCCCCN=C(N)[NH3+] FKWDSATZSMJRLC-UHFFFAOYSA-N 0.000 description 1
- 239000005907 Indoxacarb Substances 0.000 description 1
- LFVLUOAHQIVABZ-UHFFFAOYSA-N Iodofenphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(I)C=C1Cl LFVLUOAHQIVABZ-UHFFFAOYSA-N 0.000 description 1
- 239000005796 Ipconazole Substances 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 241000032989 Ipomoea lacunosa Species 0.000 description 1
- 239000005867 Iprodione Substances 0.000 description 1
- 239000005797 Iprovalicarb Substances 0.000 description 1
- XRHGWAGWAHHFLF-UHFFFAOYSA-N Isazofos Chemical compound CCOP(=S)(OCC)OC=1N=C(Cl)N(C(C)C)N=1 XRHGWAGWAHHFLF-UHFFFAOYSA-N 0.000 description 1
- 239000005799 Isopyrazam Substances 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 206010062353 Keratitis fungal Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- 239000005800 Kresoxim-methyl Substances 0.000 description 1
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 241000935930 Lasiodiplodia Species 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 241000896221 Leveillula taurica Species 0.000 description 1
- 241000144128 Lichtheimia corymbifera Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000132887 Lomentospora prolificans Species 0.000 description 1
- 241000201425 Longidoridae Species 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 239000005912 Lufenuron Substances 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 239000005575 MCPB Substances 0.000 description 1
- 101150039283 MCPB gene Proteins 0.000 description 1
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 description 1
- 241000289581 Macropus sp. Species 0.000 description 1
- 241000584607 Macrospora Species 0.000 description 1
- 241001344131 Magnaporthe grisea Species 0.000 description 1
- 241000555676 Malassezia Species 0.000 description 1
- 241001291474 Malassezia globosa Species 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- BGRDGMRNKXEXQD-UHFFFAOYSA-N Maleic hydrazide Chemical compound OC1=CC=C(O)N=N1 BGRDGMRNKXEXQD-UHFFFAOYSA-N 0.000 description 1
- 244000081841 Malus domestica Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000005803 Mandestrobin Substances 0.000 description 1
- 239000005804 Mandipropamid Substances 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000330845 Marssonina coronariae Species 0.000 description 1
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 1
- 241000366182 Melaleuca alternifolia Species 0.000 description 1
- 241000243785 Meloidogyne javanica Species 0.000 description 1
- 244000309690 Meloidogyne thamesi Species 0.000 description 1
- 241001287835 Meloidogynidae Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 239000005805 Mepanipyrim Substances 0.000 description 1
- 239000005806 Meptyldinocap Substances 0.000 description 1
- 239000005807 Metalaxyl Substances 0.000 description 1
- 239000005808 Metalaxyl-M Substances 0.000 description 1
- 239000005868 Metconazole Substances 0.000 description 1
- NTAHCMPOMKHKEU-AATRIKPKSA-N Methacrifos Chemical compound COC(=O)C(\C)=C\OP(=S)(OC)OC NTAHCMPOMKHKEU-AATRIKPKSA-N 0.000 description 1
- 239000005951 Methiocarb Substances 0.000 description 1
- 239000005916 Methomyl Substances 0.000 description 1
- 239000005917 Methoxyfenozide Substances 0.000 description 1
- 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 description 1
- 239000005809 Metiram Substances 0.000 description 1
- LTMQQEMGRMBUSL-UHFFFAOYSA-N Metoxadiazone Chemical compound O=C1OC(OC)=NN1C1=CC=CC=C1OC LTMQQEMGRMBUSL-UHFFFAOYSA-N 0.000 description 1
- 239000005810 Metrafenone Substances 0.000 description 1
- 241001022799 Microdochium sorghi Species 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- 241000893980 Microsporum canis Species 0.000 description 1
- 239000005918 Milbemectin Substances 0.000 description 1
- 241001144048 Mirafiori lettuce big-vein virus Species 0.000 description 1
- 102000013379 Mitochondrial Proton-Translocating ATPases Human genes 0.000 description 1
- 108010026155 Mitochondrial Proton-Translocating ATPases Proteins 0.000 description 1
- 241001518836 Monilinia fructigena Species 0.000 description 1
- 241000862466 Monilinia laxa Species 0.000 description 1
- 241001363493 Monilinia mali Species 0.000 description 1
- 206010028080 Mucocutaneous candidiasis Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101100008639 Mus musculus Cd55 gene Proteins 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 239000005811 Myclobutanil Substances 0.000 description 1
- 241000285727 Mycosphaerella coffeicola Species 0.000 description 1
- 241001433116 Mycosphaerella nawae Species 0.000 description 1
- 241000633856 Mycosphaerella pomi Species 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- IUOKJNROJISWRO-UHFFFAOYSA-N N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide Chemical compound CC(C)C(C)(C#N)NC(=O)C(C)OC1=CC=C(Cl)C=C1Cl IUOKJNROJISWRO-UHFFFAOYSA-N 0.000 description 1
- IEKSGOPPBDNFFP-UHFFFAOYSA-N N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide Chemical compound FC1=C(C=CC=C1)NC(C1=CC=C(C=C1)C1=NOC(=N1)C(F)(F)F)=O IEKSGOPPBDNFFP-UHFFFAOYSA-N 0.000 description 1
- RAOCRURYZCVHMG-UHFFFAOYSA-N N-(6-propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester Chemical compound CCCOC1=CC=C2N=C(NC(=O)OC)NC2=C1 RAOCRURYZCVHMG-UHFFFAOYSA-N 0.000 description 1
- XFOXDUJCOHBXRC-UHFFFAOYSA-N N-Ethyl-N-methyl-4-(trifluoromethyl)-2-(3,4-dimethoxyphenyl)benzamide Chemical compound CCN(C)C(=O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C(OC)C(OC)=C1 XFOXDUJCOHBXRC-UHFFFAOYSA-N 0.000 description 1
- FHFBSBQYPLFMHC-TURZUDJPSA-N N-[(2Z)-2-[2-chloro-4-(2-cyclopropylethynyl)phenyl]-2-propan-2-yloxyiminoethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)O\N=C(/CNC(=O)c1cn(C)nc1C(F)F)c1ccc(cc1Cl)C#CC1CC1 FHFBSBQYPLFMHC-TURZUDJPSA-N 0.000 description 1
- YSVSUCSNKUVUFZ-UHFFFAOYSA-N N-[2-[2-chloro-4-(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound ClC1=C(OC2=C(C=CC=C2)NC(=O)C=2C(=NN(C=2)C)C(F)F)C=CC(=C1)C(F)(F)F YSVSUCSNKUVUFZ-UHFFFAOYSA-N 0.000 description 1
- CCCGEKHKTPTUHJ-UHFFFAOYSA-N N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC2=C1C1CCC2C1=C(Cl)Cl CCCGEKHKTPTUHJ-UHFFFAOYSA-N 0.000 description 1
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 description 1
- XQJQCBDIXRIYRP-UHFFFAOYSA-N N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1C(C2CC2)C1 XQJQCBDIXRIYRP-UHFFFAOYSA-N 0.000 description 1
- JMPFSEBWVLAJKM-UHFFFAOYSA-N N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide Chemical compound ClC=1C=C(NC(=O)C=2C(=C(I)C=C(I)C=2)O)C(C)=CC=1C(C#N)C1=CC=C(Cl)C=C1 JMPFSEBWVLAJKM-UHFFFAOYSA-N 0.000 description 1
- 241000201432 Nacobbus aberrans Species 0.000 description 1
- 241001221840 Neofusicoccum parvum Species 0.000 description 1
- 241001286619 Neofusicoccum sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- VJAWBEFMCIINFU-UHFFFAOYSA-N Nitrothal-isopropyl Chemical compound CC(C)OC(=O)C1=CC(C(=O)OC(C)C)=CC([N+]([O-])=O)=C1 VJAWBEFMCIINFU-UHFFFAOYSA-N 0.000 description 1
- 241001329956 Nothopassalora personata Species 0.000 description 1
- 241000855598 Nothotylenchidae Species 0.000 description 1
- 241000855602 Nothotylenchus acris Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241001668536 Oculimacula yallundae Species 0.000 description 1
- 241001552243 Oidium neolycopersici Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- CDBBMEYPRMUMTR-MHHPOBJPSA-N Orobanchol Natural products O(/C=C/1\C(=O)O[C@H]2[C@@H]\1[C@H](O)C1=C2C(C)(C)CCC1)[C@@H]1OC(=O)C(C)=C1 CDBBMEYPRMUMTR-MHHPOBJPSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 239000005950 Oxamyl Substances 0.000 description 1
- 239000005812 Oxathiapiprolin Substances 0.000 description 1
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 241000179039 Paenibacillus Species 0.000 description 1
- 241000845082 Panama Species 0.000 description 1
- 241001143330 Paratrichodorus minor Species 0.000 description 1
- 241001148649 Paratylenchidae Species 0.000 description 1
- 241001148650 Paratylenchus Species 0.000 description 1
- 244000309691 Paratylenchus curvitatus Species 0.000 description 1
- 244000309648 Paratylenchus elachistus Species 0.000 description 1
- 241000315044 Passalora arachidicola Species 0.000 description 1
- 241000222291 Passalora fulva Species 0.000 description 1
- 241001438726 Passalora janseana Species 0.000 description 1
- 241001672032 Passalora nattrassii Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241001148142 Pectobacterium atrosepticum Species 0.000 description 1
- 241000196271 Peltaster sp. (in: Dothideomycetes) Species 0.000 description 1
- 239000005813 Penconazole Substances 0.000 description 1
- 239000005814 Pencycuron Substances 0.000 description 1
- 239000005815 Penflufen Substances 0.000 description 1
- 206010064458 Penicilliosis Diseases 0.000 description 1
- 235000002245 Penicillium camembertii Nutrition 0.000 description 1
- 241001507673 Penicillium digitatum Species 0.000 description 1
- 241000122123 Penicillium italicum Species 0.000 description 1
- 241000985511 Penicillium sclerotigenum Species 0.000 description 1
- 239000005816 Penthiopyrad Substances 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 241001223281 Peronospora Species 0.000 description 1
- 241001670203 Peronospora manshurica Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241001505931 Pestalotiopsis sp. Species 0.000 description 1
- 241000899392 Phaeoisariopsis griseola Species 0.000 description 1
- 241001098206 Phakopsora ampelopsidis Species 0.000 description 1
- 244000309618 Phakopsora gossypii Species 0.000 description 1
- 241000682645 Phakopsora pachyrhizi Species 0.000 description 1
- 241000287463 Phalacrocorax Species 0.000 description 1
- 241001235318 Phomopsis fukushii Species 0.000 description 1
- 241000407153 Phomopsis theae Species 0.000 description 1
- 241000257732 Phomopsis vexans Species 0.000 description 1
- 239000005921 Phosmet Substances 0.000 description 1
- 244000309557 Phyllachora pomigena Species 0.000 description 1
- 241001609671 Phyllactinia kakicola Species 0.000 description 1
- 241001123457 Phyllactinia mali Species 0.000 description 1
- 241000519856 Phyllosticta Species 0.000 description 1
- 241000210649 Phyllosticta ampelicida Species 0.000 description 1
- 241001270527 Phyllosticta citrullina Species 0.000 description 1
- 241001149949 Phytophthora cactorum Species 0.000 description 1
- 241000233616 Phytophthora capsici Species 0.000 description 1
- 241000233631 Phytophthora citrophthora Species 0.000 description 1
- 241000626603 Phytophthora colocasiae Species 0.000 description 1
- 241000233645 Phytophthora nicotianae Species 0.000 description 1
- 241000626604 Phytophthora porri Species 0.000 description 1
- 241000948155 Phytophthora sojae Species 0.000 description 1
- 241000586759 Phytopythium helicoides Species 0.000 description 1
- 241000662043 Phytopythium oedochilum Species 0.000 description 1
- 231100000674 Phytotoxicity Toxicity 0.000 description 1
- 241000235645 Pichia kudriavzevii Species 0.000 description 1
- 239000005818 Picoxystrobin Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000005924 Pirimiphos-methyl Substances 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 241001503436 Plasmodiophora brassicae Species 0.000 description 1
- 241000233610 Plasmopara halstedii Species 0.000 description 1
- 241001281803 Plasmopara viticola Species 0.000 description 1
- 102100035181 Plastin-1 Human genes 0.000 description 1
- 241000269908 Platichthys flesus Species 0.000 description 1
- 241000329767 Pleospora allii Species 0.000 description 1
- 241000142787 Pneumocystis jirovecii Species 0.000 description 1
- 241000317981 Podosphaera fuliginea Species 0.000 description 1
- 241001337928 Podosphaera leucotricha Species 0.000 description 1
- 241000896203 Podosphaera pannosa Species 0.000 description 1
- 241000896192 Podosphaera tridactyla Species 0.000 description 1
- 241000951259 Podosphaera xanthii Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010030975 Polyketide Synthases Proteins 0.000 description 1
- 229930182764 Polyoxin Natural products 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000524949 Polystigma rubrum Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000005819 Potassium phosphonate Substances 0.000 description 1
- 102100022807 Potassium voltage-gated channel subfamily H member 2 Human genes 0.000 description 1
- 102100025135 Potassium voltage-gated channel subfamily H member 6 Human genes 0.000 description 1
- 241000193945 Pratylenchidae Species 0.000 description 1
- 241000793526 Pratylenchus fallax Species 0.000 description 1
- 241000710336 Pratylenchus goodeyi Species 0.000 description 1
- 241000193977 Pratylenchus musicola Species 0.000 description 1
- 241000193940 Pratylenchus penetrans Species 0.000 description 1
- 241000193966 Pratylenchus vulnus Species 0.000 description 1
- 241000978522 Pratylenchus zeae Species 0.000 description 1
- 239000005820 Prochloraz Substances 0.000 description 1
- DTAPQAJKAFRNJB-UHFFFAOYSA-N Promecarb Chemical compound CNC(=O)OC1=CC(C)=CC(C(C)C)=C1 DTAPQAJKAFRNJB-UHFFFAOYSA-N 0.000 description 1
- 239000005821 Propamocarb Substances 0.000 description 1
- MKIMSXGUTQTKJU-UHFFFAOYSA-N Propamocarb hydrochloride Chemical compound [Cl-].CCCOC(=O)NCCC[NH+](C)C MKIMSXGUTQTKJU-UHFFFAOYSA-N 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- 239000005823 Propineb Substances 0.000 description 1
- 239000005824 Proquinazid Substances 0.000 description 1
- 239000005825 Prothioconazole Substances 0.000 description 1
- QTXHFDHVLBDJIO-UHFFFAOYSA-N Prothoate Chemical compound CCOP(=S)(OCC)SCC(=O)NC(C)C QTXHFDHVLBDJIO-UHFFFAOYSA-N 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000899394 Pseudocercospora Species 0.000 description 1
- 241001341772 Pseudocercospora circumscissa Species 0.000 description 1
- 241000087479 Pseudocercospora fijiensis Species 0.000 description 1
- 241001322464 Pseudocercospora fuligena Species 0.000 description 1
- 241000301598 Pseudocercospora kaki Species 0.000 description 1
- 241000184297 Pseudocercospora musae Species 0.000 description 1
- 241000386899 Pseudocercospora vitis Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241001646398 Pseudomonas chlororaphis Species 0.000 description 1
- 241001508466 Pseudomonas cichorii Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241001291486 Pseudomonas rhodesiae Species 0.000 description 1
- 241000609869 Pseudomonas syringae pv. maculicola Species 0.000 description 1
- 241001464820 Pseudomonas viridiflava Species 0.000 description 1
- 241001281805 Pseudoperonospora cubensis Species 0.000 description 1
- 241000342307 Pseudoperonospora humuli Species 0.000 description 1
- 241000287530 Psittaciformes Species 0.000 description 1
- 241000221300 Puccinia Species 0.000 description 1
- 241000343500 Puccinia arachidis Species 0.000 description 1
- 241001123561 Puccinia coronata Species 0.000 description 1
- 241000221301 Puccinia graminis Species 0.000 description 1
- 241000928332 Puccinia melanocephala Species 0.000 description 1
- 241001304534 Puccinia polysora Species 0.000 description 1
- 241001123567 Puccinia sorghi Species 0.000 description 1
- 241001123583 Puccinia striiformis Species 0.000 description 1
- 208000004430 Pulmonary Aspergillosis Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 239000005925 Pymetrozine Substances 0.000 description 1
- 239000005869 Pyraclostrobin Substances 0.000 description 1
- 241000228454 Pyrenophora graminea Species 0.000 description 1
- 241000520648 Pyrenophora teres Species 0.000 description 1
- 241000231139 Pyricularia Species 0.000 description 1
- 241000619663 Pyricularia sp. Species 0.000 description 1
- 239000005663 Pyridaben Substances 0.000 description 1
- 239000005926 Pyridalyl Substances 0.000 description 1
- 239000005828 Pyrimethanil Substances 0.000 description 1
- 239000005829 Pyriofenone Substances 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241001622910 Pythium dissotocum Species 0.000 description 1
- 241000202873 Pythium iwayamai Species 0.000 description 1
- 241001622896 Pythium myriotylum Species 0.000 description 1
- 241001622887 Pythium sylvaticum Species 0.000 description 1
- 239000005831 Quinoxyfen Substances 0.000 description 1
- 102000017143 RNA Polymerase I Human genes 0.000 description 1
- 108010013845 RNA Polymerase I Proteins 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 241000216550 Radopholus citrophilus Species 0.000 description 1
- 241000201375 Radopholus similis Species 0.000 description 1
- 241000589771 Ralstonia solanacearum Species 0.000 description 1
- 241000196686 Ramulariopsis gossypii Species 0.000 description 1
- 241000283011 Rangifer Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000153955 Reynoutria sachalinensis Species 0.000 description 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 1
- 241000235546 Rhizopus stolonifer Species 0.000 description 1
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 description 1
- 241001515790 Rhynchosporium secalis Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241001299714 Rosellinia necatrix Species 0.000 description 1
- 241000702971 Rotylenchulus reniformis Species 0.000 description 1
- 241000710331 Rotylenchus robustus Species 0.000 description 1
- 102000001424 Ryanodine receptors Human genes 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- OUNSASXJZHBGAI-UHFFFAOYSA-N Salithion Chemical compound C1=CC=C2OP(OC)(=S)OCC2=C1 OUNSASXJZHBGAI-UHFFFAOYSA-N 0.000 description 1
- 241000132889 Scedosporium Species 0.000 description 1
- 101100395426 Schizosaccharomyces pombe (strain 972 / ATCC 24843) sty1 gene Proteins 0.000 description 1
- 241000825108 Schizothyrium pomi Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 241001518640 Sclerotinia homoeocarpa Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 241000122799 Scopulariopsis Species 0.000 description 1
- 241000825258 Scopulariopsis brevicaulis Species 0.000 description 1
- 239000005834 Sedaxane Substances 0.000 description 1
- 241000287231 Serinus Species 0.000 description 1
- 241000276699 Seriola Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 241000332749 Setosphaeria turcica Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000005835 Silthiofam Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- KHSREFIWULNDAB-YCUBLIQYSA-N Sorgolactone Chemical compound O([C@@H]1C2=C(C[C@@H]11)CCC[C@@H]2C)C(=O)\C1=C\O[C@@H]1OC(=O)C(C)=C1 KHSREFIWULNDAB-YCUBLIQYSA-N 0.000 description 1
- 239000005929 Spinetoram Substances 0.000 description 1
- GOENIMGKWNZVDA-OAMCMWGQSA-N Spinetoram Chemical compound CO[C@@H]1[C@H](OCC)[C@@H](OC)[C@H](C)O[C@H]1OC1C[C@H]2[C@@H]3C=C4C(=O)[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@H](CC5)N(C)C)CCC[C@H](CC)OC(=O)CC4[C@@H]3CC[C@@H]2C1 GOENIMGKWNZVDA-OAMCMWGQSA-N 0.000 description 1
- 239000005930 Spinosad Substances 0.000 description 1
- 239000005664 Spirodiclofen Substances 0.000 description 1
- 239000005665 Spiromesifen Substances 0.000 description 1
- 239000005931 Spirotetramat Substances 0.000 description 1
- 239000005837 Spiroxamine Substances 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241001149962 Sporothrix Species 0.000 description 1
- 241001149963 Sporothrix schenckii Species 0.000 description 1
- 206010041736 Sporotrichosis Diseases 0.000 description 1
- 102000005782 Squalene Monooxygenase Human genes 0.000 description 1
- 108020003891 Squalene monooxygenase Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000266365 Stemphylium vesicarium Species 0.000 description 1
- 241000218483 Streptomyces lydicus Species 0.000 description 1
- 241001415849 Strigiformes Species 0.000 description 1
- 241000271567 Struthioniformes Species 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000005934 Sulfoxaflor Substances 0.000 description 1
- 239000005935 Sulfuryl fluoride Substances 0.000 description 1
- 241000059151 Swinglea glutinosa Species 0.000 description 1
- 206010042938 Systemic candida Diseases 0.000 description 1
- 102000003563 TRPV Human genes 0.000 description 1
- 108060008564 TRPV Proteins 0.000 description 1
- 241000736851 Tagetes Species 0.000 description 1
- 235000012308 Tagetes Nutrition 0.000 description 1
- 241000228343 Talaromyces flavus Species 0.000 description 1
- 241001523006 Talaromyces marneffei Species 0.000 description 1
- 241000228448 Taphrina deformans Species 0.000 description 1
- 241000231709 Taphrina pruni Species 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- 239000005937 Tebufenozide Substances 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- 239000005938 Teflubenzuron Substances 0.000 description 1
- 239000005939 Tefluthrin Substances 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 239000005840 Tetraconazole Substances 0.000 description 1
- 241001441724 Tetraodontidae Species 0.000 description 1
- QUWSDLYBOVGOCW-UHFFFAOYSA-N Tetrasul Chemical compound C1=CC(Cl)=CC=C1SC1=CC(Cl)=C(Cl)C=C1Cl QUWSDLYBOVGOCW-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 239000005940 Thiacloprid Substances 0.000 description 1
- 239000005941 Thiamethoxam Substances 0.000 description 1
- HFCYZXMHUIHAQI-UHFFFAOYSA-N Thidiazuron Chemical compound C=1C=CC=CC=1NC(=O)NC1=CN=NS1 HFCYZXMHUIHAQI-UHFFFAOYSA-N 0.000 description 1
- 239000005842 Thiophanate-methyl Substances 0.000 description 1
- 239000005843 Thiram Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 241000722093 Tilletia caries Species 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 239000005845 Tolclofos-methyl Substances 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000005846 Triadimenol Substances 0.000 description 1
- 239000005847 Triazoxide Substances 0.000 description 1
- NHTFLYKPEGXOAN-UHFFFAOYSA-N Trichlamide Chemical compound CCCCOC(C(Cl)(Cl)Cl)NC(=O)C1=CC=CC=C1O NHTFLYKPEGXOAN-UHFFFAOYSA-N 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241001460073 Trichoderma asperellum Species 0.000 description 1
- 239000005850 Trichoderma asperellum (strain T34) Substances 0.000 description 1
- 239000005852 Trichoderma atroviride strain I-1237 Substances 0.000 description 1
- 239000005853 Trichoderma atroviride strain SC1 Substances 0.000 description 1
- 241001149558 Trichoderma virens Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241001480048 Trichophyton tonsurans Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 241000223230 Trichosporon Species 0.000 description 1
- 241001634961 Trichosporon asahii Species 0.000 description 1
- 241000223231 Trichosporon beigelii Species 0.000 description 1
- 239000005857 Trifloxystrobin Substances 0.000 description 1
- 239000005858 Triflumizole Substances 0.000 description 1
- 239000005942 Triflumuron Substances 0.000 description 1
- 241001540445 Triplonchida Species 0.000 description 1
- 239000005859 Triticonazole Substances 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- 241000722921 Tulipa gesneriana Species 0.000 description 1
- 241000243782 Tylenchida Species 0.000 description 1
- 241000855019 Tylenchorhynchus Species 0.000 description 1
- 241000402796 Tylenchorhynchus claytoni Species 0.000 description 1
- 241001267621 Tylenchulus semipenetrans Species 0.000 description 1
- 241000333201 Typhula incarnata Species 0.000 description 1
- 241001091387 Uromyces beticola Species 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 241001474928 Ustilaginoidea virens Species 0.000 description 1
- 241000233791 Ustilago tritici Species 0.000 description 1
- 229930195482 Validamycin Natural products 0.000 description 1
- 239000005860 Valifenalate Substances 0.000 description 1
- 241001512566 Valsa mali Species 0.000 description 1
- 241001478283 Variovorax Species 0.000 description 1
- 241001478284 Variovorax paradoxus Species 0.000 description 1
- 241001669638 Venturia nashicola Species 0.000 description 1
- 241000905623 Venturia oleaginea Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 101710175177 Very-long-chain 3-oxoacyl-CoA reductase Proteins 0.000 description 1
- 241001416177 Vicugna pacos Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 241000282485 Vulpes vulpes Species 0.000 description 1
- 241000282188 Wilsonomyces carpophilus Species 0.000 description 1
- CVQODEWAPZVVBU-UHFFFAOYSA-N XMC Chemical compound CNC(=O)OC1=CC(C)=CC(C)=C1 CVQODEWAPZVVBU-UHFFFAOYSA-N 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241000985670 Xanthomonas arboricola pv. pruni Species 0.000 description 1
- 241000589652 Xanthomonas oryzae Species 0.000 description 1
- 241001242944 Xiphinema americanum Species 0.000 description 1
- 241000998528 Xiphinema brevicolle Species 0.000 description 1
- 241000201421 Xiphinema index Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000006011 Zinc phosphide Substances 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000005870 Ziram Substances 0.000 description 1
- 239000005863 Zoxamide Substances 0.000 description 1
- 241000825078 Zygophiala Species 0.000 description 1
- GBAWQJNHVWMTLU-RQJHMYQMSA-N [(1R,5S)-7-chloro-6-bicyclo[3.2.0]hepta-2,6-dienyl] dimethyl phosphate Chemical compound C1=CC[C@@H]2C(OP(=O)(OC)OC)=C(Cl)[C@@H]21 GBAWQJNHVWMTLU-RQJHMYQMSA-N 0.000 description 1
- VXSIXFKKSNGRRO-MXOVTSAMSA-N [(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate;[(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-3-[(e)-3-methoxy-2-methyl-3-oxoprop-1-enyl Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1.CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VXSIXFKKSNGRRO-MXOVTSAMSA-N 0.000 description 1
- IUTFTSYFDUZPPF-SECBINFHSA-N [(2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butyl] methanesulfonate Chemical compound CS(=O)(=O)OC[C@H](C(C)C)NC(=O)OC(C)(C)C IUTFTSYFDUZPPF-SECBINFHSA-N 0.000 description 1
- QQODLKZGRKWIFG-RUTXASTPSA-N [(R)-cyano-(4-fluoro-3-phenoxyphenyl)methyl] (1S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-RUTXASTPSA-N 0.000 description 1
- FZSVSABTBYGOQH-XFFZJAGNSA-N [(e)-(3,3-dimethyl-1-methylsulfanylbutan-2-ylidene)amino] n-methylcarbamate Chemical compound CNC(=O)O\N=C(C(C)(C)C)\CSC FZSVSABTBYGOQH-XFFZJAGNSA-N 0.000 description 1
- KAATUXNTWXVJKI-QPIRBTGLSA-N [(s)-cyano-(3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-QPIRBTGLSA-N 0.000 description 1
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 description 1
- QSGNQELHULIMSJ-POHAHGRESA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] dimethyl phosphate Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl QSGNQELHULIMSJ-POHAHGRESA-N 0.000 description 1
- DPJITPZADZSLBP-PIPQINALSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1r,3r)-3-[(e)-2-cyanoprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1\C=C(/C)C#N DPJITPZADZSLBP-PIPQINALSA-N 0.000 description 1
- MWFQAAWRPDRKDG-KOLCDFICSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1C=C(Cl)Cl MWFQAAWRPDRKDG-KOLCDFICSA-N 0.000 description 1
- APEPLROGLDYWBS-UHFFFAOYSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2,3,3-tetramethylcyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)C1C(C)(C)C1(C)C APEPLROGLDYWBS-UHFFFAOYSA-N 0.000 description 1
- OOWCJRMYMAMSOH-UHFFFAOYSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)C1C(C)(C)C1C=C(C)C OOWCJRMYMAMSOH-UHFFFAOYSA-N 0.000 description 1
- CFGPESLNPCIKIX-UHFFFAOYSA-N [2-[ethoxy(propylsulfanyl)phosphoryl]oxyphenyl] n-methylcarbamate Chemical compound CCCSP(=O)(OCC)OC1=CC=CC=C1OC(=O)NC CFGPESLNPCIKIX-UHFFFAOYSA-N 0.000 description 1
- FMPFURNXXAKYNE-UHFFFAOYSA-N [2-ethyl-3,7-dimethyl-6-[4-(trifluoromethoxy)phenoxy]quinolin-4-yl] methyl carbonate Chemical compound C1=C2C(OC(=O)OC)=C(C)C(CC)=NC2=CC(C)=C1OC1=CC=C(OC(F)(F)F)C=C1 FMPFURNXXAKYNE-UHFFFAOYSA-N 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- CWVZGJORVTZXFW-UHFFFAOYSA-N [benzyl(dimethyl)silyl]methyl carbamate Chemical compound NC(=O)OC[Si](C)(C)CC1=CC=CC=C1 CWVZGJORVTZXFW-UHFFFAOYSA-N 0.000 description 1
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 description 1
- IHVPAVRHNZFQKC-UHFFFAOYSA-N [cyano-(6-phenoxypyridin-2-yl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=N1 IHVPAVRHNZFQKC-UHFFFAOYSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 1
- QDRXWCAVUNHOGA-UHFFFAOYSA-N acequinocyl Chemical group C1=CC=C2C(=O)C(CCCCCCCCCCCC)=C(OC(C)=O)C(=O)C2=C1 QDRXWCAVUNHOGA-UHFFFAOYSA-N 0.000 description 1
- CXTBGQUZGIDYAT-UHFFFAOYSA-N acetic acid 2-[8-[8-(diaminomethylideneamino)octylamino]octyl]guanidine Chemical class CC(=O)O.CC(=O)O.C(CCCCN=C(N)N)CCCNCCCCCCCCN=C(N)N.C(CCCCN=C(N)N)CCCNCCCCCCCCN=C(N)N CXTBGQUZGIDYAT-UHFFFAOYSA-N 0.000 description 1
- YLJLLELGHSWIDU-OKZTUQRJSA-N acetic acid;(2s,6r)-4-cyclododecyl-2,6-dimethylmorpholine Chemical compound CC(O)=O.C1[C@@H](C)O[C@@H](C)CN1C1CCCCCCCCCCC1 YLJLLELGHSWIDU-OKZTUQRJSA-N 0.000 description 1
- GDZNYEZGJAFIKA-UHFFFAOYSA-N acetoprole Chemical compound NC1=C(S(C)=O)C(C(=O)C)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl GDZNYEZGJAFIKA-UHFFFAOYSA-N 0.000 description 1
- 229940121373 acetyl-coa carboxylase inhibitor Drugs 0.000 description 1
- 125000002336 acetylhydrazino group Chemical group [H]N([*])N([H])C(=O)C([H])([H])[H] 0.000 description 1
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- YLFSVIMMRPNPFK-WEQBUNFVSA-N acrinathrin Chemical compound CC1(C)[C@@H](\C=C/C(=O)OC(C(F)(F)F)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YLFSVIMMRPNPFK-WEQBUNFVSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002487 adenosine deaminase inhibitor Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- LRZWFURXIMFONG-HRSIRGMGSA-N afidopyropen Chemical compound C([C@@]1(C)[C@H]2[C@]([C@H]3[C@@H](O)C=4C(=O)OC(=CC=4O[C@]3(C)[C@@H](O)C2)C=2C=NC=CC=2)(C)CC[C@@H]1OC(=O)C1CC1)OC(=O)C1CC1 LRZWFURXIMFONG-HRSIRGMGSA-N 0.000 description 1
- 229960000982 afoxolaner Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- GMAUQNJOSOMMHI-JXAWBTAJSA-N alanycarb Chemical compound CSC(\C)=N/OC(=O)N(C)SN(CCC(=O)OCC)CC1=CC=CC=C1 GMAUQNJOSOMMHI-JXAWBTAJSA-N 0.000 description 1
- 229960002669 albendazole Drugs 0.000 description 1
- HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 description 1
- QGLZXHRNAYXIBU-WEVVVXLNSA-N aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000005136 alkenylsulfinyl group Chemical group 0.000 description 1
- 125000005137 alkenylsulfonyl group Chemical group 0.000 description 1
- 125000005108 alkenylthio group Chemical group 0.000 description 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004683 alkyl sulfoxy imino group Chemical group 0.000 description 1
- 125000005134 alkynylsulfinyl group Chemical group 0.000 description 1
- 125000005139 alkynylsulfonyl group Chemical group 0.000 description 1
- 125000005109 alkynylthio group Chemical group 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- ZCVAOQKBXKSDMS-UHFFFAOYSA-N allethrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-UHFFFAOYSA-N 0.000 description 1
- 229940024113 allethrin Drugs 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- HJJOHHHEKFECQI-UHFFFAOYSA-N aluminum;phosphite Chemical compound [Al+3].[O-]P([O-])[O-] HJJOHHHEKFECQI-UHFFFAOYSA-N 0.000 description 1
- GGKQIOFASHYUJZ-UHFFFAOYSA-N ametoctradin Chemical compound NC1=C(CCCCCCCC)C(CC)=NC2=NC=NN21 GGKQIOFASHYUJZ-UHFFFAOYSA-N 0.000 description 1
- 229950004370 amidantel Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 229960002749 aminolevulinic acid Drugs 0.000 description 1
- 125000004682 aminothiocarbonyl group Chemical group NC(=S)* 0.000 description 1
- BREATYVWRHIPIY-UHFFFAOYSA-N amisulbrom Chemical compound CN(C)S(=O)(=O)N1C=NC(S(=O)(=O)N2C3=CC(F)=CC=C3C(Br)=C2C)=N1 BREATYVWRHIPIY-UHFFFAOYSA-N 0.000 description 1
- 229960002587 amitraz Drugs 0.000 description 1
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- FROZIYRKKUFAOC-UHFFFAOYSA-N amobam Chemical compound N.N.SC(=S)NCCNC(S)=S FROZIYRKKUFAOC-UHFFFAOYSA-N 0.000 description 1
- IMHBYKMAHXWHRP-UHFFFAOYSA-N anilazine Chemical compound ClC1=CC=CC=C1NC1=NC(Cl)=NC(Cl)=N1 IMHBYKMAHXWHRP-UHFFFAOYSA-N 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 description 1
- 229950000294 azaconazole Drugs 0.000 description 1
- VEHPJKVTJQSSKL-UHFFFAOYSA-N azadirachtin Natural products O1C2(C)C(C3(C=COC3O3)O)CC3C21C1(C)C(O)C(OCC2(OC(C)=O)C(CC3OC(=O)C(C)=CC)OC(C)=O)C2C32COC(C(=O)OC)(O)C12 VEHPJKVTJQSSKL-UHFFFAOYSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N azadirachtin A Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-IRYYUVNJSA-N azadirachtin A Natural products C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C/C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-IRYYUVNJSA-N 0.000 description 1
- RQVGAIADHNPSME-UHFFFAOYSA-N azinphos-ethyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OCC)OCC)N=NC2=C1 RQVGAIADHNPSME-UHFFFAOYSA-N 0.000 description 1
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 description 1
- ONHBDDJJTDTLIR-UHFFFAOYSA-N azocyclotin Chemical compound C1CCCCC1[Sn](N1N=CN=C1)(C1CCCCC1)C1CCCCC1 ONHBDDJJTDTLIR-UHFFFAOYSA-N 0.000 description 1
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 1
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 description 1
- XEGGRYVFLWGFHI-UHFFFAOYSA-N bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 description 1
- FYZBOYWSHKHDMT-UHFFFAOYSA-N benfuracarb Chemical compound CCOC(=O)CCN(C(C)C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 FYZBOYWSHKHDMT-UHFFFAOYSA-N 0.000 description 1
- LJOZMWRYMKECFF-UHFFFAOYSA-N benodanil Chemical compound IC1=CC=CC=C1C(=O)NC1=CC=CC=C1 LJOZMWRYMKECFF-UHFFFAOYSA-N 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- YFXPPSKYMBTNAV-UHFFFAOYSA-N bensultap Chemical compound C=1C=CC=CC=1S(=O)(=O)SCC(N(C)C)CSS(=O)(=O)C1=CC=CC=C1 YFXPPSKYMBTNAV-UHFFFAOYSA-N 0.000 description 1
- VVSLYIKSEBPRSN-PELKAZGASA-N benthiavalicarb Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@@H](NC(O)=O)C(C)C)=NC2=C1 VVSLYIKSEBPRSN-PELKAZGASA-N 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- ZYXYTGQFPZEUFX-UHFFFAOYSA-N benzpyrimoxan Chemical compound O1C(OCCC1)C=1C(=NC=NC=1)OCC1=CC=C(C=C1)C(F)(F)F ZYXYTGQFPZEUFX-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 208000036815 beta tubulin Diseases 0.000 description 1
- VHLKTXFWDRXILV-UHFFFAOYSA-N bifenazate Chemical compound C1=C(NNC(=O)OC(C)C)C(OC)=CC=C1C1=CC=CC=C1 VHLKTXFWDRXILV-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960001901 bioallethrin Drugs 0.000 description 1
- 229950002373 bioresmethrin Drugs 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 description 1
- LDLMOOXUCMHBMZ-UHFFFAOYSA-N bixafen Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 LDLMOOXUCMHBMZ-UHFFFAOYSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- GHXRKGHKMRZBJH-UHFFFAOYSA-N boric acid Chemical compound OB(O)O.OB(O)O GHXRKGHKMRZBJH-UHFFFAOYSA-N 0.000 description 1
- 229940118790 boscalid Drugs 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- QSLZKWPYTWEWHC-UHFFFAOYSA-N broflanilide Chemical compound C=1C=CC(C(=O)NC=2C(=CC(=CC=2Br)C(F)(C(F)(F)F)C(F)(F)F)C(F)(F)F)=C(F)C=1N(C)C(=O)C1=CC=CC=C1 QSLZKWPYTWEWHC-UHFFFAOYSA-N 0.000 description 1
- FOANIXZHAMJWOI-UHFFFAOYSA-N bromopropylate Chemical compound C=1C=C(Br)C=CC=1C(O)(C(=O)OC(C)C)C1=CC=C(Br)C=C1 FOANIXZHAMJWOI-UHFFFAOYSA-N 0.000 description 1
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- DSKJPMWIHSOYEA-UHFFFAOYSA-N bupirimate Chemical compound CCCCC1=C(C)N=C(NCC)N=C1OS(=O)(=O)N(C)C DSKJPMWIHSOYEA-UHFFFAOYSA-N 0.000 description 1
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- KXRPCFINVWWFHQ-UHFFFAOYSA-N cadusafos Chemical compound CCC(C)SP(=O)(OCC)SC(C)CC KXRPCFINVWWFHQ-UHFFFAOYSA-N 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 229960003475 cambendazole Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 208000032343 candida glabrata infection Diseases 0.000 description 1
- 229940055022 candida parapsilosis Drugs 0.000 description 1
- JHRWWRDRBPCWTF-OLQVQODUSA-N captafol Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960005286 carbaryl Drugs 0.000 description 1
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 1
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- RXDMAYSSBPYBFW-UHFFFAOYSA-N carpropamid Chemical compound C=1C=C(Cl)C=CC=1C(C)NC(=O)C1(CC)C(C)C1(Cl)Cl RXDMAYSSBPYBFW-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 108010040093 cellulose synthase Proteins 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- MKFMTNNOZQXQBP-UVTDQMKNSA-N chembl2105966 Chemical compound COCC(=O)NC1=CC=C(\N=C(\C)N(C)C)C=C1 MKFMTNNOZQXQBP-UVTDQMKNSA-N 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- BIWJNBZANLAXMG-YQELWRJZSA-N chloordaan Chemical compound ClC1=C(Cl)[C@@]2(Cl)C3CC(Cl)C(Cl)C3[C@]1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-YQELWRJZSA-N 0.000 description 1
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 description 1
- XFDJMIHUAHSGKG-UHFFFAOYSA-N chlorethoxyfos Chemical compound CCOP(=S)(OCC)OC(Cl)C(Cl)(Cl)Cl XFDJMIHUAHSGKG-UHFFFAOYSA-N 0.000 description 1
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 1
- UISUNVFOGSJSKD-UHFFFAOYSA-N chlorfluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1Cl)=CC(Cl)=C1OC1=NC=C(C(F)(F)F)C=C1Cl UISUNVFOGSJSKD-UHFFFAOYSA-N 0.000 description 1
- QGTYWWGEWOBMAK-UHFFFAOYSA-N chlormephos Chemical compound CCOP(=S)(OCC)SCCl QGTYWWGEWOBMAK-UHFFFAOYSA-N 0.000 description 1
- JUZXDNPBRPUIOR-UHFFFAOYSA-N chlormequat Chemical compound C[N+](C)(C)CCCl JUZXDNPBRPUIOR-UHFFFAOYSA-N 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 description 1
- LFHISGNCFUNFFM-UHFFFAOYSA-N chloropicrin Chemical compound [O-][N+](=O)C(Cl)(Cl)Cl LFHISGNCFUNFFM-UHFFFAOYSA-N 0.000 description 1
- RQNZCZHWQZMZER-ZLDLUXBVSA-N chloroprallethrin Chemical compound CC1=C(CC#C)C(=O)C[C@@H]1OC(=O)[C@H]1C(C)(C)[C@@H]1C=C(Cl)Cl RQNZCZHWQZMZER-ZLDLUXBVSA-N 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 1
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- UXADOQPNKNTIHB-UHFFFAOYSA-N clofentezine Chemical compound ClC1=CC=CC=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 UXADOQPNKNTIHB-UHFFFAOYSA-N 0.000 description 1
- 229960000275 clorsulon Drugs 0.000 description 1
- 229950004178 closantel Drugs 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910001956 copper hydroxide Inorganic materials 0.000 description 1
- 229940120693 copper naphthenate Drugs 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- SEVNKWFHTNVOLD-UHFFFAOYSA-L copper;3-(4-ethylcyclohexyl)propanoate;3-(3-ethylcyclopentyl)propanoate Chemical compound [Cu+2].CCC1CCC(CCC([O-])=O)C1.CCC1CCC(CCC([O-])=O)CC1 SEVNKWFHTNVOLD-UHFFFAOYSA-L 0.000 description 1
- JOXAXMBQVHFGQT-UHFFFAOYSA-J copper;manganese(2+);n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[Cu+2].[S-]C(=S)NCCNC([S-])=S.[S-]C(=S)NCCNC([S-])=S JOXAXMBQVHFGQT-UHFFFAOYSA-J 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- BXNANOICGRISHX-UHFFFAOYSA-N coumaphos Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 BXNANOICGRISHX-UHFFFAOYSA-N 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 125000000332 coumarinyl group Chemical class O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- CWVRPJSBNHNJSI-XQNSMLJCSA-N coumoxystrobin Chemical compound C1=C2OC(=O)C(CCCC)=C(C)C2=CC=C1OCC1=CC=CC=C1\C(=C/OC)C(=O)OC CWVRPJSBNHNJSI-XQNSMLJCSA-N 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940112669 cuprous oxide Drugs 0.000 description 1
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- SCKHCCSZFPSHGR-UHFFFAOYSA-N cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 description 1
- DVBUIBGJRQBEDP-UHFFFAOYSA-N cyantraniliprole Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl DVBUIBGJRQBEDP-UHFFFAOYSA-N 0.000 description 1
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- LSFUGNKKPMBOMG-UHFFFAOYSA-N cycloprothrin Chemical compound ClC1(Cl)CC1(C=1C=CC=CC=1)C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 LSFUGNKKPMBOMG-UHFFFAOYSA-N 0.000 description 1
- APJLTUBHYCOZJI-VZCXRCSSSA-N cyenopyrafen Chemical compound CC1=NN(C)C(\C(OC(=O)C(C)(C)C)=C(/C#N)C=2C=CC(=CC=2)C(C)(C)C)=C1C APJLTUBHYCOZJI-VZCXRCSSSA-N 0.000 description 1
- ACMXQHFNODYQAT-UHFFFAOYSA-N cyflufenamid Chemical compound FC1=CC=C(C(F)(F)F)C(C(NOCC2CC2)=NC(=O)CC=2C=CC=CC=2)=C1F ACMXQHFNODYQAT-UHFFFAOYSA-N 0.000 description 1
- 229960001591 cyfluthrin Drugs 0.000 description 1
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 1
- NNRSYETYEADPBW-UHFFFAOYSA-N cyhalodiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(Cl)=C1C(=O)NC(C)(C)C#N NNRSYETYEADPBW-UHFFFAOYSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-UNOMPAQXSA-N cyhalothrin Chemical compound CC1(C)C(\C=C(/Cl)C(F)(F)F)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-UNOMPAQXSA-N 0.000 description 1
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 1
- 229960005424 cypermethrin Drugs 0.000 description 1
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 description 1
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 description 1
- 229950000775 cyromazine Drugs 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 229940008203 d-transallethrin Drugs 0.000 description 1
- 229960002483 decamethrin Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- WEBQKRLKWNIYKK-UHFFFAOYSA-N demeton-S-methyl Chemical compound CCSCCSP(=O)(OC)OC WEBQKRLKWNIYKK-UHFFFAOYSA-N 0.000 description 1
- 229950003960 demiditraz Drugs 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- WURGXGVFSMYFCG-UHFFFAOYSA-N dichlofluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=CC=C1 WURGXGVFSMYFCG-UHFFFAOYSA-N 0.000 description 1
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229950001327 dichlorvos Drugs 0.000 description 1
- YEJGPFZQLRMXOI-PKEIRNPWSA-N diclocymet Chemical compound N#CC(C(C)(C)C)C(=O)N[C@H](C)C1=CC=C(Cl)C=C1Cl YEJGPFZQLRMXOI-PKEIRNPWSA-N 0.000 description 1
- UWQMKVBQKFHLCE-UHFFFAOYSA-N diclomezine Chemical compound C1=C(Cl)C(C)=C(Cl)C=C1C1=NNC(=O)C=C1 UWQMKVBQKFHLCE-UHFFFAOYSA-N 0.000 description 1
- PVDQXPBKBSCNJZ-UHFFFAOYSA-N dicloromezotiaz Chemical compound CC1=CC=C[N+](C(C(C=2C=C(Cl)C=C(Cl)C=2)=C2[O-])=O)=C1N2CC1=CN=C(Cl)S1 PVDQXPBKBSCNJZ-UHFFFAOYSA-N 0.000 description 1
- UOAMTSKGCBMZTC-UHFFFAOYSA-N dicofol Chemical compound C=1C=C(Cl)C=CC=1C(C(Cl)(Cl)Cl)(O)C1=CC=C(Cl)C=C1 UOAMTSKGCBMZTC-UHFFFAOYSA-N 0.000 description 1
- VEENJGZXVHKXNB-VOTSOKGWSA-N dicrotophos Chemical compound COP(=O)(OC)O\C(C)=C\C(=O)N(C)C VEENJGZXVHKXNB-VOTSOKGWSA-N 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- LNJNFVJKDJYTEU-UHFFFAOYSA-N diethofencarb Chemical compound CCOC1=CC=C(NC(=O)OC(C)C)C=C1OCC LNJNFVJKDJYTEU-UHFFFAOYSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- RCKMWOKWVGPNJF-UHFFFAOYSA-N diethylcarbamazine Chemical compound CCN(CC)C(=O)N1CCN(C)CC1 RCKMWOKWVGPNJF-UHFFFAOYSA-N 0.000 description 1
- 229960003974 diethylcarbamazine Drugs 0.000 description 1
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- XXFACTAYGKKOQB-ZETCQYMHSA-N dihydrozeatin Chemical compound OC[C@@H](C)CCNC1=NC=NC2=C1NC=N2 XXFACTAYGKKOQB-ZETCQYMHSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- CJHXCRMKMMBYJQ-UHFFFAOYSA-N dimethirimol Chemical compound CCCCC1=C(C)NC(N(C)C)=NC1=O CJHXCRMKMMBYJQ-UHFFFAOYSA-N 0.000 description 1
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 description 1
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- OZYJVQJGKRFVHQ-UHFFFAOYSA-L dipotassium trioxidophosphanium Chemical class [K+].[K+].[O-]P([O-])=O OZYJVQJGKRFVHQ-UHFFFAOYSA-L 0.000 description 1
- FPKXBFWMIYHCID-UHFFFAOYSA-N dipymetitrone Chemical compound S1C=2C(=O)N(C)C(=O)C=2SC2=C1C(=O)N(C)C2=O FPKXBFWMIYHCID-UHFFFAOYSA-N 0.000 description 1
- YDEXUEFDPVHGHE-GGMCWBHBSA-L disodium;(2r)-3-(2-hydroxy-3-methoxyphenyl)-2-[2-methoxy-4-(3-sulfonatopropyl)phenoxy]propane-1-sulfonate Chemical compound [Na+].[Na+].COC1=CC=CC(C[C@H](CS([O-])(=O)=O)OC=2C(=CC(CCCS([O-])(=O)=O)=CC=2)OC)=C1O YDEXUEFDPVHGHE-GGMCWBHBSA-L 0.000 description 1
- CLZJMLYRPZBOPU-UHFFFAOYSA-N disodium;boric acid;hydrogen borate Chemical compound [Na+].[Na+].OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB([O-])[O-] CLZJMLYRPZBOPU-UHFFFAOYSA-N 0.000 description 1
- IIRVGTWONXBBAW-UHFFFAOYSA-M disodium;dioxido(oxo)phosphanium Chemical compound [Na+].[Na+].[O-][P+]([O-])=O IIRVGTWONXBBAW-UHFFFAOYSA-M 0.000 description 1
- 208000022682 disseminated sporotrichosis Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- DOFZAZXDOSGAJZ-UHFFFAOYSA-N disulfoton Chemical compound CCOP(=S)(OCC)SCCSCC DOFZAZXDOSGAJZ-UHFFFAOYSA-N 0.000 description 1
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 description 1
- JMXKCYUTURMERF-UHFFFAOYSA-N dodemorph Chemical compound C1C(C)OC(C)CN1C1CCCCCCCCCCC1 JMXKCYUTURMERF-UHFFFAOYSA-N 0.000 description 1
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 description 1
- 229960003997 doramectin Drugs 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 229960002125 enilconazole Drugs 0.000 description 1
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 description 1
- WPNHOHPRXXCPRA-TVXIRPTOSA-N eprinomectin Chemical compound O1[C@@H](C)[C@@H](NC(C)=O)[C@H](OC)C[C@@H]1O[C@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C\C=C/[C@@H]2C)\C)O[C@H]1C WPNHOHPRXXCPRA-TVXIRPTOSA-N 0.000 description 1
- 229960002346 eprinomectin Drugs 0.000 description 1
- KVIZNNVXXNFLMU-DUVUQDDDSA-N epsilon-metofluthrin Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1\C=C/C KVIZNNVXXNFLMU-DUVUQDDDSA-N 0.000 description 1
- DPJITPZADZSLBP-DQXQJKBJSA-N epsilon-momfluorothrin Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1\C=C(\C)C#N DPJITPZADZSLBP-DQXQJKBJSA-N 0.000 description 1
- 229960005362 epsiprantel Drugs 0.000 description 1
- LGUDKOQUWIHXOV-UHFFFAOYSA-N epsiprantel Chemical compound C1C(C2=CC=CC=C2CCC2)N2C(=O)CN1C(=O)C1CCCCC1 LGUDKOQUWIHXOV-UHFFFAOYSA-N 0.000 description 1
- NYPJDWWKZLNGGM-RPWUZVMVSA-N esfenvalerate Chemical compound C=1C([C@@H](C#N)OC(=O)[C@@H](C(C)C)C=2C=CC(Cl)=CC=2)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-RPWUZVMVSA-N 0.000 description 1
- DWRKFAJEBUWTQM-UHFFFAOYSA-N etaconazole Chemical compound O1C(CC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 DWRKFAJEBUWTQM-UHFFFAOYSA-N 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 1
- HEZNVIYQEUHLNI-UHFFFAOYSA-N ethiofencarb Chemical compound CCSCC1=CC=CC=C1OC(=O)NC HEZNVIYQEUHLNI-UHFFFAOYSA-N 0.000 description 1
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 1
- BBXXLROWFHWFQY-UHFFFAOYSA-N ethirimol Chemical compound CCCCC1=C(C)NC(NCC)=NC1=O BBXXLROWFHWFQY-UHFFFAOYSA-N 0.000 description 1
- VJYFKVYYMZPMAB-UHFFFAOYSA-N ethoprophos Chemical compound CCCSP(=O)(OCC)SCCC VJYFKVYYMZPMAB-UHFFFAOYSA-N 0.000 description 1
- 125000006627 ethoxycarbonylamino group Chemical group 0.000 description 1
- YKRQBWKLHCEKQH-KHPPLWFESA-N ethyl (z)-3-amino-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C(/N)C1=CC=CC=C1 YKRQBWKLHCEKQH-KHPPLWFESA-N 0.000 description 1
- IGUYEXXAGBDLLX-UHFFFAOYSA-N ethyl 3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1C(C(=O)OCC)(C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 IGUYEXXAGBDLLX-UHFFFAOYSA-N 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- YREQHYQNNWYQCJ-UHFFFAOYSA-N etofenprox Chemical compound C1=CC(OCC)=CC=C1C(C)(C)COCC1=CC=CC(OC=2C=CC=CC=2)=C1 YREQHYQNNWYQCJ-UHFFFAOYSA-N 0.000 description 1
- 229950005085 etofenprox Drugs 0.000 description 1
- IXSZQYVWNJNRAL-UHFFFAOYSA-N etoxazole Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C1N=C(C=2C(=CC=CC=2F)F)OC1 IXSZQYVWNJNRAL-UHFFFAOYSA-N 0.000 description 1
- KQTVWCSONPJJPE-UHFFFAOYSA-N etridiazole Chemical compound CCOC1=NC(C(Cl)(Cl)Cl)=NS1 KQTVWCSONPJJPE-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- JISACBWYRJHSMG-UHFFFAOYSA-N famphur Chemical compound COP(=S)(OC)OC1=CC=C(S(=O)(=O)N(C)C)C=C1 JISACBWYRJHSMG-UHFFFAOYSA-N 0.000 description 1
- 229960005282 febantel Drugs 0.000 description 1
- LMVPQMGRYSRMIW-KRWDZBQOSA-N fenamidone Chemical compound O=C([C@@](C)(N=C1SC)C=2C=CC=CC=2)N1NC1=CC=CC=C1 LMVPQMGRYSRMIW-KRWDZBQOSA-N 0.000 description 1
- RBWGTZRSEOIHFD-UHUFKFKFSA-N fenaminstrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C=C\C1=C(Cl)C=CC=C1Cl RBWGTZRSEOIHFD-UHUFKFKFSA-N 0.000 description 1
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 description 1
- 229960005473 fenbendazole Drugs 0.000 description 1
- HDDSHPAODJUKPD-UHFFFAOYSA-N fenbendazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1SC1=CC=CC=C1 HDDSHPAODJUKPD-UHFFFAOYSA-N 0.000 description 1
- 229950006668 fenfluthrin Drugs 0.000 description 1
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 description 1
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 description 1
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 1
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- FKLFBQCQQYDUAM-UHFFFAOYSA-N fenpiclonil Chemical compound ClC1=CC=CC(C=2C(=CNC=2)C#N)=C1Cl FKLFBQCQQYDUAM-UHFFFAOYSA-N 0.000 description 1
- QGTOTYJSCYHYFK-RBODFLQRSA-N fenpicoxamid Chemical compound COC1=CC=NC(C(=O)N[C@@H]2C(O[C@@H](C)[C@H](OC(=O)C(C)C)[C@@H](CC=3C=CC=CC=3)C(=O)OC2)=O)=C1OCOC(=O)C(C)C QGTOTYJSCYHYFK-RBODFLQRSA-N 0.000 description 1
- XQUXKZZNEFRCAW-UHFFFAOYSA-N fenpropathrin Chemical compound CC1(C)C(C)(C)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 XQUXKZZNEFRCAW-UHFFFAOYSA-N 0.000 description 1
- UTOHZQYBSYOOGC-UHFFFAOYSA-N fenpyrazamine Chemical compound O=C1N(C(C)C)N(C(=O)SCC=C)C(N)=C1C1=CC=CC=C1C UTOHZQYBSYOOGC-UHFFFAOYSA-N 0.000 description 1
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 1
- WDQNIWFZKXZFAY-UHFFFAOYSA-M fentin acetate Chemical compound CC([O-])=O.C1=CC=CC=C1[Sn+](C=1C=CC=CC=1)C1=CC=CC=C1 WDQNIWFZKXZFAY-UHFFFAOYSA-M 0.000 description 1
- NJVOZLGKTAPUTQ-UHFFFAOYSA-M fentin chloride Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 NJVOZLGKTAPUTQ-UHFFFAOYSA-M 0.000 description 1
- BFWMWWXRWVJXSE-UHFFFAOYSA-M fentin hydroxide Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(O)C1=CC=CC=C1 BFWMWWXRWVJXSE-UHFFFAOYSA-M 0.000 description 1
- WHDGWKAJBYRJJL-UHFFFAOYSA-K ferbam Chemical compound [Fe+3].CN(C)C([S-])=S.CN(C)C([S-])=S.CN(C)C([S-])=S WHDGWKAJBYRJJL-UHFFFAOYSA-K 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 229940013764 fipronil Drugs 0.000 description 1
- RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 description 1
- ATZHVIVDMUCBEY-HOTGVXAUSA-N florylpicoxamid Chemical compound C(C)(=O)OC=1C(=NC=CC=1OC)C(=O)N[C@H](C(=O)O[C@H](C(C1=CC=C(C=C1)F)C1=CC=C(C=C1)F)C)C ATZHVIVDMUCBEY-HOTGVXAUSA-N 0.000 description 1
- MXWAGQASUDSFBG-RVDMUPIBSA-N fluacrypyrim Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C(F)(F)F)=NC(OC(C)C)=N1 MXWAGQASUDSFBG-RVDMUPIBSA-N 0.000 description 1
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 description 1
- YOWNVPAUWYHLQX-UHFFFAOYSA-N fluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C(OC=2C(=CC(=CN=2)C(F)(F)F)Cl)=C1 YOWNVPAUWYHLQX-UHFFFAOYSA-N 0.000 description 1
- 229950006719 fluazuron Drugs 0.000 description 1
- 229960004500 flubendazole Drugs 0.000 description 1
- CPEUVMUXAHMANV-UHFFFAOYSA-N flubendazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=C(F)C=C1 CPEUVMUXAHMANV-UHFFFAOYSA-N 0.000 description 1
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 description 1
- RYLHNOVXKPXDIP-UHFFFAOYSA-N flufenoxuron Chemical compound C=1C=C(NC(=O)NC(=O)C=2C(=CC=CC=2F)F)C(F)=CC=1OC1=CC=C(C(F)(F)F)C=C1Cl RYLHNOVXKPXDIP-UHFFFAOYSA-N 0.000 description 1
- MBHXIQDIVCJZTD-RVDMUPIBSA-N flufenoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=C(C(F)(F)F)C=C1Cl MBHXIQDIVCJZTD-RVDMUPIBSA-N 0.000 description 1
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 description 1
- DNJKFZQFTZJKDK-UHFFFAOYSA-N fluopimomide Chemical compound FC1=C(F)C(OC)=C(F)C(F)=C1C(=O)NCC1=NC=C(C(F)(F)F)C=C1Cl DNJKFZQFTZJKDK-UHFFFAOYSA-N 0.000 description 1
- IPENDKRRWFURRE-UHFFFAOYSA-N fluoroimide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(Cl)=C(Cl)C1=O IPENDKRRWFURRE-UHFFFAOYSA-N 0.000 description 1
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 description 1
- QOIYTRGFOFZNKF-UHFFFAOYSA-N flupyradifurone Chemical compound C=1C(=O)OCC=1N(CC(F)F)CC1=CC=C(Cl)N=C1 QOIYTRGFOFZNKF-UHFFFAOYSA-N 0.000 description 1
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
- MLBZKOGAMRTSKP-UHFFFAOYSA-N fluralaner Chemical compound C1=C(C(=O)NCC(=O)NCC(F)(F)F)C(C)=CC(C=2CC(ON=2)(C=2C=C(Cl)C=C(Cl)C=2)C(F)(F)F)=C1 MLBZKOGAMRTSKP-UHFFFAOYSA-N 0.000 description 1
- 229960004498 fluralaner Drugs 0.000 description 1
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 description 1
- GNVDAZSPJWCIQZ-UHFFFAOYSA-N flusulfamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NS(=O)(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 GNVDAZSPJWCIQZ-UHFFFAOYSA-N 0.000 description 1
- KGXUEPOHGFWQKF-ZCXUNETKSA-N flutianil Chemical compound COC1=CC=CC=C1N(CCS\1)C/1=C(C#N)/SC1=CC(C(F)(F)F)=CC=C1F KGXUEPOHGFWQKF-ZCXUNETKSA-N 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- SXSGXWCSHSVPGB-UHFFFAOYSA-N fluxapyroxad Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 SXSGXWCSHSVPGB-UHFFFAOYSA-N 0.000 description 1
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 description 1
- KVGLBTYUCJYMND-UHFFFAOYSA-N fonofos Chemical compound CCOP(=S)(CC)SC1=CC=CC=C1 KVGLBTYUCJYMND-UHFFFAOYSA-N 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- GPXLRLUVLMHHIK-UHFFFAOYSA-N forchlorfenuron Chemical compound C1=NC(Cl)=CC(NC(=O)NC=2C=CC=CC=2)=C1 GPXLRLUVLMHHIK-UHFFFAOYSA-N 0.000 description 1
- RMFNNCGOSPBBAD-MDWZMJQESA-N formetanate Chemical compound CNC(=O)OC1=CC=CC(\N=C\N(C)C)=C1 RMFNNCGOSPBBAD-MDWZMJQESA-N 0.000 description 1
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- UYJUZNLFJAWNEZ-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2NC3=CC=CC=C3N=2)=C1 UYJUZNLFJAWNEZ-UHFFFAOYSA-N 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- HAWJXYBZNNRMNO-UHFFFAOYSA-N furathiocarb Chemical compound CCCCOC(=O)N(C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 HAWJXYBZNNRMNO-UHFFFAOYSA-N 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-GCMPRSNUSA-N gamma-cyhalothrin Chemical compound CC1(C)[C@@H](\C=C(/Cl)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-GCMPRSNUSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- RSQSQJNRHICNNH-NFMPGMCNSA-N gibberellin A4 Chemical compound C([C@@H]1C[C@]2(CC1=C)[C@H]1C(O)=O)C[C@H]2[C@@]2(OC3=O)[C@H]1[C@@]3(C)[C@@H](O)CC2 RSQSQJNRHICNNH-NFMPGMCNSA-N 0.000 description 1
- SEEGHKWOBVVBTQ-UHFFFAOYSA-N gibberellin GA7 Natural products OC(=O)C1C2(CC3=C)CC3CCC2C2(C=CC3O)C1C3(C)C(=O)O2 SEEGHKWOBVVBTQ-UHFFFAOYSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000848 glutamatergic effect Effects 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- WIFXJBMOTMKRMM-UHFFFAOYSA-N halfenprox Chemical compound C=1C=C(OC(F)(F)Br)C=CC=1C(C)(C)COCC(C=1)=CC=CC=1OC1=CC=CC=C1 WIFXJBMOTMKRMM-UHFFFAOYSA-N 0.000 description 1
- 125000005291 haloalkenyloxy group Chemical group 0.000 description 1
- 125000004692 haloalkylcarbonyl group Chemical group 0.000 description 1
- 125000005347 halocycloalkyl group Chemical group 0.000 description 1
- CNKHSLKYRMDDNQ-UHFFFAOYSA-N halofenozide Chemical compound C=1C=CC=CC=1C(=O)N(C(C)(C)C)NC(=O)C1=CC=C(Cl)C=C1 CNKHSLKYRMDDNQ-UHFFFAOYSA-N 0.000 description 1
- FRCCEHPWNOQAEU-UHFFFAOYSA-N heptachlor Chemical compound ClC1=C(Cl)C2(Cl)C3C=CC(Cl)C3C1(Cl)C2(Cl)Cl FRCCEHPWNOQAEU-UHFFFAOYSA-N 0.000 description 1
- BKACAEJQMLLGAV-PLNGDYQASA-N heptafluthrin Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)C1C(C)(C)C1\C=C/C(F)(F)F BKACAEJQMLLGAV-PLNGDYQASA-N 0.000 description 1
- RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000004095 hydrolyase inhibitor Substances 0.000 description 1
- USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 1
- FYQGBXGJFWXIPP-UHFFFAOYSA-N hydroprene Chemical compound CCOC(=O)C=C(C)C=CCC(C)CCCC(C)C FYQGBXGJFWXIPP-UHFFFAOYSA-N 0.000 description 1
- 229930000073 hydroprene Natural products 0.000 description 1
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical compound CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 description 1
- HICUREFSAIZXFQ-JOWPUVSESA-N i9z29i000j Chemical compound C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\[C@H](OC(=O)C(=N/OC)\C=1C=CC=CC=1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 HICUREFSAIZXFQ-JOWPUVSESA-N 0.000 description 1
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- VPRAQYXPZIFIOH-UHFFFAOYSA-N imiprothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCN1C(=O)N(CC#C)CC1=O VPRAQYXPZIFIOH-UHFFFAOYSA-N 0.000 description 1
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 1
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- YTCIYOXHHQLDEI-SNVBAGLBSA-N inpyrfluxam Chemical compound C([C@H](C=12)C)C(C)(C)C2=CC=CC=1NC(=O)C1=CN(C)N=C1C(F)F YTCIYOXHHQLDEI-SNVBAGLBSA-N 0.000 description 1
- 239000002428 insect molting hormone Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 description 1
- DSXOWZNZGWXWMX-UHFFFAOYSA-N ipflufenoquin Chemical compound CC1=NC2=C(F)C(F)=CC=C2C=C1OC1=CC=CC(F)=C1C(C)(C)O DSXOWZNZGWXWMX-UHFFFAOYSA-N 0.000 description 1
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 description 1
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 description 1
- WLSQDEYDCAGPIR-UHFFFAOYSA-N isocycloseram Chemical compound O=C1N(CC)OCC1NC(=O)C1=CC=C(C=2CC(ON=2)(C=2C=C(Cl)C(F)=C(Cl)C=2)C(F)(F)F)C=C1C WLSQDEYDCAGPIR-UHFFFAOYSA-N 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- QBSJMKIUCUGGNG-UHFFFAOYSA-N isoprocarb Chemical compound CNC(=O)OC1=CC=CC=C1C(C)C QBSJMKIUCUGGNG-UHFFFAOYSA-N 0.000 description 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 1
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 description 1
- SDMSCIWHRZJSRN-UHFFFAOYSA-N isoxathion Chemical compound O1N=C(OP(=S)(OCC)OCC)C=C1C1=CC=CC=C1 SDMSCIWHRZJSRN-UHFFFAOYSA-N 0.000 description 1
- 229960002418 ivermectin Drugs 0.000 description 1
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- UGWALRUNBSBTGI-ZKMZRDRYSA-N kadethrin Chemical compound C(/[C@@H]1C([C@@H]1C(=O)OCC=1C=C(CC=2C=CC=CC=2)OC=1)(C)C)=C1/CCSC1=O UGWALRUNBSBTGI-ZKMZRDRYSA-N 0.000 description 1
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 229930001540 kinoprene Natural products 0.000 description 1
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical group CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 230000004322 lipid homeostasis Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 229950002303 lotilaner Drugs 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960000521 lufenuron Drugs 0.000 description 1
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 description 1
- 229920000940 maneb Polymers 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960003439 mebendazole Drugs 0.000 description 1
- OPXLLQIJSORQAM-UHFFFAOYSA-N mebendazole Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(=O)C1=CC=CC=C1 OPXLLQIJSORQAM-UHFFFAOYSA-N 0.000 description 1
- KLGMSAOQDHLCOS-UHFFFAOYSA-N mecarbam Chemical compound CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC KLGMSAOQDHLCOS-UHFFFAOYSA-N 0.000 description 1
- MGEOLZFMLHYCFZ-UHFFFAOYSA-N melarsomine Chemical compound C1=CC([As](SCCN)SCCN)=CC=C1NC1=NC(N)=NC(N)=N1 MGEOLZFMLHYCFZ-UHFFFAOYSA-N 0.000 description 1
- 229960002234 melarsomine Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 description 1
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 description 1
- HYVVJDQGXFXBRZ-UHFFFAOYSA-N metam Chemical compound CNC(S)=S HYVVJDQGXFXBRZ-UHFFFAOYSA-N 0.000 description 1
- CAUHWGTUUBORAX-IKGGRYGDSA-N metarylpicoxamid Chemical compound CCC(=O)Oc1c(OC)ccnc1C(=O)N[C@@H](C)C(=O)O[C@@H](C)[C@@H](C)c1ccccc1C CAUHWGTUUBORAX-IKGGRYGDSA-N 0.000 description 1
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 1
- NNKVPIKMPCQWCG-UHFFFAOYSA-N methamidophos Chemical compound COP(N)(=O)SC NNKVPIKMPCQWCG-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- IXJOSTZEBSTPAG-UHFFFAOYSA-N methasulfocarb Chemical compound CNC(=O)SC1=CC=C(OS(C)(=O)=O)C=C1 IXJOSTZEBSTPAG-UHFFFAOYSA-N 0.000 description 1
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 description 1
- YFBPRJGDJKVWAH-UHFFFAOYSA-N methiocarb Chemical compound CNC(=O)OC1=CC(C)=C(SC)C(C)=C1 YFBPRJGDJKVWAH-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 description 1
- 229930002897 methoprene Natural products 0.000 description 1
- 229950003442 methoprene Drugs 0.000 description 1
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 description 1
- KBHDSWIXRODKSZ-UHFFFAOYSA-N methyl 5-chloro-2-(trifluoromethylsulfonylamino)benzoate Chemical compound COC(=O)C1=CC(Cl)=CC=C1NS(=O)(=O)C(F)(F)F KBHDSWIXRODKSZ-UHFFFAOYSA-N 0.000 description 1
- PKXXKDJDYMOWHE-UHFFFAOYSA-N methyl 6-chloro-3-methoxypyridazine-4-carboxylate Chemical compound COC(=O)C1=CC(Cl)=NN=C1OC PKXXKDJDYMOWHE-UHFFFAOYSA-N 0.000 description 1
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 1
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 1
- CJPQIRJHIZUAQP-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)alaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-UHFFFAOYSA-N 0.000 description 1
- CIEXPHRYOLIQQD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-2-furoylalaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)C1=CC=CO1 CIEXPHRYOLIQQD-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- VNXBKJFUJUWOCW-UHFFFAOYSA-N methylcyclopropane Chemical compound CC1CC1 VNXBKJFUJUWOCW-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000003697 methyltransferase inhibitor Substances 0.000 description 1
- 229920000257 metiram Polymers 0.000 description 1
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 1
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 description 1
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 description 1
- 229960001952 metrifonate Drugs 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- WTERNLDOAPYGJD-SFHVURJKSA-N monepantel Chemical compound C([C@@](C)(NC(=O)C=1C=CC(SC(F)(F)F)=CC=1)C#N)OC1=CC(C#N)=CC=C1C(F)(F)F WTERNLDOAPYGJD-SFHVURJKSA-N 0.000 description 1
- 229950003439 monepantel Drugs 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 229960005121 morantel Drugs 0.000 description 1
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 description 1
- 229960004816 moxidectin Drugs 0.000 description 1
- WPRKVIPHGOHZAL-UHFFFAOYSA-N n'-methyloxamide Chemical group CNC(=O)C(N)=O WPRKVIPHGOHZAL-UHFFFAOYSA-N 0.000 description 1
- COHTVILOUURPNC-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-4-hydroxy-1,3-dimethyl-2,6-dioxopyrimidine-5-carboxamide Chemical compound O=C1N(C)C(=O)N(C)C(O)=C1C(=O)NC1=CC=C(Cl)C(Cl)=C1 COHTVILOUURPNC-UHFFFAOYSA-N 0.000 description 1
- JEFUQUGZXLEHLD-UHFFFAOYSA-N n-[(5-chloro-2-propan-2-ylphenyl)methyl]-n-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1=CC=C(Cl)C=C1CN(C(=O)C=1C(=NN(C)C=1F)C(F)F)C1CC1 JEFUQUGZXLEHLD-UHFFFAOYSA-N 0.000 description 1
- DHQKLWKZSFCKTA-UHFFFAOYSA-N n-[1-[(6-chloropyridin-3-yl)methyl]pyridin-2-ylidene]-2,2,2-trifluoroacetamide Chemical compound FC(F)(F)C(=O)N=C1C=CC=CN1CC1=CC=C(Cl)N=C1 DHQKLWKZSFCKTA-UHFFFAOYSA-N 0.000 description 1
- FVJQBZVCJVMBIP-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2,4-dinitro-6-(trifluoromethyl)aniline Chemical compound FC(F)(F)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NC1=CC(C(F)(F)F)=CC=C1Cl FVJQBZVCJVMBIP-UHFFFAOYSA-N 0.000 description 1
- YNKFZRGTXAPYFD-UHFFFAOYSA-N n-[[2-chloro-3,5-bis(trifluoromethyl)phenyl]carbamoyl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1Cl YNKFZRGTXAPYFD-UHFFFAOYSA-N 0.000 description 1
- OXWFFWJKUNMMSO-UHFFFAOYSA-N n-octyl-n'-[2-(octylamino)ethyl]ethane-1,2-diamine Chemical compound CCCCCCCCNCCNCCNCCCCCCCC OXWFFWJKUNMMSO-UHFFFAOYSA-N 0.000 description 1
- OZGNYLLQHRPOBR-DHZHZOJOSA-N naftifine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OZGNYLLQHRPOBR-DHZHZOJOSA-N 0.000 description 1
- 229960004313 naftifine Drugs 0.000 description 1
- BUYMVQAILCEWRR-UHFFFAOYSA-N naled Chemical compound COP(=O)(OC)OC(Br)C(Cl)(Cl)Br BUYMVQAILCEWRR-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 125000005184 naphthylamino group Chemical group C1(=CC=CC2=CC=CC=C12)N* 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- 235000010298 natamycin Nutrition 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000002018 neem oil Substances 0.000 description 1
- 229960001920 niclosamide Drugs 0.000 description 1
- RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229940079888 nitenpyram Drugs 0.000 description 1
- 229950009909 nitroscanate Drugs 0.000 description 1
- SGKGVABHDAQAJO-UHFFFAOYSA-N nitroxynil Chemical compound OC1=C(I)C=C(C#N)C=C1[N+]([O-])=O SGKGVABHDAQAJO-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108010003516 norsynephrine receptor Proteins 0.000 description 1
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
- YTYGAJLZOJPJGH-UHFFFAOYSA-N noviflumuron Chemical compound FC1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F YTYGAJLZOJPJGH-UHFFFAOYSA-N 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- PZXOQEXFMJCDPG-UHFFFAOYSA-N omethoate Chemical compound CNC(=O)CSP(=O)(OC)OC PZXOQEXFMJCDPG-UHFFFAOYSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- JHIPUJPTQJYEQK-ZLHHXESBSA-N orysastrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C(=N\OC)\C(\C)=N\OC JHIPUJPTQJYEQK-ZLHHXESBSA-N 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- KZAUOCCYDRDERY-UHFFFAOYSA-N oxamyl Chemical compound CNC(=O)ON=C(SC)C(=O)N(C)C KZAUOCCYDRDERY-UHFFFAOYSA-N 0.000 description 1
- 229960004454 oxfendazole Drugs 0.000 description 1
- BEZZFPOZAYTVHN-UHFFFAOYSA-N oxfendazole Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1S(=O)C1=CC=CC=C1 BEZZFPOZAYTVHN-UHFFFAOYSA-N 0.000 description 1
- 239000002457 oxidoreductase inhibitor Substances 0.000 description 1
- 229960000321 oxolinic acid Drugs 0.000 description 1
- AMEKQAFGQBKLKX-UHFFFAOYSA-N oxycarboxin Chemical compound O=S1(=O)CCOC(C)=C1C(=O)NC1=CC=CC=C1 AMEKQAFGQBKLKX-UHFFFAOYSA-N 0.000 description 1
- 229950003126 oxyclozanide Drugs 0.000 description 1
- JYWIYHUXVMAGLG-UHFFFAOYSA-N oxyclozanide Chemical compound OC1=C(Cl)C=C(Cl)C=C1NC(=O)C1=C(O)C(Cl)=CC(Cl)=C1Cl JYWIYHUXVMAGLG-UHFFFAOYSA-N 0.000 description 1
- PMCVMORKVPSKHZ-UHFFFAOYSA-N oxydemeton-methyl Chemical compound CCS(=O)CCSP(=O)(OC)OC PMCVMORKVPSKHZ-UHFFFAOYSA-N 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical group COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- OGYFATSSENRIKG-UHFFFAOYSA-N pencycuron Chemical compound C1=CC(Cl)=CC=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCC1 OGYFATSSENRIKG-UHFFFAOYSA-N 0.000 description 1
- WBTYBAGIHOISOQ-UHFFFAOYSA-N pent-4-en-1-yl 2-[(2-furylmethyl)(imidazol-1-ylcarbonyl)amino]butanoate Chemical compound C1=CN=CN1C(=O)N(C(CC)C(=O)OCCCC=C)CC1=CC=CO1 WBTYBAGIHOISOQ-UHFFFAOYSA-N 0.000 description 1
- LKPLKUMXSAEKID-UHFFFAOYSA-N pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 description 1
- BULVZWIRKLYCBC-UHFFFAOYSA-N phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- LMNZTLDVJIUSHT-UHFFFAOYSA-N phosmet Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)C(=O)C2=C1 LMNZTLDVJIUSHT-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- HOKBIQDJCNTWST-UHFFFAOYSA-N phosphanylidenezinc;zinc Chemical compound [Zn].[Zn]=P.[Zn]=P HOKBIQDJCNTWST-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 1
- 229950001664 phoxim Drugs 0.000 description 1
- URHWNXDZOULUHC-ULJHMMPZSA-N picarbutrazox Chemical compound CN1N=NN=C1\C(C=1C=CC=CC=1)=N/OCC1=CC=CC(NC(=O)OC(C)(C)C)=N1 URHWNXDZOULUHC-ULJHMMPZSA-N 0.000 description 1
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 description 1
- 229960005141 piperazine Drugs 0.000 description 1
- QHOQHJPRIBSPCY-UHFFFAOYSA-N pirimiphos-methyl Chemical group CCN(CC)C1=NC(C)=CC(OP(=S)(OC)OC)=N1 QHOQHJPRIBSPCY-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 108010049148 plastin Proteins 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- YEBIHIICWDDQOL-YBHNRIQQSA-N polyoxin Polymers O[C@@H]1[C@H](O)[C@@H](C(C=O)N)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 YEBIHIICWDDQOL-YBHNRIQQSA-N 0.000 description 1
- JPFWJDMDPLEUBD-ITJAGOAWSA-N polyoxorim Polymers O[C@@H]1[C@H](O)[C@@H]([C@H](NC(=O)[C@H]([C@H](O)[C@@H](O)COC(N)=O)N)C(O)=O)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 JPFWJDMDPLEUBD-ITJAGOAWSA-N 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 239000004540 pour-on Substances 0.000 description 1
- SMKRKQBMYOFFMU-UHFFFAOYSA-N prallethrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OC1C(C)=C(CC#C)C(=O)C1 SMKRKQBMYOFFMU-UHFFFAOYSA-N 0.000 description 1
- 229960002957 praziquantel Drugs 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 1
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 1
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 description 1
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 description 1
- WTFXJFJYEJZMFO-UHFFFAOYSA-N propamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCOC1=CC=C(C(N)=N)C=C1 WTFXJFJYEJZMFO-UHFFFAOYSA-N 0.000 description 1
- 229960003761 propamidine Drugs 0.000 description 1
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 description 1
- QZWHWHNCPFEXLL-UHFFFAOYSA-N propan-2-yl n-[2-(1,3-thiazol-4-yl)-3h-benzimidazol-5-yl]carbamate Chemical compound N1C2=CC(NC(=O)OC(C)C)=CC=C2N=C1C1=CSC=N1 QZWHWHNCPFEXLL-UHFFFAOYSA-N 0.000 description 1
- WPZSAUFQHYFIPG-UHFFFAOYSA-N propanethioamide Chemical group CCC(N)=S WPZSAUFQHYFIPG-UHFFFAOYSA-N 0.000 description 1
- PWYIUEFFPNVCMW-UHFFFAOYSA-N propaphos Chemical compound CCCOP(=O)(OCCC)OC1=CC=C(SC)C=C1 PWYIUEFFPNVCMW-UHFFFAOYSA-N 0.000 description 1
- ZYHMJXZULPZUED-UHFFFAOYSA-N propargite Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1C(OS(=O)OCC#C)CCCC1 ZYHMJXZULPZUED-UHFFFAOYSA-N 0.000 description 1
- 125000000177 propargylthio group Chemical group [H]C#CC([H])([H])S* 0.000 description 1
- 125000006410 propenylene group Chemical group 0.000 description 1
- BZNDWPRGXNILMS-VQHVLOKHSA-N propetamphos Chemical compound CCNP(=S)(OC)O\C(C)=C\C(=O)OC(C)C BZNDWPRGXNILMS-VQHVLOKHSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 description 1
- FLVBXVXXXMLMOX-UHFFFAOYSA-N proquinazid Chemical compound C1=C(I)C=C2C(=O)N(CCC)C(OCCC)=NC2=C1 FLVBXVXXXMLMOX-UHFFFAOYSA-N 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- YRRBXJLFCBCKNW-UHFFFAOYSA-N prothiocarb Chemical compound CCSC(=O)NCCCN(C)C YRRBXJLFCBCKNW-UHFFFAOYSA-N 0.000 description 1
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- DZVWKNFPXMUIFA-UHFFFAOYSA-N pyflubumide Chemical compound C1=C(CC(C)C)C(C(OC)(C(F)(F)F)C(F)(F)F)=CC=C1N(C(=O)C(C)C)C(=O)C1=C(C)N(C)N=C1C DZVWKNFPXMUIFA-UHFFFAOYSA-N 0.000 description 1
- QHMTXANCGGJZRX-WUXMJOGZSA-N pymetrozine Chemical compound C1C(C)=NNC(=O)N1\N=C\C1=CC=CN=C1 QHMTXANCGGJZRX-WUXMJOGZSA-N 0.000 description 1
- QHGVXILFMXYDRS-UHFFFAOYSA-N pyraclofos Chemical compound C1=C(OP(=O)(OCC)SCCC)C=NN1C1=CC=C(Cl)C=C1 QHGVXILFMXYDRS-UHFFFAOYSA-N 0.000 description 1
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 description 1
- DDIQWGKUSJOETH-UHFFFAOYSA-N pyrafluprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SCF)=C1NCC1=CN=CC=N1 DDIQWGKUSJOETH-UHFFFAOYSA-N 0.000 description 1
- DWTVBEZBWMDXIY-UHFFFAOYSA-N pyrametostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=C(C)C(C=2C=CC=CC=2)=NN1C DWTVBEZBWMDXIY-UHFFFAOYSA-N 0.000 description 1
- 229960005134 pyrantel Drugs 0.000 description 1
- YSAUAVHXTIETRK-AATRIKPKSA-N pyrantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1 YSAUAVHXTIETRK-AATRIKPKSA-N 0.000 description 1
- URXNNPCNKVAQRA-XMHGGMMESA-N pyraoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C=2C=CC(Cl)=CC=2)=NN1C URXNNPCNKVAQRA-XMHGGMMESA-N 0.000 description 1
- KKEJMLAPZVXPOF-UHFFFAOYSA-N pyraziflumid Chemical compound C1=C(F)C(F)=CC=C1C1=CC=CC=C1NC(=O)C1=NC=CN=C1C(F)(F)F KKEJMLAPZVXPOF-UHFFFAOYSA-N 0.000 description 1
- JOOMJVFZQRQWKR-UHFFFAOYSA-N pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 description 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 1
- 229940070846 pyrethrins Drugs 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- CRFYLQMIDWBKRT-LPYMAVHISA-N pyribencarb Chemical compound C1=C(Cl)C(CNC(=O)OC)=CC(C(\C)=N\OCC=2N=C(C)C=CC=2)=C1 CRFYLQMIDWBKRT-LPYMAVHISA-N 0.000 description 1
- VTRWMTJQBQJKQH-UHFFFAOYSA-N pyributicarb Chemical compound COC1=CC=CC(N(C)C(=S)OC=2C=C(C=CC=2)C(C)(C)C)=N1 VTRWMTJQBQJKQH-UHFFFAOYSA-N 0.000 description 1
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 description 1
- AEHJMNVBLRLZKK-UHFFFAOYSA-N pyridalyl Chemical group N1=CC(C(F)(F)F)=CC=C1OCCCOC1=C(Cl)C=C(OCC=C(Cl)Cl)C=C1Cl AEHJMNVBLRLZKK-UHFFFAOYSA-N 0.000 description 1
- CXJSOEPQXUCJSA-UHFFFAOYSA-N pyridaphenthion Chemical compound N1=C(OP(=S)(OCC)OCC)C=CC(=O)N1C1=CC=CC=C1 CXJSOEPQXUCJSA-UHFFFAOYSA-N 0.000 description 1
- MIOBBYRMXGNORL-UHFFFAOYSA-N pyrifluquinazon Chemical compound C1C2=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C2N(C(=O)C)C(=O)N1NCC1=CC=CN=C1 MIOBBYRMXGNORL-UHFFFAOYSA-N 0.000 description 1
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 description 1
- ITKAIUGKVKDENI-UHFFFAOYSA-N pyrimidifen Chemical compound CC1=C(C)C(CCOCC)=CC=C1OCCNC1=NC=NC(CC)=C1Cl ITKAIUGKVKDENI-UHFFFAOYSA-N 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- BAUQXSYUDSNRHL-UHFFFAOYSA-N pyrimorph Chemical compound C1=CC(C(C)(C)C)=CC=C1C(C=1C=NC(Cl)=CC=1)=CC(=O)N1CCOCC1 BAUQXSYUDSNRHL-UHFFFAOYSA-N 0.000 description 1
- NMVCBWZLCXANER-UHFFFAOYSA-N pyriofenone Chemical compound COC1=C(OC)C(OC)=CC(C)=C1C(=O)C1=C(C)C(Cl)=CN=C1OC NMVCBWZLCXANER-UHFFFAOYSA-N 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- DHTJFQWHCVTNRY-OEMAIJDKSA-N pyrisoxazole Chemical compound C1([C@@]2(C)CC(ON2C)C=2C=CC(Cl)=CC=2)=CC=CN=C1 DHTJFQWHCVTNRY-OEMAIJDKSA-N 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 description 1
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 description 1
- WRPIRSINYZBGPK-UHFFFAOYSA-N quinoxyfen Chemical compound C1=CC(F)=CC=C1OC1=CC=NC2=CC(Cl)=CC(Cl)=C12 WRPIRSINYZBGPK-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 229950002980 rafoxanide Drugs 0.000 description 1
- NEMNPWINWMHUMR-UHFFFAOYSA-N rafoxanide Chemical compound OC1=C(I)C=C(I)C=C1C(=O)NC(C=C1Cl)=CC=C1OC1=CC=C(Cl)C=C1 NEMNPWINWMHUMR-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000012865 response to insecticide Effects 0.000 description 1
- 229940080817 rotenone Drugs 0.000 description 1
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 1
- 108091052345 ryanodine receptor (TC 1.A.3.1) family Proteins 0.000 description 1
- MSHXTAQSSIEBQS-UHFFFAOYSA-N s-[3-carbamoylsulfanyl-2-(dimethylamino)propyl] carbamothioate;hydron;chloride Chemical compound [Cl-].NC(=O)SCC([NH+](C)C)CSC(N)=O MSHXTAQSSIEBQS-UHFFFAOYSA-N 0.000 description 1
- YGBMMMOLNODPBP-GWGZPXPZSA-N s-ethyl (2e,4e)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienethioate Chemical compound CCSC(=O)\C=C(/C)\C=C\CC(C)CCCC(C)(C)OC YGBMMMOLNODPBP-GWGZPXPZSA-N 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 229960005393 sarolaner Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- AFJYYKSVHJGXSN-KAJWKRCWSA-N selamectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C(/C)=C/C[C@@H](O[C@]2(O[C@@H]([C@@H](C)CC2)C2CCCCC2)C2)C[C@@H]2OC(=O)[C@@H]([C@]23O)C=C(C)C(=N\O)/[C@H]3OC\C2=C/C=C/[C@@H]1C AFJYYKSVHJGXSN-KAJWKRCWSA-N 0.000 description 1
- 229960002245 selamectin Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- HPYNBECUCCGGPA-UHFFFAOYSA-N silafluofen Chemical compound C1=CC(OCC)=CC=C1[Si](C)(C)CCCC1=CC=C(F)C(OC=2C=CC=CC=2)=C1 HPYNBECUCCGGPA-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 125000004469 siloxy group Chemical class [SiH3]O* 0.000 description 1
- MXMXHPPIGKYTAR-UHFFFAOYSA-N silthiofam Chemical compound CC=1SC([Si](C)(C)C)=C(C(=O)NCC=C)C=1C MXMXHPPIGKYTAR-UHFFFAOYSA-N 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- NVIFVTYDZMXWGX-UHFFFAOYSA-N sodium metaborate Chemical compound [Na+].[O-]B=O NVIFVTYDZMXWGX-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 108010025009 spectrin-like proteins Proteins 0.000 description 1
- 229940014213 spinosad Drugs 0.000 description 1
- DTDSAWVUFPGDMX-UHFFFAOYSA-N spirodiclofen Chemical compound CCC(C)(C)C(=O)OC1=C(C=2C(=CC(Cl)=CC=2)Cl)C(=O)OC11CCCCC1 DTDSAWVUFPGDMX-UHFFFAOYSA-N 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- WOPFPAIGRGHWAQ-UHFFFAOYSA-N spiropidion Chemical compound CCOC(=O)OC1=C(C=2C(=CC(Cl)=CC=2C)C)C(=O)N(C)C11CCN(OC)CC1 WOPFPAIGRGHWAQ-UHFFFAOYSA-N 0.000 description 1
- CLSVJBIHYWPGQY-GGYDESQDSA-N spirotetramat Chemical compound CCOC(=O)OC1=C(C=2C(=CC=C(C)C=2)C)C(=O)N[C@@]11CC[C@H](OC)CC1 CLSVJBIHYWPGQY-GGYDESQDSA-N 0.000 description 1
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 description 1
- 239000004544 spot-on Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- VOFXXOPWCBSPAA-KCNJUGRMSA-N strigol Chemical compound O1C(=O)C(C)=C[C@@H]1O\C=C/1C(=O)O[C@@H]2C(C(C)(C)CC[C@@H]3O)=C3C[C@@H]2\1 VOFXXOPWCBSPAA-KCNJUGRMSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical compound CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical compound FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 description 1
- JXHJNEJVUNHLKO-UHFFFAOYSA-N sulprofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(SC)C=C1 JXHJNEJVUNHLKO-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000005936 tau-Fluvalinate Substances 0.000 description 1
- INISTDXBRIBGOC-XMMISQBUSA-N tau-fluvalinate Chemical compound N([C@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-XMMISQBUSA-N 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- LWLJEQHTPVPKSJ-UHFFFAOYSA-N tebufloquin Chemical compound C1=C(C(C)(C)C)C=C2C(OC(=O)C)=C(C)C(C)=NC2=C1F LWLJEQHTPVPKSJ-UHFFFAOYSA-N 0.000 description 1
- AWYOMXWDGWUJHS-UHFFFAOYSA-N tebupirimfos Chemical compound CCOP(=S)(OC(C)C)OC1=CN=C(C(C)(C)C)N=C1 AWYOMXWDGWUJHS-UHFFFAOYSA-N 0.000 description 1
- XQTLDIFVVHJORV-UHFFFAOYSA-N tecnazene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl XQTLDIFVVHJORV-UHFFFAOYSA-N 0.000 description 1
- CJDWRQLODFKPEL-UHFFFAOYSA-N teflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(Cl)=C(F)C(Cl)=C1F CJDWRQLODFKPEL-UHFFFAOYSA-N 0.000 description 1
- WWJZWCUNLNYYAU-UHFFFAOYSA-N temephos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 description 1
- LITQZINTSYBKIU-UHFFFAOYSA-F tetracopper;hexahydroxide;sulfate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Cu+2].[Cu+2].[Cu+2].[Cu+2].[O-]S([O-])(=O)=O LITQZINTSYBKIU-UHFFFAOYSA-F 0.000 description 1
- MLGCXEBRWGEOQX-UHFFFAOYSA-N tetradifon Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)C1=CC(Cl)=C(Cl)C=C1Cl MLGCXEBRWGEOQX-UHFFFAOYSA-N 0.000 description 1
- 150000005326 tetrahydropyrimidines Chemical class 0.000 description 1
- 229960005199 tetramethrin Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 1
- WOSNCVAPUOFXEH-UHFFFAOYSA-N thifluzamide Chemical compound S1C(C)=NC(C(F)(F)F)=C1C(=O)NC1=C(Br)C=C(OC(F)(F)F)C=C1Br WOSNCVAPUOFXEH-UHFFFAOYSA-N 0.000 description 1
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical group CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 1
- DNVLJEWNNDHELH-UHFFFAOYSA-N thiocyclam Chemical compound CN(C)C1CSSSC1 DNVLJEWNNDHELH-UHFFFAOYSA-N 0.000 description 1
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 1
- OPASCBHCTNRLRM-UHFFFAOYSA-N thiometon Chemical compound CCSCCSP(=S)(OC)OC OPASCBHCTNRLRM-UHFFFAOYSA-N 0.000 description 1
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical compound COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 description 1
- QSOHVSNIQHGFJU-UHFFFAOYSA-L thiosultap disodium Chemical compound [Na+].[Na+].[O-]S(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O QSOHVSNIQHGFJU-UHFFFAOYSA-L 0.000 description 1
- 125000000464 thioxo group Chemical group S=* 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical compound COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 description 1
- RSOBJVBYZCMJOS-CYBMUJFWSA-N tolprocarb Chemical compound FC(F)(F)COC(=O)N[C@@H](C(C)C)CNC(=O)C1=CC=C(C)C=C1 RSOBJVBYZCMJOS-CYBMUJFWSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- HYVWIQDYBVKITD-UHFFFAOYSA-N tolylfluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=C(C)C=C1 HYVWIQDYBVKITD-UHFFFAOYSA-N 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 1
- DDVNRFNDOPPVQJ-HQJQHLMTSA-N transfluthrin Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=CC(F)=C1F DDVNRFNDOPPVQJ-HQJQHLMTSA-N 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 description 1
- JWXZLCFGVKMEEK-UHFFFAOYSA-N triarathene Chemical compound C1=CC(Cl)=CC=C1C1=CC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)S1 JWXZLCFGVKMEEK-UHFFFAOYSA-N 0.000 description 1
- NKNFWVNSBIXGLL-UHFFFAOYSA-N triazamate Chemical compound CCOC(=O)CSC1=NC(C(C)(C)C)=NN1C(=O)N(C)C NKNFWVNSBIXGLL-UHFFFAOYSA-N 0.000 description 1
- AMFGTOFWMRQMEM-UHFFFAOYSA-N triazophos Chemical compound N1=C(OP(=S)(OCC)OCC)N=CN1C1=CC=CC=C1 AMFGTOFWMRQMEM-UHFFFAOYSA-N 0.000 description 1
- IQGKIPDJXCAMSM-UHFFFAOYSA-N triazoxide Chemical compound N=1C2=CC=C(Cl)C=C2[N+]([O-])=NC=1N1C=CN=C1 IQGKIPDJXCAMSM-UHFFFAOYSA-N 0.000 description 1
- XOIOGKHKNQYULW-HTNNXBMUSA-N tribendimidine Chemical compound C1=CC(/N=C(\C)N(C)C)=CC=C1\N=C\C(C=C1)=CC=C1\C=N\C1=CC=C(\N=C(/C)N(C)C)C=C1 XOIOGKHKNQYULW-HTNNXBMUSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- XWKBMOUUGHARTI-UHFFFAOYSA-N tricalcium;diphosphite Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])[O-].[O-]P([O-])[O-] XWKBMOUUGHARTI-UHFFFAOYSA-N 0.000 description 1
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 1
- 229960000323 triclabendazole Drugs 0.000 description 1
- QFNFRZHOXWNWAQ-UHFFFAOYSA-N triclopyricarb Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NC(Cl)=C(Cl)C=C1Cl QFNFRZHOXWNWAQ-UHFFFAOYSA-N 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 1
- UGCNRZFAUBJVPT-UHFFFAOYSA-N tricyclohexyltin;hydrate Chemical compound O.C1CCCCC1[Sn](C1CCCCC1)C1CCCCC1 UGCNRZFAUBJVPT-UHFFFAOYSA-N 0.000 description 1
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 description 1
- HSMVPDGQOIQYSR-KGENOOAVSA-N triflumizole Chemical compound C1=CN=CN1C(/COCCC)=N/C1=CC=C(Cl)C=C1C(F)(F)F HSMVPDGQOIQYSR-KGENOOAVSA-N 0.000 description 1
- XAIPTRIXGHTTNT-UHFFFAOYSA-N triflumuron Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl XAIPTRIXGHTTNT-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- RROQIUMZODEXOR-UHFFFAOYSA-N triforine Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCN(C(NC=O)C(Cl)(Cl)Cl)CC1 RROQIUMZODEXOR-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- NCPXQVVMIXIKTN-UHFFFAOYSA-N trisodium;phosphite Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])[O-] NCPXQVVMIXIKTN-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 239000003744 tubulin modulator Substances 0.000 description 1
- DBHVHTPMRCXCIY-UHFFFAOYSA-N tyclopyrazoflor Chemical compound N1=C(Cl)C(N(C(=O)CCSCCC(F)(F)F)CC)=CN1C1=CC=CN=C1 DBHVHTPMRCXCIY-UHFFFAOYSA-N 0.000 description 1
- 108010013280 ubiquinol oxidase Proteins 0.000 description 1
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 1
- DBXFMOWZRXXBRN-LWKPJOBUSA-N valifenalate Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)NC(CC(=O)OC)C1=CC=C(Cl)C=C1 DBXFMOWZRXXBRN-LWKPJOBUSA-N 0.000 description 1
- LESVOLZBIFDZGS-UHFFFAOYSA-N vamidothion Chemical compound CNC(=O)C(C)SCCSP(=O)(OC)OC LESVOLZBIFDZGS-UHFFFAOYSA-N 0.000 description 1
- 239000000664 voltage gated sodium channel blocking agent Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000004562 water dispersible granule Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- WCJYTPVNMWIZCG-UHFFFAOYSA-N xylylcarb Chemical compound CNC(=O)OC1=CC=C(C)C(C)=C1 WCJYTPVNMWIZCG-UHFFFAOYSA-N 0.000 description 1
- 239000005943 zeta-Cypermethrin Substances 0.000 description 1
- 229940048462 zinc phosphide Drugs 0.000 description 1
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1
- FJBGIXKIXPUXBY-UHFFFAOYSA-N {2-[3-(4-chlorophenyl)propyl]-2,4,4-trimethyl-1,3-oxazolidin-3-yl}(imidazol-1-yl)methanone Chemical compound C1=CN=CN1C(=O)N1C(C)(C)COC1(C)CCCC1=CC=C(Cl)C=C1 FJBGIXKIXPUXBY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/58—1,2-Diazines; Hydrogenated 1,2-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/12—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P5/00—Nematocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
- C07D237/16—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Definitions
- the present invention relates to pyridazinone compounds and agricultural and horticultural fungicides. More specifically, the present invention relates to a pyridazinone compound that has excellent bactericidal and antibacterial activity, is excellent in safety, and can be industrially advantageously synthesized, and an agricultural and horticultural fungicide containing it as an active ingredient. Furthermore, it relates to a nematicide containing the above compound as an active ingredient. Furthermore, it relates to medical and veterinary antifungal agents containing the above compounds as active ingredients.
- Patent Literature 1 discloses a compound represented by the formula (A) and the like. It is disclosed that this compound has bactericidal activity, antifungal activity, and the like.
- An object of the present invention is to provide a pyridazinone compound that has excellent bactericidal and antibacterial activity, is excellent in safety, and can be industrially advantageously synthesized, and an agricultural and horticultural fungicide containing it as an active ingredient.
- a further object is to provide a nematicide containing the above compound as an active ingredient.
- a further object of the present invention is to provide medical and veterinary antifungal agents containing the aforementioned compounds as active ingredients.
- Y represents an oxygen atom or a sulfur atom
- X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group , hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6
- [2] The compound or a salt thereof according to [1], wherein X 2 is a group represented by R 1 ON CR 6 -.
- a medical or veterinary antifungal agent containing, as an active ingredient, at least one selected from the group consisting of the compounds of [1] or [2] and salts thereof.
- Y represents an oxygen atom or a sulfur atom
- X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6
- the pyridazinone compound of the present invention is excellent in bactericidal and antibacterial activity, has a reliable effect, is excellent in safety, and can be industrially advantageously synthesized.
- the agricultural and horticultural fungicide and nematicide of the present invention have an excellent control effect, do not cause phytotoxicity to plants, and are less toxic to humans, livestock and fish, and have less impact on the environment.
- the medical and veterinary antifungal agents of the present invention have excellent antibacterial effects and are less toxic to humans, animals, and fish.
- the pyridazinone compound of the present invention is a compound represented by formula (I) (hereinafter sometimes referred to as compound (I)) or a salt of compound (I).
- the term "unsubstituted” means only scaffolding groups. When only the name of the base group is used, it means “unsubstituted” unless otherwise specified.
- the term “substituted” means that one of the hydrogen atoms in the scaffold group is replaced with a group having the same or different structure as that of the scaffold.
- a “substituent” is another group attached to a scaffold group.
- the number of substituents may be one, or two or more. Two or more substituents may be the same or different.
- a “substituent” is not particularly limited as long as it is chemically acceptable and has the effects of the present invention.
- groups that can serve as “substituents” include the following groups. Halogeno groups such as fluoro, chloro, bromo and iodo groups; C1-6 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group alkyl group; vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group , 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group
- C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group; 2-cyclopropenyl group, 2-cyclopentenyl group, C3-6 cycloalkenyl group such as 3-cyclohexenyl group; C6-10 aryl group such as phenyl group and naphthyl group; C6-10 aryl C1-6 alkyl groups such as benzyl group and phenethyl group; 3- to 6-membered heterocyclyl group; 3- to 6-membered heterocyclyl C1-6 alkyl group;
- C1-6 alkoxy groups such as methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, s-butoxy, i-butoxy and t-butoxy
- C2-6 alkenyloxy groups such as a vinyloxy group, an allyloxy group, a propenyloxy group, and a butenyloxy group
- C2-6 alkynyloxy groups such as an ethynyloxy group and a propargyloxy group
- C6-10 aryloxy groups such as phenoxy group and naphthoxy group
- C6-10 aryl C1-6 alkoxy groups such as benzyloxy group and phenethyloxy group
- carboxy group formyl group; C1-6 alkylcarbonyl groups such as acetyl group and propionyl group; formyloxy group; C1-6 alkylcarbonyloxy groups such as an acetyloxy group and a propionyloxy group; Methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, C1-6 alkoxycarbonyl group such as t-butoxycarbonyl group;
- C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, perfluoro-n-pentyl group; C2-6 haloalkenyl groups such as 2-chloro-1-propenyl group and 2-fluoro-1-butenyl group; C2-6 haloalkynyl groups such as 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, 5-bromo-2-pentynyl group; C3-6 halocycloalkyl groups such as 3,3-difluorocyclobutyl groups; C1-6 haloalkoxy groups such as 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, 2,2,2-trifluoroethoxy group; C2-6 haloalken
- amino group amino group
- C1-6 alkyl-substituted amino groups such as methylamino group, dimethylamino group and diethylamino group
- C6-10 arylamino groups such as anilino group and naphthylamino group
- C6-10 aryl C1-6 alkylamino groups such as benzylamino group and phenethylamino group
- C1-6 alkylcarbonylamino groups such as acetylamino group, propionylamino group, butyrylamino group, i-propylcarbonylamino group
- C1-6 alkoxycarbonylamino groups such as methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, i-propoxycarbonylamino group
- unsubstituted or substituted aminocarbonyl group such as carbamoyl group, dimethylaminocarbonyl group, phenylaminocarbonyl group, N-phenyl-N-methylaminocarbonyl group
- imino C1-6 alkyl groups such as iminomethyl group, (1-imino)ethyl group, (1-imino)-n-propyl group; N-hydroxy-iminomethyl group, (1-(N-hydroxy)-imino)ethyl group, (1-(N-hydroxy)
- C1-6 alkylthio groups such as methylthio, ethylthio, n-propylthio, i-propylthio, n-butylthio, i-butylthio, s-butylthio and t-butylthio; C1-6 haloalkylthio groups such as a trifluoromethylthio group and a 2,2,2-trifluoroethylthio group; C2-6 alkenylthio groups such as a vinylthio group and an allylthio group; C2-6 alkynylthio groups such as ethynylthio group and propargylthio group; C1-6 alkylsulfinyl groups such as a methylsulfinyl group, an ethylsulfinyl group and a t-butylsulfinyl group; C1-6 haloalkylsulfinyl groups such as a methyl
- tri-C1-6 alkyl-substituted silyl groups such as trimethylsilyl group, triethylsilyl group and t-butyldimethylsilyl group; tri-C6-10 aryl-substituted silyl groups such as triphenylsilyl groups; cyano group; nitro group;
- C1-6 indicates that the number of carbon atoms in the group serving as the mother nucleus is 1-6. This number of carbon atoms does not include the number of carbon atoms in substituent groups.
- an ethoxybutyl group is classified as a C2 alkoxy C4 alkyl group because the base group is a butyl group and the substituent is an ethoxy group.
- the above-mentioned "3- to 6-membered heterocyclyl group” contains 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur atoms as ring-constituting atoms.
- the "3- to 6-membered heterocyclyl group” includes a 3- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
- 3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, A dioxolanyl group, a dioxanyl group and the like can be mentioned.
- Five-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups.
- a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, etc. can be mentioned as a 6-membered heteroaryl group.
- Examples of the 5-membered partially unsaturated heterocyclyl group include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, and isoxazolinyl groups.
- Examples of the 6-membered partially unsaturated heterocyclyl group include a dihydropyranyl group. Any hydrogen atom in these "substituents" may be substituted with a group having a different structure.
- [Y] Y represents an oxygen atom or a sulfur atom.
- Y is preferably an oxygen atom.
- X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted C
- R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ⁇ 6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo It represents an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ⁇ 6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- Each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
- R 3 and R 4 may together form a divalent organic group.
- Each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
- R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted It represents a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- halogeno group examples include a fluoro group, a chloro group, a bromo group and an iodine group.
- the “C1-6 alkyl group” for X 1 and X 2 may be linear or branched.
- the "C1-6 alkyl group” for X 1 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
- the "C2-6 alkenyl group" for X 1 and X 2 includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2- propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group and the like can be mentioned.
- the "C2-6 alkynyl group" for X 1 and X 2 includes an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2- propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, 1,1-dimethyl-2-butynyl group and the like can be mentioned.
- the "C1-6 alkoxy group" for X 1 and X 2 includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, i -butoxy group, s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
- Examples of the “C2-6 alkenyloxy group” for X 1 and X 2 include vinyloxy, allyloxy, propenyloxy, butenyloxy and the like.
- Examples of the “C2-6 alkynyloxy group” for X 1 and X 2 include an ethynyloxy group and a propargyloxy group.
- Examples of the "C1-6 alkylthio group" for X 1 and X 2 include a methylthio group, an ethylthio group, an n-propylthio group, an n-butylthio group, an n-pentylthio group, an n-hexylthio group, and an i-propylthio group. can be done.
- Examples of the “C1-6 alkylsulfinyl group” for X 1 and X 2 include methylsulfinyl group, ethylsulfinyl group, t-butylsulfinyl group and the like.
- Examples of the “C1-6 alkylsulfonyl group” for X 1 and X 2 include methylsulfonyl group, ethylsulfonyl group, t-butylsulfonyl group and the like.
- C1-6 alkyl group " C2-6 alkenyl group”, “C2-6 alkynyl group”, “C1-6 alkoxy group”, “C2-6 alkenyloxy group”, “ C2- 6 alkynyloxy group”, “C1-6 alkylthio group”, “C1-6 alkylsulfinyl group” or “C1-6 alkylsulfonyl group” as substituents include fluoro group, chloro group, bromo group, iodo group Halogeno groups such as; hydroxyl group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, C1 ⁇ 6 haloalkoxy group such as trifluoromethoxy group; 6 alkylideneamino)oxy group; cyclopropyl group, cyclobutyl group, cyclopentyl group, C3-6 cycloalkyl group such as cyclohexyl group; phenyl group, C6-10 aryl group such as naphth
- Examples of the “C3-6 cycloalkyl group” for X 1 and X 2 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
- Examples of the “C3-6 cycloalkyloxy group” for X 1 and X 2 include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group and the like.
- Examples of the “C6-10 aryl group” for X 1 and X 2 include phenyl group, naphthyl group, indanyl group, indenyl group, tetralinyl group, and the like.
- Examples of the “C6-10 aryloxy group” for X 1 and X 2 include a phenoxy group and a naphthoxy group.
- Examples of the “C6-10 arylthio group” for X 1 and X 2 include a phenylthio group and a naphthylthio group.
- Examples of the “C6-10 arylsulfinyl group” for X 1 and X 2 include a phenylsulfinyl group and a naphthylsulfinyl group.
- Examples of the “C6-10 arylsulfonyl group” for X 1 and X 2 include a phenylsulfonyl group and a naphthylsulfonyl group.
- the “5- to 6-membered heterocyclyl group” for X 1 and X 2 has 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. is a group containing When there are two or more heteroatoms, they may be the same or different.
- Examples of the "5- to 6-membered heterocyclyl group” include a 5- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
- Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
- Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups.
- 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
- 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, and isoxazolinyl 5-membered partially unsaturated heterocyclyl groups; dihydro Six-membered partially unsaturated heterocyclyl groups such as pyranyl groups can be mentioned.
- the “5- to 6-membered heterocyclyloxy group” for X 1 and X 2 has a structure in which a 5- to 6-membered heterocyclyl group and an oxy group are bonded. Specific examples include a thiazolyloxy group and a pyridyloxy group.
- C3-6 cycloalkyl group "C3-6 cycloalkyloxy group”, “C6-10 aryl group”, “C6-10 aryloxy group”, “C6-10 arylthio group” in X 1 and X 2
- a fluoro group chloro group, bromo group, halogeno group such as iodine group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, C1-6 alkyl groups such as n-pentyl group and n-hexyl group; chloromethyl group, chloroeth
- R 1 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted Alternatively, it represents an unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- the "C1-6 alkyl group” for R 1 includes methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
- Examples of the “C2-6 alkenyl group” for R 1 include a vinyl group and a 1-propenyl group.
- Examples of the “C2-6 alkynyl group” for R 1 include an ethynyl group and a 1-propynyl group.
- substituents on the "C1-6 alkyl group", “C2-6 alkenyl group", or “C2-6 alkynyl group” in R 1 include halogeno groups such as fluoro, chloro, bromo, and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n -C1-6 haloalkoxy groups such as propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexy
- 6-membered heteroaryl group C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group substituted with one or more substituents 6
- a membered ring heteroaryl group; or a cyano group is preferred.
- Examples of the “C3-6 cycloalkyl group” for R 1 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
- Examples of the “C6-10 aryl group” for R 1 include a phenyl group, a naphthyl group, an indenyl group, an indanyl group, a tetralinyl group and the like.
- the “5- to 6-membered heterocyclyl group” for R 1 is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. be. When there are two or more heteroatoms, they may be the same or different.
- Examples of the "5- to 6-membered heterocyclyl group” include a 5- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
- Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
- Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups.
- 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
- 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, and isoxazolinyl 5-membered partially unsaturated heterocyclyl groups; dihydro A 6-membered partially unsaturated heterocyclyl group such as a pyranyl group can be mentioned.
- Substituents on the "C3-6 cycloalkyl group", “C6-10 aryl group”, or “5- to 6-membered heterocyclyl group” for R 1 include a fluoro group, a chloro group, a bromo group, an iodo group, and the like. Halogeno group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc.
- R 1 -CO- examples include formyl, acetyl, propionyl, butyryl, i-propylcarbonyl and the like.
- R 2 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or It represents an unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- substituents for R 2 are the same as those exemplified for R 1 .
- R 2 —O—CO— examples include a methoxycarbonyl group, an ethoxycarbonyl group, a t-butoxycarbonyl group and the like.
- R 3 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, substituted or unsubstituted C2-6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group
- R 4 represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group. Specific examples of substituents for R 3 or R 4 are the same as those exemplified for R 1 .
- R 3 and R 4 may together form a divalent organic group.
- Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
- Examples of the "C2-5 alkylene group” include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
- Examples of the "C1-3 alkyleneoxy C1-3 alkylene group” include a dimethyleneoxydimethylene group and the like.
- substituents on the "C2-5 alkylene group” or "C1-3 alkyleneoxy C1-3 alkylene group” include halogeno groups such as fluoro, chloro, bromo, and iodo groups; methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
- halogeno groups such as fluoro, chloro, bromo, and iodo groups
- methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group
- R 3 R 4 N— examples include amino group, methylamino group, dimethylamino group, i-propylamino group and the like.
- R 3 and R 4 have the same meanings as those in the above “group represented by R 3 R 4 N—” indicates Specific examples of the “group represented by R 3 R 4 N—CO—” include a carbamoyl group, an N,N-dimethylaminocarbonyl group, an N-(i-propyl)aminocarbonyl group, an N-(i-propyl )—N-methylaminocarbonyl group and the like.
- R 1 has the same meaning as the above "group represented by R 1 -CO-".
- Specific examples of the "group represented by R 1 -CO-O-" include an acetyloxy group and an i-propylcarbonyloxy group.
- R 1 has the same meaning as the above "group represented by R 1 -CO-".
- R 5 represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group. Specific examples of substituents for R 5 are the same as those exemplified for R 1 . Specific examples of the "group represented by R 1 -CO-NR 5 -" include an acetylamino group and an i-propylcarbonylamino group.
- R 2 has the same meaning as in the above "group represented by R -O - CO-".
- Specific examples of the “group represented by R 2 —O—CO—O—” include a methoxycarbonyloxy group and an ethoxycarbonyloxy group.
- R 2 has the same meaning as in the above "group represented by R 2 -O-CO-”. show.
- R 5 has the same meaning as in the above “group represented by R 1 —CO—NR 5 —”.
- Specific examples of the “group represented by R 2 —O—CO—NR 5 —” include a methoxycarbonylamino group.
- R 3 and R 4 are the same as those in the above “group represented by R 3 R 4 N—” indicates the meaning of Specific examples of the “group represented by R 3 R 4 N—CO—O—” include a carbamoyloxy group and an N,N-dimethylaminocarbonyloxy group.
- R 3 and R 4 are the same as those in the above “group represented by R 3 R 4 N—” have similar meanings.
- R 5 has the same meaning as in the above “group represented by R 1 —CO—NR 5 —”.
- Specific examples of the “group represented by R 3 R 4 N—CO—NR 5 —” include a carbamoylamino group and an N,N-dimethylaminocarbonylamino group.
- R 2 has the same meaning as the above "group represented by R 2 -O-CO-”.
- R 5 has the same meaning as in the above “group represented by R 1 —CO—NR 5 —”.
- Specific examples of the “group represented by R 2 SO 2 —NR 5 —” include a methanesulfonylamino group and the like.
- R 3 and R 4 are the same as those in the above “group represented by R 3 R 4 N—” indicate meaning.
- Specific examples of the “group represented by R 3 R 4 N—SO 2 —” include an N,N-dimethylaminosulfonyl group.
- R 1 has the same meaning as the above "group represented by R 1 -CO-".
- R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted It represents a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- substituted or unsubstituted C1-6 alkyl group or “substituted or unsubstituted 5- to 6-membered heterocyclyl group” for R 6 are the same as those exemplified for R 1 .
- halogeno group for R 6 include a fluoro group, a chloro group, a bromo group and an iodo group.
- mono C1-6 alkylamino group of the “substituted or unsubstituted mono C1-6 alkylamino group” for R 6 include a methylamino group, an ethylamino group and an i-propylamino group.
- Examples of the "di-C1-6 alkylamino group" of the "substituted or unsubstituted di-C1-6 alkylamino group” for R 6 include a dimethylamino group, a diethylamino group, an N-methyl-Ni-propylamino group, and the like. can be mentioned.
- the "C1-6 alkoxy group" of the "substituted or unsubstituted C1-6 alkoxy group” for R 6 includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, n- A hexyloxy group, i-propoxy group, i-butoxy group, s-butoxy group, t-butoxy group, i-hexyloxy group and the like can be mentioned.
- C1-6 alkylthio group of the "substituted or unsubstituted C1-6 alkylthio group” for R 6 includes methylthio, ethylthio, n-propylthio, n-butylthio, n-pentylthio, n-hexylthio groups, i-propylthio groups, and the like.
- Substituents on the "C1-6 alkoxy group”, “mono-C1-6 alkylamino group”, “di - C1-6 alkylamino group” or “C1-6 alkylthio group” for R 6 include " The same substituents as exemplified as substituents on "C1-6 alkyl group” can be mentioned.
- R 3 and R 4 are the same as those in the above "group represented by R 3 R 4 N-”. have similar meanings.
- X 1 is preferably a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
- X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 4- to 6-membered heterocyclyl group.
- Examples of the “linear C1-6 alkyl group” for X 3 include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group and n-hexyl group.
- the "linear C2-6 alkenyl group” for X 3 includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-pentenyl group, 2- Pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group and 5-hexenyl group can be mentioned.
- the "straight-chain C2-6 alkynyl group" for X 3 includes an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-pentynyl group, 2- Pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-hexynyl group and the like can be mentioned.
- Examples of the “4-membered heterocyclyl group” for X 3 include an azetidinyl group and an oxetanyl group. Specific examples of other substituents for X 3 are the same as those exemplified for X 1 and X 2 .
- preferred X 3 is a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted C3-6 cycloalkyl group, or a substituted or unsubstituted C6-10 aryl group. can. In the present invention, more preferred X 3 is a substituted linear C1-6 alkyl group.
- substituents on the aryl group or substituents on the 4- to 6-membered heterocyclyl group include one or more substituents selected from the following group of substituents (hereinafter, this substituent is sometimes represented by the symbol "G"). Moreover, when there are two or more substituents (G), two of them may combine to form a divalent organic group. Substituent groups are shown below.
- halogeno group substituted or unsubstituted C1-6 alkyl group, substituted or unsubstituted C2-6 alkenyl group, substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1 ⁇ 6 alkylsulfonyl group, substituted or unsubstituted C3 ⁇ 6 cycloalkyl group, substituted or unsubstituted C3 ⁇ 6 cycloalkyloxy group, substituted or unsubstituted C6 ⁇ 10 aryl group, substituted or unsubstit
- each R a is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group , a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 10-membered heterocyclyl group.
- R b each independently represents a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo It represents an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- Each R c is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ⁇ 6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- R d each independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group, R c and R d may together form a divalent organic group.
- Each R e independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group.
- R f represents a hydrogen atom, an amino group, or a substituted or unsubstituted C1-6 alkyl group.
- Each R g independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
- Each R h independently represents a substituted or unsubstituted C1-6 alkyl group or a substituted or unsubstituted C6-10 aryl group.
- Each R i independently represents a substituted or unsubstituted C1-6 alkyl group or a substituted or unsubstituted C6-10 aryl group, wherein R h and R i together form a divalent An organic group may be formed.
- halogeno group examples include a fluoro group, a chloro group, a bromo group, and an iodo group.
- the “C1-6 alkyl group” for G may be linear or branched.
- the "C1-6 alkyl group” in G includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s- Butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like can be mentioned.
- the "C2-6 alkenyl group” in G includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2 -methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group , 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group and the like.
- the "C2-6 alkynyl group" in G includes an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2 -methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group , 1,1-dimethyl-2-butynyl group, and the like.
- the "C1-6 alkoxy group” for G includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, an i-butoxy group, Examples include s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
- Examples of the "C2-6 alkenyloxy group” for G include a vinyloxy group, an allyloxy group, a propenyloxy group and a butenyloxy group.
- Examples of the "C2-6 alkynyloxy group” for G include an ethynyloxy group and a propargyloxy group.
- Examples of the "C1-6 alkylthio group” for G include a methylthio group, an ethylthio group, an n-propylthio group, an n-butylthio group, an n-pentylthio group, an n-hexylthio group and an i-propylthio group.
- Examples of the "C1-6 alkylsulfinyl group” for G include a methylsulfinyl group, an ethylsulfinyl group and a t-butylsulfinyl group.
- Examples of the "C1-6 alkylsulfonyl group” for G include methylsulfonyl group, ethylsulfonyl group, t-butylsulfonyl group and the like.
- C1-6 alkyl group “C2-6 alkenyl group”, “C2-6 alkynyl group”, “C1-6 alkoxy group”, “C2-6 alkenyloxy group”, “C2-6 alkynyloxy group” in G ”, “C1-6 alkylthio group”, “C1-6 alkylsulfinyl group” or “C1-6 alkylsulfonyl group” include halogeno groups such as a fluoro group, a chloro group, a bromo group and an iodo group.
- hydroxyl group methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro- C1-6 haloalkoxy groups such as n-propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C1-6 alkylthio groups such as methylthio group and ethylthio group; C1- such as methylsulfinyl group and ethylsulfinyl group C1-6 alkylsulfonyl groups such as methylsulfonyl group and ethylsulfonyl group; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group; C6 such as phenyl group and naphthy
- Examples of the "C3-6 cycloalkyl group” for G include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
- Examples of the "C3-6 cycloalkyloxy group” for G include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group and the like.
- Examples of the "C6-10 aryl group” for G include a phenyl group and a naphthyl group.
- Examples of the “C6-10 aryloxy group” for G include a phenoxy group and a naphthoxy group.
- Examples of the "C6-10 arylthio group” for G include a phenylthio group and a naphthylthio group.
- Examples of the “C6-10 arylsulfinyl group” for G include a phenylsulfinyl group and a naphthylsulfinyl group.
- Examples of the “C6-10 arylsulfonyl group” for G include a phenylsulfonyl group and a naphthylsulfonyl group.
- the "3- to 10-membered heterocyclyl group” for G is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. . When there are two or more heteroatoms, they may be the same or different. It may be monocyclic or polycyclic. Examples of the "3- to 10-membered heterocyclyl group” include a 3- to 6-membered saturated heterocyclyl group, a 5- to 10-membered heteroaryl group, a 5- to 10-membered partially unsaturated heterocyclyl group, and the like. .
- 3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, A dioxolanyl group, a dioxanyl group and the like can be mentioned.
- Examples of 5- to 10-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups.
- 5-membered heteroaryl groups such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl 6-membered heteroaryl groups; indolyl, isoindolyl, benzofuranyl, benzothienyl, indazolyl, 9-membered heteroaryl groups such as benzimidazolyl group, benzoxazolyl group, benzisoxazolyl group, benzothiazolyl group, and benzisothiazolyl group; quinolinyl group, isoquinolinyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group, quinoxalinyl group, etc.
- 10-membered heteroaryl group examples include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro 6-membered partially unsaturated heterocyclyl group such as pyranyl; 9-membered partially unsaturated such as indolinyl, isoindolinyl, 2,3-dihydrobenzofuranyl and 1,3-dihydrobenzofuranyl heterocyclyl group; 10-membered ring partially unsaturated heterocyclyl group such as 1,2,3,4-tetrahydroquinolinyl group;
- the "3- to 10-membered heterocyclyloxy group" in G has a structure in which a 3- to 10-membered heterocyclyl group and an oxy group are bonded. Specific examples include a thiazolyloxy group and a pyridyloxy group.
- C3-6 cycloalkyl group include a fluoro group, a chloro group, halogeno groups such as bromo group and iodo group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group , C1-6 alkyl groups such as n-hexyl group; C1-6 haloalkyl groups such as chloromethyl group, chloroethy
- R G1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxy may form a dimethylene group.); A group represented by R G1 R G1 N—CO— (R G1 in the formula may be the same or different.
- R G1 together may be a trimethylene group, tetramethylene group, pentamethylene group, or A methyleneoxydimethylene group may be formed.); a group represented by R G1 -CO-O-; a group represented by R G1 -CO-NR G3 - (wherein R G3 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, C1-6 haloalkoxy group, C3-6 cycloalkyl group, phenyl group, or C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; a C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or (5- to 6-membered heteroary
- RG1 together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group. may be used.); A pentafluorosulfanyl group, a nitro group, or a cyano group are preferred. Furthermore, as a substituent on the "C3-6 cycloalkyl group”, “C3-6 cycloalkyloxy group”, “3- to 10-membered heterocyclyl group”, or “3- to 10-membered heterocyclyloxy group” , oxo groups are also preferred.
- R a is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted It represents a C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 10-membered heterocyclyl group.
- the "C1-6 alkyl group” for R a includes methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
- Examples of the “C2-6 alkenyl group” for R a include a vinyl group and a 1-propenyl group.
- Examples of the “C2-6 alkynyl group” for R a include an ethynyl group and a 1-propynyl group.
- substituents on the "C1-6 alkyl group", “C2-6 alkenyl group", or “C2-6 alkynyl group” in R a include halogeno groups such as fluoro, chloro, bromo, and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n -C1-6 haloalkoxy groups such as propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C1-6 alkylthio groups such as methylthio group and ethylthio group; C1-6 groups such as methylsulfinyl group
- Examples of the “C3-6 cycloalkyl group” for R a include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
- Examples of the “C6-10 aryl group” for R a include a phenyl group, a naphthyl group, an indenyl group, an indanyl group, a tetralinyl group and the like.
- the “3- to 10-membered heterocyclyl group” for R a is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. be. When there are two or more heteroatoms, they may be the same or different. It may be monocyclic or polycyclic. Examples of the "3- to 10-membered heterocyclyl group” include a 3- to 6-membered saturated heterocyclyl group, a 5- to 10-membered heteroaryl group, a 5- to 10-membered partially unsaturated heterocyclyl group, and the like. .
- 3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, Dioxolanyl group, dioxanyl group and the like can be mentioned.
- Examples of 5- to 10-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups.
- 5-membered heteroaryl groups such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl 6-membered heteroaryl groups; indolyl, isoindolyl, benzofuranyl, benzothienyl, indazolyl, 9-membered heteroaryl groups such as benzimidazolyl group, benzoxazolyl group, benzisoxazolyl group, benzothiazolyl group, and benzisothiazolyl group; quinolinyl group, isoquinolinyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group, quinoxalinyl group, etc.
- 10-membered heteroaryl group examples include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro 6-membered partially unsaturated heterocyclyl group such as pyranyl group; 9-membered partially unsaturated ring such as indolinyl group, isoindolinyl group, 2,3-dihydrobenzofuranyl group, 1,3-dihydrobenzofuranyl group heterocyclyl group; 10-membered ring partially unsaturated heterocyclyl group such as 1,2,3,4-tetrahydroquinolinyl group;
- Substituents on the "C3-6 cycloalkyl group", “C6-10 aryl group”, or “3- to 10-membered heterocyclyl group” for R a include a fluoro group, a chloro group, a bromo group, an iodo group, and the like. Halogeno group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc.
- R q1 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, C1-6 alkyl group substituted with one or more substituents of a phenyl group or a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a haloalkyl group or a C1-6
- R q1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxy may form a dimethylene group.);
- a group represented by R q1 R q1 N—CO— (R q1 in the formula may be the same or different.
- R q1 may be a trimethylene group, a tetramethylene group, a A methyleneoxydimethylene group may be formed.); a group represented by R q1 —CO—O—; a group represented by R q1 —CO—NR q3 — (wherein R q3 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, C1-6 haloalkoxy group, C3-6 cycloalkyl group, phenyl group, or C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; a C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or (5- to 6-membered
- R q1 together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group. may be used.); A pentafluorosulfanyl group, a nitro group, or a cyano group are preferred. Furthermore, an oxo group is also preferred as a substituent on the "C3-6 cycloalkyl group” or the "3- to 10-membered heterocyclyl group".
- R a -CO- examples include a formyl group, an acetyl group, an i-propylcarbonyl group and the like.
- R b is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2 ⁇ 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- R b is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2 ⁇ 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- R b -O-CO- examples include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group and a t-butoxycarbonyl group. and the like.
- R c is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted A C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group, and R d is , a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group.
- R c or R d substituents for R c or R d are the same as those exemplified for R a .
- the "C1-6 alkoxy group" in R d includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, and an i-butoxy group. , s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
- substituents on the "C1-6 alkoxy group" in R d include halogeno groups such as fluoro, chloro, bromo and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group , n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, etc.
- halogeno groups such as fluoro, chloro, bromo and iodo groups
- hydroxyl group methoxy group, ethoxy group, n-propoxy group, i-propoxy group , n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichloro
- R c and R d may together form a divalent organic group.
- divalent organic groups that can be formed include a substituted or unsubstituted C2-5 alkylene group, a substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene group, a substituted or unsubstituted C1-3 alkylenethio C1-3 Examples include an alkylene group, or a substituted or unsubstituted C1-3 alkyleneimino C1-3 alkylene group. Additionally, mention may be made of silicon-containing divalent hydrocarbon groups such as -CH 2 CH 2 -Si(CH 3 ) 2 -CH 2 CH 2 -.
- Examples of the "C2-5 alkylene group” include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
- Examples of the “C1-3 alkyleneoxy C1-3 alkylene group” include a dimethyleneoxydimethylene group and the like.
- Examples of the “C1-3 alkylenethio C1-3 alkylene group” include a dimethylenethiodimethylene group and the like.
- Examples of the “C1-3 alkyleneimino C1-3 alkylene group” include a dimethyleneiminodimethylene group and the like.
- the imino group of "C1-3 alkylenealkyleneimino C1-3 alkylene group” means -NH-.
- Substituents on "C2-5 alkylene group", “C1-3 alkyleneoxy C1-3 alkylene group”, “C1-3 alkylenethio C1-3 alkylene group” and “C1-3 alkyleneimino C1-3 alkylene group” examples include halogeno groups such as a fluoro group, a chloro group, a bromo group and an iodine group; C1-6 alkyl group such as t-butyl group; methylidene group; or C1 such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group ⁇ 6 haloalkyl groups are preferred.
- R c R d N— examples include amino group, methylamino group, dimethylamino group, i-propylamino group and the like.
- R c and R d have the same meanings as those in the above “group represented by R c R d N—”.
- Specific examples of the “group represented by R c R d N—CO—” include a carbamoyl group, an N,N-dimethylaminocarbonyl group, an N-(i-propyl)aminocarbonyl group, an N-(i-propyl )—N-methylaminocarbonyl group and the like.
- R c and R d have the same meanings as those in the above “group represented by R c R d N—” show.
- Specific examples of the “group represented by R c R d N—NR d —CO—” include a 2,2-dimethylhydrazine-1-carbonyl group.
- R b SO 2 -NR d -CO- for G, R b has the same meaning as in the above "group represented by R b -O-CO-", and R d has the same meaning as in the above “group represented by R c R d N—”.
- Specific examples of the "group represented by R b SO 2 -NR d -CO-” include a (methylsulfonyl)carbamoyl group, a (cyclopropylsulfonyl)carbamoyl group, and a ((1-methylcyclopropyl)sulfonyl)carbamoyl group. etc. can be mentioned.
- R a has the same meaning as in the above "group represented by R a -CO-".
- Specific examples of the "group represented by R a -CO-O-" include an acetyloxy group.
- R a has the same meaning as in the above "group represented by R a -CO-".
- R e represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group. Specific examples of the substituent for R e are the same as those exemplified for R a .
- R a -CO-NR e - examples include an acetylamino group, a propionylamino group, a butyrylamino group, an i-propylcarbonylamino group and the like.
- R a has the same meaning as in the above "group represented by R a -CO-”.
- R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
- Specific examples of the “group represented by R a —CO—CO—NR e —” include an oxopropanamide group.
- R a has the same meaning as in the above "group represented by R a -CO-”.
- R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
- Specific examples of the “group represented by R a —CO—NR e —NR e —” include an acetylhydrazinyl group and an i-propylcarbonylhydrazinyl group.
- R a has the same meaning as in the above "group represented by R a -CO-”.
- R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
- Specific examples of the "group represented by R a -CO-NR e -NR e -CO-” include 2-acetylhydrazine-1-carbonyl group.
- R b has the same meaning as in the above “group represented by R b —O—CO—”.
- Specific examples of the “group represented by R b —O—CO—O—” include a methoxycarbonyloxy group and an ethoxycarbonyloxy group.
- R b has the same meaning as in the above “group represented by R b —O—CO—”.
- R e has the same meaning as in the above “group represented by R b —CO—NR e —”.
- Specific examples of the “group represented by R b —O—CO—NR e —” include a methoxycarbonylamino group.
- R c and R d have the same meanings as those in the above “group represented by R c R d N—” .
- Specific examples of the “group represented by R c R d N—CO—O—” include a carbamoyloxy group and an N,N-dimethylaminocarbonyloxy group.
- R c and R d have the same meanings as those in the above “group represented by R c R d N—” show.
- R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
- Specific examples of the “group represented by R c R d N—CO—NR e —” include a carbamoylamino group and an N,N-dimethylaminocarbonylamino group.
- R c and R d are the same as those in the above “group represented by R c R d N—” indicate meaning.
- R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
- Specific examples of the "group represented by R c R d N-CO-CO-NR e -" include 2-(methylamino)-2-oxoacetamide group, 2-(t-butylamino)-2- An oxoacetamide group and the like can be mentioned.
- R a has the same meaning as in the above "group represented by R a -CO-”.
- R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
- Specific examples of the "group represented by R a -CS-NR e -" include an ethanethioamide group, a propanethioamide group, a 2-methylpropanethioamide group and the like.
- R c and R d have the same meanings as those in the above “group represented by R c R d N—” show.
- R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
- Specific examples of the “group represented by R c R d N—CS—NR e —” include a 3,3-dimethylthioureido group.
- R b SO 2 —NR e — for G, R b has the same meaning as in the above “group represented by R b —O—CO—”.
- R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
- Specific examples of the “group represented by R b SO 2 —NR e —” include a methanesulfonylamino group.
- R c and R d have the same meanings as those in the above “group represented by R c R d N—”.
- Specific examples of the “group represented by R c R d N—SO 2 —” include an N,N-dimethylaminosulfonyl group.
- R a has the same meaning as in the above "group represented by R a -CO-”.
- R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
- Each R g independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group. Specific examples of the substituent for Rg are the same as those exemplified for Ra .
- R c and R d are the same as those in the above "group represented by R c R d N-" indicate meaning.
- each R h is independently a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted represents a C6-10 aryl group, and each R i independently represents a substituted or unsubstituted C1-6 alkyl group or a substituted or unsubstituted C6-10 aryl group;
- substituents for R h or R i are the same as those exemplified for R a .
- R h and R i may together form a divalent organic group.
- Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
- Examples of the "C2-5 alkylene group” include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
- Examples of the "C1-3 alkyleneoxy C1-3 alkylene group” include a dimethyleneoxydimethylene group and the like.
- substituents on the "C2-5 alkylene group” or "C1-3 alkyleneoxy C1-3 alkylene group” include halogeno groups such as fluoro, chloro, bromo, and iodo groups; methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
- halogeno groups such as fluoro, chloro, bromo, and iodo groups
- methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group
- Specific examples of the “group represented by R h R j C ⁇ N—O—” include (propan-2-ylideneamino)oxy group and the like.
- the divalent organic groups that can be formed by two of them together include a substituted or unsubstituted C1-5 alkylene group, a substituted or unsubstituted oxy C1-4 An alkylene group, a substituted or unsubstituted oxy C2-3 alkyleneoxy group, or a substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene group can be mentioned.
- Examples of the "C1-5 alkylene group” include methylene group, dimethylene group, trimethylene group, tetramethylene group and the like.
- Examples of the "oxy C1-4 alkylene group” include an oxymethylene group and an oxydimethylene group.
- Examples of the "oxy C2-3 alkyleneoxy group” include an oxydimethylenoxy group.
- Examples of the “C1-3 alkyleneoxy C1-3 alkylene group” include a dimethyleneoxydimethylene group and the like.
- Substituents on the "C1-5 alkylene group", “oxy-C1-4 alkylene group”, “oxy-C2-3 alkyleneoxy group” and “C1-3 alkyleneoxy C1-3 alkylene group” include a fluoro group, chloro Halogeno groups such as group, bromo group and iodo group; C1 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group and t-butyl group ⁇ 6 alkyl group; or C1 ⁇ 6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro
- preferred G is a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, a substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted 3-10 a membered heterocyclyl group, a group represented by R b --O--CO--, a group represented by R c R d N--, a group represented by R c R d N -- CO---, and R a --CO--- A group represented by O—, a group represented by R a —CO—NR e
- X 3 is a group represented by R N1 O—, a group represented by R N1 —CO—O—, a group represented by R N1 —O—CO—O—, R N1 R N1 N— a group represented by CO--O--, a group represented by R N1 --CS--O--, a group represented by R N1 R N1 N--CS--O--, a group represented by R N1 R N2 N--- , a group represented by R N1 -CO-NR N2 -, a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, R N1 R A group represented by N1 N—CO—NR N2 —, a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS—NR N
- R N1 and R N2 are each independently a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2- 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 4- to 6-membered heterocyclyl group, wherein R N1 and R N1 , or R N1 and R N2 may together form a divalent organic group.
- Examples of the "linear C1-6 alkyl group” for R N1 and R N2 include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group and n-hexyl group.
- the "linear C2-6 alkenyl group” for R N1 and R N2 includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-pentenyl 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl and 5-hexenyl groups.
- the "linear C2-6 alkynyl group" for R N1 and R N2 includes an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-hexynyl group and the like.
- Examples of the "4-membered heterocyclyl group" for R N1 and R N2 include an azetidinyl group and an oxetanyl group. Specific examples of other substituents for R N1 and R N2 are the same as those exemplified for X 1 .
- A is a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or carbonyl indicates a group.
- Examples of the "C1-6 alkylene group” for A include methylene group, dimethylene group, trimethylene group, tetramethylene group and the like.
- Examples of the "C2-6 alkynylene group” for A include an ethynylene group (-C ⁇ C-), a propynylene group (-CH 2 -C ⁇ C-, -C ⁇ C-CH 2 -), and the like.
- Examples of the "C3-6 cycloalkylene group” for A include 1,2-cyclopropylene group, 1,2-cyclobutanediyl group, 1,3-cyclobutanediyl group and the like.
- A is preferably a substituted or unsubstituted C1-6 alkylene group or a substituted or unsubstituted C2-6 alkenylene group.
- substituents on the C1-6 alkylene group or C2-6 alkenylene group include one or more substituents selected from the following group of substituents (hereinafter, this substituent is denoted by the symbol "Ga" can be expressed as ). Moreover, when there are two or more substituents (Ga), two of them may be combined to form a divalent organic group. Substituent groups are shown below.
- halogeno group substituted or unsubstituted C1-6 alkyl group, substituted or unsubstituted C2-6 alkenyl group, substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, mercapto group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted Or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted substituted or
- each R a1 is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group , a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group
- R b1 each independently represents a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubsti
- R e1 each independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
- R f1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group
- R g1 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, substituted or an unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group
- R h1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group, wherein R g1 and R h1 may together form
- halogeno group examples include a fluoro group, a chloro group, a bromo group, an iodine group, and the like.
- the "C1-6 alkyl group” in Ga may be linear or branched.
- the "C1-6 alkyl group” in Ga includes methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s- Butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like can be mentioned.
- the "C2-6 alkenyl group” in Ga includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2 -methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group , 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group and the like.
- the "C2-6 alkynyl group" in Ga includes ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2 -methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group , 1,1-dimethyl-2-butynyl group, and the like.
- the "C1-6 alkoxy group” for Ga includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, an i-butoxy group, Examples include s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
- Examples of the "C2-6 alkenyloxy group” for Ga include a vinyloxy group, an allyloxy group, a propenyloxy group, and a butenyloxy group.
- Examples of the "C2-6 alkynyloxy group” for Ga include an ethynyloxy group and a propargyloxy group.
- Examples of the "C1-6 alkylthio group” for Ga include methylthio, ethylthio, n-propylthio, n-butylthio, n-pentylthio, n-hexylthio, i-propylthio and the like.
- Examples of the "C1-6 alkylsulfinyl group” in Ga include methylsulfinyl group, ethylsulfinyl group, t-butylsulfinyl group and the like.
- Examples of the "C1-6 alkylsulfonyl group” for Ga include methylsulfonyl group, ethylsulfonyl group, t-butylsulfonyl group and the like.
- C1-6 alkyl group include halogeno groups such as a fluoro group, a chloro group, a bromo group and an iodo group.
- hydroxyl group methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro- C1-6 haloalkoxy groups such as n-propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group; phenyl group, C6-10 aryl group such as naphthyl group; C1-6 alkyl group such as 4-methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group , a C1-6 alkoxy group, a halogeno group, a C1-6 halo
- Examples of the "C3-6 cycloalkyl group” for Ga include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like.
- Examples of the "C3-6 cycloalkyloxy group” for Ga include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group and the like.
- Examples of the "C6-10 aryl group” for Ga include a phenyl group, a naphthyl group, an indenyl group, an indanyl group and a tetralinyl group.
- Examples of the "C6-10 aryloxy group” for Ga include a phenoxy group and a naphthoxy group.
- Examples of the "C6-10 arylthio group” in Ga include a phenylthio group and a naphthylthio group.
- Examples of the “C6-10 arylsulfinyl group” for Ga include a phenylsulfinyl group and a naphthylsulfinyl group.
- Examples of the “C6-10 arylsulfonyl group” for Ga include a phenylsulfonyl group and a naphthylsulfonyl group.
- the "3- to 6-membered heterocyclyl group” for Ga is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. . When there are two or more heteroatoms, they may be the same or different. Examples of the "3- to 6-membered heterocyclyl group” include a 3- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
- 3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, A dioxolanyl group, a dioxanyl group and the like can be mentioned.
- Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. and 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
- Examples of 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro Six-membered partially unsaturated heterocyclyl groups such as pyranyl groups can be mentioned.
- the "3- to 6-membered heterocyclyloxy group" in Ga has a structure in which a 3- to 6-membered heterocyclyl group and an oxy group are bonded. Specific examples include a thiazolyloxy group and a pyridyloxy group.
- C3-6 cycloalkyl group include a fluoro group, a chloro group, halogeno groups such as bromo group and iodo group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group , C1-6 alkyl groups such as n-hexyl group; C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group
- R a1 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted It represents a C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- the "C1-6 alkyl group" for R a1 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
- Examples of the “C2-6 alkenyl group” for R a1 include a vinyl group and a 1-propenyl group.
- Examples of the “C2-6 alkynyl group” for R a1 include an ethynyl group and a 1-propynyl group.
- substituents on the "C1-6 alkyl group", “C2-6 alkenyl group", or “C2-6 alkynyl group” in R a1 include halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n -C1-6 haloalkoxy groups such as propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group,
- Examples of the "C3-6 cycloalkyl group” for R a1 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
- Examples of the “C6-10 aryl group” for R a1 include a phenyl group and a naphthyl group.
- the “5- to 6-membered heterocyclyl group” for R a1 is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. be. When there are two or more heteroatoms, they may be the same or different.
- Examples of the "5- to 6-membered heterocyclyl group” include a 5- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
- Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
- Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups.
- 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
- 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro Six-membered partially unsaturated heterocyclyl groups such as pyranyl groups can be mentioned.
- substituents on the "C3-6 cycloalkyl group", “C6-10 aryl group”, or “5- to 6-membered heterocyclyl group” for R a1 include a fluoro group, a chloro group, a bromo group, an iodo group, and the like. Halogeno group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc.
- R a1 -CO- examples include a formyl group and an acetyl group.
- R b1 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2 ⁇ 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
- Specific examples of the substituent for R b1 are the same as those exemplified for R a1 .
- R b1 -O-CO- examples include a methoxycarbonyl group, an ethoxycarbonyl group, a t-butoxycarbonyl group and the like.
- R c1 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted A C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group, and R d1 is , a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
- R c1 or R d1 are the same as those exemplified for R a1 .
- R c1 and R d1 may together form a divalent organic group.
- Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
- Examples of the "C2-5 alkylene group” include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
- Examples of the "C1-3 alkyleneoxy C1-3 alkylene group” include a dimethyleneoxydimethylene group and the like.
- substituents on the "C2-5 alkylene group” or "C1-3 alkyleneoxy C1-3 alkylene group” include halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group; methyl group, ethyl group, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
- halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group
- R c1 R d1 N- examples include an amino group, a methylamino group and a dimethylamino group.
- R c1 and R d1 have the same meanings as in the above "group represented by R c1 R d1 N--".
- Specific examples of the “group represented by R c1 R d1 N—CO—” include a carbamoyl group, an N,N-dimethylaminocarbonyl group, an N-(i-propyl)aminocarbonyl group, and an N-(i-propyl )—N-methylaminocarbonyl group and the like.
- R a1 has the same meaning as in the above "group represented by R a1 -CO-".
- Specific examples of the "group represented by R a1 -CO-O-" include an acetyloxy group.
- R a1 has the same meaning as in the above "group represented by R a1 -CO-".
- R e1 represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
- Specific examples of the substituent for R e1 are the same as those exemplified for R a1 .
- Specific examples of the "group represented by R a1 -CO-NR e1 -" include an acetylamino group.
- R b1 has the same meaning as in the above “group represented by R b1 —O—CO—”.
- Specific examples of the "group represented by R b1 -O-CO-O-" include a methoxycarbonyloxy group and an ethoxycarbonyloxy group.
- R b1 has the same meaning as in the above “group represented by R b1 —O—CO—”.
- R e1 has the same meaning as in the above “group represented by R b1 —CO—NR e1 —”.
- Specific examples of the “group represented by R b1 —O—CO—NR e1 —” include a methoxycarbonylamino group.
- R c1 and R d1 have the same meanings as those in the above “group represented by R c1 R d1 N—” .
- Specific examples of the “group represented by R c1 R d1 N—CO—O—” include a carbamoyloxy group and an N,N-dimethylaminocarbonyloxy group.
- R c1 and R d1 have the same meanings as those in the above "group represented by R c1 R d1 N-”. show.
- R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
- Specific examples of the “group represented by R c1 R d1 N—CO—NR e1 —” include a carbamoylamino group and an N,N-dimethylaminocarbonylamino group.
- R b1 SO 2 —NR e1 — has the same meaning as in the above “group represented by R b1 —O—CO—”.
- R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
- Specific examples of the “group represented by R b1 SO 2 —NR e1 —” include a methanesulfonylamino group and the like.
- R c1 and R d1 have the same meanings as those in the above “group represented by R c1 R d1 N—”.
- Specific examples of the “group represented by R c1 R d1 N—SO 2 —” include an N,N-dimethylaminosulfonyl group.
- R g1 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted represents a substituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group, R h1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
- R g1 or R h1 are the same as those exemplified for R a1 .
- R g1 and R h1 may together form a divalent organic group.
- Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
- Examples of the "C2-5 alkylene group” include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
- Examples of the "C1-3 alkyleneoxy C1-3 alkylene group” include a dimethyleneoxydimethylene group and the like.
- substituents on the "C2-5 alkylene group” or "C1-3 alkyleneoxy C1-3 alkylene group” include halogeno groups such as fluoro, chloro, bromo, and iodo groups; methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
- R a1 has the same meaning as in the above "group represented by R a1 -CO-".
- R a1 has the same meaning as in the above “group represented by R a1 —CO—”.
- R c1 and R d1 have the same meanings as those in the above "group represented by R c1 R d1 N-”. show.
- R a1 has the same meaning as in the above "group represented by R a1 -CO-”.
- R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
- R b1 has the same meaning as in the above “group represented by R b1 —O—CO—” indicate.
- R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
- R b1 SO 2 —NR e1 —N ” in Ga
- R b1 has the same meaning as in the above “group represented by R b1 —O—CO—” .
- R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
- the divalent organic group that can be formed by two of them together includes a substituted or unsubstituted C1-5 alkylene group, a substituted or unsubstituted oxy C1-4
- An alkylene group, a substituted or unsubstituted oxy C2-3 alkyleneoxy group, or a substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene group can be mentioned.
- Examples of the "C1-5 alkylene group” include methylene group, dimethylene group, trimethylene group, tetramethylene group and the like.
- Examples of the "oxy C1-4 alkylene group” include an oxymethylene group and an oxydimethylene group.
- Examples of the "oxy C2-3 alkyleneoxy group” include an oxydimethylenoxy group.
- Examples of the “C1-3 alkyleneoxy C1-3 alkylene group” include a dimethyleneoxydimethylene group and the like.
- Substituents on the "C1-5 alkylene group", “oxy-C1-4 alkylene group”, “oxy-C2-3 alkyleneoxy group” and “C1-3 alkyleneoxy C1-3 alkylene group” include a fluoro group, chloro Halogeno groups such as group, bromo group and iodo group; C1 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group and t-butyl group ⁇ 6 alkyl group; or C1 ⁇ 6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro
- a preferred substituted or unsubstituted 5- to 6-membered heterocyclyloxy group is a tetrahydro-2H-pyran-4-yl group.
- B is an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group, or a group represented by -NR N3 -, and R N3 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a formyl group, or It represents a substituted or unsubstituted C1-6 alkylcarbonyl group.
- the “C1-6 alkyl group” in R N3 may be linear or branched.
- the "C1-6 alkyl group” in R N3 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
- Examples of the “C1-6 alkylcarbonyl group” for R N3 include an acetyl group, a propionyl group, a butyryl group, an i-propylcarbonyl group and the like.
- the substituents on the "C1-6 alkyl group” and "C1-6 alkylcarbonyl" in R N3 include a fluoro group, a chloro group, a bromo group, a halogeno group such as an iodo group; a hydroxyl group; a methoxy group, an ethoxy group, C1-6 alkoxy groups such as n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group; 2-chloro-n-propoxy group, 2,3- C1-6 haloalkoxy groups such as dichlorobutoxy group and trifluoromethoxy group; (C1-6 alkylideneamino)oxy groups such as (ethylideneamino)oxy group and propane-2-ylideneamino)oxy group; cyclopropyl group and cyclobutyl group , cyclopentyl group, C3-6 cycloalky
- ring heteroaryl group a 5-membered ring substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group heteroaryl group; pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, 6-membered heteroaryl group such as triazinyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or A 6-membered heteroaryl group substituted with one or more substituents selected from C1-6 haloalkoxy groups; or a cyano group is preferred.
- R 7 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
- the “C1-6 alkyl group” for R 7 may be linear or branched.
- the "C1-6 alkyl group” for R 7 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
- Substituents on the "C1-6 alkyl group" in R 7 include halogeno groups such as fluoro, chloro, bromo and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group and i-propoxy group. , n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, etc.
- halogeno groups such as fluoro, chloro, bromo and iodo groups
- hydroxyl group methoxy group, ethoxy group, n-propoxy group and i-propoxy group.
- n-butoxy group, s-butoxy group, i-butoxy group C1-6 alkoxy group such as t-butoxy group
- C1 ⁇ 6 haloalkoxy group (ethylideneamino) oxy group, propane-2-ylideneamino) oxy group such as (C1 ⁇ 6 alkylideneamino) oxy group; cyclopropyl group, cyclobutyl group, cyclopentyl group, C3 such as cyclohexyl group ⁇ 6 cycloalkyl group; phenyl group, C6 ⁇ 10 aryl group such as naphthyl group; 4-methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl a C6-10 aryl group substituted with any one or more substituents of a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group, such as a
- [Q] Q represents a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted 5- to 10-membered heterocyclyl group.
- C6-10 aryl group examples include a phenyl group, a naphthyl group, an indenyl group, an indanyl group, a tetralinyl group, and the like.
- the “5- to 10-membered heterocyclyl group” for Q is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur atoms as ring-constituting atoms. . When there are two or more heteroatoms, they may be the same or different. It may be monocyclic or polycyclic. Examples of the "5- to 10-membered heterocyclyl group” include a 5- to 6-membered saturated heterocyclyl group, a 5- to 10-membered heteroaryl group, a 5- to 10-membered partially unsaturated heterocyclyl group, and the like. .
- Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
- Examples of 5- to 10-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups.
- 5-membered heteroaryl groups such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl 6-membered heteroaryl groups; indolyl, isoindolyl, benzofuranyl, benzothienyl, indazolyl, 9-membered heteroaryl groups such as benzimidazolyl group, benzoxazolyl group, benzisoxazolyl group, benzothiazolyl group, and benzisothiazolyl group; quinolinyl group, isoquinolinyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group, quinoxalinyl group, etc.
- 10-membered heteroaryl group examples include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro 6-membered partially unsaturated heterocyclyl group such as pyranyl group; 9-membered partially unsaturated ring such as indolinyl group, isoindolinyl group, 2,3-dihydrobenzofuranyl group, 1,3-dihydrobenzofuranyl group heterocyclyl group; 10-membered ring partially unsaturated heterocyclyl group such as 1,2,3,4-tetrahydroquinolinyl group;
- substituents on the "C6-10 aryl group” or “5- to 10-membered heterocyclyl group” in Q include halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group; a methyl group, an ethyl group, C1-6 alkyl groups such as n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group; vinyl group, etc.
- halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group
- a methyl group, an ethyl group, C1-6 alkyl groups such as n-propyl group, i-propyl group, n-butyl group, s-butyl group,
- R Q1 may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxy may form a dimethylene group.); A group represented by R Q1 R Q1 N—CO— (in the formula, R Q1 may be the same or different.
- R Q1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a A methyleneoxydimethylene group may be formed.); a group represented by R Q1 -CO-O-; a group represented by R Q1 -CO-NR Q3 - (wherein R Q3 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, C1-6 haloalkoxy group, C3-6 cycloalkyl group, phenyl group, or C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; a C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or (5- to
- R Q1 together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group. may be used.); A pentafluorosulfanyl group, a trimethylsilylethynyl group, a nitro group, or a cyano group are preferred. Furthermore, an oxo group is also preferred as a substituent on the "5- to 10-membered heterocyclyl group".
- Salts of compound (I) are not particularly limited as long as they are agriculturally and horticulturally acceptable salts.
- salts of inorganic acids such as hydrochloric acid and sulfuric acid
- salts of organic acids such as acetic acid and lactic acid
- salts of alkali metals such as lithium, sodium and potassium
- salts of alkaline earth metals such as calcium and magnesium
- salts of transition metals salts of organic bases such as triethylamine, tributylamine, pyridine and hydrazine
- ammonium salts are not particularly limited as long as they are agriculturally and horticulturally acceptable salts.
- salts of inorganic acids such as hydrochloric acid and sulfuric acid
- salts of organic acids such as acetic acid and lactic acid
- salts of alkali metals such as lithium, sodium and potassium
- salts of alkaline earth metals such as calcium and magnesium
- salts of transition metals salts of organic bases
- salts of organic bases
- the method for producing compound (I) or a salt of compound (I) is not limited.
- compound (I) or a salt of compound (I) of the present invention can be obtained by known methods such as those described in Examples.
- a salt of compound (I) can be obtained from compound (I) by a known method.
- Y represents an oxygen atom or a sulfur atom
- X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6
- the "C1-6 alkoxycarbonyl group” for X 5 includes a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group, a t-butoxycarbonyl group, and the like.
- Examples of the "halogeno group” for X5 include a fluoro group, a chloro group, a bromo group, an iodo group and the like.
- salt of production intermediate and production method Examples of the salt of the production intermediate represented by formula (II) are the same as the salt of the compound represented by formula (I). Moreover, the production method of the production intermediate represented by formula (II) is not limited. For example, it can be obtained by a known method as described in Examples. Also, a salt of a production intermediate can be obtained from compound (II) by a known method.
- the agricultural and horticultural fungicide of the present invention contains as an active ingredient at least one selected from compound (I) and salts thereof.
- the amount of compound (I) or a salt thereof contained in the agricultural and horticultural fungicide of the present invention is not particularly limited as long as it exhibits a fungicidal effect.
- the agricultural and horticultural fungicides of the present invention are suitable for a wide variety of filamentous fungi such as Oomycetes, Ascomycetes, Deuteromycetes, Basidiomycetes, zygotes. It can be used to control plant diseases caused by fungi belonging to Zygomycetes.
- Examples of plant diseases (pathogens) targeted for control are shown below.
- Sugar beet brown spot (Cercospora beticola), cochlioides (Aphanomyces cochlioides), root rot (Thanatephorus cucumeris), leaf rot (Thanatephorus cucumeris), rust (Uromyces betae), powdery mildew (Oidium sp.), spot Peanuts: Mycosphaerella arachidis, Ascochyta sp., Puccinia arachidis, Pythium debaryanum ), rust (Alternaria alternata), white silk (Sclerotium rolfsii), black stain (Mycosphaerella berkeleyi), black root rot (Calonectria ilicicola), etc.
- Cucumber powdery mildew (Sphaerotheca fuliginea), downy mildew (Pseudoperonospora cubensis) , Mycosphaerella melonis, Fusarium oxysporum, Sclerotinia sclerotiorum, Botrytis cinerea, Colletotrichum orbiculare, Cladosporium cucumerinum, Brown spot Corynespora cassiicola, Pythium debaryanum, Rhizoctonia solani Kuhn, Phomopsis sp., Pseudomonas syringae pv. Lachrymans, etc.
- Tomatoes Botrytis cinerea, leaves Mold (Cladosporium fulvum), plague (Phytophthora infestans), wilt (Verticillium albo-atrum, Verticillium dahliae), powdery mildew (Oidium neolycopersici), ring spot (Alternaria solani), Pseudocercospora fuligena, Ralstonia solanacearum, Sclerotinia sclerotiorum, etc.
- Eggplant Botrytis cinerea, Corynespora melongenae, Erysiphe cichoracearum), Mycovellosiella nattrassii, Sclerotinia sclerotiorum, Verticillium dahliae, Phomopsis vexans, etc.
- Pepper Phytophthora capsici, Botrytis cinerea , Sclerotinia sclerotiorum, Colletotrichum aenigma, Colletotrichum capsici, Colletotrichum fructicola, Colletotrichum jiangxiense, Leveillula taurica
- Botrytis cinerea Sphaerotheca humuli , Colletotrichum acutatum, Colletotrichum fragariae, Phytophthora cactorum, Rhizopus stolonifer, Fusarium oxysporum, Verticillium dahliae, Sclerotinia sclerotiorum, etc.
- Onions Gray Botrytis allii, Botrytis cinerea, Botrytis squamosa, Peronospora destructor, Phytophthora porri, Ciborinia allii, Small fungi nucleus rot (Botrytis squamosa), dry rot (Fusarium oxysporum), red root rot (Pyrenochaeta terrestris), black rot sclerotium (Sclerotium cepivorum), rust (Puccinia allii), white silk disease (Sclerotium rolfsii), etc.
- Green onions soft rot (Pectobacterium carotovorum), downy mildew (Peronospora destructor), leaf blight (Pleospora allii), black rot (Sclerotium cepivorum), rust (Puccinia allii), leaf blight (Botrytis squamosa), white silk disease (Sclerotium rolfsii), red root rot (Pyrenochaeta terrestris), etc.
- Cabbage clubroot (Plasmodiophora brassicae), soft rot (Erwinia carotovora), black rot (Xanthomonas campesrtis pv.
- campestris black spot (Pseudomonas syringae pv. maculicola, P. s. pv. alisalensis), mildew (Peronospora parasitica), sclerotinia (Sclerotinia sclerotiorum) ), Black soot (Alternaria brassicicola), Gray mold (Botrytis cinerea), Root rot (Phoma lingam), Pythium aphanidermatum, Pythium ultimum, White rust (Albugo macrospora), etc.
- Apples powdery mildew (Podosphaera leucotricha), scab (Venturia inaequalis), monilia (Monilinia mali), black spot (Mycosphaerella pomi), rot (Valsa mali), leaf spot (Alternaria mali), scab (Gymnosporangium) yamadae), ring spot (Botryosphaeria berengeriana), anthracnose (Glomerella cingulata, Colletotrichum acutatum), brown spot (Diplocarpon mali), soot spot (Zygophiala jamaicensis), soot spot (Gloeodes pomigena), purple leaf spot (Helicobasidium mompa), White leaf disease (Rosellinia necatrix), Gray mold (Botrytis cinerea), Fire blight (Erwinia amylovora), Silver leaf disease (Chondrostereum purpureum), Root canker
- Grapes Botrytis cinerea, powdery mildew (Uncinula necator), late rot (Glomerella cingulata, Colletotrichum) acutatum), downy mildew (Plasmopara viticola), black rot (Elsinoe ampelina), brown spot (Pseudocercospora vitis), black rot (Guignardia bidwellii), white rot (Coniella castaneicola), rust (Phakopsora ampelopsidis), Snow white (pathogen unidentified), root cancer (Rhizobium radiobacter, Rhizobium vitis), etc.
- Pear Venturia nashicola, Gymnosporangium asiaticum, Alternaria kikuchiana, Ring spot (Botryosphaeria berengeriana), powdery mildew (Phyllactinia mali), blight (Phomopsis fukushii), brown spot (Stemphylium vesicarium), anthracnose (Glomerella cingulata), etc. Tea: Pestalotiops is longiseta, P.
- Kiwifruit Pseudomonas marginalis, Pseudomonas syringae, Pseudomonas viridiflava, Pseudomonas syringae, Botrytis cinerea, fruit soft rot (Botryosphaeria dothidea, Diaporthe sp., Lasiodiplodia theobromae), Pseudocercospora actinidiae, etc.
- Olive Colletotrichum acutatum, Colletotrichum gloeosporioides, Peacock spot (Spilocaea oleaginea), etc.
- Chestnut Colletotrichum gloeosporioides, etc.
- Powdery mildew (Blumeria graminis f.sp. tritici), Fusarium head blight (Gibberella zeae, Fusarium avenaceum, Fusarium culmorum, Fusarium crookwellense, Microdochium nivale), Fusarium rust (Puccinia recondita), Yellow rust (Puccinia striiformis), Pythium iwayamai, Monographella nivalis, Pseudocercosporella herpotrichoides, Septoria tritici, Leptosphaeria nodorum, Typhula incarnata), Myriosclerotinia borealis, Gaeumannomyces graminis, Claviceps purpurea, Tilletia caries, Ustilago nuda, Pyricularia grisea ), Damping off (Pythium spp., Fusarium spp., Rhizoc
- Rice Pyricularia oryzae, Rhizoctonia solani, Gibberella fujikuroi, Cochliobolus miyabeanus, Pythiumg raminicola), Xanthomonas oryzae, Burkholderia plantarii, Acidovorax avenae, Burkholderia glumae, Cercospora oryzae, Rice blight (Ustilaginoidea virens), Brown rice (Alternaria alternata, Curvularia intermedia), Alternaria padwickii, Epicoccum purpurascens, etc.
- Tobacco Sclerotinia sclerotiorum, Erysiphe cichoracearum, plague ( Phytophthora nicotianae), etc.
- Tulips Botrytis cinerea, Botrytis tulipae, Rhizoctonia solani, Fusarium oxysporum, Rhizoctonia solani, etc.
- Rose Black star Diplocarpon rosae, powdery mildew (Erysiphe simulans, Podosphaera pannosa), gray mold (Botrytis cinerea), etc.
- Peronospora danica Pythium aphanidermatum, Pythium dissotocum, Pythium helicoides, Pythium oedochilum, Pythium sylvaticum, Rhizoctonia solani, Fusarium solani, etc.
- Gerbera Botrytis cinerea ), powdery mildew (Podosphaera xanthii), etc.
- Lily leaf blight (Botrytis elliptica, Pestalotiopsis sp.), gray mold (Botrytis cinerea), etc.
- Sunflower downy mildew (Pla smopara halstedii), Sclerotinia sclerotiorum, Botrytis cinerea, etc.
- Bent grass Sclerotinia borealis, large patch (Rhizoctonia solani), brown patch (Rhizoctonia solani), dollar spot ( Sclerotinia homoeocarpa), Pyricularia sp., Pythium aphanidermatum, Colletotrichum graminicola, etc.
- Orchard grass Powdery mildew (Erysiphe graminis), etc.
- Soybean Purpura (Cercospora kikuchii), downy mildew Peronospora manshurica, Phytophthora sojae, Phakopsora pachyrhizi, Sclerotinia sclerotiorum, Colletotrichum truncatum, Botrytis cinerea, Elsinoe glycines ), Black spot (Diaporthe phaseolorum var. sojae), Damping off (Pythium spp., Fusarium spp., Rhizoctonia spp.), Seedling blight (Pythium spp., Fusarium spp., Rhizoctonia spp.), etc.
- Potatoes Phytophthora infestans ), Alternaria solani, Thanatephorus cucumeris, Verticillium albo-atrum, V. dahliae, V. nigrescens, Pectobacterium atrosepticum, Pectobacterium carotovorum, Gray mold (Botrytis cinerea), scab (Streptomyces spp.), sclerotinia (Sclerotinia sclerotiorum), etc. sporium dioscoreae, Colletotrichum gloeosporioides, Penicillium sclerotigenum, etc. Sweet potato: Helicobasidium mompa, Fusarium oxysporum, etc.
- Mango Anthracnose (Colletotrichum) aenigma), canker (Xanthomonas campestris), shaft rot (Diaporthe pseudophoenicicola, Lasiodiplodia theobromae, Lasiodiplodia spp., Neofusicoccum parvum, Neofusicoccum sp.), gray mold (Botrytis cinerea), etc.
- Rapeseed Sclerotinia sclerotiorum, root rot (Phoma lingam), black spot (Alternaria brassicae), powdery mildew (Erysiphe cruciferarum, Erysiphe cichoracearum, Oidium matthiolae), downy mildew (Peronospora parasitica), etc.
- Coffee rust (Hemileia vastatrix), anthracnose ( Coletotrichum coffeanum), brown eye disease (Cercospora coffeicola), etc.
- Sugarcane Brown rust (Puccinia melanocephala), etc.
- Hops Downy mildew (Pseudoperonospora humuli), powdery mildew (Oidium sp., Podosphaera macularis), gray mold disease (Botrytis cinerea), etc.
- the pyridazinone compound of the present invention is also excellent in controlling effect on various nematodes that affect plant growth.
- the nematicide of the present invention contains at least one selected from compound (I) and salts thereof as an active ingredient.
- the amount of compound (I) or a salt thereof contained in the nematicide of the present invention is not particularly limited as long as it exhibits a nematode control effect.
- Tylenchida (a) Anguinidae, for example, Anguina spp., Anguina funesta, Anguina tritici; Ditylenchus spp., Imogusare nematode ( Ditylenchus destructor), Ditylenchus dipsaci, Ditylenchus myceliophagus; (b) Aphelenchoides family (Aphelenchoididae), for example, Aphelenchoides spp., Aphelenchoides besseyi, Aphelenchoides fragariae, Aphelenchoides ritzemabosi; Bursa Bursaphelenchus xylophilus, of the genus Bursaphelenchus spp.; (c) Belonolaimidae, e.g., Belonola
- Globodera spp. Heterodera spp.
- Heterodera spp. Heterodera avenae, Heterodera cruciferae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii
- Hoplolimidae for example, Helicotylenchus spp., Helicotylenchus dihystera, Helicotylenchus multicinctus; Columbus (Hoplolaimus columbus), Hoplolaimus galeatus; Others, Rotylenchus robustus, Rotylenchus reniformis
- Dorylaimida (a) Longidoridae, e.g., Longidorus spp., Longidorus elongates; Xiphinema, Xiphinema americanum, Xiphinema brevicole (Xiphinema brevicolle), Grape Nematode (Xiphinema index), Xiphinema diversicaudatum (Xiphinema diversicaudatum).
- Triplonchida (a) Trichodoridae family (Trichodoridae), for example, Trichodorus monibus (Trichodorus planibus), Nematode nematode (Paratrichodorus minor).
- the agricultural and horticultural fungicides or nematicides of the present invention are grains; vegetables; root vegetables; potatoes; fruit trees, tea, coffee, trees such as cacao; It is preferably used for
- the agricultural and horticultural fungicide of the present invention can be applied to various parts of plants, such as leaves, stems, stems, flowers, buds, fruits, seeds, sprouts, roots, tubers, tuberous roots, shoots and cuttings. .
- Nematicides can be applied to roots, tubers, root tubers, and the like.
- improved cultivars/varieties, cultivated cultivars, mutants, hybrids, and genetically modified organisms (GMO) of these plants can also be targeted.
- the agricultural and horticultural fungicide of the present invention can be used for seed treatment, foliage application, soil application, water surface application, etc. for the control of various diseases occurring in agricultural and horticultural crops including flowers, lawns, and pastures. can be done.
- Nematicides can be used in seed treatments, soil applications, and the like.
- the agricultural and horticultural fungicide or nematicide of the present invention may contain ingredients other than the pyridazinone compound of the present invention.
- Other components include known carriers used for formulation. Examples of other components include conventionally known fungicides, insecticides/miticides, nematicides, soil pesticides, plant regulators, synergists, fertilizers, soil conditioners, animal feeds, and the like. be able to. A synergistic effect may be produced by containing such other components.
- one aspect of the present invention is an agricultural and horticultural fungicide containing one or more additional fungicides.
- fungicide that can be mixed or used together with the agricultural and horticultural fungicide or nematicide of the present invention, it is described on the FRAC (Fungicide Resistance Action Committee) website (https://www.frac.info/) Compounds or agriculturally acceptable salts or derivatives thereof can be mentioned as preferred ones. Specifically, compounds selected from the following group can be exemplified.
- A Agent acting on nucleic acid synthesis metabolism: A1) RNA polymerase I inhibitors benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M, oxadixyl, ofurace. A2) Adenosine deaminase inhibitors bupirimate, dimethirimol, ethirimol. A3) DNA/RNA biosynthesis inhibitors hymexazole, octhilinone. A4) DNA topoisomerase type II inhibitor oxolinic acid.
- B agents acting on cytoskeleton and motor proteins: B1)-B3) beta-tubulin polymerization inhibitors benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate, thiophanate-methyl, diethofencarb, zoxamide, ethaboxam, chlorfenazole, debacarb, trichlamide, zarilamid.
- B5) Delocalization inhibitors of spectrin-like proteins fluopicolide, fluopimomide.
- C1 Respiratory agents: C1) Complex I: NADH oxidoreductase inhibitors diflumetorim, tolfenpyrad, fenazaquin.
- cytochrome bc1 ubiquinol oxidase
- Qo site (cyt b gene) inhibitors azoxystrobin, coumoxystrobin, enoxastrobin, fluphenoxystrobin ( flufenoxystrobin, picoxystrobin, pyraoxystrobin, mandestrobin, pyraclostrobin, pyrametostrobin, triclopyricarb, kresoxim -methyl), trifloxystrobin, dimoxystrobin, fenaminstrobin, metominostrobin, orysastrobin, famoxadone, fluoxastrobin ), fenamidone, pyribencarb, methyltetraprole.
- azoxystrobin coumoxystrobin
- enoxastrobin fluphenoxystrobin
- fluphenoxystrobin flufenoxystrobin
- picoxystrobin pyraoxystrobin
- mandestrobin pyraclostrobin
- D Agents Affecting Amino Acid and Protein Synthesis: D1) Methionine biosynthesis (cgs gene) inhibitors cyprodinil, mepanipyrim, pyrimethanil. D2) Protein synthesis (ribosomal translation termination step) inhibitor blasticidin-S. D3), D4) Protein synthesis (ribosome translation initiation step) inhibitors kasugamycin, kasugamycin hydrochloride, streptomycin. D5) Protein synthesis (ribosomal polypeptide elongation step) inhibitor oxytetracycline.
- E agents that affect signal transduction: E1) signaling (mechanism of action unknown) inhibitors quinoxyfen, proquinazid. E2) MAP/histidine kinase (os-2, HOG1) inhibitors fenpiclonil, fludioxonil in osmotic signaling. E3) MAP/histidine kinase (os-1, Daf1) inhibitors in osmotic signaling chlozolinate, dimethachlone, iprodione, procymidone, vinclozolin.
- F agents that affect lipid biosynthesis or transport/cell membrane structure or function: F1) Dicarboximide fungicides F2) Phospholipid biosynthetic, methyltransferase inhibitors edifenphos, iprobenfos, pyrazophos, isoprothiolane. F3) Cellular peroxidation inhibitors biphenyl, chloroneb, dichloran, quintozene, tecnazene, tolclofos-methyl, etridiazole. F4) Cell membrane permeable, fatty acid inhibitors iodocarb, propamocarb, propamocarb hydrochloride, prothiocarb.
- F5 carboxylic acid amide (CAA) fungicides
- F8 ergosterol binding inhibitor natamycin
- F9) Lipid homeostasis and transport/storage inhibitors oxathiapiprolin, fluoxapiprolin.
- G Cell Membrane Sterol Biosynthesis Inhibitors G1) C14 Demethylase (erg11/cyp51) Inhibitors of Sterol Biosynthesis Triforine, Pyrifenox, Pyrisoxazole, Fenarimol, Nuarimol (nuarimol), imazalil, oxpoconazole, pefurazoate, prochloraz, triflumizole, azaconazole, bitertanol, bromuconazole , cyproconazole, difenoconazole, diniconazole, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flu triafol (flutriafol), hexaconazole, imibenconazole, ipconazole, mefentrifluconazole, metconazole, myclobutanil, penconazole, propico propiconazole, sime
- G2 ⁇ 14 reductase and ⁇ 8 ⁇ 7-isomerase (erg24, erg2) inhibitors in sterol biosynthesis aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph ), fenpropidin, piperalin, spiroxamine, buthiobate.
- (H) cell wall biosynthesis inhibitors H4) Chitin synthase inhibitors polyoxin, polyoxorim. H5) Cellulose synthase inhibitors dimethomorph, flumorph, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate, mandipropamid.
- (I) cell wall melanin synthesis inhibitor I1) Reductase inhibitors of melanin biosynthesis fthalide, pyroquilon, tricyclazole. I2) Dehydratase inhibitors of melanin biosynthesis carpropamid, diclocymet, fenoxanil. I3) Tolprocarb, a polyketide synthase inhibitor of melanin biosynthesis.
- Agents that act to induce resistance in host plants P01-P03
- Agents involved in salicylate signaling acibenzolar-S-methyl, probenazole, tiadinil, isotianil.
- P04 Polysaccharide elicitor laminarin.
- P05 Anthraquinone elicitor extract from Reynoutria sachalinensis.
- P06 Microorganism Elicitor Bacillus mycoides isolate J, cell walls of Saccharomyces cerevisiae strain LAS117.
- BM Biological/biological pesticides with multiple mechanisms of action: a) Plant extracts Polypeptide (lectin), Phenols, Sesquiterpenes, Triterpenoids, Coumarins, Terpene Hydrocarbons ), terpene alcohols, terpene phenols, extract from the cotyledons of lupine plantlets, extract from Swinglea glutinosa, mint.
- Extract from Melaleuca alternifolia (tea tree oil), plant oils (mixtures), eugenol, geraniol, thymol, ⁇ - Alpha-pinene, ⁇ -Terpinene, Alpha-Terpinol, Alpha-Terpinolene, Gamma-Terpinene, d-Limonene ), Orange Oil, Linalool, Menthol, ursolic acid, Oleanolic Acid, neem oil.
- Trichoderma atroviride strain I-1237 Trichoderma atroviride strain LU132, Trichoderma atroviride strain SC1, Trichoderma atroviride strain SKT-1 strain SKT-1), Trichoderma atroviride strain 77B; Trichoderma asperellum strain T34, Trichoderma asperellum strain kd; Trichoderma harzianum T-22 strain (Trichoderma harzianum strain T-22); Trichoderma spp., such as Trichoderma virens strain G-41. Gliocladium spp., such as Gliocladium catenulatum strain J1446.
- Clonostachys spp. such as Clonostachys rosea strain CR-7.
- Coniothyrium spp. such as Coniothyrium minitans strain CON/M/91-08.
- Talaromyces spp. such as Talaromyces flavus strain SAY-Y-94-01; Saccharomyces spp., such as Saccharomyces cerevisae strain LAS02.
- Streptomyces spp. such as Streptomyces griseovirides strain K61 and Streptomyces lydicus strain WYEC108.
- Agrobacterium spp. such as Agrobacterium radiobacter.
- Erwinia spp. such as non-pathogenic Erwinia carotovora subsp. carotovora.
- Variovorax spp. such as Variovorax paradoxus. Lactobacillus spp., such as Lactobacillus plantarum.
- Other agents Yeast or its extract, ⁇ -glucan, chitin or chitosan or fragments thereof, ⁇ -aminobutyric acid, 2,6-dichloroisonicotinic acid, salicylic acid or derivatives thereof, algae extract, algae extract (hydrolyzed , jasmine flower extract, sodium alginate, oligosaccharides, trehalose, polysaccharides, lipids, lipopolysaccharides, fatty acids, glycolipids, glycoproteins, glycopeptides, proteins or peptides derived from plants and/or pathogenic microorganisms, ergosterol, etc.
- IRAC Insecticide Resistance Action Committee
- HP https://irac-online.org/
- the compounds described, or their agriculturally acceptable salts or derivatives, etc. can be mentioned as preferred ones. Specifically, compounds selected from the following group can be exemplified.
- Acetylcholinesterase (AChE) inhibitor (carbamate): Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarbboxim, Butoxycarbboxim, Carbaryl, Carbofuran, Carbosulfan ( Carbosulfan, Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, Pirimicarb ( Pirimicarb, Propoxur, Thiodicarb, Thiofanox, Triazamate, Trimethacarb, XMC, Xylylcarb, Aldoxycarb, Allyxycarb, Aminocarb (Aminocarb), Bufencarb, Cloethocarb, Fenothiocarb, Promecarb.
- AChE Acetylcholinesterase
- Acetylcholinesterase (AChE) inhibitors organophosphorus: Acephate, Azamethifos, Azinphos-ethyl, Azinphosmethyl, Cadusafos, Chlorethoxyfos, Chlorfenvinphos, Chlormephos, Chlorpyrifos, Chlorpyrifos-methyl, Coumaphos, Cyanophos, Demeton-S-methyl, Diazinon, Dichlorvos/ DDVP, Dicrotophos, Dimethoate ( Dimethoate, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fosthiazate ( Fosthiazate, Heptenophos, Imicyafos, Isofenphos, Isopropyl O-(methoxyaminothio-phosphoryl) salicylate, Isox
- GABAergic chloride ion (chloride ion) channel blockers Chlordane, Endosulfan, Ethiprole, Fipronil, Acetoprole, Camphechlor, Dienochlor, Heptachlor, Pyrafluprole, Pyriprole ( Pyriprole), Flufiprole.
- Sodium channel modulators (pyrethroids): Acrinathrin, Allethrin, d-cis-trans Allethrin, d-transAllethrin, Bifenthrin, Bioallethrin, Bioallethrin -S-Cyclopentenyl-isomer (Bioallethrin S-cyclopentenyl-isomer), Bioresmethrin, Cycloprothrin, Cyfluthrin, beta-Cyfluthrin, Cyhalothrin, ⁇ - Cyhalothrin (lambda-Cyhalothrin), gamma-Cyhalothrin, Cypermethrin, alpha-Cypermethrin, beta-Cypermethrin, theta-Cypermethrin ), zeta-Cypermethrin, Cyphenothrin [(1R)-trans-isomers], Deltamethrin, Emp
- nicotinic acetylcholine receptor (nAChR) competitive modulators Acetamiprid, Clothianidin, Dinotefuran, Imidacloprid, Nitenpyram, Thiacloprid, Thiamethoxam, Nicotine, Sulfoxaflor, Flupyradifurone, Triflumezopyrim, Nithiazine, Dicloromezotiaz, Flupyrimin.
- Nicotinic Acetylcholine Receptor (nAChR) Allosteric Modulators Spinetoram, Spinosad.
- Glutamatergic chloride (chloride) channel (GluCl) allosteric modulators Abamectin, Emamectin, Emamectin-benzoate, Lepimectin, Milbemectin, Doramectin, Eprinomectin, Ivermectin, Moxidectin, Selamectin.
- juvenile hormone-like agents Hydroprene, Kinoprene, Methoprene, Fenoxycarb, Pyriproxifen, Diofenolan, Epofenonane, Triprene.
- Alkyl halides such as methyl bromide, Chloropicrin, Sodium aluminum fluoride, Sulfuryl fluoride, Borax, Boric acid ( Boric acid), Disodium octaborate, Sodium borate, Sodium metaborate, Tartar emetic, Dazomet, Metam, Metam Potassium Salt (Metam Sodium), Metam Sodium Salt (Metam Potassium).
- Microorganism-derived insect midgut lining-disrupting agent aizawai, Bt subsp. kurstaki, Bt subsp. tenebrionis, Bt crop proteins, Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1/Cry35Ab1, Bacillus sphaericus.
- Bt stands for Bacillus thuringiensis
- protein contained in Bt crops refers to crops into which the gene for the toxin protein (Cry1Ab, etc.) produced by Bt (Bacillus thuringiensis) has been introduced. It is a protein produced within
- Mitochondrial ATP synthase inhibitor Diafenthiuron, Azocyclotin, Cyhexatin, Fenbutatin-oxide, Propargite, Tetradifon.
- Oxidative phosphorylation uncouplers that perturb the proton gradient Chlorfenapyr, DNOC (4,6-dinitro-o-cresol), Sulfluramid, Binapacryl, Dinobuton, Dinocap.
- Nicotinic Acetylcholine Receptor (nAChR) Channel Blockers Bensultap, Cartap hydrochloride, Thiocyclam, Thiosultap-sodium.
- Chitin biosynthesis inhibitor type 0: Bistrifluron, Chlorfluazuron, Diflubenzuron, Flucycloxuron, Flufenoxuron, Hexaflumuron, Lufenuron, Novaluron ), Noviflumuron, Teflubenzuron, Triflumuron, Fluazuron.
- molting hormone (ecdysone) receptor agonists Chromafenozide, Halofenozide, Methoxyfenozide, Tebufenozide.
- Octopamine receptor agonists Amitraz, Chlordimeform.
- mitochondrial electron transport chain complex III inhibitor Hydramethylnon, Acequinocyl, Fluacrypyrim, Bifenazate.
- Acetyl-CoA carboxylase inhibitors Spirodiclofen, Spiromesifen, Spirotetramat, Spiropidion.
- (24) mitochondrial electron transport chain complex IV inhibitor Aluminum phosphide (Al-phosphide), Calcium phosphide (Ca-phosphide), Zinc phosphide (Zn-phosphide), Phosphine, Calcium cyanide (Ca-cyanide), Sodium cyanide (Na-cyanide), Potassium cyanide (K-cyanide).
- ryanodine receptor modulators Chlorantraniliprole, Cyantraniliprole, Cyclaniliprole, Flubendiamide, Cyhalodiamide, Tetrachlorantraniliprole, Tetraniliprole ( Tetraniliprole).
- GABAergic chloride (chloride) channel allosteric modulators Broflanilide, Fluxametamide, Isocycloseram, Afoxolaner, Fluralaner, Lotilaner, Sarolaner.
- Plant growth regulators can also be mixed.
- Specific examples of the plant growth regulator that can be mixed include compounds selected from the following group. abscisic acid, kinetin, benzylaminopurine, 1,3-diphenylurea, forchlorfenuron, thidiazuron, chlorfenurone ( chlorfenuron, dihydrozeatin, gibberellin A, gibberellin A4, gibberellin A7, gibberellin A3, 1-methylcyclopropane, N - N-acetyl aminoethoxyvinyl glycine (aviglycine), aminooxyacetate, silver nitrate, cobalt chloride, IAA, 4-CPA, cloprop (cloprop), 2,4-D, MCPB, indole-3-butyrate, dichlorprop, phenothiol, 1-naphthyl acetamide, eticlozate (ethychlozate), cloxyfonac, maleic acid
- Anthelmintics can also be mixed.
- an antiparasitic agent that can be mixed, specifically, compounds selected from the following group can be exemplified.
- Anthelmintic (a) Benzimidazoles: fenbendazole, albendazole, triclabendazole, oxybendazole, mebendazole, oxfendazole, perbendazole, flubendazole; febantel, netobimine, thiophanate; thiabendazole, cambendazole; (b) Salicylanilides: Closantel, Oxyclozanide, Rafoxanide, Niclosamide; (c) substituted phenolics: nitroxynil, nitroscanate; (d) pyrimidine series: pyrantel, morantel; (e) imidazothiazoles: levamisole, tetramisole; (f) tetrahydropyrimidines: praziquantel, eps
- the agricultural and horticultural fungicide or nematicide of the present invention includes the pyridazinone compound of the present invention, other active ingredients and agricultural and horticulturally acceptable auxiliary ingredients for formulation (e.g., inorganic carriers, organic carriers, surfactants, solvents, etc.) can be added.
- the agricultural and horticultural fungicide or nematicide of the present invention is not particularly limited by its dosage form.
- dosage forms such as wettable powders, emulsions, powders, granules, aqueous solutions, suspensions, wettable powders, and tablets can be mentioned.
- the preparation method for the formulation is not particularly limited, and a known preparation method can be adopted depending on the dosage form.
- (Formulation Example 3 Granules) 5 parts of the pyridazinone compound of the present invention, 40 parts of talc, 38 parts of clay, 10 parts of bentonite and 7 parts of sodium alkyl sulfate are uniformly mixed, finely pulverized, and then granulated to a particle diameter of 0.5 to 1.0 mm. to obtain 5% active ingredient granules.
- the pyridazinone compound of the present invention can be used as a prophylactic or therapeutic agent for controlling harmful pathogens, particularly fungi, that infect humans or animals.
- the medical/veterinary antifungal agent of the present invention contains at least one selected from compound (I) and salts thereof as an active ingredient.
- the amount of compound (I) or a salt thereof contained in the medical antifungal agent of the present invention is not particularly limited as long as the antifungal effect is exhibited.
- animal refers to pets, livestock and poultry, animals raised in zoos and aquariums, captured wild animals, and vertebrates such as research and experimental animals ( means ra t a).
- Examples include the following animals, but specific examples of animals are not limited to these. sheep, goat, pig, horse, cow, buffalo, donkey, mule, camel, llama, alpaca, wild boar, reindeer, deer, mink, elephant, bear, kangaroo, fox, dog, cat, squirrel, rabbit, mouse, rat, Mammals such as guinea pigs, hamsters, monkeys and ferrets.
- Birds such as pigeons, parakeets, parrots, sparrows, marigolds, canaries, chickens, ducks, turkeys, ducks, pheasants, peacocks, ostriches, swans, sparrows, quail, owls, eagles, hawks, and cormorants.
- Reptiles such as chameleons, iguanas, lizards, snakes, turtles, crocodiles and geckos.
- Amphibians such as frogs and newts.
- Fish such as carp, goldfish, killifish, tropical fish, yellowtail, yellowtail, sea bream, amberjack, salmon, mackerel, sea bass, longtooth grouper, tuna, horse mackerel, flounder, and pufferfish.
- fungi examples are shown below as pathogenic bacteria to which the medical and veterinary antifungal agent of the present invention can be applied.
- specific examples are not limited to these.
- the genus Absidia such as absidia corymbifera; the genus Acremonium; the genus Alternaria, such as Alternaria alternata; the genus Aspergillus, such as Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Aspergillus niger, Aspergillus parasiticus, and Aspergillus terreus;
- Blumeria genus such as Blumeria graminis
- Candida genus such as Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis
- Cladosporium genus such as Cladosporium cladosporoides and Cladosporium herbarium
- Cryptococcus genera such as Clad
- mycosis examples are shown below as infectious diseases to which the medical and veterinary antifungal agent of the present invention can be applied. However, specific examples are not limited to these.
- the medical/veterinary antifungal agent of the present invention can be applied to both systemic fungal infections and superficial fungal infections.
- fungal infections include Aspergillus diseases such as pulmonary aspergillosis, systemic aspergillosis (which is more likely to occur in immunosuppressed patients such as bone marrow recipients or AIDS patients), Candida diseases such as systemic candidiasis ( Candida disease, Cryptococcus meningitis, rhinocerebral mucomycosis, pulmonary mucormycosis, blastomycosis, histoplasmosis, coccidiomycosis, paracoccidiomycosis, robomycosis, Keratomycosis, sporotrichosis, chromoblastomycosis, chromomycosis, pheophyphomycosis, zygomycosis, cryptococcosis, disseminated sporotrichosis, ring worm, tinea capitis, tinea corp
- the medical/veterinary antifungal agent of the present invention can contain pharmaceutically acceptable additives.
- Additives are not particularly limited as long as they are used in known medical drugs. They are of course sterile and non-pyrogenic.
- the additive can be appropriately selected according to the dosage form and administration method of the antifungal agent.
- the dosage form that the medical/veterinary antifungal agent of the present invention can take is not particularly limited. , emulsions, suspensions, solutions, drops (Pour-on), spot-on, etc.; semi-solid preparations such as ointments, gels, etc.; aerosols, vapors, etc. Gaseous agents; nanoparticle formulations and the like can be mentioned.
- Administration of the medical antifungal agent of the present invention can be performed by known methods. Examples of administration methods include subcutaneous, intravenous, intramuscular, intrasternal injection (injection); insertion into the anus, vagina, etc.; oral administration such as oral administration; nasal administration such as inhalation.
- additives that can be used in the medical and veterinary antifungal agents of the present invention include solubilizers such as cyclodextrins or modified cyclodextrins; lactose, dextrose, sucrose, cellulose, cornstarch or Diluents such as potato starch; Lubricants such as silica, talc, stearic acid, magnesium or calcium stearate, polyethylene glycol; Binding agents such as starch, arabic gums, gelatin, methylcellulose, carboxymethylcellulose or polyvinylpyrrolidone.
- solubilizers such as cyclodextrins or modified cyclodextrins
- lactose dextrose, sucrose, cellulose, cornstarch or Diluents
- Lubricants such as silica, talc, stearic acid, magnesium or calcium stearate, polyethylene glycol
- Binding agents such as starch, arabic gums, gelatin, methylcellulose
- disaggregating agents such as starch, alginic acid, alginates or sodium starch glycolate; effervescing mixtures; dyes; sweeteners;
- effervescing mixtures dyes; sweeteners;
- non-toxic and pharmacologically inactive substances generally used in pharmaceutical formulations can be used.
- additives can be incorporated into the medical antifungal agent of the present invention by known methods such as mixing, granulation, tableting, sugar coating, or film coating.
- additives that can be used in the medical and veterinary antifungal agents of the present invention include solubilizers such as cyclodextrins or modified cyclodextrins, saccharose, glycerin, mannitol, sorbitol, natural gum, agar, sodium alginate, pectin, methylcellulose, carboxymethylcellulose, polyvinyl alcohol, and the like.
- the additives that can be used in the medical and veterinary antifungal agent of the present invention include sterilized water, olive oil, ethyl oleate, glycols such as propylene glycol, cyclodextrin, and modified cyclodextrins. Dissolution aids such as dextrin can be used. Furthermore, an appropriate amount of lidocaine hydrochloride can be included as necessary.
- the amount of compound (I) or a salt thereof contained in the medical or veterinary antifungal agent of the present invention is preferably 85% by weight or less, more preferably 50% by weight or less, based on the weight of the antifungal agent. .
- the dose of the medical/veterinary antifungal agent of the present invention can be appropriately selected according to the administration method, the type of fungi infected, the patient's age, body weight, symptoms, and the like. For example, for adults, in the case of oral or parenteral (injection, infusion, etc.) administration, 0.1 to 100 mg/kg-body weight can be administered once or several times a day.
- the medical and veterinary antifungal agents of the present invention can be used in combination with drugs other than pyridazinone compounds.
- Methyl 6-chloro-3-methoxypyridazine-4-carboxylate (2.65 g) was dissolved in dimethylformamide (90 ml), trimethylamine (150 ml). To this, 1-ethynyl-2-methoxybenzene (1.90 g), copper (I) iodide (0.42 g) and bis(triphenylphosphine) palladium (II) dichloride (1.34 g) were added and the reaction vessel was replaced with nitrogen, and then stirred at 70° C. for 1 hour. A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with ethyl acetate.
- Methyl 3-methoxy-6-((2-methoxyphenyl)ethynyl)pyridazine-4-carboxylate (1.60g) was dissolved in methanol (54ml) and palladium hydroxide (0.16g) was added. After purging the reaction vessel with hydrogen, the mixture was stirred overnight at room temperature. The reaction solution was filtered through celite, the filtrate was concentrated under reduced pressure, and the obtained residue (1.59 g) was used as it was in the next step.
- Methyl 3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylate (1.59g) was dissolved in tetrahydrofuran (9ml), water (7ml) and lithium hydroxide monohydrate (0.34g). was added. After stirring this at room temperature for 1 hour, water and ethyl acetate were added and extracted to the reaction liquid. 1N Hydrochloric acid was added to the resulting aqueous layer under ice-cooling, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue (1.24 g) was directly used in the next step.
- N,3-dimethoxy-6-(2-methoxyphenethyl)-N-methylpyridazine-4-carboxamide (0.25 g) was dissolved in anhydrous tetrahydrofuran (2.5 ml), the reaction solution was purged with nitrogen, and then- Cooled to 10°C. A 1.0 M methylmagnesium bromide tetrohydrofuran solution (1.1 ml) was added thereto, and the mixture was stirred at -10°C for 1 hour. The reaction solution was poured into a saturated aqueous ammonium chloride solution and extracted with ethyl acetate. The resulting organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue (0.19 g) was directly used in the next step.
- Step 6 1-(3-methoxy-6-(2-methoxyphenethyl)pyridazin-4-yl)ethan-1-one O-isopropyloxime [1-(3-methoxy-6-(2-methoxyphenethyl)-pyridazine-4- Synthesis of yl)ethan-1-one O-isopropyl oxime]
- step 2 The crude product obtained in step 2 was dissolved in N,N-dimethylformamide (8 ml).
- Step 4 (S,E)-2-(2-amino-3-methylbutyl)-6-chloro-4-(1-(isopropoxyimino)ethyl)pyridazin-3(2H)-one hydrochloride [(S,E) -2-(2-amino-3-methylbutyl)-6-chloro-4-(1-(isopropoxyimino)ethyl)pyridazin-3(2H)-one hydrogen chloride salt]
- step 4 The crude product obtained in step 4 was dissolved in dichloromethane (3 ml). Under ice-cooling, triethylamine (0.25 g) and isobutyryl chloride (0.10 g) were sequentially added, and the mixture was stirred at room temperature for 30 minutes. Under ice-cooling, saturated aqueous sodium bicarbonate was added to the reaction solution, followed by extraction with dichloromethane. The resulting dichloromethane layer was dried over anhydrous magnesium sulfate and then filtered.
- Step 6 (S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1(6H)-yl)- 3-Methylbutan-2-yl)isobutyramide [(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1 (6H)-yl)-3-methylbutan-2-yl)isobutyramide]
- 2-Methoxybenzyl alcohol (0.040 g), sodium t-butoxy (0.015 g), [(2-di-tert-butylphosphino-3,6-dimethoxy-2',4',6'-Triisopropyl-1,1'-biphenyl)-2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonic acid (0.003 g) was added, and the reaction vessel was flushed with nitrogen. Replaced under atmosphere. After that, the mixture was stirred at 100° C. for 1 hour in an oil bath.
- Table 1 shows some of the pyridazinone compounds of the present invention produced in the same manner as in the above Examples.
- the table also shows the melting point (°C) or physical properties of each compound as physical properties.
- the concentration of the mobile phase (B) is increased from 30% by mass to 95% by mass with a linear gradient of 1.5 minutes, and (II) is maintained at 95% by mass for 0.5 minutes, (III) Immediately lowered to 30% by weight (B) and (IV) maintained at 30% by weight for 0.50 minutes.
- Table 3 shows some of the pyridazinone compounds of the present invention produced in the same manner as in the above examples.
- the table also shows the melting point (°C) or physical properties of each compound as physical properties. Some compounds were also shown to be isomeric mixtures.
- LCMS liquid chromatography mass spectrometry
- Electrophoresis was performed on ACQUITY UPLC H-Class (Waters) using an ACQUITY UPLC photodiode array (PDA) e ⁇ detector (Waters) and an ACQUITY QDa detector (in positive and negative ion electrospray mode, UV PDA). Detection, manufactured by Waters Co., Ltd.), and Method (A) or Method (B) shown below was used.
- Table 5 shows some of the pyridazinone compounds of the present invention produced in the same manner as in the above examples.
- the table also shows the melting point (°C) or physical properties of each compound as physical properties. Some compounds were also shown to be isomeric mixtures.
- Table 6 shows retention times in liquid chromatography mass spectrometry (LCMS) for some of the compounds in the table.
- the analysis conditions for liquid chromatography-mass spectrometry (LCMS) were Method (A) mentioned above and Method (C) shown below.
- the mobile phase (A) Water containing 0.1% formic acid was used as the mobile phase (A), and acetonitrile was used as the mobile phase (B).
- the retention time (minutes) of the sample was measured at a sample injection volume of 6 ⁇ L.
- the column inlet concentration of the mobile phase (B) was maintained at 30% by mass for 0.3 minutes from the time of sample injection, and then increased at a constant rate from 30% by mass to 95% by mass over 1.7 minutes to 95% by mass. % and maintained for 1.5 minutes, then abruptly decreased to 30% by weight and maintained at 30% by weight for 2.5 minutes.
- Table 7 shows some of the pyridazinone compounds of the present invention produced in the same manner as in the above examples. For some compounds in the table, their physical properties are also shown. Some compounds were also shown to be isomeric mixtures.
- Table 8 shows retention times in liquid chromatography-mass spectrometry (LCMS) for some of the compounds in the table. Method (A) mentioned above was used as the analysis conditions for liquid chromatography-mass spectrometry (LCMS).
- Table 9 shows some of the compounds that can be production intermediates in preparing the pyridazinone compound of the present invention.
- the table also shows the melting point (° C.) as a physical property of each compound.
- test emulsion 5 parts by weight of the pyridazinone compound of the present invention, 93.5 parts by weight of N,N-dimethylformamide, and 1.5 parts by weight of polyoxyethylene sorbitan monolaurate (TWEEN (registered trademark) 20) are mixed and dissolved, An emulsion (I) with 5% active ingredient was obtained.
- TWEEN polyoxyethylene sorbitan monolaurate
- the control value was calculated using the following formula.
- Control value (%) 100- ⁇ lesion area ratio in treated area / lesion area ratio in untreated area ⁇ ⁇ 100
- B-2, B-4, B-5, B-10, B-11, B-17, B-33, B-36, B-37, B-39, B-40, B-47, C- Compounds 16 and C-17 were tested for control of cucumber gray mold. A control value of 75% or more was shown.
- Test Example 4 Wheat leaf rust control test Water was added to the emulsion (I) so that the concentration of the pyridazinone compound was 125 ppm, and dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on wheat seedlings (variety “Nourin No. 61”, 1-2 leaf stage) cultivated in nursery pots. After air-drying, uredospores of wheat leaf rust fungus (Puccinia recondita) were sprinkled on the wheat seedlings to which the chemical solution had been sprayed and inoculated (treated area). As a control, wheat seedlings not sprayed with the drug solution were inoculated in the same manner as above (untreated group).
- Antibacterial test against Fusarium graminearum Spores of Fusarium graminearum were added to Minimal SD Base medium containing glucose and dispersed, and then a pyridazinone compound dissolved in dimethyl sulfoxide was added and mixed to a concentration of 25 ppm. The cells were dispensed onto well microplates and incubated in the dark at 25°C for 3 days. After culturing, the turbidity at a wavelength of 405 nm was measured with a microplate reader, and the growth inhibition rate (%) of Fusarium graminearum was determined in comparison with the untreated case. As a result, the following compounds showed an excellent growth inhibition rate of 50% or more.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Agronomy & Crop Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Dentistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention addresses the problem of providing a pyridazinone compound which has excellent bactericidal/antibacterial activity and excellent safety, while being industrially beneficially synthesized; and an agricultural/horticultural germicide containing the pyridazinone compound as an active ingredient. The pyridazinone compound is a compound represented by formula (I) or a salt thereof. In formula (I), Y represents an oxygen atom or a sulfur atom; X1 and X2 each independently represent a hydrogen atom, a halogen group, a substituted or unsubstituted C1-6 alkyl group, or the like; X3 represents a hydrogen atom, a substituted or unsubstituted linear C1-C6 alkyl group, a substituted or unsubstituted linear C2-C6 alkenyl group, or the like; X4 represents a group represented by Q-A-, a group represented by Q-A-B-, or the like; A represents a substituted or unsubstituted C1-C6 alkylene group, a substituted or unsubstituted C2-C6 alkenylene group, or the like; B represents an oxygen atom, a sulfur atom or the like; and Q represents a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted heterocyclyl group having a 5-membered to 10-membered ring.
Description
本発明は、ピリダジノン化合物および農園芸用殺菌剤に関する。より詳細に、本発明は、殺菌・抗菌活性に優れ、安全性に優れ、且つ工業的に有利に合成できるピリダジノン化合物、並びにこれを有効成分として含有する農園芸用殺菌剤に関する。さらに、前記の化合物を有効成分として含有する殺線虫剤に関する。さらに、前記の化合物を有効成分として含有する医療用・動物用抗真菌剤に関する。
The present invention relates to pyridazinone compounds and agricultural and horticultural fungicides. More specifically, the present invention relates to a pyridazinone compound that has excellent bactericidal and antibacterial activity, is excellent in safety, and can be industrially advantageously synthesized, and an agricultural and horticultural fungicide containing it as an active ingredient. Furthermore, it relates to a nematicide containing the above compound as an active ingredient. Furthermore, it relates to medical and veterinary antifungal agents containing the above compounds as active ingredients.
農園芸作物の栽培に当り作物の病害に対して防除活性を有する化合物が種々提案されている。そのような化合物を農園芸用殺菌剤として実用するためには、効力が十分に高いだけでなく、薬剤抵抗性が生じ難いこと、植物に対する薬害や土壌汚染を生じさせないこと、家畜や魚類などに対する毒性が低いことなどが要求される。
Various compounds with control activity against crop diseases have been proposed for the cultivation of agricultural and horticultural crops. In order for such compounds to be practically used as agricultural and horticultural fungicides, they must not only have sufficiently high efficacy, but also must be resistant to drug resistance, not cause chemical damage or soil contamination to plants, and must be effective against livestock and fish. Low toxicity is required.
本発明の課題は、殺菌・抗菌活性に優れ、安全性に優れ、且つ工業的に有利に合成できるピリダジノン化合物、およびこれを有効成分として含有する農園芸用殺菌剤を提供することである。さらには、前記の化合物を有効成分として含有する殺線虫剤を提供することにある。さらには、前記の化合物を有効成分として含有する医療用・動物用抗真菌剤を提供することにある。
An object of the present invention is to provide a pyridazinone compound that has excellent bactericidal and antibacterial activity, is excellent in safety, and can be industrially advantageously synthesized, and an agricultural and horticultural fungicide containing it as an active ingredient. A further object is to provide a nematicide containing the above compound as an active ingredient. A further object of the present invention is to provide medical and veterinary antifungal agents containing the aforementioned compounds as active ingredients.
本発明者らは、上記課題を解決すべく鋭意検討した結果、以下の態様を包含する本発明を完成するに至った。
As a result of intensive studies aimed at solving the above problems, the present inventors have completed the present invention including the following aspects.
式(I)中、
Yは、酸素原子または硫黄原子を示し;
X1、およびX2は、それぞれ独立に、水素原子、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の5~6員環のヘテロシクリル基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、R1-CO-で表される基、カルボキシ基、R2-O-CO-で表される基、R3R4N-で表される基、R3R4N-CO-で表される基、R1-CO-O-で表される基、R1-CO-NR5-で表される基、R2-O-CO-O-で表される基、R2-O-CO-NR5-で表される基、R3R4N-CO-O-で表される基、R3R4N-CO-NR5-で表される基、R2SO2-NR5-で表される基、R3R4N-SO2-で表される基、R1O-N=CR6-で表される基、R3R4N-N=CR6-で表される基、またはR1-N=CR6-で表される基を示し;
R1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R2は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R3は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R4は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
ここで、R3とR4は、一緒になって二価の有機基を形成してもよく、
R5は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し;
X3は、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、R1-CO-で表される基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換の4~6員環のヘテロシクリル基、RN1O-で表される基、RN1-CO-O-で表される基、RN1-O-CO-O-で表される基、RN1RN1N-CO-O-で表される基、RN1-CS-O-で表される基、RN1RN1N-CS-O-で表される基、RN1RN2N-で表される基、RN1-CO-NRN2-で表される基、RN1-CO-CO-NRN2-で表される基、RN1-O-CO-NRN2-で表される基、RN1RN1N-CO-NRN2-で表される基、RN1RN1N-CO-CO-NRN2-で表される基、RN1-CS-NRN2-で表される基、RN1RN1N-CS-NRN2-で表される基、RN1SO2-NRN2-で表される基、またはRN1-C(=NRN1)-NRN2-で表される基を示し、
RN1、およびRN2は、それぞれ独立に、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示し、ここで、RN1とRN1、またはRN1とRN2は、一緒になって二価の有機基を形成してもよく;
X4は、Q-A-で表される基、Q-A-B-で表される基、Q-B-A-で表される基、Q-SO2-NRN3で表される基、Q-C(R7)=N-で表される基、Q-NRN3-SO2-で表される基、Q-N=C(R7)-で表される基、またはQ-B-で表される基を示し、
Aは、それぞれ独立に、置換若しくは無置換のC1~6アルキレン基、置換若しくは無置換のC2~6アルケニレン基、置換若しくは無置換のC2~6アルキニレン基、置換若しくは無置換のC3~6シクロアルキレン基、またはカルボニル基を示し;
Bは、それぞれ独立に、酸素原子、硫黄原子、スルフィニル基、スルホニル基、または-NRN3-で表される基を示し、RN3は、水素原子、置換若しくは無置換のC1~6アルキル基、ホルミル基、または置換若しくは無置換のC1~6アルキルカルボニル基を示し、
R7は、水素原子、または置換若しくは無置換のC1~6アルキル基を示し、
Qは、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~10員環のヘテロシクリル基を示す。 In formula (I),
Y represents an oxygen atom or a sulfur atom;
X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group , hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6 ~10 arylsulfonyl group, substituted or unsubstituted 5- to 6-membered heterocyclyl group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, nitro group, cyano group, represented by R 1 -CO- a carboxy group, a group represented by R 2 —O—CO—, a group represented by R 3 R 4 N—, a group represented by R 3 R 4 N—CO—, R 1 —CO—O A group represented by -, a group represented by R 1 -CO-NR 5 -, a group represented by R 2 -O-CO-O-, and a group represented by R 2 -O-CO-NR 5 - a group represented by R 3 R 4 N—CO—O—, a group represented by R 3 R 4 N—CO—NR 5 —, a group represented by R 2 SO 2 —NR 5 —, R a group represented by 3R 4 N--SO 2 --, a group represented by R 1 ON =CR 6 --, a group represented by R 3 R 4 NN=CR 6 --, or R 1 -- representing a group represented by N═CR 6 —;
R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
wherein R 3 and R 4 may together form a divalent organic group,
each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group;
X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, a substituted or unsubstituted 4- to 6-membered heterocyclyl group, R N1 O- a group represented by R N1 --CO--O--, a group represented by R N1 --O--CO--O--, a group represented by R N1 R N1 N--CO--O--, and R N1 A group represented by -CS-O-, a group represented by R N1 R N1 N-CS-O-, a group represented by R N1 R N2 N-, a group represented by R N1 -CO-NR N2 - a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, a group represented by R N1 R N1 N-CO-NR N2 - a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS-NR N2 —, and a group represented by R N1 R N1 N—CS-NR N2 — a group represented by R N1 SO 2 —NR N2 —, or a group represented by R N1 —C(=NR N1 )—NR N2 —,
R N1 and R N2 are each independently a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2- 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 4- to 6-membered heterocyclyl group, wherein R N1 and R N1 , or R N1 and R N2 may together form a divalent organic group;
X 4 is a group represented by QA-, a group represented by QA-B-, a group represented by QB-A-, a group represented by Q-SO 2 -NR N3 , a group represented by Q—C(R 7 )=N—, a group represented by Q—NR N3 —SO 2 —, a group represented by Q—N=C(R 7 )—, or Q— represents a group represented by B-,
A is each independently a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or a carbonyl group;
B each independently represents an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group, or a group represented by -NR N3 -, where R N3 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a formyl group, or a substituted or unsubstituted C1-6 alkylcarbonyl group,
R 7 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group,
Q represents a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted 5- to 10-membered heterocyclyl group.
Yは、酸素原子または硫黄原子を示し;
X1、およびX2は、それぞれ独立に、水素原子、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の5~6員環のヘテロシクリル基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、R1-CO-で表される基、カルボキシ基、R2-O-CO-で表される基、R3R4N-で表される基、R3R4N-CO-で表される基、R1-CO-O-で表される基、R1-CO-NR5-で表される基、R2-O-CO-O-で表される基、R2-O-CO-NR5-で表される基、R3R4N-CO-O-で表される基、R3R4N-CO-NR5-で表される基、R2SO2-NR5-で表される基、R3R4N-SO2-で表される基、R1O-N=CR6-で表される基、R3R4N-N=CR6-で表される基、またはR1-N=CR6-で表される基を示し;
R1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R2は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R3は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R4は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
ここで、R3とR4は、一緒になって二価の有機基を形成してもよく、
R5は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し;
X3は、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、R1-CO-で表される基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換の4~6員環のヘテロシクリル基、RN1O-で表される基、RN1-CO-O-で表される基、RN1-O-CO-O-で表される基、RN1RN1N-CO-O-で表される基、RN1-CS-O-で表される基、RN1RN1N-CS-O-で表される基、RN1RN2N-で表される基、RN1-CO-NRN2-で表される基、RN1-CO-CO-NRN2-で表される基、RN1-O-CO-NRN2-で表される基、RN1RN1N-CO-NRN2-で表される基、RN1RN1N-CO-CO-NRN2-で表される基、RN1-CS-NRN2-で表される基、RN1RN1N-CS-NRN2-で表される基、RN1SO2-NRN2-で表される基、またはRN1-C(=NRN1)-NRN2-で表される基を示し、
RN1、およびRN2は、それぞれ独立に、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示し、ここで、RN1とRN1、またはRN1とRN2は、一緒になって二価の有機基を形成してもよく;
X4は、Q-A-で表される基、Q-A-B-で表される基、Q-B-A-で表される基、Q-SO2-NRN3で表される基、Q-C(R7)=N-で表される基、Q-NRN3-SO2-で表される基、Q-N=C(R7)-で表される基、またはQ-B-で表される基を示し、
Aは、それぞれ独立に、置換若しくは無置換のC1~6アルキレン基、置換若しくは無置換のC2~6アルケニレン基、置換若しくは無置換のC2~6アルキニレン基、置換若しくは無置換のC3~6シクロアルキレン基、またはカルボニル基を示し;
Bは、それぞれ独立に、酸素原子、硫黄原子、スルフィニル基、スルホニル基、または-NRN3-で表される基を示し、RN3は、水素原子、置換若しくは無置換のC1~6アルキル基、ホルミル基、または置換若しくは無置換のC1~6アルキルカルボニル基を示し、
R7は、水素原子、または置換若しくは無置換のC1~6アルキル基を示し、
Qは、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~10員環のヘテロシクリル基を示す。 In formula (I),
Y represents an oxygen atom or a sulfur atom;
X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group , hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6 ~10 arylsulfonyl group, substituted or unsubstituted 5- to 6-membered heterocyclyl group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, nitro group, cyano group, represented by R 1 -CO- a carboxy group, a group represented by R 2 —O—CO—, a group represented by R 3 R 4 N—, a group represented by R 3 R 4 N—CO—, R 1 —CO—O A group represented by -, a group represented by R 1 -CO-NR 5 -, a group represented by R 2 -O-CO-O-, and a group represented by R 2 -O-CO-NR 5 - a group represented by R 3 R 4 N—CO—O—, a group represented by R 3 R 4 N—CO—NR 5 —, a group represented by R 2 SO 2 —NR 5 —, R a group represented by 3R 4 N--SO 2 --, a group represented by R 1 ON =CR 6 --, a group represented by R 3 R 4 NN=CR 6 --, or R 1 -- representing a group represented by N═CR 6 —;
R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
wherein R 3 and R 4 may together form a divalent organic group,
each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group;
X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, a substituted or unsubstituted 4- to 6-membered heterocyclyl group, R N1 O- a group represented by R N1 --CO--O--, a group represented by R N1 --O--CO--O--, a group represented by R N1 R N1 N--CO--O--, and R N1 A group represented by -CS-O-, a group represented by R N1 R N1 N-CS-O-, a group represented by R N1 R N2 N-, a group represented by R N1 -CO-NR N2 - a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, a group represented by R N1 R N1 N-CO-NR N2 - a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS-NR N2 —, and a group represented by R N1 R N1 N—CS-NR N2 — a group represented by R N1 SO 2 —NR N2 —, or a group represented by R N1 —C(=NR N1 )—NR N2 —,
R N1 and R N2 are each independently a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2- 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 4- to 6-membered heterocyclyl group, wherein R N1 and R N1 , or R N1 and R N2 may together form a divalent organic group;
X 4 is a group represented by QA-, a group represented by QA-B-, a group represented by QB-A-, a group represented by Q-SO 2 -NR N3 , a group represented by Q—C(R 7 )=N—, a group represented by Q—NR N3 —SO 2 —, a group represented by Q—N=C(R 7 )—, or Q— represents a group represented by B-,
A is each independently a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or a carbonyl group;
B each independently represents an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group, or a group represented by -NR N3 -, where R N3 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a formyl group, or a substituted or unsubstituted C1-6 alkylcarbonyl group,
R 7 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group,
Q represents a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted 5- to 10-membered heterocyclyl group.
〔2〕 X2が、R1O-N=CR6-で表される基である、〔1〕に記載の化合物またはそれらの塩。
〔3〕〔1〕または〔2〕に記載の化合物、およびそれらの塩からなる群から選ばれる少なくとも1つを有効成分として含有する農園芸用殺菌剤。
〔4〕種子処理用である、〔3〕に記載の農園芸用殺菌剤。
〔5〕〔1〕または〔2〕に記載の化合物、およびそれらの塩からなる群から選ばれる少なくとも1つを有効成分として含有する殺線虫剤。
〔6〕〔1〕または〔2〕に記載の化合物、およびそれらの塩からなる群から選ばれる少なくとも1つを有効成分として含有する医療用・動物用抗真菌剤。 [2] The compound or a salt thereof according to [1], wherein X 2 is a group represented by R 1 ON=CR 6 -.
[3] An agricultural and horticultural fungicide containing, as an active ingredient, at least one selected from the group consisting of the compounds of [1] or [2] and salts thereof.
[4] The agricultural and horticultural fungicide of [3], which is for seed treatment.
[5] A nematicide containing, as an active ingredient, at least one selected from the group consisting of the compounds of [1] or [2] and salts thereof.
[6] A medical or veterinary antifungal agent containing, as an active ingredient, at least one selected from the group consisting of the compounds of [1] or [2] and salts thereof.
〔3〕〔1〕または〔2〕に記載の化合物、およびそれらの塩からなる群から選ばれる少なくとも1つを有効成分として含有する農園芸用殺菌剤。
〔4〕種子処理用である、〔3〕に記載の農園芸用殺菌剤。
〔5〕〔1〕または〔2〕に記載の化合物、およびそれらの塩からなる群から選ばれる少なくとも1つを有効成分として含有する殺線虫剤。
〔6〕〔1〕または〔2〕に記載の化合物、およびそれらの塩からなる群から選ばれる少なくとも1つを有効成分として含有する医療用・動物用抗真菌剤。 [2] The compound or a salt thereof according to [1], wherein X 2 is a group represented by R 1 ON=CR 6 -.
[3] An agricultural and horticultural fungicide containing, as an active ingredient, at least one selected from the group consisting of the compounds of [1] or [2] and salts thereof.
[4] The agricultural and horticultural fungicide of [3], which is for seed treatment.
[5] A nematicide containing, as an active ingredient, at least one selected from the group consisting of the compounds of [1] or [2] and salts thereof.
[6] A medical or veterinary antifungal agent containing, as an active ingredient, at least one selected from the group consisting of the compounds of [1] or [2] and salts thereof.
式(II)中、
Yは、酸素原子または硫黄原子を示し;
X1およびX2は、それぞれ独立に、水素原子、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の5~6員環のヘテロシクリル基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、R1-CO-で表される基、カルボキシ基、R2-O-CO-で表される基、R3R4N-で表される基、R3R4N-CO-で表される基、R1-CO-O-で表される基、R1-CO-NR5-で表される基、R2-O-CO-O-で表される基、R2-O-CO-NR5-で表される基、R3R4N-CO-O-で表される基、R3R4N-CO-NR5-で表される基、R2SO2-NR5-で表される基、R3R4N-SO2-で表される基、R1O-N=CR6-で表される基、R3R4N-N=CR6-で表される基、またはR1-N=CR6-で表される基を示し;
R1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R2は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R3は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R4は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
ここで、R3とR4は、一緒になって二価の有機基を形成してもよく、
R5は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し;
X3は、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、R1-CO-で表される基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換の4~6員環のヘテロシクリル基、RN1O-で表される基、RN1-CO-O-で表される基、RN1-O-CO-O-で表される基、RN1RN1N-CO-O-で表される基、RN1-CS-O-で表される基、RN1RN1N-CS-O-で表される基、RN1RN2N-で表される基、RN1-CO-NRN2-で表される基、RN1-CO-CO-NRN2-で表される基、RN1-O-CO-NRN2-で表される基、RN1RN1N-CO-NRN2-で表される基、RN1RN1N-CO-CO-NRN2-で表される基、RN1-CS-NRN2-で表される基、RN1RN1N-CS-NRN2-で表される基、RN1SO2-NRN2-で表される基、またはRN1-C(=NRN1)-NRN2-で表される基を示し、
RN1、およびRN2は、それぞれ独立に、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示し、ここで、RN1とRN1、またはRN1とRN2は、一緒になって二価の有機基を形成してもよく;
X5は、HO-A-で表される基、C1~6アルコキシカルボニル基、またはハロゲノ基を示し、
Aは、置換若しくは無置換のC1~6アルキレン基、置換若しくは無置換のC2~6アルケニレン基、置換若しくは無置換のC2~6アルキニレン基、置換若しくは無置換のC3~6シクロアルキレン基、またはカルボニル基を示す。
〔8〕X2が、R1O-N=CR6-で表される基である、〔7〕に記載の化合物またはそれらの塩。 In formula (II),
Y represents an oxygen atom or a sulfur atom;
X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6- 10 arylsulfonyl group, substituted or unsubstituted 5- to 6-membered heterocyclyl group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, nitro group, cyano group, group represented by R 1 -CO- , a carboxy group, a group represented by R 2 —O—CO—, a group represented by R 3 R 4 N—, a group represented by R 3 R 4 N—CO—, R 1 —CO—O— a group represented by R 1 -CO-NR 5 -, a group R 2 -O-CO-O-, a group R 2 -O-CO-NR 5 - , a group represented by R 3 R 4 N—CO—O—, a group represented by R 3 R 4 N—CO—NR 5 —, a group represented by R 2 SO 2 —NR 5 —, R 3 a group represented by R 4 N--SO 2 --, a group represented by R 1 ON=CR 6 --, a group represented by R 3 R 4 N--N=CR 6 --, or R 1 --N represents a group represented by =CR 6 -;
R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
wherein R 3 and R 4 may together form a divalent organic group,
each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group;
X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, a substituted or unsubstituted 4- to 6-membered heterocyclyl group, R N1 O- a group represented by R N1 --CO--O--, a group represented by R N1 --O--CO--O--, a group represented by R N1 R N1 N--CO--O--, and R N1 A group represented by -CS-O-, a group represented by R N1 R N1 N-CS-O-, a group represented by R N1 R N2 N-, a group represented by R N1 -CO-NR N2 - a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, a group represented by R N1 R N1 N-CO-NR N2 - a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS-NR N2 —, and a group represented by R N1 R N1 N—CS-NR N2 — a group represented by R N1 SO 2 —NR N2 —, or a group represented by R N1 —C(=NR N1 )—NR N2 —,
R N1 and R N2 are each independently a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2- 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 4- to 6-membered heterocyclyl group, wherein R N1 and R N1 , or R N1 and R N2 may together form a divalent organic group;
X 5 represents a group represented by HO-A-, a C1-6 alkoxycarbonyl group, or a halogeno group,
A is a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or carbonyl indicates a group.
[8] The compound or a salt thereof according to [7], wherein X 2 is a group represented by R 1 ON=CR 6 -.
Yは、酸素原子または硫黄原子を示し;
X1およびX2は、それぞれ独立に、水素原子、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の5~6員環のヘテロシクリル基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、R1-CO-で表される基、カルボキシ基、R2-O-CO-で表される基、R3R4N-で表される基、R3R4N-CO-で表される基、R1-CO-O-で表される基、R1-CO-NR5-で表される基、R2-O-CO-O-で表される基、R2-O-CO-NR5-で表される基、R3R4N-CO-O-で表される基、R3R4N-CO-NR5-で表される基、R2SO2-NR5-で表される基、R3R4N-SO2-で表される基、R1O-N=CR6-で表される基、R3R4N-N=CR6-で表される基、またはR1-N=CR6-で表される基を示し;
R1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R2は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R3は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R4は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
ここで、R3とR4は、一緒になって二価の有機基を形成してもよく、
R5は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し;
X3は、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、R1-CO-で表される基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換の4~6員環のヘテロシクリル基、RN1O-で表される基、RN1-CO-O-で表される基、RN1-O-CO-O-で表される基、RN1RN1N-CO-O-で表される基、RN1-CS-O-で表される基、RN1RN1N-CS-O-で表される基、RN1RN2N-で表される基、RN1-CO-NRN2-で表される基、RN1-CO-CO-NRN2-で表される基、RN1-O-CO-NRN2-で表される基、RN1RN1N-CO-NRN2-で表される基、RN1RN1N-CO-CO-NRN2-で表される基、RN1-CS-NRN2-で表される基、RN1RN1N-CS-NRN2-で表される基、RN1SO2-NRN2-で表される基、またはRN1-C(=NRN1)-NRN2-で表される基を示し、
RN1、およびRN2は、それぞれ独立に、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示し、ここで、RN1とRN1、またはRN1とRN2は、一緒になって二価の有機基を形成してもよく;
X5は、HO-A-で表される基、C1~6アルコキシカルボニル基、またはハロゲノ基を示し、
Aは、置換若しくは無置換のC1~6アルキレン基、置換若しくは無置換のC2~6アルケニレン基、置換若しくは無置換のC2~6アルキニレン基、置換若しくは無置換のC3~6シクロアルキレン基、またはカルボニル基を示す。
〔8〕X2が、R1O-N=CR6-で表される基である、〔7〕に記載の化合物またはそれらの塩。 In formula (II),
Y represents an oxygen atom or a sulfur atom;
X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6- 10 arylsulfonyl group, substituted or unsubstituted 5- to 6-membered heterocyclyl group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, nitro group, cyano group, group represented by R 1 -CO- , a carboxy group, a group represented by R 2 —O—CO—, a group represented by R 3 R 4 N—, a group represented by R 3 R 4 N—CO—, R 1 —CO—O— a group represented by R 1 -CO-NR 5 -, a group R 2 -O-CO-O-, a group R 2 -O-CO-NR 5 - , a group represented by R 3 R 4 N—CO—O—, a group represented by R 3 R 4 N—CO—NR 5 —, a group represented by R 2 SO 2 —NR 5 —, R 3 a group represented by R 4 N--SO 2 --, a group represented by R 1 ON=CR 6 --, a group represented by R 3 R 4 N--N=CR 6 --, or R 1 --N represents a group represented by =CR 6 -;
R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
wherein R 3 and R 4 may together form a divalent organic group,
each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group;
X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, a substituted or unsubstituted 4- to 6-membered heterocyclyl group, R N1 O- a group represented by R N1 --CO--O--, a group represented by R N1 --O--CO--O--, a group represented by R N1 R N1 N--CO--O--, and R N1 A group represented by -CS-O-, a group represented by R N1 R N1 N-CS-O-, a group represented by R N1 R N2 N-, a group represented by R N1 -CO-NR N2 - a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, a group represented by R N1 R N1 N-CO-NR N2 - a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS-NR N2 —, and a group represented by R N1 R N1 N—CS-NR N2 — a group represented by R N1 SO 2 —NR N2 —, or a group represented by R N1 —C(=NR N1 )—NR N2 —,
R N1 and R N2 are each independently a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2- 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 4- to 6-membered heterocyclyl group, wherein R N1 and R N1 , or R N1 and R N2 may together form a divalent organic group;
X 5 represents a group represented by HO-A-, a C1-6 alkoxycarbonyl group, or a halogeno group,
A is a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or carbonyl indicates a group.
[8] The compound or a salt thereof according to [7], wherein X 2 is a group represented by R 1 ON=CR 6 -.
本発明のピリダジノン化合物は、殺菌・抗菌活性に優れ、効果が確実で、安全性に優れ、且つ工業的に有利に合成できる。
本発明の農園芸用殺菌剤及び殺線虫剤は、優れた防除効果を有し、植物体に薬害を生じることがなく、人畜魚類に対する毒性や環境への影響が少ない。
本発明の医療用・動物用抗真菌剤は、優れた抗菌効果を有し、人畜魚類に対する毒性が少ない。 The pyridazinone compound of the present invention is excellent in bactericidal and antibacterial activity, has a reliable effect, is excellent in safety, and can be industrially advantageously synthesized.
The agricultural and horticultural fungicide and nematicide of the present invention have an excellent control effect, do not cause phytotoxicity to plants, and are less toxic to humans, livestock and fish, and have less impact on the environment.
The medical and veterinary antifungal agents of the present invention have excellent antibacterial effects and are less toxic to humans, animals, and fish.
本発明の農園芸用殺菌剤及び殺線虫剤は、優れた防除効果を有し、植物体に薬害を生じることがなく、人畜魚類に対する毒性や環境への影響が少ない。
本発明の医療用・動物用抗真菌剤は、優れた抗菌効果を有し、人畜魚類に対する毒性が少ない。 The pyridazinone compound of the present invention is excellent in bactericidal and antibacterial activity, has a reliable effect, is excellent in safety, and can be industrially advantageously synthesized.
The agricultural and horticultural fungicide and nematicide of the present invention have an excellent control effect, do not cause phytotoxicity to plants, and are less toxic to humans, livestock and fish, and have less impact on the environment.
The medical and veterinary antifungal agents of the present invention have excellent antibacterial effects and are less toxic to humans, animals, and fish.
〔ピリダジノン化合物〕
本発明のピリダジノン化合物は、式(I)で表される化合物(以下、化合物(I)と表記することがある。)または化合物(I)の塩である。
[Pyridazinone compound]
The pyridazinone compound of the present invention is a compound represented by formula (I) (hereinafter sometimes referred to as compound (I)) or a salt of compound (I).
本発明のピリダジノン化合物は、式(I)で表される化合物(以下、化合物(I)と表記することがある。)または化合物(I)の塩である。
The pyridazinone compound of the present invention is a compound represented by formula (I) (hereinafter sometimes referred to as compound (I)) or a salt of compound (I).
本発明において、用語「無置換(unsubstituted)」は、母核となる基のみであることを意味する。母核となる基の名称のみで記載しているときは、別段の断りがない限り「無置換」の意味である。
一方、用語「置換(substituted)」は、母核となる基のいずれかの水素原子が、母核と同一または異なる構造の基で置換されていることを意味する。従って、「置換基」は、母核となる基に結合した他の基である。置換基は1個であってもよいし、2個以上であってもよい。2個以上の置換基は同一であってもよいし、異なるものであってもよい。 In the present invention, the term "unsubstituted" means only scaffolding groups. When only the name of the base group is used, it means "unsubstituted" unless otherwise specified.
On the other hand, the term "substituted" means that one of the hydrogen atoms in the scaffold group is replaced with a group having the same or different structure as that of the scaffold. Thus, a "substituent" is another group attached to a scaffold group. The number of substituents may be one, or two or more. Two or more substituents may be the same or different.
一方、用語「置換(substituted)」は、母核となる基のいずれかの水素原子が、母核と同一または異なる構造の基で置換されていることを意味する。従って、「置換基」は、母核となる基に結合した他の基である。置換基は1個であってもよいし、2個以上であってもよい。2個以上の置換基は同一であってもよいし、異なるものであってもよい。 In the present invention, the term "unsubstituted" means only scaffolding groups. When only the name of the base group is used, it means "unsubstituted" unless otherwise specified.
On the other hand, the term "substituted" means that one of the hydrogen atoms in the scaffold group is replaced with a group having the same or different structure as that of the scaffold. Thus, a "substituent" is another group attached to a scaffold group. The number of substituents may be one, or two or more. Two or more substituents may be the same or different.
「置換基」は化学的に許容され、本発明の効果を有する限りにおいて特に制限されない。
「置換基」となり得る基の具体例としては、以下の基を挙げることができる。
フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;
メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;
ビニル基、1-プロペニル基、2-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-メチル-2-プロペニル基、2-メチル-2-プロペニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-メチル-2-ブテニル基、2-メチル-2-ブテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基などのC2~6アルケニル基;
エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-メチル-2-プロピニル基、2-メチル-3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-メチル-2-ブチニル基、2-メチル-3-ペンチニル基、1-ヘキシニル基、1,1-ジメチル-2-ブチニル基などのC2~6アルキニル基; A "substituent" is not particularly limited as long as it is chemically acceptable and has the effects of the present invention.
Specific examples of groups that can serve as "substituents" include the following groups.
Halogeno groups such as fluoro, chloro, bromo and iodo groups;
C1-6 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group alkyl group;
vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group , 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4 -C2-6 alkenyl groups such as hexenyl group and 5-hexenyl group;
ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group , 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, 1,1-dimethyl-2-butynyl group, etc. C2-6 alkynyl group of;
「置換基」となり得る基の具体例としては、以下の基を挙げることができる。
フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;
メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;
ビニル基、1-プロペニル基、2-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-メチル-2-プロペニル基、2-メチル-2-プロペニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-メチル-2-ブテニル基、2-メチル-2-ブテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基などのC2~6アルケニル基;
エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-メチル-2-プロピニル基、2-メチル-3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-メチル-2-ブチニル基、2-メチル-3-ペンチニル基、1-ヘキシニル基、1,1-ジメチル-2-ブチニル基などのC2~6アルキニル基; A "substituent" is not particularly limited as long as it is chemically acceptable and has the effects of the present invention.
Specific examples of groups that can serve as "substituents" include the following groups.
Halogeno groups such as fluoro, chloro, bromo and iodo groups;
C1-6 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group alkyl group;
vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group , 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4 -C2-6 alkenyl groups such as hexenyl group and 5-hexenyl group;
ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group , 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, 1,1-dimethyl-2-butynyl group, etc. C2-6 alkynyl group of;
シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;
2-シクロプロペニル基、2-シクロペンテニル基、3-シクロヘキセニル基などのC3~6シクロアルケニル基;
フェニル基、ナフチル基などのC6~10アリール基;
ベンジル基、フェネチル基などのC6~10アリールC1~6アルキル基;
3~6員環のヘテロシクリル基;
3~6員環のへテロシクリルC1~6アルキル基; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group;
2-cyclopropenyl group, 2-cyclopentenyl group, C3-6 cycloalkenyl group such as 3-cyclohexenyl group;
C6-10 aryl group such as phenyl group and naphthyl group;
C6-10 aryl C1-6 alkyl groups such as benzyl group and phenethyl group;
3- to 6-membered heterocyclyl group;
3- to 6-membered heterocyclyl C1-6 alkyl group;
2-シクロプロペニル基、2-シクロペンテニル基、3-シクロヘキセニル基などのC3~6シクロアルケニル基;
フェニル基、ナフチル基などのC6~10アリール基;
ベンジル基、フェネチル基などのC6~10アリールC1~6アルキル基;
3~6員環のヘテロシクリル基;
3~6員環のへテロシクリルC1~6アルキル基; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group;
2-cyclopropenyl group, 2-cyclopentenyl group, C3-6 cycloalkenyl group such as 3-cyclohexenyl group;
C6-10 aryl group such as phenyl group and naphthyl group;
C6-10 aryl C1-6 alkyl groups such as benzyl group and phenethyl group;
3- to 6-membered heterocyclyl group;
3- to 6-membered heterocyclyl C1-6 alkyl group;
水酸基;
メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;
ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などのC2~6アルケニルオキシ基;
エチニルオキシ基、プロパルギルオキシ基などのC2~6アルキニルオキシ基;
フェノキシ基、ナフトキシ基などのC6~10アリールオキシ基;
ベンジルオキシ基、フェネチルオキシ基などのC6~10アリールC1~6アルコキシ基; hydroxyl group;
C1-6 alkoxy groups such as methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, s-butoxy, i-butoxy and t-butoxy;
C2-6 alkenyloxy groups such as a vinyloxy group, an allyloxy group, a propenyloxy group, and a butenyloxy group;
C2-6 alkynyloxy groups such as an ethynyloxy group and a propargyloxy group;
C6-10 aryloxy groups such as phenoxy group and naphthoxy group;
C6-10 aryl C1-6 alkoxy groups such as benzyloxy group and phenethyloxy group;
メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;
ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などのC2~6アルケニルオキシ基;
エチニルオキシ基、プロパルギルオキシ基などのC2~6アルキニルオキシ基;
フェノキシ基、ナフトキシ基などのC6~10アリールオキシ基;
ベンジルオキシ基、フェネチルオキシ基などのC6~10アリールC1~6アルコキシ基; hydroxyl group;
C1-6 alkoxy groups such as methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, s-butoxy, i-butoxy and t-butoxy;
C2-6 alkenyloxy groups such as a vinyloxy group, an allyloxy group, a propenyloxy group, and a butenyloxy group;
C2-6 alkynyloxy groups such as an ethynyloxy group and a propargyloxy group;
C6-10 aryloxy groups such as phenoxy group and naphthoxy group;
C6-10 aryl C1-6 alkoxy groups such as benzyloxy group and phenethyloxy group;
カルボキシ基;
ホルミル基;
アセチル基、プロピオニル基などのC1~6アルキルカルボニル基;
ホルミルオキシ基;
アセチルオキシ基、プロピオニルオキシ基などのC1~6アルキルカルボニルオキシ基;
メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基、n-ブトキシカルボニル基、t-ブトキシカルボニル基などのC1~6アルコキシカルボニル基; carboxy group;
formyl group;
C1-6 alkylcarbonyl groups such as acetyl group and propionyl group;
formyloxy group;
C1-6 alkylcarbonyloxy groups such as an acetyloxy group and a propionyloxy group;
Methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, C1-6 alkoxycarbonyl group such as t-butoxycarbonyl group;
ホルミル基;
アセチル基、プロピオニル基などのC1~6アルキルカルボニル基;
ホルミルオキシ基;
アセチルオキシ基、プロピオニルオキシ基などのC1~6アルキルカルボニルオキシ基;
メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基、n-ブトキシカルボニル基、t-ブトキシカルボニル基などのC1~6アルコキシカルボニル基; carboxy group;
formyl group;
C1-6 alkylcarbonyl groups such as acetyl group and propionyl group;
formyloxy group;
C1-6 alkylcarbonyloxy groups such as an acetyloxy group and a propionyloxy group;
Methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, C1-6 alkoxycarbonyl group such as t-butoxycarbonyl group;
クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基、パーフルオロ-n-ペンチル基などのC1~6ハロアルキル基;
2-クロロ-1-プロペニル基、2-フルオロ-1-ブテニル基などのC2~6ハロアルケニル基;
4,4-ジクロロ-1-ブチニル基、4-フルオロ-1-ペンチニル基、5-ブロモ-2-ペンチニル基などのC2~6ハロアルキニル基;
3,3-ジフルオロシクロブチル基などのC3~6ハロシクロアルキル基;
2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基、2,2,2-トリフルオロエトキシ基などのC1~6ハロアルコキシ基;
2-クロロプロペニルオキシ基、3-ブロモブテニルオキシ基などのC2~6ハロアルケニルオキシ基;
クロロアセチル基、トリフルオロアセチル基、トリクロロアセチル基などのC1~6ハロアルキルカルボニル基; C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, perfluoro-n-pentyl group;
C2-6 haloalkenyl groups such as 2-chloro-1-propenyl group and 2-fluoro-1-butenyl group;
C2-6 haloalkynyl groups such as 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, 5-bromo-2-pentynyl group;
C3-6 halocycloalkyl groups such as 3,3-difluorocyclobutyl groups;
C1-6 haloalkoxy groups such as 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, 2,2,2-trifluoroethoxy group;
C2-6 haloalkenyloxy groups such as 2-chloropropenyloxy group and 3-bromobutenyloxy group;
C1-6 haloalkylcarbonyl groups such as chloroacetyl group, trifluoroacetyl group and trichloroacetyl group;
2-クロロ-1-プロペニル基、2-フルオロ-1-ブテニル基などのC2~6ハロアルケニル基;
4,4-ジクロロ-1-ブチニル基、4-フルオロ-1-ペンチニル基、5-ブロモ-2-ペンチニル基などのC2~6ハロアルキニル基;
3,3-ジフルオロシクロブチル基などのC3~6ハロシクロアルキル基;
2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基、2,2,2-トリフルオロエトキシ基などのC1~6ハロアルコキシ基;
2-クロロプロペニルオキシ基、3-ブロモブテニルオキシ基などのC2~6ハロアルケニルオキシ基;
クロロアセチル基、トリフルオロアセチル基、トリクロロアセチル基などのC1~6ハロアルキルカルボニル基; C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, perfluoro-n-pentyl group;
C2-6 haloalkenyl groups such as 2-chloro-1-propenyl group and 2-fluoro-1-butenyl group;
C2-6 haloalkynyl groups such as 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, 5-bromo-2-pentynyl group;
C3-6 halocycloalkyl groups such as 3,3-difluorocyclobutyl groups;
C1-6 haloalkoxy groups such as 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, 2,2,2-trifluoroethoxy group;
C2-6 haloalkenyloxy groups such as 2-chloropropenyloxy group and 3-bromobutenyloxy group;
C1-6 haloalkylcarbonyl groups such as chloroacetyl group, trifluoroacetyl group and trichloroacetyl group;
アミノ基;
メチルアミノ基、ジメチルアミノ基、ジエチルアミノ基などのC1~6アルキル置換アミノ基;
アニリノ基、ナフチルアミノ基などのC6~10アリールアミノ基;
ベンジルアミノ基、フェネチルアミノ基などのC6~10アリールC1~6アルキルアミノ基; amino group;
C1-6 alkyl-substituted amino groups such as methylamino group, dimethylamino group and diethylamino group;
C6-10 arylamino groups such as anilino group and naphthylamino group;
C6-10 aryl C1-6 alkylamino groups such as benzylamino group and phenethylamino group;
メチルアミノ基、ジメチルアミノ基、ジエチルアミノ基などのC1~6アルキル置換アミノ基;
アニリノ基、ナフチルアミノ基などのC6~10アリールアミノ基;
ベンジルアミノ基、フェネチルアミノ基などのC6~10アリールC1~6アルキルアミノ基; amino group;
C1-6 alkyl-substituted amino groups such as methylamino group, dimethylamino group and diethylamino group;
C6-10 arylamino groups such as anilino group and naphthylamino group;
C6-10 aryl C1-6 alkylamino groups such as benzylamino group and phenethylamino group;
ホルミルアミノ基;
アセチルアミノ基、プロピオニルアミノ基、ブチリルアミノ基、i-プロピルカルボニルアミノ基などのC1~6アルキルカルボニルアミノ基;
メトキシカルボニルアミノ基、エトキシカルボニルアミノ基、n-プロポキシカルボニルアミノ基、i-プロポキシカルボニルアミノ基などのC1~6アルコキシカルボニルアミノ基;
カルバモイル基、ジメチルアミノカルボニル基、フェニルアミノカルボニル基、N-フェニル-N-メチルアミノカルボニル基などの無置換若しくは置換基を有するアミノカルボニル基;
イミノメチル基、(1-イミノ)エチル基、(1-イミノ)-n-プロピル基などのイミノC1~6アルキル基;
N-ヒドロキシ-イミノメチル基、(1-(N-ヒドロキシ)-イミノ)エチル基、(1-(N-ヒドロキシ)-イミノ)プロピル基、N-メトキシ-イミノメチル基、(1-(N-メトキシ)-イミノ)エチル基などの置換若しくは無置換のN-ヒドロキシイミノC1~6アルキル基;
アミノカルボニルオキシ基;
エチルアミノカルボニルオキシ基、ジメチルアミノカルボニルオキシ基などのC1~6アルキル置換アミノカルボニルオキシ基; formylamino group;
C1-6 alkylcarbonylamino groups such as acetylamino group, propionylamino group, butyrylamino group, i-propylcarbonylamino group;
C1-6 alkoxycarbonylamino groups such as methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, i-propoxycarbonylamino group;
unsubstituted or substituted aminocarbonyl group such as carbamoyl group, dimethylaminocarbonyl group, phenylaminocarbonyl group, N-phenyl-N-methylaminocarbonyl group;
imino C1-6 alkyl groups such as iminomethyl group, (1-imino)ethyl group, (1-imino)-n-propyl group;
N-hydroxy-iminomethyl group, (1-(N-hydroxy)-imino)ethyl group, (1-(N-hydroxy)-imino)propyl group, N-methoxy-iminomethyl group, (1-(N-methoxy) -imino) substituted or unsubstituted N-hydroxyimino C1-6 alkyl groups such as ethyl groups;
aminocarbonyloxy group;
C1-6 alkyl-substituted aminocarbonyloxy groups such as an ethylaminocarbonyloxy group and a dimethylaminocarbonyloxy group;
アセチルアミノ基、プロピオニルアミノ基、ブチリルアミノ基、i-プロピルカルボニルアミノ基などのC1~6アルキルカルボニルアミノ基;
メトキシカルボニルアミノ基、エトキシカルボニルアミノ基、n-プロポキシカルボニルアミノ基、i-プロポキシカルボニルアミノ基などのC1~6アルコキシカルボニルアミノ基;
カルバモイル基、ジメチルアミノカルボニル基、フェニルアミノカルボニル基、N-フェニル-N-メチルアミノカルボニル基などの無置換若しくは置換基を有するアミノカルボニル基;
イミノメチル基、(1-イミノ)エチル基、(1-イミノ)-n-プロピル基などのイミノC1~6アルキル基;
N-ヒドロキシ-イミノメチル基、(1-(N-ヒドロキシ)-イミノ)エチル基、(1-(N-ヒドロキシ)-イミノ)プロピル基、N-メトキシ-イミノメチル基、(1-(N-メトキシ)-イミノ)エチル基などの置換若しくは無置換のN-ヒドロキシイミノC1~6アルキル基;
アミノカルボニルオキシ基;
エチルアミノカルボニルオキシ基、ジメチルアミノカルボニルオキシ基などのC1~6アルキル置換アミノカルボニルオキシ基; formylamino group;
C1-6 alkylcarbonylamino groups such as acetylamino group, propionylamino group, butyrylamino group, i-propylcarbonylamino group;
C1-6 alkoxycarbonylamino groups such as methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, i-propoxycarbonylamino group;
unsubstituted or substituted aminocarbonyl group such as carbamoyl group, dimethylaminocarbonyl group, phenylaminocarbonyl group, N-phenyl-N-methylaminocarbonyl group;
imino C1-6 alkyl groups such as iminomethyl group, (1-imino)ethyl group, (1-imino)-n-propyl group;
N-hydroxy-iminomethyl group, (1-(N-hydroxy)-imino)ethyl group, (1-(N-hydroxy)-imino)propyl group, N-methoxy-iminomethyl group, (1-(N-methoxy) -imino) substituted or unsubstituted N-hydroxyimino C1-6 alkyl groups such as ethyl groups;
aminocarbonyloxy group;
C1-6 alkyl-substituted aminocarbonyloxy groups such as an ethylaminocarbonyloxy group and a dimethylaminocarbonyloxy group;
メルカプト基;
メチルチオ基、エチルチオ基、n-プロピルチオ基、i-プロピルチオ基、n-ブチルチオ基、i-ブチルチオ基、s-ブチルチオ基、t-ブチルチオ基などのC1~6アルキルチオ基;
トリフルオロメチルチオ基、2,2,2-トリフルオロエチルチオ基などのC1~6ハロアルキルチオ基;
ビニルチオ基、アリルチオ基などのC2~6アルケニルチオ基;
エチニルチオ基、プロパルギルチオ基などのC2~6アルキニルチオ基;
メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基などのC1~6アルキルスルフィニル基;
トリフルオロメチルスルフィニル基、2,2,2-トリフルオロエチルスルフィニル基などのC1~6ハロアルキルスルフィニル基;
アリルスルフィニル基などのC2~6アルケニルスルフィニル基;
プロパルギルスルフィニル基などのC2~6アルキニルスルフィニル基;
メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基などのC1~6アルキルスルホニル基;
トリフルオロメチルスルホニル基、2,2,2-トリフルオロエチルスルホニル基などのC1~6ハロアルキルスルホニル基;
アリルスルホニル基などのC2~6アルケニルスルホニル基;
プロパルギルスルホニル基などのC2~6アルキニルスルホニル基;
アミノチオカルボニル基;
S,S-ジメチルスルホキシイミノ基などのC1~6アルキルスルホキシイミノ基; mercapto group;
C1-6 alkylthio groups such as methylthio, ethylthio, n-propylthio, i-propylthio, n-butylthio, i-butylthio, s-butylthio and t-butylthio;
C1-6 haloalkylthio groups such as a trifluoromethylthio group and a 2,2,2-trifluoroethylthio group;
C2-6 alkenylthio groups such as a vinylthio group and an allylthio group;
C2-6 alkynylthio groups such as ethynylthio group and propargylthio group;
C1-6 alkylsulfinyl groups such as a methylsulfinyl group, an ethylsulfinyl group and a t-butylsulfinyl group;
C1-6 haloalkylsulfinyl groups such as a trifluoromethylsulfinyl group and a 2,2,2-trifluoroethylsulfinyl group;
C2-6 alkenylsulfinyl groups such as allylsulfinyl groups;
C2-6 alkynylsulfinyl groups such as propargylsulfinyl groups;
C1-6 alkylsulfonyl groups such as a methylsulfonyl group, an ethylsulfonyl group, and a t-butylsulfonyl group;
C1-6 haloalkylsulfonyl groups such as a trifluoromethylsulfonyl group and a 2,2,2-trifluoroethylsulfonyl group;
C2-6 alkenylsulfonyl groups such as allylsulfonyl groups;
C2-6 alkynylsulfonyl groups such as propargylsulfonyl groups;
aminothiocarbonyl group;
C1-6 alkylsulfoxyimino groups such as S,S-dimethylsulfoxyimino groups;
メチルチオ基、エチルチオ基、n-プロピルチオ基、i-プロピルチオ基、n-ブチルチオ基、i-ブチルチオ基、s-ブチルチオ基、t-ブチルチオ基などのC1~6アルキルチオ基;
トリフルオロメチルチオ基、2,2,2-トリフルオロエチルチオ基などのC1~6ハロアルキルチオ基;
ビニルチオ基、アリルチオ基などのC2~6アルケニルチオ基;
エチニルチオ基、プロパルギルチオ基などのC2~6アルキニルチオ基;
メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基などのC1~6アルキルスルフィニル基;
トリフルオロメチルスルフィニル基、2,2,2-トリフルオロエチルスルフィニル基などのC1~6ハロアルキルスルフィニル基;
アリルスルフィニル基などのC2~6アルケニルスルフィニル基;
プロパルギルスルフィニル基などのC2~6アルキニルスルフィニル基;
メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基などのC1~6アルキルスルホニル基;
トリフルオロメチルスルホニル基、2,2,2-トリフルオロエチルスルホニル基などのC1~6ハロアルキルスルホニル基;
アリルスルホニル基などのC2~6アルケニルスルホニル基;
プロパルギルスルホニル基などのC2~6アルキニルスルホニル基;
アミノチオカルボニル基;
S,S-ジメチルスルホキシイミノ基などのC1~6アルキルスルホキシイミノ基; mercapto group;
C1-6 alkylthio groups such as methylthio, ethylthio, n-propylthio, i-propylthio, n-butylthio, i-butylthio, s-butylthio and t-butylthio;
C1-6 haloalkylthio groups such as a trifluoromethylthio group and a 2,2,2-trifluoroethylthio group;
C2-6 alkenylthio groups such as a vinylthio group and an allylthio group;
C2-6 alkynylthio groups such as ethynylthio group and propargylthio group;
C1-6 alkylsulfinyl groups such as a methylsulfinyl group, an ethylsulfinyl group and a t-butylsulfinyl group;
C1-6 haloalkylsulfinyl groups such as a trifluoromethylsulfinyl group and a 2,2,2-trifluoroethylsulfinyl group;
C2-6 alkenylsulfinyl groups such as allylsulfinyl groups;
C2-6 alkynylsulfinyl groups such as propargylsulfinyl groups;
C1-6 alkylsulfonyl groups such as a methylsulfonyl group, an ethylsulfonyl group, and a t-butylsulfonyl group;
C1-6 haloalkylsulfonyl groups such as a trifluoromethylsulfonyl group and a 2,2,2-trifluoroethylsulfonyl group;
C2-6 alkenylsulfonyl groups such as allylsulfonyl groups;
C2-6 alkynylsulfonyl groups such as propargylsulfonyl groups;
aminothiocarbonyl group;
C1-6 alkylsulfoxyimino groups such as S,S-dimethylsulfoxyimino groups;
トリメチルシリル基、トリエチルシリル基、t-ブチルジメチルシリル基などのトリC1~6アルキル置換シリル基;
トリフェニルシリル基などのトリC6~10アリール置換シリル基;
シアノ基;
ニトロ基; tri-C1-6 alkyl-substituted silyl groups such as trimethylsilyl group, triethylsilyl group and t-butyldimethylsilyl group;
tri-C6-10 aryl-substituted silyl groups such as triphenylsilyl groups;
cyano group;
nitro group;
トリフェニルシリル基などのトリC6~10アリール置換シリル基;
シアノ基;
ニトロ基; tri-C1-6 alkyl-substituted silyl groups such as trimethylsilyl group, triethylsilyl group and t-butyldimethylsilyl group;
tri-C6-10 aryl-substituted silyl groups such as triphenylsilyl groups;
cyano group;
nitro group;
「C1~6」などの用語は、母核となる基の炭素原子数が1~6個などであることを表している。この炭素原子数には、置換基の中に在る炭素原子の数を含まない。例えば、エトキシブチル基は、母核となる基がブチル基であり、置換基がエトキシ基であるので、C2アルコキシC4アルキル基に分類する。
A term such as "C1-6" indicates that the number of carbon atoms in the group serving as the mother nucleus is 1-6. This number of carbon atoms does not include the number of carbon atoms in substituent groups. For example, an ethoxybutyl group is classified as a C2 alkoxy C4 alkyl group because the base group is a butyl group and the substituent is an ethoxy group.
また、上記の「3~6員環のヘテロシクリル基」とは、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1~4個のヘテロ原子を環の構成原子として含む。「3~6員環のヘテロシクリル基」としては、3~6員環の飽和ヘテロシクリル基、5~6員環のヘテロアリール基、5~6員環の部分不飽和ヘテロシクリル基などを挙げることができる。
In addition, the above-mentioned "3- to 6-membered heterocyclyl group" contains 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur atoms as ring-constituting atoms. The "3- to 6-membered heterocyclyl group" includes a 3- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
3~6員環の飽和ヘテロシクリル基としては、アジリジニル基、エポキシ基、アゼチジニル基、オキセタニル基、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, A dioxolanyl group, a dioxanyl group and the like can be mentioned.
5員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などを挙げることができる。
6員環のヘテロアリール基としては、ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などを挙げることができる。
5員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などを挙げることができる。
6員環の部分不飽和ヘテロシクリル基としては、ジヒドロピラニル基などを挙げることができる。
これらの「置換基」は、当該置換基中のいずれかの水素原子が、異なる構造の基で置換されていてもよい。 Five-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. can be mentioned.
A pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, etc. can be mentioned as a 6-membered heteroaryl group.
Examples of the 5-membered partially unsaturated heterocyclyl group include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, and isoxazolinyl groups.
Examples of the 6-membered partially unsaturated heterocyclyl group include a dihydropyranyl group.
Any hydrogen atom in these "substituents" may be substituted with a group having a different structure.
6員環のヘテロアリール基としては、ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などを挙げることができる。
5員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などを挙げることができる。
6員環の部分不飽和ヘテロシクリル基としては、ジヒドロピラニル基などを挙げることができる。
これらの「置換基」は、当該置換基中のいずれかの水素原子が、異なる構造の基で置換されていてもよい。 Five-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. can be mentioned.
A pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, etc. can be mentioned as a 6-membered heteroaryl group.
Examples of the 5-membered partially unsaturated heterocyclyl group include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, and isoxazolinyl groups.
Examples of the 6-membered partially unsaturated heterocyclyl group include a dihydropyranyl group.
Any hydrogen atom in these "substituents" may be substituted with a group having a different structure.
〔Y〕
Yは、酸素原子または硫黄原子を示す。
本発明においては、好ましいYは酸素原子である。 [Y]
Y represents an oxygen atom or a sulfur atom.
In the present invention, Y is preferably an oxygen atom.
Yは、酸素原子または硫黄原子を示す。
本発明においては、好ましいYは酸素原子である。 [Y]
Y represents an oxygen atom or a sulfur atom.
In the present invention, Y is preferably an oxygen atom.
〔X1およびX2〕
X1およびX2は、それぞれ独立に、水素原子、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の5~6員環のヘテロシクリル基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、R1-CO-で表される基、カルボキシ基、R2-O-CO-で表される基、R3R4N-で表される基、R3R4N-CO-で表される基、R1-CO-O-で表される基、R1-CO-NR5-で表される基、R2-O-CO-O-で表される基、R2-O-CO-NR5-で表される基、R3R4N-CO-O-で表される基、R3R4N-CO-NR5-で表される基、R2SO2-NR5-で表される基、R3R4N-SO2-で表される基、R1O-N=CR6-で表される基、R3R4N-N=CR6-で表される基、またはR1-N=CR6-で表される基を示す。 [X 1 and X 2 ]
X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6- 10 arylsulfonyl group, substituted or unsubstituted 5- to 6-membered heterocyclyl group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, nitro group, cyano group, group represented by R 1 -CO- , a carboxy group, a group represented by R 2 —O—CO—, a group represented by R 3 R 4 N—, a group represented by R 3 R 4 N—CO—, R 1 —CO—O— a group represented by R 1 -CO-NR 5 -, a group R 2 -O-CO-O-, a group R 2 -O-CO-NR 5 - , a group represented by R 3 R 4 N—CO—O—, a group represented by R 3 R 4 N—CO—NR 5 —, a group represented by R 2 SO 2 —NR 5 —, R 3 a group represented by R 4 N--SO 2 --, a group represented by R 1 ON=CR 6 --, a group represented by R 3 R 4 N--N=CR 6 --, or R 1 --N =CR 6 - represents a group.
X1およびX2は、それぞれ独立に、水素原子、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の5~6員環のヘテロシクリル基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、R1-CO-で表される基、カルボキシ基、R2-O-CO-で表される基、R3R4N-で表される基、R3R4N-CO-で表される基、R1-CO-O-で表される基、R1-CO-NR5-で表される基、R2-O-CO-O-で表される基、R2-O-CO-NR5-で表される基、R3R4N-CO-O-で表される基、R3R4N-CO-NR5-で表される基、R2SO2-NR5-で表される基、R3R4N-SO2-で表される基、R1O-N=CR6-で表される基、R3R4N-N=CR6-で表される基、またはR1-N=CR6-で表される基を示す。 [X 1 and X 2 ]
X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6- 10 arylsulfonyl group, substituted or unsubstituted 5- to 6-membered heterocyclyl group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, nitro group, cyano group, group represented by R 1 -CO- , a carboxy group, a group represented by R 2 —O—CO—, a group represented by R 3 R 4 N—, a group represented by R 3 R 4 N—CO—, R 1 —CO—O— a group represented by R 1 -CO-NR 5 -, a group R 2 -O-CO-O-, a group R 2 -O-CO-NR 5 - , a group represented by R 3 R 4 N—CO—O—, a group represented by R 3 R 4 N—CO—NR 5 —, a group represented by R 2 SO 2 —NR 5 —, R 3 a group represented by R 4 N--SO 2 --, a group represented by R 1 ON=CR 6 --, a group represented by R 3 R 4 N--N=CR 6 --, or R 1 --N =CR 6 - represents a group.
R1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
R2は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
R3は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
R4は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
ここで、R3とR4は、一緒になって二価の有機基を形成してもよい。
R5は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。 R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo It represents an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Here, R 3 and R 4 may together form a divalent organic group.
Each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted It represents a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
R2は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
R3は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
R4は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
ここで、R3とR4は、一緒になって二価の有機基を形成してもよい。
R5は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。 R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo It represents an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Here, R 3 and R 4 may together form a divalent organic group.
Each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted It represents a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
X1、およびX2における「ハロゲノ基」としては、フルオロ基、クロロ基、ブロモ基、イオド基などを挙げることができる。
Examples of the “halogeno group” for X 1 and X 2 include a fluoro group, a chloro group, a bromo group and an iodine group.
X1およびX2における「C1~6アルキル基」は、直鎖であってもよいし、分岐鎖であってもよい。X1における「C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、i-ヘキシル基などを挙げることができる。
The “C1-6 alkyl group” for X 1 and X 2 may be linear or branched. The "C1-6 alkyl group" for X 1 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
X1およびX2における「C2~6アルケニル基」としては、ビニル基、1-プロペニル基、2-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-メチル-2-プロペニル基、2-メチル-2-プロペニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-メチル-2-ブテニル基、2-メチル-2-ブテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基などを挙げることができる。
The "C2-6 alkenyl group" for X 1 and X 2 includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2- propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group and the like can be mentioned.
X1およびX2における「C2~6アルキニル基」としては、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-メチル-2-プロピニル基、2-メチル-3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-メチル-2-ブチニル基、2-メチル-3-ペンチニル基、1-ヘキシニル基、1,1-ジメチル-2-ブチニル基などを挙げることができる。
The "C2-6 alkynyl group" for X 1 and X 2 includes an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2- propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, 1,1-dimethyl-2-butynyl group and the like can be mentioned.
X1およびX2における「C1~6アルコキシ基」としては、メトキシ基、エトキシ基、n-プロポキシ基、n-ブトキシ基、n-ペンチルオキシ基、n-ヘキシルオキシ基、i-プロポキシ基、i-ブトキシ基、s-ブトキシ基、t-ブトキシ基、i-ヘキシルオキシ基などを挙げることができる。
X1およびX2における「C2~6アルケニルオキシ基」としては、ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などを挙げることができる。
X1およびX2における「C2~6アルキニルオキシ基」としては、エチニルオキシ基、プロパルギルオキシ基などを挙げることができる。 The "C1-6 alkoxy group" for X 1 and X 2 includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, i -butoxy group, s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
Examples of the “C2-6 alkenyloxy group” for X 1 and X 2 include vinyloxy, allyloxy, propenyloxy, butenyloxy and the like.
Examples of the “C2-6 alkynyloxy group” for X 1 and X 2 include an ethynyloxy group and a propargyloxy group.
X1およびX2における「C2~6アルケニルオキシ基」としては、ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などを挙げることができる。
X1およびX2における「C2~6アルキニルオキシ基」としては、エチニルオキシ基、プロパルギルオキシ基などを挙げることができる。 The "C1-6 alkoxy group" for X 1 and X 2 includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, i -butoxy group, s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
Examples of the “C2-6 alkenyloxy group” for X 1 and X 2 include vinyloxy, allyloxy, propenyloxy, butenyloxy and the like.
Examples of the “C2-6 alkynyloxy group” for X 1 and X 2 include an ethynyloxy group and a propargyloxy group.
X1およびX2における「C1~6アルキルチオ基」としては、メチルチオ基、エチルチオ基、n-プロピルチオ基、n-ブチルチオ基、n-ペンチルチオ基、n-ヘキシルチオ基、i-プロピルチオ基などを挙げることができる。
X1およびX2における「C1~6アルキルスルフィニル基」としては、メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基などを挙げることができる。
X1およびX2における「C1~6アルキルスルホニル基」としては、メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基などを挙げることができる。 Examples of the "C1-6 alkylthio group" for X 1 and X 2 include a methylthio group, an ethylthio group, an n-propylthio group, an n-butylthio group, an n-pentylthio group, an n-hexylthio group, and an i-propylthio group. can be done.
Examples of the “C1-6 alkylsulfinyl group” for X 1 and X 2 include methylsulfinyl group, ethylsulfinyl group, t-butylsulfinyl group and the like.
Examples of the “C1-6 alkylsulfonyl group” for X 1 and X 2 include methylsulfonyl group, ethylsulfonyl group, t-butylsulfonyl group and the like.
X1およびX2における「C1~6アルキルスルフィニル基」としては、メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基などを挙げることができる。
X1およびX2における「C1~6アルキルスルホニル基」としては、メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基などを挙げることができる。 Examples of the "C1-6 alkylthio group" for X 1 and X 2 include a methylthio group, an ethylthio group, an n-propylthio group, an n-butylthio group, an n-pentylthio group, an n-hexylthio group, and an i-propylthio group. can be done.
Examples of the “C1-6 alkylsulfinyl group” for X 1 and X 2 include methylsulfinyl group, ethylsulfinyl group, t-butylsulfinyl group and the like.
Examples of the “C1-6 alkylsulfonyl group” for X 1 and X 2 include methylsulfonyl group, ethylsulfonyl group, t-butylsulfonyl group and the like.
X1およびX2における「C1~6アルキル基」、「C2~6アルケニル基」、「C2~6アルキニル基」、「C1~6アルコキシ基」、「C2~6アルケニルオキシ基」、「C2~6アルキニルオキシ基」、「C1~6アルキルチオ基」、「C1~6アルキルスルフィニル基」、または「C1~6アルキルスルホニル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;(エチリデンアミノ)オキシ基、プロパン-2-イリデンアミノ)オキシ基などの(C1~6アルキリデンアミノ)オキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。
"C1-6 alkyl group", " C2-6 alkenyl group", "C2-6 alkynyl group", "C1-6 alkoxy group", "C2-6 alkenyloxy group", " C2- 6 alkynyloxy group", "C1-6 alkylthio group", "C1-6 alkylsulfinyl group" or "C1-6 alkylsulfonyl group" as substituents include fluoro group, chloro group, bromo group, iodo group Halogeno groups such as; hydroxyl group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, C1 ~ 6 haloalkoxy group such as trifluoromethoxy group; 6 alkylideneamino)oxy group; cyclopropyl group, cyclobutyl group, cyclopentyl group, C3-6 cycloalkyl group such as cyclohexyl group; phenyl group, C6-10 aryl group such as naphthyl group; 4-methylphenyl group, 4-methoxy C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 such as phenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, etc. C6-10 aryl group substituted with any one or more substituents of 6 haloalkoxy groups; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl 5-membered ring heteroaryl group such as group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 5-membered heteroaryl group substituted with one or more substituents; 6-membered heteroaryl group such as pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group; C1-6 alkyl group, C1-6 A 6-membered heteroaryl group substituted with one or more substituents selected from an alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or a cyano group is preferred.
X1およびX2における「C3~6シクロアルキル基」としては、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などを挙げることができる。
X1およびX2における「C3~6シクロアルキルオキシ基」としては、シクロプロピルオキシ基、シクロブチルオキシ基、シクロペンチルオキシ基、シクロヘキシルオキシ基などを挙げることができる。 Examples of the “C3-6 cycloalkyl group” for X 1 and X 2 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
Examples of the “C3-6 cycloalkyloxy group” for X 1 and X 2 include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group and the like.
X1およびX2における「C3~6シクロアルキルオキシ基」としては、シクロプロピルオキシ基、シクロブチルオキシ基、シクロペンチルオキシ基、シクロヘキシルオキシ基などを挙げることができる。 Examples of the “C3-6 cycloalkyl group” for X 1 and X 2 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
Examples of the “C3-6 cycloalkyloxy group” for X 1 and X 2 include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group and the like.
X1およびX2における「C6~10アリール基」としては、フェニル基、ナフチル基、インダニル基、インデニル基、テトラリニル基、などを挙げることができる。
X1およびX2における「C6~10アリールオキシ基」としては、フェノキシ基、ナフトキシ基などを挙げることができる。 Examples of the “C6-10 aryl group” for X 1 and X 2 include phenyl group, naphthyl group, indanyl group, indenyl group, tetralinyl group, and the like.
Examples of the “C6-10 aryloxy group” for X 1 and X 2 include a phenoxy group and a naphthoxy group.
X1およびX2における「C6~10アリールオキシ基」としては、フェノキシ基、ナフトキシ基などを挙げることができる。 Examples of the “C6-10 aryl group” for X 1 and X 2 include phenyl group, naphthyl group, indanyl group, indenyl group, tetralinyl group, and the like.
Examples of the “C6-10 aryloxy group” for X 1 and X 2 include a phenoxy group and a naphthoxy group.
X1およびX2における「C6~10アリールチオ基」としては、フェニルチオ基、ナフチルチオ基などを挙げることができる。
X1およびX2における「C6~10アリールスルフィニル基」としては、フェニルスルフィニル基、ナフチルスルフィニル基などを挙げることができる。
X1およびX2における「C6~10アリールスルホニル基」としては、フェニルスルホニル基、ナフチルスルホニル基などを挙げることができる。 Examples of the “C6-10 arylthio group” for X 1 and X 2 include a phenylthio group and a naphthylthio group.
Examples of the “C6-10 arylsulfinyl group” for X 1 and X 2 include a phenylsulfinyl group and a naphthylsulfinyl group.
Examples of the “C6-10 arylsulfonyl group” for X 1 and X 2 include a phenylsulfonyl group and a naphthylsulfonyl group.
X1およびX2における「C6~10アリールスルフィニル基」としては、フェニルスルフィニル基、ナフチルスルフィニル基などを挙げることができる。
X1およびX2における「C6~10アリールスルホニル基」としては、フェニルスルホニル基、ナフチルスルホニル基などを挙げることができる。 Examples of the “C6-10 arylthio group” for X 1 and X 2 include a phenylthio group and a naphthylthio group.
Examples of the “C6-10 arylsulfinyl group” for X 1 and X 2 include a phenylsulfinyl group and a naphthylsulfinyl group.
Examples of the “C6-10 arylsulfonyl group” for X 1 and X 2 include a phenylsulfonyl group and a naphthylsulfonyl group.
X1およびX2における「5~6員環のヘテロシクリル基」とは、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1、2、3または4個のヘテロ原子を環の構成原子として含む基である。ヘテロ原子が2個以上であるとき、それらは同じでもよいし、異なってもよい。「5~6員環のヘテロシクリル基」としては、5~6員環の飽和ヘテロシクリル基、5~6員環のヘテロアリール基、5~6員環の部分不飽和ヘテロシクリル基などを挙げることができる。
The “5- to 6-membered heterocyclyl group” for X 1 and X 2 has 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. is a group containing When there are two or more heteroatoms, they may be the same or different. Examples of the "5- to 6-membered heterocyclyl group" include a 5- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
5~6員環の飽和ヘテロシクリル基としては、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
5~6員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基を挙げることができる。
5~6員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基を挙げることができる。 Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. and 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
Examples of 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, and isoxazolinyl 5-membered partially unsaturated heterocyclyl groups; dihydro Six-membered partially unsaturated heterocyclyl groups such as pyranyl groups can be mentioned.
5~6員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基を挙げることができる。
5~6員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基を挙げることができる。 Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. and 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
Examples of 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, and isoxazolinyl 5-membered partially unsaturated heterocyclyl groups; dihydro Six-membered partially unsaturated heterocyclyl groups such as pyranyl groups can be mentioned.
X1およびX2における「5~6員環のヘテロシクリルオキシ基」は、5~6員環のヘテロシクリル基とオキシ基が結合した構造を有する。具体例としては、チアゾリルオキシ基、ピリジルオキシ基などを挙げることができる。
The “5- to 6-membered heterocyclyloxy group” for X 1 and X 2 has a structure in which a 5- to 6-membered heterocyclyl group and an oxy group are bonded. Specific examples include a thiazolyloxy group and a pyridyloxy group.
X1およびX2における「C3~6シクロアルキル基」、「C3~6シクロアルキルオキシ基」、「C6~10アリール基」、「C6~10アリールオキシ基」、「C6~10アリールチオ基」、「C6~10アリールスルフィニル基」、「C6~10アリールスルホニル基」、「5~6員環のヘテロシクリル基」、または「5~6員環のヘテロシクリルオキシ基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。
さらに、「C3~6シクロアルキル基」、「C3~6シクロアルキルオキシ基」、「5~6員環のヘテロシクリル基」、または「5~6員環のヘテロシクリルオキシ基」上の置換基としては、オキソ基も好ましい。 "C3-6 cycloalkyl group", "C3-6 cycloalkyloxy group", "C6-10 aryl group", "C6-10 aryloxy group", "C6-10 arylthio group" in X 1 and X 2 , As a substituent on the "C6-10 arylsulfinyl group", "C6-10 arylsulfonyl group", "5- to 6-membered heterocyclyl group", or "5- to 6-membered heterocyclyloxy group", a fluoro group , chloro group, bromo group, halogeno group such as iodine group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, C1-6 alkyl groups such as n-pentyl group and n-hexyl group; chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group and 1-fluoro-n-butyl group C1-6 haloalkyl group; hydroxyl group; C1-6 alkoxy group such as methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group ; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, C1-6 haloalkoxy group such as trifluoromethoxy group; phenyl group, C6-10 aryl group such as naphthyl group; 4-methylphenyl group, C1-6 alkyl groups, C1-6 alkoxy groups, halogeno groups, C1-6 haloalkyl groups such as 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, or a C6-10 aryl group substituted with one or more substituents of any one of C1-6 haloalkoxy groups; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl 5-membered ring heteroaryl group such as group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group A 5-membered heteroaryl group substituted with one or more substituents; a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a 6-membered heteroaryl group such as a triazinyl group; a C1-6 alkyl group, 6-membered substituted with one or more substituents selected from a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group Ring heteroaryl groups; or cyano groups are preferred.
Furthermore, as a substituent on the "C3-6 cycloalkyl group", "C3-6 cycloalkyloxy group", "5- to 6-membered heterocyclyl group", or "5- to 6-membered heterocyclyloxy group" , oxo groups are also preferred.
さらに、「C3~6シクロアルキル基」、「C3~6シクロアルキルオキシ基」、「5~6員環のヘテロシクリル基」、または「5~6員環のヘテロシクリルオキシ基」上の置換基としては、オキソ基も好ましい。 "C3-6 cycloalkyl group", "C3-6 cycloalkyloxy group", "C6-10 aryl group", "C6-10 aryloxy group", "C6-10 arylthio group" in X 1 and X 2 , As a substituent on the "C6-10 arylsulfinyl group", "C6-10 arylsulfonyl group", "5- to 6-membered heterocyclyl group", or "5- to 6-membered heterocyclyloxy group", a fluoro group , chloro group, bromo group, halogeno group such as iodine group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, C1-6 alkyl groups such as n-pentyl group and n-hexyl group; chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group and 1-fluoro-n-butyl group C1-6 haloalkyl group; hydroxyl group; C1-6 alkoxy group such as methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group ; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, C1-6 haloalkoxy group such as trifluoromethoxy group; phenyl group, C6-10 aryl group such as naphthyl group; 4-methylphenyl group, C1-6 alkyl groups, C1-6 alkoxy groups, halogeno groups, C1-6 haloalkyl groups such as 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, or a C6-10 aryl group substituted with one or more substituents of any one of C1-6 haloalkoxy groups; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl 5-membered ring heteroaryl group such as group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group A 5-membered heteroaryl group substituted with one or more substituents; a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a 6-membered heteroaryl group such as a triazinyl group; a C1-6 alkyl group, 6-membered substituted with one or more substituents selected from a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group Ring heteroaryl groups; or cyano groups are preferred.
Furthermore, as a substituent on the "C3-6 cycloalkyl group", "C3-6 cycloalkyloxy group", "5- to 6-membered heterocyclyl group", or "5- to 6-membered heterocyclyloxy group" , oxo groups are also preferred.
X1およびX2における「R1-CO-で表される基」中、R1は、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
In the “group represented by R 1 —CO—” for X 1 and X 2 , R 1 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted Alternatively, it represents an unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
R1における「C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、i-ヘキシル基などを挙げることができる。
R1における「C2~6アルケニル基」としては、ビニル基、1-プロペニル基などを挙げることができる。
R1における「C2~6アルキニル基」としては、エチニル基、1-プロピニル基などを挙げることができる。
R1における「C1~6アルキル基」、「C2~6アルケニル基」、または「C2~6アルキニル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。 The "C1-6 alkyl group" for R 1 includes methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
Examples of the “C2-6 alkenyl group” for R 1 include a vinyl group and a 1-propenyl group.
Examples of the “C2-6 alkynyl group” for R 1 include an ethynyl group and a 1-propynyl group.
Examples of substituents on the "C1-6 alkyl group", "C2-6 alkenyl group", or "C2-6 alkynyl group" in R 1 include halogeno groups such as fluoro, chloro, bromo, and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n -C1-6 haloalkoxy groups such as propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group; phenyl group, naphthyl C6-10 aryl groups such as groups; C1-6 alkyl groups such as 4-methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, C6-10 aryl group substituted with one or more substituents selected from C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group; pyrrolyl group, furyl group, thienyl group, imidazolyl 5-membered ring heteroaryl groups such as groups, pyrazolyl groups, oxazolyl groups, isoxazolyl groups, thiazolyl groups, isothiazolyl groups, triazolyl groups, oxadiazolyl groups, thiadiazolyl groups, tetrazolyl groups; C1-6 alkyl groups, C1-6 alkoxy groups, halogeno 5-membered heteroaryl group substituted with one or more substituents selected from group, C1-6 haloalkyl group, or C1-6 haloalkoxy group; pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group, etc. 6-membered heteroaryl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group substituted with one or more substituents 6 A membered ring heteroaryl group; or a cyano group is preferred.
R1における「C2~6アルケニル基」としては、ビニル基、1-プロペニル基などを挙げることができる。
R1における「C2~6アルキニル基」としては、エチニル基、1-プロピニル基などを挙げることができる。
R1における「C1~6アルキル基」、「C2~6アルケニル基」、または「C2~6アルキニル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。 The "C1-6 alkyl group" for R 1 includes methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
Examples of the “C2-6 alkenyl group” for R 1 include a vinyl group and a 1-propenyl group.
Examples of the “C2-6 alkynyl group” for R 1 include an ethynyl group and a 1-propynyl group.
Examples of substituents on the "C1-6 alkyl group", "C2-6 alkenyl group", or "C2-6 alkynyl group" in R 1 include halogeno groups such as fluoro, chloro, bromo, and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n -C1-6 haloalkoxy groups such as propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group; phenyl group, naphthyl C6-10 aryl groups such as groups; C1-6 alkyl groups such as 4-methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, C6-10 aryl group substituted with one or more substituents selected from C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group; pyrrolyl group, furyl group, thienyl group, imidazolyl 5-membered ring heteroaryl groups such as groups, pyrazolyl groups, oxazolyl groups, isoxazolyl groups, thiazolyl groups, isothiazolyl groups, triazolyl groups, oxadiazolyl groups, thiadiazolyl groups, tetrazolyl groups; C1-6 alkyl groups, C1-6 alkoxy groups, halogeno 5-membered heteroaryl group substituted with one or more substituents selected from group, C1-6 haloalkyl group, or C1-6 haloalkoxy group; pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group, etc. 6-membered heteroaryl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group substituted with one or more substituents 6 A membered ring heteroaryl group; or a cyano group is preferred.
R1における「C3~6シクロアルキル基」としては、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などを挙げることができる。
R1における「C6~10アリール基」としては、フェニル基、ナフチル基、インデニル基、インダニル基、テトラリニル基などを挙げることができる。 Examples of the “C3-6 cycloalkyl group” for R 1 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
Examples of the “C6-10 aryl group” for R 1 include a phenyl group, a naphthyl group, an indenyl group, an indanyl group, a tetralinyl group and the like.
R1における「C6~10アリール基」としては、フェニル基、ナフチル基、インデニル基、インダニル基、テトラリニル基などを挙げることができる。 Examples of the “C3-6 cycloalkyl group” for R 1 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
Examples of the “C6-10 aryl group” for R 1 include a phenyl group, a naphthyl group, an indenyl group, an indanyl group, a tetralinyl group and the like.
R1における「5~6員環のヘテロシクリル基」とは、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1、2、3または4個のヘテロ原子を環の構成原子として含む基である。ヘテロ原子が2個以上であるとき、それらは同じでもよいし、異なってもよい。「5~6員環のヘテロシクリル基」としては、5~6員環の飽和ヘテロシクリル基、5~6員環のヘテロアリール基、5~6員環の部分不飽和ヘテロシクリル基などを挙げることができる。
5~6員環の飽和ヘテロシクリル基としては、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
5~6員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基を挙げることができる。
5~6員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基が挙げられる。 The “5- to 6-membered heterocyclyl group” for R 1 is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. be. When there are two or more heteroatoms, they may be the same or different. Examples of the "5- to 6-membered heterocyclyl group" include a 5- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. and 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
Examples of 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, and isoxazolinyl 5-membered partially unsaturated heterocyclyl groups; dihydro A 6-membered partially unsaturated heterocyclyl group such as a pyranyl group can be mentioned.
5~6員環の飽和ヘテロシクリル基としては、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
5~6員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基を挙げることができる。
5~6員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基が挙げられる。 The “5- to 6-membered heterocyclyl group” for R 1 is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. be. When there are two or more heteroatoms, they may be the same or different. Examples of the "5- to 6-membered heterocyclyl group" include a 5- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. and 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
Examples of 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, and isoxazolinyl 5-membered partially unsaturated heterocyclyl groups; dihydro A 6-membered partially unsaturated heterocyclyl group such as a pyranyl group can be mentioned.
R1における「C3~6シクロアルキル基」、「C6~10アリール基」、または「5~6員環のヘテロシクリル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。
さらに、「C3~6シクロアルキル基」、または「5~6員環のヘテロシクリル基」上の置換基としては、オキソ基も好ましい。 Substituents on the "C3-6 cycloalkyl group", "C6-10 aryl group", or "5- to 6-membered heterocyclyl group" for R 1 include a fluoro group, a chloro group, a bromo group, an iodo group, and the like. Halogeno group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc. C1 ~ 6 alkyl group of; chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, C1 ~ 6 haloalkyl group such as 1-fluoro-n-butyl group; hydroxyl group; methoxy group , ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy groups such as t-butoxy group; 2-chloro-n-propoxy group, C1-6 haloalkoxy groups such as 2,3-dichlorobutoxy group and trifluoromethoxy group; C6-10 aryl groups such as phenyl group and naphthyl group; 4-methylphenyl group, 4-methoxyphenyl group and 4-chlorophenyl group , 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, etc., a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group C6-10 aryl group substituted with one or more substituents; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group , a 5-membered heteroaryl group such as a tetrazolyl group; substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group 5-membered heteroaryl group; pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, 6-membered heteroaryl group such as triazinyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 A 6-membered heteroaryl group substituted with one or more substituents selected from ∼6 haloalkyl groups or C1-6 haloalkoxy groups; or a cyano group is preferred.
Furthermore, an oxo group is also preferred as a substituent on the "C3-6 cycloalkyl group" or the "5- to 6-membered heterocyclyl group".
さらに、「C3~6シクロアルキル基」、または「5~6員環のヘテロシクリル基」上の置換基としては、オキソ基も好ましい。 Substituents on the "C3-6 cycloalkyl group", "C6-10 aryl group", or "5- to 6-membered heterocyclyl group" for R 1 include a fluoro group, a chloro group, a bromo group, an iodo group, and the like. Halogeno group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc. C1 ~ 6 alkyl group of; chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, C1 ~ 6 haloalkyl group such as 1-fluoro-n-butyl group; hydroxyl group; methoxy group , ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy groups such as t-butoxy group; 2-chloro-n-propoxy group, C1-6 haloalkoxy groups such as 2,3-dichlorobutoxy group and trifluoromethoxy group; C6-10 aryl groups such as phenyl group and naphthyl group; 4-methylphenyl group, 4-methoxyphenyl group and 4-chlorophenyl group , 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, etc., a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group C6-10 aryl group substituted with one or more substituents; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group , a 5-membered heteroaryl group such as a tetrazolyl group; substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group 5-membered heteroaryl group; pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, 6-membered heteroaryl group such as triazinyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 A 6-membered heteroaryl group substituted with one or more substituents selected from ∼6 haloalkyl groups or C1-6 haloalkoxy groups; or a cyano group is preferred.
Furthermore, an oxo group is also preferred as a substituent on the "C3-6 cycloalkyl group" or the "5- to 6-membered heterocyclyl group".
「R1-CO-で表される基」の具体例としては、ホルミル基、アセチル基、プロピオニル基、ブチリル基、i-プロピルカルボニル基などを挙げることができる。
Specific examples of the "group represented by R 1 -CO-" include formyl, acetyl, propionyl, butyryl, i-propylcarbonyl and the like.
X1およびX2における「R2-O-CO-で表される基」中、R2は、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
R2における置換基の具体例は、R1において例示したものと同じものを挙げることができる。 In the "group represented by R -O - CO-" for X 1 and X 2 , R 2 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or It represents an unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Specific examples of substituents for R 2 are the same as those exemplified for R 1 .
R2における置換基の具体例は、R1において例示したものと同じものを挙げることができる。 In the "group represented by R -O - CO-" for X 1 and X 2 , R 2 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or It represents an unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Specific examples of substituents for R 2 are the same as those exemplified for R 1 .
「R2-O-CO-で表される基」の具体例としては、メトキシカルボニル基、エトキシカルボニル基、t-ブトキシカルボニル基などを挙げることができる。
Specific examples of the “group represented by R 2 —O—CO—” include a methoxycarbonyl group, an ethoxycarbonyl group, a t-butoxycarbonyl group and the like.
X1およびX2における「R3R4N-で表される基」中、R3は、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、R4は、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
R3またはR4における置換基の具体例は、R1において例示したものと同じものを挙げることができる。 In the "group represented by R 3 R 4 N-" for X 1 and X 2 , R 3 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, substituted or unsubstituted C2-6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group , R 4 represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of substituents for R 3 or R 4 are the same as those exemplified for R 1 .
R3またはR4における置換基の具体例は、R1において例示したものと同じものを挙げることができる。 In the "group represented by R 3 R 4 N-" for X 1 and X 2 , R 3 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, substituted or unsubstituted C2-6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group , R 4 represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of substituents for R 3 or R 4 are the same as those exemplified for R 1 .
ここで、R3とR4は、一緒になって二価の有機基を形成してもよい。
形成できる二価の有機基としては、置換若しくは無置換のC2~5アルキレン基または置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基を挙げることができる。
「C2~5アルキレン基」としては、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C2~5アルキレン基」または「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 Here, R 3 and R 4 may together form a divalent organic group.
Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
Examples of the "C2-5 alkylene group" include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Examples of substituents on the "C2-5 alkylene group" or "C1-3 alkyleneoxy C1-3 alkylene group" include halogeno groups such as fluoro, chloro, bromo, and iodo groups; methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
形成できる二価の有機基としては、置換若しくは無置換のC2~5アルキレン基または置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基を挙げることができる。
「C2~5アルキレン基」としては、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C2~5アルキレン基」または「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 Here, R 3 and R 4 may together form a divalent organic group.
Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
Examples of the "C2-5 alkylene group" include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Examples of substituents on the "C2-5 alkylene group" or "C1-3 alkyleneoxy C1-3 alkylene group" include halogeno groups such as fluoro, chloro, bromo, and iodo groups; methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
「R3R4N-で表される基」の具体例としては、アミノ基、メチルアミノ基、ジメチルアミノ基、i-プロピルアミノ基などを挙げることができる。
Specific examples of the “group represented by R 3 R 4 N—” include amino group, methylamino group, dimethylamino group, i-propylamino group and the like.
X1およびX2における「R3R4N-CO-で表される基」中、R3およびR4は上記の「R3R4N-で表される基」におけるそれらと同様の意味を示す。
「R3R4N-CO-で表される基」の具体例としては、カルバモイル基、N,N-ジメチルアミノカルボニル基、N-(i-プロピル)アミノカルボニル基、N-(i-プロピル)-N-メチルアミノカルボニル基などを挙げることができる。 In the “group represented by R 3 R 4 N—CO—” for X 1 and X 2 , R 3 and R 4 have the same meanings as those in the above “group represented by R 3 R 4 N—” indicates
Specific examples of the “group represented by R 3 R 4 N—CO—” include a carbamoyl group, an N,N-dimethylaminocarbonyl group, an N-(i-propyl)aminocarbonyl group, an N-(i-propyl )—N-methylaminocarbonyl group and the like.
「R3R4N-CO-で表される基」の具体例としては、カルバモイル基、N,N-ジメチルアミノカルボニル基、N-(i-プロピル)アミノカルボニル基、N-(i-プロピル)-N-メチルアミノカルボニル基などを挙げることができる。 In the “group represented by R 3 R 4 N—CO—” for X 1 and X 2 , R 3 and R 4 have the same meanings as those in the above “group represented by R 3 R 4 N—” indicates
Specific examples of the “group represented by R 3 R 4 N—CO—” include a carbamoyl group, an N,N-dimethylaminocarbonyl group, an N-(i-propyl)aminocarbonyl group, an N-(i-propyl )—N-methylaminocarbonyl group and the like.
X1およびX2における「R1-CO-O-で表される基」中、R1は上記の「R1-CO-で表される基」におけるそれと同様の意味を示す。
「R1-CO-O-で表される基」の具体例としては、アセチルオキシ基、i-プロピルカルボニルオキシ基などを挙げることができる。 In the "group represented by R 1 -CO-O-" for X 1 and X 2 , R 1 has the same meaning as the above "group represented by R 1 -CO-".
Specific examples of the "group represented by R 1 -CO-O-" include an acetyloxy group and an i-propylcarbonyloxy group.
「R1-CO-O-で表される基」の具体例としては、アセチルオキシ基、i-プロピルカルボニルオキシ基などを挙げることができる。 In the "group represented by R 1 -CO-O-" for X 1 and X 2 , R 1 has the same meaning as the above "group represented by R 1 -CO-".
Specific examples of the "group represented by R 1 -CO-O-" include an acetyloxy group and an i-propylcarbonyloxy group.
X1およびX2における「R1-CO-NR5-で表される基」中、R1は上記の「R1-CO-で表される基」におけるそれと同様の意味を示す。
R5は、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
R5における置換基の具体例は、R1において例示したものと同じものを挙げることができる。
「R1-CO-NR5-で表される基」の具体例としては、アセチルアミノ基、i-プロピルカルボニルアミノ基などを挙げることができる。 In the "group represented by R 1 -CO-NR 5 -" for X 1 and X 2 , R 1 has the same meaning as the above "group represented by R 1 -CO-".
R 5 represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of substituents for R 5 are the same as those exemplified for R 1 .
Specific examples of the "group represented by R 1 -CO-NR 5 -" include an acetylamino group and an i-propylcarbonylamino group.
R5は、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
R5における置換基の具体例は、R1において例示したものと同じものを挙げることができる。
「R1-CO-NR5-で表される基」の具体例としては、アセチルアミノ基、i-プロピルカルボニルアミノ基などを挙げることができる。 In the "group represented by R 1 -CO-NR 5 -" for X 1 and X 2 , R 1 has the same meaning as the above "group represented by R 1 -CO-".
R 5 represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of substituents for R 5 are the same as those exemplified for R 1 .
Specific examples of the "group represented by R 1 -CO-NR 5 -" include an acetylamino group and an i-propylcarbonylamino group.
X1およびX2における「R2-O-CO-O-で表される基」中、R2は上記の「R2-O-CO-で表される基」におけるそれと同様の意味を示す。
「R2-O-CO-O-で表される基」の具体例としては、メトキシカルボニルオキシ基、エトキシカルボニルオキシ基などを挙げることができる。 In the "group represented by R -O-CO - O-" for X 1 and X 2 , R 2 has the same meaning as in the above "group represented by R -O - CO-". .
Specific examples of the “group represented by R 2 —O—CO—O—” include a methoxycarbonyloxy group and an ethoxycarbonyloxy group.
「R2-O-CO-O-で表される基」の具体例としては、メトキシカルボニルオキシ基、エトキシカルボニルオキシ基などを挙げることができる。 In the "group represented by R -O-CO - O-" for X 1 and X 2 , R 2 has the same meaning as in the above "group represented by R -O - CO-". .
Specific examples of the “group represented by R 2 —O—CO—O—” include a methoxycarbonyloxy group and an ethoxycarbonyloxy group.
X1およびX2における「R2-O-CO-NR5-で表される基」中、R2は上記の「R2-O-CO-で表される基」におけるそれと同様の意味を示す。R5は上記の「R1-CO-NR5-で表される基」におけるそれと同様の意味を示す。
「R2-O-CO-NR5-で表される基」の具体例としては、メトキシカルボニルアミノ基などを挙げることができる。 In the "group represented by R 2 -O-CO-NR 5 -" for X 1 and X 2 , R 2 has the same meaning as in the above "group represented by R 2 -O-CO-". show. R 5 has the same meaning as in the above “group represented by R 1 —CO—NR 5 —”.
Specific examples of the “group represented by R 2 —O—CO—NR 5 —” include a methoxycarbonylamino group.
「R2-O-CO-NR5-で表される基」の具体例としては、メトキシカルボニルアミノ基などを挙げることができる。 In the "group represented by R 2 -O-CO-NR 5 -" for X 1 and X 2 , R 2 has the same meaning as in the above "group represented by R 2 -O-CO-". show. R 5 has the same meaning as in the above “group represented by R 1 —CO—NR 5 —”.
Specific examples of the “group represented by R 2 —O—CO—NR 5 —” include a methoxycarbonylamino group.
X1およびX2における「R3R4N-CO-O-で表される基」中、R3およびR4は上記の「R3R4N-で表される基」におけるそれらと同様の意味を示す。
「R3R4N-CO-O-で表される基」の具体例としては、カルバモイルオキシ基、N,N-ジメチルアミノカルボニルオキシ基などを挙げることができる。 In the “group represented by R 3 R 4 N—CO—O—” for X 1 and X 2 , R 3 and R 4 are the same as those in the above “group represented by R 3 R 4 N—” indicates the meaning of
Specific examples of the “group represented by R 3 R 4 N—CO—O—” include a carbamoyloxy group and an N,N-dimethylaminocarbonyloxy group.
「R3R4N-CO-O-で表される基」の具体例としては、カルバモイルオキシ基、N,N-ジメチルアミノカルボニルオキシ基などを挙げることができる。 In the “group represented by R 3 R 4 N—CO—O—” for X 1 and X 2 , R 3 and R 4 are the same as those in the above “group represented by R 3 R 4 N—” indicates the meaning of
Specific examples of the “group represented by R 3 R 4 N—CO—O—” include a carbamoyloxy group and an N,N-dimethylaminocarbonyloxy group.
X1およびX2における「R3R4N-CO-NR5-で表される基」中、R3およびR4は上記の「R3R4N-で表される基」におけるそれらと同様の意味を示す。R5は上記の「R1-CO-NR5-で表される基」におけるそれと同様の意味を示す。
「R3R4N-CO-NR5-で表される基」の具体例としては、カルバモイルアミノ基、N,N-ジメチルアミノカルボニルアミノ基などを挙げることができる。 In the “group represented by R 3 R 4 N—CO—NR 5 —” for X 1 and X 2 , R 3 and R 4 are the same as those in the above “group represented by R 3 R 4 N—” have similar meanings. R 5 has the same meaning as in the above “group represented by R 1 —CO—NR 5 —”.
Specific examples of the “group represented by R 3 R 4 N—CO—NR 5 —” include a carbamoylamino group and an N,N-dimethylaminocarbonylamino group.
「R3R4N-CO-NR5-で表される基」の具体例としては、カルバモイルアミノ基、N,N-ジメチルアミノカルボニルアミノ基などを挙げることができる。 In the “group represented by R 3 R 4 N—CO—NR 5 —” for X 1 and X 2 , R 3 and R 4 are the same as those in the above “group represented by R 3 R 4 N—” have similar meanings. R 5 has the same meaning as in the above “group represented by R 1 —CO—NR 5 —”.
Specific examples of the “group represented by R 3 R 4 N—CO—NR 5 —” include a carbamoylamino group and an N,N-dimethylaminocarbonylamino group.
X1およびX2における「R2SO2-NR5-で表される基」中、R2は上記の「R2-O-CO-で表される基」におけるそれと同様の意味を示す。R5は上記の「R1-CO-NR5-で表される基」におけるそれと同様の意味を示す。
「R2SO2-NR5-で表される基」の具体例としては、メタンスルホニルアミノ基などを挙げることができる。 In the "group represented by R 2 SO 2 -NR 5 -" for X 1 and X 2 , R 2 has the same meaning as the above "group represented by R 2 -O-CO-". R 5 has the same meaning as in the above “group represented by R 1 —CO—NR 5 —”.
Specific examples of the “group represented by R 2 SO 2 —NR 5 —” include a methanesulfonylamino group and the like.
「R2SO2-NR5-で表される基」の具体例としては、メタンスルホニルアミノ基などを挙げることができる。 In the "group represented by R 2 SO 2 -NR 5 -" for X 1 and X 2 , R 2 has the same meaning as the above "group represented by R 2 -O-CO-". R 5 has the same meaning as in the above “group represented by R 1 —CO—NR 5 —”.
Specific examples of the “group represented by R 2 SO 2 —NR 5 —” include a methanesulfonylamino group and the like.
X1およびX2における「R3R4N-SO2-で表される基」中、R3およびR4は上記の「R3R4N-で表される基」におけるそれらと同様の意味を示す。
「R3R4N-SO2-で表される基」の具体例としては、N,N-ジメチルアミノスルホニル基などを挙げることができる。 In the “group represented by R 3 R 4 N—SO 2 —” for X 1 and X 2 , R 3 and R 4 are the same as those in the above “group represented by R 3 R 4 N—” indicate meaning.
Specific examples of the “group represented by R 3 R 4 N—SO 2 —” include an N,N-dimethylaminosulfonyl group.
「R3R4N-SO2-で表される基」の具体例としては、N,N-ジメチルアミノスルホニル基などを挙げることができる。 In the “group represented by R 3 R 4 N—SO 2 —” for X 1 and X 2 , R 3 and R 4 are the same as those in the above “group represented by R 3 R 4 N—” indicate meaning.
Specific examples of the “group represented by R 3 R 4 N—SO 2 —” include an N,N-dimethylaminosulfonyl group.
X1およびX2における「R1O-N=CR6-で表される基」中、R1は上記の「R1-CO-で表される基」におけるそれと同様の意味を示す。
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
R6における「置換若しくは無置換のC1~6アルキル基」または「置換若しくは無置換の5~6員環のヘテロシクリル基」の具体例は、R1において例示したものと同じものを挙げることができる。
R6における「ハロゲノ基」としては、フルオロ基、クロロ基、ブロモ基、イオド基などを挙げることができる。
R6における「置換若しくは無置換のモノC1~6アルキルアミノ基」の「モノC1~6アルキルアミノ基」としては、メチルアミノ基、エチルアミノ基、i-プロピルアミノ基などを挙げることができる。
R6における「置換若しくは無置換のジC1~6アルキルアミノ基」の「ジC1~6アルキルアミノ基」としては、ジメチルアミノ基、ジエチルアミノ基、N-メチル-N-i-プロピルアミノ基などを挙げることができる。
R6における「置換もしくは無置換のC1~6アルコキシ基」の「C1~6アルコキシ基」としては、メトキシ基、エトキシ基、n-プロポキシ基、n-ブトキシ基、n-ペンチルオキシ基、n-ヘキシルオキシ基、i-プロポキシ基、i-ブトキシ基、s-ブトキシ基、t-ブトキシ基、i-ヘキシルオキシ基などを挙げることができる。
R6における「置換若しくは無置換のC1~6アルキルチオ基」の「C1~6アルキルチオ基」としては、メチルチオ基、エチルチオ基、n-プロピルチオ基、n-ブチルチオ基、n-ペンチルチオ基、n-ヘキシルチオ基、i-プロピルチオ基などを挙げることができる。
R6における「C1~6アルコキシ基」、「モノC1~6アルキルアミノ基」、「ジC1~6アルキルアミノ基」、または「C1~6アルキルチオ基」上の置換基としては、R1において「C1~6アルキル基」上の置換基として例示した置換基と同じものを挙げることができる。
「R1O-N=CR6-で表される基」の具体例としては、1-(i-プロポキシイミノ)エチル基などを挙げることができる。 In the "group represented by R 1 ON=CR 6 -" for X 1 and X 2 , R 1 has the same meaning as the above "group represented by R 1 -CO-".
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted It represents a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Specific examples of the "substituted or unsubstituted C1-6 alkyl group" or "substituted or unsubstituted 5- to 6-membered heterocyclyl group" for R 6 are the same as those exemplified for R 1 . .
Examples of the “halogeno group” for R 6 include a fluoro group, a chloro group, a bromo group and an iodo group.
Examples of the “mono C1-6 alkylamino group” of the “substituted or unsubstituted mono C1-6 alkylamino group” for R 6 include a methylamino group, an ethylamino group and an i-propylamino group.
Examples of the "di-C1-6 alkylamino group" of the "substituted or unsubstituted di-C1-6 alkylamino group" for R 6 include a dimethylamino group, a diethylamino group, an N-methyl-Ni-propylamino group, and the like. can be mentioned.
The "C1-6 alkoxy group" of the "substituted or unsubstituted C1-6 alkoxy group" for R 6 includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, n- A hexyloxy group, i-propoxy group, i-butoxy group, s-butoxy group, t-butoxy group, i-hexyloxy group and the like can be mentioned.
The "C1-6 alkylthio group" of the "substituted or unsubstituted C1-6 alkylthio group" for R 6 includes methylthio, ethylthio, n-propylthio, n-butylthio, n-pentylthio, n-hexylthio groups, i-propylthio groups, and the like.
Substituents on the "C1-6 alkoxy group", "mono-C1-6 alkylamino group", "di - C1-6 alkylamino group" or "C1-6 alkylthio group" for R 6 include " The same substituents as exemplified as substituents on "C1-6 alkyl group" can be mentioned.
Specific examples of the “group represented by R 1 ON=CR 6 —” include a 1-(i-propoxyimino)ethyl group.
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
R6における「置換若しくは無置換のC1~6アルキル基」または「置換若しくは無置換の5~6員環のヘテロシクリル基」の具体例は、R1において例示したものと同じものを挙げることができる。
R6における「ハロゲノ基」としては、フルオロ基、クロロ基、ブロモ基、イオド基などを挙げることができる。
R6における「置換若しくは無置換のモノC1~6アルキルアミノ基」の「モノC1~6アルキルアミノ基」としては、メチルアミノ基、エチルアミノ基、i-プロピルアミノ基などを挙げることができる。
R6における「置換若しくは無置換のジC1~6アルキルアミノ基」の「ジC1~6アルキルアミノ基」としては、ジメチルアミノ基、ジエチルアミノ基、N-メチル-N-i-プロピルアミノ基などを挙げることができる。
R6における「置換もしくは無置換のC1~6アルコキシ基」の「C1~6アルコキシ基」としては、メトキシ基、エトキシ基、n-プロポキシ基、n-ブトキシ基、n-ペンチルオキシ基、n-ヘキシルオキシ基、i-プロポキシ基、i-ブトキシ基、s-ブトキシ基、t-ブトキシ基、i-ヘキシルオキシ基などを挙げることができる。
R6における「置換若しくは無置換のC1~6アルキルチオ基」の「C1~6アルキルチオ基」としては、メチルチオ基、エチルチオ基、n-プロピルチオ基、n-ブチルチオ基、n-ペンチルチオ基、n-ヘキシルチオ基、i-プロピルチオ基などを挙げることができる。
R6における「C1~6アルコキシ基」、「モノC1~6アルキルアミノ基」、「ジC1~6アルキルアミノ基」、または「C1~6アルキルチオ基」上の置換基としては、R1において「C1~6アルキル基」上の置換基として例示した置換基と同じものを挙げることができる。
「R1O-N=CR6-で表される基」の具体例としては、1-(i-プロポキシイミノ)エチル基などを挙げることができる。 In the "group represented by R 1 ON=CR 6 -" for X 1 and X 2 , R 1 has the same meaning as the above "group represented by R 1 -CO-".
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted It represents a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Specific examples of the "substituted or unsubstituted C1-6 alkyl group" or "substituted or unsubstituted 5- to 6-membered heterocyclyl group" for R 6 are the same as those exemplified for R 1 . .
Examples of the “halogeno group” for R 6 include a fluoro group, a chloro group, a bromo group and an iodo group.
Examples of the “mono C1-6 alkylamino group” of the “substituted or unsubstituted mono C1-6 alkylamino group” for R 6 include a methylamino group, an ethylamino group and an i-propylamino group.
Examples of the "di-C1-6 alkylamino group" of the "substituted or unsubstituted di-C1-6 alkylamino group" for R 6 include a dimethylamino group, a diethylamino group, an N-methyl-Ni-propylamino group, and the like. can be mentioned.
The "C1-6 alkoxy group" of the "substituted or unsubstituted C1-6 alkoxy group" for R 6 includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, n- A hexyloxy group, i-propoxy group, i-butoxy group, s-butoxy group, t-butoxy group, i-hexyloxy group and the like can be mentioned.
The "C1-6 alkylthio group" of the "substituted or unsubstituted C1-6 alkylthio group" for R 6 includes methylthio, ethylthio, n-propylthio, n-butylthio, n-pentylthio, n-hexylthio groups, i-propylthio groups, and the like.
Substituents on the "C1-6 alkoxy group", "mono-C1-6 alkylamino group", "di - C1-6 alkylamino group" or "C1-6 alkylthio group" for R 6 include " The same substituents as exemplified as substituents on "C1-6 alkyl group" can be mentioned.
Specific examples of the “group represented by R 1 ON=CR 6 —” include a 1-(i-propoxyimino)ethyl group.
X1およびX2における「R3R4N-N=CR6-で表される基」中、R3およびR4は上記の「R3R4N-で表される基」におけるそれらと同様の意味を示す。R6は上記の「R1O-N=CR6-で表される基」におけるそれと同様の意味を示す。
In the "group represented by R 3 R 4 NN=CR 6 -" for X 1 and X 2 , R 3 and R 4 are the same as those in the above "group represented by R 3 R 4 N-". have similar meanings. R 6 has the same meaning as in the above “group represented by R 1 ON=CR 6 —”.
X1およびX2における「R1-N=CR6-で表される基」中、R1およびR6は上記の「R1O-N=CR6-で表される基」におけるそれと同様の意味を示す。
In the "group represented by R 1 -N=CR 6 -" for X 1 and X 2 , R 1 and R 6 are the same as in the above "group represented by R 1 ON=CR 6 -" indicates the meaning of
本発明においては、好ましいX1としては、水素原子または置換若しくは無置換のC1~6アルキル基を挙げることができる。
好ましいX2としては、「R1O-N=CR6-で表される基」を挙げることができる。 In the present invention, X 1 is preferably a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
Preferred examples of X 2 include "a group represented by R 1 ON=CR 6 -".
好ましいX2としては、「R1O-N=CR6-で表される基」を挙げることができる。 In the present invention, X 1 is preferably a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
Preferred examples of X 2 include "a group represented by R 1 ON=CR 6 -".
〔X3〕
X3は、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、R1-CO-で表される基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示す。 [ X3 ]
X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 4- to 6-membered heterocyclyl group.
X3は、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、R1-CO-で表される基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示す。 [ X3 ]
X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 4- to 6-membered heterocyclyl group.
X3における「直鎖C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基を挙げることができる。
X3における「直鎖C2~6アルケニル基」としては、ビニル基、1-プロペニル基、2-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基を挙げることができる。
X3における「直鎖C2~6アルキニル基」としては、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-ヘキシニル基などを挙げることができる。
X3における「4員環のヘテロシクリル基」しては、アゼチジニル基、オキセタニル基を挙げることができる。
X3におけるその他の置換基の具体例は、X1およびX2において例示したものと同じものを挙げることができる。 Examples of the “linear C1-6 alkyl group” for X 3 include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group and n-hexyl group.
The "linear C2-6 alkenyl group" for X 3 includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-pentenyl group, 2- Pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group and 5-hexenyl group can be mentioned.
The "straight-chain C2-6 alkynyl group" for X 3 includes an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-pentynyl group, 2- Pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-hexynyl group and the like can be mentioned.
Examples of the “4-membered heterocyclyl group” for X 3 include an azetidinyl group and an oxetanyl group.
Specific examples of other substituents for X 3 are the same as those exemplified for X 1 and X 2 .
X3における「直鎖C2~6アルケニル基」としては、ビニル基、1-プロペニル基、2-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基を挙げることができる。
X3における「直鎖C2~6アルキニル基」としては、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-ヘキシニル基などを挙げることができる。
X3における「4員環のヘテロシクリル基」しては、アゼチジニル基、オキセタニル基を挙げることができる。
X3におけるその他の置換基の具体例は、X1およびX2において例示したものと同じものを挙げることができる。 Examples of the “linear C1-6 alkyl group” for X 3 include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group and n-hexyl group.
The "linear C2-6 alkenyl group" for X 3 includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-pentenyl group, 2- Pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group and 5-hexenyl group can be mentioned.
The "straight-chain C2-6 alkynyl group" for X 3 includes an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-pentynyl group, 2- Pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-hexynyl group and the like can be mentioned.
Examples of the “4-membered heterocyclyl group” for X 3 include an azetidinyl group and an oxetanyl group.
Specific examples of other substituents for X 3 are the same as those exemplified for X 1 and X 2 .
本発明において、好ましいX3としては、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換のC3~6シクロアルキル基、または置換若しくは無置換のC6~10アリール基を挙げることができる。
本発明において、さらに好ましいX3としては、置換の直鎖C1~6アルキル基である。 In the present invention, preferred X 3 is a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted C3-6 cycloalkyl group, or a substituted or unsubstituted C6-10 aryl group. can.
In the present invention, more preferred X 3 is a substituted linear C1-6 alkyl group.
本発明において、さらに好ましいX3としては、置換の直鎖C1~6アルキル基である。 In the present invention, preferred X 3 is a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted C3-6 cycloalkyl group, or a substituted or unsubstituted C6-10 aryl group. can.
In the present invention, more preferred X 3 is a substituted linear C1-6 alkyl group.
直鎖C1~6アルキル基上の置換基、直鎖C2~6アルケニル基上の置換基、直鎖C2~6アルキニル基上の置換基、C3~6シクロアルキル基上の置換基、C6~10アリール基上の置換基、または4~6員環のヘテロシクリル基上の置換基としては、以下の置換基群より選択される1または2以上の置換基を挙げることができる(以下、この置換基を記号「G」で表すことがある。)。
また、置換基(G)は2以上ある場合、そのうちの2つが一緒になって二価の有機基を形成してもよい。以下に置換基群を示す。
ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の3~10員環のヘテロシクリル基、置換若しくは無置換の3~10員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、Ra-CO-で表される基、カルボキシ基、Rb-O-CO-で表される基、RcRdN-で表される基、RcRdN-CO-で表される基、RcRdN-NRd-CO-で表される基、RbSO2-NRd-CO-で表される基、Ra-CO-O-で表される基、Ra-CO-NRe-で表される基、Ra-CO-CO-NRe-で表される基、Ra-CO-NRe-NRe-で表される基、Ra-CO-NRe-NRe-CO-で表される基、Rb-O-CO-O-で表される基、Rb-O-CO-NRe-で表される基、RcRdN-CO-O-で表される基、RcRdN-CO-NRe-で表される基、RcRdN-CO-CO-NRe-で表される基、Ra-CS-NRe-で表される基、RcRdN-CS-NRe-で表される基、RbSO2-NRe-で表される基、RcRdN-SO2-で表される基、RaO-N=CRf-で表される基、RhRjC=N-O-で表される基、Ra-C(=NRg)-NRe-で表される基、RcRdN-C(=NRg)-で表される基、RhRiS(=O)=N-CO-で表される基、RhRiS=N-CO-で表される基。 Substituents on Linear C1-6 Alkyl Groups, Substituents on Linear C2-6 Alkenyl Groups, Substituents on Linear C2-6 Alkynyl Groups, Substituents on C3-6 Cycloalkyl Groups, C6-10 Examples of substituents on the aryl group or substituents on the 4- to 6-membered heterocyclyl group include one or more substituents selected from the following group of substituents (hereinafter, this substituent is sometimes represented by the symbol "G").
Moreover, when there are two or more substituents (G), two of them may combine to form a divalent organic group. Substituent groups are shown below.
halogeno group, substituted or unsubstituted C1-6 alkyl group, substituted or unsubstituted C2-6 alkenyl group, substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1 ~ 6 alkylsulfonyl group, substituted or unsubstituted C3 ~ 6 cycloalkyl group, substituted or unsubstituted C3 ~ 6 cycloalkyloxy group, substituted or unsubstituted C6 ~ 10 aryl group, substituted or unsubstituted C6 ~10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6-10 arylsulfonyl group, substituted or unsubstituted 3-10 membered ring heterocyclyl group, substituted or unsubstituted 3- to 10-membered heterocyclyloxy group, nitro group, cyano group, group represented by R a —CO—, carboxy group, R b —O—CO— a group represented by R c R d N—, a group represented by R c R d N—CO—, a group represented by R c R d N—NR d —CO—, R b SO 2 a group represented by -NR d -CO-, a group represented by R a -CO-O-, a group represented by R a -CO-NR e -, a group represented by R a -CO-CO-NR e - a group represented by R a -CO-NR e -NR e -, a group represented by R a -CO-NR e -NR e -CO-, R b -O-CO-O- A group represented by R b —O—CO—NR e — A group represented by R c R d N—CO—O— R c R d N—CO—NR e — A group represented by R c R d N—CO—CO—NR e — A group represented by R a —CS-NR e — R c R d N—CS-NR e — a group represented by R b SO 2 —NR e —, a group represented by R c R d N—SO 2 —, a group represented by R a ON=CR f —, R h R j A group represented by C=NO-, a group represented by R a -C(=NR g )-NR e -, a group represented by R c R d NC(=NR g )- a group represented by R h R i S(=O)=N--CO--, a group represented by R h R i S=N--CO--.
また、置換基(G)は2以上ある場合、そのうちの2つが一緒になって二価の有機基を形成してもよい。以下に置換基群を示す。
ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の3~10員環のヘテロシクリル基、置換若しくは無置換の3~10員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、Ra-CO-で表される基、カルボキシ基、Rb-O-CO-で表される基、RcRdN-で表される基、RcRdN-CO-で表される基、RcRdN-NRd-CO-で表される基、RbSO2-NRd-CO-で表される基、Ra-CO-O-で表される基、Ra-CO-NRe-で表される基、Ra-CO-CO-NRe-で表される基、Ra-CO-NRe-NRe-で表される基、Ra-CO-NRe-NRe-CO-で表される基、Rb-O-CO-O-で表される基、Rb-O-CO-NRe-で表される基、RcRdN-CO-O-で表される基、RcRdN-CO-NRe-で表される基、RcRdN-CO-CO-NRe-で表される基、Ra-CS-NRe-で表される基、RcRdN-CS-NRe-で表される基、RbSO2-NRe-で表される基、RcRdN-SO2-で表される基、RaO-N=CRf-で表される基、RhRjC=N-O-で表される基、Ra-C(=NRg)-NRe-で表される基、RcRdN-C(=NRg)-で表される基、RhRiS(=O)=N-CO-で表される基、RhRiS=N-CO-で表される基。 Substituents on Linear C1-6 Alkyl Groups, Substituents on Linear C2-6 Alkenyl Groups, Substituents on Linear C2-6 Alkynyl Groups, Substituents on C3-6 Cycloalkyl Groups, C6-10 Examples of substituents on the aryl group or substituents on the 4- to 6-membered heterocyclyl group include one or more substituents selected from the following group of substituents (hereinafter, this substituent is sometimes represented by the symbol "G").
Moreover, when there are two or more substituents (G), two of them may combine to form a divalent organic group. Substituent groups are shown below.
halogeno group, substituted or unsubstituted C1-6 alkyl group, substituted or unsubstituted C2-6 alkenyl group, substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1 ~ 6 alkylsulfonyl group, substituted or unsubstituted C3 ~ 6 cycloalkyl group, substituted or unsubstituted C3 ~ 6 cycloalkyloxy group, substituted or unsubstituted C6 ~ 10 aryl group, substituted or unsubstituted C6 ~10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6-10 arylsulfonyl group, substituted or unsubstituted 3-10 membered ring heterocyclyl group, substituted or unsubstituted 3- to 10-membered heterocyclyloxy group, nitro group, cyano group, group represented by R a —CO—, carboxy group, R b —O—CO— a group represented by R c R d N—, a group represented by R c R d N—CO—, a group represented by R c R d N—NR d —CO—, R b SO 2 a group represented by -NR d -CO-, a group represented by R a -CO-O-, a group represented by R a -CO-NR e -, a group represented by R a -CO-CO-NR e - a group represented by R a -CO-NR e -NR e -, a group represented by R a -CO-NR e -NR e -CO-, R b -O-CO-O- A group represented by R b —O—CO—NR e — A group represented by R c R d N—CO—O— R c R d N—CO—NR e — A group represented by R c R d N—CO—CO—NR e — A group represented by R a —CS-NR e — R c R d N—CS-NR e — a group represented by R b SO 2 —NR e —, a group represented by R c R d N—SO 2 —, a group represented by R a ON=CR f —, R h R j A group represented by C=NO-, a group represented by R a -C(=NR g )-NR e -, a group represented by R c R d NC(=NR g )- a group represented by R h R i S(=O)=N--CO--, a group represented by R h R i S=N--CO--.
上記の置換基群中、Raは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の3~10員環のヘテロシクリル基を示す。
Rbは、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
Rcは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
Rdは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、または置換若しくは無置換のC6~10アリール基を示し、ここで、RcとRdは、一緒になって二価の有機基を形成してもよい。
Reは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、または置換若しくは無置換のC6~10アリール基を示す。
Rfは、水素原子、アミノ基、または置換若しくは無置換のC1~6アルキル基を示す。
Rgは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
Rhは、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
Riは、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、ここで、RhとRiは、一緒になって二価の有機基を形成してもよい。 In the above substituent groups, each R a is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group , a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 10-membered heterocyclyl group.
R b each independently represents a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo It represents an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Each R c is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
R d each independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group, R c and R d may together form a divalent organic group.
Each R e independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group.
R f represents a hydrogen atom, an amino group, or a substituted or unsubstituted C1-6 alkyl group.
Each R g independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Each R h independently represents a substituted or unsubstituted C1-6 alkyl group or a substituted or unsubstituted C6-10 aryl group.
Each R i independently represents a substituted or unsubstituted C1-6 alkyl group or a substituted or unsubstituted C6-10 aryl group, wherein R h and R i together form a divalent An organic group may be formed.
Rbは、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
Rcは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
Rdは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、または置換若しくは無置換のC6~10アリール基を示し、ここで、RcとRdは、一緒になって二価の有機基を形成してもよい。
Reは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、または置換若しくは無置換のC6~10アリール基を示す。
Rfは、水素原子、アミノ基、または置換若しくは無置換のC1~6アルキル基を示す。
Rgは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
Rhは、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
Riは、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、ここで、RhとRiは、一緒になって二価の有機基を形成してもよい。 In the above substituent groups, each R a is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group , a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 10-membered heterocyclyl group.
R b each independently represents a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo It represents an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Each R c is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
R d each independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group, R c and R d may together form a divalent organic group.
Each R e independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group.
R f represents a hydrogen atom, an amino group, or a substituted or unsubstituted C1-6 alkyl group.
Each R g independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Each R h independently represents a substituted or unsubstituted C1-6 alkyl group or a substituted or unsubstituted C6-10 aryl group.
Each R i independently represents a substituted or unsubstituted C1-6 alkyl group or a substituted or unsubstituted C6-10 aryl group, wherein R h and R i together form a divalent An organic group may be formed.
Gにおける「ハロゲノ基」としては、フルオロ基、クロロ基、ブロモ基、イオド基などを挙げることができる。
Examples of the "halogeno group" in G include a fluoro group, a chloro group, a bromo group, and an iodo group.
Gにおける「C1~6アルキル基」は、直鎖であってもよいし、分岐鎖であってもよい。
Gにおける「C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、i-ヘキシル基などを挙げることができる。 The “C1-6 alkyl group” for G may be linear or branched.
The "C1-6 alkyl group" in G includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s- Butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like can be mentioned.
Gにおける「C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、i-ヘキシル基などを挙げることができる。 The “C1-6 alkyl group” for G may be linear or branched.
The "C1-6 alkyl group" in G includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s- Butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like can be mentioned.
Gにおける「C2~6アルケニル基」としては、ビニル基、1-プロペニル基、2-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-メチル-2-プロペニル基、2-メチル-2-プロペニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-メチル-2-ブテニル基、2-メチル-2-ブテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基などを挙げることができる。
The "C2-6 alkenyl group" in G includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2 -methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group , 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group and the like.
Gにおける「C2~6アルキニル基」としては、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-メチル-2-プロピニル基、2-メチル-3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-メチル-2-ブチニル基、2-メチル-3-ペンチニル基、1-ヘキシニル基、1,1-ジメチル-2-ブチニル基などを挙げることができる。
The "C2-6 alkynyl group" in G includes an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2 -methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group , 1,1-dimethyl-2-butynyl group, and the like.
Gにおける「C1~6アルコキシ基」としては、メトキシ基、エトキシ基、n-プロポキシ基、n-ブトキシ基、n-ペンチルオキシ基、n-ヘキシルオキシ基、i-プロポキシ基、i-ブトキシ基、s-ブトキシ基、t-ブトキシ基、i-ヘキシルオキシ基などを挙げることができる。
Gにおける「C2~6アルケニルオキシ基」としては、ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などを挙げることができる。
Gにおける「C2~6アルキニルオキシ基」としては、エチニルオキシ基、プロパルギルオキシ基などを挙げることができる。 The "C1-6 alkoxy group" for G includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, an i-butoxy group, Examples include s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
Examples of the "C2-6 alkenyloxy group" for G include a vinyloxy group, an allyloxy group, a propenyloxy group and a butenyloxy group.
Examples of the "C2-6 alkynyloxy group" for G include an ethynyloxy group and a propargyloxy group.
Gにおける「C2~6アルケニルオキシ基」としては、ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などを挙げることができる。
Gにおける「C2~6アルキニルオキシ基」としては、エチニルオキシ基、プロパルギルオキシ基などを挙げることができる。 The "C1-6 alkoxy group" for G includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, an i-butoxy group, Examples include s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
Examples of the "C2-6 alkenyloxy group" for G include a vinyloxy group, an allyloxy group, a propenyloxy group and a butenyloxy group.
Examples of the "C2-6 alkynyloxy group" for G include an ethynyloxy group and a propargyloxy group.
Gにおける「C1~6アルキルチオ基」としては、メチルチオ基、エチルチオ基、n-プロピルチオ基、n-ブチルチオ基、n-ペンチルチオ基、n-ヘキシルチオ基、i-プロピルチオ基などを挙げることができる。
Gにおける「C1~6アルキルスルフィニル基」としては、メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基などを挙げることができる。
Gにおける「C1~6アルキルスルホニル基」としては、メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基などを挙げることができる。 Examples of the "C1-6 alkylthio group" for G include a methylthio group, an ethylthio group, an n-propylthio group, an n-butylthio group, an n-pentylthio group, an n-hexylthio group and an i-propylthio group.
Examples of the "C1-6 alkylsulfinyl group" for G include a methylsulfinyl group, an ethylsulfinyl group and a t-butylsulfinyl group.
Examples of the "C1-6 alkylsulfonyl group" for G include methylsulfonyl group, ethylsulfonyl group, t-butylsulfonyl group and the like.
Gにおける「C1~6アルキルスルフィニル基」としては、メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基などを挙げることができる。
Gにおける「C1~6アルキルスルホニル基」としては、メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基などを挙げることができる。 Examples of the "C1-6 alkylthio group" for G include a methylthio group, an ethylthio group, an n-propylthio group, an n-butylthio group, an n-pentylthio group, an n-hexylthio group and an i-propylthio group.
Examples of the "C1-6 alkylsulfinyl group" for G include a methylsulfinyl group, an ethylsulfinyl group and a t-butylsulfinyl group.
Examples of the "C1-6 alkylsulfonyl group" for G include methylsulfonyl group, ethylsulfonyl group, t-butylsulfonyl group and the like.
Gにおける「C1~6アルキル基」、「C2~6アルケニル基」、「C2~6アルキニル基」、「C1~6アルコキシ基」、「C2~6アルケニルオキシ基」、「C2~6アルキニルオキシ基」、「C1~6アルキルチオ基」、「C1~6アルキルスルフィニル基」、または「C1~6アルキルスルホニル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;メチルチオ基、エチルチオ基などのC1~6アルキルチオ基:メチルスルフィニル基、エチルスルフィニル基などのC1~6アルキルスルフィニル基;メチルスルホニル基、エチルスルホニル基などのC1~6アルキルスルホニル基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。
"C1-6 alkyl group", "C2-6 alkenyl group", "C2-6 alkynyl group", "C1-6 alkoxy group", "C2-6 alkenyloxy group", "C2-6 alkynyloxy group" in G ”, “C1-6 alkylthio group”, “C1-6 alkylsulfinyl group” or “C1-6 alkylsulfonyl group” include halogeno groups such as a fluoro group, a chloro group, a bromo group and an iodo group. hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro- C1-6 haloalkoxy groups such as n-propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C1-6 alkylthio groups such as methylthio group and ethylthio group; C1- such as methylsulfinyl group and ethylsulfinyl group C1-6 alkylsulfonyl groups such as methylsulfonyl group and ethylsulfonyl group; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group; C6 such as phenyl group and naphthyl group ~10 aryl group; C1-6 alkyl group, C1-6 alkoxy such as 4-methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group C6-10 aryl group substituted with one or more substituents selected from group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group , oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, 5-membered heteroaryl group such as tetrazolyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1- 5-membered heteroaryl group substituted with one or more substituents selected from 6 haloalkyl groups or C1-6 haloalkoxy groups; 6-membered rings such as pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group and triazinyl group 6-membered heteroaryl group substituted with any one or more substituents of C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group Aryl groups; or cyano groups are preferred.
Gにおける「C3~6シクロアルキル基」としては、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などを挙げることができる。
Gにおける「C3~6シクロアルキルオキシ基」としては、シクロプロピルオキシ基、シクロブチルオキシ基、シクロペンチルオキシ基、シクロヘキシルオキシ基などを挙げることができる。 Examples of the "C3-6 cycloalkyl group" for G include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
Examples of the "C3-6 cycloalkyloxy group" for G include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group and the like.
Gにおける「C3~6シクロアルキルオキシ基」としては、シクロプロピルオキシ基、シクロブチルオキシ基、シクロペンチルオキシ基、シクロヘキシルオキシ基などを挙げることができる。 Examples of the "C3-6 cycloalkyl group" for G include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
Examples of the "C3-6 cycloalkyloxy group" for G include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group and the like.
Gにおける「C6~10アリール基」としては、フェニル基、ナフチル基などを挙げることができる。
Gにおける「C6~10アリールオキシ基」としては、フェノキシ基、ナフトキシ基などを挙げることができる。 Examples of the "C6-10 aryl group" for G include a phenyl group and a naphthyl group.
Examples of the "C6-10 aryloxy group" for G include a phenoxy group and a naphthoxy group.
Gにおける「C6~10アリールオキシ基」としては、フェノキシ基、ナフトキシ基などを挙げることができる。 Examples of the "C6-10 aryl group" for G include a phenyl group and a naphthyl group.
Examples of the "C6-10 aryloxy group" for G include a phenoxy group and a naphthoxy group.
Gにおける「C6~10アリールチオ基」としては、フェニルチオ基、ナフチルチオ基などを挙げることができる。
Gにおける「C6~10アリールスルフィニル基」としては、フェニルスルフィニル基、ナフチルスルフィニル基などを挙げることができる。
Gにおける「C6~10アリールスルホニル基」としては、フェニルスルホニル基、ナフチルスルホニル基などを挙げることができる。 Examples of the "C6-10 arylthio group" for G include a phenylthio group and a naphthylthio group.
Examples of the "C6-10 arylsulfinyl group" for G include a phenylsulfinyl group and a naphthylsulfinyl group.
Examples of the "C6-10 arylsulfonyl group" for G include a phenylsulfonyl group and a naphthylsulfonyl group.
Gにおける「C6~10アリールスルフィニル基」としては、フェニルスルフィニル基、ナフチルスルフィニル基などを挙げることができる。
Gにおける「C6~10アリールスルホニル基」としては、フェニルスルホニル基、ナフチルスルホニル基などを挙げることができる。 Examples of the "C6-10 arylthio group" for G include a phenylthio group and a naphthylthio group.
Examples of the "C6-10 arylsulfinyl group" for G include a phenylsulfinyl group and a naphthylsulfinyl group.
Examples of the "C6-10 arylsulfonyl group" for G include a phenylsulfonyl group and a naphthylsulfonyl group.
Gにおける「3~10員環のヘテロシクリル基」とは、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1、2、3または4個のヘテロ原子を環の構成原子として含む基である。ヘテロ原子が2個以上であるとき、それらは同じでもよいし、異なってもよい。単環および多環のいずれでもよい。
「3~10員環のヘテロシクリル基」としては、3~6員環の飽和ヘテロシクリル基、5~10員環のヘテロアリール基、5~10員環の部分不飽和ヘテロシクリル基などを挙げることができる。 The "3- to 10-membered heterocyclyl group" for G is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. . When there are two or more heteroatoms, they may be the same or different. It may be monocyclic or polycyclic.
Examples of the "3- to 10-membered heterocyclyl group" include a 3- to 6-membered saturated heterocyclyl group, a 5- to 10-membered heteroaryl group, a 5- to 10-membered partially unsaturated heterocyclyl group, and the like. .
「3~10員環のヘテロシクリル基」としては、3~6員環の飽和ヘテロシクリル基、5~10員環のヘテロアリール基、5~10員環の部分不飽和ヘテロシクリル基などを挙げることができる。 The "3- to 10-membered heterocyclyl group" for G is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. . When there are two or more heteroatoms, they may be the same or different. It may be monocyclic or polycyclic.
Examples of the "3- to 10-membered heterocyclyl group" include a 3- to 6-membered saturated heterocyclyl group, a 5- to 10-membered heteroaryl group, a 5- to 10-membered partially unsaturated heterocyclyl group, and the like. .
3~6員環の飽和ヘテロシクリル基としては、アジリジニル基、エポキシ基、アゼチジニル基、オキセタニル基、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
5~10員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;インドリル基、イソインドリル基、ベンゾフラニル基、ベンゾチエニル基、インダゾリル基、ベンゾイミダゾリル基、ベンゾオキサゾリル基、ベンゾイソオキサオゾリル基、ベンゾチアゾリル基、ベンゾイソチアゾリル基などの9員ヘテロアリール基;キノリニル基、イソキノリニル基、シンノリニル基、フタラジニル基、キナゾリニル基、キノキサリニル基などの10員ヘテロアリール基;を挙げることができる。
5~10員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基;インドリニル基、イソインドリニル基、2,3-ジヒドロベンゾフラニル基、1,3-ジヒドロベンゾフラニル基などの9員環の部分不飽和ヘテロシクリル基;1,2,3,4-テトラヒドロキノリニル基などの10員環の部分不飽和ヘテロシクリル基;を挙げることができる。 3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, A dioxolanyl group, a dioxanyl group and the like can be mentioned.
Examples of 5- to 10-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. 5-membered heteroaryl groups such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl 6-membered heteroaryl groups; indolyl, isoindolyl, benzofuranyl, benzothienyl, indazolyl, 9-membered heteroaryl groups such as benzimidazolyl group, benzoxazolyl group, benzisoxazolyl group, benzothiazolyl group, and benzisothiazolyl group; quinolinyl group, isoquinolinyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group, quinoxalinyl group, etc. 10-membered heteroaryl group;
Examples of 5- to 10-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro 6-membered partially unsaturated heterocyclyl group such as pyranyl; 9-membered partially unsaturated such as indolinyl, isoindolinyl, 2,3-dihydrobenzofuranyl and 1,3-dihydrobenzofuranyl heterocyclyl group; 10-membered ring partially unsaturated heterocyclyl group such as 1,2,3,4-tetrahydroquinolinyl group;
5~10員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;インドリル基、イソインドリル基、ベンゾフラニル基、ベンゾチエニル基、インダゾリル基、ベンゾイミダゾリル基、ベンゾオキサゾリル基、ベンゾイソオキサオゾリル基、ベンゾチアゾリル基、ベンゾイソチアゾリル基などの9員ヘテロアリール基;キノリニル基、イソキノリニル基、シンノリニル基、フタラジニル基、キナゾリニル基、キノキサリニル基などの10員ヘテロアリール基;を挙げることができる。
5~10員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基;インドリニル基、イソインドリニル基、2,3-ジヒドロベンゾフラニル基、1,3-ジヒドロベンゾフラニル基などの9員環の部分不飽和ヘテロシクリル基;1,2,3,4-テトラヒドロキノリニル基などの10員環の部分不飽和ヘテロシクリル基;を挙げることができる。 3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, A dioxolanyl group, a dioxanyl group and the like can be mentioned.
Examples of 5- to 10-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. 5-membered heteroaryl groups such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl 6-membered heteroaryl groups; indolyl, isoindolyl, benzofuranyl, benzothienyl, indazolyl, 9-membered heteroaryl groups such as benzimidazolyl group, benzoxazolyl group, benzisoxazolyl group, benzothiazolyl group, and benzisothiazolyl group; quinolinyl group, isoquinolinyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group, quinoxalinyl group, etc. 10-membered heteroaryl group;
Examples of 5- to 10-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro 6-membered partially unsaturated heterocyclyl group such as pyranyl; 9-membered partially unsaturated such as indolinyl, isoindolinyl, 2,3-dihydrobenzofuranyl and 1,3-dihydrobenzofuranyl heterocyclyl group; 10-membered ring partially unsaturated heterocyclyl group such as 1,2,3,4-tetrahydroquinolinyl group;
Gにおける「3~10員環のヘテロシクリルオキシ基」は、3~10員環のヘテロシクリル基とオキシ基が結合した構造を有する。具体例としては、チアゾリルオキシ基、ピリジルオキシ基などを挙げることができる。
The "3- to 10-membered heterocyclyloxy group" in G has a structure in which a 3- to 10-membered heterocyclyl group and an oxy group are bonded. Specific examples include a thiazolyloxy group and a pyridyloxy group.
Gにおける「C3~6シクロアルキル基」、「C3~6シクロアルキルオキシ基」、「C6~10アリール基」、「C6~10アリールオキシ基」、「C6~10アリールチオ基」、「C6~10アリールスルフィニル基」、「C6~10アリールスルホニル基」、「3~10員環のヘテロシクリル基」、または「3~10員環のヘテロシクリルオキシ基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;C3~6シクロアルキルC1~6アルコキシ基;C6~10アリールC1~6アルコキシ基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルコキシ基;5員環のヘテロアリールC1~6アルコキシ基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール)C1~6アルコキシ基;6員環のヘテロアリールC1~6アルコキシ基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール)C1~6アルコキシ基;メチルチオ基、エチルチオ基などのC1~6アルキルチオ基:メチルスルフィニル基、エチルスルフィニル基などのC1~6アルキルスルフィニル基;メチルスルホニル基、エチルスルホニル基などのC1~6アルキルスルホニル基;トリフルオロメチルチオ基、2,2,2-トリフルオロエチルチオ基などのC1~6ハロアルキルチオ基:トリフルオロメチルスルフィニル基、2,2,2-トリフルオロエチルスルフィニル基などのC1~6ハロアルキルスルフィニル基;トリフルオロメチルスルホニル基、2,2,2-トリフルオロエチルスルホニル基などのC1~6ハロアルキルスルホニル基;シクロプロピル基、シクロブチル基などのC3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、またはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;C3~6シクロアルケニル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;アジリジニル基、エポキシ基、アゼチジニル基、オキセタニル基などの3~4員環の飽和ヘテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された3~4員環の飽和ヘテロシクリル基;ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などの5~6員環の飽和ヘテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環の飽和ヘテロシクリル基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和へテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環の部分飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和ヘテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環の部分飽和ヘテロシクリル基;
RG1-CO-で表される基(式中、RG1は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRG1においても同じ。);
カルボキシ基;
RG2-O-CO-で表される基(式中、RG2は、C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRG2においても同じ。);
RG1RG1N-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RG1RG1N-CO-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RG1-CO-O-で表される基;RG1-CO-NRG3-で表される基(式中、RG3は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;または(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;を示す。以下のRG3においても同じ。);
RG2-O-CO-O-で表される基;RG2-O-CO-NRG3-で表される基;RG1RG1N-CO-O-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RG1RG1N-CO-NRG3-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);RG2SO2-NRG3-で表される基;RG1RG1N-SO2-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RG1-O-N=C(RG4)-で表される基(式中、RG4は、水素原子またはC1~6アルキル基を示す。);(RG1)2C=N-O-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
ペンタフルオロスルファニル基、ニトロ基、またはシアノ基が好ましい。
さらに、「C3~6シクロアルキル基」、「C3~6シクロアルキルオキシ基」、「3~10員環のヘテロシクリル基」、または「3~10員環のヘテロシクリルオキシ基」上の置換基としては、オキソ基も好ましい。 "C3-6 cycloalkyl group", "C3-6 cycloalkyloxy group", "C6-10 aryl group", "C6-10 aryloxy group", "C6-10 arylthio group", "C6-10" in G Arylsulfinyl group", "C6-10 arylsulfonyl group", "3- to 10-membered heterocyclyl group" or "3- to 10-membered heterocyclyloxy group" include a fluoro group, a chloro group, halogeno groups such as bromo group and iodo group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group , C1-6 alkyl groups such as n-hexyl group; C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group group; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro - n-propoxy group, 2,3-dichlorobutoxy group, C1 ~ 6 haloalkoxy group such as trifluoromethoxy group; C3 ~ 6 cycloalkyl C1 ~ 6 alkoxy group; C6 ~ 10 aryl C1 ~ 6 alkoxy group; (C1 ~6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group substituted with one or more substituents C6-10 aryl)C1-6 alkoxy group; 5-membered heteroaryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group with one or more substituents substituted 5-membered heteroaryl) C1-6 alkoxy group; 6-membered heteroaryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or 6-membered ring heteroaryl substituted with one or more substituents of any C1-6 haloalkoxy group) C1-6 alkoxy group; methylthio group, C1-6 alkylthio group such as ethylthio group: methylsulfinyl group, ethyl C1-6 alkylsulfinyl group such as sulfinyl group; C1-6 alkylsulfonyl group such as methylsulfonyl group and ethylsulfonyl group; C such as trifluoromethylthio group and 2,2,2-trifluoroethylthio group 1-6 haloalkylthio group: C1-6 haloalkylsulfinyl group such as trifluoromethylsulfinyl group and 2,2,2-trifluoroethylsulfinyl group; trifluoromethylsulfonyl group and 2,2,2-trifluoroethylsulfonyl group C1-6 haloalkylsulfonyl group such as; C3-6 cycloalkyl group such as cyclopropyl group and cyclobutyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy a C3-6 cycloalkyl group substituted with one or more substituents, or a cyano group; a C3-6 cycloalkenyl group; a phenyl group, a C6-10 aryl group such as a naphthyl group; a 4-methylphenyl group, C1-6 alkyl groups, C1-6 alkoxy groups, halogeno groups, C1-6 haloalkyl groups such as 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, or a C6-10 aryl group substituted with any one or more substituents of a C1-6 haloalkoxy group; an aziridinyl group, an epoxy group, an azetidinyl group, a 3- to 4-membered saturated heterocyclyl group such as an oxetanyl group; 3- to 4-membered saturated heterocyclyl group substituted with one or more substituents selected from a 6-alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; pyrrolidinyl group , tetrahydrofuranyl group, thiazolidinyl group, tetrahydro-2H-pyranyl group, piperidyl group, piperazinyl group, morpholinyl group, dioxolanyl group, 5- to 6-membered saturated heterocyclyl group such as dioxanyl group; C1-6 alkyl group, C1-6 5- to 6-membered saturated heterocyclyl group substituted with one or more substituents selected from an alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; a pyrrolyl group, a furyl group, a thienyl group, 5-membered ring heteroaryl groups such as imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group; C1-6 alkyl group, C1-6 alkoxy group, 5-membered heteroaryl group substituted with one or more substituents selected from a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; 6-membered heteroaryl group such as dazinyl group and triazinyl group; substitution of any one or more of C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 6-membered heteroaryl group substituted with a group; pyrrolinyl group, dihydrofuranyl group, imidazolinyl group, pyrazolinyl group, oxazolinyl group, 5-membered partially unsaturated heterocyclyl group such as isoxazolinyl group; 5-membered ring partially saturated heterocyclyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; dihydropyranyl 6-membered ring partially unsaturated heterocyclyl group such as group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group with one or more substituents a substituted 6-membered partially saturated heterocyclyl group;
a group represented by R G1 —CO— (wherein R G1 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, C1-6 alkyl group substituted with one or more substituents of a phenyl group or a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a haloalkyl group or a C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from ∼6 haloalkyl group or C1-6 haloalkoxy group)C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or a C3-6 cycloalkyl group substituted with one or more substituents of a cyano group; a C6-10 aryl group; a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or C6-10 aryl group substituted with one or more substituents of any one of C1-6 haloalkoxy groups; 5- to 6-membered heteroaryl group; or; C1-6 alkyl group, C1-6 alkoxy group, halogeno group , a C1-6 haloalkyl group, or a C1-6 haloalkoxy group, a 5- to 6-membered heteroaryl group substituted with one or more substituents; The same applies to R G1 below.);
carboxy group;
A group represented by R G2 —O—CO— (wherein R G2 is a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, a phenyl or a C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl C6-10 aryl)C1-6 alkyl group substituted with one or more substituents, or C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1- 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from a 6-haloalkyl group or a C1-6 haloalkoxy group) C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl group C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or C3-6 cycloalkyl group substituted with cyano group; C6-10 aryl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group a C6-10 aryl group substituted with one or more substituents; a 5- to 6-membered heteroaryl group; or; a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1 A 5- to 6-membered heteroaryl group substituted with one or more substituents selected from any one of up to 6 haloalkoxy groups; The same applies to R G2 below.);
A group represented by R G1 R G1 N- (R G1 in the formula may be the same or different. R G1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxy may form a dimethylene group.);
A group represented by R G1 R G1 N—CO— (R G1 in the formula may be the same or different. R G1 together may be a trimethylene group, tetramethylene group, pentamethylene group, or A methyleneoxydimethylene group may be formed.);
a group represented by R G1 -CO-O-; a group represented by R G1 -CO-NR G3 - (wherein R G3 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, C1-6 haloalkoxy group, C3-6 cycloalkyl group, phenyl group, or C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; a C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or (5- to 6-membered heteroaryl substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group) C1-6 alkyl group; The same applies to R G3 below.);
A group represented by R G2 -O-CO-O-; a group represented by R G2 -O-CO-NR G3 -; a group represented by R G1 R G1 N-CO-O- (in the formula R G1 may be the same or different, and R G1 may together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group);
A group represented by R G1 R G1 N—CO—NR G3 — (in the formula, R G1 may be the same or different; R G1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, , or may form a dimethyleneoxydimethylene group); a group represented by R G2 SO 2 —NR G3 —; a group represented by R G1 R G1 N—SO 2 — (in the formula, R G1 may be the same or different, and R G1 together may form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group);
a group represented by R G1 -ON=C(R G4 )- (wherein R G4 represents a hydrogen atom or a C1-6 alkyl group); (R G1 ) 2 C=N-O- A group represented by (R 1 G1 in the formula may be the same or different. RG1 together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group. may be used.);
A pentafluorosulfanyl group, a nitro group, or a cyano group are preferred.
Furthermore, as a substituent on the "C3-6 cycloalkyl group", "C3-6 cycloalkyloxy group", "3- to 10-membered heterocyclyl group", or "3- to 10-membered heterocyclyloxy group" , oxo groups are also preferred.
RG1-CO-で表される基(式中、RG1は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRG1においても同じ。);
カルボキシ基;
RG2-O-CO-で表される基(式中、RG2は、C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRG2においても同じ。);
RG1RG1N-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RG1RG1N-CO-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RG1-CO-O-で表される基;RG1-CO-NRG3-で表される基(式中、RG3は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;または(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;を示す。以下のRG3においても同じ。);
RG2-O-CO-O-で表される基;RG2-O-CO-NRG3-で表される基;RG1RG1N-CO-O-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RG1RG1N-CO-NRG3-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);RG2SO2-NRG3-で表される基;RG1RG1N-SO2-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RG1-O-N=C(RG4)-で表される基(式中、RG4は、水素原子またはC1~6アルキル基を示す。);(RG1)2C=N-O-で表される基(式中のRG1は同一でも異なっていてもよい。RG1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
ペンタフルオロスルファニル基、ニトロ基、またはシアノ基が好ましい。
さらに、「C3~6シクロアルキル基」、「C3~6シクロアルキルオキシ基」、「3~10員環のヘテロシクリル基」、または「3~10員環のヘテロシクリルオキシ基」上の置換基としては、オキソ基も好ましい。 "C3-6 cycloalkyl group", "C3-6 cycloalkyloxy group", "C6-10 aryl group", "C6-10 aryloxy group", "C6-10 arylthio group", "C6-10" in G Arylsulfinyl group", "C6-10 arylsulfonyl group", "3- to 10-membered heterocyclyl group" or "3- to 10-membered heterocyclyloxy group" include a fluoro group, a chloro group, halogeno groups such as bromo group and iodo group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group , C1-6 alkyl groups such as n-hexyl group; C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group group; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro - n-propoxy group, 2,3-dichlorobutoxy group, C1 ~ 6 haloalkoxy group such as trifluoromethoxy group; C3 ~ 6 cycloalkyl C1 ~ 6 alkoxy group; C6 ~ 10 aryl C1 ~ 6 alkoxy group; (C1 ~6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group substituted with one or more substituents C6-10 aryl)C1-6 alkoxy group; 5-membered heteroaryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group with one or more substituents substituted 5-membered heteroaryl) C1-6 alkoxy group; 6-membered heteroaryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or 6-membered ring heteroaryl substituted with one or more substituents of any C1-6 haloalkoxy group) C1-6 alkoxy group; methylthio group, C1-6 alkylthio group such as ethylthio group: methylsulfinyl group, ethyl C1-6 alkylsulfinyl group such as sulfinyl group; C1-6 alkylsulfonyl group such as methylsulfonyl group and ethylsulfonyl group; C such as trifluoromethylthio group and 2,2,2-trifluoroethylthio group 1-6 haloalkylthio group: C1-6 haloalkylsulfinyl group such as trifluoromethylsulfinyl group and 2,2,2-trifluoroethylsulfinyl group; trifluoromethylsulfonyl group and 2,2,2-trifluoroethylsulfonyl group C1-6 haloalkylsulfonyl group such as; C3-6 cycloalkyl group such as cyclopropyl group and cyclobutyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy a C3-6 cycloalkyl group substituted with one or more substituents, or a cyano group; a C3-6 cycloalkenyl group; a phenyl group, a C6-10 aryl group such as a naphthyl group; a 4-methylphenyl group, C1-6 alkyl groups, C1-6 alkoxy groups, halogeno groups, C1-6 haloalkyl groups such as 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, or a C6-10 aryl group substituted with any one or more substituents of a C1-6 haloalkoxy group; an aziridinyl group, an epoxy group, an azetidinyl group, a 3- to 4-membered saturated heterocyclyl group such as an oxetanyl group; 3- to 4-membered saturated heterocyclyl group substituted with one or more substituents selected from a 6-alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; pyrrolidinyl group , tetrahydrofuranyl group, thiazolidinyl group, tetrahydro-2H-pyranyl group, piperidyl group, piperazinyl group, morpholinyl group, dioxolanyl group, 5- to 6-membered saturated heterocyclyl group such as dioxanyl group; C1-6 alkyl group, C1-6 5- to 6-membered saturated heterocyclyl group substituted with one or more substituents selected from an alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; a pyrrolyl group, a furyl group, a thienyl group, 5-membered ring heteroaryl groups such as imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group; C1-6 alkyl group, C1-6 alkoxy group, 5-membered heteroaryl group substituted with one or more substituents selected from a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; 6-membered heteroaryl group such as dazinyl group and triazinyl group; substitution of any one or more of C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 6-membered heteroaryl group substituted with a group; pyrrolinyl group, dihydrofuranyl group, imidazolinyl group, pyrazolinyl group, oxazolinyl group, 5-membered partially unsaturated heterocyclyl group such as isoxazolinyl group; 5-membered ring partially saturated heterocyclyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; dihydropyranyl 6-membered ring partially unsaturated heterocyclyl group such as group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group with one or more substituents a substituted 6-membered partially saturated heterocyclyl group;
a group represented by R G1 —CO— (wherein R G1 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, C1-6 alkyl group substituted with one or more substituents of a phenyl group or a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a haloalkyl group or a C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from ∼6 haloalkyl group or C1-6 haloalkoxy group)C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or a C3-6 cycloalkyl group substituted with one or more substituents of a cyano group; a C6-10 aryl group; a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or C6-10 aryl group substituted with one or more substituents of any one of C1-6 haloalkoxy groups; 5- to 6-membered heteroaryl group; or; C1-6 alkyl group, C1-6 alkoxy group, halogeno group , a C1-6 haloalkyl group, or a C1-6 haloalkoxy group, a 5- to 6-membered heteroaryl group substituted with one or more substituents; The same applies to R G1 below.);
carboxy group;
A group represented by R G2 —O—CO— (wherein R G2 is a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, a phenyl or a C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl C6-10 aryl)C1-6 alkyl group substituted with one or more substituents, or C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1- 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from a 6-haloalkyl group or a C1-6 haloalkoxy group) C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl group C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or C3-6 cycloalkyl group substituted with cyano group; C6-10 aryl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group a C6-10 aryl group substituted with one or more substituents; a 5- to 6-membered heteroaryl group; or; a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1 A 5- to 6-membered heteroaryl group substituted with one or more substituents selected from any one of up to 6 haloalkoxy groups; The same applies to R G2 below.);
A group represented by R G1 R G1 N- (R G1 in the formula may be the same or different. R G1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxy may form a dimethylene group.);
A group represented by R G1 R G1 N—CO— (R G1 in the formula may be the same or different. R G1 together may be a trimethylene group, tetramethylene group, pentamethylene group, or A methyleneoxydimethylene group may be formed.);
a group represented by R G1 -CO-O-; a group represented by R G1 -CO-NR G3 - (wherein R G3 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, C1-6 haloalkoxy group, C3-6 cycloalkyl group, phenyl group, or C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; a C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or (5- to 6-membered heteroaryl substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group) C1-6 alkyl group; The same applies to R G3 below.);
A group represented by R G2 -O-CO-O-; a group represented by R G2 -O-CO-NR G3 -; a group represented by R G1 R G1 N-CO-O- (in the formula R G1 may be the same or different, and R G1 may together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group);
A group represented by R G1 R G1 N—CO—NR G3 — (in the formula, R G1 may be the same or different; R G1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, , or may form a dimethyleneoxydimethylene group); a group represented by R G2 SO 2 —NR G3 —; a group represented by R G1 R G1 N—SO 2 — (in the formula, R G1 may be the same or different, and R G1 together may form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group);
a group represented by R G1 -ON=C(R G4 )- (wherein R G4 represents a hydrogen atom or a C1-6 alkyl group); (R G1 ) 2 C=N-O- A group represented by (R 1 G1 in the formula may be the same or different. RG1 together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group. may be used.);
A pentafluorosulfanyl group, a nitro group, or a cyano group are preferred.
Furthermore, as a substituent on the "C3-6 cycloalkyl group", "C3-6 cycloalkyloxy group", "3- to 10-membered heterocyclyl group", or "3- to 10-membered heterocyclyloxy group" , oxo groups are also preferred.
Gにおける「Ra-CO-で表される基」中、Raは、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の3~10員環のヘテロシクリル基を示す。
In the "group represented by R a -CO-" for G, R a is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted It represents a C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 10-membered heterocyclyl group.
Raにおける「C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、i-ヘキシル基などを挙げることができる。
Raにおける「C2~6アルケニル基」としては、ビニル基、1-プロペニル基などを挙げることができる。
Raにおける「C2~6アルキニル基」としては、エチニル基、1-プロピニル基などを挙げることができる。
Raにおける「C1~6アルキル基」、「C2~6アルケニル基」、または「C2~6アルキニル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;メチルチオ基、エチルチオ基などのC1~6アルキルチオ基:メチルスルフィニル基、エチルスルフィニル基などのC1~6アルキルスルフィニル基;メチルスルホニル基、エチルスルホニル基などのC1~6アルキルスルホニル基;カルボキシ基;メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基、n-ブトキシカルボニル基、t-ブトキシカルボニル基などのC1~6アルコキシカルボニル基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。 The "C1-6 alkyl group" for R a includes methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
Examples of the “C2-6 alkenyl group” for R a include a vinyl group and a 1-propenyl group.
Examples of the “C2-6 alkynyl group” for R a include an ethynyl group and a 1-propynyl group.
Examples of substituents on the "C1-6 alkyl group", "C2-6 alkenyl group", or "C2-6 alkynyl group" in R a include halogeno groups such as fluoro, chloro, bromo, and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n -C1-6 haloalkoxy groups such as propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C1-6 alkylthio groups such as methylthio group and ethylthio group; C1-6 groups such as methylsulfinyl group and ethylsulfinyl group alkylsulfinyl group; methylsulfonyl group, C1-6 alkylsulfonyl group such as ethylsulfonyl group; carboxy group; methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, t -C1 ~ 6 alkoxycarbonyl group such as butoxycarbonyl group; C3 ~ 6 cycloalkyl group such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group; C6 ~ 10 aryl group such as phenyl group and naphthyl group; 4-methyl phenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, etc., C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 C6-10 aryl group substituted with one or more substituents selected from haloalkyl group or C1-6 haloalkoxy group; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl 5-membered ring heteroaryl group such as group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 5-membered heteroaryl group substituted with any one or more substituents of haloalkoxy group; 6-membered heteroaryl group such as pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group; C1-6 a 6-membered heteroaryl group substituted with one or more substituents selected from an alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or cyano groups are preferred.
Raにおける「C2~6アルケニル基」としては、ビニル基、1-プロペニル基などを挙げることができる。
Raにおける「C2~6アルキニル基」としては、エチニル基、1-プロピニル基などを挙げることができる。
Raにおける「C1~6アルキル基」、「C2~6アルケニル基」、または「C2~6アルキニル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;メチルチオ基、エチルチオ基などのC1~6アルキルチオ基:メチルスルフィニル基、エチルスルフィニル基などのC1~6アルキルスルフィニル基;メチルスルホニル基、エチルスルホニル基などのC1~6アルキルスルホニル基;カルボキシ基;メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基、n-ブトキシカルボニル基、t-ブトキシカルボニル基などのC1~6アルコキシカルボニル基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。 The "C1-6 alkyl group" for R a includes methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
Examples of the “C2-6 alkenyl group” for R a include a vinyl group and a 1-propenyl group.
Examples of the “C2-6 alkynyl group” for R a include an ethynyl group and a 1-propynyl group.
Examples of substituents on the "C1-6 alkyl group", "C2-6 alkenyl group", or "C2-6 alkynyl group" in R a include halogeno groups such as fluoro, chloro, bromo, and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n -C1-6 haloalkoxy groups such as propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C1-6 alkylthio groups such as methylthio group and ethylthio group; C1-6 groups such as methylsulfinyl group and ethylsulfinyl group alkylsulfinyl group; methylsulfonyl group, C1-6 alkylsulfonyl group such as ethylsulfonyl group; carboxy group; methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, t -C1 ~ 6 alkoxycarbonyl group such as butoxycarbonyl group; C3 ~ 6 cycloalkyl group such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group; C6 ~ 10 aryl group such as phenyl group and naphthyl group; 4-methyl phenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, etc., C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 C6-10 aryl group substituted with one or more substituents selected from haloalkyl group or C1-6 haloalkoxy group; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl 5-membered ring heteroaryl group such as group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 5-membered heteroaryl group substituted with any one or more substituents of haloalkoxy group; 6-membered heteroaryl group such as pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group; C1-6 a 6-membered heteroaryl group substituted with one or more substituents selected from an alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or cyano groups are preferred.
Raにおける「C3~6シクロアルキル基」としては、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などを挙げることができる。
Raにおける「C6~10アリール基」としては、フェニル基、ナフチル基、インデニル基、インダニル基、テトラリニル基などを挙げることができる。 Examples of the “C3-6 cycloalkyl group” for R a include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
Examples of the “C6-10 aryl group” for R a include a phenyl group, a naphthyl group, an indenyl group, an indanyl group, a tetralinyl group and the like.
Raにおける「C6~10アリール基」としては、フェニル基、ナフチル基、インデニル基、インダニル基、テトラリニル基などを挙げることができる。 Examples of the “C3-6 cycloalkyl group” for R a include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
Examples of the “C6-10 aryl group” for R a include a phenyl group, a naphthyl group, an indenyl group, an indanyl group, a tetralinyl group and the like.
Raにおける「3~10員環のヘテロシクリル基」とは、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1、2、3または4個のヘテロ原子を環の構成原子として含む基である。ヘテロ原子が2個以上であるとき、それらは同じでもよいし、異なってもよい。単環および多環のいずれでもよい。
「3~10員環のヘテロシクリル基」としては、3~6員環の飽和ヘテロシクリル基、5~10員環のヘテロアリール基、5~10員環の部分不飽和ヘテロシクリル基などを挙げることができる。
3~6員環の飽和ヘテロシクリル基としては、アジリジニル基、エポキシ基、アゼチジニル基、オキセタニル基、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
5~10員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;インドリル基、イソインドリル基、ベンゾフラニル基、ベンゾチエニル基、インダゾリル基、ベンゾイミダゾリル基、ベンゾオキサゾリル基、ベンゾイソオキサオゾリル基、ベンゾチアゾリル基、ベンゾイソチアゾリル基などの9員ヘテロアリール基;キノリニル基、イソキノリニル基、シンノリニル基、フタラジニル基、キナゾリニル基、キノキサリニル基などの10員ヘテロアリール基;を挙げることができる。
5~10員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基;インドリニル基、イソインドリニル基、2,3-ジヒドロベンゾフラニル基、1,3-ジヒドロベンゾフラニル基などの9員環の部分不飽和ヘテロシクリル基;1,2,3,4-テトラヒドロキノリニル基などの10員環の部分不飽和ヘテロシクリル基;を挙げることができる。 The “3- to 10-membered heterocyclyl group” for R a is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. be. When there are two or more heteroatoms, they may be the same or different. It may be monocyclic or polycyclic.
Examples of the "3- to 10-membered heterocyclyl group" include a 3- to 6-membered saturated heterocyclyl group, a 5- to 10-membered heteroaryl group, a 5- to 10-membered partially unsaturated heterocyclyl group, and the like. .
3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, Dioxolanyl group, dioxanyl group and the like can be mentioned.
Examples of 5- to 10-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. 5-membered heteroaryl groups such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl 6-membered heteroaryl groups; indolyl, isoindolyl, benzofuranyl, benzothienyl, indazolyl, 9-membered heteroaryl groups such as benzimidazolyl group, benzoxazolyl group, benzisoxazolyl group, benzothiazolyl group, and benzisothiazolyl group; quinolinyl group, isoquinolinyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group, quinoxalinyl group, etc. 10-membered heteroaryl group;
Examples of 5- to 10-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro 6-membered partially unsaturated heterocyclyl group such as pyranyl group; 9-membered partially unsaturated ring such as indolinyl group, isoindolinyl group, 2,3-dihydrobenzofuranyl group, 1,3-dihydrobenzofuranyl group heterocyclyl group; 10-membered ring partially unsaturated heterocyclyl group such as 1,2,3,4-tetrahydroquinolinyl group;
「3~10員環のヘテロシクリル基」としては、3~6員環の飽和ヘテロシクリル基、5~10員環のヘテロアリール基、5~10員環の部分不飽和ヘテロシクリル基などを挙げることができる。
3~6員環の飽和ヘテロシクリル基としては、アジリジニル基、エポキシ基、アゼチジニル基、オキセタニル基、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
5~10員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;インドリル基、イソインドリル基、ベンゾフラニル基、ベンゾチエニル基、インダゾリル基、ベンゾイミダゾリル基、ベンゾオキサゾリル基、ベンゾイソオキサオゾリル基、ベンゾチアゾリル基、ベンゾイソチアゾリル基などの9員ヘテロアリール基;キノリニル基、イソキノリニル基、シンノリニル基、フタラジニル基、キナゾリニル基、キノキサリニル基などの10員ヘテロアリール基;を挙げることができる。
5~10員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基;インドリニル基、イソインドリニル基、2,3-ジヒドロベンゾフラニル基、1,3-ジヒドロベンゾフラニル基などの9員環の部分不飽和ヘテロシクリル基;1,2,3,4-テトラヒドロキノリニル基などの10員環の部分不飽和ヘテロシクリル基;を挙げることができる。 The “3- to 10-membered heterocyclyl group” for R a is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. be. When there are two or more heteroatoms, they may be the same or different. It may be monocyclic or polycyclic.
Examples of the "3- to 10-membered heterocyclyl group" include a 3- to 6-membered saturated heterocyclyl group, a 5- to 10-membered heteroaryl group, a 5- to 10-membered partially unsaturated heterocyclyl group, and the like. .
3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, Dioxolanyl group, dioxanyl group and the like can be mentioned.
Examples of 5- to 10-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. 5-membered heteroaryl groups such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl 6-membered heteroaryl groups; indolyl, isoindolyl, benzofuranyl, benzothienyl, indazolyl, 9-membered heteroaryl groups such as benzimidazolyl group, benzoxazolyl group, benzisoxazolyl group, benzothiazolyl group, and benzisothiazolyl group; quinolinyl group, isoquinolinyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group, quinoxalinyl group, etc. 10-membered heteroaryl group;
Examples of 5- to 10-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro 6-membered partially unsaturated heterocyclyl group such as pyranyl group; 9-membered partially unsaturated ring such as indolinyl group, isoindolinyl group, 2,3-dihydrobenzofuranyl group, 1,3-dihydrobenzofuranyl group heterocyclyl group; 10-membered ring partially unsaturated heterocyclyl group such as 1,2,3,4-tetrahydroquinolinyl group;
Raにおける「C3~6シクロアルキル基」、「C6~10アリール基」、または「3~10員環のヘテロシクリル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;C3~6シクロアルキルC1~6アルコキシ基;C6~10アリールC1~6アルコキシ基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルコキシ基;5員環のヘテロアリールC1~6アルコキシ基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール)C1~6アルコキシ基;6員環のヘテロアリールC1~6アルコキシ基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール)C1~6アルコキシ基;メチルチオ基、エチルチオ基などのC1~6アルキルチオ基:メチルスルフィニル基、エチルスルフィニル基などのC1~6アルキルスルフィニル基;メチルスルホニル基、エチルスルホニル基などのC1~6アルキルスルホニル基;トリフルオロメチルチオ基、2,2,2-トリフルオロエチルチオ基などのC1~6ハロアルキルチオ基:トリフルオロメチルスルフィニル基、2,2,2-トリフルオロエチルスルフィニル基などのC1~6ハロアルキルスルフィニル基;トリフルオロメチルスルホニル基、2,2,2-トリフルオロエチルスルホニル基などのC1~6ハロアルキルスルホニル基;シクロプロピル基、シクロブチル基、シクロペンチル基などのC3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、またはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;C3~6シクロアルケニル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;アジリジニル基、エポキシ基、アゼチジニル基、オキセタニル基などの3~4員環の飽和ヘテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された3~4員環の飽和ヘテロシクリル基;ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などの5~6員環の飽和ヘテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環の飽和ヘテロシクリル基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和へテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環の部分飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和ヘテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環の部分飽和ヘテロシクリル基;
Rq1-CO-で表される基(式中、Rq1は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRq1においても同じ。);
カルボキシ基;
Rq2-O-CO-で表される基(式中、Rq2は、C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRq2において同じ。);
Rq1Rq1N-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
Rq1Rq1N-CO-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
Rq1-CO-O-で表される基;Rq1-CO-NRq3-で表される基(式中、Rq3は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;または(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;を示す。以下のRq3において同じ。);
Rq2-O-CO-O-で表される基;Rq2-O-CO-NRq3-で表される基;Rq1Rq1N-CO-O-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
Rq1Rq1N-CO-NRq3-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);Rq2SO2-NRq3-で表される基;Rq1Rq1N-SO2-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
Rq1-O-N=C(Rq4)-で表される基(式中、Rq4は、水素原子またはC1~6アルキル基を示す。);(Rq1)2C=N-O-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
ペンタフルオロスルファニル基、ニトロ基、またはシアノ基が好ましい。
さらに、「C3~6シクロアルキル基」、または「3~10員環のヘテロシクリル基」上の置換基としては、オキソ基も好ましい。 Substituents on the "C3-6 cycloalkyl group", "C6-10 aryl group", or "3- to 10-membered heterocyclyl group" for R a include a fluoro group, a chloro group, a bromo group, an iodo group, and the like. Halogeno group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc. C1 ~ 6 alkyl group of; chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, C1 ~ 6 haloalkyl group such as 1-fluoro-n-butyl group; hydroxyl group; methoxy group , ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy groups such as t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, C1-6 haloalkoxy group such as trifluoromethoxy group; C3-6 cycloalkyl C1-6 alkoxy group; C6-10 aryl C1-6 alkoxy group; (C1-6 alkyl group, C1 ~6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group substituted with one or more substituents C6-10 aryl)C1-6 alkoxy group; 5-membered ring heteroaryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 5-membered ring substituted with one or more substituents heteroaryl) C1-6 alkoxy group; 6-membered heteroaryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy 6-membered ring heteroaryl substituted with one or more substituents) C1-6 alkoxy group; C1-6 alkylthio group such as methylthio group and ethylthio group; C1- such as methylsulfinyl group and ethylsulfinyl group 6 alkylsulfinyl group; methylsulfonyl group, C1-6 alkylsulfonyl group such as ethylsulfonyl group; trifluoromethylthio group, C1-6 haloalkylthio group such as 2,2,2-trifluoroethylthio group: trifluoromethylsulfinyl a C1-6 haloalkylsulfinyl group such as a 2,2,2-trifluoroethylsulfinyl group; a trifluoromethylsulfonyl group; a 2,2,2-trifluoroethyls C1-6 haloalkylsulfonyl group such as sulphonyl group; C3-6 cycloalkyl group such as cyclopropyl group, cyclobutyl group and cyclopentyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, a C1-6 haloalkoxy group, or a C3-6 cycloalkyl group substituted with one or more substituents of a cyano group; a C3-6 cycloalkenyl group; a phenyl group, a C6-10 aryl group such as a naphthyl group; -C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 such as methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group C6-10 aryl group substituted with one or more substituents selected from ∼6 haloalkyl groups or C1-6 haloalkoxy groups; saturated 3- to 4-membered rings such as aziridinyl groups, epoxy groups, azetidinyl groups and oxetanyl groups; Heterocyclyl group; saturated 3- to 4-membered ring substituted with one or more substituents selected from C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group heterocyclyl group; pyrrolidinyl group, tetrahydrofuranyl group, thiazolidinyl group, tetrahydro-2H-pyranyl group, piperidyl group, piperazinyl group, morpholinyl group, dioxolanyl group, dioxanyl group and other 5- to 6-membered saturated heterocyclyl groups; C1-6 alkyl a 5- to 6-membered saturated heterocyclyl group substituted with one or more substituents selected from a group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; pyrrolyl group, furyl five-membered ring heteroaryl groups such as groups, thienyl groups, imidazolyl groups, pyrazolyl groups, oxazolyl groups, isoxazolyl groups, thiazolyl groups, isothiazolyl groups, triazolyl groups, oxadiazolyl groups, thiadiazolyl groups, tetrazolyl groups; C1-6 alkyl groups, C1 ~6 alkoxy group, halogeno group, C1-6 haloalkyl group, or 5-membered heteroaryl group substituted with one or more substituents of C1-6 haloalkoxy group; pyridyl group, pyrazinyl group, pyrimidinyl group, 6-membered heteroaryl group such as pyridazinyl group and triazinyl group; substitution of one or more of C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group at base Substituted 6-membered heteroaryl group; 5-membered partially unsaturated heterocyclyl group such as pyrrolinyl group, dihydrofuranyl group, imidazolinyl group, pyrazolinyl group, oxazolinyl group, isoxazolinyl group; C1-6 alkyl a 5-membered ring partially saturated heterocyclyl group substituted with one or more substituents selected from a group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; a dihydropyranyl group, etc. 6-membered partially unsaturated heterocyclyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group substituted with one or more substituents a six-membered ring partially saturated heterocyclyl group;
A group represented by R q1 —CO— (wherein R q1 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, C1-6 alkyl group substituted with one or more substituents of a phenyl group or a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a haloalkyl group or a C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from ∼6 haloalkyl group or C1-6 haloalkoxy group)C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or a C3-6 cycloalkyl group substituted with one or more substituents of a cyano group; a C6-10 aryl group; a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or C6-10 aryl group substituted with one or more substituents of any one of C1-6 haloalkoxy groups; 5- to 6-membered heteroaryl group; or; C1-6 alkyl group, C1-6 alkoxy group, halogeno group , a 5- to 6-membered heteroaryl group substituted with one or more substituents selected from a C1-6 haloalkyl group or a C1-6 haloalkoxy group; The same applies to R q1 below.);
carboxy group;
A group represented by R q2 —O—CO— (wherein R q2 is a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, a phenyl or a C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl C6-10 aryl)C1-6 alkyl group substituted with one or more substituents, or C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1- 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from a 6-haloalkyl group or a C1-6 haloalkoxy group) C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl group C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or C3-6 cycloalkyl group substituted with any one or more substituents of cyano group; C6-10 aryl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1 C6-10 aryl group substituted with any one or more substituents of ~6 haloalkoxy group; 5- to 6-membered heteroaryl group; or; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, a 5- to 6-membered heteroaryl group substituted with one or more substituents selected from a C1-6 haloalkyl group or a C1-6 haloalkoxy group; the same applies to R q2 below.);
A group represented by R q1 R q1 N- (R q1 in the formula may be the same or different. R q1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxy may form a dimethylene group.);
A group represented by R q1 R q1 N—CO— (R q1 in the formula may be the same or different. Together, R q1 may be a trimethylene group, a tetramethylene group, a A methyleneoxydimethylene group may be formed.);
a group represented by R q1 —CO—O—; a group represented by R q1 —CO—NR q3 — (wherein R q3 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, C1-6 haloalkoxy group, C3-6 cycloalkyl group, phenyl group, or C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; a C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or (5- to 6-membered heteroaryl substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group) C1-6 alkyl group; The same applies to R q3 below.);
A group represented by R q2 —O—CO—O—; a group represented by R q2 —O—CO—NR q3 —; a group represented by R q1 R q1 N—CO—O— (in the formula R q1 may be the same or different, and R q1 may be combined to form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group.);
A group represented by R q1 R q1 N—CO—NR q3 — (in the formula, R q1 may be the same or different. R q1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, , or may form a dimethyleneoxydimethylene group); a group represented by R q2 SO 2 —NR q3 —; a group represented by R q1 R q1 N—SO 2 — (in the formula, R q1 may be the same or different, and R q1 may be combined to form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group.);
a group represented by R q1 -ON=C(R q4 )- (wherein R q4 represents a hydrogen atom or a C1-6 alkyl group); (R q1 ) 2 C=N-O- (R q1 in the formula may be the same or different. R q1 together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group. may be used.);
A pentafluorosulfanyl group, a nitro group, or a cyano group are preferred.
Furthermore, an oxo group is also preferred as a substituent on the "C3-6 cycloalkyl group" or the "3- to 10-membered heterocyclyl group".
Rq1-CO-で表される基(式中、Rq1は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRq1においても同じ。);
カルボキシ基;
Rq2-O-CO-で表される基(式中、Rq2は、C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRq2において同じ。);
Rq1Rq1N-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
Rq1Rq1N-CO-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
Rq1-CO-O-で表される基;Rq1-CO-NRq3-で表される基(式中、Rq3は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;または(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;を示す。以下のRq3において同じ。);
Rq2-O-CO-O-で表される基;Rq2-O-CO-NRq3-で表される基;Rq1Rq1N-CO-O-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
Rq1Rq1N-CO-NRq3-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);Rq2SO2-NRq3-で表される基;Rq1Rq1N-SO2-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
Rq1-O-N=C(Rq4)-で表される基(式中、Rq4は、水素原子またはC1~6アルキル基を示す。);(Rq1)2C=N-O-で表される基(式中のRq1は同一でも異なっていてもよい。Rq1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
ペンタフルオロスルファニル基、ニトロ基、またはシアノ基が好ましい。
さらに、「C3~6シクロアルキル基」、または「3~10員環のヘテロシクリル基」上の置換基としては、オキソ基も好ましい。 Substituents on the "C3-6 cycloalkyl group", "C6-10 aryl group", or "3- to 10-membered heterocyclyl group" for R a include a fluoro group, a chloro group, a bromo group, an iodo group, and the like. Halogeno group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc. C1 ~ 6 alkyl group of; chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, C1 ~ 6 haloalkyl group such as 1-fluoro-n-butyl group; hydroxyl group; methoxy group , ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy groups such as t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, C1-6 haloalkoxy group such as trifluoromethoxy group; C3-6 cycloalkyl C1-6 alkoxy group; C6-10 aryl C1-6 alkoxy group; (C1-6 alkyl group, C1 ~6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group substituted with one or more substituents C6-10 aryl)C1-6 alkoxy group; 5-membered ring heteroaryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 5-membered ring substituted with one or more substituents heteroaryl) C1-6 alkoxy group; 6-membered heteroaryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy 6-membered ring heteroaryl substituted with one or more substituents) C1-6 alkoxy group; C1-6 alkylthio group such as methylthio group and ethylthio group; C1- such as methylsulfinyl group and ethylsulfinyl group 6 alkylsulfinyl group; methylsulfonyl group, C1-6 alkylsulfonyl group such as ethylsulfonyl group; trifluoromethylthio group, C1-6 haloalkylthio group such as 2,2,2-trifluoroethylthio group: trifluoromethylsulfinyl a C1-6 haloalkylsulfinyl group such as a 2,2,2-trifluoroethylsulfinyl group; a trifluoromethylsulfonyl group; a 2,2,2-trifluoroethyls C1-6 haloalkylsulfonyl group such as sulphonyl group; C3-6 cycloalkyl group such as cyclopropyl group, cyclobutyl group and cyclopentyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, a C1-6 haloalkoxy group, or a C3-6 cycloalkyl group substituted with one or more substituents of a cyano group; a C3-6 cycloalkenyl group; a phenyl group, a C6-10 aryl group such as a naphthyl group; -C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 such as methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group C6-10 aryl group substituted with one or more substituents selected from ∼6 haloalkyl groups or C1-6 haloalkoxy groups; saturated 3- to 4-membered rings such as aziridinyl groups, epoxy groups, azetidinyl groups and oxetanyl groups; Heterocyclyl group; saturated 3- to 4-membered ring substituted with one or more substituents selected from C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group heterocyclyl group; pyrrolidinyl group, tetrahydrofuranyl group, thiazolidinyl group, tetrahydro-2H-pyranyl group, piperidyl group, piperazinyl group, morpholinyl group, dioxolanyl group, dioxanyl group and other 5- to 6-membered saturated heterocyclyl groups; C1-6 alkyl a 5- to 6-membered saturated heterocyclyl group substituted with one or more substituents selected from a group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; pyrrolyl group, furyl five-membered ring heteroaryl groups such as groups, thienyl groups, imidazolyl groups, pyrazolyl groups, oxazolyl groups, isoxazolyl groups, thiazolyl groups, isothiazolyl groups, triazolyl groups, oxadiazolyl groups, thiadiazolyl groups, tetrazolyl groups; C1-6 alkyl groups, C1 ~6 alkoxy group, halogeno group, C1-6 haloalkyl group, or 5-membered heteroaryl group substituted with one or more substituents of C1-6 haloalkoxy group; pyridyl group, pyrazinyl group, pyrimidinyl group, 6-membered heteroaryl group such as pyridazinyl group and triazinyl group; substitution of one or more of C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group at base Substituted 6-membered heteroaryl group; 5-membered partially unsaturated heterocyclyl group such as pyrrolinyl group, dihydrofuranyl group, imidazolinyl group, pyrazolinyl group, oxazolinyl group, isoxazolinyl group; C1-6 alkyl a 5-membered ring partially saturated heterocyclyl group substituted with one or more substituents selected from a group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; a dihydropyranyl group, etc. 6-membered partially unsaturated heterocyclyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group substituted with one or more substituents a six-membered ring partially saturated heterocyclyl group;
A group represented by R q1 —CO— (wherein R q1 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, C1-6 alkyl group substituted with one or more substituents of a phenyl group or a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a haloalkyl group or a C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from ∼6 haloalkyl group or C1-6 haloalkoxy group)C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or a C3-6 cycloalkyl group substituted with one or more substituents of a cyano group; a C6-10 aryl group; a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or C6-10 aryl group substituted with one or more substituents of any one of C1-6 haloalkoxy groups; 5- to 6-membered heteroaryl group; or; C1-6 alkyl group, C1-6 alkoxy group, halogeno group , a 5- to 6-membered heteroaryl group substituted with one or more substituents selected from a C1-6 haloalkyl group or a C1-6 haloalkoxy group; The same applies to R q1 below.);
carboxy group;
A group represented by R q2 —O—CO— (wherein R q2 is a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, a phenyl or a C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl C6-10 aryl)C1-6 alkyl group substituted with one or more substituents, or C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1- 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from a 6-haloalkyl group or a C1-6 haloalkoxy group) C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl group C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or C3-6 cycloalkyl group substituted with any one or more substituents of cyano group; C6-10 aryl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1 C6-10 aryl group substituted with any one or more substituents of ~6 haloalkoxy group; 5- to 6-membered heteroaryl group; or; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, a 5- to 6-membered heteroaryl group substituted with one or more substituents selected from a C1-6 haloalkyl group or a C1-6 haloalkoxy group; the same applies to R q2 below.);
A group represented by R q1 R q1 N- (R q1 in the formula may be the same or different. R q1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxy may form a dimethylene group.);
A group represented by R q1 R q1 N—CO— (R q1 in the formula may be the same or different. Together, R q1 may be a trimethylene group, a tetramethylene group, a A methyleneoxydimethylene group may be formed.);
a group represented by R q1 —CO—O—; a group represented by R q1 —CO—NR q3 — (wherein R q3 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, C1-6 haloalkoxy group, C3-6 cycloalkyl group, phenyl group, or C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; a C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or (5- to 6-membered heteroaryl substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group) C1-6 alkyl group; The same applies to R q3 below.);
A group represented by R q2 —O—CO—O—; a group represented by R q2 —O—CO—NR q3 —; a group represented by R q1 R q1 N—CO—O— (in the formula R q1 may be the same or different, and R q1 may be combined to form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group.);
A group represented by R q1 R q1 N—CO—NR q3 — (in the formula, R q1 may be the same or different. R q1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, , or may form a dimethyleneoxydimethylene group); a group represented by R q2 SO 2 —NR q3 —; a group represented by R q1 R q1 N—SO 2 — (in the formula, R q1 may be the same or different, and R q1 may be combined to form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group.);
a group represented by R q1 -ON=C(R q4 )- (wherein R q4 represents a hydrogen atom or a C1-6 alkyl group); (R q1 ) 2 C=N-O- (R q1 in the formula may be the same or different. R q1 together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group. may be used.);
A pentafluorosulfanyl group, a nitro group, or a cyano group are preferred.
Furthermore, an oxo group is also preferred as a substituent on the "C3-6 cycloalkyl group" or the "3- to 10-membered heterocyclyl group".
「Ra-CO-で表される基」の具体例としては、ホルミル基、アセチル基、i-プロピルカルボニル基などを挙げることができる。
Specific examples of the "group represented by R a -CO-" include a formyl group, an acetyl group, an i-propylcarbonyl group and the like.
Gにおける「Rb-O-CO-で表される基」中、Rbは、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
Rbにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。 In the "group represented by R b -O-CO-" for G, R b is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2 ~6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Specific examples of the substituent for R b are the same as those exemplified for R a .
Rbにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。 In the "group represented by R b -O-CO-" for G, R b is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2 ~6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Specific examples of the substituent for R b are the same as those exemplified for R a .
「Rb-O-CO-で表される基」の具体例としては、メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基、n-ブトキシカルボニル基、t-ブトキシカルボニル基などを挙げることができる。
Specific examples of the "group represented by R b -O-CO-" include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group and a t-butoxycarbonyl group. and the like.
Gにおける「RcRdN-で表される基」中、Rcは、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、Rdは、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、または置換若しくは無置換のC6~10アリール基を示す。
RcまたはRdにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。
Rdにおける「C1~6アルコキシ基」としては、メトキシ基、エトキシ基、n-プロポキシ基、n-ブトキシ基、n-ペンチルオキシ基、n-ヘキシルオキシ基、i-プロポキシ基、i-ブトキシ基、s-ブトキシ基、t-ブトキシ基、i-ヘキシルオキシ基などを挙げることができる。
Rdにおける「C1~6アルコキシ基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;またはシアノ基が好ましい。 In the "group represented by R c R d N-" for G, R c is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted A C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group, and R d is , a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of substituents for R c or R d are the same as those exemplified for R a .
The "C1-6 alkoxy group" in R d includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, and an i-butoxy group. , s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
Examples of substituents on the "C1-6 alkoxy group" in R d include halogeno groups such as fluoro, chloro, bromo and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group , n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, etc. C1 ~ 6 haloalkoxy group of; cyclopropyl group, cyclobutyl group, cyclopentyl group, C3 ~ 6 cycloalkyl group such as cyclohexyl group; phenyl group, C6 ~ 10 aryl group such as naphthyl group; 4-methylphenyl group, 4- C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1 such as methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group A C6-10 aryl group substituted with any one or more substituents of up to 6 haloalkoxy groups; or a cyano group is preferred.
RcまたはRdにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。
Rdにおける「C1~6アルコキシ基」としては、メトキシ基、エトキシ基、n-プロポキシ基、n-ブトキシ基、n-ペンチルオキシ基、n-ヘキシルオキシ基、i-プロポキシ基、i-ブトキシ基、s-ブトキシ基、t-ブトキシ基、i-ヘキシルオキシ基などを挙げることができる。
Rdにおける「C1~6アルコキシ基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;またはシアノ基が好ましい。 In the "group represented by R c R d N-" for G, R c is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted A C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group, and R d is , a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of substituents for R c or R d are the same as those exemplified for R a .
The "C1-6 alkoxy group" in R d includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, and an i-butoxy group. , s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
Examples of substituents on the "C1-6 alkoxy group" in R d include halogeno groups such as fluoro, chloro, bromo and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group , n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, etc. C1 ~ 6 haloalkoxy group of; cyclopropyl group, cyclobutyl group, cyclopentyl group, C3 ~ 6 cycloalkyl group such as cyclohexyl group; phenyl group, C6 ~ 10 aryl group such as naphthyl group; 4-methylphenyl group, 4- C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1 such as methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group A C6-10 aryl group substituted with any one or more substituents of up to 6 haloalkoxy groups; or a cyano group is preferred.
ここで、RcとRdは、一緒になって二価の有機基を形成してもよい。
形成できる二価の有機基としては、置換若しくは無置換のC2~5アルキレン基、置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基、置換若しくは無置換のC1~3アルキレンチオC1~3アルキレン基、または置換若しくは無置換のC1~3アルキレンイミノC1~3アルキレン基などを挙げることができる。
さらに、-CH2CH2-Si(CH3)2-CH2CH2-などのケイ素含有の2価炭化水素基を挙げることができる。
「C2~5アルキレン基」としては、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C1~3アルキレンチオC1~3アルキレン基」としては、ジメチレンチオジメチレン基などを挙げることができる。
「C1~3アルキレンイミノC1~3アルキレン基」としては、ジメチレンイミノジメチレン基、などを挙げることができる。
ここで、「C1~3アルキレンアルキレンイミノC1~3アルキレン基」のイミノ基とは、-NH-を意味する。
「C2~5アルキレン基」、「C1~3アルキレンオキシC1~3アルキレン基」、「C1~3アルキレンチオC1~3アルキレン基」及び「C1~3アルキレンイミノC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;メチリデン基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 Here, R c and R d may together form a divalent organic group.
Examples of divalent organic groups that can be formed include a substituted or unsubstituted C2-5 alkylene group, a substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene group, a substituted or unsubstituted C1-3 alkylenethio C1-3 Examples include an alkylene group, or a substituted or unsubstituted C1-3 alkyleneimino C1-3 alkylene group.
Additionally, mention may be made of silicon-containing divalent hydrocarbon groups such as -CH 2 CH 2 -Si(CH 3 ) 2 -CH 2 CH 2 -.
Examples of the "C2-5 alkylene group" include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Examples of the "C1-3 alkylenethio C1-3 alkylene group" include a dimethylenethiodimethylene group and the like.
Examples of the "C1-3 alkyleneimino C1-3 alkylene group" include a dimethyleneiminodimethylene group and the like.
Here, the imino group of "C1-3 alkylenealkyleneimino C1-3 alkylene group" means -NH-.
Substituents on "C2-5 alkylene group", "C1-3 alkyleneoxy C1-3 alkylene group", "C1-3 alkylenethio C1-3 alkylene group" and "C1-3 alkyleneimino C1-3 alkylene group" Examples include halogeno groups such as a fluoro group, a chloro group, a bromo group and an iodine group; C1-6 alkyl group such as t-butyl group; methylidene group; or C1 such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group ~6 haloalkyl groups are preferred.
形成できる二価の有機基としては、置換若しくは無置換のC2~5アルキレン基、置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基、置換若しくは無置換のC1~3アルキレンチオC1~3アルキレン基、または置換若しくは無置換のC1~3アルキレンイミノC1~3アルキレン基などを挙げることができる。
さらに、-CH2CH2-Si(CH3)2-CH2CH2-などのケイ素含有の2価炭化水素基を挙げることができる。
「C2~5アルキレン基」としては、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C1~3アルキレンチオC1~3アルキレン基」としては、ジメチレンチオジメチレン基などを挙げることができる。
「C1~3アルキレンイミノC1~3アルキレン基」としては、ジメチレンイミノジメチレン基、などを挙げることができる。
ここで、「C1~3アルキレンアルキレンイミノC1~3アルキレン基」のイミノ基とは、-NH-を意味する。
「C2~5アルキレン基」、「C1~3アルキレンオキシC1~3アルキレン基」、「C1~3アルキレンチオC1~3アルキレン基」及び「C1~3アルキレンイミノC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;メチリデン基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 Here, R c and R d may together form a divalent organic group.
Examples of divalent organic groups that can be formed include a substituted or unsubstituted C2-5 alkylene group, a substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene group, a substituted or unsubstituted C1-3 alkylenethio C1-3 Examples include an alkylene group, or a substituted or unsubstituted C1-3 alkyleneimino C1-3 alkylene group.
Additionally, mention may be made of silicon-containing divalent hydrocarbon groups such as -CH 2 CH 2 -Si(CH 3 ) 2 -CH 2 CH 2 -.
Examples of the "C2-5 alkylene group" include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Examples of the "C1-3 alkylenethio C1-3 alkylene group" include a dimethylenethiodimethylene group and the like.
Examples of the "C1-3 alkyleneimino C1-3 alkylene group" include a dimethyleneiminodimethylene group and the like.
Here, the imino group of "C1-3 alkylenealkyleneimino C1-3 alkylene group" means -NH-.
Substituents on "C2-5 alkylene group", "C1-3 alkyleneoxy C1-3 alkylene group", "C1-3 alkylenethio C1-3 alkylene group" and "C1-3 alkyleneimino C1-3 alkylene group" Examples include halogeno groups such as a fluoro group, a chloro group, a bromo group and an iodine group; C1-6 alkyl group such as t-butyl group; methylidene group; or C1 such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group ~6 haloalkyl groups are preferred.
「RcRdN-で表される基」の具体例としては、アミノ基、メチルアミノ基、ジメチルアミノ基、i-プロピルアミノ基などを挙げることができる。
Specific examples of the “group represented by R c R d N—” include amino group, methylamino group, dimethylamino group, i-propylamino group and the like.
Gにおける「RcRdN-CO-で表される基」中、RcおよびRdは上記の「RcRdN-で表される基」におけるそれらと同様の意味を示す。
「RcRdN-CO-で表される基」の具体例としては、カルバモイル基、N,N-ジメチルアミノカルボニル基、N-(i-プロピル)アミノカルボニル基、N-(i-プロピル)-N-メチルアミノカルボニル基などを挙げることができる。 In the “group represented by R c R d N—CO—” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—”.
Specific examples of the “group represented by R c R d N—CO—” include a carbamoyl group, an N,N-dimethylaminocarbonyl group, an N-(i-propyl)aminocarbonyl group, an N-(i-propyl )—N-methylaminocarbonyl group and the like.
「RcRdN-CO-で表される基」の具体例としては、カルバモイル基、N,N-ジメチルアミノカルボニル基、N-(i-プロピル)アミノカルボニル基、N-(i-プロピル)-N-メチルアミノカルボニル基などを挙げることができる。 In the “group represented by R c R d N—CO—” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—”.
Specific examples of the “group represented by R c R d N—CO—” include a carbamoyl group, an N,N-dimethylaminocarbonyl group, an N-(i-propyl)aminocarbonyl group, an N-(i-propyl )—N-methylaminocarbonyl group and the like.
Gにおける「RcRdN-NRd-CO-で表される基」中、RcおよびRdは上記の「RcRdN-で表される基」におけるそれらと同様の意味を示す。
「RcRdN-NRd-CO-で表される基」の具体例としては、2,2-ジメチルヒドラジン-1-カルボニル基などを挙げることができる。 In the “group represented by R c R d N—NR d —CO—” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—” show.
Specific examples of the “group represented by R c R d N—NR d —CO—” include a 2,2-dimethylhydrazine-1-carbonyl group.
「RcRdN-NRd-CO-で表される基」の具体例としては、2,2-ジメチルヒドラジン-1-カルボニル基などを挙げることができる。 In the “group represented by R c R d N—NR d —CO—” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—” show.
Specific examples of the “group represented by R c R d N—NR d —CO—” include a 2,2-dimethylhydrazine-1-carbonyl group.
Gにおける「RbSO2-NRd-CO-で表される基」中、Rbは上記の「Rb-O-CO-で表される基」におけるそれと同様の意味を示し、Rdは上記の「RcRdN-で表される基」におけるそれと同様の意味を示す。
「RbSO2-NRd-CO-で表される基」の具体例としては、(メチルスルホニル)カルバモイル基、(シクロプロピルスルホニル)カルバモイル基、((1-メチルシクロプロピル)スルホニル)カルバモイル基などを挙げることができる。 In the "group represented by R b SO 2 -NR d -CO-" for G, R b has the same meaning as in the above "group represented by R b -O-CO-", and R d has the same meaning as in the above “group represented by R c R d N—”.
Specific examples of the "group represented by R b SO 2 -NR d -CO-" include a (methylsulfonyl)carbamoyl group, a (cyclopropylsulfonyl)carbamoyl group, and a ((1-methylcyclopropyl)sulfonyl)carbamoyl group. etc. can be mentioned.
「RbSO2-NRd-CO-で表される基」の具体例としては、(メチルスルホニル)カルバモイル基、(シクロプロピルスルホニル)カルバモイル基、((1-メチルシクロプロピル)スルホニル)カルバモイル基などを挙げることができる。 In the "group represented by R b SO 2 -NR d -CO-" for G, R b has the same meaning as in the above "group represented by R b -O-CO-", and R d has the same meaning as in the above “group represented by R c R d N—”.
Specific examples of the "group represented by R b SO 2 -NR d -CO-" include a (methylsulfonyl)carbamoyl group, a (cyclopropylsulfonyl)carbamoyl group, and a ((1-methylcyclopropyl)sulfonyl)carbamoyl group. etc. can be mentioned.
Gにおける「Ra-CO-O-で表される基」中、Raは上記の「Ra-CO-で表される基」におけるそれと同様の意味を示す。
「Ra-CO-O-で表される基」の具体例としては、アセチルオキシ基などを挙げることができる。 In the "group represented by R a -CO-O-" for G, R a has the same meaning as in the above "group represented by R a -CO-".
Specific examples of the "group represented by R a -CO-O-" include an acetyloxy group.
「Ra-CO-O-で表される基」の具体例としては、アセチルオキシ基などを挙げることができる。 In the "group represented by R a -CO-O-" for G, R a has the same meaning as in the above "group represented by R a -CO-".
Specific examples of the "group represented by R a -CO-O-" include an acetyloxy group.
Gにおける「Ra-CO-NRe-で表される基」中、Raは上記の「Ra-CO-で表される基」におけるそれと同様の意味を示す。
Reは、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、または置換若しくは無置換のC6~10アリール基を示す。
Reにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。
「Ra-CO-NRe-で表される基」の具体例としては、アセチルアミノ基、プロピオニルアミノ基、ブチリルアミノ基、i-プロピルカルボニルアミノ基などを挙げることができる。 In the "group represented by R a -CO-NR e -" for G, R a has the same meaning as in the above "group represented by R a -CO-".
R e represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of the substituent for R e are the same as those exemplified for R a .
Specific examples of the "group represented by R a -CO-NR e -" include an acetylamino group, a propionylamino group, a butyrylamino group, an i-propylcarbonylamino group and the like.
Reは、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、または置換若しくは無置換のC6~10アリール基を示す。
Reにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。
「Ra-CO-NRe-で表される基」の具体例としては、アセチルアミノ基、プロピオニルアミノ基、ブチリルアミノ基、i-プロピルカルボニルアミノ基などを挙げることができる。 In the "group represented by R a -CO-NR e -" for G, R a has the same meaning as in the above "group represented by R a -CO-".
R e represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of the substituent for R e are the same as those exemplified for R a .
Specific examples of the "group represented by R a -CO-NR e -" include an acetylamino group, a propionylamino group, a butyrylamino group, an i-propylcarbonylamino group and the like.
Gにおける「Ra-CO-CO-NRe-で表される基」中、Raは上記の「Ra-CO-で表される基」におけるそれと同様の意味を示す。Reは、上記の「Ra-CO-NRe-で表される基」におけるそれと同様の意味を示す。
「Ra-CO-CO-NRe-で表される基」の具体例としては、オキソプロパンアミド基などを挙げることができる。 In the "group represented by R a -CO-CO-NR e -" for G, R a has the same meaning as in the above "group represented by R a -CO-". R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the “group represented by R a —CO—CO—NR e —” include an oxopropanamide group.
「Ra-CO-CO-NRe-で表される基」の具体例としては、オキソプロパンアミド基などを挙げることができる。 In the "group represented by R a -CO-CO-NR e -" for G, R a has the same meaning as in the above "group represented by R a -CO-". R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the “group represented by R a —CO—CO—NR e —” include an oxopropanamide group.
Gにおける「Ra-CO-NRe-NRe-で表される基」中、Raは上記の「Ra-CO-で表される基」におけるそれと同様の意味を示す。Reは、上記の「Ra-CO-NRe-で表される基」におけるそれと同様の意味を示す。
「Ra-CO-NRe-NRe-で表される基」の具体例としては、アセチルヒドラジニル基、i-プロピルカルボニルヒドラジニル基などを挙げることができる。 In the "group represented by R a -CO-NR e -NR e -" for G, R a has the same meaning as in the above "group represented by R a -CO-". R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the “group represented by R a —CO—NR e —NR e —” include an acetylhydrazinyl group and an i-propylcarbonylhydrazinyl group.
「Ra-CO-NRe-NRe-で表される基」の具体例としては、アセチルヒドラジニル基、i-プロピルカルボニルヒドラジニル基などを挙げることができる。 In the "group represented by R a -CO-NR e -NR e -" for G, R a has the same meaning as in the above "group represented by R a -CO-". R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the “group represented by R a —CO—NR e —NR e —” include an acetylhydrazinyl group and an i-propylcarbonylhydrazinyl group.
Gにおける「Ra-CO-NRe-NRe-CO-で表される基」中、Raは上記の「Ra-CO-で表される基」におけるそれと同様の意味を示す。Reは、上記の「Ra-CO-NRe-で表される基」におけるそれと同様の意味を示す。
「Ra-CO-NRe-NRe-CO-で表される基」の具体例としては、2-アセチルヒドラジン-1-カルボニル基などを挙げることができる。 In the "group represented by R a -CO-NR e -NR e -CO-" for G, R a has the same meaning as in the above "group represented by R a -CO-". R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the "group represented by R a -CO-NR e -NR e -CO-" include 2-acetylhydrazine-1-carbonyl group.
「Ra-CO-NRe-NRe-CO-で表される基」の具体例としては、2-アセチルヒドラジン-1-カルボニル基などを挙げることができる。 In the "group represented by R a -CO-NR e -NR e -CO-" for G, R a has the same meaning as in the above "group represented by R a -CO-". R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the "group represented by R a -CO-NR e -NR e -CO-" include 2-acetylhydrazine-1-carbonyl group.
Gにおける「Rb-O-CO-O-で表される基」中、Rbは上記の「Rb-O-CO-で表される基」におけるそれと同様の意味を示す。
「Rb-O-CO-O-で表される基」の具体例としては、メトキシカルボニルオキシ基、エトキシカルボニルオキシ基などを挙げることができる。 In the “group represented by R b —O—CO—O—” for G, R b has the same meaning as in the above “group represented by R b —O—CO—”.
Specific examples of the “group represented by R b —O—CO—O—” include a methoxycarbonyloxy group and an ethoxycarbonyloxy group.
「Rb-O-CO-O-で表される基」の具体例としては、メトキシカルボニルオキシ基、エトキシカルボニルオキシ基などを挙げることができる。 In the “group represented by R b —O—CO—O—” for G, R b has the same meaning as in the above “group represented by R b —O—CO—”.
Specific examples of the “group represented by R b —O—CO—O—” include a methoxycarbonyloxy group and an ethoxycarbonyloxy group.
Gにおける「Rb-O-CO-NRe-で表される基」中、Rbは上記の「Rb-O-CO-で表される基」におけるそれと同様の意味を示す。Reは上記の「Rb-CO-NRe-で表される基」におけるそれと同様の意味を示す。
「Rb-O-CO-NRe-で表される基」の具体例としては、メトキシカルボニルアミノ基などを挙げることができる。 In the “group represented by R b —O—CO—NR e —” for G, R b has the same meaning as in the above “group represented by R b —O—CO—”. R e has the same meaning as in the above “group represented by R b —CO—NR e —”.
Specific examples of the “group represented by R b —O—CO—NR e —” include a methoxycarbonylamino group.
「Rb-O-CO-NRe-で表される基」の具体例としては、メトキシカルボニルアミノ基などを挙げることができる。 In the “group represented by R b —O—CO—NR e —” for G, R b has the same meaning as in the above “group represented by R b —O—CO—”. R e has the same meaning as in the above “group represented by R b —CO—NR e —”.
Specific examples of the “group represented by R b —O—CO—NR e —” include a methoxycarbonylamino group.
Gにおける「RcRdN-CO-O-で表される基」中、RcおよびRdは上記の「RcRdN-で表される基」におけるそれらと同様の意味を示す。
「RcRdN-CO-O-で表される基」の具体例としては、カルバモイルオキシ基、N,N-ジメチルアミノカルボニルオキシ基などを挙げることができる。 In the “group represented by R c R d N—CO—O—” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—” .
Specific examples of the “group represented by R c R d N—CO—O—” include a carbamoyloxy group and an N,N-dimethylaminocarbonyloxy group.
「RcRdN-CO-O-で表される基」の具体例としては、カルバモイルオキシ基、N,N-ジメチルアミノカルボニルオキシ基などを挙げることができる。 In the “group represented by R c R d N—CO—O—” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—” .
Specific examples of the “group represented by R c R d N—CO—O—” include a carbamoyloxy group and an N,N-dimethylaminocarbonyloxy group.
Gにおける「RcRdN-CO-NRe-で表される基」中、RcおよびRdは上記の「RcRdN-で表される基」におけるそれらと同様の意味を示す。Reは上記の「Ra-CO-NRe-で表される基」におけるそれと同様の意味を示す。
「RcRdN-CO-NRe-で表される基」の具体例としては、カルバモイルアミノ基、N,N-ジメチルアミノカルボニルアミノ基などを挙げることができる。 In the “group represented by R c R d N—CO—NR e —” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—” show. R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the “group represented by R c R d N—CO—NR e —” include a carbamoylamino group and an N,N-dimethylaminocarbonylamino group.
「RcRdN-CO-NRe-で表される基」の具体例としては、カルバモイルアミノ基、N,N-ジメチルアミノカルボニルアミノ基などを挙げることができる。 In the “group represented by R c R d N—CO—NR e —” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—” show. R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the “group represented by R c R d N—CO—NR e —” include a carbamoylamino group and an N,N-dimethylaminocarbonylamino group.
Gにおける「RcRdN-CO-CO-NRe-で表される基」中、RcおよびRdは上記の「RcRdN-で表される基」におけるそれらと同様の意味を示す。Reは上記の「Ra-CO-NRe-で表される基」におけるそれと同様の意味を示す。
「RcRdN-CO-CO-NRe-で表される基」の具体例としては、2-(メチルアミノ)-2-オキソアセトアミド基、2-(t-ブチルアミノ)-2-オキソアセトアミド基などを挙げることができる。 In the “group represented by R c R d N—CO—CO—NR e —” for G, R c and R d are the same as those in the above “group represented by R c R d N—” indicate meaning. R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the "group represented by R c R d N-CO-CO-NR e -" include 2-(methylamino)-2-oxoacetamide group, 2-(t-butylamino)-2- An oxoacetamide group and the like can be mentioned.
「RcRdN-CO-CO-NRe-で表される基」の具体例としては、2-(メチルアミノ)-2-オキソアセトアミド基、2-(t-ブチルアミノ)-2-オキソアセトアミド基などを挙げることができる。 In the “group represented by R c R d N—CO—CO—NR e —” for G, R c and R d are the same as those in the above “group represented by R c R d N—” indicate meaning. R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the "group represented by R c R d N-CO-CO-NR e -" include 2-(methylamino)-2-oxoacetamide group, 2-(t-butylamino)-2- An oxoacetamide group and the like can be mentioned.
Gにおける「Ra-CS-NRe-で表される基」中、Raは上記の「Ra-CO-で表される基」におけるそれと同様の意味を示す。Reは、上記の「Ra-CO-NRe-で表される基」におけるそれと同様の意味を示す。
「Ra-CS-NRe-で表される基」の具体例としては、エタンチオアミド基、プロパンチオアミド基、2-メチルプロパンチオアミド基などを挙げることができる。 In the "group represented by R a -CS-NR e -" for G, R a has the same meaning as in the above "group represented by R a -CO-". R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the "group represented by R a -CS-NR e -" include an ethanethioamide group, a propanethioamide group, a 2-methylpropanethioamide group and the like.
「Ra-CS-NRe-で表される基」の具体例としては、エタンチオアミド基、プロパンチオアミド基、2-メチルプロパンチオアミド基などを挙げることができる。 In the "group represented by R a -CS-NR e -" for G, R a has the same meaning as in the above "group represented by R a -CO-". R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the "group represented by R a -CS-NR e -" include an ethanethioamide group, a propanethioamide group, a 2-methylpropanethioamide group and the like.
Gにおける「RcRdN-CS-NRe-で表される基」中、RcおよびRdは上記の「RcRdN-で表される基」におけるそれらと同様の意味を示す。Reは上記の「Ra-CO-NRe-で表される基」におけるそれと同様の意味を示す。
「RcRdN-CS-NRe-で表される基」の具体例としては、3,3-ジメチルチオウレイド基などを挙げることができる。 In the “group represented by R c R d N—CS—NR e —” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—” show. R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the “group represented by R c R d N—CS—NR e —” include a 3,3-dimethylthioureido group.
「RcRdN-CS-NRe-で表される基」の具体例としては、3,3-ジメチルチオウレイド基などを挙げることができる。 In the “group represented by R c R d N—CS—NR e —” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—” show. R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the “group represented by R c R d N—CS—NR e —” include a 3,3-dimethylthioureido group.
Gにおける「RbSO2-NRe-で表される基」中、Rbは上記の「Rb-O-CO-で表される基」におけるそれと同様の意味を示す。Reは上記の「Ra-CO-NRe-で表される基」におけるそれと同様の意味を示す。
「RbSO2-NRe-で表される基」の具体例としては、メタンスルホニルアミノ基などを挙げることができる。 In the “group represented by R b SO 2 —NR e —” for G, R b has the same meaning as in the above “group represented by R b —O—CO—”. R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the “group represented by R b SO 2 —NR e —” include a methanesulfonylamino group.
「RbSO2-NRe-で表される基」の具体例としては、メタンスルホニルアミノ基などを挙げることができる。 In the “group represented by R b SO 2 —NR e —” for G, R b has the same meaning as in the above “group represented by R b —O—CO—”. R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Specific examples of the “group represented by R b SO 2 —NR e —” include a methanesulfonylamino group.
Gにおける「RcRdN-SO2-で表される基」中、RcおよびRdは上記の「RcRdN-で表される基」におけるそれらと同様の意味を示す。
「RcRdN-SO2-で表される基」の具体例としては、N,N-ジメチルアミノスルホニル基などを挙げることができる。 In the “group represented by R c R d N—SO 2 —” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—”.
Specific examples of the “group represented by R c R d N—SO 2 —” include an N,N-dimethylaminosulfonyl group.
「RcRdN-SO2-で表される基」の具体例としては、N,N-ジメチルアミノスルホニル基などを挙げることができる。 In the “group represented by R c R d N—SO 2 —” for G, R c and R d have the same meanings as those in the above “group represented by R c R d N—”.
Specific examples of the “group represented by R c R d N—SO 2 —” include an N,N-dimethylaminosulfonyl group.
Gにおける「RaO-N=CRf-で表される基」中、Raは上記の「Ra-CO-で表される基」におけるそれと同様の意味を示す。
Rfは、水素原子、アミノ基、または置換若しくは無置換のC1~6アルキル基を示す。
Rfにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。
「RaO-N=CRf-で表される基」の具体例としては、(ヒドロキシイミノ)メチル基、(エトキシイミノ)メチル基などを挙げることができる。 In the "group represented by R a ON=CR f -" for G, R a has the same meaning as in the above "group represented by R a -CO-".
R f represents a hydrogen atom, an amino group, or a substituted or unsubstituted C1-6 alkyl group.
Specific examples of the substituent for R f are the same as those exemplified for Ra .
Specific examples of the "group represented by R a ON=CR f -" include (hydroxyimino)methyl group and (ethoxyimino)methyl group.
Rfは、水素原子、アミノ基、または置換若しくは無置換のC1~6アルキル基を示す。
Rfにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。
「RaO-N=CRf-で表される基」の具体例としては、(ヒドロキシイミノ)メチル基、(エトキシイミノ)メチル基などを挙げることができる。 In the "group represented by R a ON=CR f -" for G, R a has the same meaning as in the above "group represented by R a -CO-".
R f represents a hydrogen atom, an amino group, or a substituted or unsubstituted C1-6 alkyl group.
Specific examples of the substituent for R f are the same as those exemplified for Ra .
Specific examples of the "group represented by R a ON=CR f -" include (hydroxyimino)methyl group and (ethoxyimino)methyl group.
Gにおける「Ra-C(=NRg)-NRe-で表される基」中、Raは上記の「Ra-CO-で表される基」におけるそれと同様の意味を示す。Reは上記の「Ra-CO-NRe-で表される基」におけるそれと同様の意味を示す。
Rgは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
Rgにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。 In the "group represented by R a -C(=NR g )-NR e -" for G, R a has the same meaning as in the above "group represented by R a -CO-". R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Each R g independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of the substituent for Rg are the same as those exemplified for Ra .
Rgは、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
Rgにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。 In the "group represented by R a -C(=NR g )-NR e -" for G, R a has the same meaning as in the above "group represented by R a -CO-". R e has the same meaning as in the above “group represented by R a —CO—NR e —”.
Each R g independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of the substituent for Rg are the same as those exemplified for Ra .
Gにおける「RcRdN-C(=NRg)-で表される基」中、RcおよびRdは上記の「RcRdN-で表される基」におけるそれらと同様の意味を示す。Rgは上記の「Ra-C(=NRg)-NRe-で表される基」におけるそれと同様の意味を示す。
In the "group represented by R c R d NC(=NR g )-" for G, R c and R d are the same as those in the above "group represented by R c R d N-" indicate meaning. R g has the same meaning as in the above "group represented by R a -C(=NR g )-NR e -".
Gにおける「RhRiS(=O)=N-CO-で表される基」中、Rhは、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、Riは、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
RhまたはRiにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。 In the "group represented by R h R i S(=O)=N-CO-" for G, each R h is independently a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted represents a C6-10 aryl group, and each R i independently represents a substituted or unsubstituted C1-6 alkyl group or a substituted or unsubstituted C6-10 aryl group;
Specific examples of substituents for R h or R i are the same as those exemplified for R a .
RhまたはRiにおける置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。 In the "group represented by R h R i S(=O)=N-CO-" for G, each R h is independently a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted represents a C6-10 aryl group, and each R i independently represents a substituted or unsubstituted C1-6 alkyl group or a substituted or unsubstituted C6-10 aryl group;
Specific examples of substituents for R h or R i are the same as those exemplified for R a .
ここで、RhとRiは、一緒になって二価の有機基を形成してもよい。
形成できる二価の有機基としては、置換若しくは無置換のC2~5アルキレン基または置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基を挙げることができる。
「C2~5アルキレン基」としては、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C2~5アルキレン基」または「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 Here, R h and R i may together form a divalent organic group.
Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
Examples of the "C2-5 alkylene group" include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Examples of substituents on the "C2-5 alkylene group" or "C1-3 alkyleneoxy C1-3 alkylene group" include halogeno groups such as fluoro, chloro, bromo, and iodo groups; methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
形成できる二価の有機基としては、置換若しくは無置換のC2~5アルキレン基または置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基を挙げることができる。
「C2~5アルキレン基」としては、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C2~5アルキレン基」または「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 Here, R h and R i may together form a divalent organic group.
Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
Examples of the "C2-5 alkylene group" include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Examples of substituents on the "C2-5 alkylene group" or "C1-3 alkyleneoxy C1-3 alkylene group" include halogeno groups such as fluoro, chloro, bromo, and iodo groups; methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
Gにおける「RhRiS=N-CO-で表される基」中、RhまたはRiは上記の「RhRiS(=O)=N-CO-で表される基」におけるそれらと同様の意味を示す。
In the "group represented by R h R i S=N--CO-" in G, R h or R i is the above "group represented by R h R i S(=O)=N--CO--" have similar meanings to those in
Gにおける「RhRjC=N-O-で表される基」中、RhおよびRjは上記の「RhRjS=N-O-で表される基」におけるそれと同様の意味を示す。
「RhRjC=N-O-で表される基」の具体例としては、(プロパン-2-イリデンアミノ)オキシ基などを挙げることができる。 In the "group represented by R h R j C=NO-" for G, R h and R j are the same as in the above "group represented by R h R j S=NO-" indicate meaning.
Specific examples of the “group represented by R h R j C═N—O—” include (propan-2-ylideneamino)oxy group and the like.
「RhRjC=N-O-で表される基」の具体例としては、(プロパン-2-イリデンアミノ)オキシ基などを挙げることができる。 In the "group represented by R h R j C=NO-" for G, R h and R j are the same as in the above "group represented by R h R j S=NO-" indicate meaning.
Specific examples of the “group represented by R h R j C═N—O—” include (propan-2-ylideneamino)oxy group and the like.
置換基(G)が2以上ある場合に、そのうちの2つが一緒になって形成できる二価の有機基としては、置換若しくは無置換のC1~5アルキレン基、置換若しくは無置換のオキシC1~4アルキレン基、置換若しくは無置換のオキシC2~3アルキレンオキシ基、または置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基を挙げることができる。
「C1~5アルキレン基」としては、メチレン基、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「オキシC1~4アルキレン基」としては、オキシメチレン基、オキシジメチレン基などを挙げることができる。
「オキシC2~3アルキレンオキシ基」としては、オキシジメチレンオキシ基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C1~5アルキレン基」、「オキシC1~4アルキレン基」、「オキシC2~3アルキレンオキシ基」、「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 When there are two or more substituents (G), the divalent organic groups that can be formed by two of them together include a substituted or unsubstituted C1-5 alkylene group, a substituted or unsubstituted oxy C1-4 An alkylene group, a substituted or unsubstituted oxy C2-3 alkyleneoxy group, or a substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene group can be mentioned.
Examples of the "C1-5 alkylene group" include methylene group, dimethylene group, trimethylene group, tetramethylene group and the like.
Examples of the "oxy C1-4 alkylene group" include an oxymethylene group and an oxydimethylene group.
Examples of the "oxy C2-3 alkyleneoxy group" include an oxydimethylenoxy group.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Substituents on the "C1-5 alkylene group", "oxy-C1-4 alkylene group", "oxy-C2-3 alkyleneoxy group" and "C1-3 alkyleneoxy C1-3 alkylene group" include a fluoro group, chloro Halogeno groups such as group, bromo group and iodo group; C1 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group and t-butyl group ~6 alkyl group; or C1~6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group and 1-fluoro-n-butyl group are preferred.
「C1~5アルキレン基」としては、メチレン基、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「オキシC1~4アルキレン基」としては、オキシメチレン基、オキシジメチレン基などを挙げることができる。
「オキシC2~3アルキレンオキシ基」としては、オキシジメチレンオキシ基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C1~5アルキレン基」、「オキシC1~4アルキレン基」、「オキシC2~3アルキレンオキシ基」、「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 When there are two or more substituents (G), the divalent organic groups that can be formed by two of them together include a substituted or unsubstituted C1-5 alkylene group, a substituted or unsubstituted oxy C1-4 An alkylene group, a substituted or unsubstituted oxy C2-3 alkyleneoxy group, or a substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene group can be mentioned.
Examples of the "C1-5 alkylene group" include methylene group, dimethylene group, trimethylene group, tetramethylene group and the like.
Examples of the "oxy C1-4 alkylene group" include an oxymethylene group and an oxydimethylene group.
Examples of the "oxy C2-3 alkyleneoxy group" include an oxydimethylenoxy group.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Substituents on the "C1-5 alkylene group", "oxy-C1-4 alkylene group", "oxy-C2-3 alkyleneoxy group" and "C1-3 alkyleneoxy C1-3 alkylene group" include a fluoro group, chloro Halogeno groups such as group, bromo group and iodo group; C1 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group and t-butyl group ~6 alkyl group; or C1~6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group and 1-fluoro-n-butyl group are preferred.
本発明において、好ましいGとしては、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換の3~10員環のヘテロシクリル基、Rb-O-CO-で表される基、RcRdN-で表される基、RcRdN-CO-で表される基、Ra-CO-O-で表される基、Ra-CO-NRe-で表される基、Rb-O-CO-NRe-で表される基、RcRdN-CO-O-で表される基、RcRdN-CO-NRe-で表される基、RcRdN-CS-NRe-で表される基、RbSO2-NRe-で表される基、RaO-N=CRf-で表される基、またはRhRiC=N-O-で表される基が挙げることができる。
In the present invention, preferred G is a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, a substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted 3-10 a membered heterocyclyl group, a group represented by R b --O--CO--, a group represented by R c R d N--, a group represented by R c R d N -- CO--, and R a --CO-- A group represented by O—, a group represented by R a —CO—NR e —, a group represented by R b —O—CO—NR e —, a group represented by R c R d N—CO—O— a group represented by R c R d N—CO—NR e —, a group represented by R c R d N—CS—NR e —, a group represented by R b SO 2 —NR e — group, a group represented by R a ON=CR f -, or a group represented by R h R i C=NO-.
〔上記X3以外のX3及びRN1、RN2〕
さらに、X3は、RN1O-で表される基、RN1-CO-O-で表される基、RN1-O-CO-O-で表される基、RN1RN1N-CO-O-で表される基、RN1-CS-O-で表される基、RN1RN1N-CS-O-で表される基、RN1RN2N-で表される基、RN1-CO-NRN2-で表される基、RN1-CO-CO-NRN2-で表される基、RN1-O-CO-NRN2-で表される基、RN1RN1N-CO-NRN2-で表される基、RN1RN1N-CO-CO-NRN2-で表される基、RN1-CS-NRN2-で表される基、RN1RN1N-CS-NRN2-で表される基、RN1SO2-NRN2-で表される基、またはRN1-C(=NRN1)-NRN2-で表される基を示す。 [X 3 and R N1 and R N2 other than X 3 above]
Furthermore, X 3 is a group represented by R N1 O—, a group represented by R N1 —CO—O—, a group represented by R N1 —O—CO—O—, R N1 R N1 N— a group represented by CO--O--, a group represented by R N1 --CS--O--, a group represented by R N1 R N1 N--CS--O--, a group represented by R N1 R N2 N-- , a group represented by R N1 -CO-NR N2 -, a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, R N1 R A group represented by N1 N—CO—NR N2 —, a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS—NR N2 —, R N1 R A group represented by N1 N--CS--NR N2 --, a group represented by R N1 SO 2 --NR N2 --, or a group represented by R N1 --C(=NR N1 )--NR N2 --.
さらに、X3は、RN1O-で表される基、RN1-CO-O-で表される基、RN1-O-CO-O-で表される基、RN1RN1N-CO-O-で表される基、RN1-CS-O-で表される基、RN1RN1N-CS-O-で表される基、RN1RN2N-で表される基、RN1-CO-NRN2-で表される基、RN1-CO-CO-NRN2-で表される基、RN1-O-CO-NRN2-で表される基、RN1RN1N-CO-NRN2-で表される基、RN1RN1N-CO-CO-NRN2-で表される基、RN1-CS-NRN2-で表される基、RN1RN1N-CS-NRN2-で表される基、RN1SO2-NRN2-で表される基、またはRN1-C(=NRN1)-NRN2-で表される基を示す。 [X 3 and R N1 and R N2 other than X 3 above]
Furthermore, X 3 is a group represented by R N1 O—, a group represented by R N1 —CO—O—, a group represented by R N1 —O—CO—O—, R N1 R N1 N— a group represented by CO--O--, a group represented by R N1 --CS--O--, a group represented by R N1 R N1 N--CS--O--, a group represented by R N1 R N2 N-- , a group represented by R N1 -CO-NR N2 -, a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, R N1 R A group represented by N1 N—CO—NR N2 —, a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS—NR N2 —, R N1 R A group represented by N1 N--CS--NR N2 --, a group represented by R N1 SO 2 --NR N2 --, or a group represented by R N1 --C(=NR N1 )--NR N2 --.
RN1、およびRN2は、それぞれ独立に、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示し、ここで、RN1とRN1、またはRN1とRN2は、一緒になって二価の有機基を形成してもよい。
R N1 and R N2 are each independently a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2- 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 4- to 6-membered heterocyclyl group, wherein R N1 and R N1 , or R N1 and R N2 may together form a divalent organic group.
RN1、およびRN2における「直鎖C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基を挙げることができる。
RN1、およびRN2における「直鎖C2~6アルケニル基」としては、ビニル基、1-プロペニル基、2-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基を挙げることができる。
RN1、およびRN2における「直鎖C2~6アルキニル基」としては、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-ヘキシニル基などを挙げることができる。
RN1、およびRN2における「4員環のヘテロシクリル基」しては、アゼチジニル基、オキセタニル基を挙げることができる。
RN1、およびRN2におけるその他の置換基の具体例は、X1において例示したものと同じものを挙げることができる。 Examples of the "linear C1-6 alkyl group" for R N1 and R N2 include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group and n-hexyl group.
The "linear C2-6 alkenyl group" for R N1 and R N2 includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-pentenyl 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl and 5-hexenyl groups.
The "linear C2-6 alkynyl group" for R N1 and R N2 includes an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-hexynyl group and the like.
Examples of the "4-membered heterocyclyl group" for R N1 and R N2 include an azetidinyl group and an oxetanyl group.
Specific examples of other substituents for R N1 and R N2 are the same as those exemplified for X 1 .
RN1、およびRN2における「直鎖C2~6アルケニル基」としては、ビニル基、1-プロペニル基、2-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基を挙げることができる。
RN1、およびRN2における「直鎖C2~6アルキニル基」としては、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-ヘキシニル基などを挙げることができる。
RN1、およびRN2における「4員環のヘテロシクリル基」しては、アゼチジニル基、オキセタニル基を挙げることができる。
RN1、およびRN2におけるその他の置換基の具体例は、X1において例示したものと同じものを挙げることができる。 Examples of the "linear C1-6 alkyl group" for R N1 and R N2 include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group and n-hexyl group.
The "linear C2-6 alkenyl group" for R N1 and R N2 includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-pentenyl 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl and 5-hexenyl groups.
The "linear C2-6 alkynyl group" for R N1 and R N2 includes an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-hexynyl group and the like.
Examples of the "4-membered heterocyclyl group" for R N1 and R N2 include an azetidinyl group and an oxetanyl group.
Specific examples of other substituents for R N1 and R N2 are the same as those exemplified for X 1 .
〔X4〕
X4は、Q-A-で表される基、Q-A-B-で表される基、Q-B-A-で表される基、Q-SO2-NRN3で表される基、Q-C(R7)=N-で表される基、Q-NRN3-SO2-で表される基、Q-N=C(R7)-で表される基、またはQ-B-で表される基を示す。 [ X4 ]
X 4 is a group represented by QA-, a group represented by QA-B-, a group represented by QB-A-, a group represented by Q-SO 2 -NR N3 , a group represented by Q—C(R 7 )=N—, a group represented by Q—NR N3 —SO 2 —, a group represented by QN=C(R 7 )—, or Q— A group represented by B- is shown.
X4は、Q-A-で表される基、Q-A-B-で表される基、Q-B-A-で表される基、Q-SO2-NRN3で表される基、Q-C(R7)=N-で表される基、Q-NRN3-SO2-で表される基、Q-N=C(R7)-で表される基、またはQ-B-で表される基を示す。 [ X4 ]
X 4 is a group represented by QA-, a group represented by QA-B-, a group represented by QB-A-, a group represented by Q-SO 2 -NR N3 , a group represented by Q—C(R 7 )=N—, a group represented by Q—NR N3 —SO 2 —, a group represented by QN=C(R 7 )—, or Q— A group represented by B- is shown.
〔A〕
Aは、置換若しくは無置換のC1~6アルキレン基、置換若しくは無置換のC2~6アルケニレン基、置換若しくは無置換のC2~6アルキニレン基、置換若しくは無置換のC3~6シクロアルキレン基、またはカルボニル基を示す。 [A]
A is a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or carbonyl indicates a group.
Aは、置換若しくは無置換のC1~6アルキレン基、置換若しくは無置換のC2~6アルケニレン基、置換若しくは無置換のC2~6アルキニレン基、置換若しくは無置換のC3~6シクロアルキレン基、またはカルボニル基を示す。 [A]
A is a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or carbonyl indicates a group.
Aにおける「C1~6アルキレン基」としては、メチレン基、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
Aにおける「C2~6アルケニレン基」としては、ビニレン基(-CH=CH-)、ジビニレン基(-CH=CH-CH=CH-)、プロペニレン基(-CH=CH-CH2-、-CH2-CH=CH-)などを挙げることができる。
Aにおける「C2~6アルキニレン基」としては、エチニレン基(-C≡C-)、プロピニレン基(-CH2-C≡C-、-C≡C-CH2-)、などを挙げることができる。
Aにおける「C3~6シクロアルキレン基」としては、1,2-シクロプロピレン基、1,2-シクロブタンジイル基、1,3-シクロブタンジイル基などを挙げることができる。 Examples of the "C1-6 alkylene group" for A include methylene group, dimethylene group, trimethylene group, tetramethylene group and the like.
The "C2-6 alkenylene group" in A includes a vinylene group (-CH=CH-), a divinylene group (-CH=CH-CH=CH-), a propenylene group (-CH=CH-CH 2 -, -CH 2 -CH=CH-) and the like.
Examples of the "C2-6 alkynylene group" for A include an ethynylene group (-C≡C-), a propynylene group (-CH 2 -C≡C-, -C≡C-CH 2 -), and the like. .
Examples of the "C3-6 cycloalkylene group" for A include 1,2-cyclopropylene group, 1,2-cyclobutanediyl group, 1,3-cyclobutanediyl group and the like.
Aにおける「C2~6アルケニレン基」としては、ビニレン基(-CH=CH-)、ジビニレン基(-CH=CH-CH=CH-)、プロペニレン基(-CH=CH-CH2-、-CH2-CH=CH-)などを挙げることができる。
Aにおける「C2~6アルキニレン基」としては、エチニレン基(-C≡C-)、プロピニレン基(-CH2-C≡C-、-C≡C-CH2-)、などを挙げることができる。
Aにおける「C3~6シクロアルキレン基」としては、1,2-シクロプロピレン基、1,2-シクロブタンジイル基、1,3-シクロブタンジイル基などを挙げることができる。 Examples of the "C1-6 alkylene group" for A include methylene group, dimethylene group, trimethylene group, tetramethylene group and the like.
The "C2-6 alkenylene group" in A includes a vinylene group (-CH=CH-), a divinylene group (-CH=CH-CH=CH-), a propenylene group (-CH=CH-CH 2 -, -CH 2 -CH=CH-) and the like.
Examples of the "C2-6 alkynylene group" for A include an ethynylene group (-C≡C-), a propynylene group (-CH 2 -C≡C-, -C≡C-CH 2 -), and the like. .
Examples of the "C3-6 cycloalkylene group" for A include 1,2-cyclopropylene group, 1,2-cyclobutanediyl group, 1,3-cyclobutanediyl group and the like.
本発明において、好ましいAとしては、置換若しくは無置換のC1~6アルキレン基または置換若しくは無置換のC2~6アルケニレン基を挙げることができる。
C1~6アルキレン基またはC2~6アルケニレン基上の置換基としては、以下の置換基群より選択される1または2以上の置換基を挙げることができる(以下、この置換基を記号「Ga」で表すことがある。)。
また、置換基(Ga)は2以上ある場合、そのうちの2つが一緒になって二価の有機基を形成してもよい。以下に置換基群を示す。
ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、メルカプト基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の3~6員環のヘテロシクリル基、置換若しくは無置換の3~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、Ra1-CO-で表される基、カルボキシ基、Rb1-O-CO-で表される基、Rc1Rd1N-で表される基、Rc1Rd1N-CO-で表される基、Ra1-CO-O-で表される基、Ra1-CO-NRe1-で表される基、Rb1-O-CO-O-で表される基、Rb1-O-CO-NRe1-で表される基、Rc1Rd1N-CO-O-で表される基、Rc1Rd1N-CO-NRe1-で表される基、Rb1SO2-NRe1-で表される基、Rc1Rd1N-SO2-で表される基、Ra1O-N=CRf1-で表される基、Rg1Rh1C=N-O-で表される基、オキソ基(O=)、チオキソ基(S=)、Ra1-N=で表される二価の基、Ra1O-N=で表される二価の基、Rc1Rd1N-N=で表される二価の基、Ra1-CO-NRe1-N=で表される二価の基、Rb1-O-CO-NRe1-N=で表される二価の基、Rb1SO2-NRe1-N=で表される二価の基。 In the present invention, A is preferably a substituted or unsubstituted C1-6 alkylene group or a substituted or unsubstituted C2-6 alkenylene group.
Examples of substituents on the C1-6 alkylene group or C2-6 alkenylene group include one or more substituents selected from the following group of substituents (hereinafter, this substituent is denoted by the symbol "Ga" can be expressed as ).
Moreover, when there are two or more substituents (Ga), two of them may be combined to form a divalent organic group. Substituent groups are shown below.
halogeno group, substituted or unsubstituted C1-6 alkyl group, substituted or unsubstituted C2-6 alkenyl group, substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, mercapto group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted Or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6-10 arylsulfonyl group, substituted or unsubstituted 3 to 6-membered heterocyclyl group, substituted or unsubstituted 3- to 6-membered heterocyclyloxy group, nitro group, cyano group, group represented by R a1 —CO—, carboxy group, R b1 —O—CO— a group represented by R c1 R d1 N—, a group represented by R c1 R d1 N—CO—, a group represented by R a1 —CO—O—, R a1 —CO— a group represented by NR e1 —, a group represented by R b1 —O—CO—O—, a group represented by R b1 —O—CO—NR e1 —, R c1 R d1 N—CO—O— a group represented by R c1 R d1 N—CO—NR e1 — a group represented by R b1 SO 2 —NR e1 — a group represented by R c1 R d1 N—SO 2 — group, R a1 ON =CR f1 - group, R g1 R h1 C=NO- group, oxo group (O=), thioxo group (S=), R a1 - a divalent group represented by N=, a divalent group represented by R a1 ON =, a divalent group represented by R c1 R d1 NN=, R a1 -CO-NR e1 -N=, a divalent group represented by R b1 -O-CO-NR e1 -N=, a divalent group represented by R b1 SO 2 -NR e1 -N= base.
C1~6アルキレン基またはC2~6アルケニレン基上の置換基としては、以下の置換基群より選択される1または2以上の置換基を挙げることができる(以下、この置換基を記号「Ga」で表すことがある。)。
また、置換基(Ga)は2以上ある場合、そのうちの2つが一緒になって二価の有機基を形成してもよい。以下に置換基群を示す。
ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、メルカプト基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の3~6員環のヘテロシクリル基、置換若しくは無置換の3~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、Ra1-CO-で表される基、カルボキシ基、Rb1-O-CO-で表される基、Rc1Rd1N-で表される基、Rc1Rd1N-CO-で表される基、Ra1-CO-O-で表される基、Ra1-CO-NRe1-で表される基、Rb1-O-CO-O-で表される基、Rb1-O-CO-NRe1-で表される基、Rc1Rd1N-CO-O-で表される基、Rc1Rd1N-CO-NRe1-で表される基、Rb1SO2-NRe1-で表される基、Rc1Rd1N-SO2-で表される基、Ra1O-N=CRf1-で表される基、Rg1Rh1C=N-O-で表される基、オキソ基(O=)、チオキソ基(S=)、Ra1-N=で表される二価の基、Ra1O-N=で表される二価の基、Rc1Rd1N-N=で表される二価の基、Ra1-CO-NRe1-N=で表される二価の基、Rb1-O-CO-NRe1-N=で表される二価の基、Rb1SO2-NRe1-N=で表される二価の基。 In the present invention, A is preferably a substituted or unsubstituted C1-6 alkylene group or a substituted or unsubstituted C2-6 alkenylene group.
Examples of substituents on the C1-6 alkylene group or C2-6 alkenylene group include one or more substituents selected from the following group of substituents (hereinafter, this substituent is denoted by the symbol "Ga" can be expressed as ).
Moreover, when there are two or more substituents (Ga), two of them may be combined to form a divalent organic group. Substituent groups are shown below.
halogeno group, substituted or unsubstituted C1-6 alkyl group, substituted or unsubstituted C2-6 alkenyl group, substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, mercapto group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted Or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6-10 arylsulfonyl group, substituted or unsubstituted 3 to 6-membered heterocyclyl group, substituted or unsubstituted 3- to 6-membered heterocyclyloxy group, nitro group, cyano group, group represented by R a1 —CO—, carboxy group, R b1 —O—CO— a group represented by R c1 R d1 N—, a group represented by R c1 R d1 N—CO—, a group represented by R a1 —CO—O—, R a1 —CO— a group represented by NR e1 —, a group represented by R b1 —O—CO—O—, a group represented by R b1 —O—CO—NR e1 —, R c1 R d1 N—CO—O— a group represented by R c1 R d1 N—CO—NR e1 — a group represented by R b1 SO 2 —NR e1 — a group represented by R c1 R d1 N—SO 2 — group, R a1 ON =CR f1 - group, R g1 R h1 C=NO- group, oxo group (O=), thioxo group (S=), R a1 - a divalent group represented by N=, a divalent group represented by R a1 ON =, a divalent group represented by R c1 R d1 NN=, R a1 -CO-NR e1 -N=, a divalent group represented by R b1 -O-CO-NR e1 -N=, a divalent group represented by R b1 SO 2 -NR e1 -N= base.
上記の置換基群中、Ra1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
Rb1は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
Rc1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
Rd1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、ここで、Rc1とRd1は、一緒になって二価の有機基を形成してもよい。
Re1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
Rf1は、水素原子、または置換若しくは無置換のC1~6アルキル基を示し、
Rg1は、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
Rh1は、水素原子、または置換若しくは無置換のC1~6アルキル基を示し、ここで、Rg1とRh1は、一緒になって二価の有機基を形成してもよい。 In the above substituent groups, each R a1 is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group , a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R b1 each independently represents a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
Each R c1 is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
Each R d1 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group, wherein R c1 and R d1 are together A divalent organic group may be formed.
R e1 each independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
R f1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group,
R g1 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, substituted or an unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R h1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group, wherein R g1 and R h1 may together form a divalent organic group.
Rb1は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
Rc1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
Rd1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、ここで、Rc1とRd1は、一緒になって二価の有機基を形成してもよい。
Re1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
Rf1は、水素原子、または置換若しくは無置換のC1~6アルキル基を示し、
Rg1は、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
Rh1は、水素原子、または置換若しくは無置換のC1~6アルキル基を示し、ここで、Rg1とRh1は、一緒になって二価の有機基を形成してもよい。 In the above substituent groups, each R a1 is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group , a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R b1 each independently represents a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
Each R c1 is independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
Each R d1 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group, wherein R c1 and R d1 are together A divalent organic group may be formed.
R e1 each independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
R f1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group,
R g1 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, substituted or an unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R h1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group, wherein R g1 and R h1 may together form a divalent organic group.
Gaにおける「ハロゲノ基」としては、フルオロ基、クロロ基、ブロモ基、イオド基などを挙げることができる。
Examples of the "halogeno group" in Ga include a fluoro group, a chloro group, a bromo group, an iodine group, and the like.
Gaにおける「C1~6アルキル基」は、直鎖であってもよいし、分岐鎖であってもよい。Gaにおける「C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、i-ヘキシル基などを挙げることができる。
The "C1-6 alkyl group" in Ga may be linear or branched. The "C1-6 alkyl group" in Ga includes methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s- Butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like can be mentioned.
Gaにおける「C2~6アルケニル基」としては、ビニル基、1-プロペニル基、2-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-メチル-2-プロペニル基、2-メチル-2-プロペニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-メチル-2-ブテニル基、2-メチル-2-ブテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基などを挙げることができる。
The "C2-6 alkenyl group" in Ga includes a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2 -methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group , 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group and the like.
Gaにおける「C2~6アルキニル基」としては、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-メチル-2-プロピニル基、2-メチル-3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-メチル-2-ブチニル基、2-メチル-3-ペンチニル基、1-ヘキシニル基、1,1-ジメチル-2-ブチニル基などを挙げることができる。
The "C2-6 alkynyl group" in Ga includes ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2 -methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group , 1,1-dimethyl-2-butynyl group, and the like.
Gaにおける「C1~6アルコキシ基」としては、メトキシ基、エトキシ基、n-プロポキシ基、n-ブトキシ基、n-ペンチルオキシ基、n-ヘキシルオキシ基、i-プロポキシ基、i-ブトキシ基、s-ブトキシ基、t-ブトキシ基、i-ヘキシルオキシ基などを挙げることができる。
Gaにおける「C2~6アルケニルオキシ基」としては、ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などを挙げることができる。
Gaにおける「C2~6アルキニルオキシ基」としては、エチニルオキシ基、プロパルギルオキシ基などを挙げることができる。 The "C1-6 alkoxy group" for Ga includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, an i-butoxy group, Examples include s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
Examples of the "C2-6 alkenyloxy group" for Ga include a vinyloxy group, an allyloxy group, a propenyloxy group, and a butenyloxy group.
Examples of the "C2-6 alkynyloxy group" for Ga include an ethynyloxy group and a propargyloxy group.
Gaにおける「C2~6アルケニルオキシ基」としては、ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などを挙げることができる。
Gaにおける「C2~6アルキニルオキシ基」としては、エチニルオキシ基、プロパルギルオキシ基などを挙げることができる。 The "C1-6 alkoxy group" for Ga includes a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, an i-butoxy group, Examples include s-butoxy group, t-butoxy group, i-hexyloxy group and the like.
Examples of the "C2-6 alkenyloxy group" for Ga include a vinyloxy group, an allyloxy group, a propenyloxy group, and a butenyloxy group.
Examples of the "C2-6 alkynyloxy group" for Ga include an ethynyloxy group and a propargyloxy group.
Gaにおける「C1~6アルキルチオ基」としては、メチルチオ基、エチルチオ基、n-プロピルチオ基、n-ブチルチオ基、n-ペンチルチオ基、n-ヘキシルチオ基、i-プロピルチオ基などを挙げることができる。
Gaにおける「C1~6アルキルスルフィニル基」としては、メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基などを挙げることができる。
Gaにおける「C1~6アルキルスルホニル基」としては、メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基などを挙げることができる。 Examples of the "C1-6 alkylthio group" for Ga include methylthio, ethylthio, n-propylthio, n-butylthio, n-pentylthio, n-hexylthio, i-propylthio and the like.
Examples of the "C1-6 alkylsulfinyl group" in Ga include methylsulfinyl group, ethylsulfinyl group, t-butylsulfinyl group and the like.
Examples of the "C1-6 alkylsulfonyl group" for Ga include methylsulfonyl group, ethylsulfonyl group, t-butylsulfonyl group and the like.
Gaにおける「C1~6アルキルスルフィニル基」としては、メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基などを挙げることができる。
Gaにおける「C1~6アルキルスルホニル基」としては、メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基などを挙げることができる。 Examples of the "C1-6 alkylthio group" for Ga include methylthio, ethylthio, n-propylthio, n-butylthio, n-pentylthio, n-hexylthio, i-propylthio and the like.
Examples of the "C1-6 alkylsulfinyl group" in Ga include methylsulfinyl group, ethylsulfinyl group, t-butylsulfinyl group and the like.
Examples of the "C1-6 alkylsulfonyl group" for Ga include methylsulfonyl group, ethylsulfonyl group, t-butylsulfonyl group and the like.
Gaにおける「C1~6アルキル基」、「C2~6アルケニル基」、「C2~6アルキニル基」、「C1~6アルコキシ基」、「C2~6アルケニルオキシ基」、「C2~6アルキニルオキシ基」、「C1~6アルキルチオ基」、「C1~6アルキルスルフィニル基」、または「C1~6アルキルスルホニル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;またはシアノ基が好ましい。
Ga "C1-6 alkyl group", "C2-6 alkenyl group", "C2-6 alkynyl group", "C1-6 alkoxy group", "C2-6 alkenyloxy group", "C2-6 alkynyloxy group ”, “C1-6 alkylthio group”, “C1-6 alkylsulfinyl group” or “C1-6 alkylsulfonyl group” include halogeno groups such as a fluoro group, a chloro group, a bromo group and an iodo group. hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro- C1-6 haloalkoxy groups such as n-propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group; phenyl group, C6-10 aryl group such as naphthyl group; C1-6 alkyl group such as 4-methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group , a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group, a C6-10 aryl group substituted with one or more substituents; or a cyano group.
Gaにおける「C3~6シクロアルキル基」としては、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などを挙げることができる。
Gaにおける「C3~6シクロアルキルオキシ基」としては、シクロプロピルオキシ基、シクロブチルオキシ基、シクロペンチルオキシ基、シクロヘキシルオキシ基などを挙げることができる。 Examples of the "C3-6 cycloalkyl group" for Ga include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like.
Examples of the "C3-6 cycloalkyloxy group" for Ga include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group and the like.
Gaにおける「C3~6シクロアルキルオキシ基」としては、シクロプロピルオキシ基、シクロブチルオキシ基、シクロペンチルオキシ基、シクロヘキシルオキシ基などを挙げることができる。 Examples of the "C3-6 cycloalkyl group" for Ga include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like.
Examples of the "C3-6 cycloalkyloxy group" for Ga include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group and the like.
Gaにおける「C6~10アリール基」としては、フェニル基、ナフチル基、インデニル基、インダニル基、テトラリニル基などを挙げることができる。
Gaにおける「C6~10アリールオキシ基」としては、フェノキシ基、ナフトキシ基などを挙げることができる。 Examples of the "C6-10 aryl group" for Ga include a phenyl group, a naphthyl group, an indenyl group, an indanyl group and a tetralinyl group.
Examples of the "C6-10 aryloxy group" for Ga include a phenoxy group and a naphthoxy group.
Gaにおける「C6~10アリールオキシ基」としては、フェノキシ基、ナフトキシ基などを挙げることができる。 Examples of the "C6-10 aryl group" for Ga include a phenyl group, a naphthyl group, an indenyl group, an indanyl group and a tetralinyl group.
Examples of the "C6-10 aryloxy group" for Ga include a phenoxy group and a naphthoxy group.
Gaにおける「C6~10アリールチオ基」としては、フェニルチオ基、ナフチルチオ基などを挙げることができる。
Gaにおける「C6~10アリールスルフィニル基」としては、フェニルスルフィニル基、ナフチルスルフィニル基などを挙げることができる。
Gaにおける「C6~10アリールスルホニル基」としては、フェニルスルホニル基、ナフチルスルホニル基などを挙げることができる。 Examples of the "C6-10 arylthio group" in Ga include a phenylthio group and a naphthylthio group.
Examples of the "C6-10 arylsulfinyl group" for Ga include a phenylsulfinyl group and a naphthylsulfinyl group.
Examples of the “C6-10 arylsulfonyl group” for Ga include a phenylsulfonyl group and a naphthylsulfonyl group.
Gaにおける「C6~10アリールスルフィニル基」としては、フェニルスルフィニル基、ナフチルスルフィニル基などを挙げることができる。
Gaにおける「C6~10アリールスルホニル基」としては、フェニルスルホニル基、ナフチルスルホニル基などを挙げることができる。 Examples of the "C6-10 arylthio group" in Ga include a phenylthio group and a naphthylthio group.
Examples of the "C6-10 arylsulfinyl group" for Ga include a phenylsulfinyl group and a naphthylsulfinyl group.
Examples of the “C6-10 arylsulfonyl group” for Ga include a phenylsulfonyl group and a naphthylsulfonyl group.
Gaにおける「3~6員環のヘテロシクリル基」とは、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1、2、3または4個のヘテロ原子を環の構成原子として含む基である。ヘテロ原子が2個以上であるとき、それらは同じでもよいし、異なってもよい。「3~6員環のヘテロシクリル基」としては、3~6員環の飽和ヘテロシクリル基、5~6員環のヘテロアリール基、5~6員環の部分不飽和ヘテロシクリル基などを挙げることができる。
The "3- to 6-membered heterocyclyl group" for Ga is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. . When there are two or more heteroatoms, they may be the same or different. Examples of the "3- to 6-membered heterocyclyl group" include a 3- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
3~6員環の飽和ヘテロシクリル基としては、アジリジニル基、エポキシ基、アゼチジニル基、オキセタニル基、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
5~6員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基を挙げることができる。
5~6員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基を挙げることができる。 3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, A dioxolanyl group, a dioxanyl group and the like can be mentioned.
Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. and 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
Examples of 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro Six-membered partially unsaturated heterocyclyl groups such as pyranyl groups can be mentioned.
5~6員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基を挙げることができる。
5~6員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基を挙げることができる。 3- to 6-membered saturated heterocyclyl groups include aziridinyl, epoxy, azetidinyl, oxetanyl, pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, A dioxolanyl group, a dioxanyl group and the like can be mentioned.
Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. and 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
Examples of 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro Six-membered partially unsaturated heterocyclyl groups such as pyranyl groups can be mentioned.
Gaにおける「3~6員環のヘテロシクリルオキシ基」は、3~6員環のヘテロシクリル基とオキシ基が結合した構造を有する。具体例としては、チアゾリルオキシ基、ピリジルオキシ基などを挙げることができる。
The "3- to 6-membered heterocyclyloxy group" in Ga has a structure in which a 3- to 6-membered heterocyclyl group and an oxy group are bonded. Specific examples include a thiazolyloxy group and a pyridyloxy group.
Gaにおける「C3~6シクロアルキル基」、「C3~6シクロアルキルオキシ基」、「C6~10アリール基」、「C6~10アリールオキシ基」、「C6~10アリールチオ基」、「C6~10アリールスルフィニル基」、「C6~10アリールスルホニル基」、「3~6員環のヘテロシクリル基」、または「3~6員環のヘテロシクリルオキシ基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;またはシアノ基が好ましい。
Ga "C3-6 cycloalkyl group", "C3-6 cycloalkyloxy group", "C6-10 aryl group", "C6-10 aryloxy group", "C6-10 arylthio group", "C6-10 Arylsulfinyl group", "C6-10 arylsulfonyl group", "3- to 6-membered heterocyclyl group" or "3- to 6-membered heterocyclyloxy group" include a fluoro group, a chloro group, halogeno groups such as bromo group and iodo group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group , C1-6 alkyl groups such as n-hexyl group; C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group group; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro -C1-6 haloalkoxy groups such as n-propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C6-10 aryl groups such as phenyl group and naphthyl group; 4-methylphenyl group and 4-methoxyphenyl a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 A C6-10 aryl group substituted with any one or more substituents of a haloalkoxy group; or a cyano group is preferred.
Gaにおける「Ra1-CO-で表される基」中、Ra1は、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
In the "group represented by R a1 -CO-" for Ga, R a1 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted It represents a C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Ra1における「C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、i-ヘキシル基などを挙げることができる。
Ra1における「C2~6アルケニル基」としては、ビニル基、1-プロペニル基などを挙げることができる。
Ra1における「C2~6アルキニル基」としては、エチニル基、1-プロピニル基などを挙げることができる。
Ra1における「C1~6アルキル基」、「C2~6アルケニル基」、または「C2~6アルキニル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;またはシアノ基が好ましい。 The "C1-6 alkyl group" for R a1 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
Examples of the “C2-6 alkenyl group” for R a1 include a vinyl group and a 1-propenyl group.
Examples of the “C2-6 alkynyl group” for R a1 include an ethynyl group and a 1-propynyl group.
Examples of substituents on the "C1-6 alkyl group", "C2-6 alkenyl group", or "C2-6 alkynyl group" in R a1 include halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n -C1-6 haloalkoxy groups such as propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group; phenyl group, naphthyl a C6-10 aryl group such as a group; a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group such as a 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group; or a C6-10 aryl group substituted with one or more substituents; or a cyano group.
Ra1における「C2~6アルケニル基」としては、ビニル基、1-プロペニル基などを挙げることができる。
Ra1における「C2~6アルキニル基」としては、エチニル基、1-プロピニル基などを挙げることができる。
Ra1における「C1~6アルキル基」、「C2~6アルケニル基」、または「C2~6アルキニル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;またはシアノ基が好ましい。 The "C1-6 alkyl group" for R a1 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
Examples of the “C2-6 alkenyl group” for R a1 include a vinyl group and a 1-propenyl group.
Examples of the “C2-6 alkynyl group” for R a1 include an ethynyl group and a 1-propynyl group.
Examples of substituents on the "C1-6 alkyl group", "C2-6 alkenyl group", or "C2-6 alkynyl group" in R a1 include halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n -C1-6 haloalkoxy groups such as propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group; C3-6 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group; phenyl group, naphthyl a C6-10 aryl group such as a group; a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group such as a 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group; or a C6-10 aryl group substituted with one or more substituents; or a cyano group.
Ra1における「C3~6シクロアルキル基」としては、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などを挙げることができる。
Ra1における「C6~10アリール基」としては、フェニル基、ナフチル基などを挙げることができる。 Examples of the "C3-6 cycloalkyl group" for R a1 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
Examples of the “C6-10 aryl group” for R a1 include a phenyl group and a naphthyl group.
Ra1における「C6~10アリール基」としては、フェニル基、ナフチル基などを挙げることができる。 Examples of the "C3-6 cycloalkyl group" for R a1 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.
Examples of the “C6-10 aryl group” for R a1 include a phenyl group and a naphthyl group.
Ra1における「5~6員環のヘテロシクリル基」とは、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1、2、3または4個のヘテロ原子を環の構成原子として含む基である。ヘテロ原子が2個以上であるとき、それらは同じでもよいし、異なってもよい。「5~6員環のヘテロシクリル基」としては、5~6員環の飽和ヘテロシクリル基、5~6員環のヘテロアリール基、5~6員環の部分不飽和ヘテロシクリル基などを挙げることができる。
5~6員環の飽和ヘテロシクリル基としては、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
5~6員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基を挙げることができる。
5~6員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基を挙げることができる。 The “5- to 6-membered heterocyclyl group” for R a1 is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. be. When there are two or more heteroatoms, they may be the same or different. Examples of the "5- to 6-membered heterocyclyl group" include a 5- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. and 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
Examples of 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro Six-membered partially unsaturated heterocyclyl groups such as pyranyl groups can be mentioned.
5~6員環の飽和ヘテロシクリル基としては、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
5~6員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基を挙げることができる。
5~6員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基を挙げることができる。 The “5- to 6-membered heterocyclyl group” for R a1 is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring-constituting atoms. be. When there are two or more heteroatoms, they may be the same or different. Examples of the "5- to 6-membered heterocyclyl group" include a 5- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group, and the like. .
Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
Examples of 5- to 6-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. and 6-membered heteroaryl groups such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group and a triazinyl group.
Examples of 5- to 6-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro Six-membered partially unsaturated heterocyclyl groups such as pyranyl groups can be mentioned.
Ra1における「C3~6シクロアルキル基」、「C6~10アリール基」、または「5~6員環のヘテロシクリル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;またはシアノ基が好ましい。
Examples of substituents on the "C3-6 cycloalkyl group", "C6-10 aryl group", or "5- to 6-membered heterocyclyl group" for R a1 include a fluoro group, a chloro group, a bromo group, an iodo group, and the like. Halogeno group; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc. C1 ~ 6 alkyl group of; chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, C1 ~ 6 haloalkyl group such as 1-fluoro-n-butyl group; hydroxyl group; methoxy group , ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy groups such as t-butoxy group; 2-chloro-n-propoxy group, C1-6 haloalkoxy groups such as 2,3-dichlorobutoxy group and trifluoromethoxy group; C6-10 aryl groups such as phenyl group and naphthyl group; 4-methylphenyl group, 4-methoxyphenyl group and 4-chlorophenyl group , 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, etc., a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group C6-10 aryl groups substituted with one or more substituents; or cyano groups are preferred.
「Ra1-CO-で表される基」の具体例としては、ホルミル基、アセチル基などを挙げることができる。
Specific examples of the "group represented by R a1 -CO-" include a formyl group and an acetyl group.
Gaにおける「Rb1-O-CO-で表される基」中、Rb1は、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示す。
Rb1における置換基の具体例は、Ra1において例示したものと同じものを挙げることができる。 In the "group represented by R b1 -O-CO-" for Ga, R b1 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2 ~6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Specific examples of the substituent for R b1 are the same as those exemplified for R a1 .
Rb1における置換基の具体例は、Ra1において例示したものと同じものを挙げることができる。 In the "group represented by R b1 -O-CO-" for Ga, R b1 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2 ~6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group.
Specific examples of the substituent for R b1 are the same as those exemplified for R a1 .
「Rb1-O-CO-で表される基」の具体例としては、メトキシカルボニル基、エトキシカルボニル基、t-ブトキシカルボニル基などを挙げることができる。
Specific examples of the "group represented by R b1 -O-CO-" include a methoxycarbonyl group, an ethoxycarbonyl group, a t-butoxycarbonyl group and the like.
Gaにおける「Rc1Rd1N-で表される基」中、Rc1は、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、Rd1は、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
Rc1またはRd1における置換基の具体例は、Ra1において例示したものと同じものを挙げることができる。
ここで、Rc1とRd1は、一緒になって二価の有機基を形成してもよい。
形成できる二価の有機基としては、置換若しくは無置換のC2~5アルキレン基または置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基を挙げることができる。
「C2~5アルキレン基」としては、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C2~5アルキレン基」または「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 In the "group represented by R c1 R d1 N-" for Ga, R c1 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted A C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group, and R d1 is , a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of the substituent for R c1 or R d1 are the same as those exemplified for R a1 .
Here, R c1 and R d1 may together form a divalent organic group.
Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
Examples of the "C2-5 alkylene group" include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Examples of substituents on the "C2-5 alkylene group" or "C1-3 alkyleneoxy C1-3 alkylene group" include halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group; methyl group, ethyl group, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
Rc1またはRd1における置換基の具体例は、Ra1において例示したものと同じものを挙げることができる。
ここで、Rc1とRd1は、一緒になって二価の有機基を形成してもよい。
形成できる二価の有機基としては、置換若しくは無置換のC2~5アルキレン基または置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基を挙げることができる。
「C2~5アルキレン基」としては、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C2~5アルキレン基」または「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 In the "group represented by R c1 R d1 N-" for Ga, R c1 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted A C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group, and R d1 is , a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of the substituent for R c1 or R d1 are the same as those exemplified for R a1 .
Here, R c1 and R d1 may together form a divalent organic group.
Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
Examples of the "C2-5 alkylene group" include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Examples of substituents on the "C2-5 alkylene group" or "C1-3 alkyleneoxy C1-3 alkylene group" include halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group; methyl group, ethyl group, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
「Rc1Rd1N-で表される基」の具体例としては、アミノ基、メチルアミノ基、ジメチルアミノ基などを挙げることができる。
Specific examples of the "group represented by R c1 R d1 N-" include an amino group, a methylamino group and a dimethylamino group.
Gaにおける「Rc1Rd1N-CO-で表される基」中、Rc1およびRd1は上記の「Rc1Rd1N-で表される基」におけるそれらと同様の意味を示す。
「Rc1Rd1N-CO-で表される基」の具体例としては、カルバモイル基、N,N-ジメチルアミノカルボニル基、N-(i-プロピル)アミノカルボニル基、N-(i-プロピル)-N-メチルアミノカルボニル基などを挙げることができる。 In the "group represented by R c1 R d1 N--CO--" in Ga, R c1 and R d1 have the same meanings as in the above "group represented by R c1 R d1 N--".
Specific examples of the “group represented by R c1 R d1 N—CO—” include a carbamoyl group, an N,N-dimethylaminocarbonyl group, an N-(i-propyl)aminocarbonyl group, and an N-(i-propyl )—N-methylaminocarbonyl group and the like.
「Rc1Rd1N-CO-で表される基」の具体例としては、カルバモイル基、N,N-ジメチルアミノカルボニル基、N-(i-プロピル)アミノカルボニル基、N-(i-プロピル)-N-メチルアミノカルボニル基などを挙げることができる。 In the "group represented by R c1 R d1 N--CO--" in Ga, R c1 and R d1 have the same meanings as in the above "group represented by R c1 R d1 N--".
Specific examples of the “group represented by R c1 R d1 N—CO—” include a carbamoyl group, an N,N-dimethylaminocarbonyl group, an N-(i-propyl)aminocarbonyl group, and an N-(i-propyl )—N-methylaminocarbonyl group and the like.
Gaにおける「Ra1-CO-O-で表される基」中、Ra1は上記の「Ra1-CO-で表される基」におけるそれと同様の意味を示す。
「Ra1-CO-O-で表される基」の具体例としては、アセチルオキシ基などを挙げることができる。 In the "group represented by R a1 -CO-O-" for Ga, R a1 has the same meaning as in the above "group represented by R a1 -CO-".
Specific examples of the "group represented by R a1 -CO-O-" include an acetyloxy group.
「Ra1-CO-O-で表される基」の具体例としては、アセチルオキシ基などを挙げることができる。 In the "group represented by R a1 -CO-O-" for Ga, R a1 has the same meaning as in the above "group represented by R a1 -CO-".
Specific examples of the "group represented by R a1 -CO-O-" include an acetyloxy group.
Gaにおける「Ra1-CO-NRe1-で表される基」中、Ra1は上記の「Ra1-CO-で表される基」におけるそれと同様の意味を示す。
Re1は、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
Re1における置換基の具体例は、Ra1において例示したものと同じものを挙げることができる。
「Ra1-CO-NRe1-で表される基」の具体例としては、アセチルアミノ基などを挙げることができる。 In the "group represented by R a1 -CO-NR e1 -" for Ga, R a1 has the same meaning as in the above "group represented by R a1 -CO-".
R e1 represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of the substituent for R e1 are the same as those exemplified for R a1 .
Specific examples of the "group represented by R a1 -CO-NR e1 -" include an acetylamino group.
Re1は、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示す。
Re1における置換基の具体例は、Ra1において例示したものと同じものを挙げることができる。
「Ra1-CO-NRe1-で表される基」の具体例としては、アセチルアミノ基などを挙げることができる。 In the "group represented by R a1 -CO-NR e1 -" for Ga, R a1 has the same meaning as in the above "group represented by R a1 -CO-".
R e1 represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group.
Specific examples of the substituent for R e1 are the same as those exemplified for R a1 .
Specific examples of the "group represented by R a1 -CO-NR e1 -" include an acetylamino group.
Gaにおける「Rb1-O-CO-O-で表される基」中、Rb1は上記の「Rb1-O-CO-で表される基」におけるそれと同様の意味を示す。
「Rb1-O-CO-O-で表される基」の具体例としては、メトキシカルボニルオキシ基、エトキシカルボニルオキシ基などを挙げることができる。 In the “group represented by R b1 —O—CO—O—” for Ga, R b1 has the same meaning as in the above “group represented by R b1 —O—CO—”.
Specific examples of the "group represented by R b1 -O-CO-O-" include a methoxycarbonyloxy group and an ethoxycarbonyloxy group.
「Rb1-O-CO-O-で表される基」の具体例としては、メトキシカルボニルオキシ基、エトキシカルボニルオキシ基などを挙げることができる。 In the “group represented by R b1 —O—CO—O—” for Ga, R b1 has the same meaning as in the above “group represented by R b1 —O—CO—”.
Specific examples of the "group represented by R b1 -O-CO-O-" include a methoxycarbonyloxy group and an ethoxycarbonyloxy group.
Gaにおける「Rb1-O-CO-NRe1-で表される基」中、Rb1は上記の「Rb1-O-CO-で表される基」におけるそれと同様の意味を示す。Re1は上記の「Rb1-CO-NRe1-で表される基」におけるそれと同様の意味を示す。
「Rb1-O-CO-NRe1-で表される基」の具体例としては、メトキシカルボニルアミノ基などを挙げることができる。 In the “group represented by R b1 —O—CO—NR e1 —” for Ga, R b1 has the same meaning as in the above “group represented by R b1 —O—CO—”. R e1 has the same meaning as in the above “group represented by R b1 —CO—NR e1 —”.
Specific examples of the “group represented by R b1 —O—CO—NR e1 —” include a methoxycarbonylamino group.
「Rb1-O-CO-NRe1-で表される基」の具体例としては、メトキシカルボニルアミノ基などを挙げることができる。 In the “group represented by R b1 —O—CO—NR e1 —” for Ga, R b1 has the same meaning as in the above “group represented by R b1 —O—CO—”. R e1 has the same meaning as in the above “group represented by R b1 —CO—NR e1 —”.
Specific examples of the “group represented by R b1 —O—CO—NR e1 —” include a methoxycarbonylamino group.
Gaにおける「Rc1Rd1N-CO-O-で表される基」中、Rc1およびRd1は上記の「Rc1Rd1N-で表される基」におけるそれらと同様の意味を示す。
「Rc1Rd1N-CO-O-で表される基」の具体例としては、カルバモイルオキシ基、N,N-ジメチルアミノカルボニルオキシ基などを挙げることができる。 In the “group represented by R c1 R d1 N—CO—O—” for Ga, R c1 and R d1 have the same meanings as those in the above “group represented by R c1 R d1 N—” .
Specific examples of the “group represented by R c1 R d1 N—CO—O—” include a carbamoyloxy group and an N,N-dimethylaminocarbonyloxy group.
「Rc1Rd1N-CO-O-で表される基」の具体例としては、カルバモイルオキシ基、N,N-ジメチルアミノカルボニルオキシ基などを挙げることができる。 In the “group represented by R c1 R d1 N—CO—O—” for Ga, R c1 and R d1 have the same meanings as those in the above “group represented by R c1 R d1 N—” .
Specific examples of the “group represented by R c1 R d1 N—CO—O—” include a carbamoyloxy group and an N,N-dimethylaminocarbonyloxy group.
Gaにおける「Rc1Rd1N-CO-NRe1-で表される基」中、Rc1およびRd1は上記の「Rc1Rd1N-で表される基」におけるそれらと同様の意味を示す。Re1は上記の「Ra1-CO-NRe1-で表される基」におけるそれと同様の意味を示す。
「Rc1Rd1N-CO-NRe1-で表される基」の具体例としては、カルバモイルアミノ基、N,N-ジメチルアミノカルボニルアミノ基などを挙げることができる。 In the "group represented by R c1 R d1 N-CO-NR e1 -" for Ga, R c1 and R d1 have the same meanings as those in the above "group represented by R c1 R d1 N-". show. R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
Specific examples of the “group represented by R c1 R d1 N—CO—NR e1 —” include a carbamoylamino group and an N,N-dimethylaminocarbonylamino group.
「Rc1Rd1N-CO-NRe1-で表される基」の具体例としては、カルバモイルアミノ基、N,N-ジメチルアミノカルボニルアミノ基などを挙げることができる。 In the "group represented by R c1 R d1 N-CO-NR e1 -" for Ga, R c1 and R d1 have the same meanings as those in the above "group represented by R c1 R d1 N-". show. R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
Specific examples of the “group represented by R c1 R d1 N—CO—NR e1 —” include a carbamoylamino group and an N,N-dimethylaminocarbonylamino group.
Gaにおける「Rb1SO2-NRe1-で表される基」中、Rb1は上記の「Rb1-O-CO-で表される基」におけるそれと同様の意味を示す。Re1は上記の「Ra1-CO-NRe1-で表される基」におけるそれと同様の意味を示す。
「Rb1SO2-NRe1-で表される基」の具体例としては、メタンスルホニルアミノ基などを挙げることができる。 In the “group represented by R b1 SO 2 —NR e1 —” for Ga, R b1 has the same meaning as in the above “group represented by R b1 —O—CO—”. R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
Specific examples of the “group represented by R b1 SO 2 —NR e1 —” include a methanesulfonylamino group and the like.
「Rb1SO2-NRe1-で表される基」の具体例としては、メタンスルホニルアミノ基などを挙げることができる。 In the “group represented by R b1 SO 2 —NR e1 —” for Ga, R b1 has the same meaning as in the above “group represented by R b1 —O—CO—”. R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
Specific examples of the “group represented by R b1 SO 2 —NR e1 —” include a methanesulfonylamino group and the like.
Gaにおける「Rc1Rd1N-SO2-で表される基」中、Rc1およびRd1は上記の「Rc1Rd1N-で表される基」におけるそれらと同様の意味を示す。
「Rc1Rd1N-SO2-で表される基」の具体例としては、N,N-ジメチルアミノスルホニル基などを挙げることができる。 In the “group represented by R c1 R d1 N—SO 2 —” for Ga, R c1 and R d1 have the same meanings as those in the above “group represented by R c1 R d1 N—”.
Specific examples of the “group represented by R c1 R d1 N—SO 2 —” include an N,N-dimethylaminosulfonyl group.
「Rc1Rd1N-SO2-で表される基」の具体例としては、N,N-ジメチルアミノスルホニル基などを挙げることができる。 In the “group represented by R c1 R d1 N—SO 2 —” for Ga, R c1 and R d1 have the same meanings as those in the above “group represented by R c1 R d1 N—”.
Specific examples of the “group represented by R c1 R d1 N—SO 2 —” include an N,N-dimethylaminosulfonyl group.
Gaにおける「Ra1O-N=CRf1-で表される基」中、Ra1は上記の「Ra1-CO-で表される基」におけるそれと同様の意味を示す。
Rf1は、水素原子、または置換若しくは無置換のC1~6アルキル基を示す。
Rf1における置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。
「Ra1O-N=CRf1-で表される基」の具体例としては、(ヒドロキシイミノ)メチル基、(エトキシイミノ)メチル基などを挙げることができる。 In the "group represented by R a1 ON=CR f1 -" for Ga, R a1 has the same meaning as in the above "group represented by R a1 -CO-".
R f1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
Specific examples of the substituent for R f1 are the same as those exemplified for Ra .
Specific examples of the "group represented by R a1 ON =CR f1 -" include (hydroxyimino)methyl group and (ethoxyimino)methyl group.
Rf1は、水素原子、または置換若しくは無置換のC1~6アルキル基を示す。
Rf1における置換基の具体例は、Raにおいて例示したものと同じものを挙げることができる。
「Ra1O-N=CRf1-で表される基」の具体例としては、(ヒドロキシイミノ)メチル基、(エトキシイミノ)メチル基などを挙げることができる。 In the "group represented by R a1 ON=CR f1 -" for Ga, R a1 has the same meaning as in the above "group represented by R a1 -CO-".
R f1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
Specific examples of the substituent for R f1 are the same as those exemplified for Ra .
Specific examples of the "group represented by R a1 ON =CR f1 -" include (hydroxyimino)methyl group and (ethoxyimino)methyl group.
Gaにおける「Rg1Rh1C=N-O-で表される基」中、Rg1は、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、Rh1は、水素原子、または置換若しくは無置換のC1~6アルキル基を示す。
Rg1またはRh1における置換基の具体例は、Ra1において例示したものと同じものを挙げることができる。
ここで、Rg1とRh1は、一緒になって二価の有機基を形成してもよい。
形成できる二価の有機基としては、置換若しくは無置換のC2~5アルキレン基または置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基を挙げることができる。
「C2~5アルキレン基」としては、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C2~5アルキレン基」または「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。
「Rg1Rh1C=N-O-で表される基」の具体例としては、(プロパン-2-イリデンアミノ)オキシ基などを挙げることができる。 In the "group represented by R g1 R h1 C=NO-" for Ga, R g1 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted represents a substituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group, R h1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
Specific examples of the substituent for R g1 or R h1 are the same as those exemplified for R a1 .
Here, R g1 and R h1 may together form a divalent organic group.
Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
Examples of the "C2-5 alkylene group" include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Examples of substituents on the "C2-5 alkylene group" or "C1-3 alkyleneoxy C1-3 alkylene group" include halogeno groups such as fluoro, chloro, bromo, and iodo groups; methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
Specific examples of the "group represented by R g1 R h1 C=NO-" include a (propan-2-ylideneamino)oxy group.
Rg1またはRh1における置換基の具体例は、Ra1において例示したものと同じものを挙げることができる。
ここで、Rg1とRh1は、一緒になって二価の有機基を形成してもよい。
形成できる二価の有機基としては、置換若しくは無置換のC2~5アルキレン基または置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基を挙げることができる。
「C2~5アルキレン基」としては、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C2~5アルキレン基」または「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。
「Rg1Rh1C=N-O-で表される基」の具体例としては、(プロパン-2-イリデンアミノ)オキシ基などを挙げることができる。 In the "group represented by R g1 R h1 C=NO-" for Ga, R g1 is a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted represents a substituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group, R h1 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
Specific examples of the substituent for R g1 or R h1 are the same as those exemplified for R a1 .
Here, R g1 and R h1 may together form a divalent organic group.
Divalent organic groups that can be formed include substituted or unsubstituted C2-5 alkylene groups or substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene groups.
Examples of the "C2-5 alkylene group" include a dimethylene group, a trimethylene group, a tetramethylene group and the like.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Examples of substituents on the "C2-5 alkylene group" or "C1-3 alkyleneoxy C1-3 alkylene group" include halogeno groups such as fluoro, chloro, bromo, and iodo groups; methyl, ethyl, n - C1-6 alkyl groups such as propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; or chloromethyl group, chloroethyl group, trifluoromethyl group, 1 , 2-dichloro-n-propyl group, 1-fluoro-n-butyl group and other C1-6 haloalkyl groups are preferred.
Specific examples of the "group represented by R g1 R h1 C=NO-" include a (propan-2-ylideneamino)oxy group.
Gaにおける「Ra1-N=で表される二価の基」中、Ra1は上記の「Ra1-CO-で表される基」におけるそれと同様の意味を示す。
「Ra1-N=で表される二価の基」の具体例としては、イミノ基(HN=)、メチルイミノ基などを挙げることができる。 In the "divalent group represented by R a1 -N=" for Ga, R a1 has the same meaning as in the above "group represented by R a1 -CO-".
Specific examples of the "divalent group represented by R a1 -N=" include an imino group (HN=) and a methylimino group.
「Ra1-N=で表される二価の基」の具体例としては、イミノ基(HN=)、メチルイミノ基などを挙げることができる。 In the "divalent group represented by R a1 -N=" for Ga, R a1 has the same meaning as in the above "group represented by R a1 -CO-".
Specific examples of the "divalent group represented by R a1 -N=" include an imino group (HN=) and a methylimino group.
Gaにおける「Ra1O-N=で表される二価の基」中、Ra1は上記の「Ra1-CO-で表される基」におけるそれと同様の意味を示す。
「Ra1O-N=で表される二価の基」の具体例としては、N-ヒドロキシイミノ基、N-メトキシイミノ基などを挙げることができる。 In the “divalent group represented by R a1 ON=” for Ga, R a1 has the same meaning as in the above “group represented by R a1 —CO—”.
Specific examples of the "divalent group represented by R a1 ON =" include an N-hydroxyimino group and an N-methoxyimino group.
「Ra1O-N=で表される二価の基」の具体例としては、N-ヒドロキシイミノ基、N-メトキシイミノ基などを挙げることができる。 In the “divalent group represented by R a1 ON=” for Ga, R a1 has the same meaning as in the above “group represented by R a1 —CO—”.
Specific examples of the "divalent group represented by R a1 ON =" include an N-hydroxyimino group and an N-methoxyimino group.
Gaにおける「Rc1Rd1N-N=で表される二価の基」中、Rc1およびRd1は上記の「Rc1Rd1N-で表される基」におけるそれらと同様の意味を示す。
「Rc1Rd1N-N=で表される二価の基」の具体例としては、2,2-ジメチルヒドラジニリデン基などを挙げることができる。 In the "divalent group represented by R c1 R d1 NN=" for Ga, R c1 and R d1 have the same meanings as those in the above "group represented by R c1 R d1 N-". show.
Specific examples of the "divalent group represented by R c1 R d1 N--N=" include a 2,2-dimethylhydrazinylidene group.
「Rc1Rd1N-N=で表される二価の基」の具体例としては、2,2-ジメチルヒドラジニリデン基などを挙げることができる。 In the "divalent group represented by R c1 R d1 NN=" for Ga, R c1 and R d1 have the same meanings as those in the above "group represented by R c1 R d1 N-". show.
Specific examples of the "divalent group represented by R c1 R d1 N--N=" include a 2,2-dimethylhydrazinylidene group.
Gaにおける「Ra1-CO-NRe1-N=で表される二価の基」中、Ra1は上記の「Ra1-CO-で表される基」におけるそれと同様の意味を示す。Re1は上記の「Ra1-CO-NRe1-で表される基」におけるそれと同様の意味を示す。
In the "divalent group represented by R a1 -CO-NR e1 -N=" in Ga, R a1 has the same meaning as in the above "group represented by R a1 -CO-". R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
Gaにおける「Rb1-O-CO-NRe1-N=で表される二価の基」中、Rb1は上記の「Rb1-O-CO-で表される基」におけるそれと同様の意味を示す。Re1は上記の「Ra1-CO-NRe1-で表される基」におけるそれと同様の意味を示す。
In the “divalent group represented by R b1 —O—CO—NR e1 —N=” for Ga, R b1 has the same meaning as in the above “group represented by R b1 —O—CO—” indicate. R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
Gaにおける「Rb1SO2-NRe1-N=で表される二価の基」中、Rb1は上記の「Rb1-O-CO-で表される基」におけるそれと同様の意味を示す。Re1は上記の「Ra1-CO-NRe1-で表される基」におけるそれと同様の意味を示す。
In the “divalent group represented by R b1 SO 2 —NR e1 —N=” in Ga, R b1 has the same meaning as in the above “group represented by R b1 —O—CO—” . R e1 has the same meaning as in the above “group represented by R a1 —CO—NR e1 —”.
置換基(Ga)が2以上ある場合に、そのうちの2つが一緒になって形成できる二価の有機基としては、置換若しくは無置換のC1~5アルキレン基、置換若しくは無置換のオキシC1~4アルキレン基、置換若しくは無置換のオキシC2~3アルキレンオキシ基、または置換若しくは無置換のC1~3アルキレンオキシC1~3アルキレン基を挙げることができる。
「C1~5アルキレン基」としては、メチレン基、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「オキシC1~4アルキレン基」としては、オキシメチレン基、オキシジメチレン基などを挙げることができる。
「オキシC2~3アルキレンオキシ基」としては、オキシジメチレンオキシ基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C1~5アルキレン基」、「オキシC1~4アルキレン基」、「オキシC2~3アルキレンオキシ基」、「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 When there are two or more substituents (Ga), the divalent organic group that can be formed by two of them together includes a substituted or unsubstituted C1-5 alkylene group, a substituted or unsubstituted oxy C1-4 An alkylene group, a substituted or unsubstituted oxy C2-3 alkyleneoxy group, or a substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene group can be mentioned.
Examples of the "C1-5 alkylene group" include methylene group, dimethylene group, trimethylene group, tetramethylene group and the like.
Examples of the "oxy C1-4 alkylene group" include an oxymethylene group and an oxydimethylene group.
Examples of the "oxy C2-3 alkyleneoxy group" include an oxydimethylenoxy group.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Substituents on the "C1-5 alkylene group", "oxy-C1-4 alkylene group", "oxy-C2-3 alkyleneoxy group" and "C1-3 alkyleneoxy C1-3 alkylene group" include a fluoro group, chloro Halogeno groups such as group, bromo group and iodo group; C1 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group and t-butyl group ~6 alkyl group; or C1~6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group and 1-fluoro-n-butyl group are preferred.
「C1~5アルキレン基」としては、メチレン基、ジメチレン基、トリメチレン基、テトラメチレン基などを挙げることができる。
「オキシC1~4アルキレン基」としては、オキシメチレン基、オキシジメチレン基などを挙げることができる。
「オキシC2~3アルキレンオキシ基」としては、オキシジメチレンオキシ基などを挙げることができる。
「C1~3アルキレンオキシC1~3アルキレン基」としては、ジメチレンオキシジメチレン基などを挙げることができる。
「C1~5アルキレン基」、「オキシC1~4アルキレン基」、「オキシC2~3アルキレンオキシ基」、「C1~3アルキレンオキシC1~3アルキレン基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基;またはクロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基が好ましい。 When there are two or more substituents (Ga), the divalent organic group that can be formed by two of them together includes a substituted or unsubstituted C1-5 alkylene group, a substituted or unsubstituted oxy C1-4 An alkylene group, a substituted or unsubstituted oxy C2-3 alkyleneoxy group, or a substituted or unsubstituted C1-3 alkyleneoxy C1-3 alkylene group can be mentioned.
Examples of the "C1-5 alkylene group" include methylene group, dimethylene group, trimethylene group, tetramethylene group and the like.
Examples of the "oxy C1-4 alkylene group" include an oxymethylene group and an oxydimethylene group.
Examples of the "oxy C2-3 alkyleneoxy group" include an oxydimethylenoxy group.
Examples of the "C1-3 alkyleneoxy C1-3 alkylene group" include a dimethyleneoxydimethylene group and the like.
Substituents on the "C1-5 alkylene group", "oxy-C1-4 alkylene group", "oxy-C2-3 alkyleneoxy group" and "C1-3 alkyleneoxy C1-3 alkylene group" include a fluoro group, chloro Halogeno groups such as group, bromo group and iodo group; C1 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group and t-butyl group ~6 alkyl group; or C1~6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group and 1-fluoro-n-butyl group are preferred.
本発明において、好ましいGaとしては、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、Ra1-CO-O-で表される基、オキソ基(O=)、またはRa1O-N=で表される二価の基を挙げることができる。
この場合、好ましい置換若しくは無置換の5~6員環のヘテロシクリルオキシ基としては、テトラヒドロ-2H-ピラン-4-イル基を挙げることができる。 In the present invention, preferred Ga includes a hydroxyl group, a substituted or unsubstituted C1-6 alkoxy group, a substituted or unsubstituted C2-6 alkenyloxy group, a substituted or unsubstituted C2-6 alkynyloxy group, a substituted or unsubstituted C3 ~ 6 cycloalkyloxy group, substituted or unsubstituted C6 ~ 10 aryloxy group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, a group represented by R a1 -CO-O-, oxo A group (O=) or a divalent group represented by R a1 ON = can be mentioned.
In this case, a preferred substituted or unsubstituted 5- to 6-membered heterocyclyloxy group is a tetrahydro-2H-pyran-4-yl group.
この場合、好ましい置換若しくは無置換の5~6員環のヘテロシクリルオキシ基としては、テトラヒドロ-2H-ピラン-4-イル基を挙げることができる。 In the present invention, preferred Ga includes a hydroxyl group, a substituted or unsubstituted C1-6 alkoxy group, a substituted or unsubstituted C2-6 alkenyloxy group, a substituted or unsubstituted C2-6 alkynyloxy group, a substituted or unsubstituted C3 ~ 6 cycloalkyloxy group, substituted or unsubstituted C6 ~ 10 aryloxy group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, a group represented by R a1 -CO-O-, oxo A group (O=) or a divalent group represented by R a1 ON = can be mentioned.
In this case, a preferred substituted or unsubstituted 5- to 6-membered heterocyclyloxy group is a tetrahydro-2H-pyran-4-yl group.
本発明において、さらに好ましいGaとしては、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、Ra1-CO-O-で表される基、オキソ基(O=)、またはRa1O-N=で表される二価の基を挙げることができる。
In the present invention, more preferred Ga includes a hydroxyl group, a substituted or unsubstituted C1-6 alkoxy group, a substituted or unsubstituted C2-6 alkenyloxy group, a substituted or unsubstituted C2-6 alkynyloxy group, R a1 - A group represented by CO—O—, an oxo group (O=), or a divalent group represented by R a1 ON = can be mentioned.
〔B〕
Bは、酸素原子、硫黄原子、スルフィニル基、スルホニル基、または-NRN3-で表される基を示し、RN3は、水素原子、置換若しくは無置換のC1~6アルキル基、ホルミル基、または置換若しくは無置換のC1~6アルキルカルボニル基を示す。 [B]
B is an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group, or a group represented by -NR N3 -, and R N3 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a formyl group, or It represents a substituted or unsubstituted C1-6 alkylcarbonyl group.
Bは、酸素原子、硫黄原子、スルフィニル基、スルホニル基、または-NRN3-で表される基を示し、RN3は、水素原子、置換若しくは無置換のC1~6アルキル基、ホルミル基、または置換若しくは無置換のC1~6アルキルカルボニル基を示す。 [B]
B is an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group, or a group represented by -NR N3 -, and R N3 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a formyl group, or It represents a substituted or unsubstituted C1-6 alkylcarbonyl group.
RN3における「C1~6アルキル基」は、直鎖であってもよいし、分岐鎖であってもよい。RN3における「C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、i-ヘキシル基などを挙げることができる。
RN3における「C1~6アルキルカルボニル基」としては、アセチル基、プロピオニル基、ブチリル基、i-プロピルカルボニル基などを挙げることができる。 The “C1-6 alkyl group” in R N3 may be linear or branched. The "C1-6 alkyl group" in R N3 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
Examples of the “C1-6 alkylcarbonyl group” for R N3 include an acetyl group, a propionyl group, a butyryl group, an i-propylcarbonyl group and the like.
RN3における「C1~6アルキルカルボニル基」としては、アセチル基、プロピオニル基、ブチリル基、i-プロピルカルボニル基などを挙げることができる。 The “C1-6 alkyl group” in R N3 may be linear or branched. The "C1-6 alkyl group" in R N3 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
Examples of the “C1-6 alkylcarbonyl group” for R N3 include an acetyl group, a propionyl group, a butyryl group, an i-propylcarbonyl group and the like.
RN3における「C1~6アルキル基」、および「C1~6アルキルカルボニル」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;(エチリデンアミノ)オキシ基、プロパン-2-イリデンアミノ)オキシ基などの(C1~6アルキリデンアミノ)オキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。
The substituents on the "C1-6 alkyl group" and "C1-6 alkylcarbonyl" in R N3 include a fluoro group, a chloro group, a bromo group, a halogeno group such as an iodo group; a hydroxyl group; a methoxy group, an ethoxy group, C1-6 alkoxy groups such as n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group; 2-chloro-n-propoxy group, 2,3- C1-6 haloalkoxy groups such as dichlorobutoxy group and trifluoromethoxy group; (C1-6 alkylideneamino)oxy groups such as (ethylideneamino)oxy group and propane-2-ylideneamino)oxy group; cyclopropyl group and cyclobutyl group , cyclopentyl group, C3-6 cycloalkyl group such as cyclohexyl group; phenyl group, C6-10 aryl group such as naphthyl group; 4-methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethyl any one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group such as a phenyl group and a 4-trifluoromethoxyphenyl group; 5-membered substituted C6-10 aryl group; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group, etc. ring heteroaryl group; a 5-membered ring substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group heteroaryl group; pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, 6-membered heteroaryl group such as triazinyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or A 6-membered heteroaryl group substituted with one or more substituents selected from C1-6 haloalkoxy groups; or a cyano group is preferred.
〔R7〕
R7は、水素原子、または置換若しくは無置換のC1~6アルキル基を示す。
R7における「C1~6アルキル基」は、直鎖であってもよいし、分岐鎖であってもよい。 R7における「C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、i-ヘキシル基などを挙げることができる。
R7における「C1~6アルキル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;(エチリデンアミノ)オキシ基、プロパン-2-イリデンアミノ)オキシ基などの(C1~6アルキリデンアミノ)オキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。 [ R7 ]
R 7 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
The “C1-6 alkyl group” for R 7 may be linear or branched. The "C1-6 alkyl group" for R 7 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
Substituents on the "C1-6 alkyl group" in R 7 include halogeno groups such as fluoro, chloro, bromo and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group and i-propoxy group. , n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, etc. C1 ~ 6 haloalkoxy group; (ethylideneamino) oxy group, propane-2-ylideneamino) oxy group such as (C1 ~ 6 alkylideneamino) oxy group; cyclopropyl group, cyclobutyl group, cyclopentyl group, C3 such as cyclohexyl group ~6 cycloalkyl group; phenyl group, C6 ~ 10 aryl group such as naphthyl group; 4-methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl a C6-10 aryl group substituted with any one or more substituents of a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group, such as a group; five-membered heteroaryl groups such as pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl; 5-membered heteroaryl group substituted with one or more substituents selected from an alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; a pyridyl group, a pyrazinyl group , a pyrimidinyl group, a pyridazinyl group, a 6-membered heteroaryl group such as a triazinyl group; any one of a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group A 6-membered heteroaryl group substituted with one or more substituents; or a cyano group is preferred.
R7は、水素原子、または置換若しくは無置換のC1~6アルキル基を示す。
R7における「C1~6アルキル基」は、直鎖であってもよいし、分岐鎖であってもよい。 R7における「C1~6アルキル基」としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、i-ヘキシル基などを挙げることができる。
R7における「C1~6アルキル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;(エチリデンアミノ)オキシ基、プロパン-2-イリデンアミノ)オキシ基などの(C1~6アルキリデンアミノ)オキシ基;シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などのC3~6シクロアルキル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;またはシアノ基が好ましい。 [ R7 ]
R 7 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group.
The “C1-6 alkyl group” for R 7 may be linear or branched. The "C1-6 alkyl group" for R 7 includes a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s -butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, i-hexyl group and the like.
Substituents on the "C1-6 alkyl group" in R 7 include halogeno groups such as fluoro, chloro, bromo and iodo groups; hydroxyl group; methoxy group, ethoxy group, n-propoxy group and i-propoxy group. , n-butoxy group, s-butoxy group, i-butoxy group, C1-6 alkoxy group such as t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, etc. C1 ~ 6 haloalkoxy group; (ethylideneamino) oxy group, propane-2-ylideneamino) oxy group such as (C1 ~ 6 alkylideneamino) oxy group; cyclopropyl group, cyclobutyl group, cyclopentyl group, C3 such as cyclohexyl group ~6 cycloalkyl group; phenyl group, C6 ~ 10 aryl group such as naphthyl group; 4-methylphenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl a C6-10 aryl group substituted with any one or more substituents of a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group, such as a group; five-membered heteroaryl groups such as pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl; 5-membered heteroaryl group substituted with one or more substituents selected from an alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; a pyridyl group, a pyrazinyl group , a pyrimidinyl group, a pyridazinyl group, a 6-membered heteroaryl group such as a triazinyl group; any one of a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group A 6-membered heteroaryl group substituted with one or more substituents; or a cyano group is preferred.
〔Q〕
Qは、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~10員環のヘテロシクリル基を示す。 [Q]
Q represents a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted 5- to 10-membered heterocyclyl group.
Qは、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~10員環のヘテロシクリル基を示す。 [Q]
Q represents a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted 5- to 10-membered heterocyclyl group.
Qにおける「C6~10アリール基」としては、フェニル基、ナフチル基、インデニル基、インダニル基、テトラリニル基などを挙げることができる。
Examples of the "C6-10 aryl group" for Q include a phenyl group, a naphthyl group, an indenyl group, an indanyl group, a tetralinyl group, and the like.
Qにおける「5~10員環のヘテロシクリル基」とは、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1、2、3または4個のヘテロ原子を環の構成原子として含む基である。ヘテロ原子が2個以上であるとき、それらは同じでもよいし、異なってもよい。単環および多環のいずれでもよい。
「5~10員環のヘテロシクリル基」としては、5~6員環の飽和ヘテロシクリル基、5~10員環のヘテロアリール基、5~10員環の部分不飽和ヘテロシクリル基などを挙げることができる。 The “5- to 10-membered heterocyclyl group” for Q is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur atoms as ring-constituting atoms. . When there are two or more heteroatoms, they may be the same or different. It may be monocyclic or polycyclic.
Examples of the "5- to 10-membered heterocyclyl group" include a 5- to 6-membered saturated heterocyclyl group, a 5- to 10-membered heteroaryl group, a 5- to 10-membered partially unsaturated heterocyclyl group, and the like. .
「5~10員環のヘテロシクリル基」としては、5~6員環の飽和ヘテロシクリル基、5~10員環のヘテロアリール基、5~10員環の部分不飽和ヘテロシクリル基などを挙げることができる。 The “5- to 10-membered heterocyclyl group” for Q is a group containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur atoms as ring-constituting atoms. . When there are two or more heteroatoms, they may be the same or different. It may be monocyclic or polycyclic.
Examples of the "5- to 10-membered heterocyclyl group" include a 5- to 6-membered saturated heterocyclyl group, a 5- to 10-membered heteroaryl group, a 5- to 10-membered partially unsaturated heterocyclyl group, and the like. .
5~6員環の飽和ヘテロシクリル基としては、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。
5~10員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;インドリル基、イソインドリル基、ベンゾフラニル基、ベンゾチエニル基、インダゾリル基、ベンゾイミダゾリル基、ベンゾオキサゾリル基、ベンゾイソオキサオゾリル基、ベンゾチアゾリル基、ベンゾイソチアゾリル基などの9員ヘテロアリール基;キノリニル基、イソキノリニル基、シンノリニル基、フタラジニル基、キナゾリニル基、キノキサリニル基などの10員ヘテロアリール基;を挙げることができる。
5~10員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基;インドリニル基、イソインドリニル基、2,3-ジヒドロベンゾフラニル基、1,3-ジヒドロベンゾフラニル基などの9員環の部分不飽和ヘテロシクリル基;1,2,3,4-テトラヒドロキノリニル基などの10員環の部分不飽和ヘテロシクリル基;を挙げることができる。 Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
Examples of 5- to 10-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. 5-membered heteroaryl groups such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl 6-membered heteroaryl groups; indolyl, isoindolyl, benzofuranyl, benzothienyl, indazolyl, 9-membered heteroaryl groups such as benzimidazolyl group, benzoxazolyl group, benzisoxazolyl group, benzothiazolyl group, and benzisothiazolyl group; quinolinyl group, isoquinolinyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group, quinoxalinyl group, etc. 10-membered heteroaryl group;
Examples of 5- to 10-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro 6-membered partially unsaturated heterocyclyl group such as pyranyl group; 9-membered partially unsaturated ring such as indolinyl group, isoindolinyl group, 2,3-dihydrobenzofuranyl group, 1,3-dihydrobenzofuranyl group heterocyclyl group; 10-membered ring partially unsaturated heterocyclyl group such as 1,2,3,4-tetrahydroquinolinyl group;
5~10員環のヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;インドリル基、イソインドリル基、ベンゾフラニル基、ベンゾチエニル基、インダゾリル基、ベンゾイミダゾリル基、ベンゾオキサゾリル基、ベンゾイソオキサオゾリル基、ベンゾチアゾリル基、ベンゾイソチアゾリル基などの9員ヘテロアリール基;キノリニル基、イソキノリニル基、シンノリニル基、フタラジニル基、キナゾリニル基、キノキサリニル基などの10員ヘテロアリール基;を挙げることができる。
5~10員環の部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和へテロシクリル基;インドリニル基、イソインドリニル基、2,3-ジヒドロベンゾフラニル基、1,3-ジヒドロベンゾフラニル基などの9員環の部分不飽和ヘテロシクリル基;1,2,3,4-テトラヒドロキノリニル基などの10員環の部分不飽和ヘテロシクリル基;を挙げることができる。 Examples of 5- to 6-membered saturated heterocyclyl groups include pyrrolidinyl, tetrahydrofuranyl, thiazolidinyl, tetrahydro-2H-pyranyl, piperidyl, piperazinyl, morpholinyl, dioxolanyl and dioxanyl groups.
Examples of 5- to 10-membered heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, and tetrazolyl groups. 5-membered heteroaryl groups such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl 6-membered heteroaryl groups; indolyl, isoindolyl, benzofuranyl, benzothienyl, indazolyl, 9-membered heteroaryl groups such as benzimidazolyl group, benzoxazolyl group, benzisoxazolyl group, benzothiazolyl group, and benzisothiazolyl group; quinolinyl group, isoquinolinyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group, quinoxalinyl group, etc. 10-membered heteroaryl group;
Examples of 5- to 10-membered partially unsaturated heterocyclyl groups include pyrrolinyl, dihydrofuranyl, imidazolinyl, pyrazolinyl, oxazolinyl, isoxazolinyl, and other 5-membered partially unsaturated heterocyclyl groups; dihydro 6-membered partially unsaturated heterocyclyl group such as pyranyl group; 9-membered partially unsaturated ring such as indolinyl group, isoindolinyl group, 2,3-dihydrobenzofuranyl group, 1,3-dihydrobenzofuranyl group heterocyclyl group; 10-membered ring partially unsaturated heterocyclyl group such as 1,2,3,4-tetrahydroquinolinyl group;
Qにおける「C6~10アリール基」または「5~10員環のへテロシクリル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;ビニル基などのC2~6アルケニル基;エチニル基などのC2~6アルキニル基;クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基などのC1~6ハロアルキル基;メトキシメチル基などのC1~6アルコキシC1~6アルキル基;水酸基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;ヒドロキシエトキシ基などのヒドロキシC1~6アルコキシ基;メトキシメトキシ基、メトキシエトキシ基などのC1~6アルコキシアルコキシ基;トリメチルシリルオキシエトキシ基、t-ブチルジメチルシリルオキシエトキシ基などのトリC1~6アルキル置換シリルオキシC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;C3~6シクロアルキルC1~6アルコキシ基;C6~10アリールC1~6アルコキシ基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルコキシ基;5員環のヘテロアリールC1~6アルコキシ基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環のヘテロアリール)C1~6アルコキシ基;6員環のヘテロアリールC1~6アルコキシ基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール)C1~6アルコキシ基;メチルチオ基、エチルチオ基などのC1~6アルキルチオ基:メチルスルフィニル基、エチルスルフィニル基などのC1~6アルキルスルフィニル基;メチルスルホニル基、エチルスルホニル基などのC1~6アルキルスルホニル基;トリフルオロメチルチオ基、2,2,2-トリフルオロエチルチオ基などのC1~6ハロアルキルチオ基:トリフルオロメチルスルフィニル基、2,2,2-トリフルオロエチルスルフィニル基などのC1~6ハロアルキルスルフィニル基;トリフルオロメチルスルホニル基、2,2,2-トリフルオロエチルスルホニル基などのC1~6ハロアルキルスルホニル基;シクロプロピル基、シクロブチル基、シクロペンチル基などのC3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、またはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;シクロプロぺニル基、シクロブテニル基、シクロペンテニル基などのC3~6シクロアルケニル基;フェニル基、ナフチル基などのC6~10アリール基;4-メチルフェニル基、4-メトキシフェニル基、4-クロロフェニル基、4-フルオロフェニル基、4-トリフルオロメチルフェニル基、4-トリフルオロメトキシフェニル基などの、C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;アジリジニル基、エポキシ基、アゼチジニル基、オキセタニル基などの3~4員環の飽和ヘテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された3~4員環の飽和ヘテロシクリル基;ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、テトラヒドロ-2H-ピラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などの5~6員環の飽和ヘテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環の飽和ヘテロシクリル基;ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基など5員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基でのいずれか1以上の置換基で置換された5員環のヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環のヘテロアリール基;ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基などの5員環の部分不飽和へテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5員環の部分飽和ヘテロシクリル基;ジヒドロピラニル基などの6員環の部分不飽和ヘテロシクリル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、またはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された6員環の部分飽和ヘテロシクリル基;
RQ1-CO-で表される基(式中、RQ1は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRQ1においても同じ。);
カルボキシ基;
RQ2-O-CO-で表される基(式中、RQ2は、C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRQ2においても同じ。);
RQ1RQ1N-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RQ1RQ1N-CO-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RQ1-CO-O-で表される基;RQ1-CO-NRQ3-で表される基(式中、RQ3は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;または(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;を示す。以下のRQ3においても同じ。);
RQ2-O-CO-O-で表される基;RQ2-O-CO-NRQ3-で表される基;RQ1RQ1N-CO-O-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RQ1RQ1N-CO-NRQ3-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);RQ2SO2-NRQ3-で表される基;RQ1RQ1N-SO2-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RQ1-O-N=C(RQ4)-で表される基(式中、RQ4は、水素原子またはC1~6アルキル基を示す。);(RQ1)2C=N-O-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
ペンタフルオロスルファニル基、トリメチルシリルエチニル基、ニトロ基、またはシアノ基が好ましい。
さらに、「5~10員環のヘテロシクリル基」上の置換基としては、オキソ基も好ましい。 Examples of substituents on the "C6-10 aryl group" or "5- to 10-membered heterocyclyl group" in Q include halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group; a methyl group, an ethyl group, C1-6 alkyl groups such as n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group; vinyl group, etc. C2-6 alkenyl group of; C2-6 alkynyl group such as ethynyl group; chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group and the like C1-6 haloalkyl group; C1-6 alkoxy C1-6 alkyl group such as methoxymethyl group; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i C1-6 alkoxy groups such as -butoxy group and t-butoxy group; hydroxy C1-6 alkoxy groups such as hydroxyethoxy group; C1-6 alkoxyalkoxy groups such as methoxymethoxy group and methoxyethoxy group; trimethylsilyloxyethoxy group, t -Tri-C1-6 alkyl-substituted silyloxy C1-6 alkoxy groups such as butyldimethylsilyloxyethoxy group; C1-6 haloalkoxy groups such as 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group group; C3-6 cycloalkyl C1-6 alkoxy group; C6-10 aryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 halo C6-10 aryl substituted with any one or more substituents of an alkoxy group)C1-6 alkoxy group; 5-membered ring heteroaryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, 5-membered heteroaryl)C1-6 alkoxy group; 6-membered heteroaryl C1-6 substituted with one or more substituents selected from a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group Alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group) 6-membered heteroaryl substituted with one or more substituents ) C1-6 alkoxy group; C1-6 alkylthio group such as methylthio group and ethylthio group; C1-6 alkyl group such as methylsulfinyl group and ethylsulfinyl group sulfinyl group; methylsulfonyl group, C1-6 alkylsulfonyl group such as ethylsulfonyl group; trifluoromethylthio group, C1-6 haloalkylthio group such as 2,2,2-trifluoroethylthio group: trifluoromethylsulfinyl group, C1-6 haloalkylsulfinyl groups such as 2,2,2-trifluoroethylsulfinyl group; trifluoromethylsulfonyl group, C1-6 haloalkylsulfonyl groups such as 2,2,2-trifluoroethylsulfonyl group; cyclopropyl group, C3-6 cycloalkyl group such as cyclobutyl group and cyclopentyl group; any one or more of C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or cyano group C3 ~ 6 cycloalkyl group substituted with a substituent of; cyclopropenyl group, cyclobutenyl group, C3 ~ 6 cycloalkenyl group such as cyclopentenyl group; phenyl group, C6 ~ 10 aryl group such as naphthyl group; 4-methyl C1-6 alkyl groups, C1-6 alkoxy groups such as phenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-fluorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, C6-10 aryl group substituted with one or more substituents selected from halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group; 3-4 groups such as aziridinyl group, epoxy group, azetidinyl group and oxetanyl group saturated membered heterocyclyl group; 3-4 substituted with one or more substituents selected from C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 5- to 6-membered saturated heterocyclyl groups such as a pyrrolidinyl group, a tetrahydrofuranyl group, a thiazolidinyl group, a tetrahydro-2H-pyranyl group, a piperidyl group, a piperazinyl group, a morpholinyl group, a dioxolanyl group, and a dioxanyl group; A 5- to 6-membered saturated heterocyclyl group substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl 5-membered ring heteroaryl group such as group, tetrazolyl group; any one or more substituents in C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 5-membered heteroaryl group substituted with; pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, 6-membered heteroaryl group such as triazinyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group , a C1-6 haloalkyl group, or a 6-membered heteroaryl group substituted with one or more substituents of a C1-6 haloalkoxy group; pyrrolinyl group, dihydrofuranyl group, imidazolinyl group, pyrazolinyl group, oxazolinyl group , 5-membered partially unsaturated heterocyclyl group such as isoxazolinyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 5-membered partially saturated heterocyclyl group substituted with one or more substituents; 6-membered partially unsaturated heterocyclyl group such as dihydropyranyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 ~6 haloalkyl group, or a 6-membered partially saturated heterocyclyl group substituted with one or more substituents of a C1~6 haloalkoxy group;
a group represented by R Q1 —CO— (wherein R Q1 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, C1-6 alkyl group substituted with one or more substituents of a phenyl group or a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a haloalkyl group or a C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from ∼6 haloalkyl group or C1-6 haloalkoxy group)C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or a C3-6 cycloalkyl group substituted with one or more substituents of a cyano group; a C6-10 aryl group; a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or C6-10 aryl group substituted with one or more substituents of any one of C1-6 haloalkoxy groups; 5- to 6-membered heteroaryl group; or; C1-6 alkyl group, C1-6 alkoxy group, halogeno group , a C1-6 haloalkyl group, or a C1-6 haloalkoxy group, a 5- to 6-membered heteroaryl group substituted with one or more substituents; The same applies to R Q1 below.);
carboxy group;
A group represented by R Q2 —O—CO— (wherein R Q2 is a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, a phenyl or a C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl C6-10 aryl)C1-6 alkyl group substituted with one or more substituents, or C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1- 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from a 6-haloalkyl group or a C1-6 haloalkoxy group) C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl group C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or C3-6 cycloalkyl group substituted with cyano group; C6-10 aryl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group a C6-10 aryl group substituted with one or more substituents; a 5- to 6-membered heteroaryl group; or; a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1 A 5- to 6-membered heteroaryl group substituted with one or more substituents selected from ∼6 haloalkoxy groups;
A group represented by R Q1 R Q1 N— (R Q1 in the formula may be the same or different. Together, R Q1 may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxy may form a dimethylene group.);
A group represented by R Q1 R Q1 N—CO— (in the formula, R Q1 may be the same or different. R Q1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a A methyleneoxydimethylene group may be formed.);
a group represented by R Q1 -CO-O-; a group represented by R Q1 -CO-NR Q3 - (wherein R Q3 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, C1-6 haloalkoxy group, C3-6 cycloalkyl group, phenyl group, or C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; a C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or (5- to 6-membered heteroaryl substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group) C1-6 alkyl group; The same applies to R Q3 below.);
a group represented by R Q2 -O-CO-O-; a group represented by R Q2 -O-CO-NR Q3 -; a group represented by R Q1 R Q1 N-CO-O- (in the formula R Q1 may be the same or different, and R Q1 may together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group.);
A group represented by R Q1 R Q1 N—CO—NR Q3 — (R Q1 in the formula may be the same or different. Together, R Q1 may be a trimethylene group, a tetramethylene group, a pentamethylene group, , or may form a dimethyleneoxydimethylene group); a group represented by R Q2 SO 2 —NR Q3 —; a group represented by R Q1 R Q1 N—SO 2 — (in the formula, R Q1 may be the same or different, and R Q1 may together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group.);
a group represented by R Q1 -ON=C(R Q4 )- (wherein R Q4 represents a hydrogen atom or a C1-6 alkyl group); (R Q1 ) 2 C=N-O- (R Q1 in the formula may be the same or different. R Q1 together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group. may be used.);
A pentafluorosulfanyl group, a trimethylsilylethynyl group, a nitro group, or a cyano group are preferred.
Furthermore, an oxo group is also preferred as a substituent on the "5- to 10-membered heterocyclyl group".
RQ1-CO-で表される基(式中、RQ1は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基のいずれか1以上の置換基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRQ1においても同じ。);
カルボキシ基;
RQ2-O-CO-で表される基(式中、RQ2は、C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;C2~6アルケニル基;C2~6ハロアルケニル基;C2~6アルキニル基;C2~6ハロアルキニル基;C3~6シクロアルキル基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、C1~6ハロアルコキシ基、若しくはシアノ基で置換されたC3~6シクロアルキル基;C6~10アリール基;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール基;5~6員環のヘテロアリール基;または;C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール基;を示す。以下のRQ2においても同じ。);
RQ1RQ1N-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RQ1RQ1N-CO-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RQ1-CO-O-で表される基;RQ1-CO-NRQ3-で表される基(式中、RQ3は、水素原子;C1~6アルキル基;ハロゲノ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~6シクロアルキル基、フェニル基、若しくは5~6員環のヘテロアリール基のいずれか1以上の置換基で置換されたC1~6アルキル基;(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換されたC6~10アリール)C1~6アルキル基;または(C1~6アルキル基、C1~6アルコキシ基、ハロゲノ基、C1~6ハロアルキル基、若しくはC1~6ハロアルコキシ基のいずれか1以上の置換基で置換された5~6員環のヘテロアリール)C1~6アルキル基;を示す。以下のRQ3においても同じ。);
RQ2-O-CO-O-で表される基;RQ2-O-CO-NRQ3-で表される基;RQ1RQ1N-CO-O-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RQ1RQ1N-CO-NRQ3-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);RQ2SO2-NRQ3-で表される基;RQ1RQ1N-SO2-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
RQ1-O-N=C(RQ4)-で表される基(式中、RQ4は、水素原子またはC1~6アルキル基を示す。);(RQ1)2C=N-O-で表される基(式中のRQ1は同一でも異なっていてもよい。RQ1同士は一緒になって、トリメチレン基、テトラメチレン基、ペンタメチレン基、またはジメチレンオキシジメチレン基を形成してもよい。);
ペンタフルオロスルファニル基、トリメチルシリルエチニル基、ニトロ基、またはシアノ基が好ましい。
さらに、「5~10員環のヘテロシクリル基」上の置換基としては、オキソ基も好ましい。 Examples of substituents on the "C6-10 aryl group" or "5- to 10-membered heterocyclyl group" in Q include halogeno groups such as a fluoro group, a chloro group, a bromo group, and an iodo group; a methyl group, an ethyl group, C1-6 alkyl groups such as n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group; vinyl group, etc. C2-6 alkenyl group of; C2-6 alkynyl group such as ethynyl group; chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group and the like C1-6 haloalkyl group; C1-6 alkoxy C1-6 alkyl group such as methoxymethyl group; hydroxyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i C1-6 alkoxy groups such as -butoxy group and t-butoxy group; hydroxy C1-6 alkoxy groups such as hydroxyethoxy group; C1-6 alkoxyalkoxy groups such as methoxymethoxy group and methoxyethoxy group; trimethylsilyloxyethoxy group, t -Tri-C1-6 alkyl-substituted silyloxy C1-6 alkoxy groups such as butyldimethylsilyloxyethoxy group; C1-6 haloalkoxy groups such as 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group and trifluoromethoxy group group; C3-6 cycloalkyl C1-6 alkoxy group; C6-10 aryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 halo C6-10 aryl substituted with any one or more substituents of an alkoxy group)C1-6 alkoxy group; 5-membered ring heteroaryl C1-6 alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, 5-membered heteroaryl)C1-6 alkoxy group; 6-membered heteroaryl C1-6 substituted with one or more substituents selected from a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group Alkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group) 6-membered heteroaryl substituted with one or more substituents ) C1-6 alkoxy group; C1-6 alkylthio group such as methylthio group and ethylthio group; C1-6 alkyl group such as methylsulfinyl group and ethylsulfinyl group sulfinyl group; methylsulfonyl group, C1-6 alkylsulfonyl group such as ethylsulfonyl group; trifluoromethylthio group, C1-6 haloalkylthio group such as 2,2,2-trifluoroethylthio group: trifluoromethylsulfinyl group, C1-6 haloalkylsulfinyl groups such as 2,2,2-trifluoroethylsulfinyl group; trifluoromethylsulfonyl group, C1-6 haloalkylsulfonyl groups such as 2,2,2-trifluoroethylsulfonyl group; cyclopropyl group, C3-6 cycloalkyl group such as cyclobutyl group and cyclopentyl group; any one or more of C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or cyano group C3 ~ 6 cycloalkyl group substituted with a substituent of; cyclopropenyl group, cyclobutenyl group, C3 ~ 6 cycloalkenyl group such as cyclopentenyl group; phenyl group, C6 ~ 10 aryl group such as naphthyl group; 4-methyl C1-6 alkyl groups, C1-6 alkoxy groups such as phenyl group, 4-methoxyphenyl group, 4-chlorophenyl group, 4-fluorophenyl group, 4-trifluoromethylphenyl group, 4-trifluoromethoxyphenyl group, C6-10 aryl group substituted with one or more substituents selected from halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group; 3-4 groups such as aziridinyl group, epoxy group, azetidinyl group and oxetanyl group saturated membered heterocyclyl group; 3-4 substituted with one or more substituents selected from C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 5- to 6-membered saturated heterocyclyl groups such as a pyrrolidinyl group, a tetrahydrofuranyl group, a thiazolidinyl group, a tetrahydro-2H-pyranyl group, a piperidyl group, a piperazinyl group, a morpholinyl group, a dioxolanyl group, and a dioxanyl group; A 5- to 6-membered saturated heterocyclyl group substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl 5-membered ring heteroaryl group such as group, tetrazolyl group; any one or more substituents in C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 5-membered heteroaryl group substituted with; pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, 6-membered heteroaryl group such as triazinyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group , a C1-6 haloalkyl group, or a 6-membered heteroaryl group substituted with one or more substituents of a C1-6 haloalkoxy group; pyrrolinyl group, dihydrofuranyl group, imidazolinyl group, pyrazolinyl group, oxazolinyl group , 5-membered partially unsaturated heterocyclyl group such as isoxazolinyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group 5-membered partially saturated heterocyclyl group substituted with one or more substituents; 6-membered partially unsaturated heterocyclyl group such as dihydropyranyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 ~6 haloalkyl group, or a 6-membered partially saturated heterocyclyl group substituted with one or more substituents of a C1~6 haloalkoxy group;
a group represented by R Q1 —CO— (wherein R Q1 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, C1-6 alkyl group substituted with one or more substituents of a phenyl group or a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a haloalkyl group or a C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from ∼6 haloalkyl group or C1-6 haloalkoxy group)C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or a C3-6 cycloalkyl group substituted with one or more substituents of a cyano group; a C6-10 aryl group; a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or C6-10 aryl group substituted with one or more substituents of any one of C1-6 haloalkoxy groups; 5- to 6-membered heteroaryl group; or; C1-6 alkyl group, C1-6 alkoxy group, halogeno group , a C1-6 haloalkyl group, or a C1-6 haloalkoxy group, a 5- to 6-membered heteroaryl group substituted with one or more substituents; The same applies to R Q1 below.);
carboxy group;
A group represented by R Q2 —O—CO— (wherein R Q2 is a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C3-6 cycloalkyl group, a phenyl or a C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl C6-10 aryl)C1-6 alkyl group substituted with one or more substituents, or C1-6 haloalkoxy group; (C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1- 5- to 6-membered ring heteroaryl substituted with one or more substituents selected from a 6-haloalkyl group or a C1-6 haloalkoxy group) C1-6 alkyl group; C2-6 alkenyl group; C2-6 haloalkenyl group C2-6 alkynyl group; C2-6 haloalkynyl group; C3-6 cycloalkyl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, C1-6 haloalkoxy group, or C3-6 cycloalkyl group substituted with cyano group; C6-10 aryl group; C1-6 alkyl group, C1-6 alkoxy group, halogeno group, C1-6 haloalkyl group, or C1-6 haloalkoxy group a C6-10 aryl group substituted with one or more substituents; a 5- to 6-membered heteroaryl group; or; a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1 A 5- to 6-membered heteroaryl group substituted with one or more substituents selected from ∼6 haloalkoxy groups;
A group represented by R Q1 R Q1 N— (R Q1 in the formula may be the same or different. Together, R Q1 may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxy may form a dimethylene group.);
A group represented by R Q1 R Q1 N—CO— (in the formula, R Q1 may be the same or different. R Q1 together may be a trimethylene group, a tetramethylene group, a pentamethylene group, or a A methyleneoxydimethylene group may be formed.);
a group represented by R Q1 -CO-O-; a group represented by R Q1 -CO-NR Q3 - (wherein R Q3 is a hydrogen atom; a C1-6 alkyl group; a halogeno group, a C1-6 alkoxy group, C1-6 haloalkoxy group, C3-6 cycloalkyl group, phenyl group, or C1-6 alkyl group substituted with one or more substituents of a 5- to 6-membered heteroaryl group; a C6-10 aryl)C1-6 alkyl group substituted with one or more substituents selected from a 6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group; or (5- to 6-membered heteroaryl substituted with one or more substituents selected from a C1-6 alkyl group, a C1-6 alkoxy group, a halogeno group, a C1-6 haloalkyl group, or a C1-6 haloalkoxy group) C1-6 alkyl group; The same applies to R Q3 below.);
a group represented by R Q2 -O-CO-O-; a group represented by R Q2 -O-CO-NR Q3 -; a group represented by R Q1 R Q1 N-CO-O- (in the formula R Q1 may be the same or different, and R Q1 may together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group.);
A group represented by R Q1 R Q1 N—CO—NR Q3 — (R Q1 in the formula may be the same or different. Together, R Q1 may be a trimethylene group, a tetramethylene group, a pentamethylene group, , or may form a dimethyleneoxydimethylene group); a group represented by R Q2 SO 2 —NR Q3 —; a group represented by R Q1 R Q1 N—SO 2 — (in the formula, R Q1 may be the same or different, and R Q1 may together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group.);
a group represented by R Q1 -ON=C(R Q4 )- (wherein R Q4 represents a hydrogen atom or a C1-6 alkyl group); (R Q1 ) 2 C=N-O- (R Q1 in the formula may be the same or different. R Q1 together form a trimethylene group, a tetramethylene group, a pentamethylene group, or a dimethyleneoxydimethylene group. may be used.);
A pentafluorosulfanyl group, a trimethylsilylethynyl group, a nitro group, or a cyano group are preferred.
Furthermore, an oxo group is also preferred as a substituent on the "5- to 10-membered heterocyclyl group".
〔塩〕
化合物(I)の塩は、農園芸学的に許容される塩であれば、特に制限されない。例えば、塩酸、硫酸などの無機酸の塩;酢酸、乳酸などの有機酸の塩;リチウム、ナトリウム、カリウムなどのアルカリ金属の塩;カルシウム、マグネシウムなどのアルカリ土類金属の塩;鉄、銅などの遷移金属の塩;トリエチルアミン、トリブチルアミン、ピリジン、ヒドラジンなどの有機塩基の塩;アンモニウム塩などを挙げることができる。 〔salt〕
Salts of compound (I) are not particularly limited as long as they are agriculturally and horticulturally acceptable salts. For example, salts of inorganic acids such as hydrochloric acid and sulfuric acid; salts of organic acids such as acetic acid and lactic acid; salts of alkali metals such as lithium, sodium and potassium; salts of alkaline earth metals such as calcium and magnesium; salts of transition metals; salts of organic bases such as triethylamine, tributylamine, pyridine and hydrazine; and ammonium salts.
化合物(I)の塩は、農園芸学的に許容される塩であれば、特に制限されない。例えば、塩酸、硫酸などの無機酸の塩;酢酸、乳酸などの有機酸の塩;リチウム、ナトリウム、カリウムなどのアルカリ金属の塩;カルシウム、マグネシウムなどのアルカリ土類金属の塩;鉄、銅などの遷移金属の塩;トリエチルアミン、トリブチルアミン、ピリジン、ヒドラジンなどの有機塩基の塩;アンモニウム塩などを挙げることができる。 〔salt〕
Salts of compound (I) are not particularly limited as long as they are agriculturally and horticulturally acceptable salts. For example, salts of inorganic acids such as hydrochloric acid and sulfuric acid; salts of organic acids such as acetic acid and lactic acid; salts of alkali metals such as lithium, sodium and potassium; salts of alkaline earth metals such as calcium and magnesium; salts of transition metals; salts of organic bases such as triethylamine, tributylamine, pyridine and hydrazine; and ammonium salts.
〔製造方法〕
化合物(I)または化合物(I)の塩の製造方法は、限定されない。例えば、本発明の化合物(I)または化合物(I)の塩は、実施例などに記載したような公知の手法によって得ることができる。また、化合物(I)の塩は、化合物(I)から公知の手法によって得ることができる。 〔Production method〕
The method for producing compound (I) or a salt of compound (I) is not limited. For example, compound (I) or a salt of compound (I) of the present invention can be obtained by known methods such as those described in Examples. Also, a salt of compound (I) can be obtained from compound (I) by a known method.
化合物(I)または化合物(I)の塩の製造方法は、限定されない。例えば、本発明の化合物(I)または化合物(I)の塩は、実施例などに記載したような公知の手法によって得ることができる。また、化合物(I)の塩は、化合物(I)から公知の手法によって得ることができる。 〔Production method〕
The method for producing compound (I) or a salt of compound (I) is not limited. For example, compound (I) or a salt of compound (I) of the present invention can be obtained by known methods such as those described in Examples. Also, a salt of compound (I) can be obtained from compound (I) by a known method.
〔製造中間体〕
本発明のピリダジノン化合物を調製する上で、下記の式(II)で表される化合物またはその塩が、製造中間体となりうる。 [Manufacturing intermediate]
In preparing the pyridazinone compound of the present invention, the compound represented by the following formula (II) or a salt thereof can be a production intermediate.
本発明のピリダジノン化合物を調製する上で、下記の式(II)で表される化合物またはその塩が、製造中間体となりうる。 [Manufacturing intermediate]
In preparing the pyridazinone compound of the present invention, the compound represented by the following formula (II) or a salt thereof can be a production intermediate.
式(II)中、
Yは、酸素原子または硫黄原子を示し;
X1およびX2は、それぞれ独立に、水素原子、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の5~6員環のヘテロシクリル基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、R1-CO-で表される基、カルボキシ基、R2-O-CO-で表される基、R3R4N-で表される基、R3R4N-CO-で表される基、R1-CO-O-で表される基、R1-CO-NR5-で表される基、R2-O-CO-O-で表される基、R2-O-CO-NR5-で表される基、R3R4N-CO-O-で表される基、R3R4N-CO-NR5-で表される基、R2SO2-NR5-で表される基、R3R4N-SO2-で表される基、R1O-N=CR6-で表される基、R3R4N-N=CR6-で表される基、またはR1-N=CR6-で表される基を示し;
R1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R2は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R3は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R4は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
ここで、R3とR4は、一緒になって二価の有機基を形成してもよく、
R5は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し;
X3は、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、R1-CO-で表される基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換の4~6員環のヘテロシクリル基、RN1O-で表される基、RN1-CO-O-で表される基、RN1-O-CO-O-で表される基、RN1RN1N-CO-O-で表される基、RN1-CS-O-で表される基、RN1RN1N-CS-O-で表される基、RN1RN2N-で表される基、RN1-CO-NRN2-で表される基、RN1-CO-CO-NRN2-で表される基、RN1-O-CO-NRN2-で表される基、RN1RN1N-CO-NRN2-で表される基、RN1RN1N-CO-CO-NRN2-で表される基、RN1-CS-NRN2-で表される基、RN1RN1N-CS-NRN2-で表される基、RN1SO2-NRN2-で表される基、またはRN1-C(=NRN1)-NRN2-で表される基を示し、
RN1、およびRN2は、それぞれ独立に、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示し、ここで、RN1とRN1、またはRN1とRN2は、一緒になって二価の有機基を形成してもよく;
X5は、HO-A-で表される基、C1~6アルコキシカルボニル基、またはハロゲノ基を示し、
Aは、置換若しくは無置換のC1~6アルキレン基、置換若しくは無置換のC2~6アルケニレン基、置換若しくは無置換のC2~6アルキニレン基、置換若しくは無置換のC3~6シクロアルキレン基、またはカルボニル基を示す。 In formula (II),
Y represents an oxygen atom or a sulfur atom;
X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6- 10 arylsulfonyl group, substituted or unsubstituted 5- to 6-membered heterocyclyl group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, nitro group, cyano group, group represented by R 1 -CO- , a carboxy group, a group represented by R 2 —O—CO—, a group represented by R 3 R 4 N—, a group represented by R 3 R 4 N—CO—, R 1 —CO—O— a group represented by R 1 -CO-NR 5 -, a group R 2 -O-CO-O-, a group R 2 -O-CO-NR 5 - , a group represented by R 3 R 4 N—CO—O—, a group represented by R 3 R 4 N—CO—NR 5 —, a group represented by R 2 SO 2 —NR 5 —, R 3 a group represented by R 4 N--SO 2 --, a group represented by R 1 ON=CR 6 --, a group represented by R 3 R 4 N--N=CR 6 --, or R 1 --N represents a group represented by =CR 6 -;
R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
wherein R 3 and R 4 may together form a divalent organic group,
each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group;
X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, a substituted or unsubstituted 4- to 6-membered heterocyclyl group, R N1 O- a group represented by R N1 --CO--O--, a group represented by R N1 --O--CO--O--, a group represented by R N1 R N1 N--CO--O--, and R N1 A group represented by -CS-O-, a group represented by R N1 R N1 N-CS-O-, a group represented by R N1 R N2 N-, a group represented by R N1 -CO-NR N2 - a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, a group represented by R N1 R N1 N-CO-NR N2 - a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS-NR N2 —, and a group represented by R N1 R N1 N—CS-NR N2 — a group represented by R N1 SO 2 —NR N2 —, or a group represented by R N1 —C(=NR N1 )—NR N2 —,
R N1 and R N2 are each independently a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2- 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 4- to 6-membered heterocyclyl group, wherein R N1 and R N1 , or R N1 and R N2 may together form a divalent organic group;
X 5 represents a group represented by HO-A-, a C1-6 alkoxycarbonyl group, or a halogeno group,
A is a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or carbonyl indicates a group.
Yは、酸素原子または硫黄原子を示し;
X1およびX2は、それぞれ独立に、水素原子、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の5~6員環のヘテロシクリル基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、R1-CO-で表される基、カルボキシ基、R2-O-CO-で表される基、R3R4N-で表される基、R3R4N-CO-で表される基、R1-CO-O-で表される基、R1-CO-NR5-で表される基、R2-O-CO-O-で表される基、R2-O-CO-NR5-で表される基、R3R4N-CO-O-で表される基、R3R4N-CO-NR5-で表される基、R2SO2-NR5-で表される基、R3R4N-SO2-で表される基、R1O-N=CR6-で表される基、R3R4N-N=CR6-で表される基、またはR1-N=CR6-で表される基を示し;
R1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R2は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R3は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R4は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
ここで、R3とR4は、一緒になって二価の有機基を形成してもよく、
R5は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し;
X3は、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、R1-CO-で表される基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換の4~6員環のヘテロシクリル基、RN1O-で表される基、RN1-CO-O-で表される基、RN1-O-CO-O-で表される基、RN1RN1N-CO-O-で表される基、RN1-CS-O-で表される基、RN1RN1N-CS-O-で表される基、RN1RN2N-で表される基、RN1-CO-NRN2-で表される基、RN1-CO-CO-NRN2-で表される基、RN1-O-CO-NRN2-で表される基、RN1RN1N-CO-NRN2-で表される基、RN1RN1N-CO-CO-NRN2-で表される基、RN1-CS-NRN2-で表される基、RN1RN1N-CS-NRN2-で表される基、RN1SO2-NRN2-で表される基、またはRN1-C(=NRN1)-NRN2-で表される基を示し、
RN1、およびRN2は、それぞれ独立に、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示し、ここで、RN1とRN1、またはRN1とRN2は、一緒になって二価の有機基を形成してもよく;
X5は、HO-A-で表される基、C1~6アルコキシカルボニル基、またはハロゲノ基を示し、
Aは、置換若しくは無置換のC1~6アルキレン基、置換若しくは無置換のC2~6アルケニレン基、置換若しくは無置換のC2~6アルキニレン基、置換若しくは無置換のC3~6シクロアルキレン基、またはカルボニル基を示す。 In formula (II),
Y represents an oxygen atom or a sulfur atom;
X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6- 10 arylsulfonyl group, substituted or unsubstituted 5- to 6-membered heterocyclyl group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, nitro group, cyano group, group represented by R 1 -CO- , a carboxy group, a group represented by R 2 —O—CO—, a group represented by R 3 R 4 N—, a group represented by R 3 R 4 N—CO—, R 1 —CO—O— a group represented by R 1 -CO-NR 5 -, a group R 2 -O-CO-O-, a group R 2 -O-CO-NR 5 - , a group represented by R 3 R 4 N—CO—O—, a group represented by R 3 R 4 N—CO—NR 5 —, a group represented by R 2 SO 2 —NR 5 —, R 3 a group represented by R 4 N--SO 2 --, a group represented by R 1 ON=CR 6 --, a group represented by R 3 R 4 N--N=CR 6 --, or R 1 --N represents a group represented by =CR 6 -;
R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
wherein R 3 and R 4 may together form a divalent organic group,
each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group;
X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, a substituted or unsubstituted 4- to 6-membered heterocyclyl group, R N1 O- a group represented by R N1 --CO--O--, a group represented by R N1 --O--CO--O--, a group represented by R N1 R N1 N--CO--O--, and R N1 A group represented by -CS-O-, a group represented by R N1 R N1 N-CS-O-, a group represented by R N1 R N2 N-, a group represented by R N1 -CO-NR N2 - a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, a group represented by R N1 R N1 N-CO-NR N2 - a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS-NR N2 —, and a group represented by R N1 R N1 N—CS-NR N2 — a group represented by R N1 SO 2 —NR N2 —, or a group represented by R N1 —C(=NR N1 )—NR N2 —,
R N1 and R N2 are each independently a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2- 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 4- to 6-membered heterocyclyl group, wherein R N1 and R N1 , or R N1 and R N2 may together form a divalent organic group;
X 5 represents a group represented by HO-A-, a C1-6 alkoxycarbonyl group, or a halogeno group,
A is a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or carbonyl indicates a group.
式(II)中の、それぞれの記号は、式(I)中のそれらと同様の意味を示す。
X5における「C1~6アルコキシカルボニル基」は、メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基、n-ブトキシカルボニル基、t-ブトキシカルボニル基などを挙げることができる。
X5における「ハロゲノ基」としては、フルオロ基、クロロ基、ブロモ基、イオド基などを挙げることができる。
式(II)の化合物としては、X2が、R1O-N=CR6-で表される基である化合物またはそれらの塩であることが好ましい。 Each symbol in formula (II) has the same meaning as those in formula (I).
The "C1-6 alkoxycarbonyl group" for X 5 includes a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group, a t-butoxycarbonyl group, and the like. .
Examples of the "halogeno group" for X5 include a fluoro group, a chloro group, a bromo group, an iodo group and the like.
The compound of formula (II) is preferably a compound in which X 2 is a group represented by R 1 ON=CR 6 - or a salt thereof.
X5における「C1~6アルコキシカルボニル基」は、メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基、n-ブトキシカルボニル基、t-ブトキシカルボニル基などを挙げることができる。
X5における「ハロゲノ基」としては、フルオロ基、クロロ基、ブロモ基、イオド基などを挙げることができる。
式(II)の化合物としては、X2が、R1O-N=CR6-で表される基である化合物またはそれらの塩であることが好ましい。 Each symbol in formula (II) has the same meaning as those in formula (I).
The "C1-6 alkoxycarbonyl group" for X 5 includes a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group, a t-butoxycarbonyl group, and the like. .
Examples of the "halogeno group" for X5 include a fluoro group, a chloro group, a bromo group, an iodo group and the like.
The compound of formula (II) is preferably a compound in which X 2 is a group represented by R 1 ON=CR 6 - or a salt thereof.
〔製造中間体の塩及び製造方法〕
式(II)で表される製造中間体の塩は、式(I)で表される化合物の塩と同様のものを例示することができる。
また、式(II)で表される製造中間体の製造方法は、限定されない。例えば、実施例などに記載したような公知の手法によって得ることができる。また、製造中間体の塩は、化合物(II)から公知の手法によって得ることができる。 [Salt of production intermediate and production method]
Examples of the salt of the production intermediate represented by formula (II) are the same as the salt of the compound represented by formula (I).
Moreover, the production method of the production intermediate represented by formula (II) is not limited. For example, it can be obtained by a known method as described in Examples. Also, a salt of a production intermediate can be obtained from compound (II) by a known method.
式(II)で表される製造中間体の塩は、式(I)で表される化合物の塩と同様のものを例示することができる。
また、式(II)で表される製造中間体の製造方法は、限定されない。例えば、実施例などに記載したような公知の手法によって得ることができる。また、製造中間体の塩は、化合物(II)から公知の手法によって得ることができる。 [Salt of production intermediate and production method]
Examples of the salt of the production intermediate represented by formula (II) are the same as the salt of the compound represented by formula (I).
Moreover, the production method of the production intermediate represented by formula (II) is not limited. For example, it can be obtained by a known method as described in Examples. Also, a salt of a production intermediate can be obtained from compound (II) by a known method.
〔農園芸用殺菌剤〕
本発明の農園芸用殺菌剤は、化合物(I)およびその塩から選ばれる少なくともひとつを有効成分として含有するものである。本発明の農園芸用殺菌剤に含まれる化合物(I)またはその塩の量は、殺菌効果を示す限りにおいて特に制限されない。 [Fungicide for agriculture and horticulture]
The agricultural and horticultural fungicide of the present invention contains as an active ingredient at least one selected from compound (I) and salts thereof. The amount of compound (I) or a salt thereof contained in the agricultural and horticultural fungicide of the present invention is not particularly limited as long as it exhibits a fungicidal effect.
本発明の農園芸用殺菌剤は、化合物(I)およびその塩から選ばれる少なくともひとつを有効成分として含有するものである。本発明の農園芸用殺菌剤に含まれる化合物(I)またはその塩の量は、殺菌効果を示す限りにおいて特に制限されない。 [Fungicide for agriculture and horticulture]
The agricultural and horticultural fungicide of the present invention contains as an active ingredient at least one selected from compound (I) and salts thereof. The amount of compound (I) or a salt thereof contained in the agricultural and horticultural fungicide of the present invention is not particularly limited as long as it exhibits a fungicidal effect.
本発明の農園芸用殺菌剤は、広範囲の種類の糸状菌、例えば、藻菌類(Oomycetes)、子のう(嚢)菌類(Ascomycetes)、不完全菌類(Deuteromycetes)、担子菌類(Basidiomycetes)、接合菌類(Zygomycetes)に属する菌に由来する植物病害の防除に使用できる。
The agricultural and horticultural fungicides of the present invention are suitable for a wide variety of filamentous fungi such as Oomycetes, Ascomycetes, Deuteromycetes, Basidiomycetes, zygotes. It can be used to control plant diseases caused by fungi belonging to Zygomycetes.
防除の対象となる植物病害(病原菌)の例を以下に示す。
テンサイ:褐斑病(Cercospora beticola)、黒根病(Aphanomyces cochlioides )、根腐病(Thanatephorus cucumeris)、葉腐病(Thanatephorus cucumeris)、さび病(Uromyces betae)、うどんこ病(Oidium sp.)、斑点病(Ramularia beticola)、苗立枯病(Aphanomyces cochlioides、Pythium ultimum)など
ラッカセイ:褐斑病(Mycosphaerella arachidis)、汚斑病(Ascochyta sp.)、さび病(Puccinia arachidis)、立枯病(Pythium debaryanum)、さび斑病(Alternaria alternata)、白絹病(Sclerotium rolfsii)黒渋病(Mycosphaerella berkeleyi)、黒根腐病(Calonectria ilicicola)など
キュウリ:うどんこ病(Sphaerotheca fuliginea)、べと病(Pseudoperonospora cubensis)、つる枯病(Mycosphaerella melonis)、つる割病(Fusarium oxysporum)、菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)、炭そ病(Colletotrichum orbiculare)、黒星病(Cladosporium cucumerinum)、褐斑病(Corynespora cassiicola)、苗立枯病(Pythium debaryanum、Rhizoctonia solani Kuhn)、ホモプシス根腐病(Phomopsis sp.)斑点細菌病(Pseudomonas syringae pv. Lachrymans)など
トマト:灰色かび病(Botrytis cinerea)、葉かび病(Cladosporium fulvum)、疫病(Phytophthora infestans)、半身萎凋病(Verticillium albo-atrum、 Verticillium dahliae)、うどんこ病(Oidium neolycopersici)、輪紋病(Alternaria solani)、すすかび病(Pseudocercospora fuligena)、青枯病(Ralstonia solanacearum)、菌核病(Sclerotinia sclerotiorum)など
ナス:灰色かび病(Botrytis cinerea)、黒枯病(Corynespora melongenae)、うどんこ病(Erysiphe cichoracearum)、すすかび病(Mycovellosiella nattrassii)、菌核病(Sclerotinia sclerotiorum)、半身萎凋病(Verticillium dahliae)、褐紋病(Phomopsis vexans)など
トウガラシ:疫病(Phytophthora capsici)、灰色かび病(Botrytis cinerea)、菌核病(Sclerotinia sclerotiorum)、炭疽病(Colletotrichum aenigma、Colletotrichum capsici、 Colletotrichum fructicola、 Colletotrichum jiangxiense)、うどんこ病(Leveillula taurica)など
イチゴ:灰色かび病(Botrytis cinerea)、うどんこ病(Sphaerotheca humuli)、炭そ病(Colletotrichum acutatum、Colletotrichum fragariae)、疫病(Phytophthora cactorum)、軟腐病(Rhizopus stolonifer)、萎黄病(Fusarium oxysporum)、萎凋病(Verticillium dahliae)、菌核病(Sclerotinia sclerotiorum)など
タマネギ:灰色腐敗病(Botrytis allii)、灰色かび病(Botrytis cinerea)、白斑葉枯病(Botrytis squamosa)、べと病(Peronospora destructor)、白色疫病(Phytophthora porri)、小菌核病(Ciborinia allii)、小菌核腐敗病(Botrytis squamosa)、乾腐病(Fusarium oxysporum)、紅色根腐病(Pyrenochaeta terrestris)、黒腐菌核病(Sclerotium cepivorum)、さび病(Puccinia allii)、白絹病(Sclerotium rolfsii)など
ネギ:軟腐病(Pectobacterium carotovorum)、べと病(Peronospora destructor)、葉枯病(Pleospora allii)、黒腐菌核病(Sclerotium cepivorum)、さび病(Puccinia allii)、白斑葉枯病(Botrytis squamosa)、白絹病(Sclerotium rolfsii)、紅色根腐病(Pyrenochaeta terrestris)など
キャベツ:根こぶ病(Plasmodiophora brassicae)、軟腐病(Erwinia carotovora)、黒腐病(Xanthomonas campesrtis pv. campestris)、黒斑細菌病(Pseudomonas syringae pv. maculicola、P. s. pv. alisalensis)、べと病(Peronospora parasitica)、菌核病(Sclerotinia sclerotiorum)、黒すす病(Alternaria brassicicola)、灰色かび病(Botrytis cinerea)、根朽病(Phoma lingam)、ピシウム腐敗病(Pythium aphanidermatum, Pythium ultimum)、白さび病(Albugo macrospora)など
レタス:腐敗病(Pseudomonas cichorii, Pseudomonas marginalis)、軟腐病(Pectobacterium carotovorum)、べと病(Bremia lactucae)、灰色かび病(Botrytis cinerea)、菌核病(Sclerotinia sclerotiorum)、ビッグベイン病(Mirafiori lettuce big-vein ophiovirus)、根腐病(Fusarium oxysporum)、すそ枯病(Rhizoctonia solani)、うどんこ病(Golovinomyces orontii)など
インゲン:菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)、炭疽病(Colletotrichum lindemuthianum)、角斑病(Phaeoisariopsis griseola)など
エンドウ:褐紋病(Mycosphaerella blight)、灰色かび病(Botrytis cinerea)、菌核病(Sclerotinia sclerotiorum)、うどんこ病(Erysiphe pisi)など Examples of plant diseases (pathogens) targeted for control are shown below.
Sugar beet: brown spot (Cercospora beticola), cochlioides (Aphanomyces cochlioides), root rot (Thanatephorus cucumeris), leaf rot (Thanatephorus cucumeris), rust (Uromyces betae), powdery mildew (Oidium sp.), spot Peanuts: Mycosphaerella arachidis, Ascochyta sp., Puccinia arachidis, Pythium debaryanum ), rust (Alternaria alternata), white silk (Sclerotium rolfsii), black stain (Mycosphaerella berkeleyi), black root rot (Calonectria ilicicola), etc. Cucumber: powdery mildew (Sphaerotheca fuliginea), downy mildew (Pseudoperonospora cubensis) , Mycosphaerella melonis, Fusarium oxysporum, Sclerotinia sclerotiorum, Botrytis cinerea, Colletotrichum orbiculare, Cladosporium cucumerinum, Brown spot Corynespora cassiicola, Pythium debaryanum, Rhizoctonia solani Kuhn, Phomopsis sp., Pseudomonas syringae pv. Lachrymans, etc. Tomatoes: Botrytis cinerea, leaves Mold (Cladosporium fulvum), plague (Phytophthora infestans), wilt (Verticillium albo-atrum, Verticillium dahliae), powdery mildew (Oidium neolycopersici), ring spot (Alternaria solani), Pseudocercospora fuligena, Ralstonia solanacearum, Sclerotinia sclerotiorum, etc. Eggplant: Botrytis cinerea, Corynespora melongenae, Erysiphe cichoracearum), Mycovellosiella nattrassii, Sclerotinia sclerotiorum, Verticillium dahliae, Phomopsis vexans, etc. Pepper: Phytophthora capsici, Botrytis cinerea , Sclerotinia sclerotiorum, Colletotrichum aenigma, Colletotrichum capsici, Colletotrichum fructicola, Colletotrichum jiangxiense, Leveillula taurica Strawberry: Botrytis cinerea, Sphaerotheca humuli , Colletotrichum acutatum, Colletotrichum fragariae, Phytophthora cactorum, Rhizopus stolonifer, Fusarium oxysporum, Verticillium dahliae, Sclerotinia sclerotiorum, etc. Onions: Gray Botrytis allii, Botrytis cinerea, Botrytis squamosa, Peronospora destructor, Phytophthora porri, Ciborinia allii, Small fungi nucleus rot (Botrytis squamosa), dry rot (Fusarium oxysporum), red root rot (Pyrenochaeta terrestris), black rot sclerotium (Sclerotium cepivorum), rust (Puccinia allii), white silk disease (Sclerotium rolfsii), etc. Green onions: soft rot (Pectobacterium carotovorum), downy mildew (Peronospora destructor), leaf blight (Pleospora allii), black rot (Sclerotium cepivorum), rust (Puccinia allii), leaf blight (Botrytis squamosa), white silk disease (Sclerotium rolfsii), red root rot (Pyrenochaeta terrestris), etc. Cabbage: clubroot (Plasmodiophora brassicae), soft rot (Erwinia carotovora), black rot (Xanthomonas campesrtis pv. campestris), black spot (Pseudomonas syringae pv. maculicola, P. s. pv. alisalensis), mildew (Peronospora parasitica), sclerotinia (Sclerotinia sclerotiorum) ), Black soot (Alternaria brassicicola), Gray mold (Botrytis cinerea), Root rot (Phoma lingam), Pythium aphanidermatum, Pythium ultimum, White rust (Albugo macrospora), etc. Lettuce: rot ( Pseudomonas cichorii, Pseudomonas marginalis, Pectobacterium carotovorum, Bremia lactucae, Botrytis cinerea, Sclerotinia sclerotiorum, Mirafiori lettuce big-vein ophiovirus, Fusarium oxysporum, Rhizoctonia solani, Golovinomyces orontii, etc. Green beans: Sclerotinia sclerotiorum, Botrytis cinere a), Colletotrichum lindemuthianum, Phaeoisariopsis griseola, etc. Peas: Mycosphaerella blight, Botrytis cinerea, Sclerotinia sclerotiorum, Erysiphe pisi )Such
テンサイ:褐斑病(Cercospora beticola)、黒根病(Aphanomyces cochlioides )、根腐病(Thanatephorus cucumeris)、葉腐病(Thanatephorus cucumeris)、さび病(Uromyces betae)、うどんこ病(Oidium sp.)、斑点病(Ramularia beticola)、苗立枯病(Aphanomyces cochlioides、Pythium ultimum)など
ラッカセイ:褐斑病(Mycosphaerella arachidis)、汚斑病(Ascochyta sp.)、さび病(Puccinia arachidis)、立枯病(Pythium debaryanum)、さび斑病(Alternaria alternata)、白絹病(Sclerotium rolfsii)黒渋病(Mycosphaerella berkeleyi)、黒根腐病(Calonectria ilicicola)など
キュウリ:うどんこ病(Sphaerotheca fuliginea)、べと病(Pseudoperonospora cubensis)、つる枯病(Mycosphaerella melonis)、つる割病(Fusarium oxysporum)、菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)、炭そ病(Colletotrichum orbiculare)、黒星病(Cladosporium cucumerinum)、褐斑病(Corynespora cassiicola)、苗立枯病(Pythium debaryanum、Rhizoctonia solani Kuhn)、ホモプシス根腐病(Phomopsis sp.)斑点細菌病(Pseudomonas syringae pv. Lachrymans)など
トマト:灰色かび病(Botrytis cinerea)、葉かび病(Cladosporium fulvum)、疫病(Phytophthora infestans)、半身萎凋病(Verticillium albo-atrum、 Verticillium dahliae)、うどんこ病(Oidium neolycopersici)、輪紋病(Alternaria solani)、すすかび病(Pseudocercospora fuligena)、青枯病(Ralstonia solanacearum)、菌核病(Sclerotinia sclerotiorum)など
ナス:灰色かび病(Botrytis cinerea)、黒枯病(Corynespora melongenae)、うどんこ病(Erysiphe cichoracearum)、すすかび病(Mycovellosiella nattrassii)、菌核病(Sclerotinia sclerotiorum)、半身萎凋病(Verticillium dahliae)、褐紋病(Phomopsis vexans)など
トウガラシ:疫病(Phytophthora capsici)、灰色かび病(Botrytis cinerea)、菌核病(Sclerotinia sclerotiorum)、炭疽病(Colletotrichum aenigma、Colletotrichum capsici、 Colletotrichum fructicola、 Colletotrichum jiangxiense)、うどんこ病(Leveillula taurica)など
イチゴ:灰色かび病(Botrytis cinerea)、うどんこ病(Sphaerotheca humuli)、炭そ病(Colletotrichum acutatum、Colletotrichum fragariae)、疫病(Phytophthora cactorum)、軟腐病(Rhizopus stolonifer)、萎黄病(Fusarium oxysporum)、萎凋病(Verticillium dahliae)、菌核病(Sclerotinia sclerotiorum)など
タマネギ:灰色腐敗病(Botrytis allii)、灰色かび病(Botrytis cinerea)、白斑葉枯病(Botrytis squamosa)、べと病(Peronospora destructor)、白色疫病(Phytophthora porri)、小菌核病(Ciborinia allii)、小菌核腐敗病(Botrytis squamosa)、乾腐病(Fusarium oxysporum)、紅色根腐病(Pyrenochaeta terrestris)、黒腐菌核病(Sclerotium cepivorum)、さび病(Puccinia allii)、白絹病(Sclerotium rolfsii)など
ネギ:軟腐病(Pectobacterium carotovorum)、べと病(Peronospora destructor)、葉枯病(Pleospora allii)、黒腐菌核病(Sclerotium cepivorum)、さび病(Puccinia allii)、白斑葉枯病(Botrytis squamosa)、白絹病(Sclerotium rolfsii)、紅色根腐病(Pyrenochaeta terrestris)など
キャベツ:根こぶ病(Plasmodiophora brassicae)、軟腐病(Erwinia carotovora)、黒腐病(Xanthomonas campesrtis pv. campestris)、黒斑細菌病(Pseudomonas syringae pv. maculicola、P. s. pv. alisalensis)、べと病(Peronospora parasitica)、菌核病(Sclerotinia sclerotiorum)、黒すす病(Alternaria brassicicola)、灰色かび病(Botrytis cinerea)、根朽病(Phoma lingam)、ピシウム腐敗病(Pythium aphanidermatum, Pythium ultimum)、白さび病(Albugo macrospora)など
レタス:腐敗病(Pseudomonas cichorii, Pseudomonas marginalis)、軟腐病(Pectobacterium carotovorum)、べと病(Bremia lactucae)、灰色かび病(Botrytis cinerea)、菌核病(Sclerotinia sclerotiorum)、ビッグベイン病(Mirafiori lettuce big-vein ophiovirus)、根腐病(Fusarium oxysporum)、すそ枯病(Rhizoctonia solani)、うどんこ病(Golovinomyces orontii)など
インゲン:菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)、炭疽病(Colletotrichum lindemuthianum)、角斑病(Phaeoisariopsis griseola)など
エンドウ:褐紋病(Mycosphaerella blight)、灰色かび病(Botrytis cinerea)、菌核病(Sclerotinia sclerotiorum)、うどんこ病(Erysiphe pisi)など Examples of plant diseases (pathogens) targeted for control are shown below.
Sugar beet: brown spot (Cercospora beticola), cochlioides (Aphanomyces cochlioides), root rot (Thanatephorus cucumeris), leaf rot (Thanatephorus cucumeris), rust (Uromyces betae), powdery mildew (Oidium sp.), spot Peanuts: Mycosphaerella arachidis, Ascochyta sp., Puccinia arachidis, Pythium debaryanum ), rust (Alternaria alternata), white silk (Sclerotium rolfsii), black stain (Mycosphaerella berkeleyi), black root rot (Calonectria ilicicola), etc. Cucumber: powdery mildew (Sphaerotheca fuliginea), downy mildew (Pseudoperonospora cubensis) , Mycosphaerella melonis, Fusarium oxysporum, Sclerotinia sclerotiorum, Botrytis cinerea, Colletotrichum orbiculare, Cladosporium cucumerinum, Brown spot Corynespora cassiicola, Pythium debaryanum, Rhizoctonia solani Kuhn, Phomopsis sp., Pseudomonas syringae pv. Lachrymans, etc. Tomatoes: Botrytis cinerea, leaves Mold (Cladosporium fulvum), plague (Phytophthora infestans), wilt (Verticillium albo-atrum, Verticillium dahliae), powdery mildew (Oidium neolycopersici), ring spot (Alternaria solani), Pseudocercospora fuligena, Ralstonia solanacearum, Sclerotinia sclerotiorum, etc. Eggplant: Botrytis cinerea, Corynespora melongenae, Erysiphe cichoracearum), Mycovellosiella nattrassii, Sclerotinia sclerotiorum, Verticillium dahliae, Phomopsis vexans, etc. Pepper: Phytophthora capsici, Botrytis cinerea , Sclerotinia sclerotiorum, Colletotrichum aenigma, Colletotrichum capsici, Colletotrichum fructicola, Colletotrichum jiangxiense, Leveillula taurica Strawberry: Botrytis cinerea, Sphaerotheca humuli , Colletotrichum acutatum, Colletotrichum fragariae, Phytophthora cactorum, Rhizopus stolonifer, Fusarium oxysporum, Verticillium dahliae, Sclerotinia sclerotiorum, etc. Onions: Gray Botrytis allii, Botrytis cinerea, Botrytis squamosa, Peronospora destructor, Phytophthora porri, Ciborinia allii, Small fungi nucleus rot (Botrytis squamosa), dry rot (Fusarium oxysporum), red root rot (Pyrenochaeta terrestris), black rot sclerotium (Sclerotium cepivorum), rust (Puccinia allii), white silk disease (Sclerotium rolfsii), etc. Green onions: soft rot (Pectobacterium carotovorum), downy mildew (Peronospora destructor), leaf blight (Pleospora allii), black rot (Sclerotium cepivorum), rust (Puccinia allii), leaf blight (Botrytis squamosa), white silk disease (Sclerotium rolfsii), red root rot (Pyrenochaeta terrestris), etc. Cabbage: clubroot (Plasmodiophora brassicae), soft rot (Erwinia carotovora), black rot (Xanthomonas campesrtis pv. campestris), black spot (Pseudomonas syringae pv. maculicola, P. s. pv. alisalensis), mildew (Peronospora parasitica), sclerotinia (Sclerotinia sclerotiorum) ), Black soot (Alternaria brassicicola), Gray mold (Botrytis cinerea), Root rot (Phoma lingam), Pythium aphanidermatum, Pythium ultimum, White rust (Albugo macrospora), etc. Lettuce: rot ( Pseudomonas cichorii, Pseudomonas marginalis, Pectobacterium carotovorum, Bremia lactucae, Botrytis cinerea, Sclerotinia sclerotiorum, Mirafiori lettuce big-vein ophiovirus, Fusarium oxysporum, Rhizoctonia solani, Golovinomyces orontii, etc. Green beans: Sclerotinia sclerotiorum, Botrytis cinere a), Colletotrichum lindemuthianum, Phaeoisariopsis griseola, etc. Peas: Mycosphaerella blight, Botrytis cinerea, Sclerotinia sclerotiorum, Erysiphe pisi )Such
りんご:うどんこ病(Podosphaera leucotricha)、黒星病(Venturia inaequalis)、モニリア病(Monilinia mali)、黒点病(Mycosphaerella pomi)、腐らん病(Valsa mali)、斑点落葉病(Alternaria mali)、赤星病(Gymnosporangium yamadae)、輪紋病(Botryosphaeria berengeriana)、炭そ病(Glomerella cingulata、Colletotrichum acutatum)、褐斑病(Diplocarpon mali)、すす点病(Zygophiala jamaicensis)、すす斑病(Gloeodes pomigena)、紫紋羽病(Helicobasidium mompa)、白紋羽病(Rosellinia necatrix)、灰色かび病(Botrytis cinerea)、火傷病(Erwinia amylovora)、銀葉病(Chondrostereum purpureum)、根頭がんしゅ病(Rhizobium radiobacter 、 Rhizobium rhizogenes)など
ウメ:黒星病(Cladosporium carpophilum)、灰色かび病(Botrytis cinerea)、灰星病(Monilinia mumecola)、すす斑病(Peltaster sp.)、ふくろ実病(Taphrina pruni)、褐色せん孔病(Phloeosporella padi)など
カキ:うどんこ病(Phyllactinia kakicola)、炭そ病(Gloeosporium kaki)、角斑落葉病(Cercospora kaki)、円星落葉病(Mycosphaerella nawae)、灰色かび病(Botrytis cinerea)、すす点病(Zygophiala jamaicensis)など
モモ:灰星病(Monilinia fructicola、Monilia fructigena)、黒星病(Cladosporiumcarpophilum)、ホモプシス腐敗病(Phomopsis sp.)、穿孔細菌病(Xanthomonas campestris pv. pruni)、縮葉病(Taphrina deformans)、炭そ病(Colletotrichum gloeosporioides)、褐色せん孔病(Phloeosporella padi)、かわらたけ病(Coriolus versicolor)など
アーモンド:灰星病(Monilinia laxa)、斑点病(Stigmina carpophila)、黒星病(Cladosporium carpophilum)、葉ぶくれ病(Polystigma rubrum)、斑点落葉病(Alternaria alternata)、炭疽病(Colletotrichum gloeospoides)など
オウトウ:灰星病(Monilinia fructicola)、炭そ病(Colletotrichum acutatum)、黒斑病(Alternaria sp.)、幼果菌核病(Monilinia kusanoi)、褐色せん孔病(Mycosphaerella cerasella)、うどんこ病(Podosphaera tridactyla)など
ブドウ:灰色かび病(Botrytis cinerea)、うどんこ病(Uncinula necator)、晩腐病(Glomerella cingulata、Colletotrichum acutatum)、べと病(Plasmopara viticola)、黒とう病(Elsinoe ampelina)、褐斑病(Pseudocercospora vitis)、黒腐病(Guignardia bidwellii)、白腐病(Coniella castaneicola)、さび病(Phakopsora ampelopsidis)、白色綿雪症(病原菌未同定)、根頭がんしゅ病(Rhizobium radiobacter、 Rhizobium vitis)など
ナシ:黒星病(Venturia nashicola)、赤星病(Gymnosporangium asiaticum)、黒斑病(Alternaria kikuchiana)、輪紋病(Botryosphaeria berengeriana)、うどんこ病(Phyllactinia mali)、胴枯病(Phomopsis fukushii)、褐色斑点病(Stemphylium vesicarium)、炭そ病(Glomerella cingulata)など
チャ:輪斑病(Pestalotiopsis longiseta、 P. theae)、炭そ病(Colletotrichum theae-sinensis)、網もち病(Exobasidium reticulatum)、赤焼病(Pseudomonas syringae)、もち病(Exobasidium vexans)など
カンキツ:そうか病(Elsinoe fawcettii)、青かび病(Penicillium italicum)、緑かび病(Penicillium digitatum)、灰色かび病(Botrytis cinerea)、黒点病(Diaporthe citri)、かいよう病(Xanthomonas campestris pv.Citri)、うどんこ病(Oidium sp.)、疫病(Phytophthora citrophthora)、炭そ病(Colletotrichum fioriniae)など
キウイフルーツ:花腐細菌病(Pseudomonas marginalis、Pseudomonas syringae、Pseudomonas viridiflava)、かいよう病(Pseudomonas syringae)、灰色かび病(Botrytis cinerea)、果実軟腐病(Botryosphaeria dothidea、Diaporthe sp.、Lasiodiplodia theobromae)、すす斑病(Pseudocercospora actinidiae)など
オリーブ:炭疽病(Colletotrichum acutatum, Colletotrichum gloeosporioides)、Peacock spot(Spilocaea oleaginea)など
クリ:炭疽病(Colletotrichum gloeosporioides)など Apples: powdery mildew (Podosphaera leucotricha), scab (Venturia inaequalis), monilia (Monilinia mali), black spot (Mycosphaerella pomi), rot (Valsa mali), leaf spot (Alternaria mali), scab (Gymnosporangium) yamadae), ring spot (Botryosphaeria berengeriana), anthracnose (Glomerella cingulata, Colletotrichum acutatum), brown spot (Diplocarpon mali), soot spot (Zygophiala jamaicensis), soot spot (Gloeodes pomigena), purple leaf spot (Helicobasidium mompa), White leaf disease (Rosellinia necatrix), Gray mold (Botrytis cinerea), Fire blight (Erwinia amylovora), Silver leaf disease (Chondrostereum purpureum), Root canker (Rhizobium radiobacter, Rhizobium rhizogenes) Plum: Cladosporium carpophilum, Botrytis cinerea, Monilinia mumecola, Peltaster sp., Taphrina pruni, Phloeosporella padi Oysters: powdery mildew (Phyllactinia kakicola), anthracnose (Gloeosporium kaki), horn spot (Cercospora kaki), leaf spot (Mycosphaerella nawae), gray mold (Botrytis cinerea), soot spot (Zygophiala) jamaicensis), etc. Peach: Monilinia fructicola, Monilia fructigena, Cladosporiumcarpophilum, Phomopsis sp., Xanthomonas campestris pv. pruni, Taphrina deformans, charcoal Colletotrichum gloeosporioides, Phloeosporella padi, Coriolus versicolor, etc. Almonds: Monilinia laxa, Stigmina carpophila, Cladosporium carpophilum, leaf blisters Polystigma rubrum, Alternaria alternata, Colletotrichum gloeospoides, etc. Cherry: Monilinia fructicola, Colletotrichum acutatum, Alternaria sp., young fruit Sclerotinia (Monilinia kusanoi), brown pit (Mycosphaerella cerasella), powdery mildew (Podosphaera tridactyla), etc. Grapes: Botrytis cinerea, powdery mildew (Uncinula necator), late rot (Glomerella cingulata, Colletotrichum) acutatum), downy mildew (Plasmopara viticola), black rot (Elsinoe ampelina), brown spot (Pseudocercospora vitis), black rot (Guignardia bidwellii), white rot (Coniella castaneicola), rust (Phakopsora ampelopsidis), Snow white (pathogen unidentified), root cancer (Rhizobium radiobacter, Rhizobium vitis), etc. Pear: Venturia nashicola, Gymnosporangium asiaticum, Alternaria kikuchiana, Ring spot (Botryosphaeria berengeriana), powdery mildew (Phyllactinia mali), blight (Phomopsis fukushii), brown spot (Stemphylium vesicarium), anthracnose (Glomerella cingulata), etc. Tea: Pestalotiops is longiseta, P. theae), anthracnose (Colletotrichum theae-sinensis), net blister (Exobasidium reticulatum), red scorch (Pseudomonas syringae), blast (Exobasidium vexans), etc. Citrus: scab (Elsinoe fawcettii) , Penicillium italicum, Penicillium digitatum, Botrytis cinerea, Diaporthe citri, Xanthomonas campestris pv. Citri, Powdery mildew (Oidium sp.), Late blight (Phytophthora citrophthora), anthracnose (Colletotrichum fioriniae), etc. Kiwifruit: Pseudomonas marginalis, Pseudomonas syringae, Pseudomonas viridiflava, Pseudomonas syringae, Botrytis cinerea, fruit soft rot (Botryosphaeria dothidea, Diaporthe sp., Lasiodiplodia theobromae), Pseudocercospora actinidiae, etc. Olive: Colletotrichum acutatum, Colletotrichum gloeosporioides, Peacock spot (Spilocaea oleaginea), etc. Chestnut: Colletotrichum gloeosporioides, etc.
ウメ:黒星病(Cladosporium carpophilum)、灰色かび病(Botrytis cinerea)、灰星病(Monilinia mumecola)、すす斑病(Peltaster sp.)、ふくろ実病(Taphrina pruni)、褐色せん孔病(Phloeosporella padi)など
カキ:うどんこ病(Phyllactinia kakicola)、炭そ病(Gloeosporium kaki)、角斑落葉病(Cercospora kaki)、円星落葉病(Mycosphaerella nawae)、灰色かび病(Botrytis cinerea)、すす点病(Zygophiala jamaicensis)など
モモ:灰星病(Monilinia fructicola、Monilia fructigena)、黒星病(Cladosporiumcarpophilum)、ホモプシス腐敗病(Phomopsis sp.)、穿孔細菌病(Xanthomonas campestris pv. pruni)、縮葉病(Taphrina deformans)、炭そ病(Colletotrichum gloeosporioides)、褐色せん孔病(Phloeosporella padi)、かわらたけ病(Coriolus versicolor)など
アーモンド:灰星病(Monilinia laxa)、斑点病(Stigmina carpophila)、黒星病(Cladosporium carpophilum)、葉ぶくれ病(Polystigma rubrum)、斑点落葉病(Alternaria alternata)、炭疽病(Colletotrichum gloeospoides)など
オウトウ:灰星病(Monilinia fructicola)、炭そ病(Colletotrichum acutatum)、黒斑病(Alternaria sp.)、幼果菌核病(Monilinia kusanoi)、褐色せん孔病(Mycosphaerella cerasella)、うどんこ病(Podosphaera tridactyla)など
ブドウ:灰色かび病(Botrytis cinerea)、うどんこ病(Uncinula necator)、晩腐病(Glomerella cingulata、Colletotrichum acutatum)、べと病(Plasmopara viticola)、黒とう病(Elsinoe ampelina)、褐斑病(Pseudocercospora vitis)、黒腐病(Guignardia bidwellii)、白腐病(Coniella castaneicola)、さび病(Phakopsora ampelopsidis)、白色綿雪症(病原菌未同定)、根頭がんしゅ病(Rhizobium radiobacter、 Rhizobium vitis)など
ナシ:黒星病(Venturia nashicola)、赤星病(Gymnosporangium asiaticum)、黒斑病(Alternaria kikuchiana)、輪紋病(Botryosphaeria berengeriana)、うどんこ病(Phyllactinia mali)、胴枯病(Phomopsis fukushii)、褐色斑点病(Stemphylium vesicarium)、炭そ病(Glomerella cingulata)など
チャ:輪斑病(Pestalotiopsis longiseta、 P. theae)、炭そ病(Colletotrichum theae-sinensis)、網もち病(Exobasidium reticulatum)、赤焼病(Pseudomonas syringae)、もち病(Exobasidium vexans)など
カンキツ:そうか病(Elsinoe fawcettii)、青かび病(Penicillium italicum)、緑かび病(Penicillium digitatum)、灰色かび病(Botrytis cinerea)、黒点病(Diaporthe citri)、かいよう病(Xanthomonas campestris pv.Citri)、うどんこ病(Oidium sp.)、疫病(Phytophthora citrophthora)、炭そ病(Colletotrichum fioriniae)など
キウイフルーツ:花腐細菌病(Pseudomonas marginalis、Pseudomonas syringae、Pseudomonas viridiflava)、かいよう病(Pseudomonas syringae)、灰色かび病(Botrytis cinerea)、果実軟腐病(Botryosphaeria dothidea、Diaporthe sp.、Lasiodiplodia theobromae)、すす斑病(Pseudocercospora actinidiae)など
オリーブ:炭疽病(Colletotrichum acutatum, Colletotrichum gloeosporioides)、Peacock spot(Spilocaea oleaginea)など
クリ:炭疽病(Colletotrichum gloeosporioides)など Apples: powdery mildew (Podosphaera leucotricha), scab (Venturia inaequalis), monilia (Monilinia mali), black spot (Mycosphaerella pomi), rot (Valsa mali), leaf spot (Alternaria mali), scab (Gymnosporangium) yamadae), ring spot (Botryosphaeria berengeriana), anthracnose (Glomerella cingulata, Colletotrichum acutatum), brown spot (Diplocarpon mali), soot spot (Zygophiala jamaicensis), soot spot (Gloeodes pomigena), purple leaf spot (Helicobasidium mompa), White leaf disease (Rosellinia necatrix), Gray mold (Botrytis cinerea), Fire blight (Erwinia amylovora), Silver leaf disease (Chondrostereum purpureum), Root canker (Rhizobium radiobacter, Rhizobium rhizogenes) Plum: Cladosporium carpophilum, Botrytis cinerea, Monilinia mumecola, Peltaster sp., Taphrina pruni, Phloeosporella padi Oysters: powdery mildew (Phyllactinia kakicola), anthracnose (Gloeosporium kaki), horn spot (Cercospora kaki), leaf spot (Mycosphaerella nawae), gray mold (Botrytis cinerea), soot spot (Zygophiala) jamaicensis), etc. Peach: Monilinia fructicola, Monilia fructigena, Cladosporiumcarpophilum, Phomopsis sp., Xanthomonas campestris pv. pruni, Taphrina deformans, charcoal Colletotrichum gloeosporioides, Phloeosporella padi, Coriolus versicolor, etc. Almonds: Monilinia laxa, Stigmina carpophila, Cladosporium carpophilum, leaf blisters Polystigma rubrum, Alternaria alternata, Colletotrichum gloeospoides, etc. Cherry: Monilinia fructicola, Colletotrichum acutatum, Alternaria sp., young fruit Sclerotinia (Monilinia kusanoi), brown pit (Mycosphaerella cerasella), powdery mildew (Podosphaera tridactyla), etc. Grapes: Botrytis cinerea, powdery mildew (Uncinula necator), late rot (Glomerella cingulata, Colletotrichum) acutatum), downy mildew (Plasmopara viticola), black rot (Elsinoe ampelina), brown spot (Pseudocercospora vitis), black rot (Guignardia bidwellii), white rot (Coniella castaneicola), rust (Phakopsora ampelopsidis), Snow white (pathogen unidentified), root cancer (Rhizobium radiobacter, Rhizobium vitis), etc. Pear: Venturia nashicola, Gymnosporangium asiaticum, Alternaria kikuchiana, Ring spot (Botryosphaeria berengeriana), powdery mildew (Phyllactinia mali), blight (Phomopsis fukushii), brown spot (Stemphylium vesicarium), anthracnose (Glomerella cingulata), etc. Tea: Pestalotiops is longiseta, P. theae), anthracnose (Colletotrichum theae-sinensis), net blister (Exobasidium reticulatum), red scorch (Pseudomonas syringae), blast (Exobasidium vexans), etc. Citrus: scab (Elsinoe fawcettii) , Penicillium italicum, Penicillium digitatum, Botrytis cinerea, Diaporthe citri, Xanthomonas campestris pv. Citri, Powdery mildew (Oidium sp.), Late blight (Phytophthora citrophthora), anthracnose (Colletotrichum fioriniae), etc. Kiwifruit: Pseudomonas marginalis, Pseudomonas syringae, Pseudomonas viridiflava, Pseudomonas syringae, Botrytis cinerea, fruit soft rot (Botryosphaeria dothidea, Diaporthe sp., Lasiodiplodia theobromae), Pseudocercospora actinidiae, etc. Olive: Colletotrichum acutatum, Colletotrichum gloeosporioides, Peacock spot (Spilocaea oleaginea), etc. Chestnut: Colletotrichum gloeosporioides, etc.
コムギ:うどんこ病(Blumeria graminis f.sp. tritici)、赤かび病(Gibberella zeae、Fusarium avenaceum、Fusarium culmorum、Fusarium crookwellense、Microdochium nivale)、赤さび病(Puccinia recondita)、黄さび病(Puccinia striiformis)、褐色雪腐病(Pythium iwayamai)、紅色雪腐病(Monographella nivalis)、眼紋病(Pseudocercosporella herpotrichoides)、葉枯病(Septoria tritici)、ふ枯病(Leptosphaeria nodorum)、雪腐小粒菌核病(Typhula incarnata)、雪腐大粒菌核病(Myriosclerotinia borealis)、立枯病(Gaeumannomyces graminis)、麦角病(Claviceps purpurea)、なまぐさ黒穂病(Tilletia caries)、裸黒穂病(Ustilago nuda)、いもち病(Pyricularia grisea)、Damping off(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)、Seedling blight(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)など
オオムギ:斑葉病(Pyrenophora graminea)、網斑病(Pyrenophora teres)、雲形病(Rhynchosporium secalis)、裸黒穂病(Ustilago tritici、U.nuda)、Damping off(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)、Seedling blight(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)など
イネ:いもち病(Pyricularia oryzae)、紋枯病(Rhizoctonia solani)、馬鹿苗病(Gibberella fujikuroi)、ごま葉枯病(Cochliobolus miyabeanus)、苗立枯病(Pythiumgraminicola)、白葉枯病(Xanthomonas oryzae)、苗立枯細菌病(Burkholderia plantarii)、褐条病(Acidovorax avenae)、もみ枯細菌病(Burkholderia glumae)、すじ葉枯病(Cercospora oryzae)、稲こうじ病(Ustilaginoidea virens)、褐色米(Alternaria alternata、Curvularia intermedia)、腹黒米(Alternaria padwickii)、紅変米(Epicoccum purpurascens)など
タバコ:菌核病(Sclerotinia sclerotiorum)、うどんこ病(Erysiphe cichoracearum)、疫病(Phytophthora nicotianae)、など
チューリップ:灰色かび病(Botrytis cinerea)、褐色斑点病(Botrytis tulipae)、葉腐病(Rhizoctonia solani)、球根腐敗病(Fusarium oxysporum)、皮腐病(Rhizoctonia solani)など
バラ:黒星病(Diplocarpon rosae)、うどんこ病(Erysiphe simulans、Podosphaera pannosa)、灰色かび病(Botrytis cinerea)など
キク:灰色かび病(Botrytis cinerea)、白さび病(Puccinia horiana)、べと病(Paraperonospora minor, Peronospora danica)、ピシウム立枯病(Pythium aphanidermatum、Pythium dissotocum、Pythium helicoides、Pythium oedochilum、Pythium sylvaticum)、立枯病(Rhizoctonia solani)、フザリウム立枯病(Fusarium solani)など
ガーベラ:灰色かび病(Botrytis cinerea)、うどんこ病(Podosphaera xanthii)など
ユリ:葉枯病(Botrytis elliptica, Pestalotiopsis sp.)、灰色かび病(Botrytis cinerea)など
ヒマワリ:べと病(Plasmopara halstedii)、菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)など
ベントグラス:雪腐大粒菌核病(Sclerotinia borealis)、ラージパッチ(Rhizoctonia solani)、ブラウンパッチ(Rhizoctonia solani)、ダラースポット(Sclerotinia homoeocarpa)、いもち病(Pyricularia sp.)、赤焼病(Pythium aphanidermatum)、炭そ病(Colletotrichum graminicola)など
オーチャードグラス:うどんこ病(Erysiphe graminis)など
ダイズ:紫斑病(Cercospora kikuchii)、べと病(Peronospora manshurica)、茎疫病(Phytophthora sojae)、さび病(Phakopsora pachyrhizi)、菌核病(Sclerotinia sclerotiorum)、炭そ病(Colletotrichum truncatum)、灰色かび病(Botrytis cinerea)、黒とう病(Elsinoe glycines)、黒点病(Diaporthe phaseolorum var. sojae)、Damping off(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)、Seedling blight(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)など
ジャガイモ:疫病(Phytophthora infestans)、夏疫病(Alternaria solani)、黒あざ病(Thanatephorus cucumeris)、半身萎凋病(Verticillium albo-atrum、V. dahliae、V. nigrescens)、黒あし病(Pectobacterium atrosepticum)、軟腐病(Pectobacterium carotovorum)、灰色かび病(Botrytis cinerea)、そうか病(Streptomyces spp.)、菌核病(Sclerotinia sclerotiorum)など
ヤマノイモ:葉渋病(Cylindrosporium dioscoreae)、炭疽病(Colletotrichum gloeosporioides)、青かび病(Penicillium sclerotigenum)など
サツマイモ:紫紋羽病(Helicobasidium mompa)、つる割病(Fusarium oxysporum)など
サトイモ:疫病(Phytophthora colocasiae)、茎腐病(Rhizoctonia solani)など
ショウガ:根茎腐敗病(Pythium ultimum、Pythium myriotylum)、白星病(Phyllosticta zingiberis)など
バナナ:パナマ病(Fusarium oxysporum)、シガトカ病(Mycosphaerella fijiensis、M. musicola)など
マンゴー:炭そ病(Colletotrichum aenigma)、かいよう病(Xanthomonas campestris)、軸腐病(Diaporthe pseudophoenicicola、Lasiodiplodia theobromae、Lasiodiplodia spp.、Neofusicoccum parvum、Neofusicoccum sp.)、灰色かび病(Botrytis cinerea)など
ナタネ:菌核病(Sclerotinia sclerotiorum)、根朽病(Phoma lingam)、黒斑病(Alternaria brassicae)、うどんこ病(Erysiphe cruciferarum、Erysiphe cichoracearum、Oidium matthiolae)、べと病(Peronospora parasitica)など
コーヒー:さび病(Hemileia vastatrix)、炭疽病(Colletotrichum coffeanum)、褐眼病(Cercospora coffeicola)など
サトウキビ:褐さび病(Puccinia melanocephala)など
トウモロコシ:ひょう紋病(Gloeocercospora sorghi)、さび病(Puccinia sorghi)、南方さび病(Puccinia polysora)、黒穂病(Ustilago maydis)、ごま葉枯病(Cochliobolus heterostrophus)、すす紋病(Setosphaeria turcica)、Damping off(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)、Seedling blight(Pythium spp.、Fusariumspp.、Rhizoctonia spp.)など
ワタ:苗立枯病(Pythium sp.)、さび病(Phakopsora gossypii)、白かび病(Mycosphaerella areola)、炭疽病(Glomerella gossypii)など
ホップ:べと病(Pseudoperonospora humuli)、うどんこ病(Oidium sp.、Podosphaera macularis)、灰色かび病(Botrytis cinerea)など Wheat: Powdery mildew (Blumeria graminis f.sp. tritici), Fusarium head blight (Gibberella zeae, Fusarium avenaceum, Fusarium culmorum, Fusarium crookwellense, Microdochium nivale), Fusarium rust (Puccinia recondita), Yellow rust (Puccinia striiformis), Pythium iwayamai, Monographella nivalis, Pseudocercosporella herpotrichoides, Septoria tritici, Leptosphaeria nodorum, Typhula incarnata), Myriosclerotinia borealis, Gaeumannomyces graminis, Claviceps purpurea, Tilletia caries, Ustilago nuda, Pyricularia grisea ), Damping off (Pythium spp., Fusarium spp., Rhizoctonia spp.), Seedling blight (Pythium spp., Fusarium spp., Rhizoctonia spp.), etc. Barley: Pyrenophora graminea, Pyrenophora teres ), Rhynchosporium secalis, Naked smut (Ustilago tritici, U.nuda), Damping off (Pythium spp., Fusarium spp., Rhizoctonia spp.), Seedling blight (Pythium spp., Fusarium spp., Rhizoctonia spp. Rice: Pyricularia oryzae, Rhizoctonia solani, Gibberella fujikuroi, Cochliobolus miyabeanus, Pythiumg raminicola), Xanthomonas oryzae, Burkholderia plantarii, Acidovorax avenae, Burkholderia glumae, Cercospora oryzae, Rice blight (Ustilaginoidea virens), Brown rice (Alternaria alternata, Curvularia intermedia), Alternaria padwickii, Epicoccum purpurascens, etc. Tobacco: Sclerotinia sclerotiorum, Erysiphe cichoracearum, plague ( Phytophthora nicotianae), etc. Tulips: Botrytis cinerea, Botrytis tulipae, Rhizoctonia solani, Fusarium oxysporum, Rhizoctonia solani, etc. Rose: Black star Diplocarpon rosae, powdery mildew (Erysiphe simulans, Podosphaera pannosa), gray mold (Botrytis cinerea), etc. Peronospora danica), Pythium aphanidermatum, Pythium dissotocum, Pythium helicoides, Pythium oedochilum, Pythium sylvaticum, Rhizoctonia solani, Fusarium solani, etc. Gerbera: Botrytis cinerea ), powdery mildew (Podosphaera xanthii), etc. Lily: leaf blight (Botrytis elliptica, Pestalotiopsis sp.), gray mold (Botrytis cinerea), etc. Sunflower: downy mildew (Pla smopara halstedii), Sclerotinia sclerotiorum, Botrytis cinerea, etc. Bent grass: Sclerotinia borealis, large patch (Rhizoctonia solani), brown patch (Rhizoctonia solani), dollar spot ( Sclerotinia homoeocarpa), Pyricularia sp., Pythium aphanidermatum, Colletotrichum graminicola, etc. Orchard grass: Powdery mildew (Erysiphe graminis), etc. Soybean: Purpura (Cercospora kikuchii), downy mildew Peronospora manshurica, Phytophthora sojae, Phakopsora pachyrhizi, Sclerotinia sclerotiorum, Colletotrichum truncatum, Botrytis cinerea, Elsinoe glycines ), Black spot (Diaporthe phaseolorum var. sojae), Damping off (Pythium spp., Fusarium spp., Rhizoctonia spp.), Seedling blight (Pythium spp., Fusarium spp., Rhizoctonia spp.), etc. Potatoes: Phytophthora infestans ), Alternaria solani, Thanatephorus cucumeris, Verticillium albo-atrum, V. dahliae, V. nigrescens, Pectobacterium atrosepticum, Pectobacterium carotovorum, Gray mold (Botrytis cinerea), scab (Streptomyces spp.), sclerotinia (Sclerotinia sclerotiorum), etc. sporium dioscoreae, Colletotrichum gloeosporioides, Penicillium sclerotigenum, etc. Sweet potato: Helicobasidium mompa, Fusarium oxysporum, etc. Taro: Phytophthora colocasiae, Rhizoctonia solani), etc. Ginger: Root rot (Pythium ultimum, Pythium myriotylum), White star disease (Phyllosticta zingiberis), etc. Banana: Panama disease (Fusarium oxysporum), Sigatoka disease (Mycosphaerella fijiensis, M. musicola), etc. Mango: Anthracnose (Colletotrichum) aenigma), canker (Xanthomonas campestris), shaft rot (Diaporthe pseudophoenicicola, Lasiodiplodia theobromae, Lasiodiplodia spp., Neofusicoccum parvum, Neofusicoccum sp.), gray mold (Botrytis cinerea), etc. Rapeseed: Sclerotinia sclerotiorum, root rot (Phoma lingam), black spot (Alternaria brassicae), powdery mildew (Erysiphe cruciferarum, Erysiphe cichoracearum, Oidium matthiolae), downy mildew (Peronospora parasitica), etc. Coffee: rust (Hemileia vastatrix), anthracnose ( Coletotrichum coffeanum), brown eye disease (Cercospora coffeicola), etc. Sugarcane: Brown rust (Puccinia melanocephala), etc. Corn: Gloeocercospora sorghi, rust (Puccinia sorghi), southern rust (Puccinia polysora), smut (Ustilago) maydis), sesame leaf blight (Cochliobolus hetero strophus), Setosphaeria turcica, Damping off (Pythium spp., Fusarium spp., Rhizoctonia spp.), Seedling blight (Pythium spp., Fusarium spp., Rhizoctonia spp.), etc. sp.), rust (Phakopsora gossypii), white mold (Mycosphaerella areola), anthracnose (Glomerella gossypii), etc. Hops: Downy mildew (Pseudoperonospora humuli), powdery mildew (Oidium sp., Podosphaera macularis), gray mold disease (Botrytis cinerea), etc.
オオムギ:斑葉病(Pyrenophora graminea)、網斑病(Pyrenophora teres)、雲形病(Rhynchosporium secalis)、裸黒穂病(Ustilago tritici、U.nuda)、Damping off(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)、Seedling blight(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)など
イネ:いもち病(Pyricularia oryzae)、紋枯病(Rhizoctonia solani)、馬鹿苗病(Gibberella fujikuroi)、ごま葉枯病(Cochliobolus miyabeanus)、苗立枯病(Pythiumgraminicola)、白葉枯病(Xanthomonas oryzae)、苗立枯細菌病(Burkholderia plantarii)、褐条病(Acidovorax avenae)、もみ枯細菌病(Burkholderia glumae)、すじ葉枯病(Cercospora oryzae)、稲こうじ病(Ustilaginoidea virens)、褐色米(Alternaria alternata、Curvularia intermedia)、腹黒米(Alternaria padwickii)、紅変米(Epicoccum purpurascens)など
タバコ:菌核病(Sclerotinia sclerotiorum)、うどんこ病(Erysiphe cichoracearum)、疫病(Phytophthora nicotianae)、など
チューリップ:灰色かび病(Botrytis cinerea)、褐色斑点病(Botrytis tulipae)、葉腐病(Rhizoctonia solani)、球根腐敗病(Fusarium oxysporum)、皮腐病(Rhizoctonia solani)など
バラ:黒星病(Diplocarpon rosae)、うどんこ病(Erysiphe simulans、Podosphaera pannosa)、灰色かび病(Botrytis cinerea)など
キク:灰色かび病(Botrytis cinerea)、白さび病(Puccinia horiana)、べと病(Paraperonospora minor, Peronospora danica)、ピシウム立枯病(Pythium aphanidermatum、Pythium dissotocum、Pythium helicoides、Pythium oedochilum、Pythium sylvaticum)、立枯病(Rhizoctonia solani)、フザリウム立枯病(Fusarium solani)など
ガーベラ:灰色かび病(Botrytis cinerea)、うどんこ病(Podosphaera xanthii)など
ユリ:葉枯病(Botrytis elliptica, Pestalotiopsis sp.)、灰色かび病(Botrytis cinerea)など
ヒマワリ:べと病(Plasmopara halstedii)、菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)など
ベントグラス:雪腐大粒菌核病(Sclerotinia borealis)、ラージパッチ(Rhizoctonia solani)、ブラウンパッチ(Rhizoctonia solani)、ダラースポット(Sclerotinia homoeocarpa)、いもち病(Pyricularia sp.)、赤焼病(Pythium aphanidermatum)、炭そ病(Colletotrichum graminicola)など
オーチャードグラス:うどんこ病(Erysiphe graminis)など
ダイズ:紫斑病(Cercospora kikuchii)、べと病(Peronospora manshurica)、茎疫病(Phytophthora sojae)、さび病(Phakopsora pachyrhizi)、菌核病(Sclerotinia sclerotiorum)、炭そ病(Colletotrichum truncatum)、灰色かび病(Botrytis cinerea)、黒とう病(Elsinoe glycines)、黒点病(Diaporthe phaseolorum var. sojae)、Damping off(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)、Seedling blight(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)など
ジャガイモ:疫病(Phytophthora infestans)、夏疫病(Alternaria solani)、黒あざ病(Thanatephorus cucumeris)、半身萎凋病(Verticillium albo-atrum、V. dahliae、V. nigrescens)、黒あし病(Pectobacterium atrosepticum)、軟腐病(Pectobacterium carotovorum)、灰色かび病(Botrytis cinerea)、そうか病(Streptomyces spp.)、菌核病(Sclerotinia sclerotiorum)など
ヤマノイモ:葉渋病(Cylindrosporium dioscoreae)、炭疽病(Colletotrichum gloeosporioides)、青かび病(Penicillium sclerotigenum)など
サツマイモ:紫紋羽病(Helicobasidium mompa)、つる割病(Fusarium oxysporum)など
サトイモ:疫病(Phytophthora colocasiae)、茎腐病(Rhizoctonia solani)など
ショウガ:根茎腐敗病(Pythium ultimum、Pythium myriotylum)、白星病(Phyllosticta zingiberis)など
バナナ:パナマ病(Fusarium oxysporum)、シガトカ病(Mycosphaerella fijiensis、M. musicola)など
マンゴー:炭そ病(Colletotrichum aenigma)、かいよう病(Xanthomonas campestris)、軸腐病(Diaporthe pseudophoenicicola、Lasiodiplodia theobromae、Lasiodiplodia spp.、Neofusicoccum parvum、Neofusicoccum sp.)、灰色かび病(Botrytis cinerea)など
ナタネ:菌核病(Sclerotinia sclerotiorum)、根朽病(Phoma lingam)、黒斑病(Alternaria brassicae)、うどんこ病(Erysiphe cruciferarum、Erysiphe cichoracearum、Oidium matthiolae)、べと病(Peronospora parasitica)など
コーヒー:さび病(Hemileia vastatrix)、炭疽病(Colletotrichum coffeanum)、褐眼病(Cercospora coffeicola)など
サトウキビ:褐さび病(Puccinia melanocephala)など
トウモロコシ:ひょう紋病(Gloeocercospora sorghi)、さび病(Puccinia sorghi)、南方さび病(Puccinia polysora)、黒穂病(Ustilago maydis)、ごま葉枯病(Cochliobolus heterostrophus)、すす紋病(Setosphaeria turcica)、Damping off(Pythium spp.、Fusarium spp.、Rhizoctonia spp.)、Seedling blight(Pythium spp.、Fusariumspp.、Rhizoctonia spp.)など
ワタ:苗立枯病(Pythium sp.)、さび病(Phakopsora gossypii)、白かび病(Mycosphaerella areola)、炭疽病(Glomerella gossypii)など
ホップ:べと病(Pseudoperonospora humuli)、うどんこ病(Oidium sp.、Podosphaera macularis)、灰色かび病(Botrytis cinerea)など Wheat: Powdery mildew (Blumeria graminis f.sp. tritici), Fusarium head blight (Gibberella zeae, Fusarium avenaceum, Fusarium culmorum, Fusarium crookwellense, Microdochium nivale), Fusarium rust (Puccinia recondita), Yellow rust (Puccinia striiformis), Pythium iwayamai, Monographella nivalis, Pseudocercosporella herpotrichoides, Septoria tritici, Leptosphaeria nodorum, Typhula incarnata), Myriosclerotinia borealis, Gaeumannomyces graminis, Claviceps purpurea, Tilletia caries, Ustilago nuda, Pyricularia grisea ), Damping off (Pythium spp., Fusarium spp., Rhizoctonia spp.), Seedling blight (Pythium spp., Fusarium spp., Rhizoctonia spp.), etc. Barley: Pyrenophora graminea, Pyrenophora teres ), Rhynchosporium secalis, Naked smut (Ustilago tritici, U.nuda), Damping off (Pythium spp., Fusarium spp., Rhizoctonia spp.), Seedling blight (Pythium spp., Fusarium spp., Rhizoctonia spp. Rice: Pyricularia oryzae, Rhizoctonia solani, Gibberella fujikuroi, Cochliobolus miyabeanus, Pythiumg raminicola), Xanthomonas oryzae, Burkholderia plantarii, Acidovorax avenae, Burkholderia glumae, Cercospora oryzae, Rice blight (Ustilaginoidea virens), Brown rice (Alternaria alternata, Curvularia intermedia), Alternaria padwickii, Epicoccum purpurascens, etc. Tobacco: Sclerotinia sclerotiorum, Erysiphe cichoracearum, plague ( Phytophthora nicotianae), etc. Tulips: Botrytis cinerea, Botrytis tulipae, Rhizoctonia solani, Fusarium oxysporum, Rhizoctonia solani, etc. Rose: Black star Diplocarpon rosae, powdery mildew (Erysiphe simulans, Podosphaera pannosa), gray mold (Botrytis cinerea), etc. Peronospora danica), Pythium aphanidermatum, Pythium dissotocum, Pythium helicoides, Pythium oedochilum, Pythium sylvaticum, Rhizoctonia solani, Fusarium solani, etc. Gerbera: Botrytis cinerea ), powdery mildew (Podosphaera xanthii), etc. Lily: leaf blight (Botrytis elliptica, Pestalotiopsis sp.), gray mold (Botrytis cinerea), etc. Sunflower: downy mildew (Pla smopara halstedii), Sclerotinia sclerotiorum, Botrytis cinerea, etc. Bent grass: Sclerotinia borealis, large patch (Rhizoctonia solani), brown patch (Rhizoctonia solani), dollar spot ( Sclerotinia homoeocarpa), Pyricularia sp., Pythium aphanidermatum, Colletotrichum graminicola, etc. Orchard grass: Powdery mildew (Erysiphe graminis), etc. Soybean: Purpura (Cercospora kikuchii), downy mildew Peronospora manshurica, Phytophthora sojae, Phakopsora pachyrhizi, Sclerotinia sclerotiorum, Colletotrichum truncatum, Botrytis cinerea, Elsinoe glycines ), Black spot (Diaporthe phaseolorum var. sojae), Damping off (Pythium spp., Fusarium spp., Rhizoctonia spp.), Seedling blight (Pythium spp., Fusarium spp., Rhizoctonia spp.), etc. Potatoes: Phytophthora infestans ), Alternaria solani, Thanatephorus cucumeris, Verticillium albo-atrum, V. dahliae, V. nigrescens, Pectobacterium atrosepticum, Pectobacterium carotovorum, Gray mold (Botrytis cinerea), scab (Streptomyces spp.), sclerotinia (Sclerotinia sclerotiorum), etc. sporium dioscoreae, Colletotrichum gloeosporioides, Penicillium sclerotigenum, etc. Sweet potato: Helicobasidium mompa, Fusarium oxysporum, etc. Taro: Phytophthora colocasiae, Rhizoctonia solani), etc. Ginger: Root rot (Pythium ultimum, Pythium myriotylum), White star disease (Phyllosticta zingiberis), etc. Banana: Panama disease (Fusarium oxysporum), Sigatoka disease (Mycosphaerella fijiensis, M. musicola), etc. Mango: Anthracnose (Colletotrichum) aenigma), canker (Xanthomonas campestris), shaft rot (Diaporthe pseudophoenicicola, Lasiodiplodia theobromae, Lasiodiplodia spp., Neofusicoccum parvum, Neofusicoccum sp.), gray mold (Botrytis cinerea), etc. Rapeseed: Sclerotinia sclerotiorum, root rot (Phoma lingam), black spot (Alternaria brassicae), powdery mildew (Erysiphe cruciferarum, Erysiphe cichoracearum, Oidium matthiolae), downy mildew (Peronospora parasitica), etc. Coffee: rust (Hemileia vastatrix), anthracnose ( Coletotrichum coffeanum), brown eye disease (Cercospora coffeicola), etc. Sugarcane: Brown rust (Puccinia melanocephala), etc. Corn: Gloeocercospora sorghi, rust (Puccinia sorghi), southern rust (Puccinia polysora), smut (Ustilago) maydis), sesame leaf blight (Cochliobolus hetero strophus), Setosphaeria turcica, Damping off (Pythium spp., Fusarium spp., Rhizoctonia spp.), Seedling blight (Pythium spp., Fusarium spp., Rhizoctonia spp.), etc. sp.), rust (Phakopsora gossypii), white mold (Mycosphaerella areola), anthracnose (Glomerella gossypii), etc. Hops: Downy mildew (Pseudoperonospora humuli), powdery mildew (Oidium sp., Podosphaera macularis), gray mold disease (Botrytis cinerea), etc.
〔殺線虫剤〕
本発明のピリダジノン化合物は、植物の生育に影響する各種の線虫類の防除効果にも優れている。
本発明の殺線虫剤は、化合物(I)およびその塩から選ばれる少なくともひとつを有効成分として含有するものである。本発明の殺線虫剤に含まれる化合物(I)またはその塩の量は、線虫の防除効果を示す限りにおいて特に制限されない。 [Nematicide]
The pyridazinone compound of the present invention is also excellent in controlling effect on various nematodes that affect plant growth.
The nematicide of the present invention contains at least one selected from compound (I) and salts thereof as an active ingredient. The amount of compound (I) or a salt thereof contained in the nematicide of the present invention is not particularly limited as long as it exhibits a nematode control effect.
本発明のピリダジノン化合物は、植物の生育に影響する各種の線虫類の防除効果にも優れている。
本発明の殺線虫剤は、化合物(I)およびその塩から選ばれる少なくともひとつを有効成分として含有するものである。本発明の殺線虫剤に含まれる化合物(I)またはその塩の量は、線虫の防除効果を示す限りにおいて特に制限されない。 [Nematicide]
The pyridazinone compound of the present invention is also excellent in controlling effect on various nematodes that affect plant growth.
The nematicide of the present invention contains at least one selected from compound (I) and salts thereof as an active ingredient. The amount of compound (I) or a salt thereof contained in the nematicide of the present invention is not particularly limited as long as it exhibits a nematode control effect.
本発明の殺線虫剤によって防除可能な各種の植物寄生性線虫類の具体例を以下に示す。(1)クキセンチュウ目(Tylenchida)
(a)アングイナ科(Anguinidae)の、例えば、アングイナ属種(Anguina spp.)の、アングイナ・フネスタ(Anguina funesta)、コムギツブセンチュウ(Anguina tritici);ジチレンクス属種(Ditylenchus spp.)の、イモグサレセンチュウ(Ditylenchus destructor)、ナミクキセンチュウ(Ditylenchus dipsaci)、キノコセンチュウ(Ditylenchusmyceliophagus);
(b)アフェレンコイデス科(Aphelenchoididae)の、例えば、アフェレンコイデス属種(Aphelenchoides spp.)の、イネシンガレセンチュウ(Aphelenchoides besseyi)、イチゴセンチュウ(Aphelenchoides fragariae)、ハガレセンチュウ(Aphelenchoides ritzemabosi);ブルサフェレンクス属種(Bursaphelenchus spp.)の、マツノザイセンチュウ(Bursaphelenchus xylophilus);
(c)ベロノライムス科(Belonolaimidae)の、例えば、ベロノライムス属種(Belonolaimus spp.)の、ベロノライムス・ロンギカウダツス(Belonolaimus longicaudatus);チレンコリンクス属種(Tylenchorhynchus spp.)の、ナミイシュクセンチュウ(Tylenchorhynchus claytoni)、チレンコリンクス・ズビウス(Tylenchorhynchus dubius);
(d)クリコネマ科(Criconematidae)の、例えば、クリコネマ・ムタビル(Criconema mutabile);
(e)ドリコドルス科(Dolichodoridae)の、例えば、ドリコドルス・メディテラネウス(Dolichodorus mediterraneus);
(f)エクフャドフォラ科(Ecphyadophoridae)の、例えば、エクフャドフォラ・テヌイシマ(Ecphyadophora tenuissima)
(g)ヘミシクリオフォラ科(Hemicycliophoridae)の、例えば、ローフィア・チエネマニ(Loofia thienemanni);
(h)ヘテロデラ科(Heteroderidae)の、例えば、グロボデラ属種(Globodera spp.)の、ジャガイモシストセンチュウ(Globodera rostochiensis)、ジャガイモシロシストセンチュウ(Globodera pallida)、タバコシストセンチュウ(Globodera tabacum);ヘテロデア属種(Heterodera spp.)の、ムギシストセンチュウ(Heterodera avenae)、ヘテロデア・フルシフェラ(Heterodera cruciferae)、ダイズシストセンチュウ(Heterodera glycines)、テンサイシストセンチュウ(Heterodera schachtii)、クローバシストセンチュウ(Heterodera trifolii);
(i)ホプロライムス科(Hoplolaimidae)の、例えば、ヘリコチレンクス属種(Helicotylenchus spp.)の、ナミラセンセンチュウ(Helicotylenchus dihystera)、ヘリコチレンクス・ムルチシンクツス(Helicotylenchus multicinctus);ホプロライムス属種(Hoplolaimus spp.)の、ホプロライムス・コロンブス(Hoplolaimus columbus)、ホプロライムス・ガレアツス(Hoplolaimus galeatus);その他の、ロチレンカス・ロブスタス(Rotylenchus robustus)、ロチレンクルス・レニホルミス(Rotylenchulus reniformis);
(j)メロイドギネ科(Meloidogynidae)の、例えば、メロイドギネ属種の(Meloidogynespp.)、アレナリアネコブセンチュウ(Meloidogyne arenaria)、コロンビアネコブセンチュウ(Meloidogyne chitwoodi)、キタネコブセンチュウ(Meloidogyne hapla)、サツマイモネコブセンチュウ(Meloidogyne incognita)、ジャワネコブセンチュウ(Meloidogyne javanica)、テムズネコブセンチュウ(Meloidogyne thamesi);
(k)ノスティレンクス科(Nothotylenchidae)の、例えば、イチゴメセンチュウ(Nothotylenchus acris);
(l)パラティレンクス科(Paratylenchidae)の、例えば、パラティレンクス属種(Paratylenchus spp.)の、チャピンセンチュウ(Paratylenchus curvitatus)、ヒメピンセンチュウ(Paratylenchus elachistus);
(m)プラティレンクス科(Pratylenchidae)の、例えば、プラティレンクス属(Pratylenchus spp.)種の、プラティレンクスネグサレセンチュウ(Pratylenchus brachyurus)、ミナミネグサレセンチュウ(Pratylenchus coffeae)、ピンセンチュウ(Pratylenchuscurvitatus)、キクネグサレセンチュウ(Pratylenchus fallax)、プラティレンクス・ゴーデイ(Pratylenchus goodeyi)、プラティレンクス・ネグレクツス(Pratylencus neglectus)、キタネグサレセンチュウ(Pratylenchus penetrans)、プラティレンクス・スクリブネリ(Pratylenchus scribneri)、クルミネグサレセンチュウ(Pratylenchus vulnus)、モロコシネグサレセンチュウ(Pratylenchus zeae);その他の、ニセネコブセンチュウ(Nacobbus aberrans)、バナナネモグリセンチュウ(Radopholus similis)、ミカンネセンチュウ(Tylenchulus semipenetrans)、カンキツネモグリセンチュウ(Radopholus citrophilus)。 Specific examples of various plant parasitic nematodes that can be controlled by the nematicide of the present invention are shown below. (1) Tylenchida
(a) Anguinidae, for example, Anguina spp., Anguina funesta, Anguina tritici; Ditylenchus spp., Imogusare nematode ( Ditylenchus destructor), Ditylenchus dipsaci, Ditylenchus myceliophagus;
(b) Aphelenchoides family (Aphelenchoididae), for example, Aphelenchoides spp., Aphelenchoides besseyi, Aphelenchoides fragariae, Aphelenchoides ritzemabosi; Bursa Bursaphelenchus xylophilus, of the genus Bursaphelenchus spp.;
(c) Belonolaimidae, e.g., Belonolaimus spp., Belonolaimus longicaudatus; Tylenchorhynchus spp., Tylenchorhynchus claytoni , Tylenchorhynchus dubius;
(d) of the family Criconematidae, such as Criconema mutabile;
(e) of the family Dolichoodoridae, such as Dolichoodorus mediterraneus;
(f) Ecphyadophoridae, for example, Ecphyadophora tenuissima
(g) Hemicycliophoridae, such as Loofia thienemanni;
(h) Globodera rostochiensis, Globodera pallida, Globodera tabacum of the family Heteroderidae, e.g. Globodera spp.; (Heterodera spp.), Heterodera avenae, Heterodera cruciferae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii;
(i) of the family Hoplolimidae, for example, Helicotylenchus spp., Helicotylenchus dihystera, Helicotylenchus multicinctus; Columbus (Hoplolaimus columbus), Hoplolaimus galeatus; Others, Rotylenchus robustus, Rotylenchus reniformis;
(j) Meloidogyne family (Meloidogynidae), for example, Meloidogyne spp. Meloidogyne javanica, Meloidogyne thamesi;
(k) of the family Nothotylenchidae, such as Nothotylenchus acris;
(l) Paratylenchidae, for example, Paratylenchus spp. Paratylenchus curvitatus, Paratylenchus elachistus;
(m) Platylenchus family (Pratylenchidae), for example, Pratylenchus spp. species, Platylenchus brachyurus, Pratylenchus coffeae, Pinnematode (Pratylenchus curvitatus) , Pratylenchus fallax, Pratylenchus goodeyi, Pratylencus neglectus, Pratylenchus penetrans, Platylenchus scribneri, Walnut Pratylenchus vulnus, Pratylenchus zeae; others, Nacobbus aberrans, Radopholus similis, Tylenchulus semipenetrans, Radopholus citrophilus ).
(a)アングイナ科(Anguinidae)の、例えば、アングイナ属種(Anguina spp.)の、アングイナ・フネスタ(Anguina funesta)、コムギツブセンチュウ(Anguina tritici);ジチレンクス属種(Ditylenchus spp.)の、イモグサレセンチュウ(Ditylenchus destructor)、ナミクキセンチュウ(Ditylenchus dipsaci)、キノコセンチュウ(Ditylenchusmyceliophagus);
(b)アフェレンコイデス科(Aphelenchoididae)の、例えば、アフェレンコイデス属種(Aphelenchoides spp.)の、イネシンガレセンチュウ(Aphelenchoides besseyi)、イチゴセンチュウ(Aphelenchoides fragariae)、ハガレセンチュウ(Aphelenchoides ritzemabosi);ブルサフェレンクス属種(Bursaphelenchus spp.)の、マツノザイセンチュウ(Bursaphelenchus xylophilus);
(c)ベロノライムス科(Belonolaimidae)の、例えば、ベロノライムス属種(Belonolaimus spp.)の、ベロノライムス・ロンギカウダツス(Belonolaimus longicaudatus);チレンコリンクス属種(Tylenchorhynchus spp.)の、ナミイシュクセンチュウ(Tylenchorhynchus claytoni)、チレンコリンクス・ズビウス(Tylenchorhynchus dubius);
(d)クリコネマ科(Criconematidae)の、例えば、クリコネマ・ムタビル(Criconema mutabile);
(e)ドリコドルス科(Dolichodoridae)の、例えば、ドリコドルス・メディテラネウス(Dolichodorus mediterraneus);
(f)エクフャドフォラ科(Ecphyadophoridae)の、例えば、エクフャドフォラ・テヌイシマ(Ecphyadophora tenuissima)
(g)ヘミシクリオフォラ科(Hemicycliophoridae)の、例えば、ローフィア・チエネマニ(Loofia thienemanni);
(h)ヘテロデラ科(Heteroderidae)の、例えば、グロボデラ属種(Globodera spp.)の、ジャガイモシストセンチュウ(Globodera rostochiensis)、ジャガイモシロシストセンチュウ(Globodera pallida)、タバコシストセンチュウ(Globodera tabacum);ヘテロデア属種(Heterodera spp.)の、ムギシストセンチュウ(Heterodera avenae)、ヘテロデア・フルシフェラ(Heterodera cruciferae)、ダイズシストセンチュウ(Heterodera glycines)、テンサイシストセンチュウ(Heterodera schachtii)、クローバシストセンチュウ(Heterodera trifolii);
(i)ホプロライムス科(Hoplolaimidae)の、例えば、ヘリコチレンクス属種(Helicotylenchus spp.)の、ナミラセンセンチュウ(Helicotylenchus dihystera)、ヘリコチレンクス・ムルチシンクツス(Helicotylenchus multicinctus);ホプロライムス属種(Hoplolaimus spp.)の、ホプロライムス・コロンブス(Hoplolaimus columbus)、ホプロライムス・ガレアツス(Hoplolaimus galeatus);その他の、ロチレンカス・ロブスタス(Rotylenchus robustus)、ロチレンクルス・レニホルミス(Rotylenchulus reniformis);
(j)メロイドギネ科(Meloidogynidae)の、例えば、メロイドギネ属種の(Meloidogynespp.)、アレナリアネコブセンチュウ(Meloidogyne arenaria)、コロンビアネコブセンチュウ(Meloidogyne chitwoodi)、キタネコブセンチュウ(Meloidogyne hapla)、サツマイモネコブセンチュウ(Meloidogyne incognita)、ジャワネコブセンチュウ(Meloidogyne javanica)、テムズネコブセンチュウ(Meloidogyne thamesi);
(k)ノスティレンクス科(Nothotylenchidae)の、例えば、イチゴメセンチュウ(Nothotylenchus acris);
(l)パラティレンクス科(Paratylenchidae)の、例えば、パラティレンクス属種(Paratylenchus spp.)の、チャピンセンチュウ(Paratylenchus curvitatus)、ヒメピンセンチュウ(Paratylenchus elachistus);
(m)プラティレンクス科(Pratylenchidae)の、例えば、プラティレンクス属(Pratylenchus spp.)種の、プラティレンクスネグサレセンチュウ(Pratylenchus brachyurus)、ミナミネグサレセンチュウ(Pratylenchus coffeae)、ピンセンチュウ(Pratylenchuscurvitatus)、キクネグサレセンチュウ(Pratylenchus fallax)、プラティレンクス・ゴーデイ(Pratylenchus goodeyi)、プラティレンクス・ネグレクツス(Pratylencus neglectus)、キタネグサレセンチュウ(Pratylenchus penetrans)、プラティレンクス・スクリブネリ(Pratylenchus scribneri)、クルミネグサレセンチュウ(Pratylenchus vulnus)、モロコシネグサレセンチュウ(Pratylenchus zeae);その他の、ニセネコブセンチュウ(Nacobbus aberrans)、バナナネモグリセンチュウ(Radopholus similis)、ミカンネセンチュウ(Tylenchulus semipenetrans)、カンキツネモグリセンチュウ(Radopholus citrophilus)。 Specific examples of various plant parasitic nematodes that can be controlled by the nematicide of the present invention are shown below. (1) Tylenchida
(a) Anguinidae, for example, Anguina spp., Anguina funesta, Anguina tritici; Ditylenchus spp., Imogusare nematode ( Ditylenchus destructor), Ditylenchus dipsaci, Ditylenchus myceliophagus;
(b) Aphelenchoides family (Aphelenchoididae), for example, Aphelenchoides spp., Aphelenchoides besseyi, Aphelenchoides fragariae, Aphelenchoides ritzemabosi; Bursa Bursaphelenchus xylophilus, of the genus Bursaphelenchus spp.;
(c) Belonolaimidae, e.g., Belonolaimus spp., Belonolaimus longicaudatus; Tylenchorhynchus spp., Tylenchorhynchus claytoni , Tylenchorhynchus dubius;
(d) of the family Criconematidae, such as Criconema mutabile;
(e) of the family Dolichoodoridae, such as Dolichoodorus mediterraneus;
(f) Ecphyadophoridae, for example, Ecphyadophora tenuissima
(g) Hemicycliophoridae, such as Loofia thienemanni;
(h) Globodera rostochiensis, Globodera pallida, Globodera tabacum of the family Heteroderidae, e.g. Globodera spp.; (Heterodera spp.), Heterodera avenae, Heterodera cruciferae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii;
(i) of the family Hoplolimidae, for example, Helicotylenchus spp., Helicotylenchus dihystera, Helicotylenchus multicinctus; Columbus (Hoplolaimus columbus), Hoplolaimus galeatus; Others, Rotylenchus robustus, Rotylenchus reniformis;
(j) Meloidogyne family (Meloidogynidae), for example, Meloidogyne spp. Meloidogyne javanica, Meloidogyne thamesi;
(k) of the family Nothotylenchidae, such as Nothotylenchus acris;
(l) Paratylenchidae, for example, Paratylenchus spp. Paratylenchus curvitatus, Paratylenchus elachistus;
(m) Platylenchus family (Pratylenchidae), for example, Pratylenchus spp. species, Platylenchus brachyurus, Pratylenchus coffeae, Pinnematode (Pratylenchus curvitatus) , Pratylenchus fallax, Pratylenchus goodeyi, Pratylencus neglectus, Pratylenchus penetrans, Platylenchus scribneri, Walnut Pratylenchus vulnus, Pratylenchus zeae; others, Nacobbus aberrans, Radopholus similis, Tylenchulus semipenetrans, Radopholus citrophilus ).
(2)ドリライムス目(Dorylaimida)
(a)ロンギドルス科(Longidoridae)の、例えば、ロンギドルス属種(Longidorus spp.)の、ロンギドルス・エロンガテス(Longidorus elongates);キシフィネマ属種(Xiphinema)の、アメリカオオハリセンチュウ(Xiphinema americanum)、キシフィネマ・ブレビコーレ(Xiphinema brevicolle)、ブドウオオハリセンチュウ(Xiphinema index)、キシフィネマ・ディバーシカウダツム(Xiphinema diversicaudatum)。 (2) Dorylaimida
(a) Longidoridae, e.g., Longidorus spp., Longidorus elongates; Xiphinema, Xiphinema americanum, Xiphinema brevicole (Xiphinema brevicolle), Grape Nematode (Xiphinema index), Xiphinema diversicaudatum (Xiphinema diversicaudatum).
(a)ロンギドルス科(Longidoridae)の、例えば、ロンギドルス属種(Longidorus spp.)の、ロンギドルス・エロンガテス(Longidorus elongates);キシフィネマ属種(Xiphinema)の、アメリカオオハリセンチュウ(Xiphinema americanum)、キシフィネマ・ブレビコーレ(Xiphinema brevicolle)、ブドウオオハリセンチュウ(Xiphinema index)、キシフィネマ・ディバーシカウダツム(Xiphinema diversicaudatum)。 (2) Dorylaimida
(a) Longidoridae, e.g., Longidorus spp., Longidorus elongates; Xiphinema, Xiphinema americanum, Xiphinema brevicole (Xiphinema brevicolle), Grape Nematode (Xiphinema index), Xiphinema diversicaudatum (Xiphinema diversicaudatum).
(3)トリプロンキダ目(Triplonchida)
(a)トリコドルス科(Trichodoridae)の、例えば、トリコドルス・プリミチブス(Trichodorus primitivus)、ヒメユミハリセンチュウ(Paratrichodorus minor)。 (3) Triplonchida
(a) Trichodoridae family (Trichodoridae), for example, Trichodorus primitibus (Trichodorus primitibus), Nematode nematode (Paratrichodorus minor).
(a)トリコドルス科(Trichodoridae)の、例えば、トリコドルス・プリミチブス(Trichodorus primitivus)、ヒメユミハリセンチュウ(Paratrichodorus minor)。 (3) Triplonchida
(a) Trichodoridae family (Trichodoridae), for example, Trichodorus primitibus (Trichodorus primitibus), Nematode nematode (Paratrichodorus minor).
〔施用方法・混合剤〕
本発明の農園芸用殺菌剤または殺線虫剤は、穀物類;野菜類;根菜類;イモ類;果樹類、茶、コーヒー、カカオなどの樹木類;牧草類;芝類;ワタなどの植物に対して用いることが好ましい。 [Method of application/mixture]
The agricultural and horticultural fungicides or nematicides of the present invention are grains; vegetables; root vegetables; potatoes; fruit trees, tea, coffee, trees such as cacao; It is preferably used for
本発明の農園芸用殺菌剤または殺線虫剤は、穀物類;野菜類;根菜類;イモ類;果樹類、茶、コーヒー、カカオなどの樹木類;牧草類;芝類;ワタなどの植物に対して用いることが好ましい。 [Method of application/mixture]
The agricultural and horticultural fungicides or nematicides of the present invention are grains; vegetables; root vegetables; potatoes; fruit trees, tea, coffee, trees such as cacao; It is preferably used for
本発明の農園芸用殺菌剤は、植物類の各部位、たとえば、葉、茎、柄、花、蕾、果実、種子、スプラウト、根、塊茎、塊根、苗条、挿し木などに施用することができる。殺線虫剤は、根、塊茎、塊根などに施用することができる。また、これら植物類の改良品種・変種、栽培品種、さらには突然変異体、ハイブリッド体、遺伝子組み換え体(GMO)を対象とすることもできる。
The agricultural and horticultural fungicide of the present invention can be applied to various parts of plants, such as leaves, stems, stems, flowers, buds, fruits, seeds, sprouts, roots, tubers, tuberous roots, shoots and cuttings. . Nematicides can be applied to roots, tubers, root tubers, and the like. In addition, improved cultivars/varieties, cultivated cultivars, mutants, hybrids, and genetically modified organisms (GMO) of these plants can also be targeted.
本発明の農園芸用殺菌剤は、花卉、芝、牧草を含む農園芸作物に発生する種々の病害の防除をするために行われる種子処理、茎葉散布、土壌施用、水面施用などに使用することができる。殺線虫剤は、種子処理、土壌施用などに使用することができる。
The agricultural and horticultural fungicide of the present invention can be used for seed treatment, foliage application, soil application, water surface application, etc. for the control of various diseases occurring in agricultural and horticultural crops including flowers, lawns, and pastures. can be done. Nematicides can be used in seed treatments, soil applications, and the like.
本発明の農園芸用殺菌剤または殺線虫剤は、本発明のピリダジノン化合物以外の成分を含有してもよい。他の成分として、製剤化のために使用する公知の担体などを挙げることができる。また、他の成分として、従来公知の、殺菌剤、殺虫・殺ダニ剤、殺線虫剤、殺土壌害虫剤、植物調節剤、共力剤、肥料、土壌改良剤、動物用飼料などを挙げることができる。このような他の成分を含有することによって、相乗効果を奏することがある。
すなわち、本発明の態様のひとつとしては、1つ以上のさらなる殺菌剤を含む農園芸用殺菌剤を挙げることができる。 The agricultural and horticultural fungicide or nematicide of the present invention may contain ingredients other than the pyridazinone compound of the present invention. Other components include known carriers used for formulation. Examples of other components include conventionally known fungicides, insecticides/miticides, nematicides, soil pesticides, plant regulators, synergists, fertilizers, soil conditioners, animal feeds, and the like. be able to. A synergistic effect may be produced by containing such other components.
Thus, one aspect of the present invention is an agricultural and horticultural fungicide containing one or more additional fungicides.
すなわち、本発明の態様のひとつとしては、1つ以上のさらなる殺菌剤を含む農園芸用殺菌剤を挙げることができる。 The agricultural and horticultural fungicide or nematicide of the present invention may contain ingredients other than the pyridazinone compound of the present invention. Other components include known carriers used for formulation. Examples of other components include conventionally known fungicides, insecticides/miticides, nematicides, soil pesticides, plant regulators, synergists, fertilizers, soil conditioners, animal feeds, and the like. be able to. A synergistic effect may be produced by containing such other components.
Thus, one aspect of the present invention is an agricultural and horticultural fungicide containing one or more additional fungicides.
本発明の農園芸用殺菌剤または殺線虫剤と混用または併用することができる殺菌剤として、FRAC(Fungicide Resistance Action Committee)のHP(https://www.frac.info/)に記載される化合物、または農業上許容されるそれらの塩若しくは誘導体等を好ましいものとして挙げることができる。
具体的には以下の群から選択される化合物を例示することができる。 As a fungicide that can be mixed or used together with the agricultural and horticultural fungicide or nematicide of the present invention, it is described on the FRAC (Fungicide Resistance Action Committee) website (https://www.frac.info/) Compounds or agriculturally acceptable salts or derivatives thereof can be mentioned as preferred ones.
Specifically, compounds selected from the following group can be exemplified.
具体的には以下の群から選択される化合物を例示することができる。 As a fungicide that can be mixed or used together with the agricultural and horticultural fungicide or nematicide of the present invention, it is described on the FRAC (Fungicide Resistance Action Committee) website (https://www.frac.info/) Compounds or agriculturally acceptable salts or derivatives thereof can be mentioned as preferred ones.
Specifically, compounds selected from the following group can be exemplified.
殺菌剤:
Fungicide:
(A)核酸合成代謝に作用する剤:
A1)RNAポリメラーゼI阻害剤
ベナラキシル(benalaxyl)、ベナラキシルM(benalaxyl-M)、フララキシル(furalaxyl)、メタラキシル(metalaxyl)、メタラキシルM(metalaxyl-M)、オキサジキシル(oxadixyl)、オフラセ(ofurace)。
A2)アデノシンデアミナーゼ阻害剤
ブピリメート(bupirimate)、ジメチリモール(dimethirimol)、エチリモール(ethirimol)。
A3)DNA/RNA生合成阻害剤
ヒメキサゾール(hymexazole)、オクチリノン(octhilinone)。
A4)DNAトポイソメラーゼ タイプII阻害剤
オキソリニック酸(oxolinic acid)。 (A) Agent acting on nucleic acid synthesis metabolism:
A1) RNA polymerase I inhibitors benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M, oxadixyl, ofurace.
A2) Adenosine deaminase inhibitors bupirimate, dimethirimol, ethirimol.
A3) DNA/RNA biosynthesis inhibitors hymexazole, octhilinone.
A4) DNA topoisomerase type II inhibitor oxolinic acid.
A1)RNAポリメラーゼI阻害剤
ベナラキシル(benalaxyl)、ベナラキシルM(benalaxyl-M)、フララキシル(furalaxyl)、メタラキシル(metalaxyl)、メタラキシルM(metalaxyl-M)、オキサジキシル(oxadixyl)、オフラセ(ofurace)。
A2)アデノシンデアミナーゼ阻害剤
ブピリメート(bupirimate)、ジメチリモール(dimethirimol)、エチリモール(ethirimol)。
A3)DNA/RNA生合成阻害剤
ヒメキサゾール(hymexazole)、オクチリノン(octhilinone)。
A4)DNAトポイソメラーゼ タイプII阻害剤
オキソリニック酸(oxolinic acid)。 (A) Agent acting on nucleic acid synthesis metabolism:
A1) RNA polymerase I inhibitors benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M, oxadixyl, ofurace.
A2) Adenosine deaminase inhibitors bupirimate, dimethirimol, ethirimol.
A3) DNA/RNA biosynthesis inhibitors hymexazole, octhilinone.
A4) DNA topoisomerase type II inhibitor oxolinic acid.
(B)細胞骨格とモーター蛋白質に作用する剤:
B1)~B3)β-チューブリン重合阻害剤
ベノミル(benomyl)、カルベンダジム(carbendazim)、フベリダゾール(fuberidazole)、チアベンダゾール(thiabendazole)、チオファネート(thiophanate)、チオファネートメチル(thiophanate-methyl)、ジエトフェンカルブ(diethofencarb)、ゾキサミド(zoxamide)、エタボキサム(ethaboxam)、クロルフェナゾール(chlorfenazole)、デバカルブ(debacarb)、トリクラミド(trichlamide)、ザリラミド(zarilamid)。
B4)細胞分裂(作用点不明)阻害剤
ペンシクロン(pencycuron)。
B5)スペクトリン様蛋白質の非局在化阻害剤
フルオピコリド(fluopicolide)、フルオピモミド(fluopimomide)。
B6)アクチン/ミオシン/フィンブリン機能阻害剤
フェナマクリル(phenamacril)、メトラフェノン(metrafenone)、ピリオフェノン(pyriofenone)。 (B) agents acting on cytoskeleton and motor proteins:
B1)-B3) beta-tubulin polymerization inhibitors benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate, thiophanate-methyl, diethofencarb, zoxamide, ethaboxam, chlorfenazole, debacarb, trichlamide, zarilamid.
B4) cell division (point of action unknown) inhibitor pencycuron.
B5) Delocalization inhibitors of spectrin-like proteins fluopicolide, fluopimomide.
B6) Actin/myosin/fimbrin function inhibitors phenamacril, metrafenone, pyriofenone.
B1)~B3)β-チューブリン重合阻害剤
ベノミル(benomyl)、カルベンダジム(carbendazim)、フベリダゾール(fuberidazole)、チアベンダゾール(thiabendazole)、チオファネート(thiophanate)、チオファネートメチル(thiophanate-methyl)、ジエトフェンカルブ(diethofencarb)、ゾキサミド(zoxamide)、エタボキサム(ethaboxam)、クロルフェナゾール(chlorfenazole)、デバカルブ(debacarb)、トリクラミド(trichlamide)、ザリラミド(zarilamid)。
B4)細胞分裂(作用点不明)阻害剤
ペンシクロン(pencycuron)。
B5)スペクトリン様蛋白質の非局在化阻害剤
フルオピコリド(fluopicolide)、フルオピモミド(fluopimomide)。
B6)アクチン/ミオシン/フィンブリン機能阻害剤
フェナマクリル(phenamacril)、メトラフェノン(metrafenone)、ピリオフェノン(pyriofenone)。 (B) agents acting on cytoskeleton and motor proteins:
B1)-B3) beta-tubulin polymerization inhibitors benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate, thiophanate-methyl, diethofencarb, zoxamide, ethaboxam, chlorfenazole, debacarb, trichlamide, zarilamid.
B4) cell division (point of action unknown) inhibitor pencycuron.
B5) Delocalization inhibitors of spectrin-like proteins fluopicolide, fluopimomide.
B6) Actin/myosin/fimbrin function inhibitors phenamacril, metrafenone, pyriofenone.
(C)呼吸に作用する剤:
C1)複合体I: NADH酸化還元酵素阻害剤
ジフルメトリム(diflumetorim)、トルフェンピラド(tolfenpyrad)、フェナザキン(fenazaquin)。
C2)複合体II:コハク酸脱水素酵素阻害剤
ベノダニル(benodanil)、フルトラニル(flutolanil)、メプロニル(mepronil)、イソフェタミド(isofetamid)、フルオピラム(fluopyram)、シクロブトリフルラム(cyclobutrifluram)、フェンフラム(fenfuram)、カルボキシン(carboxin)、オキシカルボキシン(oxycarboxin)、チフルザミド(thifluzamide)、ベンゾビンジフルピル(benzovindiflupyr)、ビキサフェン(bixafen)、フルインダピル(fluindapyr)、フルキサピロキサド(fluxapyroxad)、フラメトピル(furametpyr)、インピルフルキサム(inpyrfluxam)、イソピラザム(isopyrazam)、ペンフルフェン(penflufen)、ペンチオピラド(penthiopyrad)、セダキサン(sedaxane)、イソフルシプラム(isoflucypram)、ピジフルメトフェン(pydiflumetofen)、ボスカリド(boscalid)、ピラジフルミド(pyraziflumid)、フルベネテラム(Flubeneteram)、フルメシクロックス(furmecyclox)。
C3)複合体III:チトクローム bc1(ユビキノール酸化酵素)Qo部位(cyt b遺伝子)阻害剤
アゾキシストロビン(azoxystrobin)、クモキシストロビン(coumoxystrobin)、エノキサストロビン(enoxastrobin)、フルフェノキシストロビン(flufenoxystrobin)、ピコキシストロビン(picoxystrobin)、ピラオキシストロビン(pyraoxystrobin)、マンデストロビン (mandestrobin)、ピラクロストロビン(pyraclostrobin)、ピラメトストロビン(pyrametostrobin)、トリクロピリカルブ(triclopyricarb)、クレソキシムメチル(kresoxim-methyl)、トリフロキシストロビン(trifloxystrobin)、ジモキシストロビン(dimoxystrobin)、フェナミンストロビン(fenaminstrobin)、メトミノストロビン(metominostrobin)、オリサストロビン(orysastrobin)、ファモキサドン(famoxadone)、フルオキサストロビン(fluoxastrobin)、フェンアミドン(fenamidone)、ピリベンカルブ(pyribencarb)、メチルテトラプロール(metyltetraprole)。
C4)複合体III:チトクローム bc1(ユビキノン還元酵素) Qi部位阻害剤
シアゾファミド(cyazofamid)、アミスルブロム(amisulbrom)、フェンピコキサミド(fenpicoxamid)、フロリルピコキサミド(florylpicoxamid)、メタリルピコキサミド(metarylpicoxamid)。
C5)酸化的リン酸化の脱共役阻害剤
ビナパクリル(binapacryl)、ジノカップ(dinocap)、メプチルジノカップ(meptyldinocap)、フルアジナム(fluazinam)。
C6)酸化的リン酸化、ATP合成酵素の阻害剤
酢酸トリフェニルスズ(fentin acetate)、塩化トリフェニルスズ(fentin chloride)、水酸化トリフェニルスズ(fentin hydroxide)。
C7)ATP輸送阻害剤
シルチオファム(silthiofam)。
C8)複合体III:チトクローム bc1(ユビキノン還元酵素)Qo部位、スチグマテリン結合サブサイト 阻害剤
アメトクトラジン(ametoctradin)。 (C) Respiratory agents:
C1) Complex I: NADH oxidoreductase inhibitors diflumetorim, tolfenpyrad, fenazaquin.
C2) Complex II: succinate dehydrogenase inhibitors benodanil, flutolanil, mepronil, isofetamide, fluopyram, cyclobutrifluram, fenfuram , carboxin, oxycarboxin, thifluzamide, benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, furametpyr, inpyrfluxam, isopyrazam, penflufen, penthiopyrad, sedaxane, isoflucypram, pydiflumetofen, boscalid, pyraziflumide ( pyraziflumid, Flubeneteram, furmecyclox.
C3) Complex III: cytochrome bc1 (ubiquinol oxidase) Qo site (cyt b gene) inhibitors azoxystrobin, coumoxystrobin, enoxastrobin, fluphenoxystrobin ( flufenoxystrobin, picoxystrobin, pyraoxystrobin, mandestrobin, pyraclostrobin, pyrametostrobin, triclopyricarb, kresoxim -methyl), trifloxystrobin, dimoxystrobin, fenaminstrobin, metominostrobin, orysastrobin, famoxadone, fluoxastrobin ), fenamidone, pyribencarb, methyltetraprole.
C4) Complex III: Cytochrome bc1 (ubiquinone reductase) Qi site inhibitors cyazofamid, amisulbrom, fenpicoxamid, florylpicoxamid, methallylpicoxamide ( metarylpicoxamid).
C5) Uncoupling inhibitors of oxidative phosphorylation binapacryl, dinocap, meptyldinocap, fluazinam.
C6) Oxidative phosphorylation, inhibitors of ATP synthase Triphenyltin acetate, fentin chloride, triphenyltin hydroxide.
C7) ATP transport inhibitor silthiofam.
C8) Complex III: cytochrome bc1 (ubiquinone reductase) Qo site, stigmaterin-binding subsite inhibitor ametoctradin.
C1)複合体I: NADH酸化還元酵素阻害剤
ジフルメトリム(diflumetorim)、トルフェンピラド(tolfenpyrad)、フェナザキン(fenazaquin)。
C2)複合体II:コハク酸脱水素酵素阻害剤
ベノダニル(benodanil)、フルトラニル(flutolanil)、メプロニル(mepronil)、イソフェタミド(isofetamid)、フルオピラム(fluopyram)、シクロブトリフルラム(cyclobutrifluram)、フェンフラム(fenfuram)、カルボキシン(carboxin)、オキシカルボキシン(oxycarboxin)、チフルザミド(thifluzamide)、ベンゾビンジフルピル(benzovindiflupyr)、ビキサフェン(bixafen)、フルインダピル(fluindapyr)、フルキサピロキサド(fluxapyroxad)、フラメトピル(furametpyr)、インピルフルキサム(inpyrfluxam)、イソピラザム(isopyrazam)、ペンフルフェン(penflufen)、ペンチオピラド(penthiopyrad)、セダキサン(sedaxane)、イソフルシプラム(isoflucypram)、ピジフルメトフェン(pydiflumetofen)、ボスカリド(boscalid)、ピラジフルミド(pyraziflumid)、フルベネテラム(Flubeneteram)、フルメシクロックス(furmecyclox)。
C3)複合体III:チトクローム bc1(ユビキノール酸化酵素)Qo部位(cyt b遺伝子)阻害剤
アゾキシストロビン(azoxystrobin)、クモキシストロビン(coumoxystrobin)、エノキサストロビン(enoxastrobin)、フルフェノキシストロビン(flufenoxystrobin)、ピコキシストロビン(picoxystrobin)、ピラオキシストロビン(pyraoxystrobin)、マンデストロビン (mandestrobin)、ピラクロストロビン(pyraclostrobin)、ピラメトストロビン(pyrametostrobin)、トリクロピリカルブ(triclopyricarb)、クレソキシムメチル(kresoxim-methyl)、トリフロキシストロビン(trifloxystrobin)、ジモキシストロビン(dimoxystrobin)、フェナミンストロビン(fenaminstrobin)、メトミノストロビン(metominostrobin)、オリサストロビン(orysastrobin)、ファモキサドン(famoxadone)、フルオキサストロビン(fluoxastrobin)、フェンアミドン(fenamidone)、ピリベンカルブ(pyribencarb)、メチルテトラプロール(metyltetraprole)。
C4)複合体III:チトクローム bc1(ユビキノン還元酵素) Qi部位阻害剤
シアゾファミド(cyazofamid)、アミスルブロム(amisulbrom)、フェンピコキサミド(fenpicoxamid)、フロリルピコキサミド(florylpicoxamid)、メタリルピコキサミド(metarylpicoxamid)。
C5)酸化的リン酸化の脱共役阻害剤
ビナパクリル(binapacryl)、ジノカップ(dinocap)、メプチルジノカップ(meptyldinocap)、フルアジナム(fluazinam)。
C6)酸化的リン酸化、ATP合成酵素の阻害剤
酢酸トリフェニルスズ(fentin acetate)、塩化トリフェニルスズ(fentin chloride)、水酸化トリフェニルスズ(fentin hydroxide)。
C7)ATP輸送阻害剤
シルチオファム(silthiofam)。
C8)複合体III:チトクローム bc1(ユビキノン還元酵素)Qo部位、スチグマテリン結合サブサイト 阻害剤
アメトクトラジン(ametoctradin)。 (C) Respiratory agents:
C1) Complex I: NADH oxidoreductase inhibitors diflumetorim, tolfenpyrad, fenazaquin.
C2) Complex II: succinate dehydrogenase inhibitors benodanil, flutolanil, mepronil, isofetamide, fluopyram, cyclobutrifluram, fenfuram , carboxin, oxycarboxin, thifluzamide, benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, furametpyr, inpyrfluxam, isopyrazam, penflufen, penthiopyrad, sedaxane, isoflucypram, pydiflumetofen, boscalid, pyraziflumide ( pyraziflumid, Flubeneteram, furmecyclox.
C3) Complex III: cytochrome bc1 (ubiquinol oxidase) Qo site (cyt b gene) inhibitors azoxystrobin, coumoxystrobin, enoxastrobin, fluphenoxystrobin ( flufenoxystrobin, picoxystrobin, pyraoxystrobin, mandestrobin, pyraclostrobin, pyrametostrobin, triclopyricarb, kresoxim -methyl), trifloxystrobin, dimoxystrobin, fenaminstrobin, metominostrobin, orysastrobin, famoxadone, fluoxastrobin ), fenamidone, pyribencarb, methyltetraprole.
C4) Complex III: Cytochrome bc1 (ubiquinone reductase) Qi site inhibitors cyazofamid, amisulbrom, fenpicoxamid, florylpicoxamid, methallylpicoxamide ( metarylpicoxamid).
C5) Uncoupling inhibitors of oxidative phosphorylation binapacryl, dinocap, meptyldinocap, fluazinam.
C6) Oxidative phosphorylation, inhibitors of ATP synthase Triphenyltin acetate, fentin chloride, triphenyltin hydroxide.
C7) ATP transport inhibitor silthiofam.
C8) Complex III: cytochrome bc1 (ubiquinone reductase) Qo site, stigmaterin-binding subsite inhibitor ametoctradin.
(D)アミノ酸および蛋白質合成に作用する剤:
D1)メチオニン生合成(cgs遺伝子)阻害剤
シプロジニル(cyprodinil)、メパニピリム(mepanipyrim)、ピリメタニル(pyrimethanil)。
D2)蛋白質合成(リボソーム 翻訳終了段階)阻害剤
ブラストサイジンS(blasticidin-S)。
D3)、D4)蛋白質合成(リボソーム 翻訳開始段階)阻害剤
カスガマイシン(kasugamycin)、カスガマイシン塩酸塩(kasugamycin hydrochloride)、ストレプトマイシン(streptomycin)。
D5)蛋白質合成(リボソーム ポリペプチド伸長段階)阻害剤
オキシテトラサイクリン(oxytetracycline)。 (D) Agents Affecting Amino Acid and Protein Synthesis:
D1) Methionine biosynthesis (cgs gene) inhibitors cyprodinil, mepanipyrim, pyrimethanil.
D2) Protein synthesis (ribosomal translation termination step) inhibitor blasticidin-S.
D3), D4) Protein synthesis (ribosome translation initiation step) inhibitors kasugamycin, kasugamycin hydrochloride, streptomycin.
D5) Protein synthesis (ribosomal polypeptide elongation step) inhibitor oxytetracycline.
D1)メチオニン生合成(cgs遺伝子)阻害剤
シプロジニル(cyprodinil)、メパニピリム(mepanipyrim)、ピリメタニル(pyrimethanil)。
D2)蛋白質合成(リボソーム 翻訳終了段階)阻害剤
ブラストサイジンS(blasticidin-S)。
D3)、D4)蛋白質合成(リボソーム 翻訳開始段階)阻害剤
カスガマイシン(kasugamycin)、カスガマイシン塩酸塩(kasugamycin hydrochloride)、ストレプトマイシン(streptomycin)。
D5)蛋白質合成(リボソーム ポリペプチド伸長段階)阻害剤
オキシテトラサイクリン(oxytetracycline)。 (D) Agents Affecting Amino Acid and Protein Synthesis:
D1) Methionine biosynthesis (cgs gene) inhibitors cyprodinil, mepanipyrim, pyrimethanil.
D2) Protein synthesis (ribosomal translation termination step) inhibitor blasticidin-S.
D3), D4) Protein synthesis (ribosome translation initiation step) inhibitors kasugamycin, kasugamycin hydrochloride, streptomycin.
D5) Protein synthesis (ribosomal polypeptide elongation step) inhibitor oxytetracycline.
(E)シグナル伝達に作用する剤:
E1)シグナル伝達(作用機構不明)阻害剤
キノキシフェン(quinoxyfen)、プロキナジド(proquinazid)。
E2)浸透圧シグナル伝達におけるMAP/ヒスチジンキナーゼ(os-2、HOG1)阻害剤
フェンピクロニル(fenpiclonil)、フルジオキソニル(fludioxonil)。
E3)浸透圧シグナル伝達におけるMAP/ヒスチジンキナーゼ(os-1、Daf1)阻害剤
クロゾリネート(chlozolinate)、ジメタクロン(dimethachlone)、イプロジオン(iprodione)、プロシミドン(procymidone)、ビンクロゾリン(vinclozolin)。 (E) agents that affect signal transduction:
E1) signaling (mechanism of action unknown) inhibitors quinoxyfen, proquinazid.
E2) MAP/histidine kinase (os-2, HOG1) inhibitors fenpiclonil, fludioxonil in osmotic signaling.
E3) MAP/histidine kinase (os-1, Daf1) inhibitors in osmotic signaling chlozolinate, dimethachlone, iprodione, procymidone, vinclozolin.
E1)シグナル伝達(作用機構不明)阻害剤
キノキシフェン(quinoxyfen)、プロキナジド(proquinazid)。
E2)浸透圧シグナル伝達におけるMAP/ヒスチジンキナーゼ(os-2、HOG1)阻害剤
フェンピクロニル(fenpiclonil)、フルジオキソニル(fludioxonil)。
E3)浸透圧シグナル伝達におけるMAP/ヒスチジンキナーゼ(os-1、Daf1)阻害剤
クロゾリネート(chlozolinate)、ジメタクロン(dimethachlone)、イプロジオン(iprodione)、プロシミドン(procymidone)、ビンクロゾリン(vinclozolin)。 (E) agents that affect signal transduction:
E1) signaling (mechanism of action unknown) inhibitors quinoxyfen, proquinazid.
E2) MAP/histidine kinase (os-2, HOG1) inhibitors fenpiclonil, fludioxonil in osmotic signaling.
E3) MAP/histidine kinase (os-1, Daf1) inhibitors in osmotic signaling chlozolinate, dimethachlone, iprodione, procymidone, vinclozolin.
(F)脂質生合成または輸送/細胞膜の構造または機能に作用する剤:
F1)ジカルボキシイミド系殺菌剤
F2)リン脂質生合成、メチルトランスフェラーゼ阻害剤
エジフェンホス(edifenphos)、イプロベンホス(iprobenfos)、ピラゾホス(pyrazophos)、イソプロチオラン(isoprothiolane)。
F3)細胞の過酸化阻害剤
ビフェニル(biphenyl)、クロロネブ(chloroneb)、ジクロラン(dicloran)、キントゼン(quintozene)、テクナゼン(tecnazene)、トルクロホスメチル(tolclofos-methyl)、エトリジアゾール(etridiazole)。
F4)細胞膜透過性、脂肪酸阻害剤
ヨードカルブ(iodocarb)、プロパモカルブ(propamocarb)、プロパモカルブ塩酸塩(propamocarb hydrochloride)、プロチオカルブ(prothiocarb)。
F5)カルボン酸アミド系(CAA)殺菌剤
F8)エルゴステロール結合阻害剤
ナタマイシン(natamycin);
F9)脂質恒常性および輸送/貯蔵阻害剤
オキサチアピプロリン(oxathiapiprolin)、フルオキサピプロリン(fluoxapiprolin)。 (F) agents that affect lipid biosynthesis or transport/cell membrane structure or function:
F1) Dicarboximide fungicides F2) Phospholipid biosynthetic, methyltransferase inhibitors edifenphos, iprobenfos, pyrazophos, isoprothiolane.
F3) Cellular peroxidation inhibitors biphenyl, chloroneb, dichloran, quintozene, tecnazene, tolclofos-methyl, etridiazole.
F4) Cell membrane permeable, fatty acid inhibitors iodocarb, propamocarb, propamocarb hydrochloride, prothiocarb.
F5) carboxylic acid amide (CAA) fungicides F8) ergosterol binding inhibitor natamycin;
F9) Lipid homeostasis and transport/storage inhibitors oxathiapiprolin, fluoxapiprolin.
F1)ジカルボキシイミド系殺菌剤
F2)リン脂質生合成、メチルトランスフェラーゼ阻害剤
エジフェンホス(edifenphos)、イプロベンホス(iprobenfos)、ピラゾホス(pyrazophos)、イソプロチオラン(isoprothiolane)。
F3)細胞の過酸化阻害剤
ビフェニル(biphenyl)、クロロネブ(chloroneb)、ジクロラン(dicloran)、キントゼン(quintozene)、テクナゼン(tecnazene)、トルクロホスメチル(tolclofos-methyl)、エトリジアゾール(etridiazole)。
F4)細胞膜透過性、脂肪酸阻害剤
ヨードカルブ(iodocarb)、プロパモカルブ(propamocarb)、プロパモカルブ塩酸塩(propamocarb hydrochloride)、プロチオカルブ(prothiocarb)。
F5)カルボン酸アミド系(CAA)殺菌剤
F8)エルゴステロール結合阻害剤
ナタマイシン(natamycin);
F9)脂質恒常性および輸送/貯蔵阻害剤
オキサチアピプロリン(oxathiapiprolin)、フルオキサピプロリン(fluoxapiprolin)。 (F) agents that affect lipid biosynthesis or transport/cell membrane structure or function:
F1) Dicarboximide fungicides F2) Phospholipid biosynthetic, methyltransferase inhibitors edifenphos, iprobenfos, pyrazophos, isoprothiolane.
F3) Cellular peroxidation inhibitors biphenyl, chloroneb, dichloran, quintozene, tecnazene, tolclofos-methyl, etridiazole.
F4) Cell membrane permeable, fatty acid inhibitors iodocarb, propamocarb, propamocarb hydrochloride, prothiocarb.
F5) carboxylic acid amide (CAA) fungicides F8) ergosterol binding inhibitor natamycin;
F9) Lipid homeostasis and transport/storage inhibitors oxathiapiprolin, fluoxapiprolin.
(G)細胞膜のステロール生合成阻害剤
G1)ステロール生合成のC14位のデメチラーゼ(erg11/cyp51)阻害剤
トリホリン(triforine)、ピリフェノックス(pyrifenox)、ピリソキサゾール(pyrisoxazole)、フェナリモル(fenarimol)、ヌアリモール(nuarimol)、イマザリル(imazalil)、オキスポコナゾール(oxpoconazole)、ペフラゾエート(pefurazoate)、プロクロラズ(prochloraz)、トリフルミゾール(triflumizole)、アザコナゾール(azaconazole)、ビテルタノール(bitertanol)、ブロムコナゾール(bromuconazole)、シプロコナゾール(cyproconazole)、ジフェノコナゾール(difenoconazole)、ジニコナゾール(diniconazole)、エポキシコナゾール(epoxiconazole)、エタコナゾール(etaconazole)、フェンブコナゾール(enbuconazole)、フルキンコナゾール(fluquinconazole)、フルシラゾール(flusilazole)、フルトリアホール(flutriafol)、ヘキサコナゾール(hexaconazole)、イミベンコナゾール(imibenconazole)、イプコナゾール(ipconazole)、メフェントリフルコナゾール(mefentrifluconazole)、メトコナゾール(metconazole)、ミクロブタニル(myclobutanil)、ペンコナゾール(penconazole)、プロピコナゾール(propiconazole)、シメコナゾール(simeconazole)、テブコナゾール(tebuconazole)、テトラコナゾール(tetraconazole)、トリアジメホン(triadimefon)、トリアジメノール(triadimenol)、トリチコナゾール(triticonazole)、プロチオコナゾール(prothioconazole)、フルオキシチオコナゾール(Fluoxytioconazole)、フルコナゾール(furconazole)、フルコナゾール-シス(furconazole-cis)、ジニコナゾールM(diniconazole-M)。
G2)ステロール生合成におけるΔ14還元酵素及びΔ8→Δ7-イソメラーゼ(erg24、erg2)阻害剤
アルジモルフ(aldimorph)、ドデモルフ(dodemorph)、ドデモルフ酢酸塩(dodemorph acetate)、フェンプロピモルフ(fenpropimorph)、トリデモルフ(tridemorph)、フェンプロピジン(fenpropidin)、ピペラリン(piperalin)、スピロキサミン(spiroxamine)、ブチオベート(buthiobate)。
G3)ステロール生合成系のC4位脱メチル化における3-ケト還元酵素(erg27)阻害剤
フェンヘキサミド(fenhexamid)、フェンピラザミン(fenpyrazamine)。
G4)ステロール生合成系のスクワレンエポキシダーゼ(erg1)阻害剤
ピリブチカルブ(pyributicarb)、ナフチフィン(naftifine)、テルビナフィン(terbinafine)。 (G) Cell Membrane Sterol Biosynthesis Inhibitors G1) C14 Demethylase (erg11/cyp51) Inhibitors of Sterol Biosynthesis Triforine, Pyrifenox, Pyrisoxazole, Fenarimol, Nuarimol (nuarimol), imazalil, oxpoconazole, pefurazoate, prochloraz, triflumizole, azaconazole, bitertanol, bromuconazole , cyproconazole, difenoconazole, diniconazole, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flu triafol (flutriafol), hexaconazole, imibenconazole, ipconazole, mefentrifluconazole, metconazole, myclobutanil, penconazole, propico propiconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, prothioconazole, fluoxy Tioconazole (Fluoxytioconazole), fluconazole (furconazole), fluconazole-cis, diniconazole-M.
G2) Δ14 reductase and Δ8→Δ7-isomerase (erg24, erg2) inhibitors in sterol biosynthesis aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph ), fenpropidin, piperalin, spiroxamine, buthiobate.
G3) 3-keto reductase (erg27) inhibitors fenhexamid and fenpyrazamine in C4 demethylation of sterol biosynthesis.
G4) Squalene epoxidase (erg1) inhibitors of sterol biosynthesis pyributicarb, naftifine, terbinafine.
G1)ステロール生合成のC14位のデメチラーゼ(erg11/cyp51)阻害剤
トリホリン(triforine)、ピリフェノックス(pyrifenox)、ピリソキサゾール(pyrisoxazole)、フェナリモル(fenarimol)、ヌアリモール(nuarimol)、イマザリル(imazalil)、オキスポコナゾール(oxpoconazole)、ペフラゾエート(pefurazoate)、プロクロラズ(prochloraz)、トリフルミゾール(triflumizole)、アザコナゾール(azaconazole)、ビテルタノール(bitertanol)、ブロムコナゾール(bromuconazole)、シプロコナゾール(cyproconazole)、ジフェノコナゾール(difenoconazole)、ジニコナゾール(diniconazole)、エポキシコナゾール(epoxiconazole)、エタコナゾール(etaconazole)、フェンブコナゾール(enbuconazole)、フルキンコナゾール(fluquinconazole)、フルシラゾール(flusilazole)、フルトリアホール(flutriafol)、ヘキサコナゾール(hexaconazole)、イミベンコナゾール(imibenconazole)、イプコナゾール(ipconazole)、メフェントリフルコナゾール(mefentrifluconazole)、メトコナゾール(metconazole)、ミクロブタニル(myclobutanil)、ペンコナゾール(penconazole)、プロピコナゾール(propiconazole)、シメコナゾール(simeconazole)、テブコナゾール(tebuconazole)、テトラコナゾール(tetraconazole)、トリアジメホン(triadimefon)、トリアジメノール(triadimenol)、トリチコナゾール(triticonazole)、プロチオコナゾール(prothioconazole)、フルオキシチオコナゾール(Fluoxytioconazole)、フルコナゾール(furconazole)、フルコナゾール-シス(furconazole-cis)、ジニコナゾールM(diniconazole-M)。
G2)ステロール生合成におけるΔ14還元酵素及びΔ8→Δ7-イソメラーゼ(erg24、erg2)阻害剤
アルジモルフ(aldimorph)、ドデモルフ(dodemorph)、ドデモルフ酢酸塩(dodemorph acetate)、フェンプロピモルフ(fenpropimorph)、トリデモルフ(tridemorph)、フェンプロピジン(fenpropidin)、ピペラリン(piperalin)、スピロキサミン(spiroxamine)、ブチオベート(buthiobate)。
G3)ステロール生合成系のC4位脱メチル化における3-ケト還元酵素(erg27)阻害剤
フェンヘキサミド(fenhexamid)、フェンピラザミン(fenpyrazamine)。
G4)ステロール生合成系のスクワレンエポキシダーゼ(erg1)阻害剤
ピリブチカルブ(pyributicarb)、ナフチフィン(naftifine)、テルビナフィン(terbinafine)。 (G) Cell Membrane Sterol Biosynthesis Inhibitors G1) C14 Demethylase (erg11/cyp51) Inhibitors of Sterol Biosynthesis Triforine, Pyrifenox, Pyrisoxazole, Fenarimol, Nuarimol (nuarimol), imazalil, oxpoconazole, pefurazoate, prochloraz, triflumizole, azaconazole, bitertanol, bromuconazole , cyproconazole, difenoconazole, diniconazole, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flu triafol (flutriafol), hexaconazole, imibenconazole, ipconazole, mefentrifluconazole, metconazole, myclobutanil, penconazole, propico propiconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, prothioconazole, fluoxy Tioconazole (Fluoxytioconazole), fluconazole (furconazole), fluconazole-cis, diniconazole-M.
G2) Δ14 reductase and Δ8→Δ7-isomerase (erg24, erg2) inhibitors in sterol biosynthesis aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph ), fenpropidin, piperalin, spiroxamine, buthiobate.
G3) 3-keto reductase (erg27) inhibitors fenhexamid and fenpyrazamine in C4 demethylation of sterol biosynthesis.
G4) Squalene epoxidase (erg1) inhibitors of sterol biosynthesis pyributicarb, naftifine, terbinafine.
(H)細胞壁生合成阻害剤:
H4)キチン合成酵素阻害剤
ポリオキシン(polyoxin)、ポリオクソリム(polyoxorim)。
H5)セルロース合成酵素阻害剤
ジメトモルフ(dimethomorph)、フルモルフ(flumorph)、ピリモルフ(pyrimorph)、ベンチアバリカルブ(benthiavalicarb)、イプロバリカルブ(iprovalicarb)、バリフェナレート(valifenalate)、マンジプロパミド(mandipropamid)。 (H) cell wall biosynthesis inhibitors:
H4) Chitin synthase inhibitors polyoxin, polyoxorim.
H5) Cellulose synthase inhibitors dimethomorph, flumorph, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate, mandipropamid.
H4)キチン合成酵素阻害剤
ポリオキシン(polyoxin)、ポリオクソリム(polyoxorim)。
H5)セルロース合成酵素阻害剤
ジメトモルフ(dimethomorph)、フルモルフ(flumorph)、ピリモルフ(pyrimorph)、ベンチアバリカルブ(benthiavalicarb)、イプロバリカルブ(iprovalicarb)、バリフェナレート(valifenalate)、マンジプロパミド(mandipropamid)。 (H) cell wall biosynthesis inhibitors:
H4) Chitin synthase inhibitors polyoxin, polyoxorim.
H5) Cellulose synthase inhibitors dimethomorph, flumorph, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate, mandipropamid.
(I)細胞壁のメラニン合成阻害剤:
I1)メラニン生合成の還元酵素阻害剤
フサライド(fthalide)、ピロキロン(pyroquilon)、トリシクラゾール(tricyclazole)。
I2)メラニン生合成の脱水酵素阻害剤
カルプロパミド(carpropamid)、ジクロシメット(diclocymet)、フェノキサニル(fenoxanil)。
I3)メラニン生合成のポリケタイド合成酵素阻害剤
トルプロカルブ(tolprocarb)。 (I) cell wall melanin synthesis inhibitor:
I1) Reductase inhibitors of melanin biosynthesis fthalide, pyroquilon, tricyclazole.
I2) Dehydratase inhibitors of melanin biosynthesis carpropamid, diclocymet, fenoxanil.
I3) Tolprocarb, a polyketide synthase inhibitor of melanin biosynthesis.
I1)メラニン生合成の還元酵素阻害剤
フサライド(fthalide)、ピロキロン(pyroquilon)、トリシクラゾール(tricyclazole)。
I2)メラニン生合成の脱水酵素阻害剤
カルプロパミド(carpropamid)、ジクロシメット(diclocymet)、フェノキサニル(fenoxanil)。
I3)メラニン生合成のポリケタイド合成酵素阻害剤
トルプロカルブ(tolprocarb)。 (I) cell wall melanin synthesis inhibitor:
I1) Reductase inhibitors of melanin biosynthesis fthalide, pyroquilon, tricyclazole.
I2) Dehydratase inhibitors of melanin biosynthesis carpropamid, diclocymet, fenoxanil.
I3) Tolprocarb, a polyketide synthase inhibitor of melanin biosynthesis.
(P)宿主植物の抵抗性誘導に作用する剤:
P01~P03)サリチル酸シグナル伝達に関連する剤
アシベンゾラルSメチル(acibenzolar-S-methyl)、プロベナゾール(probenazole)、チアジニル(tiadinil)、イソチアニル(isotianil)。
P04)多糖類エリシター
ラミナリン(laminarin)。
P05)アントラキノンエリシター
オオイタドリ抽出液(extract from Reynoutria sachalinensis)。
P06)微生物エリシター
バチルス・マイコイデス分離株J(Bacillus mycoides isolate J)、サッカロミセス・セレビシア LAS117 株の細胞壁(cell walls of Saccharomyces cerevisiae strain LAS117)。
P07)ホスホナート
ホセチル(fosetyl-Al)、亜リン酸および亜リン酸カルシウム(Calcium phosphite)、亜リン酸アルミニウム(Aluminum phosphite)、亜リン酸ナトリウム(Sodium Phosphite、Disodium phosphonate)等の塩(phosphorous acid and salts)。
P08)サリチル酸シグナル伝達に関連する剤
ジクロベンチアゾクス(dichlobentiazox)。 (P) Agents that act to induce resistance in host plants:
P01-P03) Agents involved in salicylate signaling: acibenzolar-S-methyl, probenazole, tiadinil, isotianil.
P04) Polysaccharide elicitor laminarin.
P05) Anthraquinone elicitor extract from Reynoutria sachalinensis.
P06) Microorganism Elicitor Bacillus mycoides isolate J, cell walls of Saccharomyces cerevisiae strain LAS117.
P07) phosphorous acid and salts such as fosetyl-Al, phosphorous acid and calcium phosphite, aluminum phosphite, sodium phosphite, disodium phosphonate ).
P08) Dichlobentiazox, an agent involved in salicylate signaling.
P01~P03)サリチル酸シグナル伝達に関連する剤
アシベンゾラルSメチル(acibenzolar-S-methyl)、プロベナゾール(probenazole)、チアジニル(tiadinil)、イソチアニル(isotianil)。
P04)多糖類エリシター
ラミナリン(laminarin)。
P05)アントラキノンエリシター
オオイタドリ抽出液(extract from Reynoutria sachalinensis)。
P06)微生物エリシター
バチルス・マイコイデス分離株J(Bacillus mycoides isolate J)、サッカロミセス・セレビシア LAS117 株の細胞壁(cell walls of Saccharomyces cerevisiae strain LAS117)。
P07)ホスホナート
ホセチル(fosetyl-Al)、亜リン酸および亜リン酸カルシウム(Calcium phosphite)、亜リン酸アルミニウム(Aluminum phosphite)、亜リン酸ナトリウム(Sodium Phosphite、Disodium phosphonate)等の塩(phosphorous acid and salts)。
P08)サリチル酸シグナル伝達に関連する剤
ジクロベンチアゾクス(dichlobentiazox)。 (P) Agents that act to induce resistance in host plants:
P01-P03) Agents involved in salicylate signaling: acibenzolar-S-methyl, probenazole, tiadinil, isotianil.
P04) Polysaccharide elicitor laminarin.
P05) Anthraquinone elicitor extract from Reynoutria sachalinensis.
P06) Microorganism Elicitor Bacillus mycoides isolate J, cell walls of Saccharomyces cerevisiae strain LAS117.
P07) phosphorous acid and salts such as fosetyl-Al, phosphorous acid and calcium phosphite, aluminum phosphite, sodium phosphite, disodium phosphonate ).
P08) Dichlobentiazox, an agent involved in salicylate signaling.
(U)作用機構不明の剤:
シモキサニル(cymoxanil)、テクロフタラム(teclofthalam)、トリアゾキシド(triazoxide)、フルスルファミド(flusulfamide)、ジクロメジン(diclomezine)、シフルフェナミド(cyflufenamid)、ドジン(dodine)、ドジン遊離塩基(dodine free base)、フルチアニル(flutianil)、フェリムゾン(ferimzone)、テブフロキン(tebufloquin)、ピカルブトラゾクス(picarbutrazox)、バリダマイシン(validamycin)、ベトキサジン(bethoxazin)、シプロフラム(cyprofuram)、フルメトベル(flumetover)、ニトロタールイソプロピル(nitrothal-isopropyl)、プロパミジン(propamidine)、、イプフルフェノキン(ipflufenoquin)、ピリダクロメチル(pyridachlometyl)、ピラプロポイン(pyrapropoyne)、アミノピリフェン(aminopyrifen)、イプフェントリフルコナゾール(ipfentrifluconazole)、キノフメリン(quinofumelin)、ジピメチトロン(dipymetitrone)、クロインコナジド(chloroinconazide)、セボクチルアミン(seboctylamine)、フルメチルスルホリム(Flumetylsulforim)、フルフェノキサジアザム(Flufenoxadiazam)。 (U) Agents with unknown mechanisms of action:
cymoxanil, teclofthalam, triazoxide, flusulfamide, diclomezine, cyflufenamid, dodine, dodine free base, flutianil, ferimzone (ferimzone), tebufloquin, picarbutrazox, validamycin, bethoxazin, cyprofuram, flumetover, nitrothal-isopropyl, propamidine , ipflufenoquin, pyridaclomethyl, pyrapropoyne, aminopyrifen, ipfentrifluconazole, quinofumelin, dipymetitrone, cloinconazide (chloroinconazide), seboctylamine, Flumetylsulforim, Flufenoxadiazam.
シモキサニル(cymoxanil)、テクロフタラム(teclofthalam)、トリアゾキシド(triazoxide)、フルスルファミド(flusulfamide)、ジクロメジン(diclomezine)、シフルフェナミド(cyflufenamid)、ドジン(dodine)、ドジン遊離塩基(dodine free base)、フルチアニル(flutianil)、フェリムゾン(ferimzone)、テブフロキン(tebufloquin)、ピカルブトラゾクス(picarbutrazox)、バリダマイシン(validamycin)、ベトキサジン(bethoxazin)、シプロフラム(cyprofuram)、フルメトベル(flumetover)、ニトロタールイソプロピル(nitrothal-isopropyl)、プロパミジン(propamidine)、、イプフルフェノキン(ipflufenoquin)、ピリダクロメチル(pyridachlometyl)、ピラプロポイン(pyrapropoyne)、アミノピリフェン(aminopyrifen)、イプフェントリフルコナゾール(ipfentrifluconazole)、キノフメリン(quinofumelin)、ジピメチトロン(dipymetitrone)、クロインコナジド(chloroinconazide)、セボクチルアミン(seboctylamine)、フルメチルスルホリム(Flumetylsulforim)、フルフェノキサジアザム(Flufenoxadiazam)。 (U) Agents with unknown mechanisms of action:
cymoxanil, teclofthalam, triazoxide, flusulfamide, diclomezine, cyflufenamid, dodine, dodine free base, flutianil, ferimzone (ferimzone), tebufloquin, picarbutrazox, validamycin, bethoxazin, cyprofuram, flumetover, nitrothal-isopropyl, propamidine , ipflufenoquin, pyridaclomethyl, pyrapropoyne, aminopyrifen, ipfentrifluconazole, quinofumelin, dipymetitrone, cloinconazide (chloroinconazide), seboctylamine, Flumetylsulforim, Flufenoxadiazam.
(M)多作用点接触活性を有する剤:
銅(種々の塩)(copper(different salts))、塩基性硫酸銅(basic copper sulfate)、ボルドー液(Bordeaux mixture)、水酸化銅(copper hydroxide)、銅ナフタレート(copper naphthenate)、オキシ塩化銅(copper oxychloride)、硫酸銅(copper sulfate)、酸化銅(cuprous oxide)、オキシン銅(oxine-copper)、硫黄(sulphur)、石灰硫黄合剤(Lime sulfur)、アンバム(amobam)、ファーバム(ferbam)、マンゼブ(mancozeb)、マンネブ(maneb)、メチラム(metiram)、プロピネブ(propineb)、チウラム(thiram)、チアゾール亜鉛(zinc thiazole)、ジネブ(zineb)、ジラム(ziram)、キャプタン(captan)、カプタホール(captafol)、ホルペット(folpet)、クロロタロニル(chlorothalonil)、ジクロフルアニド(dichlofluanid)、トリルフルアニド(tolylfluanid);グアザチン(guazatine)、グアザチン酢酸塩(guazatine acetates)、イミノクタジン(iminoctadine)、イミノクタジン酢酸塩(iminoctadine triacetate)、イミノクタジンアルベシル酸塩(iminoctadine trialbesilate)、アニラジン(anilazine)、ジチアノン(dithianon)、キノメチオナート(chinomethionat/quinomethionate)、フルオルイミド(fluoroimide)、メタスルホカルブ(methasulfocarb)、ダゾメット(dazomet)、クフラネブ(cufraneb)、マンカッパー(mancopper)、ポリカーバメート(polycarbamate)。 (M) an agent having multisite contact activity:
Copper (different salts), basic copper sulfate, Bordeaux mixture, copper hydroxide, copper naphthenate, copper oxychloride oxychloride), copper sulfate, cuprous oxide, oxine-copper, sulfur, lime sulfur, amobam, ferbam, mancozeb (mancozeb), maneb, metiram, propineb, thiram, zinc thiazole, zineb, ziram, captan, captafol , folpet, chlorothalonil, dichlofluanid, tolylfluanid; guazatine, guazatine acetates, iminoctadine, iminoctadine triacetate , iminoctadine trialbesilate, anilazine, dithianon, chinomethionat/quinomethionate, fluoroimide, methasulfocarb, dazomet, cufraneb, mancopper, polycarbamate.
銅(種々の塩)(copper(different salts))、塩基性硫酸銅(basic copper sulfate)、ボルドー液(Bordeaux mixture)、水酸化銅(copper hydroxide)、銅ナフタレート(copper naphthenate)、オキシ塩化銅(copper oxychloride)、硫酸銅(copper sulfate)、酸化銅(cuprous oxide)、オキシン銅(oxine-copper)、硫黄(sulphur)、石灰硫黄合剤(Lime sulfur)、アンバム(amobam)、ファーバム(ferbam)、マンゼブ(mancozeb)、マンネブ(maneb)、メチラム(metiram)、プロピネブ(propineb)、チウラム(thiram)、チアゾール亜鉛(zinc thiazole)、ジネブ(zineb)、ジラム(ziram)、キャプタン(captan)、カプタホール(captafol)、ホルペット(folpet)、クロロタロニル(chlorothalonil)、ジクロフルアニド(dichlofluanid)、トリルフルアニド(tolylfluanid);グアザチン(guazatine)、グアザチン酢酸塩(guazatine acetates)、イミノクタジン(iminoctadine)、イミノクタジン酢酸塩(iminoctadine triacetate)、イミノクタジンアルベシル酸塩(iminoctadine trialbesilate)、アニラジン(anilazine)、ジチアノン(dithianon)、キノメチオナート(chinomethionat/quinomethionate)、フルオルイミド(fluoroimide)、メタスルホカルブ(methasulfocarb)、ダゾメット(dazomet)、クフラネブ(cufraneb)、マンカッパー(mancopper)、ポリカーバメート(polycarbamate)。 (M) an agent having multisite contact activity:
Copper (different salts), basic copper sulfate, Bordeaux mixture, copper hydroxide, copper naphthenate, copper oxychloride oxychloride), copper sulfate, cuprous oxide, oxine-copper, sulfur, lime sulfur, amobam, ferbam, mancozeb (mancozeb), maneb, metiram, propineb, thiram, zinc thiazole, zineb, ziram, captan, captafol , folpet, chlorothalonil, dichlofluanid, tolylfluanid; guazatine, guazatine acetates, iminoctadine, iminoctadine triacetate , iminoctadine trialbesilate, anilazine, dithianon, chinomethionat/quinomethionate, fluoroimide, methasulfocarb, dazomet, cufraneb, mancopper, polycarbamate.
(BM)複数の作用機構を有する生物農薬/生物由来の農薬:
a)植物抽出物
ポリペプチド(レクチン)(Polypeptide(lectin))、フェノール化合物(Phenols)、セスキテルペン化合物(Sesquiterpenes)、トリテルペノイド化合物(Triterpenoids)、クマリン化合物(Coumarins)、テルペン系炭化水素化合物(Terpene Hydrocarbons)、テルペンアルコール化合物(Terpene alcohols)、テルペンフェノール化合物(Terpene phenols)、ハウチワマメ苗木の子葉からの抽出物(extract from the cotyledons of lupine plantlets)、Swinglea glutinosa からの抽出物 (extract from Swinglea glutinosa)、ゴセイカユプテ(ティーツリー)の抽出物(extract from Melaleuca alternifolia (tea tree oil))、植物油類(混合物)(plant oils (mixtures))、オイゲノール(eugenol)、ゲラニオール(geraniol)、チモール(thymol)、α -ピネン(Alpha-pinene) 、α -テルピネン(Alpha-terpinene)、α -テルピネオール(Alpha-terpinol)、α -テルピノレン(Alpha-terpinoline) 、γ -テルピネン(Gamma-terpinene)、d-リモネン(d-Limonene)、オレンジオイル(Orange Oil)、リナロール(Linalool) 、メントール(Menthol)、ウルソール酸(ursolic acid)、オレアノール酸( Oleanolic Acid)、ニームオイル(neem oil)。
b)微生物(微生物株又はその抽出物や代謝物)
トリコデルマ・アトロビリデ I-1237株(Trichoderma atroviride strain I-1237)、トリコデルマ・アトロビリデ LU132株(Trichoderma atroviride strain LU132)、トリコデルマ・アトロビリデ SC1株(Trichoderma atroviride strain SC1)、トリコデルマ・アトロビリデ SKT-1株(Trichoderma atroviride strain SKT-1)、トリコデルマ・アトロビリデ 77B株(Trichoderma atroviride strain 77B);
トリコデルマ・アスペレルム T34 株(Trichoderma asperellum strain T34)、トリコデルマ・アスペレルムkd株(Trichoderma asperellum strain kd);
トリコデルマ・ハルチアナム T-22 株(Trichoderma harzianum strain T-22);
トリコデルマ・ ビレンスG-41株(Trichoderma virens strain G-41)などの、トリコデルマ属菌(Trichoderma spp.)。
グリオクラディウム・カテナラタム J1446 株(Gliocladium catenulatum strain J1446)などの、グリオクラディウム属菌(Gliocladium spp.)。
クロノスタキス・ロゼアCR-7株(Clonostachys rosea strain CR-7)などのクロノスタキス属菌(Clonostachys spp.)。
コニオチリウム・ミニタンスCON/M/91-08株(Coniothyrium minitans strain CON/M/91-08)などのコニオチリウム属菌(Coniothyrium spp.)。
タラロマイセス・ フラバス SAY-Y-94-01 株(Talaromyces flavus strain SAY-Y-94-01);などのタラロマイセス 属菌(Talaromyces spp.)。
サッカロマイセス・セレビシエLAS02株(Saccharomyces cerevisae strain LAS02)などのサッカロミケス属菌(Saccharomyces spp.)。
バチルス・アミロリクエファシエンスQST713 株(Bacillus amyloliquefaciens strain QST713)、バチルス・アミロリクエファシエンスFZB24 株(Bacillus amyloliquefaciens strain FZB24)、バチルス・アミロリクエファシエンスMBI600 株(Bacillus amyloliquefaciens strain MBI600)、バチルス・アミロリクエファシエンスD747 株(Bacillus amyloliquefaciens strain D747)、バチルス・アミロリクエファシエンスF727 株(Bacillus amyloliquefaciens strain F727)、バチルス・アミロリクエファシエンスAT-332 株(Bacillus amyloliquefaciens strain AT-332);
バチルス・ズブチリスAFS032321 株(Bacillus subtilis strain AFS032321) 、バチルス・ズブチリスY1336 株 (Bacillus subtilis strain Y1336)、バチルス・ズブチリスHAI-0404 株(Bacillus subtilis strain HAI-0404);バチルス・シンプレクス(Bacillus simplex)などのバチルス属菌(Bacillus spp.)。
パエニバシルス属菌(Paenibacillus spp.) 。
バークホルデリア属菌(Burkholderia spp.) 。
フザリウム属菌(Fusarium spp.)。
シュードモナス・クロロファフィスAFS 009 株(Pseudomonas chlororaphis strain AFS009)、シュードモナス フルオレッセンス(Pseudomonas fluorescens)、シュードモナス・ロデシアHAI-0804株(Pseudomonas rhodesiae HAI-0804)などのシュードモナス属菌(Pseudomonas spp.)。
ストレプトミセス・グリセオビリデス K61 株(Streptomyces griseovirides strain K61)、ストレプトミセス・リディクス WYEC 108株(Streptomyces lydicus strain WYEC108)などのストレプトミセス属菌(Streptomyces spp.)。
アグロバクテリウム・ラジオバクター(Agrobacterium radiobacter)などのアグロバクテリウム属菌(Agrobacterium spp.)。
非病原性エルビニア・カロトボーラ(Erwinia carotovora subsp. carotovora)などのエルビニア属菌(Erwinia spp.)。
バリオボラックス・パラドクス(Variovorax paradoxus)などのバリオボラックス属菌(Variovorax spp.)。
ラクトバチルス・プランタラム(Lactobacillus plantarum)などのラクトバチルス属菌(Lactobacillus spp.)。
c)その他の剤
酵母若しくはそのエキス、β-グルカン、キチン若しくはキトサンまたはこれらの断片、β-アミノ酪酸、2 ,6-ジクロロイソニコチン酸、サリチル酸若しくはその誘導体、藻類抽出物、藻類エキス(加水分解物) 、ジャスミン花エキス、アルギン酸ナトリウム、オリゴ糖、トレハロース、多糖、脂質、リポ多糖、脂肪酸、糖脂質、糖タンパク、糖ペプチド、植物および/または病原微生物に由来のタンパク質若しくはペプチド、およびエルゴステロールなどの、エリシター(elicitor)となり得る物質。 (BM) Biological/biological pesticides with multiple mechanisms of action:
a) Plant extracts Polypeptide (lectin), Phenols, Sesquiterpenes, Triterpenoids, Coumarins, Terpene Hydrocarbons ), terpene alcohols, terpene phenols, extract from the cotyledons of lupine plantlets, extract from Swinglea glutinosa, mint. extract from Melaleuca alternifolia (tea tree oil), plant oils (mixtures), eugenol, geraniol, thymol, α- Alpha-pinene, α-Terpinene, Alpha-Terpinol, Alpha-Terpinolene, Gamma-Terpinene, d-Limonene ), Orange Oil, Linalool, Menthol, ursolic acid, Oleanolic Acid, neem oil.
b) Microorganisms (microbial strains or their extracts or metabolites)
Trichoderma atroviride strain I-1237, Trichoderma atroviride strain LU132, Trichoderma atroviride strain SC1, Trichoderma atroviride strain SKT-1 strain SKT-1), Trichoderma atroviride strain 77B;
Trichoderma asperellum strain T34, Trichoderma asperellum strain kd;
Trichoderma harzianum T-22 strain (Trichoderma harzianum strain T-22);
Trichoderma spp., such as Trichoderma virens strain G-41.
Gliocladium spp., such as Gliocladium catenulatum strain J1446.
Clonostachys spp., such as Clonostachys rosea strain CR-7.
Coniothyrium spp., such as Coniothyrium minitans strain CON/M/91-08.
Talaromyces spp., such as Talaromyces flavus strain SAY-Y-94-01;
Saccharomyces spp., such as Saccharomyces cerevisae strain LAS02.
Bacillus amyloliquefaciens strain QST713, Bacillus amyloliquefaciens strain FZB24, Bacillus amyloliquefaciens strain MBI600, Bacillus amyloliquefaciens strain MBI600 Bacillus amyloliquefaciens strain D747, Bacillus amyloliquefaciens strain F727, Bacillus amyloliquefaciens AT-332 strain (Bacillus amyloliquefaciens strain AT-332);
Bacillus subtilis strain AFS032321, Bacillus subtilis strain Y1336, Bacillus subtilis strain HAI-0404; Bacillus simplex and other bacilli Bacillus spp.
Paenibacillus spp.
Burkholderia spp.
Fusarium spp.
Pseudomonas spp., such as Pseudomonas chlororaphis strain AFS009, Pseudomonas fluorescens, and Pseudomonas rhodesiae HAI-0804.
Streptomyces spp. such as Streptomyces griseovirides strain K61 and Streptomyces lydicus strain WYEC108.
Agrobacterium spp., such as Agrobacterium radiobacter.
Erwinia spp., such as non-pathogenic Erwinia carotovora subsp. carotovora.
Variovorax spp., such as Variovorax paradoxus.
Lactobacillus spp., such as Lactobacillus plantarum.
c) Other agents Yeast or its extract, β-glucan, chitin or chitosan or fragments thereof, β-aminobutyric acid, 2,6-dichloroisonicotinic acid, salicylic acid or derivatives thereof, algae extract, algae extract (hydrolyzed , jasmine flower extract, sodium alginate, oligosaccharides, trehalose, polysaccharides, lipids, lipopolysaccharides, fatty acids, glycolipids, glycoproteins, glycopeptides, proteins or peptides derived from plants and/or pathogenic microorganisms, ergosterol, etc. A substance that can be an elicitor of
a)植物抽出物
ポリペプチド(レクチン)(Polypeptide(lectin))、フェノール化合物(Phenols)、セスキテルペン化合物(Sesquiterpenes)、トリテルペノイド化合物(Triterpenoids)、クマリン化合物(Coumarins)、テルペン系炭化水素化合物(Terpene Hydrocarbons)、テルペンアルコール化合物(Terpene alcohols)、テルペンフェノール化合物(Terpene phenols)、ハウチワマメ苗木の子葉からの抽出物(extract from the cotyledons of lupine plantlets)、Swinglea glutinosa からの抽出物 (extract from Swinglea glutinosa)、ゴセイカユプテ(ティーツリー)の抽出物(extract from Melaleuca alternifolia (tea tree oil))、植物油類(混合物)(plant oils (mixtures))、オイゲノール(eugenol)、ゲラニオール(geraniol)、チモール(thymol)、α -ピネン(Alpha-pinene) 、α -テルピネン(Alpha-terpinene)、α -テルピネオール(Alpha-terpinol)、α -テルピノレン(Alpha-terpinoline) 、γ -テルピネン(Gamma-terpinene)、d-リモネン(d-Limonene)、オレンジオイル(Orange Oil)、リナロール(Linalool) 、メントール(Menthol)、ウルソール酸(ursolic acid)、オレアノール酸( Oleanolic Acid)、ニームオイル(neem oil)。
b)微生物(微生物株又はその抽出物や代謝物)
トリコデルマ・アトロビリデ I-1237株(Trichoderma atroviride strain I-1237)、トリコデルマ・アトロビリデ LU132株(Trichoderma atroviride strain LU132)、トリコデルマ・アトロビリデ SC1株(Trichoderma atroviride strain SC1)、トリコデルマ・アトロビリデ SKT-1株(Trichoderma atroviride strain SKT-1)、トリコデルマ・アトロビリデ 77B株(Trichoderma atroviride strain 77B);
トリコデルマ・アスペレルム T34 株(Trichoderma asperellum strain T34)、トリコデルマ・アスペレルムkd株(Trichoderma asperellum strain kd);
トリコデルマ・ハルチアナム T-22 株(Trichoderma harzianum strain T-22);
トリコデルマ・ ビレンスG-41株(Trichoderma virens strain G-41)などの、トリコデルマ属菌(Trichoderma spp.)。
グリオクラディウム・カテナラタム J1446 株(Gliocladium catenulatum strain J1446)などの、グリオクラディウム属菌(Gliocladium spp.)。
クロノスタキス・ロゼアCR-7株(Clonostachys rosea strain CR-7)などのクロノスタキス属菌(Clonostachys spp.)。
コニオチリウム・ミニタンスCON/M/91-08株(Coniothyrium minitans strain CON/M/91-08)などのコニオチリウム属菌(Coniothyrium spp.)。
タラロマイセス・ フラバス SAY-Y-94-01 株(Talaromyces flavus strain SAY-Y-94-01);などのタラロマイセス 属菌(Talaromyces spp.)。
サッカロマイセス・セレビシエLAS02株(Saccharomyces cerevisae strain LAS02)などのサッカロミケス属菌(Saccharomyces spp.)。
バチルス・アミロリクエファシエンスQST713 株(Bacillus amyloliquefaciens strain QST713)、バチルス・アミロリクエファシエンスFZB24 株(Bacillus amyloliquefaciens strain FZB24)、バチルス・アミロリクエファシエンスMBI600 株(Bacillus amyloliquefaciens strain MBI600)、バチルス・アミロリクエファシエンスD747 株(Bacillus amyloliquefaciens strain D747)、バチルス・アミロリクエファシエンスF727 株(Bacillus amyloliquefaciens strain F727)、バチルス・アミロリクエファシエンスAT-332 株(Bacillus amyloliquefaciens strain AT-332);
バチルス・ズブチリスAFS032321 株(Bacillus subtilis strain AFS032321) 、バチルス・ズブチリスY1336 株 (Bacillus subtilis strain Y1336)、バチルス・ズブチリスHAI-0404 株(Bacillus subtilis strain HAI-0404);バチルス・シンプレクス(Bacillus simplex)などのバチルス属菌(Bacillus spp.)。
パエニバシルス属菌(Paenibacillus spp.) 。
バークホルデリア属菌(Burkholderia spp.) 。
フザリウム属菌(Fusarium spp.)。
シュードモナス・クロロファフィスAFS 009 株(Pseudomonas chlororaphis strain AFS009)、シュードモナス フルオレッセンス(Pseudomonas fluorescens)、シュードモナス・ロデシアHAI-0804株(Pseudomonas rhodesiae HAI-0804)などのシュードモナス属菌(Pseudomonas spp.)。
ストレプトミセス・グリセオビリデス K61 株(Streptomyces griseovirides strain K61)、ストレプトミセス・リディクス WYEC 108株(Streptomyces lydicus strain WYEC108)などのストレプトミセス属菌(Streptomyces spp.)。
アグロバクテリウム・ラジオバクター(Agrobacterium radiobacter)などのアグロバクテリウム属菌(Agrobacterium spp.)。
非病原性エルビニア・カロトボーラ(Erwinia carotovora subsp. carotovora)などのエルビニア属菌(Erwinia spp.)。
バリオボラックス・パラドクス(Variovorax paradoxus)などのバリオボラックス属菌(Variovorax spp.)。
ラクトバチルス・プランタラム(Lactobacillus plantarum)などのラクトバチルス属菌(Lactobacillus spp.)。
c)その他の剤
酵母若しくはそのエキス、β-グルカン、キチン若しくはキトサンまたはこれらの断片、β-アミノ酪酸、2 ,6-ジクロロイソニコチン酸、サリチル酸若しくはその誘導体、藻類抽出物、藻類エキス(加水分解物) 、ジャスミン花エキス、アルギン酸ナトリウム、オリゴ糖、トレハロース、多糖、脂質、リポ多糖、脂肪酸、糖脂質、糖タンパク、糖ペプチド、植物および/または病原微生物に由来のタンパク質若しくはペプチド、およびエルゴステロールなどの、エリシター(elicitor)となり得る物質。 (BM) Biological/biological pesticides with multiple mechanisms of action:
a) Plant extracts Polypeptide (lectin), Phenols, Sesquiterpenes, Triterpenoids, Coumarins, Terpene Hydrocarbons ), terpene alcohols, terpene phenols, extract from the cotyledons of lupine plantlets, extract from Swinglea glutinosa, mint. extract from Melaleuca alternifolia (tea tree oil), plant oils (mixtures), eugenol, geraniol, thymol, α- Alpha-pinene, α-Terpinene, Alpha-Terpinol, Alpha-Terpinolene, Gamma-Terpinene, d-Limonene ), Orange Oil, Linalool, Menthol, ursolic acid, Oleanolic Acid, neem oil.
b) Microorganisms (microbial strains or their extracts or metabolites)
Trichoderma atroviride strain I-1237, Trichoderma atroviride strain LU132, Trichoderma atroviride strain SC1, Trichoderma atroviride strain SKT-1 strain SKT-1), Trichoderma atroviride strain 77B;
Trichoderma asperellum strain T34, Trichoderma asperellum strain kd;
Trichoderma harzianum T-22 strain (Trichoderma harzianum strain T-22);
Trichoderma spp., such as Trichoderma virens strain G-41.
Gliocladium spp., such as Gliocladium catenulatum strain J1446.
Clonostachys spp., such as Clonostachys rosea strain CR-7.
Coniothyrium spp., such as Coniothyrium minitans strain CON/M/91-08.
Talaromyces spp., such as Talaromyces flavus strain SAY-Y-94-01;
Saccharomyces spp., such as Saccharomyces cerevisae strain LAS02.
Bacillus amyloliquefaciens strain QST713, Bacillus amyloliquefaciens strain FZB24, Bacillus amyloliquefaciens strain MBI600, Bacillus amyloliquefaciens strain MBI600 Bacillus amyloliquefaciens strain D747, Bacillus amyloliquefaciens strain F727, Bacillus amyloliquefaciens AT-332 strain (Bacillus amyloliquefaciens strain AT-332);
Bacillus subtilis strain AFS032321, Bacillus subtilis strain Y1336, Bacillus subtilis strain HAI-0404; Bacillus simplex and other bacilli Bacillus spp.
Paenibacillus spp.
Burkholderia spp.
Fusarium spp.
Pseudomonas spp., such as Pseudomonas chlororaphis strain AFS009, Pseudomonas fluorescens, and Pseudomonas rhodesiae HAI-0804.
Streptomyces spp. such as Streptomyces griseovirides strain K61 and Streptomyces lydicus strain WYEC108.
Agrobacterium spp., such as Agrobacterium radiobacter.
Erwinia spp., such as non-pathogenic Erwinia carotovora subsp. carotovora.
Variovorax spp., such as Variovorax paradoxus.
Lactobacillus spp., such as Lactobacillus plantarum.
c) Other agents Yeast or its extract, β-glucan, chitin or chitosan or fragments thereof, β-aminobutyric acid, 2,6-dichloroisonicotinic acid, salicylic acid or derivatives thereof, algae extract, algae extract (hydrolyzed , jasmine flower extract, sodium alginate, oligosaccharides, trehalose, polysaccharides, lipids, lipopolysaccharides, fatty acids, glycolipids, glycoproteins, glycopeptides, proteins or peptides derived from plants and/or pathogenic microorganisms, ergosterol, etc. A substance that can be an elicitor of
(N)未分類の剤
鉱物油(mineral oils)、有機油(organic oils)、無機塩類(inorganic salts)、天然物起源(material of biological origin)、炭酸水素カリウム(Potassium bicarbonate),炭酸水素ナトリウム(Sodium hydrogen carbonate)、炭酸カルシウム(Calcium carbonate)、水酸化カルシウム(Calcium hydroxide)、ヨウ化カリウム(Potassium iodide)、ホスホン酸カリウム(Potassium phosphonates)、キトサン塩酸塩(Chitosan hydrochloride)、尿素(Urea)。 (N) unclassified agents mineral oils, organic oils, inorganic salts, material of biological origin, Potassium bicarbonate, sodium bicarbonate ( Sodium hydrogen carbonate, Calcium carbonate, Calcium hydroxide, Potassium iodide, Potassium phosphonates, Chitosan hydrochloride, Urea.
鉱物油(mineral oils)、有機油(organic oils)、無機塩類(inorganic salts)、天然物起源(material of biological origin)、炭酸水素カリウム(Potassium bicarbonate),炭酸水素ナトリウム(Sodium hydrogen carbonate)、炭酸カルシウム(Calcium carbonate)、水酸化カルシウム(Calcium hydroxide)、ヨウ化カリウム(Potassium iodide)、ホスホン酸カリウム(Potassium phosphonates)、キトサン塩酸塩(Chitosan hydrochloride)、尿素(Urea)。 (N) unclassified agents mineral oils, organic oils, inorganic salts, material of biological origin, Potassium bicarbonate, sodium bicarbonate ( Sodium hydrogen carbonate, Calcium carbonate, Calcium hydroxide, Potassium iodide, Potassium phosphonates, Chitosan hydrochloride, Urea.
本発明の農園芸用殺菌剤または殺線虫剤と混用または併用することができる殺虫・殺ダニ剤として、IRAC(Insecticide Resistance Action Committee)のHP(https://irac-online.org/)に記載される化合物、または農業上許容されるそれらの塩、若しくは誘導体等を好ましいものとして挙げることができる。
具体的には以下の群から選択される化合物を例示することができる。 As an insecticide / acaricide that can be mixed or used together with the agricultural and horticultural fungicide or nematicide of the present invention, IRAC (Insecticide Resistance Action Committee) HP (https://irac-online.org/) The compounds described, or their agriculturally acceptable salts or derivatives, etc. can be mentioned as preferred ones.
Specifically, compounds selected from the following group can be exemplified.
具体的には以下の群から選択される化合物を例示することができる。 As an insecticide / acaricide that can be mixed or used together with the agricultural and horticultural fungicide or nematicide of the present invention, IRAC (Insecticide Resistance Action Committee) HP (https://irac-online.org/) The compounds described, or their agriculturally acceptable salts or derivatives, etc. can be mentioned as preferred ones.
Specifically, compounds selected from the following group can be exemplified.
殺虫剤・殺ダニ剤:
(1A)アセチルコリンエステラーゼ(AChE)阻害剤(カーバメート系):
アラニカルブ(Alanycarb)、アルジカルブ(Aldicarb)、ベンダイオカルブ(Bendiocarb)、ベンフラカルブ(Benfuracarb)、ブトカルボキシム(Butocarboxim)、 ブトキシカルボキシム(Butoxycarboxim)、カルバリル(Carbaryl)、カルボフラン(Carbofuran)、カルボスルファン(Carbosulfan)、エチオフェンカルブ(Ethiofencarb)、フェノブカルブ(Fenobucarb)、ホルメタネート(Formetanate)、フラチオカルブ(Furathiocarb)、イソプロカルブ(Isoprocarb)、メチオカルブ(Methiocarb)、メソミル(Methomyl)、メトルカルブ(Metolcarb)、オキサミル(Oxamyl)、ピリミカーブ(Pirimicarb)、プロポキスル(Propoxur)、チオジカルブ(Thiodicarb)、チオファノックス(Thiofanox)、トリアザメート(Triazamate)、トリメタカルブ(Trimethacarb)、XMC、キシリルカルブ(Xylylcarb)、アルドキシカルブ(Aldoxycarb)、アリキシカルブ(Allyxycarb)、アミノカルブ(Aminocarb)、ブフェンカルブ(Bufencarb)、クロエトカルブ(Cloethocarb)、フェノチオカルブ(Fenothiocarb)、プロメカルブ(Promecarb)。 Insecticides and acaricides:
(1A) Acetylcholinesterase (AChE) inhibitor (carbamate):
Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarbboxim, Butoxycarbboxim, Carbaryl, Carbofuran, Carbosulfan ( Carbosulfan, Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, Pirimicarb ( Pirimicarb, Propoxur, Thiodicarb, Thiofanox, Triazamate, Trimethacarb, XMC, Xylylcarb, Aldoxycarb, Allyxycarb, Aminocarb (Aminocarb), Bufencarb, Cloethocarb, Fenothiocarb, Promecarb.
(1A)アセチルコリンエステラーゼ(AChE)阻害剤(カーバメート系):
アラニカルブ(Alanycarb)、アルジカルブ(Aldicarb)、ベンダイオカルブ(Bendiocarb)、ベンフラカルブ(Benfuracarb)、ブトカルボキシム(Butocarboxim)、 ブトキシカルボキシム(Butoxycarboxim)、カルバリル(Carbaryl)、カルボフラン(Carbofuran)、カルボスルファン(Carbosulfan)、エチオフェンカルブ(Ethiofencarb)、フェノブカルブ(Fenobucarb)、ホルメタネート(Formetanate)、フラチオカルブ(Furathiocarb)、イソプロカルブ(Isoprocarb)、メチオカルブ(Methiocarb)、メソミル(Methomyl)、メトルカルブ(Metolcarb)、オキサミル(Oxamyl)、ピリミカーブ(Pirimicarb)、プロポキスル(Propoxur)、チオジカルブ(Thiodicarb)、チオファノックス(Thiofanox)、トリアザメート(Triazamate)、トリメタカルブ(Trimethacarb)、XMC、キシリルカルブ(Xylylcarb)、アルドキシカルブ(Aldoxycarb)、アリキシカルブ(Allyxycarb)、アミノカルブ(Aminocarb)、ブフェンカルブ(Bufencarb)、クロエトカルブ(Cloethocarb)、フェノチオカルブ(Fenothiocarb)、プロメカルブ(Promecarb)。 Insecticides and acaricides:
(1A) Acetylcholinesterase (AChE) inhibitor (carbamate):
Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarbboxim, Butoxycarbboxim, Carbaryl, Carbofuran, Carbosulfan ( Carbosulfan, Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, Pirimicarb ( Pirimicarb, Propoxur, Thiodicarb, Thiofanox, Triazamate, Trimethacarb, XMC, Xylylcarb, Aldoxycarb, Allyxycarb, Aminocarb (Aminocarb), Bufencarb, Cloethocarb, Fenothiocarb, Promecarb.
(1B)アセチルコリンエステラーゼ(AChE)阻害剤(有機リン系):
アセフェート(Acephate)、アザメチホス(Azamethiphos)、アジンホスエチル(Azinphos-ethyl)、アジンホスメチル(Azinphosmethyl)、カズサホス(Cadusafos)、クロレトキシホス(Chlorethoxyfos)、クロルフェンビンホス(Chlorfenvinphos)、クロルメホス(Chlormephos)、クロルピリホス(Chlorpyrifos)、クロルピリホスメチル(Chlorpyrifos-methyl)、クマホス(Coumaphos)、シアノホス(Cyanophos)、ジメトン-S-メチル(Demeton-S-methyl)、ダイアジノン(Diazinon)、ジクロルボス(Dichlorvos/ DDVP)、ジクロトホス(Dicrotophos)、ジメトエート(Dimethoate)、ジメチルビンホス(Dimethylvinphos)、ジスルホトン(Disulfoton)、EPN、エチオン(Ethion)、エトプロホス(Ethoprophos)、ファンフル(Famphur)、フェナミホス(Fenamiphos)、フェニトロチオン(Fenitrothion)、フェンチオン(Fenthion)、ホスチアゼート(Fosthiazate)、ヘプテノホス(Heptenophos)、イミシアホス(Imicyafos)、イソフェンホス(Isofenphos)、イソプロピル=O-(メトキシアミノチオホスホリル)サリチラート(Isopropyl O-(methoxyaminothio-phosphoryl) salicylate)、イソキサチオン(Isoxathion)、マラチオン(Malathion)、メカルバム(Mecarbam)、メタミドホス(Methamidophos)、メチダチオン(Methidathion)、メビンホス(Mevinphos)、モノクロトホス(Monocrotophos)、ナレッド(Naled)、オメトエート(Omethoate)、オキシジメトンメチル(Oxydemeton-methyl)、パラチオン(Parathion)、パラチオンメチル(Parathion-methyl)、フェントエート(Phenthoate)、ホレート(Phorate)、ホサロン(Phosalone)、ホスメット(Phosmet)、ホスファミドン(Phosphamidon)、ホキシム(Phoxim)、ピリミホスメチル(Pirimiphos- methyl)、プロフェノホス(Profenofos)、プロペタムホス(Propetamphos)、プロチオホス(Prothiofos)、ピラクロホス(Pyraclofos)、ピリダフェンチオン(Pyridaphenthion)、キナルホス(Quinalphos)、スルホテップ(Sulfotep)、テブピリムホス(Tebupirimfos)、テメホス(Temephos)、テルブホス(Terbufos)、テトラクロルビンホス(Tetrachlorvinphos)、チオメトン(Thiometon)、トリアゾホス(Triazophos)、トリクロルホン(Trichlorfon)、バミドチオン(Vamidothion)、ブロモホス-エチル(Bromophos-e)、シアノフェンホス(Cyanofenphos)、デメトン-S-メチルスルホン(Demeton-S-methylsulfone )、ジアリホス(Dialifos)、ジクロフェンチオン(Dichlofenthion)、ジオキサベンゾホス(Dioxabenzofos)、エトリムホス(Etrimfos)、フェンスルホチオン(Fensulfothion)、ホノホス(Fonofos)、ホルモチオン(Formothion)、ヨードフェンホス(iodofenphos)、イサゾホス(Isazofos)、イソカルボホス(Isocarbofos)、メタクリホス(Methacrifos)、ホスホカルブ(Phosphocarb)、ピリミホス-エチル(Pirimiphos-e)、プロパホス(Propaphos)、プロトエート(Prothoate)、スルプロホス(Sulprofos)。 (1B) Acetylcholinesterase (AChE) inhibitors (organophosphorus):
Acephate, Azamethifos, Azinphos-ethyl, Azinphosmethyl, Cadusafos, Chlorethoxyfos, Chlorfenvinphos, Chlormephos, Chlorpyrifos, Chlorpyrifos-methyl, Coumaphos, Cyanophos, Demeton-S-methyl, Diazinon, Dichlorvos/ DDVP, Dicrotophos, Dimethoate ( Dimethoate, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fosthiazate ( Fosthiazate, Heptenophos, Imicyafos, Isofenphos, Isopropyl O-(methoxyaminothio-phosphoryl) salicylate, Isoxathion, Malathion , Mecarbam, Methamidophos, Methidathion, Mevinphos, Monocrotophos, Naled, Omethoate, Oxydemeton-methyl, Parathion , Parathion-methyl, Phenthoate, Phorate, Phosalone, Phosmet , Phosphamidon, Phoxim, Pirimiphos-methyl, Profenofos, Propetamphos, Prothiofos, Pyraclofos, Pyridaphenthion, Quinalphos, Sulfotep ( Sulfotep, Tebupirimfos, Temephos, Terbufos, Tetrachlorvinphos, Thiometon, Triazophos, Trichlorfon, Vamidothion, Bromophos-ethyl ( Bromophos-e, Cyanofenphos, Demeton-S-methylsulfone, Dialifos, Dichlofenthion, Dioxabenzofos, Etrimfos, Fensulfothion (Fensulfothion), Fonofos, Formothion, iodofenphos, Isazofos, Isocarbofos, Methacrifos, Phosphocarb, Pirimiphos-e, Propaphos, Prothoate, Sulprofos.
アセフェート(Acephate)、アザメチホス(Azamethiphos)、アジンホスエチル(Azinphos-ethyl)、アジンホスメチル(Azinphosmethyl)、カズサホス(Cadusafos)、クロレトキシホス(Chlorethoxyfos)、クロルフェンビンホス(Chlorfenvinphos)、クロルメホス(Chlormephos)、クロルピリホス(Chlorpyrifos)、クロルピリホスメチル(Chlorpyrifos-methyl)、クマホス(Coumaphos)、シアノホス(Cyanophos)、ジメトン-S-メチル(Demeton-S-methyl)、ダイアジノン(Diazinon)、ジクロルボス(Dichlorvos/ DDVP)、ジクロトホス(Dicrotophos)、ジメトエート(Dimethoate)、ジメチルビンホス(Dimethylvinphos)、ジスルホトン(Disulfoton)、EPN、エチオン(Ethion)、エトプロホス(Ethoprophos)、ファンフル(Famphur)、フェナミホス(Fenamiphos)、フェニトロチオン(Fenitrothion)、フェンチオン(Fenthion)、ホスチアゼート(Fosthiazate)、ヘプテノホス(Heptenophos)、イミシアホス(Imicyafos)、イソフェンホス(Isofenphos)、イソプロピル=O-(メトキシアミノチオホスホリル)サリチラート(Isopropyl O-(methoxyaminothio-phosphoryl) salicylate)、イソキサチオン(Isoxathion)、マラチオン(Malathion)、メカルバム(Mecarbam)、メタミドホス(Methamidophos)、メチダチオン(Methidathion)、メビンホス(Mevinphos)、モノクロトホス(Monocrotophos)、ナレッド(Naled)、オメトエート(Omethoate)、オキシジメトンメチル(Oxydemeton-methyl)、パラチオン(Parathion)、パラチオンメチル(Parathion-methyl)、フェントエート(Phenthoate)、ホレート(Phorate)、ホサロン(Phosalone)、ホスメット(Phosmet)、ホスファミドン(Phosphamidon)、ホキシム(Phoxim)、ピリミホスメチル(Pirimiphos- methyl)、プロフェノホス(Profenofos)、プロペタムホス(Propetamphos)、プロチオホス(Prothiofos)、ピラクロホス(Pyraclofos)、ピリダフェンチオン(Pyridaphenthion)、キナルホス(Quinalphos)、スルホテップ(Sulfotep)、テブピリムホス(Tebupirimfos)、テメホス(Temephos)、テルブホス(Terbufos)、テトラクロルビンホス(Tetrachlorvinphos)、チオメトン(Thiometon)、トリアゾホス(Triazophos)、トリクロルホン(Trichlorfon)、バミドチオン(Vamidothion)、ブロモホス-エチル(Bromophos-e)、シアノフェンホス(Cyanofenphos)、デメトン-S-メチルスルホン(Demeton-S-methylsulfone )、ジアリホス(Dialifos)、ジクロフェンチオン(Dichlofenthion)、ジオキサベンゾホス(Dioxabenzofos)、エトリムホス(Etrimfos)、フェンスルホチオン(Fensulfothion)、ホノホス(Fonofos)、ホルモチオン(Formothion)、ヨードフェンホス(iodofenphos)、イサゾホス(Isazofos)、イソカルボホス(Isocarbofos)、メタクリホス(Methacrifos)、ホスホカルブ(Phosphocarb)、ピリミホス-エチル(Pirimiphos-e)、プロパホス(Propaphos)、プロトエート(Prothoate)、スルプロホス(Sulprofos)。 (1B) Acetylcholinesterase (AChE) inhibitors (organophosphorus):
Acephate, Azamethifos, Azinphos-ethyl, Azinphosmethyl, Cadusafos, Chlorethoxyfos, Chlorfenvinphos, Chlormephos, Chlorpyrifos, Chlorpyrifos-methyl, Coumaphos, Cyanophos, Demeton-S-methyl, Diazinon, Dichlorvos/ DDVP, Dicrotophos, Dimethoate ( Dimethoate, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fosthiazate ( Fosthiazate, Heptenophos, Imicyafos, Isofenphos, Isopropyl O-(methoxyaminothio-phosphoryl) salicylate, Isoxathion, Malathion , Mecarbam, Methamidophos, Methidathion, Mevinphos, Monocrotophos, Naled, Omethoate, Oxydemeton-methyl, Parathion , Parathion-methyl, Phenthoate, Phorate, Phosalone, Phosmet , Phosphamidon, Phoxim, Pirimiphos-methyl, Profenofos, Propetamphos, Prothiofos, Pyraclofos, Pyridaphenthion, Quinalphos, Sulfotep ( Sulfotep, Tebupirimfos, Temephos, Terbufos, Tetrachlorvinphos, Thiometon, Triazophos, Trichlorfon, Vamidothion, Bromophos-ethyl ( Bromophos-e, Cyanofenphos, Demeton-S-methylsulfone, Dialifos, Dichlofenthion, Dioxabenzofos, Etrimfos, Fensulfothion (Fensulfothion), Fonofos, Formothion, iodofenphos, Isazofos, Isocarbofos, Methacrifos, Phosphocarb, Pirimiphos-e, Propaphos, Prothoate, Sulprofos.
(2)GABA作動性塩化物イオン(塩素イオン)チャネルブロッカー:
クロルデン(Chlordane)、エンドスルファン(Endosulfan)、エチプロール(Ethiprole)、フィプロニル(Fipronil)、アセトプロール(Acetoprole)、カンフェクロル(Camphechlor)、ジエノクロル(Dienochlor)、ヘプタクロル(Heptachlor)、ピラフルプロール(Pyrafluprole)、ピリプロール(Pyriprole)、フルフィプロル(Flufiprole)。 (2) GABAergic chloride ion (chloride ion) channel blockers:
Chlordane, Endosulfan, Ethiprole, Fipronil, Acetoprole, Camphechlor, Dienochlor, Heptachlor, Pyrafluprole, Pyriprole ( Pyriprole), Flufiprole.
クロルデン(Chlordane)、エンドスルファン(Endosulfan)、エチプロール(Ethiprole)、フィプロニル(Fipronil)、アセトプロール(Acetoprole)、カンフェクロル(Camphechlor)、ジエノクロル(Dienochlor)、ヘプタクロル(Heptachlor)、ピラフルプロール(Pyrafluprole)、ピリプロール(Pyriprole)、フルフィプロル(Flufiprole)。 (2) GABAergic chloride ion (chloride ion) channel blockers:
Chlordane, Endosulfan, Ethiprole, Fipronil, Acetoprole, Camphechlor, Dienochlor, Heptachlor, Pyrafluprole, Pyriprole ( Pyriprole), Flufiprole.
(3A)ナトリウムチャネルモジュレーター(ピレスロイド系):
アクリナトリン(Acrinathrin)、アレスリン(Allethrin)、d-シス-トランス-アレスリン(d-cis-trans Allethrin)、d-トランス-アレスリン(d-transAllethrin)、ビフェントリン(Bifenthrin)、ビオアレスリン(Bioallethrin)、ビオアレスリン-S-シクロペンテニル-異性体(Bioallethrin S-cyclopentenyl-isomer)、ビオレスメトリン(Bioresmethrin)、シクロプロトリン(Cycloprothrin)、シフルトリン(Cyfluthrin)、β-シフルトリン(beta-Cyfluthrin)、シハロトリン(Cyhalothrin)、λ-シハロトリン(lambda-Cyhalothrin)、γ-シハロトリン(gamma-Cyhalothrin)、シペルメトリン(Cypermethrin)、α-シペルメトリン(alpha-Cypermethrin)、β-シペルメトリン(beta-Cypermethrin)、θ-シペルメトリン(theta-Cypermethrin)、ζ-シペルメトリン(zeta-Cypermethrin)、シフェノトリン[(1R)-トランス異性体](Cyphenothrin [(1R)-trans-isomers] )、デルタメトリン(Deltamethrin)、エンペントリン[(EZ)-(1R)-異性体](Empenthrin[(EZ)-(1R)-isomers] )、エスフェンバレレート(Esfenvalerate)、エトフェンプロックス(Etofenprox)、フェンプロパトリン(Fenpropathrin)、フェンバレレート(Fenvalerate)、フルシトリネート(Flucythrinate)、フルメトリン(Flumethrin)、τ-フルバリネート(tau-Fluvalinate)、ハルフェンプロックス(Halfenprox)、イミプロトリン(Imiprothrin)、カデスリン(Kadethrin)、ペルメトリン(Permethrin)、フェノトリン[(1R)-トランス異性体](Phenothrin [(1R)-trans-isomer] )、プラレトリン(Prallethrin)、ピレトリン(Pyrethrins)、レスメトリン(Resmethrin)、シラフルオフェン(Silafluofen)、テフルトリン(Tefluthrin)、テトラメスリン(Tetramethrin)、テトラメスリン[(1R)-異性体](Tetramethrin[(1R)-isomers] )、トラロメトリン(Tralomethrin)、トランスフルトリン(Transfluthrin)、κ-ビフェントリン(kappa-Bifenthrin)、ビオペルメトリン(Biopermethrin)、クロロプラレスリン(Chloroprallethrin)、ジメフルトリン(Dimefluthrin)、フェンフルトリン(Fenfluthrin)、フェンピリトリン(Fenpirithrin)、フルフェンプロックス(Flufenprox)、ヘプタフルスリン(Heptafluthrin)、メペルフルスリン(Meperfluthrin)、ε-メトフルトリン(epsilon-Metofluthrin)、モンフルオロトリン(Momfluorothrin)、ε-モンフルオロトリン(epsilon-Momfluorothrin)、トランス-ペルメトリン(trans-Permethrin)、プロフルトリン(Profluthrin)、プロトリフェンブト(Protrifenbute)、κ-テフルトリン(kappa-Tefluthrin)、テラレトリン(Terallethrin)、テトラメチルフルスリン(Tetramethylfluthrin)、ビオエタノメトリン(Bioethanomethrin)。 (3A) Sodium channel modulators (pyrethroids):
Acrinathrin, Allethrin, d-cis-trans Allethrin, d-transAllethrin, Bifenthrin, Bioallethrin, Bioallethrin -S-Cyclopentenyl-isomer (Bioallethrin S-cyclopentenyl-isomer), Bioresmethrin, Cycloprothrin, Cyfluthrin, beta-Cyfluthrin, Cyhalothrin, λ- Cyhalothrin (lambda-Cyhalothrin), gamma-Cyhalothrin, Cypermethrin, alpha-Cypermethrin, beta-Cypermethrin, theta-Cypermethrin ), zeta-Cypermethrin, Cyphenothrin [(1R)-trans-isomers], Deltamethrin, Empentrin [(EZ)-(1R) -isomers] (Emphenthrin [(EZ)-(1R)-isomers] ), Esfenvalerate, Etofenprox, Fenpropathrin, Fenvalerate, Flucythrinate ( Flucythrinate, Flumethrin, tau-Fluvalinate, Halfenprox, Imiprothrin, Kadethrin, Permethrin, Phenothrin [(1R)-trans isomer] (Phenothrin [(1R)-trans-isomer] ), Prallethrin, Pyrethrins, Resmethrin ( Resmethrin), Silafluofen, Tefluthrin, Tetramethrin, Tetramethrin [(1R)-isomers], Tralomethrin, Transfluthrin, κ-Bifenthrin, Biopermethrin, Chloroprallethrin, Dimefluthrin, Fenfluthrin, Fenpirithrin, Flufenprox, Heptaflu Heptafluthrin, Meperfluthrin, epsilon-Metofluthrin, Momfluorothrin, epsilon-Momfluorothrin, trans-Permethrin, Profluthrin , Protrifenbute, kappa-Tefluthrin, Terallethrin, Tetramethylfluthrin, Bioethanomethrin.
アクリナトリン(Acrinathrin)、アレスリン(Allethrin)、d-シス-トランス-アレスリン(d-cis-trans Allethrin)、d-トランス-アレスリン(d-transAllethrin)、ビフェントリン(Bifenthrin)、ビオアレスリン(Bioallethrin)、ビオアレスリン-S-シクロペンテニル-異性体(Bioallethrin S-cyclopentenyl-isomer)、ビオレスメトリン(Bioresmethrin)、シクロプロトリン(Cycloprothrin)、シフルトリン(Cyfluthrin)、β-シフルトリン(beta-Cyfluthrin)、シハロトリン(Cyhalothrin)、λ-シハロトリン(lambda-Cyhalothrin)、γ-シハロトリン(gamma-Cyhalothrin)、シペルメトリン(Cypermethrin)、α-シペルメトリン(alpha-Cypermethrin)、β-シペルメトリン(beta-Cypermethrin)、θ-シペルメトリン(theta-Cypermethrin)、ζ-シペルメトリン(zeta-Cypermethrin)、シフェノトリン[(1R)-トランス異性体](Cyphenothrin [(1R)-trans-isomers] )、デルタメトリン(Deltamethrin)、エンペントリン[(EZ)-(1R)-異性体](Empenthrin[(EZ)-(1R)-isomers] )、エスフェンバレレート(Esfenvalerate)、エトフェンプロックス(Etofenprox)、フェンプロパトリン(Fenpropathrin)、フェンバレレート(Fenvalerate)、フルシトリネート(Flucythrinate)、フルメトリン(Flumethrin)、τ-フルバリネート(tau-Fluvalinate)、ハルフェンプロックス(Halfenprox)、イミプロトリン(Imiprothrin)、カデスリン(Kadethrin)、ペルメトリン(Permethrin)、フェノトリン[(1R)-トランス異性体](Phenothrin [(1R)-trans-isomer] )、プラレトリン(Prallethrin)、ピレトリン(Pyrethrins)、レスメトリン(Resmethrin)、シラフルオフェン(Silafluofen)、テフルトリン(Tefluthrin)、テトラメスリン(Tetramethrin)、テトラメスリン[(1R)-異性体](Tetramethrin[(1R)-isomers] )、トラロメトリン(Tralomethrin)、トランスフルトリン(Transfluthrin)、κ-ビフェントリン(kappa-Bifenthrin)、ビオペルメトリン(Biopermethrin)、クロロプラレスリン(Chloroprallethrin)、ジメフルトリン(Dimefluthrin)、フェンフルトリン(Fenfluthrin)、フェンピリトリン(Fenpirithrin)、フルフェンプロックス(Flufenprox)、ヘプタフルスリン(Heptafluthrin)、メペルフルスリン(Meperfluthrin)、ε-メトフルトリン(epsilon-Metofluthrin)、モンフルオロトリン(Momfluorothrin)、ε-モンフルオロトリン(epsilon-Momfluorothrin)、トランス-ペルメトリン(trans-Permethrin)、プロフルトリン(Profluthrin)、プロトリフェンブト(Protrifenbute)、κ-テフルトリン(kappa-Tefluthrin)、テラレトリン(Terallethrin)、テトラメチルフルスリン(Tetramethylfluthrin)、ビオエタノメトリン(Bioethanomethrin)。 (3A) Sodium channel modulators (pyrethroids):
Acrinathrin, Allethrin, d-cis-trans Allethrin, d-transAllethrin, Bifenthrin, Bioallethrin, Bioallethrin -S-Cyclopentenyl-isomer (Bioallethrin S-cyclopentenyl-isomer), Bioresmethrin, Cycloprothrin, Cyfluthrin, beta-Cyfluthrin, Cyhalothrin, λ- Cyhalothrin (lambda-Cyhalothrin), gamma-Cyhalothrin, Cypermethrin, alpha-Cypermethrin, beta-Cypermethrin, theta-Cypermethrin ), zeta-Cypermethrin, Cyphenothrin [(1R)-trans-isomers], Deltamethrin, Empentrin [(EZ)-(1R) -isomers] (Emphenthrin [(EZ)-(1R)-isomers] ), Esfenvalerate, Etofenprox, Fenpropathrin, Fenvalerate, Flucythrinate ( Flucythrinate, Flumethrin, tau-Fluvalinate, Halfenprox, Imiprothrin, Kadethrin, Permethrin, Phenothrin [(1R)-trans isomer] (Phenothrin [(1R)-trans-isomer] ), Prallethrin, Pyrethrins, Resmethrin ( Resmethrin), Silafluofen, Tefluthrin, Tetramethrin, Tetramethrin [(1R)-isomers], Tralomethrin, Transfluthrin, κ-Bifenthrin, Biopermethrin, Chloroprallethrin, Dimefluthrin, Fenfluthrin, Fenpirithrin, Flufenprox, Heptaflu Heptafluthrin, Meperfluthrin, epsilon-Metofluthrin, Momfluorothrin, epsilon-Momfluorothrin, trans-Permethrin, Profluthrin , Protrifenbute, kappa-Tefluthrin, Terallethrin, Tetramethylfluthrin, Bioethanomethrin.
(3B)ナトリウムチャネルモジュレーター(DDT類):
DDT、メトキシクロル(Methoxychlor)。 (3B) Sodium channel modulators (DDTs):
DDT, Methoxychlor.
DDT、メトキシクロル(Methoxychlor)。 (3B) Sodium channel modulators (DDTs):
DDT, Methoxychlor.
(4)ニコチン性アセチルコリン受容体(nAChR)競合的モジュレーター:
アセタミプリド(Acetamiprid)、クロチアニジン(Clothianidin)、ジノテフラン(Dinotefuran)、イミダクロプリド(Imidacloprid)、ニテンピラム(Nitenpyram)、チアクロプリド(Thiacloprid)、チアメトキサム(Thiamethoxam)、ニコチン(Nicotine)、スルホキサフロル(Sulfoxaflor)、フルピラジフロン(Flupyradifurone)、トリフルメゾピリム(Triflumezopyrim)、ニチアジン(Nithiazine)、ジクロロメゾチアズ(Dicloromezotiaz)、フルピリミン(Flupyrimin)。 (4) nicotinic acetylcholine receptor (nAChR) competitive modulators:
Acetamiprid, Clothianidin, Dinotefuran, Imidacloprid, Nitenpyram, Thiacloprid, Thiamethoxam, Nicotine, Sulfoxaflor, Flupyradifurone, Triflumezopyrim, Nithiazine, Dicloromezotiaz, Flupyrimin.
アセタミプリド(Acetamiprid)、クロチアニジン(Clothianidin)、ジノテフラン(Dinotefuran)、イミダクロプリド(Imidacloprid)、ニテンピラム(Nitenpyram)、チアクロプリド(Thiacloprid)、チアメトキサム(Thiamethoxam)、ニコチン(Nicotine)、スルホキサフロル(Sulfoxaflor)、フルピラジフロン(Flupyradifurone)、トリフルメゾピリム(Triflumezopyrim)、ニチアジン(Nithiazine)、ジクロロメゾチアズ(Dicloromezotiaz)、フルピリミン(Flupyrimin)。 (4) nicotinic acetylcholine receptor (nAChR) competitive modulators:
Acetamiprid, Clothianidin, Dinotefuran, Imidacloprid, Nitenpyram, Thiacloprid, Thiamethoxam, Nicotine, Sulfoxaflor, Flupyradifurone, Triflumezopyrim, Nithiazine, Dicloromezotiaz, Flupyrimin.
(5)ニコチン性アセチルコリン受容体(nAChR)アロステリックモジュレーター:
スピネトラム(Spinetoram)、スピノサド(Spinosad)。 (5) Nicotinic Acetylcholine Receptor (nAChR) Allosteric Modulators:
Spinetoram, Spinosad.
スピネトラム(Spinetoram)、スピノサド(Spinosad)。 (5) Nicotinic Acetylcholine Receptor (nAChR) Allosteric Modulators:
Spinetoram, Spinosad.
(6)グルタミン酸作動性塩化物イオン(塩素イオン)チャネル(GluCl) アロステリックモジュレーター:
アバメクチン(Abamectin)、エマメクチン(Emamectin)、エマメクチン安息香酸塩(Emamectin-benzoate)、レピメクチン(Lepimectin)、ミルベメクチン(Milbemectin)、ドラメクチン(Doramectin)、エプリノメクチン(Eprinomectin)、イベルメクチン(Ivermectin)、モキシデクチン(Moxidectin)、セラメクチン(Selamectin)。 (6) Glutamatergic chloride (chloride) channel (GluCl) allosteric modulators:
Abamectin, Emamectin, Emamectin-benzoate, Lepimectin, Milbemectin, Doramectin, Eprinomectin, Ivermectin, Moxidectin, Selamectin.
アバメクチン(Abamectin)、エマメクチン(Emamectin)、エマメクチン安息香酸塩(Emamectin-benzoate)、レピメクチン(Lepimectin)、ミルベメクチン(Milbemectin)、ドラメクチン(Doramectin)、エプリノメクチン(Eprinomectin)、イベルメクチン(Ivermectin)、モキシデクチン(Moxidectin)、セラメクチン(Selamectin)。 (6) Glutamatergic chloride (chloride) channel (GluCl) allosteric modulators:
Abamectin, Emamectin, Emamectin-benzoate, Lepimectin, Milbemectin, Doramectin, Eprinomectin, Ivermectin, Moxidectin, Selamectin.
(7)幼若ホルモン類似剤:
ヒドロプレン(Hydroprene)、キノプレン(Kinoprene)、メトプレン(Methoprene)、フェノキシカルブ(Fenoxycarb)、ピリプロキシフェン(Pyriproxifen)、ジオフェノラン(Diofenolan)、エポフェノナン(Epofenonane)、トリプレン(Triprene)。 (7) juvenile hormone-like agents:
Hydroprene, Kinoprene, Methoprene, Fenoxycarb, Pyriproxifen, Diofenolan, Epofenonane, Triprene.
ヒドロプレン(Hydroprene)、キノプレン(Kinoprene)、メトプレン(Methoprene)、フェノキシカルブ(Fenoxycarb)、ピリプロキシフェン(Pyriproxifen)、ジオフェノラン(Diofenolan)、エポフェノナン(Epofenonane)、トリプレン(Triprene)。 (7) juvenile hormone-like agents:
Hydroprene, Kinoprene, Methoprene, Fenoxycarb, Pyriproxifen, Diofenolan, Epofenonane, Triprene.
(8)その他の非特異的(マルチサイト)阻害剤:
臭化メチル(Methyl bromide)等のハロゲン化アルキル類(alkyl halides)、クロルピクリン(Chloropicrin)、弗化アルミニウムナトリウム(Sodium aluminum fluoride)、フッ化スルフリル(Sulfuryl fluoride)、ホウ砂(Borax)、ホウ酸(Boric acid)、オクタホウ酸ニナトリウム塩(Disodium octaborate)、ホウ酸ナトリウム塩(Sodium borate)、メタホウ酸ナトリウム塩(Sodium metaborate)、吐酒石(Tartar emetic)、ダゾメット(Dazomet)、メタム(Metam)、メタムカリウム塩(Metam Sodium)、メタムナトリウム塩(Metam Potassium)。 (8) Other non-specific (multi-site) inhibitors:
Alkyl halides such as methyl bromide, Chloropicrin, Sodium aluminum fluoride, Sulfuryl fluoride, Borax, Boric acid ( Boric acid), Disodium octaborate, Sodium borate, Sodium metaborate, Tartar emetic, Dazomet, Metam, Metam Potassium Salt (Metam Sodium), Metam Sodium Salt (Metam Potassium).
臭化メチル(Methyl bromide)等のハロゲン化アルキル類(alkyl halides)、クロルピクリン(Chloropicrin)、弗化アルミニウムナトリウム(Sodium aluminum fluoride)、フッ化スルフリル(Sulfuryl fluoride)、ホウ砂(Borax)、ホウ酸(Boric acid)、オクタホウ酸ニナトリウム塩(Disodium octaborate)、ホウ酸ナトリウム塩(Sodium borate)、メタホウ酸ナトリウム塩(Sodium metaborate)、吐酒石(Tartar emetic)、ダゾメット(Dazomet)、メタム(Metam)、メタムカリウム塩(Metam Sodium)、メタムナトリウム塩(Metam Potassium)。 (8) Other non-specific (multi-site) inhibitors:
Alkyl halides such as methyl bromide, Chloropicrin, Sodium aluminum fluoride, Sulfuryl fluoride, Borax, Boric acid ( Boric acid), Disodium octaborate, Sodium borate, Sodium metaborate, Tartar emetic, Dazomet, Metam, Metam Potassium Salt (Metam Sodium), Metam Sodium Salt (Metam Potassium).
(9)弦音器官TRPVチャネルモジュレーター:
ピメトロジン(Pymetrozine)、ピリフルキナゾン(Pyrifluquinazon)、アフィドピロペン(Afidopyropen)。 (9) String tone organ TRPV channel modulators:
Pymetrozine, Pyrifluquinazon, Afidopyropen.
ピメトロジン(Pymetrozine)、ピリフルキナゾン(Pyrifluquinazon)、アフィドピロペン(Afidopyropen)。 (9) String tone organ TRPV channel modulators:
Pymetrozine, Pyrifluquinazon, Afidopyropen.
(10)ダニ類成長阻害剤:
クロフェンテジン(Clofentezine)、ジフロビダジン(Diflovidazin)、ヘキシチアゾクス(Hexythiazox)、エトキサゾール(Etoxazole)。 (10) Mites growth inhibitor:
Clofentezine, Diflovidazin, Hexythiazox, Etoxazole.
クロフェンテジン(Clofentezine)、ジフロビダジン(Diflovidazin)、ヘキシチアゾクス(Hexythiazox)、エトキサゾール(Etoxazole)。 (10) Mites growth inhibitor:
Clofentezine, Diflovidazin, Hexythiazox, Etoxazole.
(11)微生物由来昆虫中腸内膜破壊剤:
B.t. subsp. israelensis、B.t. subsp. aizawai、B.t. subsp. kurstaki、B.t. subsp. tenebrionis、B.t.作物に含まれるタンパク質(B.t. crop proteins)、Cry1Ab、Cry1Ac、Cry1Fa、Cry1A.105、Cry2Ab、Vip3A、mCry3A、Cry3Ab、Cry3Bb、Cry34Ab1/Cry35Ab1、Bacillus sphaericus。
注)「B.t.」はバチルス・チューリンゲンシス(Bacillus thuringiensis)であり、「B.t.作物に含まれるタンパク質」とは、B.t.(バチルス・チューリンゲンシス)の生産する毒素たんぱく質(Cry1Ab等)の遺伝子を組み込んだ作物内において生産されたタンパク質である。 (11) Microorganism-derived insect midgut lining-disrupting agent:
aizawai, Bt subsp. kurstaki, Bt subsp. tenebrionis, Bt crop proteins, Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1/Cry35Ab1, Bacillus sphaericus.
Note) "Bt" stands for Bacillus thuringiensis, and "protein contained in Bt crops" refers to crops into which the gene for the toxin protein (Cry1Ab, etc.) produced by Bt (Bacillus thuringiensis) has been introduced. It is a protein produced within
B.t. subsp. israelensis、B.t. subsp. aizawai、B.t. subsp. kurstaki、B.t. subsp. tenebrionis、B.t.作物に含まれるタンパク質(B.t. crop proteins)、Cry1Ab、Cry1Ac、Cry1Fa、Cry1A.105、Cry2Ab、Vip3A、mCry3A、Cry3Ab、Cry3Bb、Cry34Ab1/Cry35Ab1、Bacillus sphaericus。
注)「B.t.」はバチルス・チューリンゲンシス(Bacillus thuringiensis)であり、「B.t.作物に含まれるタンパク質」とは、B.t.(バチルス・チューリンゲンシス)の生産する毒素たんぱく質(Cry1Ab等)の遺伝子を組み込んだ作物内において生産されたタンパク質である。 (11) Microorganism-derived insect midgut lining-disrupting agent:
aizawai, Bt subsp. kurstaki, Bt subsp. tenebrionis, Bt crop proteins, Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1/Cry35Ab1, Bacillus sphaericus.
Note) "Bt" stands for Bacillus thuringiensis, and "protein contained in Bt crops" refers to crops into which the gene for the toxin protein (Cry1Ab, etc.) produced by Bt (Bacillus thuringiensis) has been introduced. It is a protein produced within
(12)ミトコンドリアATP合成酵素阻害剤:
ジアフェンチウロン(Diafenthiuron)、アゾシクロチン(Azocyclotin)、シヘキサチン(Cyhexatin)、酸化フェンブタスズ(Fenbutatin-oxide)、プロパルギット(Propargite)、テトラジホン(Tetradifon)。 (12) Mitochondrial ATP synthase inhibitor:
Diafenthiuron, Azocyclotin, Cyhexatin, Fenbutatin-oxide, Propargite, Tetradifon.
ジアフェンチウロン(Diafenthiuron)、アゾシクロチン(Azocyclotin)、シヘキサチン(Cyhexatin)、酸化フェンブタスズ(Fenbutatin-oxide)、プロパルギット(Propargite)、テトラジホン(Tetradifon)。 (12) Mitochondrial ATP synthase inhibitor:
Diafenthiuron, Azocyclotin, Cyhexatin, Fenbutatin-oxide, Propargite, Tetradifon.
(13)プロトン勾配を撹乱する酸化的リン酸化脱共役剤:
クロルフェナピル(Chlorfenapyr)、DNOC(4,6-dinitro-o-cresol)、スルフルラミド(Sulfluramid)、ビナパクリル(Binapacryl)、ジノブトン(Dinobuton)、ジノカップ(Dinocap)。 (13) Oxidative phosphorylation uncouplers that perturb the proton gradient:
Chlorfenapyr, DNOC (4,6-dinitro-o-cresol), Sulfluramid, Binapacryl, Dinobuton, Dinocap.
クロルフェナピル(Chlorfenapyr)、DNOC(4,6-dinitro-o-cresol)、スルフルラミド(Sulfluramid)、ビナパクリル(Binapacryl)、ジノブトン(Dinobuton)、ジノカップ(Dinocap)。 (13) Oxidative phosphorylation uncouplers that perturb the proton gradient:
Chlorfenapyr, DNOC (4,6-dinitro-o-cresol), Sulfluramid, Binapacryl, Dinobuton, Dinocap.
(14)ニコチン性アセチルコリン受容体(nAChR)チャネルブロッカー:
ベンスルタップ(Bensultap)、カルタップ塩酸塩(Cartap hydrochloride)、チオシクラム(Thiocyclam)、チオスルタップ-ナトリウム塩(Thiosultap-sodium)。 (14) Nicotinic Acetylcholine Receptor (nAChR) Channel Blockers:
Bensultap, Cartap hydrochloride, Thiocyclam, Thiosultap-sodium.
ベンスルタップ(Bensultap)、カルタップ塩酸塩(Cartap hydrochloride)、チオシクラム(Thiocyclam)、チオスルタップ-ナトリウム塩(Thiosultap-sodium)。 (14) Nicotinic Acetylcholine Receptor (nAChR) Channel Blockers:
Bensultap, Cartap hydrochloride, Thiocyclam, Thiosultap-sodium.
(15)キチン生合成阻害剤、タイプ0:
ビストリフルロン(Bistrifluron)、クロルフルアズロン(Chlorfluazuron)、ジフルベンズロン(Diflubenzuron)、フルシクロクスロン(Flucycloxuron)、フルフェノクスロン(Flufenoxuron)、ヘキサフルムロン(Hexaflumuron)、ルフェヌロン(Lufenuron)、ノバルロン(Novaluron)、ノビフルムロン(Noviflumuron)、テフルベンズロン(Teflubenzuron)、トリフルムロン(Triflumuron)、フルアズロン(Fluazuron)。 (15) Chitin biosynthesis inhibitor, type 0:
Bistrifluron, Chlorfluazuron, Diflubenzuron, Flucycloxuron, Flufenoxuron, Hexaflumuron, Lufenuron, Novaluron ), Noviflumuron, Teflubenzuron, Triflumuron, Fluazuron.
ビストリフルロン(Bistrifluron)、クロルフルアズロン(Chlorfluazuron)、ジフルベンズロン(Diflubenzuron)、フルシクロクスロン(Flucycloxuron)、フルフェノクスロン(Flufenoxuron)、ヘキサフルムロン(Hexaflumuron)、ルフェヌロン(Lufenuron)、ノバルロン(Novaluron)、ノビフルムロン(Noviflumuron)、テフルベンズロン(Teflubenzuron)、トリフルムロン(Triflumuron)、フルアズロン(Fluazuron)。 (15) Chitin biosynthesis inhibitor, type 0:
Bistrifluron, Chlorfluazuron, Diflubenzuron, Flucycloxuron, Flufenoxuron, Hexaflumuron, Lufenuron, Novaluron ), Noviflumuron, Teflubenzuron, Triflumuron, Fluazuron.
(16)キチン生合成阻害剤、タイプ1:
ブプロフェジン(Buprofezin)。 (16) chitin biosynthesis inhibitor, type 1:
Buprofezin.
ブプロフェジン(Buprofezin)。 (16) chitin biosynthesis inhibitor, type 1:
Buprofezin.
(17)脱皮阻害剤:
シロマジン(Cyromazine)。 (17) molting inhibitor:
Cyromazine.
シロマジン(Cyromazine)。 (17) molting inhibitor:
Cyromazine.
(18)脱皮ホルモン(エクダイソン)受容体アゴニスト:
クロマフェノジド(Chromafenozide)、ハロフェノジド(Halofenozid)、メトキシフェノジド(Methoxyfenozide)、テブフェノジド(Tebufenozide)。 (18) molting hormone (ecdysone) receptor agonists:
Chromafenozide, Halofenozide, Methoxyfenozide, Tebufenozide.
クロマフェノジド(Chromafenozide)、ハロフェノジド(Halofenozid)、メトキシフェノジド(Methoxyfenozide)、テブフェノジド(Tebufenozide)。 (18) molting hormone (ecdysone) receptor agonists:
Chromafenozide, Halofenozide, Methoxyfenozide, Tebufenozide.
(19)オクトパミン受容体アゴニスト:
アミトラズ(Amitraz)、クロルジメホルム(Chlordimeform)。 (19) Octopamine receptor agonists:
Amitraz, Chlordimeform.
アミトラズ(Amitraz)、クロルジメホルム(Chlordimeform)。 (19) Octopamine receptor agonists:
Amitraz, Chlordimeform.
(20)ミトコンドリア電子伝達系複合体III阻害剤:
ヒドラメチルノン(Hydramethylnon)、アセキノシル(Acequinocyl)、フルアクリピリム(Fluacrypyrim)、ビフェナゼート(Bifenazate)。 (20) mitochondrial electron transport chain complex III inhibitor:
Hydramethylnon, Acequinocyl, Fluacrypyrim, Bifenazate.
ヒドラメチルノン(Hydramethylnon)、アセキノシル(Acequinocyl)、フルアクリピリム(Fluacrypyrim)、ビフェナゼート(Bifenazate)。 (20) mitochondrial electron transport chain complex III inhibitor:
Hydramethylnon, Acequinocyl, Fluacrypyrim, Bifenazate.
(21)ミトコンドリア電子伝達系複合体I阻害剤(METI):
フェナザキン(Fenazaquin)、フェンピロキシメート(Fenpyroximate)、ピリダベン(Pyridaben)、ピリミジフェン(Pyrimidifen)、テブフェンピラド(Tebufenpyrad)、トルフェンピラド(Tolfenpyrad)、ロテノン(Rotenone)。 (21) mitochondrial electron transport chain complex I inhibitor (METI):
Fenazaquin, Fenpyroximate, Pyridaben, Pyrimidifen, Tebufenpyrad, Tolfenpyrad, Rotenone.
フェナザキン(Fenazaquin)、フェンピロキシメート(Fenpyroximate)、ピリダベン(Pyridaben)、ピリミジフェン(Pyrimidifen)、テブフェンピラド(Tebufenpyrad)、トルフェンピラド(Tolfenpyrad)、ロテノン(Rotenone)。 (21) mitochondrial electron transport chain complex I inhibitor (METI):
Fenazaquin, Fenpyroximate, Pyridaben, Pyrimidifen, Tebufenpyrad, Tolfenpyrad, Rotenone.
(22)電位依存性ナトリウムチャネルブロッカー:
インドキサカルブ(Indoxacarb)、メタフルミゾン(Metaflumizone)。 (22) voltage-gated sodium channel blockers:
Indoxacarb, Metaflumizone.
インドキサカルブ(Indoxacarb)、メタフルミゾン(Metaflumizone)。 (22) voltage-gated sodium channel blockers:
Indoxacarb, Metaflumizone.
(23)アセチルCoAカルボキシラーゼ阻害剤:
スピロジクロフェン(Spirodiclofen)、スピロメシフェン(Spiromesifen)、スピロテトラマト(Spirotetramat)、スピロピジオン(Spiropidion)。 (23) Acetyl-CoA carboxylase inhibitors:
Spirodiclofen, Spiromesifen, Spirotetramat, Spiropidion.
スピロジクロフェン(Spirodiclofen)、スピロメシフェン(Spiromesifen)、スピロテトラマト(Spirotetramat)、スピロピジオン(Spiropidion)。 (23) Acetyl-CoA carboxylase inhibitors:
Spirodiclofen, Spiromesifen, Spirotetramat, Spiropidion.
(24)ミトコンドリア電子伝達系複合体IV阻害剤:
リン化アルミニウム(Al-phosphide)、リン化カルシウム(Ca-phosphide)、リン化亜鉛(Zn-phosphide)、ホスフィン(Phosphine)、シアン化カルシウム(Ca-cyanide)、シアン化ナトリウム(Na-cyanide)、シアン化カリウム(K-cyanide)。 (24) mitochondrial electron transport chain complex IV inhibitor:
Aluminum phosphide (Al-phosphide), Calcium phosphide (Ca-phosphide), Zinc phosphide (Zn-phosphide), Phosphine, Calcium cyanide (Ca-cyanide), Sodium cyanide (Na-cyanide), Potassium cyanide (K-cyanide).
リン化アルミニウム(Al-phosphide)、リン化カルシウム(Ca-phosphide)、リン化亜鉛(Zn-phosphide)、ホスフィン(Phosphine)、シアン化カルシウム(Ca-cyanide)、シアン化ナトリウム(Na-cyanide)、シアン化カリウム(K-cyanide)。 (24) mitochondrial electron transport chain complex IV inhibitor:
Aluminum phosphide (Al-phosphide), Calcium phosphide (Ca-phosphide), Zinc phosphide (Zn-phosphide), Phosphine, Calcium cyanide (Ca-cyanide), Sodium cyanide (Na-cyanide), Potassium cyanide (K-cyanide).
(25)ミトコンドリア電子伝達系複合体II阻害剤:
シエノピラフェン(Cyenopyrafen)、シフルメトフェン(Cyflumetofen)、ピフルブミド(Pyflubumide)。 (25) mitochondrial electron transport chain complex II inhibitor:
Cyenopyrafen, Cyflumetofen, Pyflubumide.
シエノピラフェン(Cyenopyrafen)、シフルメトフェン(Cyflumetofen)、ピフルブミド(Pyflubumide)。 (25) mitochondrial electron transport chain complex II inhibitor:
Cyenopyrafen, Cyflumetofen, Pyflubumide.
(26)リアノジン受容体モジュレーター:
クロラントラニリプロール(Chlorantraniliprole)、シアントラニリプロール(Cyantraniliprole)、シクラニリプロール(Cyclaniliprole)、フルベンジアミド(Flubendiamide)、シハロジアミド(Cyhalodiamide)、テトラクロラントラニリプロール(Tetrachlorantraniliprole)、テトラニリプロール(Tetraniliprole)。 (26) ryanodine receptor modulators:
Chlorantraniliprole, Cyantraniliprole, Cyclaniliprole, Flubendiamide, Cyhalodiamide, Tetrachlorantraniliprole, Tetraniliprole ( Tetraniliprole).
クロラントラニリプロール(Chlorantraniliprole)、シアントラニリプロール(Cyantraniliprole)、シクラニリプロール(Cyclaniliprole)、フルベンジアミド(Flubendiamide)、シハロジアミド(Cyhalodiamide)、テトラクロラントラニリプロール(Tetrachlorantraniliprole)、テトラニリプロール(Tetraniliprole)。 (26) ryanodine receptor modulators:
Chlorantraniliprole, Cyantraniliprole, Cyclaniliprole, Flubendiamide, Cyhalodiamide, Tetrachlorantraniliprole, Tetraniliprole ( Tetraniliprole).
(27)弦音器官モジュレーター 標的部位未特定:
フロニカミド(Flonicamid)。 (27) Chordotome modulator Target site unspecified:
Flonicamid.
フロニカミド(Flonicamid)。 (27) Chordotome modulator Target site unspecified:
Flonicamid.
(28)GABA作動性塩化物イオン(塩素イオン)チャネルアロステリックモジュレーター:
ブロフラニリド(Broflanilide)、フルキサメタミド(Fluxametamide)、イソシクロセラム(Isocycloseram)、アフォキソラネル(Afoxolaner)、フルララネル(Fluralaner)、ロチラネル(Lotilaner)、サロラネル(Sarolaner)。 (28) GABAergic chloride (chloride) channel allosteric modulators:
Broflanilide, Fluxametamide, Isocycloseram, Afoxolaner, Fluralaner, Lotilaner, Sarolaner.
ブロフラニリド(Broflanilide)、フルキサメタミド(Fluxametamide)、イソシクロセラム(Isocycloseram)、アフォキソラネル(Afoxolaner)、フルララネル(Fluralaner)、ロチラネル(Lotilaner)、サロラネル(Sarolaner)。 (28) GABAergic chloride (chloride) channel allosteric modulators:
Broflanilide, Fluxametamide, Isocycloseram, Afoxolaner, Fluralaner, Lotilaner, Sarolaner.
(29)作用機構不明(UN)の剤:
アザジラクチン(Azadirachtin)、ベンゾキシメート(Benzoximate)、ブロモプロピレート(Bromopropylate)、キノメチオナート(Chinomethionat/Quinomethionate)、ジコホル(Dicofol)、石灰硫黄合剤(Lime sulfur)、マンコゼブ(Mancozeb)、ピリダリル(Pyridalyl)、硫黄(Sulfur)。 (29) Agents with unknown mechanism of action (UN):
Azadirachtin, Benzoximate, Bromopropylate, Chinomethionat/Quinomethionate, Dicofol, Lime sulfur, Mancozeb, Pyridalyl, Sulfur.
アザジラクチン(Azadirachtin)、ベンゾキシメート(Benzoximate)、ブロモプロピレート(Bromopropylate)、キノメチオナート(Chinomethionat/Quinomethionate)、ジコホル(Dicofol)、石灰硫黄合剤(Lime sulfur)、マンコゼブ(Mancozeb)、ピリダリル(Pyridalyl)、硫黄(Sulfur)。 (29) Agents with unknown mechanism of action (UN):
Azadirachtin, Benzoximate, Bromopropylate, Chinomethionat/Quinomethionate, Dicofol, Lime sulfur, Mancozeb, Pyridalyl, Sulfur.
(30)その他の殺虫剤、殺ダニ剤:
アシノナピル(Acynonapyr)、アミドフルメット(Amidoflumet)、ベンゾメート(Benzomate)、ベンズピリモキサン(Benzpyrimoxan)、クロルベンジレート(Chlorobenzilate)、ジシクラニル(Dicyclanil)、フェノキサクリム(Fenoxacrim)、フェントリファニル(Fentrifanil)、フロメトキン(Flometoquin)、フルベンジミン(Flubenzimine)、フルフェンジン(Flufenzine)、フルヘキサホン(Fluhexafon)、フルオピラム(Fluopyram)、メタフルミゾン(Metaflumizone)、メトキサジアゾン(Metoxadiazone)、オキサゾスルフィル(Oxazosulfyl)、テトラスル(Tetrasul)、トリアラセン(Triarathene)、チクロピラゾフロル(Tyclopyrazoflor)。 (30) Other insecticides, acaricides:
Acinonapyr, Amidoflumet, Benzomate, Benzpyrimoxan, Chlorobenzilate, Dicyclanil, Fenoxacrim, Fentrifanil, Flometoquin, Flubenzimine, Flufenzine, Fluhexafon, Fluopyram, Metaflumizone, Metoxadiazone, Oxazosulfyl, Tetrasul, Triarasen ( Triarathene), Tyclopyrazoflor.
アシノナピル(Acynonapyr)、アミドフルメット(Amidoflumet)、ベンゾメート(Benzomate)、ベンズピリモキサン(Benzpyrimoxan)、クロルベンジレート(Chlorobenzilate)、ジシクラニル(Dicyclanil)、フェノキサクリム(Fenoxacrim)、フェントリファニル(Fentrifanil)、フロメトキン(Flometoquin)、フルベンジミン(Flubenzimine)、フルフェンジン(Flufenzine)、フルヘキサホン(Fluhexafon)、フルオピラム(Fluopyram)、メタフルミゾン(Metaflumizone)、メトキサジアゾン(Metoxadiazone)、オキサゾスルフィル(Oxazosulfyl)、テトラスル(Tetrasul)、トリアラセン(Triarathene)、チクロピラゾフロル(Tyclopyrazoflor)。 (30) Other insecticides, acaricides:
Acinonapyr, Amidoflumet, Benzomate, Benzpyrimoxan, Chlorobenzilate, Dicyclanil, Fenoxacrim, Fentrifanil, Flometoquin, Flubenzimine, Flufenzine, Fluhexafon, Fluopyram, Metaflumizone, Metoxadiazone, Oxazosulfyl, Tetrasul, Triarasen ( Triarathene), Tyclopyrazoflor.
また、植物成長調整剤も混合することができる。混合することができる植物成長調整剤として、具体的には以下の群から選択される化合物を例示することができる。
アブシジン酸(abscisic acid)、カイネチン(kinetin)、ベンジルアミノプリン(Benzylaminopurine)、1,3-ジフェニルウレア(1,3-diphenylurea)、ホルクロルフェニュロン(forchlorfenuron)、チジアズロン(thidiazuron)、クロルフェヌロン(chlorfenuron)、ジヒドロゼアチン(dihydrozeatin)、ジベレリンA(gibberellin A)、ジベレリンA4(gibberellin A4)、ジベレリンA7(gibberellin A7)、ジベレリンA3(gibberellin A3)、1-メチルシクロプロパン(1-methylcyclopropane)、N-アセチルアミノエトキシビニルグリシン(別名:アビグリシン)(N-acetyl aminoethoxyvinyl glycine (aviglycine))、アミノオキシ酢酸(aminooxyacetate)、硝酸銀(silver nitrate)、塩化コバルト(cobalt chloride)、IAA、4-CPA、クロプロップ(cloprop)、2,4-D、MCPB、インドール-3-酪酸(indole-3-butyrate)、ジクロルプロップ(dichlorprop)、フェノチオール(phenothiol)、1-ナフチルアセトアミド(1-naphthyl acetamide)、エチクロゼート(ethychlozate)、クロキシホナック(cloxyfonac)、マレイン酸ヒドラジド(maleic acid hydrazide)、2,3,5-トリヨード安息香酸(2,3,5-triiodobenzoic acid)、サリチル酸(salicylic acid)、サリチル酸メチル(methyl salicylate)、(-)-ジャスモン酸((-)-jasmonic acid)、ジャスモン酸メチル(methyl jasmonate)、(+)-ストリゴール((+)-strigol)、(+)-デオキシストリゴール((+)-deoxystrigol)、(+)-オロバンコール((+)-orobanchol)、(+)-ソルゴラクトン((+)-sorgolactone)、4-オキソ-4-(2-フェニルエチル)アミノ酪酸(4-oxo-4-(2-phenylethyl)aminobutyric acid)、エテホン(ethephon)、クロルメコート(chlormequat)、メピコートクロリド(mepiquat chloride)、ベンジルアデニン(benzyladenine)、5-アミノレブリン酸(5-amino levulinic acid)、ダミノジッド(daminozide)。 Plant growth regulators can also be mixed. Specific examples of the plant growth regulator that can be mixed include compounds selected from the following group.
abscisic acid, kinetin, benzylaminopurine, 1,3-diphenylurea, forchlorfenuron, thidiazuron, chlorfenurone ( chlorfenuron, dihydrozeatin, gibberellin A, gibberellin A4, gibberellin A7, gibberellin A3, 1-methylcyclopropane, N - N-acetyl aminoethoxyvinyl glycine (aviglycine), aminooxyacetate, silver nitrate, cobalt chloride, IAA, 4-CPA, cloprop (cloprop), 2,4-D, MCPB, indole-3-butyrate, dichlorprop, phenothiol, 1-naphthyl acetamide, eticlozate (ethychlozate), cloxyfonac, maleic acid hydrazide, 2,3,5-triiodobenzoic acid, salicylic acid, methyl salicylate salicylate), (-)-jasmonic acid, methyl jasmonate, (+)-strigol, (+)-deoxystrigol ((+ )-deoxystrigol), (+)-orobanchol, (+)-sorgolactone, 4-oxo-4-(2-phenylethyl)aminobutyric acid (4-oxo -4-(2-phen ylethyl)aminobutyric acid, ethephon, chlormequat, mepiquat chloride, benzyladenine, 5-aminolevulinic acid, daminozide.
アブシジン酸(abscisic acid)、カイネチン(kinetin)、ベンジルアミノプリン(Benzylaminopurine)、1,3-ジフェニルウレア(1,3-diphenylurea)、ホルクロルフェニュロン(forchlorfenuron)、チジアズロン(thidiazuron)、クロルフェヌロン(chlorfenuron)、ジヒドロゼアチン(dihydrozeatin)、ジベレリンA(gibberellin A)、ジベレリンA4(gibberellin A4)、ジベレリンA7(gibberellin A7)、ジベレリンA3(gibberellin A3)、1-メチルシクロプロパン(1-methylcyclopropane)、N-アセチルアミノエトキシビニルグリシン(別名:アビグリシン)(N-acetyl aminoethoxyvinyl glycine (aviglycine))、アミノオキシ酢酸(aminooxyacetate)、硝酸銀(silver nitrate)、塩化コバルト(cobalt chloride)、IAA、4-CPA、クロプロップ(cloprop)、2,4-D、MCPB、インドール-3-酪酸(indole-3-butyrate)、ジクロルプロップ(dichlorprop)、フェノチオール(phenothiol)、1-ナフチルアセトアミド(1-naphthyl acetamide)、エチクロゼート(ethychlozate)、クロキシホナック(cloxyfonac)、マレイン酸ヒドラジド(maleic acid hydrazide)、2,3,5-トリヨード安息香酸(2,3,5-triiodobenzoic acid)、サリチル酸(salicylic acid)、サリチル酸メチル(methyl salicylate)、(-)-ジャスモン酸((-)-jasmonic acid)、ジャスモン酸メチル(methyl jasmonate)、(+)-ストリゴール((+)-strigol)、(+)-デオキシストリゴール((+)-deoxystrigol)、(+)-オロバンコール((+)-orobanchol)、(+)-ソルゴラクトン((+)-sorgolactone)、4-オキソ-4-(2-フェニルエチル)アミノ酪酸(4-oxo-4-(2-phenylethyl)aminobutyric acid)、エテホン(ethephon)、クロルメコート(chlormequat)、メピコートクロリド(mepiquat chloride)、ベンジルアデニン(benzyladenine)、5-アミノレブリン酸(5-amino levulinic acid)、ダミノジッド(daminozide)。 Plant growth regulators can also be mixed. Specific examples of the plant growth regulator that can be mixed include compounds selected from the following group.
abscisic acid, kinetin, benzylaminopurine, 1,3-diphenylurea, forchlorfenuron, thidiazuron, chlorfenurone ( chlorfenuron, dihydrozeatin, gibberellin A, gibberellin A4, gibberellin A7, gibberellin A3, 1-methylcyclopropane, N - N-acetyl aminoethoxyvinyl glycine (aviglycine), aminooxyacetate, silver nitrate, cobalt chloride, IAA, 4-CPA, cloprop (cloprop), 2,4-D, MCPB, indole-3-butyrate, dichlorprop, phenothiol, 1-naphthyl acetamide, eticlozate (ethychlozate), cloxyfonac, maleic acid hydrazide, 2,3,5-triiodobenzoic acid, salicylic acid, methyl salicylate salicylate), (-)-jasmonic acid, methyl jasmonate, (+)-strigol, (+)-deoxystrigol ((+ )-deoxystrigol), (+)-orobanchol, (+)-sorgolactone, 4-oxo-4-(2-phenylethyl)aminobutyric acid (4-oxo -4-(2-phen ylethyl)aminobutyric acid, ethephon, chlormequat, mepiquat chloride, benzyladenine, 5-aminolevulinic acid, daminozide.
また、駆虫剤も混合することができる。混合することができる駆虫剤として、具体的には以下の群から選択される化合物を例示することができる。
駆虫剤:
(a)ベンズイミダゾール系:フェンベンダゾール、アルベンダゾール、トリクラベンダゾール、オキシベンダゾール、メベンダゾール、オクスフェンダゾール、パーベンダゾール、フルベンダゾール;フェバンテル、ネトビミン、チオファネート;チアベンダゾール、カンベンダゾール;
(b)サリチルアニリド系:クロサンテル、オキシクロザニド、ラフォキサニド、ニクロサミド;
(c)置換フェノール系:ニトロキシニル、ニトロスカネート;
(d)ピリミジン系:ピランテル、モランテル;
(e)イミダゾチアゾール系:レバミソール、テトラミソール;
(f)テトラヒドロピリミジン系:プラジカンテル、エプシプランテル;
(g)その他の駆虫薬:シクロジエン、リアニア、クロルスロン、メトロニダゾール、デミジトラズ;ピペラジン、ジエチルカルバマジン、ジクロロフェン、モネパンテル、トリベンジミジン、アミダンテル;チアセタルサミド、メラルソミン、アルセナマイド。 Anthelmintics can also be mixed. As an antiparasitic agent that can be mixed, specifically, compounds selected from the following group can be exemplified.
Anthelmintic:
(a) Benzimidazoles: fenbendazole, albendazole, triclabendazole, oxybendazole, mebendazole, oxfendazole, perbendazole, flubendazole; febantel, netobimine, thiophanate; thiabendazole, cambendazole;
(b) Salicylanilides: Closantel, Oxyclozanide, Rafoxanide, Niclosamide;
(c) substituted phenolics: nitroxynil, nitroscanate;
(d) pyrimidine series: pyrantel, morantel;
(e) imidazothiazoles: levamisole, tetramisole;
(f) tetrahydropyrimidines: praziquantel, epsiprantel;
(g) Other anthelmintics: cyclodiene, liania, clorsulon, metronidazole, demiditraz; piperazine, diethylcarbamazine, dichlorophen, monepantel, tribendimidine, amidantel; thiacetarsamide, melarsomine, arsenamide.
駆虫剤:
(a)ベンズイミダゾール系:フェンベンダゾール、アルベンダゾール、トリクラベンダゾール、オキシベンダゾール、メベンダゾール、オクスフェンダゾール、パーベンダゾール、フルベンダゾール;フェバンテル、ネトビミン、チオファネート;チアベンダゾール、カンベンダゾール;
(b)サリチルアニリド系:クロサンテル、オキシクロザニド、ラフォキサニド、ニクロサミド;
(c)置換フェノール系:ニトロキシニル、ニトロスカネート;
(d)ピリミジン系:ピランテル、モランテル;
(e)イミダゾチアゾール系:レバミソール、テトラミソール;
(f)テトラヒドロピリミジン系:プラジカンテル、エプシプランテル;
(g)その他の駆虫薬:シクロジエン、リアニア、クロルスロン、メトロニダゾール、デミジトラズ;ピペラジン、ジエチルカルバマジン、ジクロロフェン、モネパンテル、トリベンジミジン、アミダンテル;チアセタルサミド、メラルソミン、アルセナマイド。 Anthelmintics can also be mixed. As an antiparasitic agent that can be mixed, specifically, compounds selected from the following group can be exemplified.
Anthelmintic:
(a) Benzimidazoles: fenbendazole, albendazole, triclabendazole, oxybendazole, mebendazole, oxfendazole, perbendazole, flubendazole; febantel, netobimine, thiophanate; thiabendazole, cambendazole;
(b) Salicylanilides: Closantel, Oxyclozanide, Rafoxanide, Niclosamide;
(c) substituted phenolics: nitroxynil, nitroscanate;
(d) pyrimidine series: pyrantel, morantel;
(e) imidazothiazoles: levamisole, tetramisole;
(f) tetrahydropyrimidines: praziquantel, epsiprantel;
(g) Other anthelmintics: cyclodiene, liania, clorsulon, metronidazole, demiditraz; piperazine, diethylcarbamazine, dichlorophen, monepantel, tribendimidine, amidantel; thiacetarsamide, melarsomine, arsenamide.
〔製剤処方〕
本発明の農園芸用殺菌剤または殺線虫剤は、本発明のピリダジノン化合物のほか、他の有効成分や農園芸学的に許容される製剤化のための補助成分(たとえば、無機担体、有機担体、界面活性剤、溶媒など)を添加することができる。
本発明の農園芸用殺菌剤または殺線虫剤は、剤形によって特に限定されない。たとえば、水和剤、乳剤、粉剤、粒剤、水溶剤、懸濁剤、顆粒水和剤、錠剤などの剤形を挙げることができる。製剤への調製方法は、特に制限されず、剤形に応じて公知の調製方法を採用することができる。
以下に、製剤実施例を若干示す。なお、以下に示す製剤処方は単なる例示であり、本発明の主旨に反しない範囲で修正することができ、本発明は以下の製剤実施例によって何ら制限されるものではない。「部」は特段の断りが無い限り「重量部」を意味する。 [Formulation formulation]
The agricultural and horticultural fungicide or nematicide of the present invention includes the pyridazinone compound of the present invention, other active ingredients and agricultural and horticulturally acceptable auxiliary ingredients for formulation (e.g., inorganic carriers, organic carriers, surfactants, solvents, etc.) can be added.
The agricultural and horticultural fungicide or nematicide of the present invention is not particularly limited by its dosage form. For example, dosage forms such as wettable powders, emulsions, powders, granules, aqueous solutions, suspensions, wettable powders, and tablets can be mentioned. The preparation method for the formulation is not particularly limited, and a known preparation method can be adopted depending on the dosage form.
Some formulation examples are shown below. The formulation shown below is merely an example, and can be modified within the scope of the present invention, and the present invention is not limited by the following formulation examples. "Parts" means "parts by weight" unless otherwise specified.
本発明の農園芸用殺菌剤または殺線虫剤は、本発明のピリダジノン化合物のほか、他の有効成分や農園芸学的に許容される製剤化のための補助成分(たとえば、無機担体、有機担体、界面活性剤、溶媒など)を添加することができる。
本発明の農園芸用殺菌剤または殺線虫剤は、剤形によって特に限定されない。たとえば、水和剤、乳剤、粉剤、粒剤、水溶剤、懸濁剤、顆粒水和剤、錠剤などの剤形を挙げることができる。製剤への調製方法は、特に制限されず、剤形に応じて公知の調製方法を採用することができる。
以下に、製剤実施例を若干示す。なお、以下に示す製剤処方は単なる例示であり、本発明の主旨に反しない範囲で修正することができ、本発明は以下の製剤実施例によって何ら制限されるものではない。「部」は特段の断りが無い限り「重量部」を意味する。 [Formulation formulation]
The agricultural and horticultural fungicide or nematicide of the present invention includes the pyridazinone compound of the present invention, other active ingredients and agricultural and horticulturally acceptable auxiliary ingredients for formulation (e.g., inorganic carriers, organic carriers, surfactants, solvents, etc.) can be added.
The agricultural and horticultural fungicide or nematicide of the present invention is not particularly limited by its dosage form. For example, dosage forms such as wettable powders, emulsions, powders, granules, aqueous solutions, suspensions, wettable powders, and tablets can be mentioned. The preparation method for the formulation is not particularly limited, and a known preparation method can be adopted depending on the dosage form.
Some formulation examples are shown below. The formulation shown below is merely an example, and can be modified within the scope of the present invention, and the present invention is not limited by the following formulation examples. "Parts" means "parts by weight" unless otherwise specified.
(製剤例1:水和剤)
本発明のピリダジノン化合物40部、珪藻土53部、高級アルコール硫酸エステル4部およびアルキルナフタレンスルホン酸塩3部を均一に混合して微細に粉砕して、有効成分40%の水和剤を得る。
(製剤例2:乳剤)
本発明のピリダジノン化合物30部、キシレン33部、ジメチルホルムアミド30部およびポリオキシエチレンアルキルアリルエーテル7部を混合し溶解させて、有効成分30%の乳剤を得る。
(製剤例3:粒剤)
本発明のピリダジノン化合物5部、タルク40部、クレー38部、ベントナイト10部およびアルキル硫酸ソーダ7部を均一に混合し、微細に粉砕し、その後、粒子直径0.5~1.0mmに造粒して有効成分5%の粒剤を得る。
(製剤例4:粒剤)
本発明のピリダジノン化合物5部、クレー73部、ベントナイト20部、ジオクチルスルホサクシネートナトリウム塩1部およびリン酸カリウム1部を均一に混合し、粉砕した。これに水を加えてよく練り合せ、その後、造粒し、乾燥させて、有効成分5%の粒剤を得る。
(製剤例5:懸濁剤)
本発明のピリダジノン化合物10部、ポリオキシエチレンアルキルアリルエーテル4部、ポリカルボン酸ナトリウム塩2部、グリセリン10部、キサンタンガム0.2部および水73.8部を混合し、粒度が3ミクロン以下になるまで湿式粉砕し、有効成分10%の懸濁剤を得る。
(製剤例6:顆粒水和剤)
本発明のピリダジノン化合物40部、クレー36部、塩化カリウム10部、アルキルベンゼンスルホン酸ナトリウム塩1部、リグニンスルホン酸ナトリウム塩8部およびアルキルベンゼンスルホン酸ナトリウム塩のホルムアルデヒド縮合物5部を均一に混合して微細に粉砕後、適量の水を加えてから練り込んで粘土状にする。粘土状物を造粒し、次いで乾燥させて有効成分40%の顆粒水和剤を得る。 (Formulation Example 1: wettable powder)
40 parts of the pyridazinone compound of the present invention, 53 parts of diatomaceous earth, 4 parts of higher alcohol sulfate and 3 parts of alkylnaphthalene sulfonate are uniformly mixed and finely pulverized to obtain a wettable powder containing 40% of the active ingredient.
(Formulation Example 2: Emulsion)
30 parts of the pyridazinone compound of the present invention, 33 parts of xylene, 30 parts of dimethylformamide and 7 parts of polyoxyethylene alkylallyl ether are mixed and dissolved to obtain an emulsion containing 30% active ingredient.
(Formulation Example 3: Granules)
5 parts of the pyridazinone compound of the present invention, 40 parts of talc, 38 parts of clay, 10 parts of bentonite and 7 parts of sodium alkyl sulfate are uniformly mixed, finely pulverized, and then granulated to a particle diameter of 0.5 to 1.0 mm. to obtain 5% active ingredient granules.
(Formulation Example 4: Granules)
5 parts of the pyridazinone compound of the present invention, 73 parts of clay, 20 parts of bentonite, 1 part of dioctylsulfosuccinate sodium salt and 1 part of potassium phosphate were uniformly mixed and pulverized. Water is added to this and the mixture is thoroughly kneaded, then granulated and dried to obtain granules containing 5% of the active ingredient.
(Formulation Example 5: Suspension agent)
10 parts of the pyridazinone compound of the present invention, 4 parts of polyoxyethylene alkylallyl ether, 2 parts of polycarboxylic acid sodium salt, 10 parts of glycerin, 0.2 parts of xanthan gum and 73.8 parts of water are mixed to reduce the particle size to 3 microns or less. Wet pulverize until it becomes a suspension of 10% of the active ingredient.
(Formulation Example 6: Granule wettable powder)
40 parts of the pyridazinone compound of the present invention, 36 parts of clay, 10 parts of potassium chloride, 1 part of sodium alkylbenzenesulfonate, 8 parts of sodium ligninsulfonate and 5 parts of formaldehyde condensate of sodium alkylbenzenesulfonate are uniformly mixed. After pulverizing it finely, add an appropriate amount of water and knead it into clay. The clay is granulated and then dried to obtain water dispersible granules containing 40% active ingredient.
本発明のピリダジノン化合物40部、珪藻土53部、高級アルコール硫酸エステル4部およびアルキルナフタレンスルホン酸塩3部を均一に混合して微細に粉砕して、有効成分40%の水和剤を得る。
(製剤例2:乳剤)
本発明のピリダジノン化合物30部、キシレン33部、ジメチルホルムアミド30部およびポリオキシエチレンアルキルアリルエーテル7部を混合し溶解させて、有効成分30%の乳剤を得る。
(製剤例3:粒剤)
本発明のピリダジノン化合物5部、タルク40部、クレー38部、ベントナイト10部およびアルキル硫酸ソーダ7部を均一に混合し、微細に粉砕し、その後、粒子直径0.5~1.0mmに造粒して有効成分5%の粒剤を得る。
(製剤例4:粒剤)
本発明のピリダジノン化合物5部、クレー73部、ベントナイト20部、ジオクチルスルホサクシネートナトリウム塩1部およびリン酸カリウム1部を均一に混合し、粉砕した。これに水を加えてよく練り合せ、その後、造粒し、乾燥させて、有効成分5%の粒剤を得る。
(製剤例5:懸濁剤)
本発明のピリダジノン化合物10部、ポリオキシエチレンアルキルアリルエーテル4部、ポリカルボン酸ナトリウム塩2部、グリセリン10部、キサンタンガム0.2部および水73.8部を混合し、粒度が3ミクロン以下になるまで湿式粉砕し、有効成分10%の懸濁剤を得る。
(製剤例6:顆粒水和剤)
本発明のピリダジノン化合物40部、クレー36部、塩化カリウム10部、アルキルベンゼンスルホン酸ナトリウム塩1部、リグニンスルホン酸ナトリウム塩8部およびアルキルベンゼンスルホン酸ナトリウム塩のホルムアルデヒド縮合物5部を均一に混合して微細に粉砕後、適量の水を加えてから練り込んで粘土状にする。粘土状物を造粒し、次いで乾燥させて有効成分40%の顆粒水和剤を得る。 (Formulation Example 1: wettable powder)
40 parts of the pyridazinone compound of the present invention, 53 parts of diatomaceous earth, 4 parts of higher alcohol sulfate and 3 parts of alkylnaphthalene sulfonate are uniformly mixed and finely pulverized to obtain a wettable powder containing 40% of the active ingredient.
(Formulation Example 2: Emulsion)
30 parts of the pyridazinone compound of the present invention, 33 parts of xylene, 30 parts of dimethylformamide and 7 parts of polyoxyethylene alkylallyl ether are mixed and dissolved to obtain an emulsion containing 30% active ingredient.
(Formulation Example 3: Granules)
5 parts of the pyridazinone compound of the present invention, 40 parts of talc, 38 parts of clay, 10 parts of bentonite and 7 parts of sodium alkyl sulfate are uniformly mixed, finely pulverized, and then granulated to a particle diameter of 0.5 to 1.0 mm. to obtain 5% active ingredient granules.
(Formulation Example 4: Granules)
5 parts of the pyridazinone compound of the present invention, 73 parts of clay, 20 parts of bentonite, 1 part of dioctylsulfosuccinate sodium salt and 1 part of potassium phosphate were uniformly mixed and pulverized. Water is added to this and the mixture is thoroughly kneaded, then granulated and dried to obtain granules containing 5% of the active ingredient.
(Formulation Example 5: Suspension agent)
10 parts of the pyridazinone compound of the present invention, 4 parts of polyoxyethylene alkylallyl ether, 2 parts of polycarboxylic acid sodium salt, 10 parts of glycerin, 0.2 parts of xanthan gum and 73.8 parts of water are mixed to reduce the particle size to 3 microns or less. Wet pulverize until it becomes a suspension of 10% of the active ingredient.
(Formulation Example 6: Granule wettable powder)
40 parts of the pyridazinone compound of the present invention, 36 parts of clay, 10 parts of potassium chloride, 1 part of sodium alkylbenzenesulfonate, 8 parts of sodium ligninsulfonate and 5 parts of formaldehyde condensate of sodium alkylbenzenesulfonate are uniformly mixed. After pulverizing it finely, add an appropriate amount of water and knead it into clay. The clay is granulated and then dried to obtain water dispersible granules containing 40% active ingredient.
〔医療用・動物用(獣医療用)抗真菌剤〕
本発明のピリダジノン化合物は、人または動物に感染する有害な病原菌、特に真菌を防除対象とした予防薬、治療薬として用いることができる。
本発明の医療用・動物用抗真菌剤は、化合物(I)およびその塩から選ばれる少なくともひとつを有効成分として含有するものである。本発明の医療用抗真菌剤に含まれる化合物(I)またはその塩の量は、抗真菌効果を示す限りにおいて特に制限されない。 [Medical and veterinary (veterinary) antifungal agents]
The pyridazinone compound of the present invention can be used as a prophylactic or therapeutic agent for controlling harmful pathogens, particularly fungi, that infect humans or animals.
The medical/veterinary antifungal agent of the present invention contains at least one selected from compound (I) and salts thereof as an active ingredient. The amount of compound (I) or a salt thereof contained in the medical antifungal agent of the present invention is not particularly limited as long as the antifungal effect is exhibited.
本発明のピリダジノン化合物は、人または動物に感染する有害な病原菌、特に真菌を防除対象とした予防薬、治療薬として用いることができる。
本発明の医療用・動物用抗真菌剤は、化合物(I)およびその塩から選ばれる少なくともひとつを有効成分として含有するものである。本発明の医療用抗真菌剤に含まれる化合物(I)またはその塩の量は、抗真菌効果を示す限りにおいて特に制限されない。 [Medical and veterinary (veterinary) antifungal agents]
The pyridazinone compound of the present invention can be used as a prophylactic or therapeutic agent for controlling harmful pathogens, particularly fungi, that infect humans or animals.
The medical/veterinary antifungal agent of the present invention contains at least one selected from compound (I) and salts thereof as an active ingredient. The amount of compound (I) or a salt thereof contained in the medical antifungal agent of the present invention is not particularly limited as long as the antifungal effect is exhibited.
本明細書における「動物」とは、愛玩動物や家畜・家禽、動物園や水族館等で飼育される展示動物、捕獲した野生動物、さらには研究・実験動物等の脊椎動物( V e r t e b ra t a)を意味する。
The term "animal" as used herein refers to pets, livestock and poultry, animals raised in zoos and aquariums, captured wild animals, and vertebrates such as research and experimental animals ( means ra t a).
例えば、以下の動物が挙げられるが、動物の具体例はこれらのみに限定されるものではない。
ヒツジ、ヤギ、ブタ、ウマ、ウシ、スイギュウ、ロバ、ラバ、ラクダ、ラマ、アルパカ、イノシシ、トナカイ、シカ、ミンク、ゾウ、クマ、カンガルー、キツネ、イヌ、ネコ、リス、ウサギ、マウス、ラット、モルモット、ハムスター、サル、フェレット等の哺乳類。
ハト、インコ、オウム、ブンチョウ、ジュウシマツ、カナリア、ニワトリ、アヒル、シチメンチョウ、カモ、キジ、クジャク、ダチョウ、ハクチョウ、スズメ、ウズラ、フクロウ、ワシ、タカ、ウミウなどの鳥類。
カメレオン、イグアナ、トカゲ、ヘビ、カメ、ワニ、ヤモリなどの爬虫類。
カエル、イモリなどの両生類。
コイ、キンギョ、メダカ、熱帯魚、ブリ・ハマチ、タイ、カンパチ、サケ、サバ、スズキ、クエ、マグロ、アジ、ヒラメ、フグなどの魚類。 Examples include the following animals, but specific examples of animals are not limited to these.
sheep, goat, pig, horse, cow, buffalo, donkey, mule, camel, llama, alpaca, wild boar, reindeer, deer, mink, elephant, bear, kangaroo, fox, dog, cat, squirrel, rabbit, mouse, rat, Mammals such as guinea pigs, hamsters, monkeys and ferrets.
Birds such as pigeons, parakeets, parrots, sparrows, marigolds, canaries, chickens, ducks, turkeys, ducks, pheasants, peacocks, ostriches, swans, sparrows, quail, owls, eagles, hawks, and cormorants.
Reptiles such as chameleons, iguanas, lizards, snakes, turtles, crocodiles and geckos.
Amphibians such as frogs and newts.
Fish such as carp, goldfish, killifish, tropical fish, yellowtail, yellowtail, sea bream, amberjack, salmon, mackerel, sea bass, longtooth grouper, tuna, horse mackerel, flounder, and pufferfish.
ヒツジ、ヤギ、ブタ、ウマ、ウシ、スイギュウ、ロバ、ラバ、ラクダ、ラマ、アルパカ、イノシシ、トナカイ、シカ、ミンク、ゾウ、クマ、カンガルー、キツネ、イヌ、ネコ、リス、ウサギ、マウス、ラット、モルモット、ハムスター、サル、フェレット等の哺乳類。
ハト、インコ、オウム、ブンチョウ、ジュウシマツ、カナリア、ニワトリ、アヒル、シチメンチョウ、カモ、キジ、クジャク、ダチョウ、ハクチョウ、スズメ、ウズラ、フクロウ、ワシ、タカ、ウミウなどの鳥類。
カメレオン、イグアナ、トカゲ、ヘビ、カメ、ワニ、ヤモリなどの爬虫類。
カエル、イモリなどの両生類。
コイ、キンギョ、メダカ、熱帯魚、ブリ・ハマチ、タイ、カンパチ、サケ、サバ、スズキ、クエ、マグロ、アジ、ヒラメ、フグなどの魚類。 Examples include the following animals, but specific examples of animals are not limited to these.
sheep, goat, pig, horse, cow, buffalo, donkey, mule, camel, llama, alpaca, wild boar, reindeer, deer, mink, elephant, bear, kangaroo, fox, dog, cat, squirrel, rabbit, mouse, rat, Mammals such as guinea pigs, hamsters, monkeys and ferrets.
Birds such as pigeons, parakeets, parrots, sparrows, marigolds, canaries, chickens, ducks, turkeys, ducks, pheasants, peacocks, ostriches, swans, sparrows, quail, owls, eagles, hawks, and cormorants.
Reptiles such as chameleons, iguanas, lizards, snakes, turtles, crocodiles and geckos.
Amphibians such as frogs and newts.
Fish such as carp, goldfish, killifish, tropical fish, yellowtail, yellowtail, sea bream, amberjack, salmon, mackerel, sea bass, longtooth grouper, tuna, horse mackerel, flounder, and pufferfish.
本発明の医療用・動物用抗真菌剤の適用が可能な病原菌として、真菌(カビ)の例を以下に示す。なお、具体例はこれらのみに限定されるものではない。
例えば、absidia corymbiferaなどのAbsidia属;Acremonium属;Alternaria alternataなどのAlternaria属;Aspergillus flavus、Aspergillus fumigatus、Aspergillus nidulans、Aspergillus niger、Aspergillus parasiticus、Aspergillus terreusなどのAspergillus属;Bipolaris属;Blastomyces dermatitidis などのBlastomyces属;Blumeria graminis などのBlumeria属;Candida albicans、Candida glabrata、Candida krusei、Candida parapsilosis、Candida tropicalis などのCandida属;Cladosporium cladosporoides、Cladosporium herbarium などのCladosporium属;Coccidioides immitis、Coccidioides posadasii などのCoccidioides属;Colletotrichium trifolii などのColletotrichium属;Cryptococcus neoformans などのCryptococcus属;Curvularia lunata などのCurvularia属;Encephalitozoon cuniculiなどのEncephalitozoon属;Epicoccum nigrum などのEpicoccum属;Epidermophyton floccosum などのEpidermophyton属;Exophiala属; Exserohilum rostratum などのExserohilum属;Fusarium graminarium、Fusarium solani、Fusarium sporotrichoides などのFusarium属;Fonsecaea monophora などのFonsecaea属; Histoplasma capsulatumなどのHistoplasma属;Leptosphaeria nodorumなどのLeptosphaeria属; Malassezia globosa などのMalassezia 属; Microsporum canis などのMicrosporum属;Mycosphaerella graminicolaなどのMycosphaerella属;Neurospora属;Paecilomyces lilanicus、Paecilomyces varioti などのPaecilomyces属;PenicilliumchrysogenumなどのPenicillium属; Phytophthora capsici、Phytophthora infestansなどのPhytophthora属;Plasmopara viticola などのPlasmopara属;Pneumocystis jiroveciiなどのPneumocystis属;Pyricularia oryzaeなどのPyricularia属;Pythium ultimumなどのPythium属;Puccinia coronata、Puccinia graminis などのPuccinia属;Rhizoctonia solaniなどのRhizoctonia属;Rhizomucor属;Fusarium apiospermum、Scedosporium prolificansなどのScedosporium属;Scopulariopsis brevicaulisなどのScopulariopsis属;Sporothrix schenckii などのSporothrix 属; Talaromyces marneffeiなどのTalaromyces属、Trichophyton mentagrophytes、Trichophyton interdigitale、Trichophyton rubrum、Trichophyton tonsurans、Trichophyton verrucosumなどのTrichophyton属;Trichosporon asahii、Trichosporon beigeliiなどのTrichosporon属;Ustilago属など。
これらの中、本発明の抗真菌剤は、Aspergillus属、Trichophyton属またはCandida属に対して好適であり、Aspergillus fumigatusまたはTrichophyton tonsuransに対して特に好適である。 Examples of fungi (molds) are shown below as pathogenic bacteria to which the medical and veterinary antifungal agent of the present invention can be applied. However, specific examples are not limited to these.
For example, the genus Absidia, such as absidia corymbifera; the genus Acremonium; the genus Alternaria, such as Alternaria alternata; the genus Aspergillus, such as Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Aspergillus niger, Aspergillus parasiticus, and Aspergillus terreus; ; Blumeria genus such as Blumeria graminis; Candida genus such as Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis; Cladosporium genus such as Cladosporium cladosporoides and Cladosporium herbarium; Cryptococcus genera such as Cryptococcus neoformans; Curvularia genera such as Curvularia lunata; Encephalitozoon genera such as Encephalitozoon cuniculi; Epicoccum genera such as Epicoccum nigrum; Fusarium genera, such as graminarium, Fusarium solani, and Fusarium sporotrichoides; Fonsecaea genera, such as Fonsecaea monophora; Histoplasma genera, such as Histoplasma capsulatum; Leptos, such as Leptosphaeria nodorum Genus phaeria; genus Malassezia such as Malassezia globosa; genus Microsporum such as Microsporum canis; genus Mycosphaerella such as Mycosphaerella graminicola; genus Neurospora; Pneumocystis genus such as Pneumocystis jirovecii; Pyricularia genus such as Pyricularia oryzae; Pythium genus such as Pythium ultimum; Puccinia genus such as Puccinia coronata and Puccinia graminis; Rhizoctonia genus such as Rhizoctonia solani; Scedosporium genera such as Fusarium apiospermum and Scedosporium prolificans; Scopulariopsis genera such as Scopulariopsis brevicaulis; Sporothrix genera such as Sporothrix schenckii; Talaromyces genera such as Talaromyces marneffei; genus Trichosporon, such as Trichosporon asahii and Trichosporon beigelii; genus Ustilago;
Among these, the antifungal agent of the present invention is suitable for Aspergillus, Trichophyton or Candida, and particularly suitable for Aspergillus fumigatus or Trichophyton tonsurans.
例えば、absidia corymbiferaなどのAbsidia属;Acremonium属;Alternaria alternataなどのAlternaria属;Aspergillus flavus、Aspergillus fumigatus、Aspergillus nidulans、Aspergillus niger、Aspergillus parasiticus、Aspergillus terreusなどのAspergillus属;Bipolaris属;Blastomyces dermatitidis などのBlastomyces属;Blumeria graminis などのBlumeria属;Candida albicans、Candida glabrata、Candida krusei、Candida parapsilosis、Candida tropicalis などのCandida属;Cladosporium cladosporoides、Cladosporium herbarium などのCladosporium属;Coccidioides immitis、Coccidioides posadasii などのCoccidioides属;Colletotrichium trifolii などのColletotrichium属;Cryptococcus neoformans などのCryptococcus属;Curvularia lunata などのCurvularia属;Encephalitozoon cuniculiなどのEncephalitozoon属;Epicoccum nigrum などのEpicoccum属;Epidermophyton floccosum などのEpidermophyton属;Exophiala属; Exserohilum rostratum などのExserohilum属;Fusarium graminarium、Fusarium solani、Fusarium sporotrichoides などのFusarium属;Fonsecaea monophora などのFonsecaea属; Histoplasma capsulatumなどのHistoplasma属;Leptosphaeria nodorumなどのLeptosphaeria属; Malassezia globosa などのMalassezia 属; Microsporum canis などのMicrosporum属;Mycosphaerella graminicolaなどのMycosphaerella属;Neurospora属;Paecilomyces lilanicus、Paecilomyces varioti などのPaecilomyces属;PenicilliumchrysogenumなどのPenicillium属; Phytophthora capsici、Phytophthora infestansなどのPhytophthora属;Plasmopara viticola などのPlasmopara属;Pneumocystis jiroveciiなどのPneumocystis属;Pyricularia oryzaeなどのPyricularia属;Pythium ultimumなどのPythium属;Puccinia coronata、Puccinia graminis などのPuccinia属;Rhizoctonia solaniなどのRhizoctonia属;Rhizomucor属;Fusarium apiospermum、Scedosporium prolificansなどのScedosporium属;Scopulariopsis brevicaulisなどのScopulariopsis属;Sporothrix schenckii などのSporothrix 属; Talaromyces marneffeiなどのTalaromyces属、Trichophyton mentagrophytes、Trichophyton interdigitale、Trichophyton rubrum、Trichophyton tonsurans、Trichophyton verrucosumなどのTrichophyton属;Trichosporon asahii、Trichosporon beigeliiなどのTrichosporon属;Ustilago属など。
これらの中、本発明の抗真菌剤は、Aspergillus属、Trichophyton属またはCandida属に対して好適であり、Aspergillus fumigatusまたはTrichophyton tonsuransに対して特に好適である。 Examples of fungi (molds) are shown below as pathogenic bacteria to which the medical and veterinary antifungal agent of the present invention can be applied. However, specific examples are not limited to these.
For example, the genus Absidia, such as absidia corymbifera; the genus Acremonium; the genus Alternaria, such as Alternaria alternata; the genus Aspergillus, such as Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Aspergillus niger, Aspergillus parasiticus, and Aspergillus terreus; ; Blumeria genus such as Blumeria graminis; Candida genus such as Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis; Cladosporium genus such as Cladosporium cladosporoides and Cladosporium herbarium; Cryptococcus genera such as Cryptococcus neoformans; Curvularia genera such as Curvularia lunata; Encephalitozoon genera such as Encephalitozoon cuniculi; Epicoccum genera such as Epicoccum nigrum; Fusarium genera, such as graminarium, Fusarium solani, and Fusarium sporotrichoides; Fonsecaea genera, such as Fonsecaea monophora; Histoplasma genera, such as Histoplasma capsulatum; Leptos, such as Leptosphaeria nodorum Genus phaeria; genus Malassezia such as Malassezia globosa; genus Microsporum such as Microsporum canis; genus Mycosphaerella such as Mycosphaerella graminicola; genus Neurospora; Pneumocystis genus such as Pneumocystis jirovecii; Pyricularia genus such as Pyricularia oryzae; Pythium genus such as Pythium ultimum; Puccinia genus such as Puccinia coronata and Puccinia graminis; Rhizoctonia genus such as Rhizoctonia solani; Scedosporium genera such as Fusarium apiospermum and Scedosporium prolificans; Scopulariopsis genera such as Scopulariopsis brevicaulis; Sporothrix genera such as Sporothrix schenckii; Talaromyces genera such as Talaromyces marneffei; genus Trichosporon, such as Trichosporon asahii and Trichosporon beigelii; genus Ustilago;
Among these, the antifungal agent of the present invention is suitable for Aspergillus, Trichophyton or Candida, and particularly suitable for Aspergillus fumigatus or Trichophyton tonsurans.
本発明の医療用・動物用抗真菌剤の適用が可能な感染症として、真菌症の例を以下に示す。なお、具体例はこれらのみに限定されるものではない。
Examples of mycosis are shown below as infectious diseases to which the medical and veterinary antifungal agent of the present invention can be applied. However, specific examples are not limited to these.
本発明の医療用・動物用抗真菌剤は、全身性真菌感染症、表在性真菌感染症などのいずれにも適用できる。真菌感染症の具体例としては、肺アスペルギルス症、全身性アスペルギルス症(骨髄受容者またはAIDS患者などの免疫抑制患者において発症しやすい)などのアスペルギルス(Aspergillus)症、全身性カンジダ症などのカンジダ(Candida)症、クリプトコッカス(Cryptococcus)髄膜炎、鼻脳型ムコール症(rhinocerebral mucomycosis)、肺ムコール症、ブラストミセス症、ヒストプラスマ症、コクシジオイデス症(coccidiomycosis)、パラコクシジオイデス症(paracoccidiomycosis)、ロボ真菌症、角膜真菌症、スポロトリクム症、クロモブラストミコーシス、クロモミコーシス、フェオフィホ真菌症、接合菌症、クリプトコッカス症、播種性スポロトリクム症、白癬(ring worm)、頭部白癬(しらくも)、体部白癬(たむし)、股部白癬(いんきん)、足白癬(水虫)、爪白癬(爪水虫)、皮膚、口、または膣のカンジダ症、マラセチア症、慢性粘膜皮膚カンジダ症、ニューモシスチス肺炎、マルネフェイ型ペニシリウム症等が挙げられる。
また、本発明の抗真菌剤は、真菌によって引き起こされるアレルギー疾患、例えば、アレルギー性気管支肺喘息(allergic bronchopulmonary asthma)(ABPA);喘息、鼻副鼻腔炎、または副鼻腔炎等にも適用可能である。 The medical/veterinary antifungal agent of the present invention can be applied to both systemic fungal infections and superficial fungal infections. Specific examples of fungal infections include Aspergillus diseases such as pulmonary aspergillosis, systemic aspergillosis (which is more likely to occur in immunosuppressed patients such as bone marrow recipients or AIDS patients), Candida diseases such as systemic candidiasis ( Candida disease, Cryptococcus meningitis, rhinocerebral mucomycosis, pulmonary mucormycosis, blastomycosis, histoplasmosis, coccidiomycosis, paracoccidiomycosis, robomycosis, Keratomycosis, sporotrichosis, chromoblastomycosis, chromomycosis, pheophyphomycosis, zygomycosis, cryptococcosis, disseminated sporotrichosis, ring worm, tinea capitis, tinea corporis , tinea pedis (athlete's foot), tinea pedis (athlete's foot), tinea unguium (athlete's foot), candidiasis of the skin, mouth, or vagina, malassechiosis, chronic mucocutaneous candidiasis, Pneumocystis pneumoniae, and penicilliosis of the Marnefei type. be done.
In addition, the antifungal agent of the present invention can also be applied to allergic diseases caused by fungi, such as allergic bronchopulmonary asthma (ABPA); asthma, rhinosinusitis, or sinusitis. be.
また、本発明の抗真菌剤は、真菌によって引き起こされるアレルギー疾患、例えば、アレルギー性気管支肺喘息(allergic bronchopulmonary asthma)(ABPA);喘息、鼻副鼻腔炎、または副鼻腔炎等にも適用可能である。 The medical/veterinary antifungal agent of the present invention can be applied to both systemic fungal infections and superficial fungal infections. Specific examples of fungal infections include Aspergillus diseases such as pulmonary aspergillosis, systemic aspergillosis (which is more likely to occur in immunosuppressed patients such as bone marrow recipients or AIDS patients), Candida diseases such as systemic candidiasis ( Candida disease, Cryptococcus meningitis, rhinocerebral mucomycosis, pulmonary mucormycosis, blastomycosis, histoplasmosis, coccidiomycosis, paracoccidiomycosis, robomycosis, Keratomycosis, sporotrichosis, chromoblastomycosis, chromomycosis, pheophyphomycosis, zygomycosis, cryptococcosis, disseminated sporotrichosis, ring worm, tinea capitis, tinea corporis , tinea pedis (athlete's foot), tinea pedis (athlete's foot), tinea unguium (athlete's foot), candidiasis of the skin, mouth, or vagina, malassechiosis, chronic mucocutaneous candidiasis, Pneumocystis pneumoniae, and penicilliosis of the Marnefei type. be done.
In addition, the antifungal agent of the present invention can also be applied to allergic diseases caused by fungi, such as allergic bronchopulmonary asthma (ABPA); asthma, rhinosinusitis, or sinusitis. be.
本発明の医療用・動物用抗真菌剤は、薬学的に許容される添加剤を含むことができる。添加剤は、公知の医療用薬剤において、使用されているものであれば特に制限されない。これらは、当然ながら、無菌であり、発熱性がない。また、添加剤は、抗真菌剤の剤型や投与方法などに応じて、適宜、選択することができる。
The medical/veterinary antifungal agent of the present invention can contain pharmaceutically acceptable additives. Additives are not particularly limited as long as they are used in known medical drugs. They are of course sterile and non-pyrogenic. In addition, the additive can be appropriately selected according to the dosage form and administration method of the antifungal agent.
本発明の医療用・動物用抗真菌剤が採り得る剤型は、特に限定されず、例えば、錠剤、粉剤、粒剤、顆粒剤、カプセル剤、トローチ(飴)、ペレットなどの固体剤;シロップ、乳濁剤、懸濁剤、溶液、滴下(Pour-on)剤、点下(Spot-on)剤、などの液体剤;軟膏剤、ゲルなどの半固体調製物など;エアロゾル、蒸気などの気体剤;ナノ粒子製剤などを挙げることができる。
本発明の医療用抗真菌剤の投与は、公知の方法で行うことができる。投与方法としては、例えば、皮下、静脈内、筋肉内、胸骨内(intrasternally)等への注入(注射);肛門、膣などへの挿入、皮膚表面への塗布や散布、滴下などの経皮投与;口から服用などの経口投与;吸気などによる経鼻投与などを挙げることができる。 The dosage form that the medical/veterinary antifungal agent of the present invention can take is not particularly limited. , emulsions, suspensions, solutions, drops (Pour-on), spot-on, etc.; semi-solid preparations such as ointments, gels, etc.; aerosols, vapors, etc. Gaseous agents; nanoparticle formulations and the like can be mentioned.
Administration of the medical antifungal agent of the present invention can be performed by known methods. Examples of administration methods include subcutaneous, intravenous, intramuscular, intrasternal injection (injection); insertion into the anus, vagina, etc.; oral administration such as oral administration; nasal administration such as inhalation.
本発明の医療用抗真菌剤の投与は、公知の方法で行うことができる。投与方法としては、例えば、皮下、静脈内、筋肉内、胸骨内(intrasternally)等への注入(注射);肛門、膣などへの挿入、皮膚表面への塗布や散布、滴下などの経皮投与;口から服用などの経口投与;吸気などによる経鼻投与などを挙げることができる。 The dosage form that the medical/veterinary antifungal agent of the present invention can take is not particularly limited. , emulsions, suspensions, solutions, drops (Pour-on), spot-on, etc.; semi-solid preparations such as ointments, gels, etc.; aerosols, vapors, etc. Gaseous agents; nanoparticle formulations and the like can be mentioned.
Administration of the medical antifungal agent of the present invention can be performed by known methods. Examples of administration methods include subcutaneous, intravenous, intramuscular, intrasternal injection (injection); insertion into the anus, vagina, etc.; oral administration such as oral administration; nasal administration such as inhalation.
経口投与用の固体剤の場合、本発明の医療用・動物用抗真菌剤に使用できる添加剤としては、シクロデキストリンまたは修飾シクロデキストリン等の溶解補助剤;ラクトース、デキストロース、サッカロース、セルロース、コーンスターチまたはジャガイモデンプン等の希釈剤;シリカ、タルク、ステアリン酸、ステアリン酸マグネシウムもしくはステアリン酸カルシウム、ポリエチレングリコール等の滑沢剤;デンプン、アラビアゴム(arabic gums)、ゼラチン、メチルセルロース、カルボキシメチルセルロースまたはポリビニルピロリドン等の結合剤;デンプン、アルギン酸、アルギン酸塩またはグリコール酸デンプンナトリウム等の脱凝集剤(disaggregating agents);発泡性混合物(effervescing mixtures);色素;甘味剤;レシチン、ポリソルベート、ラウリル硫酸(laurylsulphates)等の湿潤剤;または一般に医薬製剤に用いられる非毒性で薬理学的に不活性な物質等を挙げることができる。これら添加剤は、混合、造粒、打錠、糖衣、またはフィルムコーティング等の公知の方法により本発明の医療用抗真菌剤に含有させることができる。
In the case of oral solid formulations, additives that can be used in the medical and veterinary antifungal agents of the present invention include solubilizers such as cyclodextrins or modified cyclodextrins; lactose, dextrose, sucrose, cellulose, cornstarch or Diluents such as potato starch; Lubricants such as silica, talc, stearic acid, magnesium or calcium stearate, polyethylene glycol; Binding agents such as starch, arabic gums, gelatin, methylcellulose, carboxymethylcellulose or polyvinylpyrrolidone. agents; disaggregating agents such as starch, alginic acid, alginates or sodium starch glycolate; effervescing mixtures; dyes; sweeteners; Alternatively, non-toxic and pharmacologically inactive substances generally used in pharmaceutical formulations can be used. These additives can be incorporated into the medical antifungal agent of the present invention by known methods such as mixing, granulation, tableting, sugar coating, or film coating.
経口投与用の液体剤の場合、本発明の医療用・動物用抗真菌剤に使用できる添加剤としては、シクロデキストリンまたは修飾シクロデキストリン等の溶解補助剤、サッカロースを、グリセリン、マンニトール、ソルビトール、天然ガム、寒天、アルギン酸ナトリウム、ペクチン、メチルセルロース、カルボキシメチルセルロース、またはポリビニルアルコール等を挙げることができる。
In the case of liquid formulations for oral administration, additives that can be used in the medical and veterinary antifungal agents of the present invention include solubilizers such as cyclodextrins or modified cyclodextrins, saccharose, glycerin, mannitol, sorbitol, natural gum, agar, sodium alginate, pectin, methylcellulose, carboxymethylcellulose, polyvinyl alcohol, and the like.
筋肉内注射用の液体剤の場合、本発明の医療用・動物用抗真菌剤に使用できる添加剤としては、滅菌水、オリーブ油、オレイン酸エチル、プロピレングリコール等のグリコール類、シクロデキストリン、修飾シクロデキストリン等の溶解補助剤等を挙げることができる。さらに必要に応じて適切な量のリドカイン塩酸塩を含ませることもできる。
In the case of a liquid preparation for intramuscular injection, the additives that can be used in the medical and veterinary antifungal agent of the present invention include sterilized water, olive oil, ethyl oleate, glycols such as propylene glycol, cyclodextrin, and modified cyclodextrins. Dissolution aids such as dextrin can be used. Furthermore, an appropriate amount of lidocaine hydrochloride can be included as necessary.
静脈注射用の液体剤の場合、本発明の医療用・動物用抗真菌剤に使用できる添加剤としては、滅菌水等の担体;シクロデキストリン、修飾シクロデキストリン等の溶解補助剤等を挙げることができる。これらは滅菌した等張生理食塩水溶液の形態で含ませることもできる。
In the case of a liquid preparation for intravenous injection, examples of additives that can be used in the medical or veterinary antifungal agent of the present invention include carriers such as sterile water; solubilizers such as cyclodextrins and modified cyclodextrins. can. They can also be included in the form of sterile isotonic saline solutions.
本発明の医療用・動物用抗真菌剤に含有する化合物(I)またはその塩の量は、抗真菌剤の重量に対して、好ましくは85重量%以下、より好ましくは50重量%以下である。
本発明の医療用・動物用抗真菌剤の用量は、投与方法、感染した真菌の種類、患者の年齢、体重、症状等に応じて適宜選択することができる。例えば、成人に対しては、経口または非経口(注射、点滴等)的投与の場合、1日に1または数回、0.1~100mg/kg-体重にて投与することができる。
また、本発明の医療用・動物用抗真菌剤は、ピリダジノン化合物以外の他の薬剤と組み合わせで使用することができる。 The amount of compound (I) or a salt thereof contained in the medical or veterinary antifungal agent of the present invention is preferably 85% by weight or less, more preferably 50% by weight or less, based on the weight of the antifungal agent. .
The dose of the medical/veterinary antifungal agent of the present invention can be appropriately selected according to the administration method, the type of fungi infected, the patient's age, body weight, symptoms, and the like. For example, for adults, in the case of oral or parenteral (injection, infusion, etc.) administration, 0.1 to 100 mg/kg-body weight can be administered once or several times a day.
In addition, the medical and veterinary antifungal agents of the present invention can be used in combination with drugs other than pyridazinone compounds.
本発明の医療用・動物用抗真菌剤の用量は、投与方法、感染した真菌の種類、患者の年齢、体重、症状等に応じて適宜選択することができる。例えば、成人に対しては、経口または非経口(注射、点滴等)的投与の場合、1日に1または数回、0.1~100mg/kg-体重にて投与することができる。
また、本発明の医療用・動物用抗真菌剤は、ピリダジノン化合物以外の他の薬剤と組み合わせで使用することができる。 The amount of compound (I) or a salt thereof contained in the medical or veterinary antifungal agent of the present invention is preferably 85% by weight or less, more preferably 50% by weight or less, based on the weight of the antifungal agent. .
The dose of the medical/veterinary antifungal agent of the present invention can be appropriately selected according to the administration method, the type of fungi infected, the patient's age, body weight, symptoms, and the like. For example, for adults, in the case of oral or parenteral (injection, infusion, etc.) administration, 0.1 to 100 mg/kg-body weight can be administered once or several times a day.
In addition, the medical and veterinary antifungal agents of the present invention can be used in combination with drugs other than pyridazinone compounds.
以下に合成実施例を示し、本発明をより具体的に説明する。ただし、本発明は以下の合成実施例によって何ら制限されるものではない。
〔実施例1〕
(E)‐2‐(5‐(1‐(イソプロポキシイミノ)エチル‐3‐(2‐メトキシフェネチル)‐6‐オキソピリダジン‐1(6H)‐イル)‐N‐イソプロピルプロパンアミド〔(E)-2-(5-(1-(isopropoxyimino)ethyl)-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide〕の合成
(工程1)
メチル 3‐メトキシ‐6‐((2‐メトキシフェニル)エチニル)ピリダジン‐4‐カルボキシラート〔methyl 3-methoxy-6-((2-methoxyphenyl)ethynyl)pyridazine-4-carboxylate〕の合成 Synthesis examples are shown below to describe the present invention more specifically. However, the present invention is in no way limited by the following synthesis examples.
[Example 1]
(E)-2-(5-(1-(isopropoxyimino)ethyl-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide [(E) Synthesis of -2-(5-(1-(isopropoxyimino)ethyl)-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide] (Step 1)
Synthesis of methyl 3-methoxy-6-((2-methoxyphenyl)ethynyl)pyridazine-4-carboxylate
〔実施例1〕
(E)‐2‐(5‐(1‐(イソプロポキシイミノ)エチル‐3‐(2‐メトキシフェネチル)‐6‐オキソピリダジン‐1(6H)‐イル)‐N‐イソプロピルプロパンアミド〔(E)-2-(5-(1-(isopropoxyimino)ethyl)-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide〕の合成
(工程1)
メチル 3‐メトキシ‐6‐((2‐メトキシフェニル)エチニル)ピリダジン‐4‐カルボキシラート〔methyl 3-methoxy-6-((2-methoxyphenyl)ethynyl)pyridazine-4-carboxylate〕の合成 Synthesis examples are shown below to describe the present invention more specifically. However, the present invention is in no way limited by the following synthesis examples.
[Example 1]
(E)-2-(5-(1-(isopropoxyimino)ethyl-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide [(E) Synthesis of -2-(5-(1-(isopropoxyimino)ethyl)-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide] (Step 1)
Synthesis of methyl 3-methoxy-6-((2-methoxyphenyl)ethynyl)pyridazine-4-carboxylate
メチル 6‐クロロ‐3‐メトキシピリダジン‐4‐カルボキシラート(2.65g)をジメチルホルムアミド(90ml)、トリメチルアミン(150ml)へ溶解させた。これに、1‐エチニル‐2‐メトキシベンゼン(1.90g)、ヨウ化銅(I)(0.42g)、ビス(トリフェニルホスフィン)パラジウム(II)ジクロリド(1.34g)を加え、反応容器を窒素で置換した後、70℃で1時間撹拌した。
反応液に飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。得られた有機層を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物1.47g(収率38%)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.96 (1H, s), 7.57 (1H, q), 7.38-7.36 (1H, m), 6.99-6.92 (2H, m), 4.28 (3H, s), 3.96 (3H, s), 3.93 (3H, s). Methyl 6-chloro-3-methoxypyridazine-4-carboxylate (2.65 g) was dissolved in dimethylformamide (90 ml), trimethylamine (150 ml). To this, 1-ethynyl-2-methoxybenzene (1.90 g), copper (I) iodide (0.42 g) and bis(triphenylphosphine) palladium (II) dichloride (1.34 g) were added and the reaction vessel was replaced with nitrogen, and then stirred at 70° C. for 1 hour.
A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 1.47 g of the desired product (yield 38%).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.96 (1H, s), 7.57 (1H, q), 7.38-7.36 (1H, m), 6.99-6.92 (2H, m), 4.28 (3H, s ), 3.96 (3H, s), 3.93 (3H, s).
反応液に飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。得られた有機層を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物1.47g(収率38%)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.96 (1H, s), 7.57 (1H, q), 7.38-7.36 (1H, m), 6.99-6.92 (2H, m), 4.28 (3H, s), 3.96 (3H, s), 3.93 (3H, s). Methyl 6-chloro-3-methoxypyridazine-4-carboxylate (2.65 g) was dissolved in dimethylformamide (90 ml), trimethylamine (150 ml). To this, 1-ethynyl-2-methoxybenzene (1.90 g), copper (I) iodide (0.42 g) and bis(triphenylphosphine) palladium (II) dichloride (1.34 g) were added and the reaction vessel was replaced with nitrogen, and then stirred at 70° C. for 1 hour.
A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 1.47 g of the desired product (yield 38%).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.96 (1H, s), 7.57 (1H, q), 7.38-7.36 (1H, m), 6.99-6.92 (2H, m), 4.28 (3H, s ), 3.96 (3H, s), 3.93 (3H, s).
(工程2)
メチル 3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐カルボキシラート〔methyl 3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylate〕の合成 (Step 2)
Synthesis of methyl 3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylate
メチル 3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐カルボキシラート〔methyl 3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylate〕の合成 (Step 2)
Synthesis of methyl 3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylate
メチル 3‐メトキシ‐6‐((2‐メトキシフェニル)エチニル)ピリダジン‐4‐カルボキシラート(1.60g)をメタノール(54ml)へ溶解させ、水酸化パラジウム(0.16g)を加えた。反応容器を水素で置換した後、室温で終夜撹拌した。
反応液をセライトろ過し、ろ液を減圧濃縮し、得られた残渣(1.59g)をそのまま次工程に用いた。 Methyl 3-methoxy-6-((2-methoxyphenyl)ethynyl)pyridazine-4-carboxylate (1.60g) was dissolved in methanol (54ml) and palladium hydroxide (0.16g) was added. After purging the reaction vessel with hydrogen, the mixture was stirred overnight at room temperature.
The reaction solution was filtered through celite, the filtrate was concentrated under reduced pressure, and the obtained residue (1.59 g) was used as it was in the next step.
反応液をセライトろ過し、ろ液を減圧濃縮し、得られた残渣(1.59g)をそのまま次工程に用いた。 Methyl 3-methoxy-6-((2-methoxyphenyl)ethynyl)pyridazine-4-carboxylate (1.60g) was dissolved in methanol (54ml) and palladium hydroxide (0.16g) was added. After purging the reaction vessel with hydrogen, the mixture was stirred overnight at room temperature.
The reaction solution was filtered through celite, the filtrate was concentrated under reduced pressure, and the obtained residue (1.59 g) was used as it was in the next step.
(工程3)
3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐カルボン酸〔3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylic acid〕の合成 (Step 3)
Synthesis of 3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylic acid
3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐カルボン酸〔3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylic acid〕の合成 (Step 3)
Synthesis of 3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylic acid
メチル 3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐カルボキシラート(1.59g)をテトラヒドロフラン(9ml)、水(7ml)へ溶解させ、水酸化リチウム一水和物(0.34g)を加えた。これを室温で1時間撹拌した後、反応液に水と酢酸エチルを加え、抽出した。
得られた水層に氷冷下、1N塩酸を加え、酢酸エチルで抽出した。得られた有機層を無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣(1.24g)をそのまま次工程に用いた。 Methyl 3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylate (1.59g) was dissolved in tetrahydrofuran (9ml), water (7ml) and lithium hydroxide monohydrate (0.34g). was added. After stirring this at room temperature for 1 hour, water and ethyl acetate were added and extracted to the reaction liquid.
1N Hydrochloric acid was added to the resulting aqueous layer under ice-cooling, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue (1.24 g) was directly used in the next step.
得られた水層に氷冷下、1N塩酸を加え、酢酸エチルで抽出した。得られた有機層を無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣(1.24g)をそのまま次工程に用いた。 Methyl 3-methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylate (1.59g) was dissolved in tetrahydrofuran (9ml), water (7ml) and lithium hydroxide monohydrate (0.34g). was added. After stirring this at room temperature for 1 hour, water and ethyl acetate were added and extracted to the reaction liquid.
1N Hydrochloric acid was added to the resulting aqueous layer under ice-cooling, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue (1.24 g) was directly used in the next step.
(工程4)
N,3‐ジメトキシ‐6‐(2‐メトキシフェネチル)‐N‐メチルピリダジン‐4‐カルボキシアミド〔N,3-dimethoxy-6-(2-methoxyphenethyl)-N-methylpyridazine-4-carboxamide〕の合成 (Step 4)
Synthesis of N,3-dimethoxy-6-(2-methoxyphenethyl)-N-methylpyridazine-4-carboxamide [N,3-dimethoxy-6-(2-methoxyphenethyl)-N-methylpyridazine-4-carboxamide]
N,3‐ジメトキシ‐6‐(2‐メトキシフェネチル)‐N‐メチルピリダジン‐4‐カルボキシアミド〔N,3-dimethoxy-6-(2-methoxyphenethyl)-N-methylpyridazine-4-carboxamide〕の合成 (Step 4)
Synthesis of N,3-dimethoxy-6-(2-methoxyphenethyl)-N-methylpyridazine-4-carboxamide [N,3-dimethoxy-6-(2-methoxyphenethyl)-N-methylpyridazine-4-carboxamide]
3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐カルボン酸(1.24g)を塩化メチレン(20ml)へ溶解させた。これにN,O‐ジメチルヒドロキシルアミン塩酸塩(0.50g)、1‐エチル‐3‐(3‐ジメチルアミノプロピル)カルボジイミド塩酸塩(2.06g)、1‐ヒドロキシベンゾトリアゾール一水和物(0.07g)、トリエチルアミン(1.8ml)を加え、室温で終夜撹拌した。
反応液に水を注ぎ、クロロホルムで抽出した。得られた有機層を無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物1.15g(収率65%,三工程)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.21-7.16 (1H, m), 7.11-7.09 (2H, m), 6.86-6.83 (2H,m), 4.16 (3H, s), 3.82 (3H, s), 3.46 (3H, s), 3.35 (3H, s) 3.22-3.05 (4H, m). 3-Methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylic acid (1.24 g) was dissolved in methylene chloride (20 ml). To this was added N,O-dimethylhydroxylamine hydrochloride (0.50 g), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (2.06 g), 1-hydroxybenzotriazole monohydrate (0 .07 g) and triethylamine (1.8 ml) were added and stirred overnight at room temperature.
Water was poured into the reaction solution and extracted with chloroform. The resulting organic layer was dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 1.15 g of the desired product (yield 65%, 3 steps).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.21-7.16 (1H, m), 7.11-7.09 (2H, m), 6.86-6.83 (2H, m), 4.16 (3H, s), 3.82 (3H , s), 3.46 (3H, s), 3.35 (3H, s) 3.22-3.05 (4H, m).
反応液に水を注ぎ、クロロホルムで抽出した。得られた有機層を無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物1.15g(収率65%,三工程)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.21-7.16 (1H, m), 7.11-7.09 (2H, m), 6.86-6.83 (2H,m), 4.16 (3H, s), 3.82 (3H, s), 3.46 (3H, s), 3.35 (3H, s) 3.22-3.05 (4H, m). 3-Methoxy-6-(2-methoxyphenethyl)pyridazine-4-carboxylic acid (1.24 g) was dissolved in methylene chloride (20 ml). To this was added N,O-dimethylhydroxylamine hydrochloride (0.50 g), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (2.06 g), 1-hydroxybenzotriazole monohydrate (0 .07 g) and triethylamine (1.8 ml) were added and stirred overnight at room temperature.
Water was poured into the reaction solution and extracted with chloroform. The resulting organic layer was dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 1.15 g of the desired product (yield 65%, 3 steps).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.21-7.16 (1H, m), 7.11-7.09 (2H, m), 6.86-6.83 (2H, m), 4.16 (3H, s), 3.82 (3H , s), 3.46 (3H, s), 3.35 (3H, s) 3.22-3.05 (4H, m).
(工程5)
1‐(3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐イル)エタン‐1‐オン〔1-(3-methoxy-6-(2-methoxyphenethyl)-pyridazine-4-yl)ethan-1-one〕の合成 (Step 5)
1-(3-methoxy-6-(2-methoxyphenethyl)pyridazin-4-yl)ethan-1-one [1-(3-methoxy-6-(2-methoxyphenethyl)-pyridazine-4-yl)ethan- 1-one] synthesis
1‐(3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐イル)エタン‐1‐オン〔1-(3-methoxy-6-(2-methoxyphenethyl)-pyridazine-4-yl)ethan-1-one〕の合成 (Step 5)
1-(3-methoxy-6-(2-methoxyphenethyl)pyridazin-4-yl)ethan-1-one [1-(3-methoxy-6-(2-methoxyphenethyl)-pyridazine-4-yl)ethan- 1-one] synthesis
N,3‐ジメトキシ‐6‐(2‐メトキシフェネチル)‐N‐メチルピリダジン‐4‐カルボキシアミド(0.25g)を無水テトラヒドロフラン(2.5ml)へ溶解させ、反応溶液を窒素置換した後、-10℃に冷却した。これに1.0Mメチルマグネシウムブロマイドテトロヒドロフラン溶液(1.1ml)を加え、-10℃で1時間撹拌した。
反応液を飽和塩化アンモニウム水溶液に注ぎ、酢酸エチルで抽出した。得られた有機層を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣(0.19g)をそのまま次工程に用いた。 N,3-dimethoxy-6-(2-methoxyphenethyl)-N-methylpyridazine-4-carboxamide (0.25 g) was dissolved in anhydrous tetrahydrofuran (2.5 ml), the reaction solution was purged with nitrogen, and then- Cooled to 10°C. A 1.0 M methylmagnesium bromide tetrohydrofuran solution (1.1 ml) was added thereto, and the mixture was stirred at -10°C for 1 hour.
The reaction solution was poured into a saturated aqueous ammonium chloride solution and extracted with ethyl acetate. The resulting organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue (0.19 g) was directly used in the next step.
反応液を飽和塩化アンモニウム水溶液に注ぎ、酢酸エチルで抽出した。得られた有機層を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣(0.19g)をそのまま次工程に用いた。 N,3-dimethoxy-6-(2-methoxyphenethyl)-N-methylpyridazine-4-carboxamide (0.25 g) was dissolved in anhydrous tetrahydrofuran (2.5 ml), the reaction solution was purged with nitrogen, and then- Cooled to 10°C. A 1.0 M methylmagnesium bromide tetrohydrofuran solution (1.1 ml) was added thereto, and the mixture was stirred at -10°C for 1 hour.
The reaction solution was poured into a saturated aqueous ammonium chloride solution and extracted with ethyl acetate. The resulting organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue (0.19 g) was directly used in the next step.
(工程6)
1‐(3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐イル)エタン‐1‐オン O‐イソプロピルオキシム〔1-(3-methoxy-6-(2-methoxyphenethyl)-pyridazine-4-yl)ethan-1-one O-isopropyl oxime〕の合成 (Step 6)
1-(3-methoxy-6-(2-methoxyphenethyl)pyridazin-4-yl)ethan-1-one O-isopropyloxime [1-(3-methoxy-6-(2-methoxyphenethyl)-pyridazine-4- Synthesis of yl)ethan-1-one O-isopropyl oxime]
1‐(3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐イル)エタン‐1‐オン O‐イソプロピルオキシム〔1-(3-methoxy-6-(2-methoxyphenethyl)-pyridazine-4-yl)ethan-1-one O-isopropyl oxime〕の合成 (Step 6)
1-(3-methoxy-6-(2-methoxyphenethyl)pyridazin-4-yl)ethan-1-one O-isopropyloxime [1-(3-methoxy-6-(2-methoxyphenethyl)-pyridazine-4- Synthesis of yl)ethan-1-one O-isopropyl oxime]
1‐(3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐イル)エタン‐1‐オン(0.19g)をエタノール(4.5ml)、クロロホルム(4.5ml)に溶解させた。これにO‐イソプロピルヒドロキシルアミン塩酸塩(0.10g)、ピリジン(0.07ml)を加え、室温で終夜撹拌した。
反応液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物0.25g(収率96%,二工程)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.21-6.94 (m, 3H), 6.89-6.84 (m, 2H), 4.48-4.29 (1H, m), 4.15-4.09 (3H, m), 3.82 (3H, s), 3.19-3.04 (4H, m), 2.15-2.09 (3H, m), 1.31-1.13 (6H, m). 1-(3-Methoxy-6-(2-methoxyphenethyl)pyridazin-4-yl)ethan-1-one (0.19 g) was dissolved in ethanol (4.5 ml) and chloroform (4.5 ml). O-Isopropylhydroxylamine hydrochloride (0.10 g) and pyridine (0.07 ml) were added thereto, and the mixture was stirred overnight at room temperature.
The reaction solution was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 0.25 g of the desired product (yield 96%, two steps).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.21-6.94 (m, 3H), 6.89-6.84 (m, 2H), 4.48-4.29 (1H, m), 4.15-4.09 (3H, m), 3.82 (3H, s), 3.19-3.04 (4H, m), 2.15-2.09 (3H, m), 1.31-1.13 (6H, m).
反応液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物0.25g(収率96%,二工程)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.21-6.94 (m, 3H), 6.89-6.84 (m, 2H), 4.48-4.29 (1H, m), 4.15-4.09 (3H, m), 3.82 (3H, s), 3.19-3.04 (4H, m), 2.15-2.09 (3H, m), 1.31-1.13 (6H, m). 1-(3-Methoxy-6-(2-methoxyphenethyl)pyridazin-4-yl)ethan-1-one (0.19 g) was dissolved in ethanol (4.5 ml) and chloroform (4.5 ml). O-Isopropylhydroxylamine hydrochloride (0.10 g) and pyridine (0.07 ml) were added thereto, and the mixture was stirred overnight at room temperature.
The reaction solution was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 0.25 g of the desired product (yield 96%, two steps).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.21-6.94 (m, 3H), 6.89-6.84 (m, 2H), 4.48-4.29 (1H, m), 4.15-4.09 (3H, m), 3.82 (3H, s), 3.19-3.04 (4H, m), 2.15-2.09 (3H, m), 1.31-1.13 (6H, m).
(工程7)
(E)‐4‐(1‐(イソプロポキシイミノ)エチル)‐6‐(2‐メトキシフェネチル)ピリダジン‐3(2H)‐オン〔(E)-4-(1-(isopropoxyimino)ethyl)-6-(2-methoxyphenethyl)-pyridazin-3(2H)-one〕の合成 (Step 7)
(E)-4-(1-(isopropoxyimino)ethyl)-6-(2-methoxyphenethyl)pyridazin-3(2H)-one [(E)-4-(1-(isopropoxyimino)ethyl)-6 Synthesis of -(2-methoxyphenethyl)-pyridazin-3(2H)-one]
(E)‐4‐(1‐(イソプロポキシイミノ)エチル)‐6‐(2‐メトキシフェネチル)ピリダジン‐3(2H)‐オン〔(E)-4-(1-(isopropoxyimino)ethyl)-6-(2-methoxyphenethyl)-pyridazin-3(2H)-one〕の合成 (Step 7)
(E)-4-(1-(isopropoxyimino)ethyl)-6-(2-methoxyphenethyl)pyridazin-3(2H)-one [(E)-4-(1-(isopropoxyimino)ethyl)-6 Synthesis of -(2-methoxyphenethyl)-pyridazin-3(2H)-one]
1‐(3‐メトキシ‐6‐(2‐メトキシフェネチル)ピリダジン‐4‐イル)エタン‐1‐オン O‐イソプロピルオキシム(0.12g)をジオキサン(7ml)に溶解させた。これに12N塩酸(0.18ml)を加え、60℃で終夜撹拌した。
反応液に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルで抽出した。得られた有機層を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣(0.12g)をそのまま次工程に用いた。 1-(3-Methoxy-6-(2-methoxyphenethyl)pyridazin-4-yl)ethan-1-one O-isopropyloxime (0.12 g) was dissolved in dioxane (7 ml). 12N Hydrochloric acid (0.18 ml) was added thereto, and the mixture was stirred at 60°C overnight.
A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue (0.12 g) was used as such for the next step.
反応液に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルで抽出した。得られた有機層を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣(0.12g)をそのまま次工程に用いた。 1-(3-Methoxy-6-(2-methoxyphenethyl)pyridazin-4-yl)ethan-1-one O-isopropyloxime (0.12 g) was dissolved in dioxane (7 ml). 12N Hydrochloric acid (0.18 ml) was added thereto, and the mixture was stirred at 60°C overnight.
A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue (0.12 g) was used as such for the next step.
(工程8)
(E)‐2‐(5‐(1‐(イソプロポキシイミノ)エチル‐3‐(2‐メトキシフェネチル)‐6‐オキソピリダジン‐1(6H)‐イル)‐N‐イソプロピルプロパンアミド〔(E)-2-(5-(1-(isopropoxyimino)ethyl)-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide〕の合成 (Step 8)
(E)-2-(5-(1-(isopropoxyimino)ethyl-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide [(E) Synthesis of -2-(5-(1-(isopropoxyimino)ethyl)-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide]
(E)‐2‐(5‐(1‐(イソプロポキシイミノ)エチル‐3‐(2‐メトキシフェネチル)‐6‐オキソピリダジン‐1(6H)‐イル)‐N‐イソプロピルプロパンアミド〔(E)-2-(5-(1-(isopropoxyimino)ethyl)-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide〕の合成 (Step 8)
(E)-2-(5-(1-(isopropoxyimino)ethyl-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide [(E) Synthesis of -2-(5-(1-(isopropoxyimino)ethyl)-3-(2-methoxyphenethyl)-6-oxopyridazin-1(6H)-yl)-N-isopropylpropanamide]
(E)‐4‐(1‐(イソプロポキシイミノ)エチル)‐6‐(2‐メトキシフェネチル)ピリダジン‐3(2H)‐オン(0.12g)をN,N‐ジメチルホルムアミド(3ml)に溶解させた。これに2‐ブロモ‐N‐イソプロピルプロパンアミド(0.08g)、炭酸カリウム(0.10g)を加え、室温で終夜撹拌した。
反応液に飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。得られた有機層を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物0.15g(収率97%,二工程)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.21-7.19 (1H, m), 7.16 (1H, s), 7.10 (1H, q), 6.88-6.83 (2H, m), 6.13 (1H, d), 5.53 (1H, q), 4.48-4.38 (1H, m), 4.07-3.98 (1H, m), 3.80 (3H, s), 3.00-2.88 (4H, m), 2.19 (3H, s), 1.56 (3H, d), 1.29 (6H, d), 1.10 (6H, q). (E)-4-(1-(isopropoxyimino)ethyl)-6-(2-methoxyphenethyl)pyridazin-3(2H)-one (0.12 g) dissolved in N,N-dimethylformamide (3 ml) let me 2-Bromo-N-isopropylpropanamide (0.08 g) and potassium carbonate (0.10 g) were added thereto, and the mixture was stirred overnight at room temperature.
A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 0.15 g of the desired product (yield 97%, two steps).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.21-7.19 (1H, m), 7.16 (1H, s), 7.10 (1H, q), 6.88-6.83 (2H, m), 6.13 (1H, d ), 5.53 (1H, q), 4.48-4.38 (1H, m), 4.07-3.98 (1H, m), 3.80 (3H, s), 3.00-2.88 (4H, m), 2.19 (3H, s), 1.56 (3H, d), 1.29 (6H, d), 1.10 (6H, q).
反応液に飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。得られた有機層を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させ、ろ過した。ろ液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物0.15g(収率97%,二工程)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.21-7.19 (1H, m), 7.16 (1H, s), 7.10 (1H, q), 6.88-6.83 (2H, m), 6.13 (1H, d), 5.53 (1H, q), 4.48-4.38 (1H, m), 4.07-3.98 (1H, m), 3.80 (3H, s), 3.00-2.88 (4H, m), 2.19 (3H, s), 1.56 (3H, d), 1.29 (6H, d), 1.10 (6H, q). (E)-4-(1-(isopropoxyimino)ethyl)-6-(2-methoxyphenethyl)pyridazin-3(2H)-one (0.12 g) dissolved in N,N-dimethylformamide (3 ml) let me 2-Bromo-N-isopropylpropanamide (0.08 g) and potassium carbonate (0.10 g) were added thereto, and the mixture was stirred overnight at room temperature.
A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 0.15 g of the desired product (yield 97%, two steps).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.21-7.19 (1H, m), 7.16 (1H, s), 7.10 (1H, q), 6.88-6.83 (2H, m), 6.13 (1H, d ), 5.53 (1H, q), 4.48-4.38 (1H, m), 4.07-3.98 (1H, m), 3.80 (3H, s), 3.00-2.88 (4H, m), 2.19 (3H, s), 1.56 (3H, d), 1.29 (6H, d), 1.10 (6H, q).
〔実施例2〕
(S,E)-N-(1-(5-(1-(イソプロポキシイミノ)エチル)-3-((2-メトキシベンジル)オキシ)-6-オキソピリダジン-1(6H)-イル)-3-メチルブタン-2-イル)イソブチルアミド [(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl)isobutyramide〕の合成
(工程1)
1‐(6‐クロロ‐3‐メトキシピリダジン‐4‐イル)エタン‐1‐オン O‐イソプロピルオキシム〔1-(6-chloro-3-methoxypyridazine-4-yl)ethan-1-one O-isopropyl oxime〕の合成 [Example 2]
(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1(6H)-yl)- 3-Methylbutan-2-yl)isobutyramide [(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1 (6H)-yl)-3-methylbutan-2-yl)isobutyramide] (Step 1)
1-(6-chloro-3-methoxypyridazin-4-yl)ethan-1-one O-isopropyl oxime ] synthesis
(S,E)-N-(1-(5-(1-(イソプロポキシイミノ)エチル)-3-((2-メトキシベンジル)オキシ)-6-オキソピリダジン-1(6H)-イル)-3-メチルブタン-2-イル)イソブチルアミド [(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl)isobutyramide〕の合成
(工程1)
1‐(6‐クロロ‐3‐メトキシピリダジン‐4‐イル)エタン‐1‐オン O‐イソプロピルオキシム〔1-(6-chloro-3-methoxypyridazine-4-yl)ethan-1-one O-isopropyl oxime〕の合成 [Example 2]
(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1(6H)-yl)- 3-Methylbutan-2-yl)isobutyramide [(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1 (6H)-yl)-3-methylbutan-2-yl)isobutyramide] (Step 1)
1-(6-chloro-3-methoxypyridazin-4-yl)ethan-1-one O-isopropyl oxime ] synthesis
1‐(6‐クロロ‐3‐メトキシピリダジン‐4‐イル)エタン‐1‐オン(1.21g)をエタノール(30ml)、クロロホルム(30ml)に溶解させた。これにO‐イソプロピルヒドロキシルアミン塩酸塩(0.87g)を加え、室温で終夜撹拌した。
反応液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物0.88g(収率56%)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.44-7.21 (1H, m), 4.50-4.29 (1H, m), 4.19-4.13 (3H, m), 2.20-2.14 (3H, m), 1.36-1.15 (6H, m). 1-(6-Chloro-3-methoxypyridazin-4-yl)ethan-1-one (1.21 g) was dissolved in ethanol (30 ml) and chloroform (30 ml). To this was added O-isopropylhydroxylamine hydrochloride (0.87 g) and stirred overnight at room temperature.
The reaction solution was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 0.88 g of the desired product (yield 56%).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.44-7.21 (1H, m), 4.50-4.29 (1H, m), 4.19-4.13 (3H, m), 2.20-2.14 (3H, m), 1.36 -1.15 (6H, m).
反応液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物0.88g(収率56%)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.44-7.21 (1H, m), 4.50-4.29 (1H, m), 4.19-4.13 (3H, m), 2.20-2.14 (3H, m), 1.36-1.15 (6H, m). 1-(6-Chloro-3-methoxypyridazin-4-yl)ethan-1-one (1.21 g) was dissolved in ethanol (30 ml) and chloroform (30 ml). To this was added O-isopropylhydroxylamine hydrochloride (0.87 g) and stirred overnight at room temperature.
The reaction solution was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 0.88 g of the desired product (yield 56%).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.44-7.21 (1H, m), 4.50-4.29 (1H, m), 4.19-4.13 (3H, m), 2.20-2.14 (3H, m), 1.36 -1.15 (6H, m).
(工程2)
(E)-1-(6-クロロ-3-ヒドロキシピリダジン-4-イル)エタン-1-オン O-イソプロピルオキシム[(E)-1-(6-chloro-3-hydroxypyridazin-4-yl)ethan-1-one O-isopropyl oxime〕の合成 (Step 2)
(E)-1-(6-chloro-3-hydroxypyridazin-4-yl)ethan-1-one O-isopropyloxime [(E)-1-(6-chloro-3-hydroxypyridazin-4-yl)ethan -1-one O-isopropyl oxime]
(E)-1-(6-クロロ-3-ヒドロキシピリダジン-4-イル)エタン-1-オン O-イソプロピルオキシム[(E)-1-(6-chloro-3-hydroxypyridazin-4-yl)ethan-1-one O-isopropyl oxime〕の合成 (Step 2)
(E)-1-(6-chloro-3-hydroxypyridazin-4-yl)ethan-1-one O-isopropyloxime [(E)-1-(6-chloro-3-hydroxypyridazin-4-yl)ethan -1-one O-isopropyl oxime]
1‐(6‐クロロ‐3‐メトキシピリダジン‐4‐イル)エタン‐1‐オン O‐イソプロピルオキシム(0.45g)をN,N-ジメチルホルムアミド(8ml)に溶解させた。これにパラトルエンスルホン酸一水和物(1.76g)、塩化リチウム(0.39g)を加え、オイルバス中、70℃で2時間攪拌した。
その後、室温まで冷却した後、水と飽和重曹水を加え、酢酸エチルで抽出した。得られた酢酸エチル層を無水硫酸マグネシウムで乾燥させた後、ろ過をした。ろ液を減圧濃縮し、得られた粗生成物をそのまま次工程に使用した。 1-(6-Chloro-3-methoxypyridazin-4-yl)ethan-1-one O-isopropyloxime (0.45 g) was dissolved in N,N-dimethylformamide (8 ml). Paratoluenesulfonic acid monohydrate (1.76 g) and lithium chloride (0.39 g) were added thereto, and the mixture was stirred at 70° C. for 2 hours in an oil bath.
Then, after cooling to room temperature, water and saturated aqueous sodium bicarbonate were added, and the mixture was extracted with ethyl acetate. The obtained ethyl acetate layer was dried with anhydrous magnesium sulfate and then filtered. The filtrate was concentrated under reduced pressure, and the resulting crude product was used as such for the next step.
その後、室温まで冷却した後、水と飽和重曹水を加え、酢酸エチルで抽出した。得られた酢酸エチル層を無水硫酸マグネシウムで乾燥させた後、ろ過をした。ろ液を減圧濃縮し、得られた粗生成物をそのまま次工程に使用した。 1-(6-Chloro-3-methoxypyridazin-4-yl)ethan-1-one O-isopropyloxime (0.45 g) was dissolved in N,N-dimethylformamide (8 ml). Paratoluenesulfonic acid monohydrate (1.76 g) and lithium chloride (0.39 g) were added thereto, and the mixture was stirred at 70° C. for 2 hours in an oil bath.
Then, after cooling to room temperature, water and saturated aqueous sodium bicarbonate were added, and the mixture was extracted with ethyl acetate. The obtained ethyl acetate layer was dried with anhydrous magnesium sulfate and then filtered. The filtrate was concentrated under reduced pressure, and the resulting crude product was used as such for the next step.
(工程3)
Tert-ブチル (S,E)-(1-(3-クロロ-5-(1-イソプロポキシイミノ)エチル)-6-オキソピリダジン-1(6H)-イル)-3-メチルブタン-2-イル)カーバメート〔tert-butyl (S,E)-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl)carbamate〕の合成 (Step 3)
Tert-Butyl (S,E)-(1-(3-chloro-5-(1-isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) Carbamate [tert-butyl (S,E)-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) synthesis of carbamate]
Tert-ブチル (S,E)-(1-(3-クロロ-5-(1-イソプロポキシイミノ)エチル)-6-オキソピリダジン-1(6H)-イル)-3-メチルブタン-2-イル)カーバメート〔tert-butyl (S,E)-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl)carbamate〕の合成 (Step 3)
Tert-Butyl (S,E)-(1-(3-chloro-5-(1-isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) Carbamate [tert-butyl (S,E)-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) synthesis of carbamate]
工程2で得た粗生成物をN,N-ジメチルホルムアミド(8ml)に溶解させた。これに(S)-2-((tert-ブトキシカルボニル)アミノ)-3-メチルブチルメタンスルホネート(1.56g)、炭酸セシウム(3.01g)を加え、オイルバス中、70℃で30分間攪拌した。
その後室温まで冷却した後、水と飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。得られた酢酸エチル層を無水硫酸マグネシウムで乾燥させた後、ろ過をした。ろ液を減圧濃縮し、得られた粗生成物をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって、目的物0.60g(収率78%、二工程)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.29 (1H, s), 4.69 (1H, d), 4.49-4.38 (1H, m), 4.24-3.94 (3H, m), 2.22 (3H, s), 1.97-1.77 (1H, m), 1.34 (9H, s), 1.30 (6H, d), 1.01 (6H, dd). The crude product obtained in step 2 was dissolved in N,N-dimethylformamide (8 ml). (S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutyl methanesulfonate (1.56 g) and cesium carbonate (3.01 g) were added thereto, and the mixture was stirred in an oil bath at 70°C for 30 minutes. did.
After cooling to room temperature, water and saturated ammonium chloride aqueous solution were added, and the mixture was extracted with ethyl acetate. The obtained ethyl acetate layer was dried with anhydrous magnesium sulfate and then filtered. The filtrate was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to give 0.60 g of the desired product (yield 78%, two steps). Obtained.
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.29 (1H, s), 4.69 (1H, d), 4.49-4.38 (1H, m), 4.24-3.94 (3H, m), 2.22 (3H, s ), 1.97-1.77 (1H, m), 1.34 (9H, s), 1.30 (6H, d), 1.01 (6H, dd).
その後室温まで冷却した後、水と飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。得られた酢酸エチル層を無水硫酸マグネシウムで乾燥させた後、ろ過をした。ろ液を減圧濃縮し、得られた粗生成物をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって、目的物0.60g(収率78%、二工程)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.29 (1H, s), 4.69 (1H, d), 4.49-4.38 (1H, m), 4.24-3.94 (3H, m), 2.22 (3H, s), 1.97-1.77 (1H, m), 1.34 (9H, s), 1.30 (6H, d), 1.01 (6H, dd). The crude product obtained in step 2 was dissolved in N,N-dimethylformamide (8 ml). (S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutyl methanesulfonate (1.56 g) and cesium carbonate (3.01 g) were added thereto, and the mixture was stirred in an oil bath at 70°C for 30 minutes. did.
After cooling to room temperature, water and saturated ammonium chloride aqueous solution were added, and the mixture was extracted with ethyl acetate. The obtained ethyl acetate layer was dried with anhydrous magnesium sulfate and then filtered. The filtrate was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to give 0.60 g of the desired product (yield 78%, two steps). Obtained.
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.29 (1H, s), 4.69 (1H, d), 4.49-4.38 (1H, m), 4.24-3.94 (3H, m), 2.22 (3H, s ), 1.97-1.77 (1H, m), 1.34 (9H, s), 1.30 (6H, d), 1.01 (6H, dd).
(工程4)
(S,E)-2-(2-アミノ-3-メチルブチル)-6-クロロ-4-(1-(イソプロポキシイミノ)エチル)ピリダジン-3(2H)-オン 塩酸塩[(S,E)-2-(2-amino-3-methylbutyl)-6-chloro-4-(1-(isopropoxyimino)ethyl)pyridazin-3(2H)-one hydrogen chloride salt〕の合成 (Step 4)
(S,E)-2-(2-amino-3-methylbutyl)-6-chloro-4-(1-(isopropoxyimino)ethyl)pyridazin-3(2H)-one hydrochloride [(S,E) -2-(2-amino-3-methylbutyl)-6-chloro-4-(1-(isopropoxyimino)ethyl)pyridazin-3(2H)-one hydrogen chloride salt]
(S,E)-2-(2-アミノ-3-メチルブチル)-6-クロロ-4-(1-(イソプロポキシイミノ)エチル)ピリダジン-3(2H)-オン 塩酸塩[(S,E)-2-(2-amino-3-methylbutyl)-6-chloro-4-(1-(isopropoxyimino)ethyl)pyridazin-3(2H)-one hydrogen chloride salt〕の合成 (Step 4)
(S,E)-2-(2-amino-3-methylbutyl)-6-chloro-4-(1-(isopropoxyimino)ethyl)pyridazin-3(2H)-one hydrochloride [(S,E) -2-(2-amino-3-methylbutyl)-6-chloro-4-(1-(isopropoxyimino)ethyl)pyridazin-3(2H)-one hydrogen chloride salt]
Tert-ブチル (S,E)-(1-(3-クロロ-5-(1-イソプロポキシイミノ)エチル)-6-オキソピリダジン-1(6H)-イル)-3-メチルブタン-2-イル)カーバメート(0.26g)を1,4-ジオキサン(2ml)に溶解させた。ここに、4M塩酸―ジオキサン溶液(6ml)をゆっくりと加え、室温下で一晩静置した。その後、反応液を減圧濃縮し、得られた粗生成物をそのまま次工程に使用した。
Tert-Butyl (S,E)-(1-(3-chloro-5-(1-isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) Carbamate (0.26 g) was dissolved in 1,4-dioxane (2 ml). A 4M hydrochloric acid-dioxane solution (6 ml) was slowly added thereto, and the mixture was allowed to stand overnight at room temperature. After that, the reaction solution was concentrated under reduced pressure, and the obtained crude product was directly used in the next step.
(工程5)
(S,E)-N-(1-(3-クロロ-5-(1-(イソプロポキシイミノ)エチル)-6-オキソピリダジン-1(6H)-イル)-3-メチルブタン-2-イル)イソブチルアミド[(S,E)-N-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl)isobutyramide〕の合成 (Step 5)
(S,E)-N-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) Isobutyramide [(S,E)-N-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) synthesis of isobutyramide]
(S,E)-N-(1-(3-クロロ-5-(1-(イソプロポキシイミノ)エチル)-6-オキソピリダジン-1(6H)-イル)-3-メチルブタン-2-イル)イソブチルアミド[(S,E)-N-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl)isobutyramide〕の合成 (Step 5)
(S,E)-N-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) Isobutyramide [(S,E)-N-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) synthesis of isobutyramide]
工程4で得られた粗生成物をジクロロメタン(3ml)に溶解させた。氷冷下、トリエチルアミン(0.25g)、イソブチリルクロリド(0.10g)を順次加え、室温下で30分間攪拌した。
氷冷下、反応液に飽和重曹水を加えた後、ジクロロメタンで抽出した。得られたジクロロメタン層を無水硫酸マグネシウムで乾燥後、ろ過をした。得られたろ液を減圧濃縮し、シリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物0.18g(収率75%、二工程)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.30 (1H, s), 5.78 (1H, d), 4.49-4.38 (1H, m), 4.36-4.27 (2H, m), 4.15-4.01 (1H, m), 2.33-2.22 (1H, m), 2.20 (3H, s), 1.98-1.84 (1H, m), 1.32-1.24 (6H, m), 1.09 (3H, d), 1.04 (3H, d), 1.01 (6H, dd). The crude product obtained in step 4 was dissolved in dichloromethane (3 ml). Under ice-cooling, triethylamine (0.25 g) and isobutyryl chloride (0.10 g) were sequentially added, and the mixture was stirred at room temperature for 30 minutes.
Under ice-cooling, saturated aqueous sodium bicarbonate was added to the reaction solution, followed by extraction with dichloromethane. The resulting dichloromethane layer was dried over anhydrous magnesium sulfate and then filtered. The resulting filtrate was concentrated under reduced pressure and purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 0.18 g of the desired product (yield 75%, two steps).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.30 (1H, s), 5.78 (1H, d), 4.49-4.38 (1H, m), 4.36-4.27 (2H, m), 4.15-4.01 (1H , m), 2.33-2.22 (1H, m), 2.20 (3H, s), 1.98-1.84 (1H, m), 1.32-1.24 (6H, m), 1.09 (3H, d), 1.04 (3H, d ), 1.01 (6H, dd).
氷冷下、反応液に飽和重曹水を加えた後、ジクロロメタンで抽出した。得られたジクロロメタン層を無水硫酸マグネシウムで乾燥後、ろ過をした。得られたろ液を減圧濃縮し、シリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物0.18g(収率75%、二工程)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.30 (1H, s), 5.78 (1H, d), 4.49-4.38 (1H, m), 4.36-4.27 (2H, m), 4.15-4.01 (1H, m), 2.33-2.22 (1H, m), 2.20 (3H, s), 1.98-1.84 (1H, m), 1.32-1.24 (6H, m), 1.09 (3H, d), 1.04 (3H, d), 1.01 (6H, dd). The crude product obtained in step 4 was dissolved in dichloromethane (3 ml). Under ice-cooling, triethylamine (0.25 g) and isobutyryl chloride (0.10 g) were sequentially added, and the mixture was stirred at room temperature for 30 minutes.
Under ice-cooling, saturated aqueous sodium bicarbonate was added to the reaction solution, followed by extraction with dichloromethane. The resulting dichloromethane layer was dried over anhydrous magnesium sulfate and then filtered. The resulting filtrate was concentrated under reduced pressure and purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 0.18 g of the desired product (yield 75%, two steps).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.30 (1H, s), 5.78 (1H, d), 4.49-4.38 (1H, m), 4.36-4.27 (2H, m), 4.15-4.01 (1H , m), 2.33-2.22 (1H, m), 2.20 (3H, s), 1.98-1.84 (1H, m), 1.32-1.24 (6H, m), 1.09 (3H, d), 1.04 (3H, d ), 1.01 (6H, dd).
(工程6)
(S,E)-N-(1-(5-(1-(イソプロポキシイミノ)エチル)-3-((2-メトキシベンジル)オキシ)-6-オキソピリダジン-1(6H)-イル)-3-メチルブタン-2-イル)イソブチルアミド [(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl)isobutyramide〕の合成 (Step 6)
(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1(6H)-yl)- 3-Methylbutan-2-yl)isobutyramide [(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1 (6H)-yl)-3-methylbutan-2-yl)isobutyramide]
(S,E)-N-(1-(5-(1-(イソプロポキシイミノ)エチル)-3-((2-メトキシベンジル)オキシ)-6-オキソピリダジン-1(6H)-イル)-3-メチルブタン-2-イル)イソブチルアミド [(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl)isobutyramide〕の合成 (Step 6)
(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1(6H)-yl)- 3-Methylbutan-2-yl)isobutyramide [(S,E)-N-(1-(5-(1-(isopropoxyimino)ethyl)-3-((2-methoxybenzyl)oxy)-6-oxopyridazin-1 (6H)-yl)-3-methylbutan-2-yl)isobutyramide]
(S,E)-N-(1-(3-クロロ-5-(1-(イソプロポキシイミノ)エチル)-6-オキソピリダジン-1(6H)-イル)-3-メチルブタン-2-イル)イソブチルアミド(0.050g)を1,4-ジオキサン(2ml)に溶解させた。ここに、2-メトキシベンジルアルコール(0.040g)、t-ブトキシナトリウム(0.015g)、 [(2-ジ-tert-ブチルホスフィノ-3,6-ジメトキシ-2′,4′,6′-トリイソプロピル-1,1′-ビフェニル)-2-(2′-アミノ-1,1′-ビフェニル)]パラジウム(II)メタンスルホン酸(0.003g)を加えた後、反応容器内を窒素雰囲気下に置換した。その後オイルバス中、100℃で1時間攪拌した。
反応溶液に水と飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。得られた酢酸エチル層を無水硫酸マグネシウムで乾燥させた後、ろ過をした。得られたろ液を減圧濃縮し、シリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物0.016g(収率25%)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.42 (1H, dd), 7.36 (1H, dt), 7.08 (1H, s), 7.00 (1H, dt), 6.93 (1H, d), 6.21 (1H, d), 5.27 (2H, q), 4.62 (1H, dd), 4.45-4.27 (2H, m), 3.89 (3H, s), 3.79 (1H, dd), 2.33-2.22 (1H, m), 2.19 (3H, s), 1.99-1.88 (1H, m), 1.27 (6H, dd), 1.09 (3H, d), 1.03 (3H, d), 1.01 (6H, d). (S,E)-N-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) Isobutyramide (0.050 g) was dissolved in 1,4-dioxane (2 ml). 2-Methoxybenzyl alcohol (0.040 g), sodium t-butoxy (0.015 g), [(2-di-tert-butylphosphino-3,6-dimethoxy-2',4',6'-Triisopropyl-1,1'-biphenyl)-2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonic acid (0.003 g) was added, and the reaction vessel was flushed with nitrogen. Replaced under atmosphere. After that, the mixture was stirred at 100° C. for 1 hour in an oil bath.
Water and saturated aqueous ammonium chloride solution were added to the reaction solution, and the mixture was extracted with ethyl acetate. The obtained ethyl acetate layer was dried with anhydrous magnesium sulfate and then filtered. The resulting filtrate was concentrated under reduced pressure and purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 0.016 g of the desired product (yield 25%).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.42 (1H, dd), 7.36 (1H, dt), 7.08 (1H, s), 7.00 (1H, dt), 6.93 (1H, d), 6.21 ( 1H, d), 5.27 (2H, q), 4.62 (1H, dd), 4.45-4.27 (2H, m), 3.89 (3H, s), 3.79 (1H, dd), 2.33-2.22 (1H, m) , 2.19 (3H, s), 1.99-1.88 (1H, m), 1.27 (6H, dd), 1.09 (3H, d), 1.03 (3H, d), 1.01 (6H, d).
反応溶液に水と飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。得られた酢酸エチル層を無水硫酸マグネシウムで乾燥させた後、ろ過をした。得られたろ液を減圧濃縮し、シリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製することによって目的物0.016g(収率25%)を得た。
得られた目的物の1H‐NMRを以下に示す。
1H-NMR (400 MHz, CDCl3) δ: 7.42 (1H, dd), 7.36 (1H, dt), 7.08 (1H, s), 7.00 (1H, dt), 6.93 (1H, d), 6.21 (1H, d), 5.27 (2H, q), 4.62 (1H, dd), 4.45-4.27 (2H, m), 3.89 (3H, s), 3.79 (1H, dd), 2.33-2.22 (1H, m), 2.19 (3H, s), 1.99-1.88 (1H, m), 1.27 (6H, dd), 1.09 (3H, d), 1.03 (3H, d), 1.01 (6H, d). (S,E)-N-(1-(3-chloro-5-(1-(isopropoxyimino)ethyl)-6-oxopyridazin-1(6H)-yl)-3-methylbutan-2-yl) Isobutyramide (0.050 g) was dissolved in 1,4-dioxane (2 ml). 2-Methoxybenzyl alcohol (0.040 g), sodium t-butoxy (0.015 g), [(2-di-tert-butylphosphino-3,6-dimethoxy-2',4',6'-Triisopropyl-1,1'-biphenyl)-2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonic acid (0.003 g) was added, and the reaction vessel was flushed with nitrogen. Replaced under atmosphere. After that, the mixture was stirred at 100° C. for 1 hour in an oil bath.
Water and saturated aqueous ammonium chloride solution were added to the reaction solution, and the mixture was extracted with ethyl acetate. The obtained ethyl acetate layer was dried with anhydrous magnesium sulfate and then filtered. The resulting filtrate was concentrated under reduced pressure and purified by silica gel column chromatography (developing solvent: n-hexane/ethyl acetate) to obtain 0.016 g of the desired product (yield 25%).
1 H-NMR of the obtained target product is shown below.
1 H-NMR (400 MHz, CDCl 3 ) δ: 7.42 (1H, dd), 7.36 (1H, dt), 7.08 (1H, s), 7.00 (1H, dt), 6.93 (1H, d), 6.21 ( 1H, d), 5.27 (2H, q), 4.62 (1H, dd), 4.45-4.27 (2H, m), 3.89 (3H, s), 3.79 (1H, dd), 2.33-2.22 (1H, m) , 2.19 (3H, s), 1.99-1.88 (1H, m), 1.27 (6H, dd), 1.09 (3H, d), 1.03 (3H, d), 1.01 (6H, d).
前記の実施例と同様の方法で製造した本発明のピリダジノン化合物の一部を表1に示す。表中には、各化合物の物性として融点(℃)または物性を併せて示す。
Table 1 shows some of the pyridazinone compounds of the present invention produced in the same manner as in the above Examples. The table also shows the melting point (°C) or physical properties of each compound as physical properties.
表中の化合物の一部については、液体クロマトグラフィー質量分析法(LCMS)における保持時間を示す。
For some of the compounds in the table, the retention time in liquid chromatography mass spectrometry (LCMS) is shown.
分析条件は以下に示す。
Waters CORTECS UPLC C18カラム(ウォーターズ社製、2.1×50mm、1.6μm)を、温度40℃および流量0.6mL/分、2μL注入、移動相(A)0.1%ギ酸を含む水、移動相(B)アセトニトリルで使用し、保持時間を分単位(分間)で表した。(I)泳動はACQUITY UPLC H-Class(ウォーターズ社製)にてACQUITY UPLCフォトダイオードアレイ(PDA)eλ検出器(ウォーターズ社製)及びACQUITY QDa 検出器(正及び負イオンエレクトロスプレーモードで、UV PDA検出、ウォーターズ社製)で行い、移動相(B)の濃度を、1.5分の直線勾配で30質量%から95質量%に上げ、(II)0.5分間95質量%で維持し、(III)直ちに30質量%(B)に下げ、(IV)0.50分間30質量%で維持した。 Analysis conditions are shown below.
Waters CORTECS UPLC C18 column (manufactured by Waters, 2.1 x 50 mm, 1.6 µm), temperature 40°C and flow rate 0.6 mL/min, 2 µL injection, mobile phase (A) water containing 0.1% formic acid, Mobile phase (B) was used with acetonitrile and retention times are expressed in minutes (minutes). (I) Electrophoresis was performed on ACQUITY UPLC H-Class (Waters) using an ACQUITY UPLC photodiode array (PDA) eλ detector (Waters) and an ACQUITY QDa detector (in positive and negative ion electrospray mode, UV PDA). Detection, manufactured by Waters), the concentration of the mobile phase (B) is increased from 30% by mass to 95% by mass with a linear gradient of 1.5 minutes, and (II) is maintained at 95% by mass for 0.5 minutes, (III) Immediately lowered to 30% by weight (B) and (IV) maintained at 30% by weight for 0.50 minutes.
Waters CORTECS UPLC C18カラム(ウォーターズ社製、2.1×50mm、1.6μm)を、温度40℃および流量0.6mL/分、2μL注入、移動相(A)0.1%ギ酸を含む水、移動相(B)アセトニトリルで使用し、保持時間を分単位(分間)で表した。(I)泳動はACQUITY UPLC H-Class(ウォーターズ社製)にてACQUITY UPLCフォトダイオードアレイ(PDA)eλ検出器(ウォーターズ社製)及びACQUITY QDa 検出器(正及び負イオンエレクトロスプレーモードで、UV PDA検出、ウォーターズ社製)で行い、移動相(B)の濃度を、1.5分の直線勾配で30質量%から95質量%に上げ、(II)0.5分間95質量%で維持し、(III)直ちに30質量%(B)に下げ、(IV)0.50分間30質量%で維持した。 Analysis conditions are shown below.
Waters CORTECS UPLC C18 column (manufactured by Waters, 2.1 x 50 mm, 1.6 µm), temperature 40°C and flow rate 0.6 mL/min, 2 µL injection, mobile phase (A) water containing 0.1% formic acid, Mobile phase (B) was used with acetonitrile and retention times are expressed in minutes (minutes). (I) Electrophoresis was performed on ACQUITY UPLC H-Class (Waters) using an ACQUITY UPLC photodiode array (PDA) eλ detector (Waters) and an ACQUITY QDa detector (in positive and negative ion electrospray mode, UV PDA). Detection, manufactured by Waters), the concentration of the mobile phase (B) is increased from 30% by mass to 95% by mass with a linear gradient of 1.5 minutes, and (II) is maintained at 95% by mass for 0.5 minutes, (III) Immediately lowered to 30% by weight (B) and (IV) maintained at 30% by weight for 0.50 minutes.
前記の実施例と同様の方法で製造した本発明のピリダジノン化合物の一部を表3に示す。表中には、各化合物の物性として融点(℃)または物性を併せて示す。いくつかの化合物については、異性体混合物であることも示した。
Table 3 shows some of the pyridazinone compounds of the present invention produced in the same manner as in the above examples. The table also shows the melting point (°C) or physical properties of each compound as physical properties. Some compounds were also shown to be isomeric mixtures.
表中の化合物の一部については、液体クロマトグラフィー質量分析法(LCMS)における保持時間を示す。
液体クロマトグラフィー質量分析法(LCMS)の分析条件は以下に示す。
Waters CORTECS UPLC C18カラム(ウォーターズ社製、2.1×50mm、1.6μm)を、温度40℃および流量0.6mL/分、2μL注入、移動相(A)0.1%ギ酸を含む水、移動相(B)アセトニトリルで使用し、保持時間を分単位(分間)で表した。
(I)泳動はACQUITY UPLC H-Class(ウォーターズ社製)にてACQUITY UPLCフォトダイオードアレイ(PDA)eλ検出器(ウォーターズ社製)及びACQUITY QDa 検出器(正及び負イオンエレクトロスプレーモードで、UV PDA検出、ウォーターズ社製)で行い、以下に示すMethod (A)またはMethod (B)の方法を用いた。
Method (A):
移動相(B)の濃度を30質量%で0.15分維持し、その後1.35分の直線勾配で30質量%から95質量%に上げ、(II)0.5分間95質量%で維持し、(III)直ちに30質量%(B)に下げ、(IV)0.50分間30質量%で維持した。
Method (B):
移動相(B)の濃度を30質量%で0.15分維持し、その後0.85分の直線勾配で30質量%から95質量%に上げ、(II)1.0分間95質量%で維持し、(III)直ちに30質量%(B)に下げ、(IV)0.50分間30質量%で維持した。 Retention times in liquid chromatography mass spectrometry (LCMS) are given for some of the compounds in the table.
Analysis conditions for liquid chromatography mass spectrometry (LCMS) are shown below.
Waters CORTECS UPLC C18 column (manufactured by Waters, 2.1 x 50 mm, 1.6 µm), temperature 40°C and flow rate 0.6 mL/min, 2 µL injection, mobile phase (A) water containing 0.1% formic acid, Mobile phase (B) was used with acetonitrile and retention times are expressed in minutes (minutes).
(I) Electrophoresis was performed on ACQUITY UPLC H-Class (Waters) using an ACQUITY UPLC photodiode array (PDA) eλ detector (Waters) and an ACQUITY QDa detector (in positive and negative ion electrospray mode, UV PDA). Detection, manufactured by Waters Co., Ltd.), and Method (A) or Method (B) shown below was used.
Method (A):
The concentration of the mobile phase (B) was maintained at 30 wt% for 0.15 min, then increased linearly from 30 wt% to 95 wt% for 1.35 min, and (II) maintained at 95 wt% for 0.5 min. (III) immediately lowered to 30% by weight (B) and (IV) maintained at 30% by weight for 0.50 minutes.
Method (B):
The concentration of the mobile phase (B) was maintained at 30 wt% for 0.15 min, then increased linearly from 30 wt% to 95 wt% in 0.85 min, and (II) maintained at 95 wt% for 1.0 min. (III) immediately lowered to 30% by weight (B) and (IV) maintained at 30% by weight for 0.50 minutes.
液体クロマトグラフィー質量分析法(LCMS)の分析条件は以下に示す。
Waters CORTECS UPLC C18カラム(ウォーターズ社製、2.1×50mm、1.6μm)を、温度40℃および流量0.6mL/分、2μL注入、移動相(A)0.1%ギ酸を含む水、移動相(B)アセトニトリルで使用し、保持時間を分単位(分間)で表した。
(I)泳動はACQUITY UPLC H-Class(ウォーターズ社製)にてACQUITY UPLCフォトダイオードアレイ(PDA)eλ検出器(ウォーターズ社製)及びACQUITY QDa 検出器(正及び負イオンエレクトロスプレーモードで、UV PDA検出、ウォーターズ社製)で行い、以下に示すMethod (A)またはMethod (B)の方法を用いた。
Method (A):
移動相(B)の濃度を30質量%で0.15分維持し、その後1.35分の直線勾配で30質量%から95質量%に上げ、(II)0.5分間95質量%で維持し、(III)直ちに30質量%(B)に下げ、(IV)0.50分間30質量%で維持した。
Method (B):
移動相(B)の濃度を30質量%で0.15分維持し、その後0.85分の直線勾配で30質量%から95質量%に上げ、(II)1.0分間95質量%で維持し、(III)直ちに30質量%(B)に下げ、(IV)0.50分間30質量%で維持した。 Retention times in liquid chromatography mass spectrometry (LCMS) are given for some of the compounds in the table.
Analysis conditions for liquid chromatography mass spectrometry (LCMS) are shown below.
Waters CORTECS UPLC C18 column (manufactured by Waters, 2.1 x 50 mm, 1.6 µm), temperature 40°C and flow rate 0.6 mL/min, 2 µL injection, mobile phase (A) water containing 0.1% formic acid, Mobile phase (B) was used with acetonitrile and retention times are expressed in minutes (minutes).
(I) Electrophoresis was performed on ACQUITY UPLC H-Class (Waters) using an ACQUITY UPLC photodiode array (PDA) eλ detector (Waters) and an ACQUITY QDa detector (in positive and negative ion electrospray mode, UV PDA). Detection, manufactured by Waters Co., Ltd.), and Method (A) or Method (B) shown below was used.
Method (A):
The concentration of the mobile phase (B) was maintained at 30 wt% for 0.15 min, then increased linearly from 30 wt% to 95 wt% for 1.35 min, and (II) maintained at 95 wt% for 0.5 min. (III) immediately lowered to 30% by weight (B) and (IV) maintained at 30% by weight for 0.50 minutes.
Method (B):
The concentration of the mobile phase (B) was maintained at 30 wt% for 0.15 min, then increased linearly from 30 wt% to 95 wt% in 0.85 min, and (II) maintained at 95 wt% for 1.0 min. (III) immediately lowered to 30% by weight (B) and (IV) maintained at 30% by weight for 0.50 minutes.
前記の実施例と同様の方法で製造した本発明のピリダジノン化合物の一部を表5に示す。表中には、各化合物の物性として融点(℃)または物性を併せて示す。いくつかの化合物については、異性体混合物であることも示した。
Table 5 shows some of the pyridazinone compounds of the present invention produced in the same manner as in the above examples. The table also shows the melting point (°C) or physical properties of each compound as physical properties. Some compounds were also shown to be isomeric mixtures.
表中の化合物の一部については、液体クロマトグラフィー質量分析法(LCMS)における保持時間を表6に示す。
液体クロマトグラフィー質量分析法(LCMS)の分析条件は先に挙げたMethod (A)に、加え以下に示すMethod (C)も用いた。
Method (C):
HPLCシステムとしてWaters Alliance e2695セパレーションモジュール、シングル四重極MS検出器 (LC/MS)としてSQ Detector 2(大気圧化学イオン化モードで、PDA検出、ウォーターズ社製)、HPLC/UHPLC検出器として2998 PDA Photodiode Array Detector(ウォーターズ社製)をそれぞれ用い、カラムとしてXBridgeBEH C18(ウォーターズ社製、2.1×50mm、2.5μm)をセットし、温度40℃に設定した。移動相(A)として0.1%ギ酸を含む水、移動相(B)としてアセトニトリルを用い、移動相(A)と移動相(B)とを下記濃度にて流量0.4mL/分でカラムに通し、試料注入量6μLにて、試料の保持時間(分)を計測した。
なお、移動相(B)のカラム入口濃度は、30質量%で試料注入時から0.3分間維持し、次いで1.7分間かけて30質量%から95質量%に定速度で上げ、95質量%で1.5分間維持し、その後30質量%に一気に下げ、30質量%で2.5分間維持した。 Table 6 shows retention times in liquid chromatography mass spectrometry (LCMS) for some of the compounds in the table.
The analysis conditions for liquid chromatography-mass spectrometry (LCMS) were Method (A) mentioned above and Method (C) shown below.
Method (C):
Waters Alliance e2695 separation module as HPLC system, SQ Detector 2 (in atmospheric pressure chemical ionization mode, PDA detection, Waters) as single quadrupole MS detector (LC/MS), 2998 PDA Photodiode as HPLC/UHPLC detector An Array Detector (manufactured by Waters) was used, XBridge BEH C18 (manufactured by Waters, 2.1 x 50 mm, 2.5 µm) was set as a column, and the temperature was set to 40°C. Water containing 0.1% formic acid was used as the mobile phase (A), and acetonitrile was used as the mobile phase (B). The retention time (minutes) of the sample was measured at a sample injection volume of 6 μL.
The column inlet concentration of the mobile phase (B) was maintained at 30% by mass for 0.3 minutes from the time of sample injection, and then increased at a constant rate from 30% by mass to 95% by mass over 1.7 minutes to 95% by mass. % and maintained for 1.5 minutes, then abruptly decreased to 30% by weight and maintained at 30% by weight for 2.5 minutes.
液体クロマトグラフィー質量分析法(LCMS)の分析条件は先に挙げたMethod (A)に、加え以下に示すMethod (C)も用いた。
Method (C):
HPLCシステムとしてWaters Alliance e2695セパレーションモジュール、シングル四重極MS検出器 (LC/MS)としてSQ Detector 2(大気圧化学イオン化モードで、PDA検出、ウォーターズ社製)、HPLC/UHPLC検出器として2998 PDA Photodiode Array Detector(ウォーターズ社製)をそれぞれ用い、カラムとしてXBridgeBEH C18(ウォーターズ社製、2.1×50mm、2.5μm)をセットし、温度40℃に設定した。移動相(A)として0.1%ギ酸を含む水、移動相(B)としてアセトニトリルを用い、移動相(A)と移動相(B)とを下記濃度にて流量0.4mL/分でカラムに通し、試料注入量6μLにて、試料の保持時間(分)を計測した。
なお、移動相(B)のカラム入口濃度は、30質量%で試料注入時から0.3分間維持し、次いで1.7分間かけて30質量%から95質量%に定速度で上げ、95質量%で1.5分間維持し、その後30質量%に一気に下げ、30質量%で2.5分間維持した。 Table 6 shows retention times in liquid chromatography mass spectrometry (LCMS) for some of the compounds in the table.
The analysis conditions for liquid chromatography-mass spectrometry (LCMS) were Method (A) mentioned above and Method (C) shown below.
Method (C):
Waters Alliance e2695 separation module as HPLC system, SQ Detector 2 (in atmospheric pressure chemical ionization mode, PDA detection, Waters) as single quadrupole MS detector (LC/MS), 2998 PDA Photodiode as HPLC/UHPLC detector An Array Detector (manufactured by Waters) was used, XBridge BEH C18 (manufactured by Waters, 2.1 x 50 mm, 2.5 µm) was set as a column, and the temperature was set to 40°C. Water containing 0.1% formic acid was used as the mobile phase (A), and acetonitrile was used as the mobile phase (B). The retention time (minutes) of the sample was measured at a sample injection volume of 6 μL.
The column inlet concentration of the mobile phase (B) was maintained at 30% by mass for 0.3 minutes from the time of sample injection, and then increased at a constant rate from 30% by mass to 95% by mass over 1.7 minutes to 95% by mass. % and maintained for 1.5 minutes, then abruptly decreased to 30% by weight and maintained at 30% by weight for 2.5 minutes.
前記の実施例と同様の方法で製造した本発明のピリダジノン化合物の一部を表7に示す。表中のいくつかの化合物については、その物性を併せて示す。いくつかの化合物については、異性体混合物であることも示した。
Table 7 shows some of the pyridazinone compounds of the present invention produced in the same manner as in the above examples. For some compounds in the table, their physical properties are also shown. Some compounds were also shown to be isomeric mixtures.
表中の化合物の一部については、液体クロマトグラフィー質量分析法(LCMS)における保持時間を表8に示す。
液体クロマトグラフィー質量分析法(LCMS)の分析条件は先に挙げたMethod (A)を用いた。 Table 8 shows retention times in liquid chromatography-mass spectrometry (LCMS) for some of the compounds in the table.
Method (A) mentioned above was used as the analysis conditions for liquid chromatography-mass spectrometry (LCMS).
液体クロマトグラフィー質量分析法(LCMS)の分析条件は先に挙げたMethod (A)を用いた。 Table 8 shows retention times in liquid chromatography-mass spectrometry (LCMS) for some of the compounds in the table.
Method (A) mentioned above was used as the analysis conditions for liquid chromatography-mass spectrometry (LCMS).
また、本発明のピリダジノン化合物を調製する上で、製造中間体となりうる化合物の一部を表9に示す。表中には、各化合物の物性として融点(℃)を併せて示す。
In addition, Table 9 shows some of the compounds that can be production intermediates in preparing the pyridazinone compound of the present invention. The table also shows the melting point (° C.) as a physical property of each compound.
〔生物試験〕
本発明のピリダジノン化合物が、農園芸用殺菌剤の有効成分として有用であることを以下の試験例で示す。
(試験用乳剤の調製)
本発明のピリダジノン化合物5重量部、N,N-ジメチルホルムアミド93.5重量部、およびポリオキシエチレンソルビタンモノラウレート(TWEEN(登録商標)20)1.5重量部を混合し、溶解させて、有効成分5%の乳剤(I)を得た。 [Biological test]
The following test examples demonstrate that the pyridazinone compound of the present invention is useful as an active ingredient in agricultural and horticultural fungicides.
(Preparation of test emulsion)
5 parts by weight of the pyridazinone compound of the present invention, 93.5 parts by weight of N,N-dimethylformamide, and 1.5 parts by weight of polyoxyethylene sorbitan monolaurate (TWEEN (registered trademark) 20) are mixed and dissolved, An emulsion (I) with 5% active ingredient was obtained.
本発明のピリダジノン化合物が、農園芸用殺菌剤の有効成分として有用であることを以下の試験例で示す。
(試験用乳剤の調製)
本発明のピリダジノン化合物5重量部、N,N-ジメチルホルムアミド93.5重量部、およびポリオキシエチレンソルビタンモノラウレート(TWEEN(登録商標)20)1.5重量部を混合し、溶解させて、有効成分5%の乳剤(I)を得た。 [Biological test]
The following test examples demonstrate that the pyridazinone compound of the present invention is useful as an active ingredient in agricultural and horticultural fungicides.
(Preparation of test emulsion)
5 parts by weight of the pyridazinone compound of the present invention, 93.5 parts by weight of N,N-dimethylformamide, and 1.5 parts by weight of polyoxyethylene sorbitan monolaurate (TWEEN (registered trademark) 20) are mixed and dissolved, An emulsion (I) with 5% active ingredient was obtained.
防除価は、下記の式により計算した。
The control value was calculated using the following formula.
[数1]
防除価(%)=100-{処理区における病斑面積率/無処理区における病斑面積率}×100 [Number 1]
Control value (%) = 100-{lesion area ratio in treated area / lesion area ratio in untreated area} × 100
防除価(%)=100-{処理区における病斑面積率/無処理区における病斑面積率}×100 [Number 1]
Control value (%) = 100-{lesion area ratio in treated area / lesion area ratio in untreated area} × 100
(試験例1)リンゴ黒星病防除試験
乳剤(I)にピリダジノン化合物の濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したリンゴ幼苗(品種「王林」、3~4葉期)に、前記薬剤溶液を散布した。風乾後、リンゴ黒星病菌(Venturia inaequalis)の分生胞子を接種した(処理区)。対照として、薬剤溶液を散布しなかったリンゴ幼苗に同様に接種した(無処理区)。それらを、明暗を12時間毎に繰り返す20℃の湿室に静置した。
接種から2週間経過した日にリンゴ幼苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
B-1、B-2、B-3、B-4、B-5、B-6、B-7、B-8、B-10、B-11、B-12、B-13、B-14、B-15、B-16、B-17、B-18、B-19、B-20、B-21、B-22、B-23、B-24、B-25、B-26、B-27、B-28、B-29、B-30、B-31、B-33、B-34、B-36、B-37、B-38、B-39、B-40、B-41、B-42、B-43、B-44、B-45、B-46、B-47、B-48、B-49、C-16、C-17、C-18、およびC-19の化合物の化合物について、リンゴ黒星病防除試験を行った。いずれの化合物も75%以上の防除価を示した。 (Test Example 1) Apple scab control test Water was added to the emulsion (I) so that the concentration of the pyridazinone compound was 125 ppm, and dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on apple seedlings (variety “Orin”, 3-4 leaf stage) cultivated in pots for raising seedlings. After air-drying, conidia of Venturia inaequalis were inoculated (treated area). As a control, apple seedlings not sprayed with the drug solution were similarly inoculated (untreated group). They were placed in a moist chamber at 20°C with alternating light and dark cycles every 12 hours.
Two weeks after the inoculation, the leaves of the young apple seedlings were visually observed to determine the lesion area ratio, and the control value was calculated.
B-1, B-2, B-3, B-4, B-5, B-6, B-7, B-8, B-10, B-11, B-12, B-13, B- 14, B-15, B-16, B-17, B-18, B-19, B-20, B-21, B-22, B-23, B-24, B-25, B-26, B-27, B-28, B-29, B-30, B-31, B-33, B-34, B-36, B-37, B-38, B-39, B-40, B- 41, B-42, B-43, B-44, B-45, B-46, B-47, B-48, B-49, C-16, C-17, C-18, and C-19 The apple scab control test was conducted for the compound of the compound of . All compounds showed a control value of 75% or more.
乳剤(I)にピリダジノン化合物の濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したリンゴ幼苗(品種「王林」、3~4葉期)に、前記薬剤溶液を散布した。風乾後、リンゴ黒星病菌(Venturia inaequalis)の分生胞子を接種した(処理区)。対照として、薬剤溶液を散布しなかったリンゴ幼苗に同様に接種した(無処理区)。それらを、明暗を12時間毎に繰り返す20℃の湿室に静置した。
接種から2週間経過した日にリンゴ幼苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
B-1、B-2、B-3、B-4、B-5、B-6、B-7、B-8、B-10、B-11、B-12、B-13、B-14、B-15、B-16、B-17、B-18、B-19、B-20、B-21、B-22、B-23、B-24、B-25、B-26、B-27、B-28、B-29、B-30、B-31、B-33、B-34、B-36、B-37、B-38、B-39、B-40、B-41、B-42、B-43、B-44、B-45、B-46、B-47、B-48、B-49、C-16、C-17、C-18、およびC-19の化合物の化合物について、リンゴ黒星病防除試験を行った。いずれの化合物も75%以上の防除価を示した。 (Test Example 1) Apple scab control test Water was added to the emulsion (I) so that the concentration of the pyridazinone compound was 125 ppm, and dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on apple seedlings (variety “Orin”, 3-4 leaf stage) cultivated in pots for raising seedlings. After air-drying, conidia of Venturia inaequalis were inoculated (treated area). As a control, apple seedlings not sprayed with the drug solution were similarly inoculated (untreated group). They were placed in a moist chamber at 20°C with alternating light and dark cycles every 12 hours.
Two weeks after the inoculation, the leaves of the young apple seedlings were visually observed to determine the lesion area ratio, and the control value was calculated.
B-1, B-2, B-3, B-4, B-5, B-6, B-7, B-8, B-10, B-11, B-12, B-13, B- 14, B-15, B-16, B-17, B-18, B-19, B-20, B-21, B-22, B-23, B-24, B-25, B-26, B-27, B-28, B-29, B-30, B-31, B-33, B-34, B-36, B-37, B-38, B-39, B-40, B- 41, B-42, B-43, B-44, B-45, B-46, B-47, B-48, B-49, C-16, C-17, C-18, and C-19 The apple scab control test was conducted for the compound of the compound of . All compounds showed a control value of 75% or more.
(試験例2)キュウリ灰色かび病防除試験
乳剤(I)にピリダジノン化合物の濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したキュウリ幼苗(品種「地這」系、子葉期)に、前記薬剤溶液を散布した。風乾後、キュウリ灰色かび病菌(Botrytis cinerea)の分生胞子懸濁液を滴下接種した(処理区)。対照として、薬剤溶液を散布しなかったキュウリ幼苗に上記と同じ方法で滴下接種した(無処理区)。それらを20℃の湿室に静置した。
接種から4日間経過した日にキュウリ幼苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
B-2、B-4、B-5、B-10、B-11、B-17、B-33、B-36、B-37、B-39、B-40、B-47、C-16、およびC-17の化合物について、キュウリ灰色かび病防除試験を行った。75%以上の防除価を示した。 (Test Example 2) Cucumber gray mold control test Water was added to the emulsion (I) so that the concentration of the pyridazinone compound was 125 ppm, and dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on cucumber seedlings (cultivar “Jibori” type, cotyledon stage) cultivated in pots for raising seedlings. After air-drying, a suspension of conidia of cucumber Botrytis cinerea was dropped and inoculated (treated area). As a control, cucumber seedlings not sprayed with the drug solution were inoculated dropwise in the same manner as above (untreated group). They were placed in a moist chamber at 20°C.
After 4 days from the inoculation, the leaves of the cucumber seedlings were visually observed, the lesion area ratio was determined, and the preventive value was calculated.
B-2, B-4, B-5, B-10, B-11, B-17, B-33, B-36, B-37, B-39, B-40, B-47, C- Compounds 16 and C-17 were tested for control of cucumber gray mold. A control value of 75% or more was shown.
乳剤(I)にピリダジノン化合物の濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したキュウリ幼苗(品種「地這」系、子葉期)に、前記薬剤溶液を散布した。風乾後、キュウリ灰色かび病菌(Botrytis cinerea)の分生胞子懸濁液を滴下接種した(処理区)。対照として、薬剤溶液を散布しなかったキュウリ幼苗に上記と同じ方法で滴下接種した(無処理区)。それらを20℃の湿室に静置した。
接種から4日間経過した日にキュウリ幼苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
B-2、B-4、B-5、B-10、B-11、B-17、B-33、B-36、B-37、B-39、B-40、B-47、C-16、およびC-17の化合物について、キュウリ灰色かび病防除試験を行った。75%以上の防除価を示した。 (Test Example 2) Cucumber gray mold control test Water was added to the emulsion (I) so that the concentration of the pyridazinone compound was 125 ppm, and dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on cucumber seedlings (cultivar “Jibori” type, cotyledon stage) cultivated in pots for raising seedlings. After air-drying, a suspension of conidia of cucumber Botrytis cinerea was dropped and inoculated (treated area). As a control, cucumber seedlings not sprayed with the drug solution were inoculated dropwise in the same manner as above (untreated group). They were placed in a moist chamber at 20°C.
After 4 days from the inoculation, the leaves of the cucumber seedlings were visually observed, the lesion area ratio was determined, and the preventive value was calculated.
B-2, B-4, B-5, B-10, B-11, B-17, B-33, B-36, B-37, B-39, B-40, B-47, C- Compounds 16 and C-17 were tested for control of cucumber gray mold. A control value of 75% or more was shown.
(試験例3)コムギうどんこ病防除試験
乳剤(I)にピリダジノン化合物の濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したコムギ幼苗(品種「チホク」、1~2葉期)に前記薬剤溶液を散布した。風乾後、コムギうどんこ病菌(Erysiphe graminis f.sp.tritici)の分生胞子を振りかけて接種した(処理区)。対照として、薬剤溶液を散布しなかったコムギ幼苗に上記と同じ方法で接種した(無処理区)。それらを20℃の温室に静置した。
接種から6日間経過した日にコムギ幼苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
B-5、B-6、B-8、B-9、B-10、B-11、B-12、B-13、B-14、B-15、B-16、B-17、B-18、B-19、B-20、B-21、B-22、B-23、B-24、B-25、B-26、B-27、B-28、B-33、B-34、B-36、B-37、B-38、B-39、B-40、B-41、B-42、B-43、B-44、B-45、B-46、B-47、B-48、C-17、およびD-3の化合物について、コムギうどんこ病防除試験を行った。いずれの化合物も75%以上の防除価を示した。 (Test Example 3) Wheat powdery mildew control test Water was added to the emulsion (I) so that the concentration of the pyridazinone compound was 125 ppm, and dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on wheat seedlings (variety “Chihoku”, 1-2 leaf stage) cultivated in nursery pots. After air-drying, conidia of wheat powdery mildew (Erysiphe graminis f.sp.tritici) were sprinkled and inoculated (treated group). As a control, wheat seedlings not sprayed with the drug solution were inoculated in the same manner as above (untreated group). They were placed in a greenhouse at 20°C.
After 6 days from the inoculation, the leaves of the seedlings of wheat were visually observed to determine the lesion area ratio, and the control value was calculated.
B-5, B-6, B-8, B-9, B-10, B-11, B-12, B-13, B-14, B-15, B-16, B-17, B- 18, B-19, B-20, B-21, B-22, B-23, B-24, B-25, B-26, B-27, B-28, B-33, B-34, B-36, B-37, B-38, B-39, B-40, B-41, B-42, B-43, B-44, B-45, B-46, B-47, B- Compounds 48, C-17 and D-3 were tested against wheat powdery mildew. All compounds showed a control value of 75% or more.
乳剤(I)にピリダジノン化合物の濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したコムギ幼苗(品種「チホク」、1~2葉期)に前記薬剤溶液を散布した。風乾後、コムギうどんこ病菌(Erysiphe graminis f.sp.tritici)の分生胞子を振りかけて接種した(処理区)。対照として、薬剤溶液を散布しなかったコムギ幼苗に上記と同じ方法で接種した(無処理区)。それらを20℃の温室に静置した。
接種から6日間経過した日にコムギ幼苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
B-5、B-6、B-8、B-9、B-10、B-11、B-12、B-13、B-14、B-15、B-16、B-17、B-18、B-19、B-20、B-21、B-22、B-23、B-24、B-25、B-26、B-27、B-28、B-33、B-34、B-36、B-37、B-38、B-39、B-40、B-41、B-42、B-43、B-44、B-45、B-46、B-47、B-48、C-17、およびD-3の化合物について、コムギうどんこ病防除試験を行った。いずれの化合物も75%以上の防除価を示した。 (Test Example 3) Wheat powdery mildew control test Water was added to the emulsion (I) so that the concentration of the pyridazinone compound was 125 ppm, and dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on wheat seedlings (variety “Chihoku”, 1-2 leaf stage) cultivated in nursery pots. After air-drying, conidia of wheat powdery mildew (Erysiphe graminis f.sp.tritici) were sprinkled and inoculated (treated group). As a control, wheat seedlings not sprayed with the drug solution were inoculated in the same manner as above (untreated group). They were placed in a greenhouse at 20°C.
After 6 days from the inoculation, the leaves of the seedlings of wheat were visually observed to determine the lesion area ratio, and the control value was calculated.
B-5, B-6, B-8, B-9, B-10, B-11, B-12, B-13, B-14, B-15, B-16, B-17, B- 18, B-19, B-20, B-21, B-22, B-23, B-24, B-25, B-26, B-27, B-28, B-33, B-34, B-36, B-37, B-38, B-39, B-40, B-41, B-42, B-43, B-44, B-45, B-46, B-47, B- Compounds 48, C-17 and D-3 were tested against wheat powdery mildew. All compounds showed a control value of 75% or more.
(試験例4)コムギ赤さび病防除試験
乳剤(I)にピリダジノン化合物の濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したコムギ幼苗(品種「農林61号」、1~2葉期)に前記薬剤溶液を散布した。風乾後、薬剤溶液を散布したコムギ幼苗にコムギ赤さび病菌(Puccinia recondita)の夏胞子をふり掛けて接種した(処理区)。対照として、薬剤溶液を散布しなかったコムギ幼苗に上記と同様にして接種した(無処理区)。それらを20℃の温室に静置した。
接種から12日間経過した日にコムギ苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
B-4、B-5、B-36、B-37、B-40、およびB-47の化合物について、コムギ赤さび病防除試験を行った。この化合物は75%以上の防除価を示した。 (Test Example 4) Wheat leaf rust control test Water was added to the emulsion (I) so that the concentration of the pyridazinone compound was 125 ppm, and dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on wheat seedlings (variety “Nourin No. 61”, 1-2 leaf stage) cultivated in nursery pots. After air-drying, uredospores of wheat leaf rust fungus (Puccinia recondita) were sprinkled on the wheat seedlings to which the chemical solution had been sprayed and inoculated (treated area). As a control, wheat seedlings not sprayed with the drug solution were inoculated in the same manner as above (untreated group). They were placed in a greenhouse at 20°C.
On the day 12 days after inoculation, the leaves of the wheat seedlings were visually observed to determine the lesion area ratio, and the control value was calculated.
Compounds B-4, B-5, B-36, B-37, B-40 and B-47 were tested for wheat leaf rust control. This compound showed a control value of 75% or more.
乳剤(I)にピリダジノン化合物の濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したコムギ幼苗(品種「農林61号」、1~2葉期)に前記薬剤溶液を散布した。風乾後、薬剤溶液を散布したコムギ幼苗にコムギ赤さび病菌(Puccinia recondita)の夏胞子をふり掛けて接種した(処理区)。対照として、薬剤溶液を散布しなかったコムギ幼苗に上記と同様にして接種した(無処理区)。それらを20℃の温室に静置した。
接種から12日間経過した日にコムギ苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
B-4、B-5、B-36、B-37、B-40、およびB-47の化合物について、コムギ赤さび病防除試験を行った。この化合物は75%以上の防除価を示した。 (Test Example 4) Wheat leaf rust control test Water was added to the emulsion (I) so that the concentration of the pyridazinone compound was 125 ppm, and dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on wheat seedlings (variety “Nourin No. 61”, 1-2 leaf stage) cultivated in nursery pots. After air-drying, uredospores of wheat leaf rust fungus (Puccinia recondita) were sprinkled on the wheat seedlings to which the chemical solution had been sprayed and inoculated (treated area). As a control, wheat seedlings not sprayed with the drug solution were inoculated in the same manner as above (untreated group). They were placed in a greenhouse at 20°C.
On the day 12 days after inoculation, the leaves of the wheat seedlings were visually observed to determine the lesion area ratio, and the control value was calculated.
Compounds B-4, B-5, B-36, B-37, B-40 and B-47 were tested for wheat leaf rust control. This compound showed a control value of 75% or more.
〔抗菌試験〕
(試験例)Fusarium graminearumに対する抗菌試験
グルコースを添加したMinimal SD Base培地にFusarium graminearumの胞子を添加して分散させ、さらにジメチルスルホキシドに溶解したピリダジノン化合物を25ppmとなるように添加混合し、これらを96穴マイクロプレート上に分注し、暗所、25℃で3日間培養した。培養後、マイクロプレートリーダーで波長405nmにおける濁度を測定し、無処理の場合と比較してFusarium graminearumの生育阻害率(%)を求めた。
その結果、下記の化合物が50%以上の優れた生育阻害率を示した。
化合物番号:B-1、B-2、B-3、B-4、B-5、B-6、B-7、B-8、B-9、B-10、B-11、B-12、B-13、B-14、B-15、B-16、B-17、B-18、B-19、B-20、B-21、B-22、B-24、B-25、B-26、B-27、B-28、B-29、B-30、B-33、B-34、B-36、B-37、B-38、B-39、B-40、B-41、B-43、B-44、B-45、B-46、B-47、B-50、B-53、C-16、C-17、C-18、C-19。 [Antibacterial test]
(Test example) Antibacterial test against Fusarium graminearum Spores of Fusarium graminearum were added to Minimal SD Base medium containing glucose and dispersed, and then a pyridazinone compound dissolved in dimethyl sulfoxide was added and mixed to a concentration of 25 ppm. The cells were dispensed onto well microplates and incubated in the dark at 25°C for 3 days. After culturing, the turbidity at a wavelength of 405 nm was measured with a microplate reader, and the growth inhibition rate (%) of Fusarium graminearum was determined in comparison with the untreated case.
As a result, the following compounds showed an excellent growth inhibition rate of 50% or more.
Compound number: B-1, B-2, B-3, B-4, B-5, B-6, B-7, B-8, B-9, B-10, B-11, B-12 , B-13, B-14, B-15, B-16, B-17, B-18, B-19, B-20, B-21, B-22, B-24, B-25, B -26, B-27, B-28, B-29, B-30, B-33, B-34, B-36, B-37, B-38, B-39, B-40, B-41 , B-43, B-44, B-45, B-46, B-47, B-50, B-53, C-16, C-17, C-18, C-19.
(試験例)Fusarium graminearumに対する抗菌試験
グルコースを添加したMinimal SD Base培地にFusarium graminearumの胞子を添加して分散させ、さらにジメチルスルホキシドに溶解したピリダジノン化合物を25ppmとなるように添加混合し、これらを96穴マイクロプレート上に分注し、暗所、25℃で3日間培養した。培養後、マイクロプレートリーダーで波長405nmにおける濁度を測定し、無処理の場合と比較してFusarium graminearumの生育阻害率(%)を求めた。
その結果、下記の化合物が50%以上の優れた生育阻害率を示した。
化合物番号:B-1、B-2、B-3、B-4、B-5、B-6、B-7、B-8、B-9、B-10、B-11、B-12、B-13、B-14、B-15、B-16、B-17、B-18、B-19、B-20、B-21、B-22、B-24、B-25、B-26、B-27、B-28、B-29、B-30、B-33、B-34、B-36、B-37、B-38、B-39、B-40、B-41、B-43、B-44、B-45、B-46、B-47、B-50、B-53、C-16、C-17、C-18、C-19。 [Antibacterial test]
(Test example) Antibacterial test against Fusarium graminearum Spores of Fusarium graminearum were added to Minimal SD Base medium containing glucose and dispersed, and then a pyridazinone compound dissolved in dimethyl sulfoxide was added and mixed to a concentration of 25 ppm. The cells were dispensed onto well microplates and incubated in the dark at 25°C for 3 days. After culturing, the turbidity at a wavelength of 405 nm was measured with a microplate reader, and the growth inhibition rate (%) of Fusarium graminearum was determined in comparison with the untreated case.
As a result, the following compounds showed an excellent growth inhibition rate of 50% or more.
Compound number: B-1, B-2, B-3, B-4, B-5, B-6, B-7, B-8, B-9, B-10, B-11, B-12 , B-13, B-14, B-15, B-16, B-17, B-18, B-19, B-20, B-21, B-22, B-24, B-25, B -26, B-27, B-28, B-29, B-30, B-33, B-34, B-36, B-37, B-38, B-39, B-40, B-41 , B-43, B-44, B-45, B-46, B-47, B-50, B-53, C-16, C-17, C-18, C-19.
Claims (8)
- 式(I)で表される化合物またはその塩。
Yは、酸素原子または硫黄原子を示し;
X1およびX2は、それぞれ独立に、水素原子、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の5~6員環のヘテロシクリル基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、R1-CO-で表される基、カルボキシ基、R2-O-CO-で表される基、R3R4N-で表される基、R3R4N-CO-で表される基、R1-CO-O-で表される基、R1-CO-NR5-で表される基、R2-O-CO-O-で表される基、R2-O-CO-NR5-で表される基、R3R4N-CO-O-で表される基、R3R4N-CO-NR5-で表される基、R2SO2-NR5-で表される基、R3R4N-SO2-で表される基、R1O-N=CR6-で表される基、R3R4N-N=CR6-で表される基、またはR1-N=CR6-で表される基を示し;
R1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R2は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R3は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R4は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
ここで、R3とR4は、一緒になって二価の有機基を形成してもよく、
R5は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し;
X3は、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、R1-CO-で表される基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換の4~6員環のヘテロシクリル基、RN1O-で表される基、RN1-CO-O-で表される基、RN1-O-CO-O-で表される基、RN1RN1N-CO-O-で表される基、RN1-CS-O-で表される基、RN1RN1N-CS-O-で表される基、RN1RN2N-で表される基、RN1-CO-NRN2-で表される基、RN1-CO-CO-NRN2-で表される基、RN1-O-CO-NRN2-で表される基、RN1RN1N-CO-NRN2-で表される基、RN1RN1N-CO-CO-NRN2-で表される基、RN1-CS-NRN2-で表される基、RN1RN1N-CS-NRN2-で表される基、RN1SO2-NRN2-で表される基、またはRN1-C(=NRN1)-NRN2-で表される基を示し、
RN1、およびRN2は、それぞれ独立に、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示し、ここで、RN1とRN1、またはRN1とRN2は、一緒になって二価の有機基を形成してもよく;
X4は、Q-A-で表される基、Q-A-B-で表される基、Q-B-A-で表される基、Q-SO2-NRN3-で表される基、Q-C(R7)=N-で表される基、Q-NRN3-SO2-で表される基、Q-N=C(R7)-で表される基、またはQ-B-で表される基を示し、
Aは、それぞれ独立に、置換若しくは無置換のC1~6アルキレン基、置換若しくは無置換のC2~6アルケニレン基、置換若しくは無置換のC2~6アルキニレン基、置換若しくは無置換のC3~6シクロアルキレン基、またはカルボニル基を示し、
Bは、それぞれ独立に、酸素原子、硫黄原子、スルフィニル基、スルホニル基、または-NRN3-で表される基を示し、RN3は、水素原子、置換若しくは無置換のC1~6アルキル基、ホルミル基、または置換若しくは無置換のC1~6アルキルカルボニル基を示し、
R7は、水素原子、または置換若しくは無置換のC1~6アルキル基を示し、
Qは、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~10員環のヘテロシクリル基を示す。〕 A compound represented by formula (I) or a salt thereof.
Y represents an oxygen atom or a sulfur atom;
X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6- 10 arylsulfonyl group, substituted or unsubstituted 5- to 6-membered heterocyclyl group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, nitro group, cyano group, group represented by R 1 -CO- , a carboxy group, a group represented by R 2 —O—CO—, a group represented by R 3 R 4 N—, a group represented by R 3 R 4 N—CO—, R 1 —CO—O— a group represented by R 1 -CO-NR 5 -, a group R 2 -O-CO-O-, a group R 2 -O-CO-NR 5 - , a group represented by R 3 R 4 N—CO—O—, a group represented by R 3 R 4 N—CO—NR 5 —, a group represented by R 2 SO 2 —NR 5 —, R 3 a group represented by R 4 N--SO 2 --, a group represented by R 1 ON=CR 6 --, a group represented by R 3 R 4 N--N=CR 6 --, or R 1 --N represents a group represented by =CR 6 -;
R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
wherein R 3 and R 4 may together form a divalent organic group,
each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group;
X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, a substituted or unsubstituted 4- to 6-membered heterocyclyl group, R N1 O- a group represented by R N1 --CO--O--, a group represented by R N1 --O--CO--O--, a group represented by R N1 R N1 N--CO--O--, and R N1 A group represented by -CS-O-, a group represented by R N1 R N1 N-CS-O-, a group represented by R N1 R N2 N-, a group represented by R N1 -CO-NR N2 - a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, a group represented by R N1 R N1 N-CO-NR N2 - a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS-NR N2 —, and a group represented by R N1 R N1 N—CS-NR N2 — a group represented by R N1 SO 2 —NR N2 —, or a group represented by R N1 —C(=NR N1 )—NR N2 —,
R N1 and R N2 are each independently a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2- 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 4- to 6-membered heterocyclyl group, wherein R N1 and R N1 , or R N1 and R N2 may together form a divalent organic group;
X 4 is a group represented by QA-, a group represented by QAB-, a group represented by QBA-, or represented by Q-SO 2 -NR N3 - a group represented by Q—C(R 7 )=N—, a group represented by Q—NR N3 —SO 2 —, a group represented by Q—N=C(R 7 )—, or Q - represents a group represented by B-,
A is each independently a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or a carbonyl group,
B each independently represents an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group, or a group represented by -NR N3 -, where R N3 is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a formyl group, or a substituted or unsubstituted C1-6 alkylcarbonyl group,
R 7 represents a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group,
Q represents a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted 5- to 10-membered heterocyclyl group. ] - X2が、R1O-N=CR6-で表される基である、請求項1に記載の化合物またはそれらの塩。 The compound or a salt thereof according to claim 1, wherein X 2 is a group represented by R 1 ON=CR 6 -.
- 請求項1または2に記載の化合物、およびそれらの塩からなる群から選ばれる少なくとも1つを有効成分として含有する農園芸用殺菌剤。 An agricultural and horticultural fungicide containing as an active ingredient at least one selected from the group consisting of the compound according to claim 1 or 2 and salts thereof.
- 種子処理用である、請求項3に記載の農園芸用殺菌剤。 The agricultural and horticultural fungicide according to claim 3, which is for seed treatment.
- 請求項1または2に記載の化合物、およびそれらの塩からなる群から選ばれる少なくとも1つを有効成分として含有する殺線虫剤。 A nematicide containing at least one selected from the group consisting of the compound according to claim 1 or 2 and salts thereof as an active ingredient.
- 請求項1または2に記載の化合物、およびそれらの塩からなる群から選ばれる少なくとも1つを有効成分として含有する医療用・動物用抗真菌剤。 A medical/veterinary antifungal agent containing, as an active ingredient, at least one selected from the group consisting of the compounds according to claim 1 or 2 and salts thereof.
- 式(II)で表される化合物またはその塩。
Yは、酸素原子または硫黄原子を示し;
X1およびX2は、それぞれ独立に、水素原子、ハロゲノ基、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC2~6アルケニルオキシ基、置換若しくは無置換のC2~6アルキニルオキシ基、置換若しくは無置換のC1~6アルキルチオ基、置換若しくは無置換のC1~6アルキルスルフィニル基、置換若しくは無置換のC1~6アルキルスルホニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC3~6シクロアルキルオキシ基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換のC6~10アリールオキシ基、置換若しくは無置換のC6~10アリールチオ基、置換若しくは無置換のC6~10アリールスルフィニル基、置換若しくは無置換のC6~10アリールスルホニル基、置換若しくは無置換の5~6員環のヘテロシクリル基、置換若しくは無置換の5~6員環のヘテロシクリルオキシ基、ニトロ基、シアノ基、R1-CO-で表される基、カルボキシ基、R2-O-CO-で表される基、R3R4N-で表される基、R3R4N-CO-で表される基、R1-CO-O-で表される基、R1-CO-NR5-で表される基、R2-O-CO-O-で表される基、R2-O-CO-NR5-で表される基、R3R4N-CO-O-で表される基、R3R4N-CO-NR5-で表される基、R2SO2-NR5-で表される基、R3R4N-SO2-で表される基、R1O-N=CR6-で表される基、R3R4N-N=CR6-で表される基、またはR1-N=CR6-で表される基を示し;
R1は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R2は、それぞれ独立に、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R3は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC2~6アルケニル基、置換若しくは無置換のC2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し、
R4は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
ここで、R3とR4は、一緒になって二価の有機基を形成してもよく、
R5は、それぞれ独立に、水素原子、置換若しくは無置換のC1~6アルキル基、または置換若しくは無置換のC6~10アリール基を示し、
R6は、ハロゲノ基、アミノ基、置換若しくは無置換のモノC1~6アルキルアミノ基、置換若しくは無置換のジC1~6アルキルアミノ基、置換若しくは無置換のC1~6アルキル基、置換もしくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルチオ基、または置換若しくは無置換の5~6員環のヘテロシクリル基を示し;
X3は、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、R1-CO-で表される基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、置換若しくは無置換の4~6員環のヘテロシクリル基、RN1O-で表される基、RN1-CO-O-で表される基、RN1-O-CO-O-で表される基、RN1RN1N-CO-O-で表される基、RN1-CS-O-で表される基、RN1RN1N-CS-O-で表される基、RN1RN2N-で表される基、RN1-CO-NRN2-で表される基、RN1-CO-CO-NRN2-で表される基、RN1-O-CO-NRN2-で表される基、RN1RN1N-CO-NRN2-で表される基、RN1RN1N-CO-CO-NRN2-で表される基、RN1-CS-NRN2-で表される基、RN1RN1N-CS-NRN2-で表される基、RN1SO2-NRN2-で表される基、またはRN1-C(=NRN1)-NRN2-で表される基を示し、
RN1、およびRN2は、それぞれ独立に、水素原子、置換若しくは無置換の直鎖C1~6アルキル基、置換若しくは無置換の直鎖C2~6アルケニル基、置換若しくは無置換の直鎖C2~6アルキニル基、置換若しくは無置換のC3~6シクロアルキル基、置換若しくは無置換のC6~10アリール基、または置換若しくは無置換の4~6員環のヘテロシクリル基を示し、ここで、RN1とRN1、またはRN1とRN2は、一緒になって二価の有機基を形成してもよく;
X5は、HO-A-で表される基、C1~6アルコキシカルボニル基、またはハロゲノ基を示し、
Aは、置換若しくは無置換のC1~6アルキレン基、置換若しくは無置換のC2~6アルケニレン基、置換若しくは無置換のC2~6アルキニレン基、置換若しくは無置換のC3~6シクロアルキレン基、またはカルボニル基を示す。〕 A compound represented by formula (II) or a salt thereof.
Y represents an oxygen atom or a sulfur atom;
X 1 and X 2 are each independently a hydrogen atom, a halogeno group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, hydroxyl group, substituted or unsubstituted C1-6 alkoxy group, substituted or unsubstituted C2-6 alkenyloxy group, substituted or unsubstituted C2-6 alkynyloxy group, substituted or unsubstituted C1-6 alkylthio group, substituted or unsubstituted C1-6 alkylsulfinyl group, substituted or unsubstituted C1-6 alkylsulfonyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C3-6 cycloalkyloxy group, substituted or unsubstituted substituted or unsubstituted C6-10 aryl group, substituted or unsubstituted C6-10 aryloxy group, substituted or unsubstituted C6-10 arylthio group, substituted or unsubstituted C6-10 arylsulfinyl group, substituted or unsubstituted C6- 10 arylsulfonyl group, substituted or unsubstituted 5- to 6-membered heterocyclyl group, substituted or unsubstituted 5- to 6-membered heterocyclyloxy group, nitro group, cyano group, group represented by R 1 -CO- , a carboxy group, a group represented by R 2 —O—CO—, a group represented by R 3 R 4 N—, a group represented by R 3 R 4 N—CO—, R 1 —CO—O— a group represented by R 1 -CO-NR 5 -, a group R 2 -O-CO-O-, a group R 2 -O-CO-NR 5 - , a group represented by R 3 R 4 N—CO—O—, a group represented by R 3 R 4 N—CO—NR 5 —, a group represented by R 2 SO 2 —NR 5 —, R 3 a group represented by R 4 N--SO 2 --, a group represented by R 1 ON=CR 6 --, a group represented by R 3 R 4 N--N=CR 6 --, or R 1 --N represents a group represented by =CR 6 -;
R 1 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 2 is each independently a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3-6 cyclo an alkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group,
R 3 is each independently a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a substituted or unsubstituted C3 ~6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 5- to 6-membered heterocyclyl group,
each R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
wherein R 3 and R 4 may together form a divalent organic group,
each R 5 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or a substituted or unsubstituted C6-10 aryl group;
R 6 is a halogeno group, an amino group, a substituted or unsubstituted mono C1-6 alkylamino group, a substituted or unsubstituted di-C1-6 alkylamino group, a substituted or unsubstituted C1-6 alkyl group, a substituted or unsubstituted a substituted C1-6 alkoxy group, a substituted or unsubstituted C1-6 alkylthio group, or a substituted or unsubstituted 5- to 6-membered heterocyclyl group;
X 3 is a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2-6 alkynyl group, R 1 -CO A group represented by -, a substituted or unsubstituted C3-6 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, a substituted or unsubstituted 4- to 6-membered heterocyclyl group, R N1 O- a group represented by R N1 --CO--O--, a group represented by R N1 --O--CO--O--, a group represented by R N1 R N1 N--CO--O--, and R N1 A group represented by -CS-O-, a group represented by R N1 R N1 N-CS-O-, a group represented by R N1 R N2 N-, a group represented by R N1 -CO-NR N2 - a group represented by R N1 -CO-CO-NR N2 -, a group represented by R N1 -O-CO-NR N2 -, a group represented by R N1 R N1 N-CO-NR N2 - a group represented by R N1 R N1 N—CO—CO—NR N2 —, a group represented by R N1 —CS-NR N2 —, and a group represented by R N1 R N1 N—CS-NR N2 — a group represented by R N1 SO 2 —NR N2 —, or a group represented by R N1 —C(=NR N1 )—NR N2 —,
R N1 and R N2 are each independently a hydrogen atom, a substituted or unsubstituted linear C1-6 alkyl group, a substituted or unsubstituted linear C2-6 alkenyl group, a substituted or unsubstituted linear C2- 6 alkynyl group, substituted or unsubstituted C3-6 cycloalkyl group, substituted or unsubstituted C6-10 aryl group, or substituted or unsubstituted 4- to 6-membered heterocyclyl group, wherein R N1 and R N1 , or R N1 and R N2 may together form a divalent organic group;
X 5 represents a group represented by HO-A-, a C1-6 alkoxycarbonyl group, or a halogeno group,
A is a substituted or unsubstituted C1-6 alkylene group, a substituted or unsubstituted C2-6 alkenylene group, a substituted or unsubstituted C2-6 alkynylene group, a substituted or unsubstituted C3-6 cycloalkylene group, or carbonyl indicates a group. ] - X2が、R1O-N=CR6-で表される基である、請求項7に記載の化合物またはそれらの塩。 8. The compound or a salt thereof according to claim 7, wherein X 2 is a group represented by R 1 ON=CR 6 -.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023531858A JPWO2023276813A1 (en) | 2021-06-28 | 2022-06-22 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021106256 | 2021-06-28 | ||
JP2021-106256 | 2021-06-28 | ||
JP2021-164636 | 2021-10-06 | ||
JP2021164636 | 2021-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023276813A1 true WO2023276813A1 (en) | 2023-01-05 |
Family
ID=84691780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/024872 WO2023276813A1 (en) | 2021-06-28 | 2022-06-22 | Pyridazinone compound, agricultural and horticultural germicide, nematicide, and medical and animal antifungal agent |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2023276813A1 (en) |
WO (1) | WO2023276813A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023190015A1 (en) * | 2022-03-28 | 2023-10-05 | 日本農薬株式会社 | 1-aryl tetrahydropyridazine-3,5-dione derivative or salt thereof, pesticide containing said compound, and method for using same |
WO2023204124A1 (en) * | 2022-04-20 | 2023-10-26 | 日本曹達株式会社 | Pyridazinone compound, agricultural and horticultural germicide, nematicide, and medical and veterinary antifungal agent |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4719035A (en) * | 1971-02-09 | 1972-09-19 | ||
JPS4810234A (en) * | 1971-06-28 | 1973-02-08 | ||
JPH08225540A (en) * | 1994-11-14 | 1996-09-03 | Rohm & Haas Co | Pyridazinones and their use as antibacterials |
JPH08291147A (en) * | 1995-04-21 | 1996-11-05 | Rohm & Haas Co | Dihydropyridazinone and pyridazinone compound |
JP2012526123A (en) * | 2009-05-05 | 2012-10-25 | ダウ アグロサイエンシィズ エルエルシー | Insecticidal composition |
-
2022
- 2022-06-22 WO PCT/JP2022/024872 patent/WO2023276813A1/en active Application Filing
- 2022-06-22 JP JP2023531858A patent/JPWO2023276813A1/ja active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4719035A (en) * | 1971-02-09 | 1972-09-19 | ||
JPS4810234A (en) * | 1971-06-28 | 1973-02-08 | ||
JPH08225540A (en) * | 1994-11-14 | 1996-09-03 | Rohm & Haas Co | Pyridazinones and their use as antibacterials |
JPH08291147A (en) * | 1995-04-21 | 1996-11-05 | Rohm & Haas Co | Dihydropyridazinone and pyridazinone compound |
JP2012526123A (en) * | 2009-05-05 | 2012-10-25 | ダウ アグロサイエンシィズ エルエルシー | Insecticidal composition |
Non-Patent Citations (7)
Title |
---|
DATABASE REGISTRY 14 July 2004 (2004-07-14), ANONYMOUS : "3-Pyridazinecarboxylic acid, 4-amino-1,6-dihydro-5- [(hydroxyamino)iminomethyl]-1-(4-methoxyphenyl)-6-oxo-, ethyl ester (CA INDEX NAME)", XP093019782, retrieved from STN Database accession no. 709638-59-5 * |
DONALD E. BIERER, JEFFREY M. DENER, LARISA G. DUBENKO, R. ERIC GERBER, JOANE LITVAK, STEFAN PETERLI, PATRICIA PETERLI-ROTH, THIEN : "Novel 1,2-dithiins: synthesis, molecular modeling studies, and antifungal activity", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 38, no. 14, 7 July 1995 (1995-07-07), US , pages 2628 - 2648, XP002173882, ISSN: 0022-2623, DOI: 10.1021/jm00014a016 * |
GHOZLAN SAID AHMED SOLIMAN, MOHAMED MONA HASSAN, FAKHR YEHIA, ELNAGDI MOHAMED HILMY: "Synthesis of polyfunctionally substituted pyridazines", LIEBIGS ANNALEN DER CHEMIE, vol. 1990, no. 3, 1 March 1990 (1990-03-01), DE , pages 293 - 296, XP001183662, ISSN: 0170-2041 * |
ITO TOSHIHIKO, AKIRA HOSONO, HAJIME TACHIBANA, KIYOAKI NITANAI: "Synthesis of Benzyloxypyridazine Derivatives and Preventive Activities against Rice Sheath Blight", NIPPON NOGEI KAGAKUKAISHI - JOURNAL OF THE AGRICULTURAL CHEMICAL SOCIETY OF JAPAN, vol. 57, no. 5, 1 January 1983 (1983-01-01), JP , pages 445 - 452, XP093019797, ISSN: 0002-1407, DOI: 10.1271/nogeikagaku1924.57.445 * |
LIU WEI-DONG, LI, ZHI-WEIB , LI, ZHONG-YINGB , WANG, XIAO-GUANGA ,GAO, BI-DA: "Synthesis and Biological Activity of Methyl N-Methoxy-N-[2-(1,6-dihydro-1-substituent-6-oxo-pyridazin-3-yloxymethyl)phenl]carbamates", CHINESE JOURNAL OF ORGANIC CHEMISTRY, vol. 25, no. 4, 1 January 2005 (2005-01-01), pages 445 - 448, XP093019805 * |
MEHTA DINESH KUMAR, SAINI MINAXI: "Design, synthesis, molecular docking studies and biological evaluation of novel pyridazin-3-one derivatives", INTERNATIONAL JOURNAL OF PHARMA AND BIO SCIENCES, vol. 10, no. 1, 1 January 2019 (2019-01-01), pages 127 - 140, XP093019787, DOI: 10.22376/ijpbs.2019.10.1.p127-140 * |
MOHAMED NADIA RAGAB, EL-SAIDI MANAL MOHAMED TALAAT, ALI YASSER MAHMOUD, ELNAGDI MOHAMED HILMY: "Microwaves in organic synthesis: Facile synthesis of biologically active pyridazinone and iminopyridazine derivatives", JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 44, no. 6, 1 November 2007 (2007-11-01), US , pages 1333 - 1337, XP093019774, ISSN: 0022-152X, DOI: 10.1002/jhet.5570440615 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023190015A1 (en) * | 2022-03-28 | 2023-10-05 | 日本農薬株式会社 | 1-aryl tetrahydropyridazine-3,5-dione derivative or salt thereof, pesticide containing said compound, and method for using same |
WO2023204124A1 (en) * | 2022-04-20 | 2023-10-26 | 日本曹達株式会社 | Pyridazinone compound, agricultural and horticultural germicide, nematicide, and medical and veterinary antifungal agent |
Also Published As
Publication number | Publication date |
---|---|
JPWO2023276813A1 (en) | 2023-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7158386B2 (en) | Oxadiazole compounds and agricultural and horticultural fungicides | |
CA3157658A1 (en) | 2,6-dioxo-3,6-dihydropyrimidine compound, agricultural and horticultural bactericide, nematicide, and medical and veterinary antifungal agent | |
WO2023276813A1 (en) | Pyridazinone compound, agricultural and horticultural germicide, nematicide, and medical and animal antifungal agent | |
JP6508540B2 (en) | Pyridine compound and use thereof | |
WO2019065483A1 (en) | 1, 3, 5, 6-tetra substituted thieno[2, 3-d]pyrimidine-2, 4(1h, 3h)dione compound and bactericide for agricultural and horticultural use | |
WO2019031384A1 (en) | 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4-(1h,3h)dione compound and agricultural or horticultural bactericide | |
WO2019107393A1 (en) | 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4(1h,3h)dione compound and agricultural and horticultural fungicide | |
WO2019065516A1 (en) | Quinoline compound, and bactericidal agent for agricultural and horticultural use | |
JPWO2017155052A1 (en) | Pyridine compounds and uses thereof | |
TW201609655A (en) | Pyridine compound and use thereof | |
EP4344545A1 (en) | Agricultural and horticultural fungicidal composition | |
WO2023017699A1 (en) | 3-substituted uracil compound, agricultural and horticultural germicide, nematicide, and medical and animal antifungal agent | |
JP2020147544A (en) | Quinoline compound and fungicide for agricultural and horticultural use | |
WO2023106175A1 (en) | Uracil compound, germicide for agricultural and horticultural use, nematicide, and antifungal agent for medical and animal use | |
WO2023204124A1 (en) | Pyridazinone compound, agricultural and horticultural germicide, nematicide, and medical and veterinary antifungal agent | |
JP2020097575A (en) | 1,3,5,6-TETRA SUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND AND HORTICULTURAL BACTERICIDE | |
WO2022224924A1 (en) | Nitrogen-containing heteroaryl compound, agricultural and horticultural anti-bacterial agent, nematicide, and anti-fungal agent for medical and veterinary uses | |
JP2022167333A (en) | 2,6-dioxo-3,6-dihydropyrimidine compound, and bactericide for agricultural and horticultural use, nematicide, and antifungal agent for medical and animal use | |
JP2019163223A (en) | 1,3,5,6-TETRASUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL BACTERICIDE | |
WO2021112213A1 (en) | 2,4-dioxo-1,4-dihydrothienopyrimidine compound, agricultural or horticultural fungicidal agent, or medical/animal antifungal agent, containing this | |
WO2021054393A1 (en) | 2,3-dihydrothienopyrimidin-4(h)-one compound and agricultural and horticultural fungicide | |
WO2020189525A1 (en) | Heterocyclic compound and agricultural or horticultural bactericide | |
WO2024143336A1 (en) | Hydrazide compound and agricultural/horticultural bactericidal agent | |
JP2023003357A (en) | Oxadiazole compound and bactericide for agricultural and horticultural use | |
JP2022134284A (en) | Oxadiazole compounds, and agricultural and horticultural antimicrobial agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22832961 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2023531858 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22832961 Country of ref document: EP Kind code of ref document: A1 |